FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ledo, JH
   Azevedo, EP
   Clarke, JR
   Ribeiro, FC
   Figueiredo, CP
   Foguel, D
   De Felice, FG
   Ferreira, ST
AF Ledo, J. H.
   Azevedo, E. P.
   Clarke, J. R.
   Ribeiro, F. C.
   Figueiredo, C. P.
   Foguel, D.
   De Felice, F. G.
   Ferreira, S. T.
TI Amyloid-beta oligomers link depressive-like behavior and cognitive
   deficits in mice (vol 18, pg 1053, 2013)
SO MOLECULAR PSYCHIATRY
LA English
DT Correction; Early Access
AB An amendment to this paper has been published and can be accessed via a link at the top of the paper.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
NR 1
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
DI 10.1038/s41380-020-00873-6
EA SEP 2020
PG 2
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA NI6LR
UT WOS:000565463400001
PM 32879389
OA Other Gold
DA 2020-09-29
ER

PT J
AU Mejido, DCP
   Peny, JA
   Vieira, MNN
   Ferreira, ST
   De Felice, FG
AF Mejido, Diana C. P.
   Peny, Julyanna A.
   Vieira, Marcelo N. N.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Insulin and leptin as potential cognitive enhancers in metabolic
   disorders and Alzheimer's disease
SO NEUROPHARMACOLOGY
LA English
DT Review
DE Insulin; Leptin; Cognition; Neuroprotection; Obesity; Diabetes;
   Alzheimer's disease
ID CENTRAL-NERVOUS-SYSTEM; RECEPTOR-DEPENDENT MECHANISM; AMYLOID-BETA
   OLIGOMERS; D-ASPARTATE RECEPTOR; INTRANASAL INSULIN; MEMORY IMPAIRMENT;
   BODY-WEIGHT; GLUCOSE-METABOLISM; DIABETES-MELLITUS; IMPROVES MEMORY
AB Recent clinical and epidemiological observations point to a correlation between disorders of energy metabolism, such as obesity and diabetes, and cognitive decline and dementia. Many studies indicate that these age-related conditions closely interact with each other, but the underlying molecular and physiological mechanisms for such correlations are largely unknown. Insulin and leptin, hormones classically implicated in diabetes and obesity, are gaining increasing attention for their participation in cognitive processes and memory. Disrupted signaling by those hormones is associated with impaired brain function. The current review discusses how restoration of insulin and leptin signaling in the brain may attenuate neuronal damage and promote cognition. We further discuss potential therapeutic approaches involving the use of insulin and leptin as cognitive enhancers in the context of metabolic disorders and Alzheimer's disease.
   This article is part of the special issue entitled 'The Quest for Disease-Modifying Therapies for Neurodegenerative Disorders'.
C1 [Mejido, Diana C. P.; Peny, Julyanna A.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Vieira, Marcelo N. N.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada.
RP Ferreira, ST; De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br; fdf1@queensu.ca
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); National Institute for Translational
   Neuroscience (INNT, Brazil); Alzheimer Society Canada; Weston Brain
   Institute; Canadian Institutes of Health Research (CIHR)Canadian
   Institutes of Health Research (CIHR)
FX Work in the De Felice and Ferreira laboratories is funded by grants from
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ), and National Institute for Translational Neuroscience (INNT,
   Brazil). FDF is further supported by Alzheimer Society Canada, Weston
   Brain Institute and Canadian Institutes of Health Research (CIHR).
CR ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0
   Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755
   Alzheimer's Association, 2016, Alzheimers Dement, V12, P459
   Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185
   Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295
   Balasko M, 2014, J CHEM NEUROANAT, V61-62, P248, DOI 10.1016/j.jchemneu.2014.08.006
   Banks WA, 2006, PHYSIOL BEHAV, V88, P244, DOI 10.1016/j.physbeh.2006.05.037
   Banting FG, 1922, J LAB CLIN MED, V7, P251
   Banting FG, 1922, AM J PHYSIOL, V62, P162
   Batista AF, 2019, CNS DRUGS, V33, P209, DOI 10.1007/s40263-018-0593-6
   Batista AF, 2018, J PATHOL, V245, P85, DOI 10.1002/path.5056
   Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850
   Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003
   Benedict C, 2012, DIABETES CARE, V35, P488, DOI 10.2337/dc11-2075
   BEREITER DA, 1979, BRAIN RES, V165, P249, DOI 10.1016/0006-8993(79)90557-2
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   BONADONNA RC, 1991, DIABETES METAB, V17, P112
   Bonda DJ, 2014, J NEUROCHEM, V128, P162, DOI 10.1111/jnc.12380
   Brooks SJ, 2013, INT J OBESITY, V37, P230, DOI 10.1038/ijo.2012.13
   Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122
   Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0
   Chapman CD, 2013, PHARM RES-DORDR, V30, P2475, DOI 10.1007/s11095-012-0915-1
   Cholerton Brenna, 2016, Diabetes Spectr, V29, P210
   Craft S., 2019, OPEN LABEL EXTENSION
   Craft S, 2017, J ALZHEIMERS DIS, V57, P1325, DOI 10.3233/JAD-161256
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010
   Davis C, 2014, NEUROBIOL DIS, V72, P61, DOI 10.1016/j.nbd.2014.04.012
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2015, DIABETES, V64, P3653, DOI 10.2337/dbi15-0011
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092
   Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782
   Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225
   Enriori PJ, 2006, OBESITY, V14, P254
   Farr OM, 2015, METABOLISM, V64, P114, DOI 10.1016/j.metabol.2014.07.004
   Farr SA, 2006, PEPTIDES, V27, P1420, DOI 10.1016/j.peptides.2005.10.006
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com
   Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93
   Flak JN, 2016, MOL ENDOCRINOL, V30, P3, DOI 10.1210/me.2015-1232
   Fliedner S, 2006, ENDOCRINOLOGY, V147, P2088, DOI 10.1210/en.2005-1016
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27
   Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175
   Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8
   Friedman J, 2014, J ENDOCRINOL, V223, pT1, DOI 10.1530/JOE-14-0405
   Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376
   Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160
   Gejl M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00108
   Gray SM, 2014, DIABETES, V63, P3992, DOI 10.2337/db14-0340
   Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308
   Greco SJ, 2009, NEUROSCI LETT, V455, P191, DOI 10.1016/j.neulet.2009.03.066
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087
   Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742
   Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200
   Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89
   HANSON L, 2002, BMC NEUROSCI S3, V9, DOI DOI 10.1186/1471-2202-9-S2-S5
   Harvey J, 2007, CURR OPIN PHARMACOL, V7, P643, DOI 10.1016/j.coph.2007.10.006
   HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Hojberg PV, 2008, DIABETOLOGIA, V51, P632, DOI 10.1007/s00125-008-0943-x
   Holscher C, 2020, EXPERT OPIN INV DRUG, V29, P333, DOI 10.1080/13543784.2020.1738383
   Holscher C, 2018, NEUROPHARMACOLOGY, V136, P251, DOI 10.1016/j.neuropharm.2018.01.040
   Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717
   Kenna H, 2013, NEUROBIOL AGING, V34, P641, DOI 10.1016/j.neurobiolaging.2012.06.006
   Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694
   Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3
   Klein S, 1996, DIABETES, V45, P984, DOI 10.2337/diabetes.45.7.984
   Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112
   Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376
   Koenner AC, 2009, PHYSIOL BEHAV, V97, P632, DOI 10.1016/j.physbeh.2009.03.027
   Kubota T, 2017, CELL METAB, V25, P797, DOI 10.1016/j.cmet.2017.03.004
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lieb W, 2010, JAMA-J AM MED ASSOC, V302, P2565
   Lochhead JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39191-5
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Martin RL, 2000, METABOLISM, V49, P1479, DOI 10.1053/meta.2000.17695
   Matarese G, 2010, NAT REV NEUROL, V6, P455, DOI 10.1038/nrneurol.2010.89
   McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   McGuire MJ, 2016, CELL MOL NEUROBIOL, V36, P203, DOI 10.1007/s10571-015-0282-7
   McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002
   Melo HM, 2020, CELL REP, V30, P2180, DOI 10.1016/j.celrep.2020.01.072
   Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   MIYAMOTO M, 1992, PHYSIOL BEHAV, V51, P979, DOI 10.1016/0031-9384(92)90081-C
   Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143
   Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P401, DOI 10.1016/j.bbadis.2008.12.004
   Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454
   Murphy JE, 1997, P NATL ACAD SCI USA, V94, P13921, DOI 10.1073/pnas.94.25.13921
   Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707
   MYERS MG, 1995, TRENDS ENDOCRIN MET, V6, P209, DOI 10.1016/1043-2760(95)00092-V
   Oomura Y, 2006, PEPTIDES, V27, P2738, DOI 10.1016/j.peptides.2006.07.001
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ozek C, 2014, J BIOL CHEM, V289, P31682, DOI 10.1074/jbc.M114.603621
   Pan WW, 2018, NAT REV NEUROSCI, V19, P95, DOI 10.1038/nrn.2017.168
   Park CR, 2000, PHYSIOL BEHAV, V68, P509, DOI 10.1016/S0031-9384(99)00220-6
   Paz G, 2015, METABOLISM, V64, P146, DOI 10.1016/j.metabol.2014.07.014
   Paz GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003098
   PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776
   Perez-Gonzalez R, 2014, GENE THER, V21, P298, DOI 10.1038/gt.2013.85
   Pitt J, 2017, MOL BIOL CELL, V28, P2623, DOI 10.1091/mbc.E17-06-0416
   REAVEN GM, 1995, PHYSIOL REV, V75, P473
   Rom S, 2019, MOL NEUROBIOL, V56, P1883, DOI 10.1007/s12035-018-1195-5
   Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767
   Sabia S, 2009, AM J CLIN NUTR, V89, P601, DOI 10.3945/ajcn.2008.26482
   Sanderson TH, 2009, NEUROL RES, V31, P947, DOI 10.1179/174313209X382449
   SARA VR, 1982, NEUROSCI LETT, V34, P39
   Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101
   Schulz C, 2004, ENDOCRINOLOGY, V145, P2696, DOI 10.1210/en.2003-1431
   Schulz C, 2012, ENDOCRINOLOGY, V153, P143, DOI 10.1210/en.2011-1586
   SENA A, 1985, J NEUROL SCI, V68, P233, DOI 10.1016/0022-510X(85)90104-2
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001
   Shapiro ML, 2014, SPACE, TIME AND MEMORY IN THE HIPPOCAMPAL FORMATION, P517, DOI 10.1007/978-3-7091-1292-2_19
   Shimizu H, 2005, INT J OBESITY, V29, P858, DOI 10.1038/sj.ijo.0802951
   Sima AAF, 2004, EUR J PHARMACOL, V490, P187, DOI 10.1016/j.ejphar.2004.02.056
   Song GJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0545-3
   Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004
   Steppan CM, 1999, BIOCHEM BIOPH RES CO, V256, P600, DOI 10.1006/bbrc.1999.0382
   Su F, 2017, NEUROIMAGE-CLIN, V13, P280, DOI 10.1016/j.nicl.2016.12.009
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021
   van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x
   Vecchio I, 2018, FRONTIERS ENDOCRINOL, V9, P1, DOI DOI 10.3389/FEND0.2018.00613
   Vieira MNN, 2018, NEUROPHARMACOLOGY, V136, P160, DOI 10.1016/j.neuropharm.2017.11.014
   Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23
   Watson KT, 2019, BEHAV BRAIN RES, V356, P271, DOI 10.1016/j.bbr.2018.08.006
   Weng Z, 2007, J BIOL CHEM, V282, P34479, DOI 10.1074/jbc.M705426200
   White M. F., 2004, SCIENCE, V80, P1710
   Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef
   Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517
   Witte AV, 2016, HUM BRAIN MAPP, V37, P4539, DOI 10.1002/hbm.23327
   Yang Y, 2013, J ALZHEIMERS DIS, V33, P329, DOI 10.3233/JAD-2012-121294
   Yarchoan M, 2014, DIABETES, V63, P2253, DOI 10.2337/db14-0287
   Yu LY, 2015, CHINESE MED J-PEKING, V128, P976, DOI 10.4103/0366-6999.154323
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893
   Zhu HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26859
   Zwanenburg RJ, 2016, EUR J HUM GENET, V24, P1696, DOI 10.1038/ejhg.2016.109
NR 153
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3908
EI 1873-7064
J9 NEUROPHARMACOLOGY
JI Neuropharmacology
PD JUL
PY 2020
VL 171
AR 108115
DI 10.1016/j.neuropharm.2020.108115
PG 8
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA LS2AZ
UT WOS:000536193600027
PM 32344008
DA 2020-09-29
ER

PT J
AU Pinheiro, DJLL
   Oliveira, LF
   Souza, INO
   Brogin, JAF
   Bueno, DD
   Miranda, IA
   Da Poian, AT
   Ferreira, ST
   Figueiredo, CP
   Clarke, JR
   Cavalheiro, EA
   Faber, J
AF Pinheiro, Daniel J. L. L.
   Oliveira, Leandro F.
   Souza, Isis N. O.
   Brogin, Joao A. Ferres
   Bueno, Douglas D.
   Miranda, Iranaia Assuncao
   Da Poian, Andrea T.
   Ferreira, Sergio T.
   Figueiredo, Claudia P.
   Clarke, Julia R.
   Cavalheiro, Esper A.
   Faber, Jean
TI Modulation in phase and frequency of neural oscillations during
   epileptiform activity induced by neonatal Zika virus infection in mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SYNCHRONIZED GAMMA-OSCILLATIONS; NEURONAL OSCILLATIONS; RHYTHMIC
   ACTIVITY; EPILEPSY; NETWORK; PROPAGATION; MECHANISMS; INFANTS; BIRTH;
   EEG
AB Modulation of brain activity is one of the main mechanisms capable of demonstrating the synchronization dynamics of neural oscillations. In epilepsy, modulation is a key concept since seizures essentially result from neural hypersynchronization and hyperexcitability. In this study, we have introduced a time-dependent index based on the Kullback-Leibler divergence to quantify the effects of phase and frequency modulations of neural oscillations in neonatal mice exhibiting epileptiform activity induced by Zika virus (ZIKV) infection. Through this index, we demonstrate that fast oscillations (gamma and beta 2) are the more susceptible modulated rhythms in terms of phase, during seizures, whereas slow waves (delta and theta) mainly undergo changes in frequency. The index also allowed detection of specific patterns associated with the interdependent modulation of phase and frequency in neural activity. Furthermore, by comparing ZIKV modulations with the general computational model Epileptors, we verify different signatures related to the brain rhythms modulation in phase and frequency. These findings instigate new studies on the effects of ZIKV infection on neuronal networks from electrophysiological activities, and how different mechanisms can trigger epilepsy.
C1 [Pinheiro, Daniel J. L. L.; Oliveira, Leandro F.; Cavalheiro, Esper A.; Faber, Jean] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Neurol & Neurosurg, Sao Paulo, Brazil.
   [Souza, Isis N. O.; Figueiredo, Claudia P.; Clarke, Julia R.] Fed Univ Rio De Janeiro UFRJ, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Brogin, Joao A. Ferres] Sao Paulo State Univ, Dept Mech Engn, BR-15385000 Ilha Solteira, SP, Brazil.
   [Bueno, Douglas D.] Sao Paulo State Univ, Dept Math, BR-15385000 Ilha Solteira, SP, Brazil.
   [Miranda, Iranaia Assuncao] Fed Univ Rio de Janeiro UFRJ, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Da Poian, Andrea T.; Ferreira, Sergio T.] Fed Univ Rio de Janeiro UFRJ, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Fed Univ Rio de Janeiro UFRJ, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Faber, Jean] Fed Univ Sao Paulo UNIFESP, Inst Sci & Technol, Nucleus Neuroengn & Computat, Sao Paulo, Brazil.
RP Pinheiro, DJLL (corresponding author), Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Neurol & Neurosurg, Sao Paulo, Brazil.
EM pdanielleal@gmail.com
RI Ferreira, Sergio/AAZ-1576-2020; de Oliveira Souza, Isis
   Nem/AAA-3423-2019; Bueno, Douglas D./K-7771-2015
OI Ferreira, Sergio/0000-0001-7160-9866; de Oliveira Souza, Isis
   Nem/0000-0002-0335-2541; Bueno, Douglas D./0000-0002-1783-0524;
   Pinheiro, Daniel/0000-0003-0078-993X; Miranda,
   Iranaia/0000-0001-5684-4788
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001, AUXPE: 0561/2018]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [442563/2016-7]; Fundacao de Amparo
   a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Institutos
   Nacionais de Pesquisa - Instituto Nacional de Neurociencia
   Translacional; Institutos Nacionais de Pesquisa - Inovacao em
   Medicamentos e Identificacao de Novos Alvos Terapeuticos
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001, no.
   AUXPE: 0561/2018 (Capes); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (process no 442563/2016-7); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro; Institutos Nacionais de Pesquisa
   - Instituto Nacional de Neurociencia Translacional and Institutos
   Nacionais de Pesquisa - Inovacao em Medicamentos e Identificacao de
   Novos Alvos Terapeuticos.
CR Agumadu VC, 2018, CUREUS, V10, DOI 10.7759/cureus.3025
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Augusto A, 2016, EMERG INFECT DIS, V22
   Avena-Koenigsberger A, 2018, NAT REV NEUROSCI, V19, P17, DOI 10.1038/nrn.2017.149
   Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044
   Bassett DS, 2017, NAT NEUROSCI, V20, P353, DOI 10.1038/nn.4502
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Benedek K, 2016, EPILEPSIA, V57, P796, DOI 10.1111/epi.13355
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745
   Buzsaki G, 2006, RHYTHMS BRAIN
   Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241
   Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Ding N, 2013, J COMPUT NEUROSCI, V12, DOI DOI 10.1038/JID.2014.371
   Dobre OA, 2007, IET COMMUN, V1, P137, DOI 10.1049/iet-com:20050176
   Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015
   Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550
   Frauscher B, 2017, CLIN NEUROPHYSIOL, V128, P1282, DOI 10.1016/j.clinph.2017.04.020
   Frederick DE, 2016, J NEUROSCI, V36, P7750, DOI 10.1523/JNEUROSCI.0569-16.2016
   Fries P, 2016, SCI ADV, V291, P1560
   Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034
   Friston KJ, 2015, CURR OPIN NEUROBIOL, V31, P1, DOI 10.1016/j.conb.2014.05.004
   Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063
   Hur YJ, 2017, J PEDIATR-US, V184, P172, DOI 10.1016/j.jpeds.2017.01.050
   Hya A, 2015, TRENDS NEUROSCI, V38, P725, DOI [10.1016/j.tins.2015.09.001, DOI 10.1016/J.TINS.2015.09.001]
   Jirsa VK, 2014, BRAIN, V137, P2210, DOI 10.1093/brain/awu133
   Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754
   Levesque M, 2009, NEUROBIOL DIS, V35, P209, DOI 10.1016/j.nbd.2009.04.011
   Liu TT, 2014, AM J TRANSL RES, V6, P625
   Luhmann HJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00004
   MacKay D. J. C., 2005, INFORM THEORY INFERE, V100
   Maris E, 2016, TRENDS NEUROSCI, V39, P86, DOI 10.1016/j.tins.2015.12.004
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oliveira Filho J, 2018, AM J TROP MED HYG
   Ozluoglu LN, 2007, AUDIOL NEURO-OTOL, V12, P160, DOI 10.1159/000099018
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Park Chae Jung, 2019, J Epilepsy Res, V9, P1, DOI 10.14581/jer.19001
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pikovsky A., 2001, SYNCHRONIZATION UNIV
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pressler R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00036
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ren L., 2015, AM ACAD NEUROL
   Salimpour Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00125
   Sarnthein J., 2003, Thalamus & Related Systems, V2, P231, DOI 10.1017/S1472928803000219
   Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Sitnikova E, 2016, BRAIN RES BULL, V120, P106, DOI 10.1016/j.brainresbull.2015.11.012
   Sorokin Jordan M, 2016, J Physiol Paris, V110, P372, DOI 10.1016/j.jphysparis.2017.05.004
   Spitzer B, 2017, COGN BEHAV THERAPY, V4
   Thut G, 2012, CURR BIOL, V22, pR658, DOI 10.1016/j.cub.2012.06.061
   Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010
   TREHUB A, 1969, BIOPHYS J, V9, P965, DOI 10.1016/S0006-3495(69)86430-1
   Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774
   Valipour MH, 2012, 2012 SIXTH INTERNATIONAL SYMPOSIUM ON TELECOMMUNICATIONS (IST), P378, DOI 10.1109/ISTEL.2012.6483016
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282X20170066, 10.1590/0004-282x20170066]
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Vodovozov W, 2018, PFLUG ARCH EUR J PHY, V470, P1377, DOI 10.1007/s00424-018-2156-6
   Weaver S. C, 2017, ANTIVIR RES, P69, DOI [10.1016/j.antiviral.2016.03.010.Zika, DOI 10.1016/J.ANTIVIRAL.2016.03.010.ZIKA]
   Wilson S, 2016, EPILEPSIA, V57, P1521, DOI 10.1111/epi.13478
   Yeh C. H., 2018, SCI REP, V8, P1, DOI DOI 10.1038/S41598-017-17765-5
NR 67
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 21
PY 2020
VL 10
IS 1
AR 6763
DI 10.1038/s41598-020-63685-2
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NA4DE
UT WOS:000559764600034
PM 32317689
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU de Oliveira, J
   Engel, DF
   de Paula, GC
   Melo, HM
   Lopes, SC
   Ribeiro, CT
   Delanogare, E
   Moreira, JCF
   Gelain, DP
   Prediger, RD
   Gabilan, NH
   Moreira, ELG
   Ferreira, ST
   de Bem, AF
AF de Oliveira, Jade
   Engel, Daiane F.
   de Paula, Gabriela C.
   Melo, Helen M.
   Lopes, Samantha C.
   Ribeiro, Camila T.
   Delanogare, Eslen
   Moreira, Jose Claudio F.
   Gelain, Daniel P.
   Prediger, Rui D.
   Gabilan, Nelson H.
   Moreira, Eduardo Luiz G.
   Ferreira, Sergio T.
   de Bem, Andreza F.
TI LDL Receptor Deficiency Does not Alter Brain Amyloid-beta Levels but
   Causes an Exacerbation of Apoptosis
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Article
DE Familial hypercholesterolemia; LDLr-/- mice; memory impairment;
   amyloid-beta; apoptosis
ID DENSITY-LIPOPROTEIN RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; BCL-2
   FAMILY; COGNITIVE IMPAIRMENTS; KNOCKOUT; MICE; RABBIT; OVEREXPRESSION;
   DYSFUNCTION; PROTEIN
AB Familial hypercholesterolemia (FH) is a genetic disorder caused by dysfunction of low density lipoprotein receptors (LDLr), resulting in elevated plasma cholesterol levels. FH patients frequently exhibit cognitive impairment, a finding recapitulated in LDLr deficient mice (LDLr-/-), an animal model of FH. In addition, LDLr-/- mice are more vulnerable to the deleterious memory impact of amyloid-beta (A beta), a peptide linked to Alzheimer's disease. Here, we investigated whether the expression of proteins involved in A beta metabolism are altered in the brains of adult or middle-aged LDLr-/- mice. After spatial memory assessment, A beta levels and gene expression of LDLr related-protein 1, proteins involved in A beta synthesis, and apoptosis-related proteins were evaluated in prefrontal cortex and hippocampus. Moreover, the location and cell-specificity of apoptosis signals were evaluated. LDLr-/- mice presented memory impairment, which was more severe in middle-aged animals. Memory deficit in LDLr-/- mice was not associated with altered expression of proteins involved in A beta processing or changes in A beta levels in either hippocampus or prefrontal cortex. We further found that the expression of Bcl-2 was reduced while the expression of Bax was increased in both prefrontal cortex and hippocampus in 3- and 14-month-old LDLr(-/- )mice Finally, LDLr-/- mice presented increased immunoreactivity for activated caspase-3 in the prefrontal cortex and hippocampus. The activation of caspase 3 was predominantly associated with neurons in LDLr-/- mice. Cognitive impairment in LDLr(-/- )imice is thus accompanied by an exacerbation of neuronal apoptosis in brain regions related to memory formation, but not by changes in A beta processing or levels.
C1 [de Oliveira, Jade; Ribeiro, Camila T.; Moreira, Jose Claudio F.; Gelain, Daniel P.] Univ Fed Rio Grande do Sul, Dept Bioquim, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil.
   [de Oliveira, Jade; Engel, Daiane F.; de Paula, Gabriela C.; Gabilan, Nelson H.; de Bem, Andreza F.] Univ Fed Santa Catarina, Dept Bioquim, Florianopolis, SC, Brazil.
   [Melo, Helen M.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil.
   [Lopes, Samantha C.; Prediger, Rui D.] Univ Fed Santa Catarina, Dept Farmacol, Florianopolis, SC, Brazil.
   [Delanogare, Eslen; Moreira, Eduardo Luiz G.] Univ Fed Santa Catarina, Dept Ciencias Fisiol, Florianopolis, SC, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
   [de Bem, Andreza F.] Univ Brasilia, Inst Ciencias Biol, Dept Ciencias Fisiol, Brasilia, DF, Brazil.
RP de Oliveira, J (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil.
EM deoliveirajade10@gmail.com
RI Prediger, Rui/AAV-3419-2020; Ferreira, Sergio/AAZ-1576-2020; Engel,
   Daiane F./AAN-9044-2020; de Oliveira, Jade/AAJ-6849-2020; de,
   Andreza/AAA-1523-2019; Moreira, Eduardo/S-6205-2016
OI Prediger, Rui/0000-0002-7547-6463; Ferreira, Sergio/0000-0001-7160-9866;
   Engel, Daiane F./0000-0002-1950-196X; de Oliveira,
   Jade/0000-0003-1454-2866; de, Andreza/0000-0003-1090-5244; Moreira,
   Eduardo/0000-0003-2306-2207
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (Capes)CAPES; Fundacao de Amparo a Pesquisa e Inovacao do Estado de
   Santa Catarina (FAPESC)
FX This research was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Capes) and Fundacao de
   Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC).
CR Akioyamen LE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016461
   Ariza M, 2016, EUR J INTERN MED, V34, pE29, DOI 10.1016/j.ejim.2016.05.009
   Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8
   Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011
   Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109
   D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180
   de Oliveira J, 2011, NEUROSCIENCE, V197, P99, DOI 10.1016/j.neuroscience.2011.09.009
   de Oliveira J, 2014, J ALZHEIMERS DIS, V41, P43, DOI 10.3233/JAD-132228
   Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3
   Engel DF, 2019, MOL METAB, V30, P1, DOI 10.1016/j.molmet.2019.09.002
   Ettcheto M, 2015, EXP GERONTOL, V65, P69, DOI 10.1016/j.exger.2015.03.010
   Moreira ELG, 2012, J ALZHEIMERS DIS, V32, P495, DOI 10.3233/JAD-2012-120541
   Ghribi O, 2006, EXP NEUROL, V200, P460, DOI 10.1016/j.expneurol.2006.03.019
   Herz J, 2003, CELL, V112, P289, DOI 10.1016/S0092-8674(03)00073-4
   Jeynes B, 2008, CURR ALZHEIMER RES, V5, P432, DOI 10.2174/156720508785908937
   Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013
   Lopes JB, 2015, CNS NEUROSCI THER, V21, P964, DOI 10.1111/cns.12479
   Mulder M, 2004, NEUROBIOL DIS, V16, P212, DOI 10.1016/j.nbd.2004.01.015
   Opferman JT, 2018, CELL DEATH DIFFER, V25, P37, DOI 10.1038/cdd.2017.170
   Prasanthi RPJ, 2008, MECH AGEING DEV, V129, P649, DOI 10.1016/j.mad.2008.09.002
   Prediger RDS, 2007, BEHAV BRAIN RES, V177, P205, DOI 10.1016/j.bbr.2006.11.032
   Ramirez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022712
   Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304
   Ribeiro CT, 2019, NEUROCHEM INT, V126, P27, DOI 10.1016/j.neuint.2019.02.021
   Santos RD, 2016, LANCET DIABETES ENDO, V4, P850, DOI 10.1016/S2213-8587(16)30041-9
   Santos RD, 2015, J CLIN LIPIDOL, V9, P201, DOI 10.1016/j.jacl.2014.12.008
   Santos RD, 2014, CURR OPIN LIPIDOL, V25, P183, DOI 10.1097/MOL.0000000000000073
   Sharma S, 2008, NEUROBIOL DIS, V32, P426, DOI 10.1016/j.nbd.2008.08.002
   Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959
   SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044
   Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x
   Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5
   Ullrich C, 2010, MOL CELL NEUROSCI, V45, P408, DOI 10.1016/j.mcn.2010.08.001
   Wang SH, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-175
   Zambon D, 2010, AM J MED, V123, P267, DOI 10.1016/j.amjmed.2009.08.015
   Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067
NR 36
TC 0
Z9 0
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PY 2020
VL 73
IS 2
BP 585
EP 596
DI 10.3233/JAD-190742
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA KJ8PU
UT WOS:000512318900014
PM 31815695
DA 2020-09-29
ER

PT J
AU Selles, MC
   Fortuna, JTS
   Zappa-Villar, MF
   de Faria, YPR
   Souza, AS
   Suemoto, CK
   Leite, REP
   Rodriguez, RD
   Grinberg, LT
   Reggiani, PC
   Ferreira, ST
AF Selles, Maria Clara
   Fortuna, Juliana T. S.
   Zappa-Villar, Maria F.
   de Faria, Yasmin P. R.
   Souza, Amanda S.
   Suemoto, Claudia K.
   Leite, Renata E. P.
   Rodriguez, Roberta D.
   Grinberg, Lea T.
   Reggiani, Paula C.
   Ferreira, Sergio T.
TI Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1
   Protects Hippocampal Neurons from the Toxicity of A beta Oligomers and
   Prevents Memory Loss in an Alzheimer Mouse Model
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Dementia; Human brain; Hippocampus; Insulin-like growth factor I;
   Adenovirus; Memory
ID MILD COGNITIVE IMPAIRMENT; I GENE-THERAPY; INTRANASAL INSULIN;
   DIABETES-MELLITUS; OXIDATIVE STRESS; DISEASE PATIENTS; IGF-1 RECEPTOR;
   SYNAPSE DAMAGE; DEMENTIA; SERUM
AB Alzheimer's disease (AD) is the main cause of dementia in the elderly. Although activation of brain insulin signaling has been shown to be neuroprotective, to preserve memory in AD models, and appears beneficial in patients, the role of insulin-like growth factor 1 (IGF1) remains incompletely understood. We found reduced active/inactive IGF1 ratio and increased IGF1R expression in postmortem hippocampal tissue from AD patients, suggesting impaired brain IGF1 signaling in AD. Active/inactive IGF-1 ratio was also reduced in the brains of mouse models of AD. We next investigated the possible protective role of IGF1 in AD models. We used a recombinant adenoviral vector, RAd-IGF1, to drive the expression of IGF1 in primary hippocampal neuronal cultures prior to exposure to A beta Os, toxins that accumulate in AD brains and have been implicated in early synapse dysfunction and memory impairment. Cultures transduced with RAd-IGF1 showed decreased binding of A beta Os to neurons and were protected against A beta O-induced neuronal oxidative stress and loss of dendritic spines. Significantly, in vivo transduction with RAd-IGF1 blocked memory impairment caused by intracerebroventricular (i.c.v.) infusion of A beta Os in mice. Our results demonstrate altered active IGF1 and IGF1R levels in AD hippocampi, and suggest that boosting brain expression of IGF1 may comprise an approach to prevent neuronal damage and memory loss in AD.
C1 [Selles, Maria Clara; de Faria, Yasmin P. R.; Souza, Amanda S.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Fortuna, Juliana T. S.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Zappa-Villar, Maria F.; Reggiani, Paula C.] Natl Univ La Plata, UNLP, Sch Med Sci, Natl Sci & Tech Res Council CONICET,Inst Biochem, La Plata, Buenos Aires, Argentina.
   [Suemoto, Claudia K.; Leite, Renata E. P.] Univ Sao Paulo, Med Sch, Discipline Geriatr, Sao Paulo, SP, Brazil.
   [Suemoto, Claudia K.; Leite, Renata E. P.; Rodriguez, Roberta D.; Grinberg, Lea T.] Univ Sao Paulo, Med Sch, Dept Pathol, LIM 22, Sao Paulo, SP, Brazil.
   [Rodriguez, Roberta D.] Univ Sao Paulo, Dept Neurol, Med Sch, Sao Paulo, SP, Brazil.
   [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Av Carlos Chagas Filho 373,Room C-31,Cidade Univ, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Av Carlos Chagas Filho 373,Room C-31,Cidade Univ, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM paulareggiani@conicet.gov.ar; ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Selles, Maria
   Clara/0000-0002-0008-6081
FU National Institute for Translational Neuroscience (INNT/Brazil);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); International Brain Research Organization
   (IBRO/PROLAB); Argentine Agency for Science and Technology
   (ANPCyT)ANPCyT [PICT15-1998]; CNPqNational Council for Scientific and
   Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Argentine Research Council
   (CONICET)Consejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET); CAPES/FAPERJCAPESCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [K24AG053435]
FX This work was supported by grants from the National Institute for
   Translational Neuroscience (INNT/Brazil), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ) to STF, and by a travel
   award from International Brain Research Organization (IBRO/PROLAB) to
   MPCR and STF; and by grant #PICT15-1998 from the Argentine Agency for
   Science and Technology (ANPCyT) to PCR. MCS and JTSF are pre-doctoral
   fellows supported by CNPq and Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES), respectively. MFZV is a postdoctoral fellow
   supported by the Argentine Research Council (CONICET). YPRF is an
   undergraduate student and ASS is a postdoctoral fellow supported by CNPq
   and CAPES/FAPERJ, respectively. LTG is supported by NIH K24AG053435.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Ashpole NM, 2015, EXP GERONTOL, V68, P76, DOI 10.1016/j.exger.2014.10.002
   Batista AF, 2018, J PATHOL, V245, P85, DOI 10.1002/path.5056
   BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015
   Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793
   Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791
   Claxton A, 2013, J ALZHEIMERS DIS, V35, P789, DOI 10.3233/JAD-122308
   Cohen E, 2010, AGING CELL, V9, P126, DOI 10.1111/j.1474-9726.2009.00541.x
   Craft S, 2017, J ALZHEIMERS DIS, V57, P1325, DOI 10.3233/JAD-161256
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, EXPERT REV NEUROTHER, V13, P1297, DOI 10.1586/14737175.2013.864824
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de Godoy MA, 2018, J BIOL CHEM, V293, P1957, DOI 10.1074/jbc.M117.807180
   de la Monte SM, 2012, DRUGS, V72, P49, DOI 10.2165/11597760-000000000-00000
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Dore S, 1997, TRENDS NEUROSCI, V20, P326
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Folch J, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00236
   Freude S, 2009, CURR ALZHEIMER RES, V6, P213, DOI 10.2174/156720509788486527
   George C, 2017, BRAIN, V140, P2012, DOI 10.1093/brain/awx132
   Gontier G, 2015, J NEUROSCI, V35, P11500, DOI 10.1523/JNEUROSCI.0343-15.2015
   Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z
   Gubbi S, 2018, J MOL ENDOCRINOL, V61, pT171, DOI 10.1530/JME-18-0093
   Herenu CB, 2007, GENE THER, V14, P237, DOI 10.1038/sj.gt.3302870
   Herenu CB, 2009, NEUROSCIENCE, V163, P442, DOI 10.1016/j.neuroscience.2009.06.024
   Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095
   Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lewitt MS, 2019, BIOCHEM INSIGHTS, V12, DOI 10.1177/1178626419842176
   Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
   MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Mustafa A, 1999, DEMENT GERIATR COGN, V10, P446, DOI 10.1159/000017188
   Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435
   Ostrowski PP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155733
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Pardo J, 2016, EUR J NEUROSCI, V44, P2120, DOI 10.1111/ejn.13278
   Pitt J, 2017, MOL BIOL CELL, V28, P2623, DOI 10.1091/mbc.E17-06-0416
   Poirier R, 2012, NEUROSCI LETT, V509, P101, DOI 10.1016/j.neulet.2011.12.048
   Puig KL, 2016, NEUROBIOL AGING, V40, P22, DOI 10.1016/j.neurobiolaging.2015.12.021
   Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016
   Ribe EM, 2016, J INTERN MED, V280, P430, DOI 10.1111/joim.12534
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Suemoto CK, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002267
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671
   Trueba-Saiz A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.102
   Tumminia A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113306
   van Exel E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.08.014
   Vidal JS, 2016, J ALZHEIMERS DIS, V52, P641, DOI 10.3233/JAD-151162
   Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3
   Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382
   Wrigley S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00014
   Zegarra-Valdivia JA, 2019, J ALZHEIMERS DIS, V69, P979, DOI 10.3233/JAD-190241
   Zemva J, 2014, CNS NEUROL DISORD-DR, V13, P322, DOI 10.2174/18715273113126660141
NR 71
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD MAR
PY 2020
VL 57
IS 3
BP 1473
EP 1483
DI 10.1007/s12035-019-01827-y
EA NOV 2019
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA KT0YX
UT WOS:000498110700001
PM 31760608
DA 2020-09-29
ER

PT J
AU Bodart-Santos, V
   de Carvalho, LRP
   de Godoy, MA
   Batista, AF
   Saraiva, LM
   Lima, LG
   Abreu, CA
   De Felice, FG
   Galina, A
   Mendez-Otero, R
   Ferreira, ST
AF Bodart-Santos, Victor
   de Carvalho, Luiza R. P.
   de Godoy, Mariana A.
   Batista, Andre F.
   Saraiva, Leonardo M.
   Lima, Luize G.
   Abreu, Carla Andreia
   De Felice, Fernanda G.
   Galina, Antonio
   Mendez-Otero, Rosalia
   Ferreira, Sergio T.
TI Extracellular vesicles derived from human Wharton's jelly mesenchymal
   stem cells protect hippocampal neurons from oxidative stress and synapse
   damage induced by amyloid-beta oligomers
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
ID AMYOTROPHIC-LATERAL-SCLEROSIS; A-BETA; ALZHEIMERS-DISEASE; STROMAL
   CELLS; MITOCHONDRIAL DYSFUNCTION; NEUROVASCULAR PLASTICITY; FUNCTIONAL
   RECOVERY; MEMORY LOSS; EXOSOMES; BRAIN
AB Background Mesenchymal stem cells (MSCs) have been explored as promising tools for treatment of several neurological and neurodegenerative diseases. MSCs release abundant extracellular vesicles (EVs) containing a variety of biomolecules, including mRNAs, miRNAs, and proteins. We hypothesized that EVs derived from human Wharton's jelly would act as mediators of the communication between hMSCs and neurons and could protect hippocampal neurons from damage induced by Alzheimer's disease-linked amyloid beta oligomers (A beta Os). Methods We isolated and characterized EVs released by human Wharton's jelly mesenchymal stem cells (hMSC-EVs). The neuroprotective action of hMSC-EVs was investigated in primary hippocampal cultures exposed to A beta Os. Results hMSC-EVs were internalized by hippocampal cells in culture, and this was enhanced in the presence of A beta Os in the medium. hMSC-EVs protected hippocampal neurons from oxidative stress and synapse damage induced by A beta Os. Neuroprotection by hMSC-EVs was mediated by catalase and was abolished in the presence of the catalase inhibitor, aminotriazole. Conclusions hMSC-EVs protected hippocampal neurons from damage induced by A beta Os, and this was related to the transfer of enzymatically active catalase contained in EVs. Results suggest that hMSC-EVs should be further explored as a cell-free therapeutic approach to prevent neuronal damage in Alzheimer's disease.
C1 [Bodart-Santos, Victor; de Carvalho, Luiza R. P.; de Godoy, Mariana A.; Abreu, Carla Andreia; Mendez-Otero, Rosalia; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Bodart-Santos, Victor; de Godoy, Mariana A.; Batista, Andre F.; Saraiva, Leonardo M.; De Felice, Fernanda G.; Galina, Antonio; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Bodart-Santos, Victor] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Lima, Luize G.] Natl Canc Inst, BR-20230240 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada.
   [Mendez-Otero, Rosalia] Natl Inst Sci & Technol Regenerat Med, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Mendez-Otero, R; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM rmotero@biof.ufrj.br; ferreira@bioqmed.ufrj.br
RI Mendez-Otero, Rosalia/AAL-7551-2020; Ferreira, Sergio/AAZ-1576-2020
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; Ferreira,
   Sergio/0000-0001-7160-9866
FU National Institute for Translational Neuroscience (Brazil); National
   Institute of Science and Technology for Regenerative Medicine; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This study was supported by National Institute for Translational
   Neuroscience (Brazil, to STF and FDF), National Institute of Science and
   Technology for Regenerative Medicine (RM-O), the Brazilian agencies
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
   (to STF, FDF and RM-O). VBS and LRPC were supported by pre-and
   post-doctoral fellowships, respectively, from CNPq.
CR Acosta C, 2017, J NEUROSCI RES, V95, P2430, DOI 10.1002/jnr.24075
   Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004
   Baez-Jurado E, 2019, MOL NEUROBIOL, V56, P6902, DOI 10.1007/s12035-019-1570-x
   Barczewska M, 2019, NEURAL REGEN RES, V14, P313, DOI 10.4103/1673-5374.243723
   Batista AF, 2018, J PATHOL, V245, P85, DOI 10.1002/path.5056
   Bharti D, 2018, CELL TISSUE RES, V372, P51, DOI 10.1007/s00441-017-2699-4
   Borger V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071450
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Calio ML, 2014, FREE RADICAL BIO MED, V70, P141, DOI 10.1016/j.freeradbiomed.2014.01.024
   Chen DD, 2017, J NEUROSCI RES, V95, P907, DOI 10.1002/jnr.23879
   Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484
   Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326
   Crivelli B, 2017, J CONTROL RELEASE, V262, P104, DOI 10.1016/j.jconrel.2017.07.023
   Cui GH, 2018, FASEB J, V32, P654, DOI 10.1096/fj.201700600R
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   de Godoy MA, 2018, J BIOL CHEM, V293, P1957, DOI 10.1074/jbc.M117.807180
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Dey R, 2012, CEREBELLUM, V11, P861, DOI 10.1007/s12311-012-0406-2
   Ding GP, 2015, ONCOTARGET, V6, P29877, DOI 10.18632/oncotarget.4924
   Diniz LP, 2017, J NEUROSCI, V37, P6797, DOI 10.1523/JNEUROSCI.3351-16.2017
   dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094
   Fang ZH, 2016, EXP THER MED, V12, P3328, DOI 10.3892/etm.2016.3748
   Fatima F, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00161
   Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030
   Felicetti F, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0811-2
   Ferreira IL, 2015, NEUROBIOL AGING, V36, P680, DOI 10.1016/j.neurobiolaging.2014.09.006
   Ferreira JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02837
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Gubert F, 2016, NEURAL REGEN RES, V11, P1216, DOI 10.4103/1673-5374.189167
   Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033
   Harach T, 2017, NEUROBIOL AGING, V51, P83, DOI 10.1016/j.neurobiolaging.2016.11.009
   Hart ML, 2017, PLACENTA, V49, P64, DOI 10.1016/j.placenta.2016.11.007
   Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630
   Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003
   Ishikawa J, 2016, BONE, V83, P210, DOI 10.1016/j.bone.2015.11.012
   Jarmalaviciute A, 2015, CYTOTHERAPY, V17, P932, DOI 10.1016/j.jcyt.2014.07.013
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197
   Kehl D, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0070-y
   Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113
   Kim HO, 2013, TISSUE ENG REGEN MED, V10, P93, DOI 10.1007/s13770-013-0010-7
   Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140
   Koniusz S, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00109
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024
   Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643
   Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277
   Lee JK, 2009, NEUROSCI LETT, V450, P136, DOI 10.1016/j.neulet.2008.11.059
   Lee NE, 2017, CYTOTHERAPY, V19, P170, DOI 10.1016/j.jcyt.2016.11.002
   Leuner K, 2012, MOL NEUROBIOL, V46, P194, DOI 10.1007/s12035-012-8300-y
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Liew LC, 2017, INT IMMUNOL, V29, P11, DOI 10.1093/intimm/dxx002
   Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Mesentier-Louro LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110722
   Millan-Rivero JE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34527-z
   Mitchell R, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1213-1
   Moraes L, 2012, STEM CELL RES, V9, P143, DOI 10.1016/j.scr.2012.05.005
   Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   NICHOLLS P, 1962, BIOCHIM BIOPHYS ACTA, V59, P414, DOI 10.1016/0006-3002(62)90191-9
   Noh MY, 2016, STEM CELL TRANSL MED, V5, P1538, DOI 10.5966/sctm.2015-0217
   Patten DA, 2010, J ALZHEIMERS DIS, V20, pS357, DOI 10.3233/JAD-2010-100498
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Pohanka M, 2014, CURR MED CHEM, V21, P356
   Rani S, 2015, MOL THER, V23, P812, DOI 10.1038/mt.2015.44
   Ranjbaran Hossein, 2018, Acta Med Iran, V56, P28
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Redondo J, 2018, STEM CELL TRANSL MED, V7, P748, DOI 10.1002/sctm.18-0045
   Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Spuch Carlos, 2012, J Aging Res, V2012, P324968, DOI 10.1155/2012/324968
   Turturici G, 2014, AM J PHYSIOL-CELL PH, V306, pC621, DOI 10.1152/ajpcell.00228.2013
   Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093
   van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   Vizoso FJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091852
   Volkman R, 2017, STEM CELLS, V35, P1867, DOI 10.1002/stem.2651
   Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010
   Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409
   Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152
   Yang M, 2011, ANN SURG, V253, P202, DOI 10.1097/SLA.0b013e3181f9ba1ah
   Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055
   Yun HM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.490
   Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181
   Zhang GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092129
   Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770
NR 94
TC 7
Z9 7
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD NOV 20
PY 2019
VL 10
IS 1
AR 332
DI 10.1186/s13287-019-1432-5
PG 13
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
SC Cell Biology; Research & Experimental Medicine
GA JP9XX
UT WOS:000498610900003
PM 31747944
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Figueiredo, CP
   Barros-Aragao, FGQ
   Neris, RLS
   Frost, PS
   Soares, C
   Souza, INO
   Zeidler, JD
   Zamberlan, DC
   de Sousa, VL
   Souza, AS
   Guimaraes, ALA
   Bellio, M
   de Souza, JM
   Alves-Leon, SV
   Neves, GA
   Paula-Neto, HA
   Castro, NG
   De Felice, FG
   Assuncao-Miranda, I
   Clarke, JR
   Da Poian, AT
   Ferreira, ST
AF Figueiredo, Claudia P.
   Barros-Aragao, Fernanda G. Q.
   Neris, Romulo L. S.
   Frost, Paula S.
   Soares, Carolina
   Souza, Isis N. O.
   Zeidler, Julianna D.
   Zamberlan, Daniele C.
   de Sousa, Virginia L.
   Souza, Amanda S.
   Guimaraes, Andre Luis A.
   Bellio, Maria
   de Souza, Jorge Marcondes
   Alves-Leon, Soniza V.
   Neves, Gilda A.
   Paula-Neto, Heitor A.
   Castro, Newton G.
   De Felice, Fernanda G.
   Assuncao-Miranda, Iranaia
   Clarke, Julia R.
   Da Poian, Andrea T.
   Ferreira, Sergio T.
TI Zika virus replicates in adult human brain tissue and impairs synapses
   and memory in mice
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; A-BETA OLIGOMERS; ACTIVATION; INFECTION;
   COMPLICATIONS; MICROGLIA; EPIDEMIC; DISEASE; IMPACT
AB Neurological complications affecting the central nervous system have been reported in adult patients infected by Zika virus (ZIKV) but the underlying mechanisms remain unknown. Here, we report that ZIKV replicates in human and mouse adult brain tissue, targeting mature neurons. ZIKV preferentially targets memory-related brain regions, inhibits hippocampal long-term potentiation and induces memory impairment in adult mice. TNF-alpha upregulation, microgliosis and upregulation of complement system proteins, C1q and C3, are induced by ZIKV infection. Microglia are found to engulf hippocampal presynaptic terminals during acute infection. Neutralization of TNF-alpha signaling, blockage of microglial activation or of C1q/C3 prevent synapse and memory impairment in ZIKV-infected mice. Results suggest that ZIKV induces synapse and memory dysfunction via aberrant activation of TNF-alpha, microglia and complement. Our findings establish a mechanism by which ZIKV affects the adult brain, and point to the need of evaluating cognitive deficits as a potential comorbidity in ZIKV-infected adults.
C1 [Figueiredo, Claudia P.; Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Soares, Carolina; Souza, Isis N. O.; Zamberlan, Daniele C.; de Sousa, Virginia L.; Guimaraes, Andre Luis A.; Paula-Neto, Heitor A.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Soares, Carolina; Neves, Gilda A.; Castro, Newton G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Bellio, Maria; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Zeidler, Julianna D.; De Felice, Fernanda G.; Da Poian, Andrea T.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Souza, Amanda S.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge Marcondes; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge Marcondes; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.] Queens Univ, Fed Univ Rio de Janeiro State, Grad Program Neurol, Kingston, ON, Canada.
   [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RP Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM claudia@pharma.ufrj.br; dapoian@bioqmed.ufrj.br;
   ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Castro, Newton G/C-3263-2009; de
   Oliveira Souza, Isis Nem/AAA-3423-2019; Clarke, Julia/AAF-9434-2019;
   Neves, Gilda A./K-7573-2012; BELLIO, MARIA/N-8525-2018
OI Ferreira, Sergio/0000-0001-7160-9866; Castro, Newton
   G/0000-0001-9570-7428; de Oliveira Souza, Isis Nem/0000-0002-0335-2541;
   Neves, Gilda A./0000-0002-7027-3851; BELLIO, MARIA/0000-0002-3360-2740;
   Gomes de Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; Souza,
   Amanda/0000-0002-7561-8150; da Silva Frost, Paula/0000-0002-3814-999X;
   Zeidler, Julianna D./0000-0003-3168-1518
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alves-Leon SV, 2019, MULT SCLER J, V25, P427, DOI 10.1177/1352458518781992
   Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bellesi M, 2017, J NEUROSCI, V37, P5263, DOI 10.1523/JNEUROSCI.3981-16.2017
   Bido-Medina R, 2018, ANN CLIN TRANSL NEUR, V5, P752, DOI 10.1002/acn3.575
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Ennaceur A, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.223
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Ferreira J, 2005, PAIN, V117, P171, DOI 10.1016/j.pain.2005.06.001
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gonzalez-Dunia D, 2000, J VIROL, V74, P3441, DOI 10.1128/JVI.74.8.3441-3448.2000
   Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14
   Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54
   Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Mamik MK, 2016, J NEUROSCI, V36, P10683, DOI 10.1523/JNEUROSCI.1287-16.2016
   Matheus FC, 2016, MOL NEUROBIOL, V53, P3891, DOI 10.1007/s12035-015-9330-z
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Piacentini R, 2015, SCI REP-UK, V5, DOI 10.1038/srep15444
   Presumey J, 2017, ADV IMMUNOL, V135, P53, DOI 10.1016/bs.ai.2017.06.004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047
   Ronca SE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00959
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Souza INO, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020060
   STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14
   Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   World Health Organization, 2017, ZIK VIR MICR GUILL B
NR 59
TC 14
Z9 14
U1 1
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 5
PY 2019
VL 10
AR 3890
DI 10.1038/s41467-019-11866-7
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IU9SV
UT WOS:000483921700001
PM 31488835
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Almeida, DS
   Brigido, MM
   Anjos, MJ
   Ferreira, ST
   Souza, AS
   Lopes, RT
AF Almeida, D. S.
   Brigido, M. M.
   Anjos, M. J.
   Ferreira, S. T.
   Souza, A. S.
   Lopes, R. T.
TI Using a portable total reflection X-ray fluorescence system for a
   multielement analysis of Swiss mice brains with experimental Alzheimer's
   disease induced by beta-amyloid oligomers
SO X-RAY SPECTROMETRY
LA English
DT Article; Proceedings Paper
CT 18th European Conference on X-Ray Spectrometry (EXRS)
CY JUN 24-29, 2018
CL Ljubljana, SLOVENIA
SP Jozef Stefan Inst, Univ Ljubljana, Fac Math & Phys, Soc Mathematicians, Physicists & Astronomers Slovenia, Jozef Stefan Int Postgraduate Sch
ID GENDER-DIFFERENCES; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; MEMORY LOSS;
   PEPTIDE; TAU; PATHOGENESIS; PHOSPHORUS; EXPRESSION; COPPER
AB Alzheimer's disease (AD) is a progressive and irreversible disorder whose pathological features include beta-amyloid (A beta) plaques and neuronal and synaptic loss. Metals such as iron, copper, and zinc are increased in the brains of patients with AD. Those metals can interact with A beta, resulting in the promotion of A beta deposition and formation of plaque. However, no study analyzing the effects of single injection of A beta soluble oligomers (A beta Os) in the elements' homeostasis in mice was developed. Total reflection X-ray fluorescence (TXRF) is a multielement analytical technique that can be utilized to identify and quantify trace elements present in a sample at very low concentrations. In this study, in order to evaluate the concentration of metals in brain regions of Swiss mice, three groups of female mice and three of male mice were studied: control, AD10, and AD100. The AD groups received an A beta Os intracerebroventricular injection so as to induce experimental AD. Afterwards, a craniotomy was performed, and six brain compartments were dissected and evaluated. TXRF measurements were performed using a portable TXRF system that uses an X-ray tube with a molybdenum anode and a detector Si-PIN. It is proved to determine the following elements' concentrations: phosphorus, sulfur, potassium, iron, copper, zinc, and rubidium. Results showed differences in the elemental concentration in some brain regions between AD groups. These alterations suggest that A beta Os act quickly, even before the amyloid plaques' formation, explaining cognitive deficits independently of amyloid plaques. This study helped to understand that this modification on elemental concentration can be influenced by A beta Os.
C1 [Almeida, D. S.; Lopes, R. T.] Univ Fed Rio de Janeiro, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
   [Brigido, M. M.; Anjos, M. J.] Univ Estado Rio De Janeiro, Phys Inst, Rio De Janeiro, Brazil.
   [Ferreira, S. T.; Souza, A. S.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Ferreira, S. T.; Souza, A. S.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
RP Almeida, DS (corresponding author), Univ Fed Rio de Janeiro, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
EM dani.almeida84@gmail.com
RI Ferreira, Sergio/AAZ-1576-2020; Lopes, Ricardo/O-8840-2014
OI Ferreira, Sergio/0000-0001-7160-9866; Lopes, Ricardo/0000-0001-7250-824X
CR ANDRASI E, 1995, MICROCHEM J, V51, P99, DOI 10.1006/mchj.1995.1013
   Andrasi E, 2005, J ALZHEIMERS DIS, V7, P273
   Ayton S, 2013, FREE RADICAL BIO MED, V62, P76, DOI 10.1016/j.freeradbiomed.2012.10.558
   Azad NA, 2007, GENDER MED, V4, P120, DOI 10.1016/S1550-8579(07)80026-X
   Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685
   Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200
   Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011
   Butterfield DA, 2013, ANTIOXID REDOX SIGN, V19, P823, DOI 10.1089/ars.2012.5027
   Butterfield DA, 2010, FREE RADICAL BIO MED, V48, P136, DOI 10.1016/j.freeradbiomed.2009.10.035
   Canzoniero LMT, 2005, J ALZHEIMERS DIS, V8, P147
   Chong-Bo Z., 2004, NEUROSCI LETT, V373, P99
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   de Godoy MA, 2018, J BIOL CHEM, V293, P1957, DOI 10.1074/jbc.M117.807180
   Duran-Gonzalez J, 2013, NEUROBIOL AGING, V34, P2071, DOI 10.1016/j.neurobiolaging.2013.02.005
   Eskici G, 2012, BIOCHEMISTRY-US, V51, P6289, DOI 10.1021/bi3006169
   Faucher P, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00245
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Gambassi G, 1999, NEUROLOGY, V53, P508, DOI 10.1212/WNL.53.3.508
   Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01
   Hane F, 2014, BIOMOLECULES, V4, P101, DOI 10.3390/biom4010101
   HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270
   Inan SY, 2000, EUR J PHARMACOL, V407, P159, DOI 10.1016/S0014-2999(00)00736-6
   Jari I., 2011, MICROCHEM J, V1, P77
   Kepp KP, 2017, COORDIN CHEM REV, V351, P127, DOI 10.1016/j.ccr.2017.05.007
   Kim S, 2015, COMPR PSYCHIAT, V62, P114, DOI 10.1016/j.comppsych.2015.07.002
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   Klockenkamper R, 2015, CHEM ANAL SERIES MON, V181
   Kozlowski H, 2012, COORDIN CHEM REV, V256, P2129, DOI 10.1016/j.ccr.2012.03.013
   Krebs N, 2014, J TRACE ELEM MED BIO, V28, P1, DOI 10.1016/j.jtemb.2013.09.006
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Li TZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173923
   Lopes RT, 2011, PRAMANA-J PHYS, V76, P271, DOI 10.1007/s12043-011-0043-1
   Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x
   Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065
   Miller L. M., 2005, STRUCT BIOL, V155, P30
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Musicco M, 2009, FUNCT NEUROL, V24, P89
   Nuttall R. J., 2014, GENES NUTR, V9, P379
   Pan YP, 2004, J NEUROSCI RES, V77, P94, DOI 10.1002/jnr.20134
   Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061
   Perneczky R, 2007, INT J GERIATR PSYCH, V22, P1135, DOI 10.1002/gps.1803
   Perneczky R, 2007, J NEUROL, V254, P1395, DOI 10.1007/s00415-007-0558-z
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541
   Sinforiani E, 2010, DEMENT GERIATR COGN, V30, P147, DOI 10.1159/000318842
   Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010
   Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3
   Takeda E, 2012, NUTR REV, V70, P311, DOI 10.1111/j.1753-4887.2012.00473.x
   Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977
   Viles JH, 2012, COORDIN CHEM REV, V256, P2271, DOI 10.1016/j.ccr.2012.05.003
   Von Lippard S. J., 1994, BIOORGANISCHE CHEM
   Wasiak T, 2012, MOL PHARMACEUT, V9, P458, DOI 10.1021/mp2005627
   Watt N. T., 2011, INT J ALZHEIMERS DIS, V97, P1021
   Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8
   Yumoto S, 2009, J INORG BIOCHEM, V103, P1579, DOI 10.1016/j.jinorgbio.2009.07.023
   Zatta P, 2009, TRENDS PHARMACOL SCI, V30, P346, DOI 10.1016/j.tips.2009.05.002
   Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9
NR 69
TC 1
Z9 1
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0049-8246
EI 1097-4539
J9 X-RAY SPECTROM
JI X-Ray Spectrom.
PD SEP
PY 2019
VL 48
IS 5
SI SI
BP 452
EP 464
DI 10.1002/xrs.3044
PG 13
WC Spectroscopy
SC Spectroscopy
GA IU4RL
UT WOS:000483574400019
DA 2020-09-29
ER

PT J
AU Melo, HD
   Silva, GS
   Melo, B
   Fortuna, J
   Coreixas, V
   Ferreira, S
   Felice, FD
AF Melo, H. D.
   Silva, G. Sd.
   Melo, B.
   Fortuna, J.
   Coreixas, V.
   Ferreira, S.
   Felice, F. D.
TI Palmitate increases microglia-derived TNF-alpha levels and impairs
   hippocampal insulin signaling
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-Neurochemistry and
   American-Society-for-Neurochemistry (ISN-ASN)
CY AUG 04-08, 2019
CL Montreal, CANADA
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Melo, H. D.; Melo, B.; Fortuna, J.; Coreixas, V.; Ferreira, S.; Felice, F. D.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Silva, G. Sd.] Fed Inst Educ Sci & Technol Rio de Janeiro, Dept Biochem, Rio De Janeiro, Brazil.
   [Ferreira, S.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Felice, F. D.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Felice, F. D.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUL
PY 2019
VL 150
SU 1
SI SI
MA MTU04-13
BP 95
EP 95
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IN4IY
UT WOS:000478639800206
DA 2020-09-29
ER

PT J
AU Souza, INDO
   Frost, P
   Franca, J
   Nascimento-Viana, J
   Neris, R
   Nogueira, C
   Neves, G
   Chimelli, L
   De-Felice, F
   Ferreira, S
   Assuncao-Miranda, I
   Figueiredo, C
   Poian, AD
   Clarke, J
AF Souza, I. N. D. O.
   Frost, P.
   Franca, J.
   Nascimento-Viana, J.
   Neris, R.
   Nogueira, C.
   Neves, G.
   Chimelli, L.
   De-Felice, F.
   Ferreira, S.
   Assuncao-Miranda, I.
   Figueiredo, C.
   Poian, A. D.
   Clarke, J.
TI Acute and chronic neurological consequences of neonatal zika virus
   infection in mice
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-Neurochemistry and
   American-Society-for-Neurochemistry (ISN-ASN)
CY AUG 04-08, 2019
CL Montreal, CANADA
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Souza, I. N. D. O.; Frost, P.; Nascimento-Viana, J.; Nogueira, C.; Figueiredo, C.; Clarke, J.] Univ Fed Rio de Janeiro, Fac Pharm, Rio De Janeiro, Brazil.
   [Frost, P.; Franca, J.; Neves, G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Neris, R.; Assuncao-Miranda, I.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
   [Chimelli, L.] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [De-Felice, F.; Ferreira, S.; Poian, A. D.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [De-Felice, F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Ferreira, S.] Univ Fed Rio de Janeiro, Inst Biophys, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUL
PY 2019
VL 150
SU 1
SI SI
MA MTU05-06
BP 105
EP 105
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IN4IY
UT WOS:000478639800238
DA 2020-09-29
ER

PT J
AU Rodrigues, B
   Clodomiro, M
   Rego, A
   Oliveira, I
   Beckman, D
   Ferreira, S
   Mello, F
   Todeschini, A
   Reis, R
   Dias, W
AF Rodrigues, B.
   Clodomiro, M.
   Rego, A.
   Oliveira, I.
   Beckman, D.
   Ferreira, S.
   Mello, F.
   Todeschini, A.
   Reis, R.
   Dias, W.
TI The interplay between O-GlcNAc and phosphorylation on tyrosine
   hydroxylase activity and catecholamines synthesis
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-Neurochemistry and
   American-Society-for-Neurochemistry (ISN-ASN)
CY AUG 04-08, 2019
CL Montreal, CANADA
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Rodrigues, B.; Clodomiro, M.; Rego, A.; Oliveira, I.; Beckman, D.; Ferreira, S.; Mello, F.; Todeschini, A.; Reis, R.; Dias, W.] Univ Fed Rio de Janeiro, Inst Biophys, Rio De Janeiro, Brazil.
RI Todeschini, Adriane/AAG-8128-2020; Ferreira, Sergio/AAZ-1576-2020;
   Beckman, Danielle/J-5331-2015; Beckman, Danielle/AAA-1016-2019
OI Ferreira, Sergio/0000-0001-7160-9866; Beckman,
   Danielle/0000-0002-9584-4411; Beckman, Danielle/0000-0002-9584-4411
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUL
PY 2019
VL 150
SU 1
SI SI
MA WTH06-06
BP 197
EP 197
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IN4IY
UT WOS:000478639800507
DA 2020-09-29
ER

PT J
AU Santos, R
   Bergamo, A
   Ferreira, S
   Gomes, F
AF Santos, R.
   Bergamo, A.
   Ferreira, S.
   Gomes, F.
TI Influence of astrocyte heterogeneity to A beta oligomers toxicity
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-Neurochemistry and
   American-Society-for-Neurochemistry (ISN-ASN)
CY AUG 04-08, 2019
CL Montreal, CANADA
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Santos, R.; Bergamo, A.; Gomes, F.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [Ferreira, S.] Univ Fed Rio de Janeiro, Inst Biophys, Rio De Janeiro, RJ, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUL
PY 2019
VL 150
SU 1
SI SI
MA WTH11-31
BP 234
EP 234
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IN4IY
UT WOS:000478639800612
DA 2020-09-29
ER

PT J
AU Melo, HM
   Santos, LE
   Ferreira, ST
AF Melo, Helen M.
   Santos, Luis Eduardo
   Ferreira, Sergio T.
TI Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Review
DE fatty acids; high-fat diet; Western diet; mood disorders;
   neuroinflammation
ID INDUCED INSULIN-RESISTANCE; SUGAR-SWEETENED BEVERAGES; DEPRESSIVE-LIKE
   BEHAVIOR; NECROSIS-FACTOR-ALPHA; BINDING PROTEIN 5; DOCOSAHEXAENOIC
   ACID; ALZHEIMERS-DISEASE; MICROGLIAL CELLS; ADIPOSE-TISSUE; BODY-WEIGHT
AB Western societies experienced drastic changes in eating habits during the past century. The modern nutritional profile, typically rich in saturated fats and refined sugars, is recognized as a major contributing factor, along with reduced physical activity, to the current epidemics of metabolic disorders, notably obesity and diabetes. Alongside these conditions, recent years have witnessed a gradual and significant increase in prevalence of brain diseases, particularly mood disorders. While substantial clinical/epidemiological evidence supports a correlation between metabolic and neuropsychiatric disorders, the mechanisms of pathogenesis in the latter are often multifactorial and causal links have been hard to establish. Neuroinflammation stands out as a hallmark feature of brain disorders that may be linked to peripheral metabolic dyshomeostasis caused by an unhealthy diet. Dietary fatty acids are of particular interest, as they may play a dual role, both as a component of high-calorie obesogenic diets and as signaling molecules involved in inflammatory responses. Here, we review current literature connecting diet-related nutritional imbalance and neuropsychiatric disorders, focusing on the role of dietary fatty acids as signaling molecules directly relevant to inflammatory processes and to neuronal function.
C1 [Melo, Helen M.; Santos, Luis Eduardo; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Santos, Luis Eduardo; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Santos, Luis/B-4961-2015; Ferreira, Sergio/AAZ-1576-2020
OI Santos, Luis/0000-0002-0694-733X; Ferreira, Sergio/0000-0001-7160-9866
FU National Institute for Translational Neuroscience (Brazil); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX Work in the authors' group has been funded by grants from National
   Institute for Translational Neuroscience (Brazil) and the Brazilian
   agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES). LS and HM are recipients of post-doctoral fellowships from
   CAPES and FAPERJ, respectively.
CR Ajmone-Cat MA, 2012, J NEUROSCI RES, V90, P575, DOI 10.1002/jnr.22783
   Arcego DM, 2018, MOL NEUROBIOL, V55, P2740, DOI 10.1007/s12035-017-0538-y
   Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185
   Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52
   Barberger-Gateau P, 2011, CURR ALZHEIMER RES, V8, P479, DOI 10.2174/156720511796391926
   Barnard ND, 2014, NEUROBIOL AGING, V35, pS65, DOI 10.1016/j.neurobiolaging.2014.02.030
   Barnes AS, 2011, TEX HEART I J, V38, P142
   Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820
   Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859
   Berger ME, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.190
   Berthoud HR, 2012, P NUTR SOC, V71, P478, DOI 10.1017/S0029665112000602
   Bray GA, 1998, AM J CLIN NUTR, V68, P1157
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Cai WK, 2018, J CLIN INVEST, V128, P2914, DOI 10.1172/JCI99366
   Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430
   Calder PC, 2018, P NUTR SOC, V77, P52, DOI [10.1017/S0029665117003950, 10.1017/s0029665117003950]
   Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010
   Chabry J, 2015, BRAIN BEHAV IMMUN, V50, P275, DOI 10.1016/j.bbi.2015.07.018
   Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5
   Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791
   Chen XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1151-3
   CURB D, 1991, AM J CLIN NUTR, V53, pS1552
   Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   De Smedt-Peyrusse V, 2008, J NEUROCHEM, V105, P296, DOI 10.1111/j.1471-4159.2007.05129.x
   Sevilla-Gonzalez MD, 2017, ARCH MED RES, V48, P582, DOI 10.1016/j.arcmed.2018.02.004
   DiNicolantonio JJ, 2018, PROG CARDIOVASC DIS, V61, P3, DOI 10.1016/j.pcad.2017.12.001
   Domenichiello AF, 2014, J LIPID RES, V55, P62, DOI 10.1194/jlr.M042275
   Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001
   Dutheil S, 2016, NEUROPSYCHOPHARMACOL, V41, P1874, DOI 10.1038/npp.2015.357
   Ebinuma H, 2007, CLIN CHEM, V53, P1541, DOI 10.1373/clinchem.2007.085654
   Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4
   Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030
   Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4
   Fordahl SC, 2017, ACS CHEM NEUROSCI, V8, P290, DOI 10.1021/acschemneuro.6b00308
   Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476
   GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909
   Greenberg A.S., 2006, AM J CLIN NUTR, V83, p461S, DOI DOI 10.1093/ajcn/83.2.461S
   Gu MQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101351
   Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017
   Hachem M, 2016, MOL NEUROBIOL, V53, P3205, DOI 10.1007/s12035-015-9228-9
   HAGNELL O, 1989, ACTA PSYCHIAT SCAND, V79, P61, DOI 10.1111/j.1600-0447.1989.tb05216.x
   Hamazaki K, 2012, J PSYCHIATR RES, V46, P1024, DOI 10.1016/j.jpsychires.2012.04.012
   Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168
   Hassan AM, 2019, NUTR NEUROSCI, V22, P877, DOI 10.1080/1028415X.2018.1465713
   Heyward FD, 2012, NEUROBIOL LEARN MEM, V98, P25, DOI 10.1016/j.nlm.2012.04.005
   Hidaka BH, 2012, J AFFECT DISORDERS, V140, P205, DOI 10.1016/j.jad.2011.12.036
   Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Holt RIG, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0491-3
   HORTON TJ, 1995, AM J CLIN NUTR, V62, P19
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Hu SM, 2018, CELL METAB, V28, P415, DOI 10.1016/j.cmet.2018.06.010
   Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546
   Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004
   Jacka FN, 2017, EBIOMEDICINE, V17, P24, DOI 10.1016/j.ebiom.2017.02.020
   Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881
   Jeon BT, 2012, DIABETES, V61, P1444, DOI 10.2337/db11-1498
   Kahn R, 2014, DIABETES CARE, V37, P957, DOI 10.2337/dc13-2506
   Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514
   Kelly JR, 2016, J PSYCHIATR RES, V82, P109, DOI 10.1016/j.jpsychires.2016.07.019
   Khan TA, 2016, EUR J NUTR, V55, pS25, DOI 10.1007/s00394-016-1345-3
   Kim HW, 2011, MOL PSYCHIATR, V16, P419, DOI 10.1038/mp.2009.137
   Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161
   Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112
   Kopelman PG, 2000, NATURE, V404, P635
   Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7
   Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108
   Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880
   Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478
   Lancaster GI, 2018, CELL METAB, V27, P1096, DOI 10.1016/j.cmet.2018.03.014
   Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5
   Lawton GL, 2000, BRIT J NUTR, V83, P473
   Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336
   Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200
   Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194
   Lin PY, 2010, BIOL PSYCHIAT, V68, P140, DOI 10.1016/j.biopsych.2010.03.018
   Liu J, 2012, P NATL ACAD SCI USA, V109, P12248, DOI 10.1073/pnas.1202835109
   Liu JJ, 2015, BRAIN RES, V1597, P220, DOI 10.1016/j.brainres.2014.11.059
   Liuzzi GM, 2007, NEUROCHEM RES, V32, P2184, DOI 10.1007/s11064-007-9415-9
   Logan AC, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-22
   Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006
   Luchsinger JA, 2012, J ALZHEIMERS DIS, V30, pS185, DOI 10.3233/JAD-2012-111433
   Ludwig DS, 2018, SCIENCE, V362, P764, DOI 10.1126/science.aau2096
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670
   Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040
   McNamara RK, 2007, BIOL PSYCHIAT, V62, P17, DOI 10.1016/j.biopsych.2006.08.026
   McNamara RK, 2013, J PSYCHIATR RES, V47, P1187, DOI 10.1016/j.jpsychires.2013.05.007
   Mechawar N, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.212
   Mock K, 2017, J NUTR BIOCHEM, V39, P32, DOI 10.1016/j.jnutbio.2016.09.010
   Mocking RJT, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.29
   Montonen J, 2007, J NUTR, V137, P1447
   Morris MC, 2004, NEUROLOGY, V62, P1573, DOI 10.1212/01.WNL.0000123250.82849.B6
   Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194
   Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940
   Mosca A, 2017, J HEPATOL, V66, P1031, DOI 10.1016/j.jhep.2016.12.025
   Moussavi N, 2008, OBESITY, V16, P7, DOI 10.1038/oby.2007.14
   Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006
   Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241
   O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009
   O'Neil A, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2014.302110
   Ortega RM, 1997, AM J CLIN NUTR, V66, P803
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026
   Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011
   Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851
   Pan YJ, 2016, J NEUROSCI, V36, P11755, DOI 10.1523/JNEUROSCI.1583-16.2016
   Pan YJ, 2015, MOL PHARMACEUT, V12, P4375, DOI 10.1021/acs.molpharmaceut.5b00580
   Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529
   Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830
   Phillips CM, 2012, J NUTR, V142, P824, DOI 10.3945/jn.111.153460
   Piers LS, 2003, BRIT J NUTR, V90, P717, DOI 10.1079/BJN2003948
   Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]
   Psaltopoulou T, 2013, ANN NEUROL, V74, P580, DOI 10.1002/ana.23944
   Rebolledo-Solleiro D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176554
   Reichelt AC, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00096
   Rey C, 2016, BRAIN BEHAV IMMUN, V55, P249, DOI 10.1016/j.bbi.2015.12.013
   Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742
   Rogero MM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040432
   Rosqvist F, 2014, DIABETES, V63, P2356, DOI 10.2337/db13-1622
   Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949
   Santos LE, 2016, BRAIN BEHAV IMMUN, V55, P151, DOI 10.1016/j.bbi.2015.11.011
   Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854
   Sheline YI, 2011, BIOL PSYCHIAT, V70, P308, DOI 10.1016/j.biopsych.2011.06.006
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0
   Singh A, 2017, EXP BRAIN RES, V235, P1645, DOI 10.1007/s00221-017-4928-1
   Sinyor M, 2010, CAN J PSYCHIAT, V55, P126, DOI 10.1177/070674371005500303
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990
   Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385
   Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887
   Swardfager W, 2016, NEUROSCI BIOBEHAV R, V64, P148, DOI 10.1016/j.neubiorev.2016.02.017
   Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740
   Umhau JC, 2009, J LIPID RES, V50, P1259, DOI 10.1194/jlr.M800530-JLR200
   Vagena E, 2018, SSRN ELECT J, DOI [10.2139/ssrn.3188483, DOI 10.2139/SSRN.3188483]
   Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018
   van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792
   Vergnaud AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057300
   Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620
   Wang H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02576-5
   Wang Z, 2012, BRIT J NUTR, V107, P229, DOI 10.1017/S0007114511002868
   Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514
   Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11
   Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x
   Willett WC, 1998, AM J CLIN NUTR, V67, p556S, DOI 10.1093/ajcn/67.3.556S
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Xu L, 2018, NEUROSCIENCE, V372, P237, DOI 10.1016/j.neuroscience.2018.01.001
   Yang JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35239
   Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150
   Yanguas-Casas N, 2018, GLIA, V66, P522, DOI 10.1002/glia.23263
   Yehuda S, 1999, J NEUROSCI RES, V56, P565, DOI 10.1002/(SICI)1097-4547(19990615)56:6<565::AID-JNR2>3.3.CO;2-8
   Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001
   Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620
   Zarate R, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-017-0153-6
   Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44
NR 173
TC 9
Z9 9
U1 2
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PD MAR 26
PY 2019
VL 13
AR 265
DI 10.3389/fnins.2019.00265
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA HQ6YC
UT WOS:000462563800002
PM 30983955
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Batista, AF
   Bodart-Santos, V
   De Felice, FG
   Ferreira, ST
AF Batista, Andre F.
   Bodart-Santos, Victor
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in
   Alzheimer's and Parkinson's Diseases
SO CNS DRUGS
LA English
DT Article
ID BRAIN INSULIN-RESISTANCE; AMYLOID-BETA OLIGOMERS; ENDOPLASMIC-RETICULUM
   STRESS; UNFOLDED PROTEIN RESPONSE; DEPRESSIVE-LIKE BEHAVIOR;
   CENTRAL-NERVOUS-SYSTEM; REDUCES PLAQUE LOAD; MPTP MOUSE MODEL; A-BETA;
   COGNITIVE IMPAIRMENT
AB The current absence of effective treatments for Alzheimer's disease (AD) and Parkinson's disease (PD) reflects an incomplete knowledge of the underlying disease processes. Considerable efforts have been made to investigate the central pathological features of these diseases, giving rise to numerous attempts to develop compounds that interfere with such features. However, further characterization of the molecular targets within the interconnected AD and PD pathways is still required. Impaired brain insulin signaling has emerged as a feature that contributes to neuronal dysfunction in both AD and PD, leading to strategies aiming at restoring this pathway in the brain. Long-acting glucagon-like peptide-1 (GLP-1) analogues marketed for treatment of type 2 diabetes mellitus have been tested and have shown encouraging protective actions in experimental models of AD and PD as well as in initial clinical trials. We review studies revealing the neuroprotective actions of GLP-1 analogues in pre-clinical models of AD and PD and promising results from recent clinical trials.
C1 [Batista, Andre F.; Bodart-Santos, Victor; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Bodart-Santos, Victor] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP De Felice, FG; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.; De Felice, FG (corresponding author), Queens Univ, Dept Psychiat, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM felice@bioqmed.ufrj.br; ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU National Institute for Translational Neuroscience (Brazil); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Alzheimer Society Canada; Weston Brain Institute; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX Work in the authors' groups has been supported by the National Institute
   for Translational Neuroscience (Brazil), the Brazilian agencies Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to STF and
   FDF), and Alzheimer Society Canada and Weston Brain Institute (to FDF).
   AFB and VBS are supported by post-doctoral and pre-doctoral fellowships,
   respectively, from CNPq.
CR Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035
   Abisambra JF, 2013, J NEUROSCI, V33, P9498, DOI 10.1523/JNEUROSCI.5397-12.2013
   Acharya NK, 2013, J ALZHEIMERS DIS, V35, P179, DOI 10.3233/JAD-122254
   Andersen A, 2018, NAT REV ENDOCRINOL, V14, P390, DOI 10.1038/s41574-018-0016-2
   Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185
   Athauda D, 2017, NEUROPHARMACOLOGY
   Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4
   Athauda D, 2016, PARKINSONISM RELAT D, V32, P1, DOI 10.1016/j.parkreldis.2016.07.019
   Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364
   Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295
   Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009
   Banks WA, 1997, PEPTIDES, V18, P1423, DOI 10.1016/S0196-9781(97)00231-3
   Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006
   Batista AF, 2018, J PATHOL, V245, P85, DOI 10.1002/path.5056
   Becker C, 2008, DIABETES CARE, V31, P1808, DOI 10.2337/dc08-0479
   Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483
   Bhavsar S, 2013, CURR DIABETES REV, V9, P161
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Brodacki B, 2008, NEUROSCI LETT, V441, P158, DOI 10.1016/j.neulet.2008.06.040
   Broeders M, 2013, J INT NEUROPSYCH SOC, V19, P695, DOI 10.1017/S1355617713000295
   Brosseron F, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0353-3
   Brosseron F, 2014, MOL NEUROBIOL, V50, P534, DOI 10.1007/s12035-014-8657-1
   Cai HY, 2018, BIOCHEM BIOPH RES CO, V495, P1034, DOI 10.1016/j.bbrc.2017.11.114
   Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008
   Cao Y, 2018, EUR J PHARMACOL, V827, P215, DOI 10.1016/j.ejphar.2018.03.024
   Chalmanov V, 1987, Vutr Boles, V26, P68
   Chen SY, 2017, NEUROCHEM RES, V42, P2326, DOI 10.1007/s11064-017-2250-8
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Christensen M, 2015, INT J OBESITY, V39, P1651, DOI 10.1038/ijo.2015.136
   Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010
   Cork SC, 2015, MOL METAB, V4, P718, DOI 10.1016/j.molmet.2015.07.008
   Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Pablo-Fernandez E, 2018, NEUROLOGY, V91, pE139, DOI [10.1212/WNL.0000000000005771, 10.1212/wnl.0000000000005771]
   DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126
   DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952
   DEBONS AF, 1969, AM J PHYSIOL, V217, P1114
   Di Renzo L, 2007, PHARMACOL RES, V55, P131, DOI 10.1016/j.phrs.2006.11.002
   Duffy AM, 2013, NEUROSCIENCE, V228, P294, DOI 10.1016/j.neuroscience.2012.10.045
   Duke DC, 2007, NEUROGENETICS, V8, P83, DOI 10.1007/s10048-006-0077-6
   Dunn L, 2014, NEUROBIOL AGING, V35, P1111, DOI 10.1016/j.neurobiolaging.2013.11.001
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4
   Egefjord L, 2012, DAN MED J, V59
   ERBSLOH F, 1958, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V196, P611, DOI 10.1007/BF00344388
   Faivre E, 2013, J ALZHEIMERS DIS, V35, P267, DOI 10.3233/JAD-121888
   Faivre E, 2012, EUR J PHARMACOL, V674, P294, DOI 10.1016/j.ejphar.2011.11.007
   Farr OM, 2016, DIABETOLOGIA, V59, P954, DOI 10.1007/s00125-016-3874-y
   Feng P, 2018, NEUROPHARMACOLOGY, V133, P385, DOI 10.1016/j.neuropharm.2018.02.012
   Ferrario CR, 2017, NEUROPHARMACOLOGY
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218
   Foltynie T, 2013, J NEUROL, V260, P1433, DOI 10.1007/s00415-013-6915-1
   Forloni G, 2018, J ALZHEIMERS DIS, V62, P1261, DOI 10.3233/JAD-170819
   Frias JP, 2017, CELL METAB, V26, P343, DOI 10.1016/j.cmet.2017.07.011
   Gejl M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00108
   Ghasemi R, 2013, MOL NEUROBIOL, V47, P1045, DOI 10.1007/s12035-013-8404-z
   Godau J, 2011, ARCH NEUROL-CHICAGO, V68, P925, DOI 10.1001/archneurol.2011.129
   Goldman JG, 2014, MOVEMENT DISORD, V29, P608, DOI 10.1002/mds.25866
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Gray SM, 2014, DIABETES, V63, P3992, DOI 10.2337/db14-0340
   Greenhill C, 2015, NAT REV ENDOCRINOL, V13, P249, DOI [10.1038/nrendo.2015.40, 10.1038/nrendo.2017.38]
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Haan MN, 2004, ANNU REV PUBL HEALTH, V25, P1, DOI 10.1146/annurev.publhealth.25.101802.122951
   Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89
   Hansen HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158205
   Hansen HH, 2015, J ALZHEIMERS DIS, V46, P877, DOI 10.3233/JAD-143090
   Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19
   HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Heppner KM, 2015, ENDOCRINOLOGY, V156, P255, DOI 10.1210/en.2014-1675
   Hoene M, 2008, OBES REV, V9, P20, DOI 10.1111/j.1467-789X.2007.00410.x
   Holscher C, 2018, NEUROPHARMACOLOGY, V136, P251, DOI 10.1016/j.neuropharm.2018.01.040
   Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006
   Hoogland J, 2017, MOVEMENT DISORD, V32, P1056, DOI 10.1002/mds.27002
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33
   International Diabetes Federation, 2015, IDF DIABETES ATLAS
   Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692
   Jalewa J, 2017, NEUROPHARMACOLOGY, V117, P238, DOI 10.1016/j.neuropharm.2017.02.013
   Jall S, 2017, MOL METAB, V6, P440, DOI 10.1016/j.molmet.2017.02.002
   Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474
   Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
   Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206
   Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132
   Kjems LL, 2003, DIABETES, V52, P380, DOI 10.2337/diabetes.52.2.380
   Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee Sarah, 2013, J Alzheimers Dis Parkinsonism, V3, P128
   Leibson CL, 1997, AM J EPIDEMIOL, V145, P301
   Levy G, 2002, MOVEMENT DISORD, V17, P250, DOI 10.1002/mds.10086
   Li YW, 2017, EUR J PHARMACOL, V797, P162, DOI 10.1016/j.ejphar.2016.11.050
   Li YW, 2016, NEUROPHARMACOLOGY, V101, P255, DOI 10.1016/j.neuropharm.2015.10.002
   Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314
   Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106
   Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Liepelt I, 2009, MOVEMENT DISORD, V24, P1504, DOI 10.1002/mds.22662
   Liu S, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.38
   Liu W, 2015, NEUROSCIENCE, V303, P42, DOI 10.1016/j.neuroscience.2015.06.054
   Liu XY, 2016, NEUROL RES, V38, P313, DOI 10.1080/01616412.2016.1145914
   Llewellyn-Smith IJ, 2013, NEUROSCIENCE, V229, P130, DOI 10.1016/j.neuroscience.2012.09.071
   Llewellyn-Smith IJ, 2011, NEUROSCIENCE, V180, P111, DOI 10.1016/j.neuroscience.2011.02.023
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc
   Ma JF, 2015, DEMENT GERIATR COGN, V39, P251, DOI 10.1159/000371510
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239
   Mansur RB, 2017, J AFFECT DISORDERS, V207, P114, DOI 10.1016/j.jad.2016.09.056
   Mashayekhi F, 2010, J CLIN NEUROSCI, V17, P623, DOI 10.1016/j.jocn.2009.08.013
   Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f
   Mattson MP, 2003, NAT MED, V9, P1113, DOI 10.1038/nm0903-1113
   McClean PL, 2015, BEHAV BRAIN RES, V293, P96, DOI 10.1016/j.bbr.2015.07.024
   McClean PL, 2014, NEUROPHARMACOLOGY, V86, P241, DOI 10.1016/j.neuropharm.2014.07.015
   McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285
   McManus RM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0241-2
   Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781
   Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Mooradian AD, 1997, BRAIN RES REV, V23, P210, DOI 10.1016/S0165-0173(97)00003-9
   MOROO I, 1994, ACTA NEUROPATHOL, V87, P343
   Morris JK, 2011, EXP NEUROL, V231, P171, DOI 10.1016/j.expneurol.2011.06.005
   Morris JK, 2010, AM J PHYSIOL-REG I, V299, pR1082, DOI 10.1152/ajpregu.00449.2010
   Motta M, 2007, IMMUNOL LETT, V114, P46, DOI 10.1016/j.imlet.2007.09.002
   Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591
   Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pagano G, 2018, NEUROLOGY, V90, pE1654, DOI 10.1212/WNL.0000000000005475
   Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911
   Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611
   PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.physiol.54.1.885
   Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498
   Pressley JC, 2003, NEUROLOGY, V60, P87, DOI 10.1212/WNL.60.1.87
   Qi LQ, 2017, AM J TRANSL RES, V9, P247
   Qi LQ, 2016, EUR J PHARMACOL, V783, P23, DOI 10.1016/j.ejphar.2016.04.052
   Qiao LY, 1999, J BIOL CHEM, V274, P10625, DOI 10.1074/jbc.274.15.10625
   Reale M, 2009, MINI-REV MED CHEM, V9, P1229, DOI 10.2174/138955709789055199
   REAVEN GM, 1983, AM J MED, V75, P8, DOI 10.1016/0002-9343(83)90248-6
   Rehman K, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0303-y
   Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202
   Ritzel U, 1998, J ENDOCRINOL, V159, P93, DOI 10.1677/joe.0.1590093
   Roytblat L, 2000, OBES RES, V8, P673, DOI 10.1038/oby.2000.86
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Sandoval DA, 2015, PHYSIOL REV, V95, P513, DOI 10.1152/physrev.00013.2014
   Sanna PP, 2002, J NEUROSCI, V22, P3359
   Scheper W, 2009, CURR MED CHEM, V16, P615, DOI 10.2174/092986709787458506
   SCHWAB RS, 1960, J NERV MENT DIS, V130, P556, DOI 10.1097/00005053-196006000-00017
   Sekiyama K, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/271732
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Sharma MK, 2014, J NEUROCHEM, V128, P459, DOI 10.1111/jnc.12469
   SHOJI M, BRAIN RES MOL BRAIN, V85, P221
   Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a
   SIRTORI CR, 1972, NEW ENGL J MED, V287, P729, DOI 10.1056/NEJM197210122871501
   Skow MA, 2016, DIABETES OBES METAB, V18, P847, DOI 10.1111/dom.12685
   Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797
   Song IU, 2009, EUR NEUROL, V62, P99, DOI 10.1159/000222780
   Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Tai JJ, 2018, BRAIN RES, V1678, P64, DOI 10.1016/j.brainres.2017.10.012
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Thon M, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00138
   Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778
   Uccellatore A, 2015, DIABETES THER, V6, P239, DOI 10.1007/s13300-015-0127-x
   UNGER JW, 1991, NEUROSCIENCE, V42, P853, DOI 10.1016/0306-4522(91)90049-T
   United Nations Department of Economic and Social Affairs population division, 2015, WORLD POP PROP 2015
   VANWOERT MH, 1973, J ENDOCRINOL, V59, P523, DOI 10.1677/joe.0.0590523
   VANWOERT MH, 1971, CLIN PHARMACOL THER, V12, P360
   VARNDELL IM, 1985, J HISTOCHEM CYTOCHEM, V33, P1080, DOI 10.1177/33.10.3900195
   Vrang N, 2007, BRAIN RES, V1149, P118, DOI 10.1016/j.brainres.2007.02.043
   Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428
   Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065
   Werner U, 2010, REGUL PEPTIDES, V164, P58, DOI 10.1016/j.regpep.2010.05.008
   WERTHER GA, 1987, ENDOCRINOLOGY, V121, P1562, DOI 10.1210/endo-121-4-1562
   Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517
   Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922
   Yang Y, 2013, J ALZHEIMERS DIS, V37, P637, DOI 10.3233/JAD-130491
   Yang YW, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005921
   Yuan ZY, 2017, EUR J PHARMACOL, V812, P82, DOI 10.1016/j.ejphar.2017.06.029
   Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5
   Zhang LP, 2018, NEUROPEPTIDES, V71, P70, DOI 10.1016/j.npep.2018.07.003
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893
   Zhou J, 2017, EUR J MED CHEM, V138, P1158, DOI 10.1016/j.ejmech.2017.07.046
NR 199
TC 13
Z9 12
U1 0
U2 11
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1172-7047
EI 1179-1934
J9 CNS DRUGS
JI CNS Drugs
PD MAR
PY 2019
VL 33
IS 3
BP 209
EP 223
DI 10.1007/s40263-018-0593-6
PG 15
WC Clinical Neurology; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA HQ1ZR
UT WOS:000462199000002
PM 30511349
DA 2020-09-29
ER

PT J
AU Wendler, E
   De Souza, CP
   Dornellas, APS
   Santos, LE
   Ferreira, ST
   Galduroz, JCF
   Wohr, M
   Schwarting, RKW
   Andreatini, R
AF Wendler, Etieli
   De Souza, Camila Pasquini
   Segantine Dornellas, Ana Paula
   Santos, Luis Eduardo
   Ferreira, Sergio T.
   Fernandes Galduroz, Jose Carlos
   Woehr, Markus
   Schwarting, Rainer K. W.
   Andreatini, Roberto
TI Mania-like elevated mood in rats: Enhanced 50-kHz ultrasonic
   vocalizations after sleep deprivation
SO PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
LA English
DT Article
DE Bipolar disorder; Dopamine; Lithium; Positive Affect; Sleep deprivation;
   Social communication
ID PARADOXICAL SLEEP; BIPOLAR DISORDER; ANIMAL-MODELS; ADULT RATS;
   DOPAMINERGIC RECEPTORS; NUCLEUS-ACCUMBENS; JUVENILE RATS; D2 RECEPTORS;
   AMPHETAMINE; BRAIN
AB Mania is characterized by elevated drive and mood but animal models of mania have often neglected elevated mood. Ultrasonic vocalizations (USV) of 50-kHz emitted by rats are thought to index the subject's positive affective state. Fifty-kHz USV emission is increased by amphetamine, an effect blocked by lithium administration. Sleep deprivation (SD) is an environmental model of mania and the present study evaluated SD effects on behavioral activity and USV emission, together with the impact of lithium treatment. Adult rats were submitted to 24h or 72h SD, and locomotor activity and USV emission were assessed. To test their sensitivity to a standard antimanic drug, these behavioral parameters were also evaluated after acute administration of lithium carbonate (25, 50 or 100 mg/kg, i.p.). Striatal monoamine content was measured post-mortem. SD (24h and 72h) led to increased locomotor activity, rearing behavior and 50-kHz USV emission, together with a change in the call profile characterized by an increase in the percentage of frequency-modulated 50-kHz USV, which may indicate the mania-like consequences of SD. Importantly, all SD effects were reverted by lithium administration. SD also led to a decrease in dopamine content in the ventral striatum, while increasing dopamine turnover. In conclusion, SD increased 50-kHz USV emission, an effect prevented by acute lithium administration. This suggests 50-kHz USV as a new marker for mania-like elevated mood, which shows construct validity (associated with increased dopaminergic tone), face validity (reflecting increased positive affect) and predictive validity (high sensitivity to lithium treatment).
C1 [Wendler, Etieli; De Souza, Camila Pasquini; Segantine Dornellas, Ana Paula; Andreatini, Roberto] Univ Fed Parana, Biol Sci Sect, Dept Pharmacol, Ctr Politecn, CP 19031, BR-81540990 Curitiba, Parana, Brazil.
   [Santos, Luis Eduardo; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Santos, Luis Eduardo; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Fernandes Galduroz, Jose Carlos] Univ Fed Sao Paulo, Dept Psychobiol, Rua Napoleao de Barros 925, BR-04024002 Sao Paulo, SP, Brazil.
   [Woehr, Markus; Schwarting, Rainer K. W.] Philipps Univ Marburg, Behav Neurosci Expt & Biol Psychol, Gutenbergstr 18, D-35032 Marburg, Germany.
   [Woehr, Markus; Schwarting, Rainer K. W.] Philipps Univ Marburg, CMBB, Hans Meerwein Str 6, D-35032 Marburg, Germany.
RP Andreatini, R (corresponding author), Univ Fed Parana, Dept Pharmacol, Lab Physiol & Pharmacol Cent Nervous Syst, Ctr Politecn, BR-81540990 Curitiba, Parana, Brazil.
EM randreatini@ufpr.br
RI Ferreira, Sergio/AAZ-1576-2020; Andreatini, Roberto/R-2947-2019; Santos,
   Luis/B-4961-2015; Galduroz, Jose Carlos Fernandes/G-3305-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Santos, Luis/0000-0002-0694-733X;
   Galduroz, Jose Carlos Fernandes/0000-0002-2710-9693; Pasquini de Souza,
   Camila/0000-0002-5634-609X; Wohr, Markus/0000-0001-6986-5684;
   Andreatini, Roberto/0000-0002-8661-9132
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG
   SCHW 559/14-1, SCHW 559/14-2, DFG WO 1732/4-1, WO 1732/4-2];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [308412/2015-0]; CNPq National Institute for Translational Neuroscience;
   Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES
FX This work was supported by grants from the Deutsche
   Forschungsgemeinschaft to R.S. (DFG SCHW 559/14-1 and SCHW 559/14-2) and
   M.W. (DFG WO 1732/4-1 and WO 1732/4-2), R.A. (CNPq308412/2015-0) and
   S.T.F. (CNPq National Institute for Translational Neuroscience and
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro). JCFG is
   recipient of a research fellowship from CNPq. C.P.S. and E.W. are
   recipient of student fellowship from CAPES.
CR Abrial E, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu031
   Ahrens AM, 2009, BEHAV BRAIN RES, V197, P205, DOI 10.1016/j.bbr.2008.08.037
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Armani F, 2014, PSYCHOPHARMACOLOGY, V231, P639, DOI 10.1007/s00213-013-3397-x
   Armani F, 2012, CNS NEUROSCI THER, V18, P119, DOI 10.1111/j.1755-5949.2010.00224.x
   Ashok AH, 2017, MOL PSYCHIATR, V22, P666, DOI 10.1038/mp.2017.16
   Beckman D, 2015, J BIOL CHEM, V290, P20488, DOI 10.1074/jbc.M115.666156
   Brudzynski SM, 2015, CURR NEUROPHARMACOL, V13, P180, DOI 10.2174/1570159X13999150210141444
   Brudzynski SM, 2012, BEHAV BRAIN RES, V226, P511, DOI 10.1016/j.bbr.2011.10.004
   Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010
   Burgdorf J, 2011, NEUROSCI BIOBEHAV R, V35, P1831, DOI 10.1016/j.neubiorev.2010.11.011
   COENEN AML, 1985, PHYSIOL BEHAV, V35, P501, DOI 10.1016/0031-9384(85)90130-1
   COHEN HB, 1965, SCIENCE, V150, P1318, DOI 10.1126/science.150.3701.1318
   Colombo C, 1999, PSYCHIAT RES, V86, P267, DOI 10.1016/S0165-1781(99)00036-0
   Costa G, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv057
   Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x
   de Miranda AS, 2017, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, 2ND EDITION, P1131
   Einat H, 2007, BEHAV GENET, V37, P244, DOI 10.1007/s10519-006-9093-4
   Engelhardt KA, 2018, PSYCHOPHARMACOLOGY, V235, P83, DOI 10.1007/s00213-017-4746-y
   Engelhardt KA, 2017, EUR NEUROPSYCHOPHARM, V27, P261, DOI 10.1016/j.euroneuro.2017.01.003
   Frau R, 2017, NEUROPSYCHOPHARMACOL, V42, P2196, DOI 10.1038/npp.2017.13
   Gallo EF, 2015, NEUROPSYCHOPHARMACOL, V40, P1609, DOI 10.1038/npp.2015.11
   Gessa GL, 1995, EUR NEUROPSYCHOPHARM, V5, P89, DOI 10.1016/0924-977X(95)00023-I
   Goodwin FK, 2007, MANIC DEPRESSIVE ILL
   Heal DJ, 2009, NEUROPHARMACOLOGY, V57, P608, DOI 10.1016/j.neuropharm.2009.08.020
   Kanazawa LKS, 2016, FREE RADICAL BIO MED, V99, P79, DOI 10.1016/j.freeradbiomed.2016.07.027
   Kara NZ, 2013, CELL TISSUE RES, V354, P191, DOI 10.1007/s00441-013-1594-x
   Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961
   Logan RW, 2016, NEUROSCIENCE, V321, P163, DOI 10.1016/j.neuroscience.2015.08.041
   Lukas M, 2015, PSYCHONEUROENDOCRINO, V56, P35, DOI 10.1016/j.psyneuen.2015.03.005
   Machado L, 2017, REV BRAS PSIQUIATR, V39, P172, DOI 10.1590/1516-4446-2016-1988
   Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019
   McBride WJ, 2010, HBK BEHAV NEUROSCI, V21, P399, DOI 10.1016/B978-0-12-374634-4.00024-1
   Natusch C, 2010, PHARMACOL BIOCHEM BE, V96, P251, DOI 10.1016/j.pbb.2010.05.013
   Nogoceke FP, 2016, NEUROSCI LETT, V619, P43, DOI 10.1016/j.neulet.2016.03.013
   NUNES GP, 1994, BRAIN RES BULL, V34, P453, DOI 10.1016/0361-9230(94)90018-3
   Pereira M, 2014, PSYCHOPHARMACOLOGY, V231, P2567, DOI 10.1007/s00213-013-3413-1
   Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58
   Proenca MB, 2014, NEUROPHARMACOLOGY, V76, P118, DOI 10.1016/j.neuropharm.2013.08.024
   Proudfoot J, 2011, J AFFECT DISORDERS, V133, P381, DOI 10.1016/j.jad.2010.10.051
   Rippberger H, 2015, CURR NEUROPHARMACOL, V13, P220, DOI 10.2174/1570159X1302150525124408
   Sadananda M, 2008, NEUROSCI LETT, V435, P17, DOI 10.1016/j.neulet.2008.02.002
   Sadananda M, 2012, PHARMACOL BIOCHEM BE, V101, P258, DOI 10.1016/j.pbb.2012.01.012
   Saxena Ashwini, 2017, Mol Neuropsychiatry, V3, P108, DOI 10.1159/000480349
   Scardochio T, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00331
   Schwarting RKW, 2007, BEHAV BRAIN RES, V182, P208, DOI 10.1016/j.bbr.2007.01.029
   Sharma AN, 2016, PROG NEURO-PSYCHOPH, V66, P22, DOI 10.1016/j.pnpbp.2015.11.001
   Sidor MM, 2015, MOL PSYCHIATR, V20, P1406, DOI 10.1038/mp.2014.167
   Simola N, 2015, CURR NEUROPHARMACOL, V13, P164, DOI 10.2174/1570159X13999150318113800
   Simola N, 2015, EUR NEUROPSYCHOPHARM, V25, P343, DOI 10.1016/j.euroneuro.2015.01.010
   Stern CAJ, 2017, NEUROPHARMACOLOGY, V125, P220, DOI 10.1016/j.neuropharm.2017.07.024
   Streck EL, 2015, NEUROCHEM RES, V40, P1144, DOI 10.1007/s11064-015-1575-4
   Suchecki D, 1998, J SLEEP RES, V7, P276, DOI 10.1046/j.1365-2869.1998.00122.x
   Taracha E, 2014, NEUROPHARMACOLOGY, V83, P128, DOI 10.1016/j.neuropharm.2014.04.008
   Thompson B, 2006, BEHAV BRAIN RES, V168, P64, DOI 10.1016/j.bbr.2005.10.012
   Tsuchiya KJ, 2003, BIPOLAR DISORD, V5, P231, DOI 10.1034/j.1399-5618.2003.00038.x
   TUFIK S, 1978, PHARMACOLOGY, V16, P98, DOI 10.1159/000136753
   TUFIK S, 1981, PSYCHOPHARMACOLOGY, V72, P257, DOI 10.1007/BF00431826
   TUFIK S, 1981, J PHARM PHARMACOL, V33, P732, DOI 10.1111/j.2042-7158.1981.tb13916.x
   Tufik S, 2009, AN ACAD BRAS CIENC, V81, P521, DOI 10.1590/S0001-37652009000300016
   Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603
   Volkow ND, 2008, J NEUROSCI, V28, P8454, DOI 10.1523/JNEUROSCI.1443-08.2008
   Volkow ND, 2009, NEUROIMAGE, V45, P1232, DOI 10.1016/j.neuroimage.2009.01.003
   Wendler E, 2016, EUR NEUROPSYCHOPHARM, V26, P1900, DOI 10.1016/j.euroneuro.2016.10.012
   Wintink AJ, 2001, PHARMACOL BIOCHEM BE, V70, P317, DOI 10.1016/S0091-3057(01)00615-3
   Wohr M, 2008, PHYSIOL BEHAV, V93, P766, DOI 10.1016/j.physbeh.2007.11.031
   Wohr M, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-017-2427-9
   Wohr M, 2015, PSYCHOPHARMACOLOGY, V232, P1817, DOI 10.1007/s00213-014-3814-9
   Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9
   Wright JM, 2013, PSYCHOPHARMACOLOGY, V225, P853, DOI 10.1007/s00213-012-2871-1
   Wright JM, 2012, NEUROPSYCHOPHARMACOL, V37, P808, DOI 10.1038/npp.2011.258
   Young JW, 2011, BRIT J PHARMACOL, V164, P1263, DOI 10.1111/j.1476-5381.2011.01318.x
NR 72
TC 3
Z9 3
U1 1
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-5846
EI 1878-4216
J9 PROG NEURO-PSYCHOPH
JI Prog. Neuro-Psychopharmacol. Biol. Psychiatry
PD JAN 10
PY 2019
VL 88
BP 142
EP 150
DI 10.1016/j.pnpbp.2018.07.002
PG 9
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA GU8ZY
UT WOS:000445634300015
PM 29981775
DA 2020-09-29
ER

PT J
AU Andreatini, R
   Wendler, E
   De Souza, CP
   Dornellas, APS
   Dos Santos, LE
   Ferreira, ST
   Galduroz, JC
   Wohr, M
   Schwarting, RK
AF Andreatini, R.
   Wendler, E.
   De Souza, C. P.
   Dornellas, A. P. S.
   Dos Santos, L. E.
   Ferreira, S. T.
   Galduroz, J. C.
   Woehr, M.
   Schwarting, R. K.
TI 50-kHz ultrasonic vocalizations increase after sleep deprivation as
   mania-like elevated mood in rats: Effects of lithium
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP)
CY OCT 06-09, 2018
CL Barcelona, SPAIN
SP European Coll Neuropsychopharmacol
ID ANIMAL-MODELS
C1 [Andreatini, R.] Univ Fed Parana, Ctr Politecn, Dept Pharmacol, Curitiba, Parana, Brazil.
   [Wendler, E.; De Souza, C. P.; Dornellas, A. P. S.] Univ Fed Parana, Dept Pharmacol, Curitiba, Parana, Brazil.
   [Dos Santos, L. E.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Dos Santos, L. E.; Ferreira, S. T.] Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Galduroz, J. C.] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.
   [Woehr, M.; Schwarting, R. K.] Philipps Univ Marburg, Behav Neurosci Expt & Biol Psychol, Marburg, Germany.
RI Galduroz, Jose Carlos Fernandes/G-3305-2012; Ferreira,
   Sergio/AAZ-1576-2020; Andreatini, Roberto/R-2947-2019
OI Galduroz, Jose Carlos Fernandes/0000-0002-2710-9693; Ferreira,
   Sergio/0000-0001-7160-9866; Wohr, Markus/0000-0001-6986-5684
CR Machado RB, 2006, BRAIN RES BULL, V70, P213, DOI 10.1016/j.brainresbull.2006.04.001
   Pereira M, 2014, PSYCHOPHARMACOLOGY, V231, P2567, DOI 10.1007/s00213-013-3413-1
   Wendler E, 2016, EUR NEUROPSYCHOPHARM, V26, P1900, DOI 10.1016/j.euroneuro.2016.10.012
   Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9
   Young JW, 2011, BRIT J PHARMACOL, V164, P1263, DOI 10.1111/j.1476-5381.2011.01318.x
NR 5
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PY 2019
VL 29
SU 1
MA P.557
BP S373
EP S374
DI 10.1016/j.euroneuro.2018.11.572
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA HL0RB
UT WOS:000458400500497
DA 2020-09-29
ER

PT J
AU Lourenco, MV
   Frozza, RL
   de Freitas, GB
   Zhang, H
   Kincheski, GC
   Ribeiro, FC
   Goncalves, RA
   Clarke, JR
   Beckman, D
   Staniszewski, A
   Berman, H
   Guerra, LA
   Forny-Germano, L
   Meier, S
   Wilcock, DM
   de Souza, JM
   Alves-Leon, S
   Prado, VF
   Prado, MAM
   Abisambra, JF
   Tovar-Moll, F
   Mattos, P
   Arancio, O
   Ferreira, ST
   De Felice, FG
AF Lourenco, Mychael V.
   Frozza, Rudimar L.
   de Freitas, Guilherme B.
   Zhang, Hong
   Kincheski, Grasielle C.
   Ribeiro, Felipe C.
   Goncalves, Rafaella A.
   Clarke, Julia R.
   Beckman, Danielle
   Staniszewski, Agnieszka
   Berman, Hanna
   Guerra, Lorena A.
   Forny-Germano, Leticia
   Meier, Shelby
   Wilcock, Donna M.
   de Souza, Jorge M.
   Alves-Leon, Soniza
   Prado, Vania F.
   Prado, Marco A. M.
   Abisambra, Jose F.
   Tovar-Moll, Fernanda
   Mattos, Paulo
   Arancio, Ottavio
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory
   defects in Alzheimer's models
SO NATURE MEDICINE
LA English
DT Article
ID DEPRESSIVE-LIKE BEHAVIOR; AMYLOID-BETA OLIGOMERS; HIPPOCAMPAL
   INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; MOUSE MODEL; EIF2-ALPHA KINASES;
   GENE-EXPRESSION; ENERGY-INTAKE; BRAIN; DISEASE
AB Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a disorder characterized by synapse and memory failure. Irisin is an exercise-induced myokine released on cleavage of the membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5), also expressed in the hippocampus. Here we show that FNDC5/irisin levels are reduced in AD hippocampi and cerebrospinal fluid, and in experimental AD models. Knockdown of brain FNDC5/irisin impairs long-term potentiation and novel object recognition memory in mice. Conversely, boosting brain levels of FNDC5/irisin rescues synaptic plasticity and memory in AD mouse models. Peripheral overexpression of FNDC5/irisin rescues memory impairment, whereas blockade of either peripheral or brain FNDC5/irisin attenuates the neuroprotective actions of physical exercise on synaptic plasticity and memory in AD mice. By showing that FNDC5/irisin is an important mediator of the beneficial effects of exercise in AD models, our findings place FNDC5/irisin as a novel agent capable of opposing synapse failure and memory impairment in AD.
C1 [Lourenco, Mychael V.; Frozza, Rudimar L.; de Freitas, Guilherme B.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Clarke, Julia R.; Beckman, Danielle; Guerra, Lorena A.; Forny-Germano, Leticia; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Lourenco, Mychael V.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Guerra, Lorena A.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Lourenco, Mychael V.; Zhang, Hong; Staniszewski, Agnieszka; Berman, Hanna; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.
   [Frozza, Rudimar L.] Fiocruz MS, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [de Freitas, Guilherme B.; Goncalves, Rafaella A.; De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
   [Meier, Shelby; Wilcock, Donna M.; Abisambra, Jose F.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.
   [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, Rio De Janeiro, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, Rio De Janeiro, Brazil.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.
   [Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.
   [Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.
   [Arancio, Ottavio] Columbia Univ, Dept Med, New York, NY 10027 USA.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RP Ferreira, ST; De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.; Arancio, O (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Arancio, O (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Arancio, O (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Dept Psychiat, Kingston, ON, Canada.
EM oa1@cumc.columbia.edu; ferreira@biof.ufrj.br;
   fernanda.defelice@queensu.ca
RI Ferreira, Sergio/AAZ-1576-2020; de Mattos, Paulo Eduardo
   Luiz/D-2328-2014; Clarke, Julia/AAF-9434-2019; Prado, Vania
   Ferreira/K-7630-2013; Ribeiro, Felipe Campos/W-9758-2019; Abisambra,
   Joe/AAP-3269-2020; Forny-Germano, Leticia/D-1342-2017; Abisambra,
   Jose/V-6860-2019; Leon, Soniza V Alves/J-7786-2012; Beckman,
   Danielle/AAA-1016-2019; Prado, Marco Antonio Maximo/K-7638-2013;
   Lourenco, Mychael/G-2614-2014; Lourenco, Mychael/AAG-9732-2020; Beckman,
   Danielle/J-5331-2015; Forny-Germano, Leticia/L-6639-2019; arancio,
   ottavio/AAB-7959-2019
OI Ferreira, Sergio/0000-0001-7160-9866; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783; Prado, Vania Ferreira/0000-0003-4994-6393;
   Ribeiro, Felipe Campos/0000-0003-3028-3307; Forny-Germano,
   Leticia/0000-0001-8301-0711; Abisambra, Jose/0000-0001-6341-679X;
   Beckman, Danielle/0000-0002-9584-4411; Prado, Marco Antonio
   Maximo/0000-0002-3028-5778; Lourenco, Mychael/0000-0002-1078-0296;
   Lourenco, Mychael/0000-0002-1078-0296; Beckman,
   Danielle/0000-0002-9584-4411; Forny-Germano,
   Leticia/0000-0001-8301-0711; Meier, Shelby/0000-0003-1946-9004; Frozza,
   Rudimar Luiz/0000-0003-0918-4128; De Freitas,
   Guilherme/0000-0003-4614-4280; Berman, Hanna/0000-0002-8616-8167
FU Alzheimer Society of Canada; Weston Brain Institute; National Institute
   for Translational Neuroscience (INNT/Brazil) [465346/2014-6]; Human
   Frontier Science ProgramHuman Frontier Science Program; International
   Society for Neurochemistry (CAEN 1B); National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NIH-R01NS049442]; Canadian Institutes
   of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR
   MOP 136940, MOP 89919]; Brazilian funding agency Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [451195/2017-5,
   406436/2016-9, 473324/2013-0]; Brazilian funding agency Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [202.817/2016, 201.432/2014, 202.944/2015];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); Comissao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES/Brazil)CAPES [001]; NIH T32 grantUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AG057461]
FX This work was supported by grants from Alzheimer Society of Canada (to
   F.G.D.F.) and the Weston Brain Institute (to F.G.D.F.), National
   Institute for Translational Neuroscience (INNT/Brazil) (465346/2014-6 to
   S.T.F. and F.G.F.), Human Frontier Science Program (to F.G.D.F.),
   International Society for Neurochemistry (CAEN 1B to M.V.L.), National
   Institutes of Health (NIH-R01NS049442 to O.A.), Canadian Institutes of
   Health Research (CIHR MOP 136940 and MOP 89919 to V.F.P. and M.A.M.P.),
   and from the Brazilian funding agencies Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (451195/2017-5 to
   M.V.L., 406436/2016-9 to S.T.F., and 473324/2013-0 to F.G.D.F.) and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (202.817/2016 to M.V.L., 201.432/2014 to S.T.F., and
   202.944/2015 to F.G.D.F.). R.L.F, G.B.d.F., G.C.K., F.C.R., J.R.C.,
   D.B., and L.F.-G. were supported by fellowships granted by FAPERJ, CNPq,
   or Comissao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/Brazil; financial code 001). S.M. was supported by an NIH T32
   grant (AG057461). We acknowledge the University of Kentucky Alzheimer's
   Disease Center and its Neuropathology Core, which is supported by
   NIH/NIA P30 AG028383, for brain samples. We thank W.L. Klein
   (Northwestern University) for the kind gift of oligomer-specific NU4
   antibodies, B.M. Spiegelman (Harvard University) for sharing AdGFP and
   AdFNDC5 adenoviral constructs, and J. Wang (Queen's University, Canada)
   for help with mass spectrometry analyses. We also thank A. Lepelley, M.
   Oliveira, M. Melo, A.C. Rangel, and the CENABIO team for technical
   and/or administrative assistance.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275
   Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889
   Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307
   Beckman D, 2015, J BIOL CHEM, V290, P20488, DOI 10.1074/jbc.M115.666156
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35
   Chen K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao6298
   Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   Drummond C, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00096
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097
   Irving AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0155
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001
   Katsnelson A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aal2074
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017
   Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9
   Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012
   McEwen BS, 2015, P NATL ACAD SCI USA, V112, P15544, DOI 10.1073/pnas.1521416112
   Mendes ND, 2018, J NEUROSCI METH, V307, P203, DOI 10.1016/j.jneumeth.2018.05.021
   Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025
   Mucke L, 2012, COLD SPRING HARB PER, V2
   Muller S, 2018, ALZHEIMERS DEMENT, V14, P1427, DOI 10.1016/j.jalz.2018.06.3059
   Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011
   Okonkwo OC, 2014, NEUROLOGY, V83, P1753, DOI 10.1212/WNL.0000000000000964
   Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
   Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009
   Schaefer N, 2017, J NEUROCHEM, V142, P790, DOI 10.1111/jnc.14107
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]
   Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092
   Smith RW, 2007, PROTEOMICS, V7, P4171, DOI 10.1002/pmic.200700573
   Suwabe K, 2018, P NATL ACAD SCI USA, V115, P10487, DOI 10.1073/pnas.1805668115
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364
   Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254
   Trinh MA, 2013, NEUROBIOL LEARN MEM, V105, P93, DOI 10.1016/j.nlm.2013.04.013
   van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Yang WZ, 2016, NEUROBIOL AGING, V41, P19, DOI 10.1016/j.neurobiolaging.2016.02.005
   Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106
NR 70
TC 94
Z9 97
U1 19
U2 98
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JAN
PY 2019
VL 25
IS 1
BP 165
EP +
DI 10.1038/s41591-018-0275-4
PG 26
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA HG5OR
UT WOS:000455027700034
PM 30617325
OA Green Accepted
DA 2020-09-29
ER

PT J
AU Madeira, C
   Alheira, FV
   Calcia, MA
   Silva, TCS
   Tannos, FM
   Vargas-Lopes, C
   Fisher, M
   Goldenstein, N
   Brasil, MA
   Vinogradov, S
   Ferreira, ST
   Panizzutti, R
AF Madeira, Caroline
   Alheira, Flavio, V
   Calcia, Marilia A.
   Silva, Thuany C. S.
   Tannos, Filippe M.
   Vargas-Lopes, Charles
   Fisher, Melissa
   Goldenstein, Nelson
   Brasil, Marco Antonio
   Vinogradov, Sophia
   Ferreira, Sergio T.
   Panizzutti, Rogerio
TI Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic
   Schizophrenia
SO FRONTIERS IN PSYCHIATRY
LA English
DT Article
DE recent onset schizophrenia; chronic schizophrenia; glutamate; glutamine;
   blood
ID PREFRONTAL CORTEX; CEREBROSPINAL-FLUID; MONOAMINE METABOLITES;
   WORKING-MEMORY; SERUM; SYNTHETASE; EXPRESSION; PROTEIN; ANTAGONIST;
   KETAMINE
AB Converging evidence indicates that dysfunctions in glutamatergic neurotransmission and in the glutamate-glutamine cycle play a role in the pathophysiology of schizophrenia. Here, we investigated glutamate and glutamine levels in the blood of patients with recent onset schizophrenia or chronic schizophrenia compared to healthy controls. Compared with healthy controls, patients with recent onset schizophrenia showed increased glutamine/glutamate ratio, while patients with chronic schizophrenia showed decreased glutamine/glutamate ratio. Results indicate that circulating glutamate and glutamine levels exhibit a dual behavior in schizophrenia, with an increase of glutamine/glutamate ratio at the onset of schizophrenia followed by a decrease with progression of the disorder. Further studies are warranted to elucidate the mechanisms and consequences of changes in circulating glutamate and glutamine in schizophrenia.
C1 [Madeira, Caroline; Vargas-Lopes, Charles; Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Inst Glandes Biomed, Rio De Janeiro, Brazil.
   [Alheira, Flavio, V; Calcia, Marilia A.; Silva, Thuany C. S.; Tannos, Filippe M.; Goldenstein, Nelson; Brasil, Marco Antonio; Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Psiquiatria & Psicol Med, Rio De Janeiro, Brazil.
   [Fisher, Melissa; Vinogradov, Sophia] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA USA.
   [Fisher, Melissa; Vinogradov, Sophia] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Panizzutti, R (corresponding author), Univ Fed Rio de Janeiro, Inst Glandes Biomed, Rio De Janeiro, Brazil.; Panizzutti, R (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Psiquiatria & Psicol Med, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
EM fereira@bioqmed.ufrj.br; rogerio@icb.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Calcia,
   Marilia/0000-0001-8488-9342
FU DECIT/SCTIE/MS; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Instituto Nacional de
   Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB);
   National Institute for Translational Neuroscience; Human Frontier
   Science ProgramHuman Frontier Science Program; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); SESDC
FX We thank A. C. Rangel and A. Fantinatti for administrative and technical
   support. This research was supported by grants from DECIT/SCTIE/MS,
   SESDC, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (RP and SF); Instituto Nacional de Ciencia e
   Tecnologia de Biologia Estrutural e Bioimagem (INBEB) (RP); and National
   Institute for Translational Neuroscience (SF). RP was recipient of a
   Long-Term Fellowship from the Human Frontier Science Program. CM and
   CV-L were supported by pre-doctoral fellowships from FAPERJ and CNPq.
CR ALFREDSSON G, 1988, BIOL PSYCHIAT, V23, P689, DOI 10.1016/0006-3223(88)90052-2
   ALFREDSSON G, 1989, PSYCHOPHARMACOLOGY, V99, P322, DOI 10.1007/BF00445551
   ALFREDSSON G, 1988, J CHROMATOGR-BIOMED, V424, P378, DOI 10.1016/S0378-4347(00)81116-0
   Bachman P, 2010, SCHIZOPHR RES, V118, P6, DOI 10.1016/j.schres.2010.02.1029
   Blouin M, 2008, OBESITY, V16, P1780, DOI 10.1038/oby.2008.277
   Bruneau EG, 2005, SCHIZOPHR RES, V75, P27, DOI 10.1016/j.schres.2004.12.012
   Burbaeva GS, 2003, PROG NEURO-PSYCHOPH, V27, P675, DOI 10.1016/S0278-5846(03)00078-2
   Bushe Chris, 2005, J Psychopharmacol, V19, P28, DOI 10.1177/0269881105058682
   Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014
   Domino EF, 2012, SCHIZOPHRENIA BULL, V38, P914, DOI 10.1093/schbul/sbs011
   Egerton A, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00066
   ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7
   Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757
   GATTAZ WF, 1982, ARCH PSYCHIAT NERVEN, V231, P221, DOI 10.1007/BF00343292
   Gluck MR, 2002, AM J PSYCHIAT, V159, P1165, DOI 10.1176/appi.ajp.159.7.1165
   Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367
   Goff DC, 2002, BIOL PSYCHIAT, V51, P493, DOI 10.1016/S0006-3223(01)01321-X
   Gupta DS, 2005, SYNAPSE, V57, P123, DOI 10.1002/syn.20164
   HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F
   Hashimoto K, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-6
   Hassan TH, 2013, RES AUTISM SPECT DIS, V7, P541, DOI 10.1016/j.rasd.2012.12.005
   He Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.76
   Ivanova SA, 2014, PROCEDIA CHEM, V10, P80, DOI 10.1016/j.proche.2014.10.015
   KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004
   Krystal JH, 2005, PSYCHOPHARMACOLOGY, V179, P303, DOI 10.1007/s00213-004-1982-8
   Kwak SK, 2017, KOREAN J ANESTHESIOL, V70, P407, DOI 10.4097/kjae.2017.70.4.407
   Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599
   Leucht S, 2013, EUR NEUROPSYCHOPHARM, V23, P956, DOI 10.1016/j.euroneuro.2012.11.004
   LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011
   MACCIARDI F, 1990, PSYCHIAT RES, V32, P63, DOI 10.1016/0165-1781(90)90136-S
   Maksymetz J, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0293-z
   MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x
   Mei YY, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00544
   Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181
   Ohtsuki T, 2008, SCHIZOPHR RES, V101, P9, DOI 10.1016/j.schres.2008.01.027
   OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1016/0893-133X(95)00079-S
   Palomino A, 2007, SCHIZOPHR RES, V95, P174, DOI 10.1016/j.schres.2007.06.012
   Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632
   Sacchi S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46288
   Shulman Y, 2006, J PSYCHIATR NEUROSCI, V31, P406
   Song J, 2014, NEUROPSYCHOBIOLOGY, V70, P133, DOI 10.1159/000364828
   Steffek AE, 2008, SCHIZOPHR RES, V103, P71, DOI 10.1016/j.schres.2008.04.032
   Vinogradov S, 2009, BIOL PSYCHIAT, V66, P549, DOI 10.1016/j.biopsych.2009.02.017
   Vinogradov S, 2009, AM J PSYCHIAT, V166, P1055, DOI 10.1176/appi.ajp.2009.09010017
   Volk DW, 2010, AM J PSYCHIAT, V167, P1489, DOI 10.1176/appi.ajp.2010.10030318
   Walton HS, 2007, NEUROCHEM INT, V50, P1052, DOI 10.1016/j.neuint.2006.10.007
NR 46
TC 6
Z9 6
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-0640
J9 FRONT PSYCHIATRY
JI Front. Psychiatry
PD DEC 19
PY 2018
VL 9
AR 713
DI 10.3389/fpsyt.2018.00713
PG 8
WC Psychiatry
SC Psychiatry
GA HF0PG
UT WOS:000453863500001
PM 30618883
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Madeira, C
   Vargas-Lopes, C
   Brandao, CO
   Reis, T
   Laks, J
   Panizzutti, R
   Ferreira, ST
AF Madeira, Caroline
   Vargas-Lopes, Charles
   Brandao, Carlos Otavio
   Reis, Taylor
   Laks, Jerson
   Panizzutti, Rogerio
   Ferreira, Sergio T.
TI Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of
   Patients With Probable Alzheimer's Disease and Depression
SO FRONTIERS IN PSYCHIATRY
LA English
DT Article
DE Alzheimer's disease; depression; glutamate; glutamine; cerebrospinal
   fluid; innotest amyloid tau index
ID MILD COGNITIVE IMPAIRMENT; AMINO-ACID-CONCENTRATIONS; AMYLOID-BETA
   OLIGOMERS; LATE-LIFE DEPRESSION; VASCULAR DEMENTIA; MAJOR DEPRESSION;
   ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE;
   SYNAPSE FAILURE
AB Recent evidence suggests that Alzheimer's disease (AD) and depression share common mechanisms of pathogenesis. In particular, deregulation of glutamate-mediated excitatory signaling may play a role in brain dysfunction in both AD and depression. We have investigated levels of glutamate and its precursor glutamine in the cerebrospinal fluid (CSF) of patients with a diagnosis of probable AD or major depression compared to healthy controls and patients with hydrocephalus. Patients with probable AD or major depression showed significantly increased CSF levels of glutamate and glutamine compared to healthy controls or hydrocephalus patients. Furthermore, CSF glutamate and glutamine levels were inversely correlated to the amyloid tau index, a biomarker for AD. Results suggest that glutamate and glutamine should be further explored as potential CSF biomarkers for AD and depression.
C1 [Madeira, Caroline; Vargas-Lopes, Charles; Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Brandao, Carlos Otavio; Reis, Taylor; Laks, Jerson; Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Panizzutti, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Panizzutti, R (corresponding author), Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
EM rogerio@icb.ufrj.br; ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU DECIT/SCTIE/MS; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Instituto Nacional de
   Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB);
   National Institute for Translational Neuroscience; Human Frontier
   Science ProgramHuman Frontier Science Program; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); SESDC
FX We thank A. C. Rangel and A. Fantinatti for administrative and technical
   support. We also thank Dr. L. Scoriels for review of the manuscript.
   This research was supported by grants from DECIT/SCTIE/MS, SESDC,
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to RP
   and SF; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) to RP, SF, and JL; Instituto Nacional de Ciencia e Tecnologia de
   Biologia Estrutural e Bioimagem (INBEB) to RP; and National Institute
   for Translational Neuroscience to SF. RP was recipient of a Long-Term
   Fellowship from the Human Frontier Science Program. CM and CV-L were
   supported by pre-doctoral fellowships from FAPERJ and CNPq.
CR American Psychiatryc Assotiation, 1994, DIAGN STAT MAN MENT
   Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x
   Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014
   D'Aniello A, 2005, NEUROSCI LETT, V388, P49, DOI 10.1016/j.neulet.2005.06.030
   DEGRELL I, 1989, ARCH GERONTOL GERIAT, V9, P123, DOI 10.1016/0167-4943(89)90033-2
   Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307
   Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Frye MA, 2007, BIOL PSYCHIAT, V61, P162, DOI 10.1016/j.biopsych.2006.01.024
   Garakani A, 2013, J AFFECT DISORDERS, V146, P262, DOI 10.1016/j.jad.2012.06.037
   Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753
   Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8
   Gualtieri CT, 2008, PROG NEURO-PSYCHOPH, V32, P962, DOI 10.1016/j.pnpbp.2007.12.030
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F
   Hashimoto K, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.8
   Hashimoto K, 2013, EUR ARCH PSY CLIN N, V263, P367, DOI 10.1007/s00406-013-0399-y
   Hermida AP, 2012, EXPERT REV NEUROTHER, V12, P1339, DOI [10.1586/ERN.12.127, 10.1586/ern.12.127]
   Heser K, 2013, PSYCHOL MED, V43, P1597, DOI 10.1017/S0033291712002449
   Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555
   Hurley LL, 2013, NEUROTOX RES, V23, P131, DOI 10.1007/s12640-012-9348-1
   Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007
   Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004
   Jimenez-Jimenez FJ, 1998, J NEURAL TRANSM, V105, P269, DOI 10.1007/s007020050056
   Kaiser E, 2010, NEURODEGENER DIS, V7, P251, DOI 10.1159/000287953
   Kochhann Renata, 2010, Dement. neuropsychol., V4, P35, DOI 10.1590/S1980-57642010DN40100006
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Leonard Brian E., 2010, Current Immunology Reviews, V6, P205
   Levine J, 2000, BIOL PSYCHIAT, V47, P586, DOI 10.1016/S0006-3223(99)00284-X
   Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Machado-Vieira R, 2009, CURR PHARM DESIGN, V15, P1595, DOI 10.2174/138161209788168010
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   MAIER W, 1985, ACTA PSYCHIAT SCAND, V72, P239, DOI 10.1111/j.1600-0447.1985.tb02601.x
   MARTINEZ M, 1993, J NEURAL TRANSM-PARK, V6, P1, DOI 10.1007/BF02252617
   McKeage K, 2009, CNS DRUGS, V23, P881, DOI 10.2165/11201020-000000000-00000
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
   Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5
   Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029
   MORENO DH, 1994, INT CLIN PSYCHOPHARM, V9, P11, DOI 10.1097/00004850-199406002-00003
   MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Niciu MJ, 2014, J NEURAL TRANSM, V121, P907, DOI 10.1007/s00702-013-1130-x
   Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304
   POMARA N, 1992, AM J PSYCHIAT, V149, P251
   PROCTER AW, 1988, J NEUROCHEM, V50, P790, DOI 10.1111/j.1471-4159.1988.tb02983.x
   Reis T, 2012, CNS NEUROSCI THER, V18, P524, DOI 10.1111/j.1755-5949.2012.00311.x
   Reppermund S, 2009, PSYCHOL MED, V39, P603, DOI 10.1017/S003329170800411X
   Reppermund S, 2007, BIOL PSYCHIAT, V62, P400, DOI 10.1016/j.biopsych.2006.09.027
   Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3
   Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138
   Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457
   SMITH CCT, 1985, J NEUROL NEUROSUR PS, V48, P469, DOI 10.1136/jnnp.48.5.469
   Tabaraud F, 2012, ACTA NEUROL SCAND, V125, P416, DOI 10.1111/j.1600-0404.2011.01592.x
   TOHGI H, 1992, NEUROSCI LETT, V141, P5, DOI 10.1016/0304-3940(92)90321-W
   Walton HS, 2007, NEUROCHEM INT, V50, P1052, DOI 10.1016/j.neuint.2006.10.007
   Wang Z, 2017, J ALZHEIMERS DIS, V56, P415, DOI 10.3233/JAD-160724
   *WHO, 1992, INT STAT CLASS DIS
   Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856
   Zubenko GS, 2003, AM J PSYCHIAT, V160, P857, DOI 10.1176/appi.ajp.160.5.857
NR 67
TC 16
Z9 16
U1 2
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-0640
J9 FRONT PSYCHIATRY
JI Front. Psychiatry
PD NOV 6
PY 2018
VL 9
AR 561
DI 10.3389/fpsyt.2018.00561
PG 8
WC Psychiatry
SC Psychiatry
GA GZ3ZV
UT WOS:000449329700004
PM 30459657
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Mendes, ND
   Fernandes, A
   Almeida, GM
   Santos, LE
   Selles, MC
   Silva, NMLE
   Machado, CM
   Horta, JAC
   Louzada, PR
   De Felice, FG
   Alves-Leon, S
   Marcondes, J
   Assirati, JA
   Matios, CM
   Klein, WL
   Garcia-Cairasco, N
   Ferreira, ST
   Neder, L
   Sebollela, A
AF Mendes, Niele D.
   Fernandes, Artur
   Almeida, Glaucia M.
   Santos, Luis E.
   Selles, Maria Clara
   Lyra e Silva, N. M.
   Machado, Carla M.
   Horta-Junior, Jose A. C.
   Louzada, Paulo R.
   De Felice, Fernando G.
   Alves-Leon, Soniza
   Marcondes, Jorge
   Assirati Jr, Joao Alberto
   Matios, Caio M.
   Klein, William L.
   Garcia-Cairasco, Norberto
   Ferreira, Sergio T.
   Neder, Luciano
   Sebollela, Adriano
TI Free-floating adult human brain-derived slice cultures as a model to
   study the neuronal impact of Alzheimer's disease-associated A beta
   oligomers
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Tissue slices; Organotypic culture; Human brain; Alzheimer's disease; A
   beta oligomers; Epilepsy
ID POSTMORTEM CHANGES; PATHOGENESIS; MECHANISMS; HYPOTHESIS; EVOLUTION;
   RELEASE; GROWTH; NEED
AB Background: Slice cultures have been prepared from several organs. With respect to the brain, advantages of slice cultures over dissociated cell cultures include maintenance of the cytoarchitecture and neuronal connectivity. Slice cultures from adult human brain have been reported and constitute a promising method to study neurological diseases. Despite this potential, few studies have characterized in detail cell survival and function along time in short-term, free-floating cultures.
   New Method: We used tissue from adult human brain cortex from patients undergoing temporal lobectomy to prepare 200 pm-thick slices. Along the period in culture, we evaluated neuronal survival, histological modifications, and neurotransmitter release. The toxicity of Alzheimer's-associated A beta oligomers (A beta Os) to cultured slices was also analyzed.
   Results: Neurons in human brain slices remain viable and neurochemically active for at least four days in vitro, which allowed detection of binding of A beta Os. We further found that slices exposed to A beta Os presented elevated levels of hyperphosphorylated Tau, a hallmark of Alzheimer's disease.
   Comparison with Existing Method(s): Although slice cultures from adult human brain have been previously prepared, this is the first report to analyze cell viability and neuronal activity in short-term free-floating cultures as a function of days in vitro.
   Conclusions: Once surgical tissue is available, the current protocol is easy to perform and produces functional slices from adult human brain. These slice cultures may represent a preferred model for translational studies of neurodegenerative disorders when long term culturing in not required, as in investigations on A beta O neurotoxicity.
C1 [Mendes, Niele D.; Fernandes, Artur; Almeida, Glaucia M.; Sebollela, Adriano] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.
   [Mendes, Niele D.; Neder, Luciano] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Forens Med, Ribeirao Preto, SP, Brazil.
   [Fernandes, Artur; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Ribeirao Preto, SP, Brazil.
   [Santos, Luis E.; Selles, Maria Clara; Lyra e Silva, N. M.; De Felice, Fernando G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, RJ, Brazil.
   [Machado, Carla M.; Horta-Junior, Jose A. C.] Sao Paulo State Univ, Inst Biosci, Dept Anat, Sao Paulo, Brazil.
   [Louzada, Paulo R.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernando G.] Queens Univ, Ctr Neurosci Studies, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Alves-Leon, Soniza; Marcondes, Jorge] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, RJ, Brazil.
   [Assirati Jr, Joao Alberto; Matios, Caio M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Hosp, Ribeirao Preto, SP, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
   [Neder, Luciano] Barretos Canc Hosp, Barretos, SP, Brazil.
RP Sebollela, A (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.
EM sebollela@fmrp.usp.br
RI de Anchieta Horta-Junior, Jose/X-7878-2019; Santos, Luis/B-4961-2015;
   Almeida, Glaucia Maria/AAC-4390-2019; Sebollela, Adriano/O-4385-2014;
   Leon, Soniza V Alves/J-7786-2012; Ferreira, Sergio/AAZ-1576-2020;
   Machado, Carla M/M-7479-2015
OI de Anchieta Horta-Junior, Jose/0000-0003-3639-9861; Santos,
   Luis/0000-0002-0694-733X; Almeida, Glaucia Maria/0000-0003-4149-5313;
   Sebollela, Adriano/0000-0002-7444-9156; Ferreira,
   Sergio/0000-0001-7160-9866; Machado, Carla M/0000-0002-6640-8186
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); FAEPA; National
   Institute for Translational Neuroscience; Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) and FAEPA to AS and NGC; National Institute
   for Translational Neuroscience, Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) to STF and FGDF; and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). We thank Deise L
   Chesca and Silvana El-Chaedroui, and CIREP staff (especially Tania A. C.
   Becker and Adriana A. C. Ferrari) for excellent technical assistance.
   NGC holds a CNPq Researcher fellowship.
CR Alzheimer's Association, 2016, Alzheimers Dement, V12, P459
   Andersson M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24818
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Brewer GJ, 2001, J NEUROSCI METH, V107, P15, DOI 10.1016/S0165-0270(01)00342-9
   Cazemier JL, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00110
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Dai JP, 2004, BRIT J PHARMACOL, V143, P606, DOI 10.1038/sj.bjp.0705995
   Darlington PJ, 2008, J NEUROCHEM, V104, P1201, DOI 10.1111/j.1471-4159.2007.05043.x
   Dash A, 2017, TOXICOL IN VITRO, V39, P93, DOI 10.1016/j.tiv.2016.11.014
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357
   Eugene E, 2014, J NEUROSCI METH, V235, P234, DOI 10.1016/j.jneumeth.2014.07.009
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529
   Freiman TM, 2006, NEUROSCI RES, V55, P204, DOI 10.1016/j.neures.2006.01.007
   GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0
   Gilbride CJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12889
   Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017
   Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013
   Hoffman R. M., 2001, HISTOCULTURES ORGAN
   Horta-Junior JAC, 2008, J COMP NEUROL, V507, P1763, DOI 10.1002/cne.21625
   Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086
   Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008
   Jones RSG, 2016, J NEUROSCI METH, V260, P221, DOI 10.1016/j.jneumeth.2015.09.021
   Kadar A, 2009, J NEUROSCI METH, V184, P115, DOI 10.1016/j.jneumeth.2009.07.010
   Kowalska Anna, 2004, Neurol Neurochir Pol, V38, P405
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lavenex P, 2009, J COMP NEUROL, V512, P27, DOI 10.1002/cne.21906
   Born JPL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182765
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   MILLER BE, 1985, CANCER RES, V45, P4200
   Monge-Acuna AA, 2009, J NEUROSCI METH, V183, P176, DOI 10.1016/j.jneumeth.2009.06.042
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701
   Mucke L., 2012, PERSPECT MED, V2
   MULLEN RJ, 1992, DEVELOPMENT, V116, P201
   Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7
   Olinga P, 2013, J HEPATOL, V58, P1252, DOI 10.1016/j.jhep.2013.01.009
   PATERNITI I, 2013, J NEUROINFLAMM, V10
   Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522
   Puzzo D, 2015, NEUROSCIENCE, V307, P26, DOI 10.1016/j.neuroscience.2015.08.039
   Puzzo D, 2015, EXPERT OPIN DRUG DIS, V10, P703, DOI 10.1517/17460441.2015.1041913
   Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719
   Risher WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022351
   SCHWARZ N, 2017, SCI REP UK, V7
   Sebollela A., 2017, J NEUROCHEM, V3
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741
   Sobieski C, 2015, J NEUROSCI, V35, P11105, DOI 10.1523/JNEUROSCI.1289-15.2015
   Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040
   Steinstraesser Lars, 2009, Eplasty, V9, pe5
   STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M
   Tobita T, 2010, INT J ORAL MAX SURG, V39, P364, DOI 10.1016/j.ijom.2009.12.020
   Trevelyan AJ, 2016, TRENDS NEUROSCI, V39, P502, DOI 10.1016/j.tins.2016.06.002
   Um S.-H., 2013, PLOS ONE, V8
   Velasco PT, 2012, ACS CHEM NEUROSCI, V3, P972, DOI 10.1021/cn300122k
   Verhoog MB, 2013, J NEUROSCI, V 33, P17197, DOI 10.1523/JNEUROSCI.3158-13.2013
   Verwer RWH, 2002, FASEB J, V16, P54, DOI 10.1096/fj.01-0504com
   Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3
   Wallach G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003964
   Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6
   Wang L, 2010, ACTA PHARMACOL SIN, V31, P470, DOI 10.1038/aps.2009.202
NR 65
TC 8
Z9 8
U1 1
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD SEP 1
PY 2018
VL 307
BP 203
EP 209
DI 10.1016/j.jneumeth.2018.05.021
PG 7
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA GQ8ZN
UT WOS:000442055800021
PM 29859877
DA 2020-09-29
ER

PT J
AU Holscher, C
   De Felice, FG
   Greig, NH
   Ferreira, ST
AF Holscher, Christian
   De Felice, Fernanda G.
   Greig, Nigel H.
   Ferreira, Sergio T.
TI Are Alzheimer's disease and other neurodegenerative disorders caused by
   impaired signalling of insulin and other hormones?
SO NEUROPHARMACOLOGY
LA English
DT Editorial Material
C1 [Holscher, Christian] Univ Lancaster, Biomed & Life Sci, Lancaster, England.
   [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Greig, Nigel H.] NIA, Translat Gerontol Branch, Drug Design & Dev Sect, NIH, Baltimore, MD 21224 USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Holscher, C (corresponding author), Univ Lancaster, Biomed & Life Sci, Lancaster, England.
EM c.holscher@lancaster.ac.uk
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Holscher,
   Christian/0000-0002-8159-3260
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [Z99 AG999999, ZIA
   AG000333-10] Funding Source: Medline
NR 0
TC 0
Z9 0
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3908
EI 1873-7064
J9 NEUROPHARMACOLOGY
JI Neuropharmacology
PD JUL 1
PY 2018
VL 136
SI SI
BP 159
EP 159
DI 10.1016/j.neuropharm.2018.05.021
PN B
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GO6CL
UT WOS:000440121600001
PM 29782874
OA Green Accepted
DA 2020-09-29
ER

PT J
AU Santos, LE
   Ferreira, ST
AF Santos, Luis E.
   Ferreira, Sergio T.
TI Crosstalk between endoplasmic reticulum stress and brain inflammation in
   Alzheimer's disease
SO NEUROPHARMACOLOGY
LA English
DT Review
DE Alzheimer's disease; Endoplasmic reticulum stress; Unfolded protein
   response; Inflammation
ID UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE;
   NONSTEROIDAL ANTIINFLAMMATORY DRUG; DEPRESSIVE-LIKE BEHAVIOR; TRANSGENIC
   MOUSE MODEL; AMYLOID-BETA OLIGOMERS; NECROSIS-FACTOR-ALPHA; NEURONAL
   CELL-DEATH; ER STRESS
AB While most often noted for its cognitive symptoms, Alzheimer's disease (AD) is, at its core, a disease of protein misfolding/aggregation, with an intriguing inflammatory component. Defective clearance and/or abnormal production of the amyloid-beta peptide (A beta), and its ensuing accumulation and aggregation, underlie two hallmark features of AD: brain accumulation of insoluble protein deposits known as amyloid or senile plaques, and buildup of soluble AP oligomers (A beta Os), diffusible toxins linked to synapse dysfunction and memory impairment. In neurons, as in typical eukaryotic cells, the endoplasmic reticulum (ER) serves as a main compartment for the folding, maturation, trafficking and quality control of newly synthesized proteins. The ER lumen, a calcium-rich, oxidizing environment, provides favorable conditions for these physiological functions to occur. These conditions, however, also favor protein aggregation. Several stressors, including metabolic/nutrient stress and certain pathologies, may upset the ER homeostasis, e.g., by affecting calcium levels or by causing the accumulation of unfolded or misfolded proteins. Whatever the underlying cause, the result is what is commonly known as "ER stress". This, in turn, triggers a conserved cellular response mechanism known as the "unfolded protein response" (UPR). The UPR comprises three pathways involving transcriptional or translational regulators aimed at normalizing ER function, and each of them results in pro-inflammatory signaling. A positive feedback loop exists between ER stress and inflammation, with clear implications for neurodegeneration and AD. Here, we explore recent findings on the role of ER stress and the UPR in inflammatory processes leading to synapse failure and memory impairment in AD.
   This article is part of the Special Issue entitled 'Metabolic Impairment as Risk Factors for Neurodegenerative Disorders. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Santos, Luis E.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Santos, Luis/B-4961-2015
OI Ferreira, Sergio/0000-0001-7160-9866; Santos, Luis/0000-0002-0694-733X
FU National Institute for Translational Neuroscience/Brazil; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro; CAPESCAPES
FX Work in the authors' laboratory is supported by grants from the National
   Institute for Translational Neuroscience/Brazil, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico and Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro. L.E.S. is a
   postdoctoral fellow supported by CAPES.
CR Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918
   Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042
   Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014
   Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001
   Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200
   Barbero-Camps E, 2014, AM J PATHOL, V184, P2066, DOI 10.1016/j.ajpath.2014.03.014
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326
   Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363
   Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648
   Bown C, 2000, NEUROPSYCHOPHARMACOL, V22, P327, DOI 10.1016/S0893-133X(99)00091-3
   Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598
   Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026
   Butchart J, 2015, NEUROLOGY, V84, P2161, DOI 10.1212/WNL.0000000000001617
   Butterfield DA, 2007, BRAIN RES, V1148, P243, DOI 10.1016/j.brainres.2007.02.084
   Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6
   Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645
   Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213
   Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98
   Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115
   Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108
   Cisse M, 2017, MOL PSYCHIATR, V22, P1562, DOI 10.1038/mp.2016.152
   Cisse M, 2017, MOL MED, V22, P905, DOI 10.2119/molmed.2016.00229
   Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176
   Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897
   Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050
   Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055
   COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A
   Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   de la Monte SM, 2000, NEUROBIOL AGING, V21, P309, DOI 10.1016/S0197-4580(99)00108-6
   Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004
   Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9
   Dogan A, 2017, ANNU REV PATHOL-MECH, V12, P277, DOI 10.1146/annurev-pathol-052016-100200
   Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6
   Duran-Aniotz C, 2017, ACTA NEUROPATHOL, V134, P489, DOI 10.1007/s00401-017-1694-x
   DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055
   Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643
   Fan Z, 2017, BRAIN, V140, P792, DOI 10.1093/brain/aww349
   Femminella GD, 2016, J ALZHEIMERS DIS, V51, P1275, DOI 10.3233/JAD-150827
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Flu P., 2006, MOL CELL BIOL, V26, P3071, DOI [10.1128/MCB.26.8.3071-3084.2006, DOI 10.1128/MCB.26.8.3071-3084.2006]
   Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007
   Fuger P, 2017, NAT NEUROSCI, V20, P1371, DOI 10.1038/nn.4631
   Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99
   Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103
   Garcez ML, 2017, PROG NEURO-PSYCHOPH, V77, P23, DOI 10.1016/j.pnpbp.2017.03.010
   Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126
   Garret-Rebillat AS., 2015, SCI REP, V5, P8489, DOI DOI 10.1038/SREP08489
   Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Glockel C., 2008, BMC PHARM, V8, pA45, DOI [10.1186/1471-2210-8-S1-A45, DOI 10.1186/1471-2210-8-S1-A45]
   Gold PW, 2013, MOL PSYCHIATR, V18, P154, DOI 10.1038/mp.2012.167
   Goldbach-Mansky R, 2011, CURR RHEUMATOL REP, V13, P123, DOI 10.1007/s11926-011-0165-y
   Good PF, 1996, AM J PATHOL, V149, P21
   Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200
   Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753
   GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276
   GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611
   GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913
   GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084
   Guo FJ, 2010, CELL SIGNAL, V22, P1818, DOI 10.1016/j.cellsig.2010.07.006
   Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hallegua DS, 2002, ANN RHEUM DIS, V61, P960, DOI 10.1136/ard.61.11.960
   HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345
   Harding HP, 1999, NATURE, V397, P271
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787
   He P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055091
   Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102
   Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015
   Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15
   Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021
   Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983
   Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95
   Hong F, 2017, NAT STRUCT MOL BIOL, V24, P834, DOI 10.1038/nsmb.3458
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Honjo K, 2009, ALZHEIMERS DEMENT, V5, P348, DOI 10.1016/j.jalz.2008.12.001
   Honjo Y, 2015, NEUROSCI LETT, V602, P50, DOI 10.1016/j.neulet.2015.06.052
   Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0
   Hosoi T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03388
   Hosoi T, 2009, NEUROCHEM INT, V54, P1, DOI 10.1016/j.neuint.2008.09.017
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409
   Iadecola C, 1997, J NEUROSCI, V17, P9157
   Ide M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151081
   Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838
   Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104
   Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550
   Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991
   Jiang T, 2015, NEUROBIOL AGING, V36, P3176, DOI 10.1016/j.neurobiolaging.2015.08.019
   Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Kim S, 2014, INNATE IMMUN-LONDON, V20, P799, DOI 10.1177/1753425913508593
   Kim YH, 2010, NITRIC OXIDE-BIOL CH, V23, P112, DOI 10.1016/j.niox.2010.04.009
   Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008
   Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54
   Kohno K, 1997, NEUROSCI LETT, V224, P17, DOI 10.1016/S0304-3940(97)13459-0
   KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044
   KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0
   Lebeaupin C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.248
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003
   Lee JH, 2010, EXP MOL MED, V42, P386, DOI 10.3858/emm.2010.42.5.040
   LENNY N, 1991, J BIOL CHEM, V266, P20532
   Leonardi A, 2002, ENDOCRINOLOGY, V143, P2169, DOI 10.1210/en.143.6.2169
   LI WW, 1994, MOL CELL BIOL, V14, P5533, DOI 10.1128/MCB.14.8.5533
   Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778
   Liu SY, 2013, CNS NEUROSCI THER, V19, P229, DOI 10.1111/cns.12064
   Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046
   Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072
   Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12
   Lyketsos C. C., 2011, ALZHEIMERS DEMENT, DOI [10.1016/jjalz.2011.05.2410, DOI 10.1016/JJALZ.2011.05.2410]
   Lyketsos CG, 2002, BIOL PSYCHIAT, V52, P243, DOI 10.1016/S0006-3223(02)01348-3
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Maes M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-66
   Maixner Dylan Warren, 2013, J Pharm Pharmacol (Los Angel), V1, P001
   Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071
   Martinez G, 2016, CELL REP, V14, P1382, DOI 10.1016/j.celrep.2016.01.028
   Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14
   Meares GP, 2011, MOL CELL BIOL, V31, P4286, DOI 10.1128/MCB.05668-11
   Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317
   Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411
   MORI K, 1993, CELL, V74, P743
   Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005
   Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001
   Nakamura T, 2013, NEURON, V78, P596, DOI 10.1016/j.neuron.2013.05.005
   Nakato R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14812
   Nevell L, 2014, PSYCHONEUROENDOCRINO, V43, P62, DOI 10.1016/j.psyneuen.2014.01.013
   Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302
   Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028
   Omi T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.301
   Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195
   PEREZ N, 1991, MOL BRAIN RES, V11, P249, DOI 10.1016/0169-328X(91)90033-T
   Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38
   Prince M, 2015, ALZHEIMERS DIS INT, V2015, P84, DOI DOI 10.1111/J.0963-7214.2004.00293.X
   Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784
   Rao J, 2014, AM J TRANSPLANT, V14, P1552, DOI 10.1111/ajt.12711
   Reed TT, 2009, J CELL MOL MED, V13, P2019, DOI 10.1111/j.1582-4934.2008.00478.x
   Resende R, 2008, J NEUROSCI RES, V86, P2091, DOI 10.1002/jnr.21648
   Reynolds MR, 2006, J NEUROSCI, V26, P10636, DOI 10.1523/JNEUROSCI.2143-06.2006
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41
   Santos LE, 2016, BRAIN BEHAV IMMUN, V55, P151, DOI 10.1016/j.bbi.2015.11.011
   Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4
   Shi JQ, 2011, J AM GERIATR SOC, V59, P1142, DOI 10.1111/j.1532-5415.2011.03445.x
   Shie FS, 2005, GLIA, V52, P70, DOI 10.1002/glia.20220
   Sly LM, 2001, BRAIN RES BULL, V56, P581, DOI 10.1016/S0361-9230(01)00730-4
   Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016
   Stelzma R. A., 1995, CLIN ANAT, V8, P429, DOI DOI 10.1002/CA.980080612
   Stutzbach LD, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-31
   Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012
   Timberlake MA, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00319
   Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2
   Tohgi H, 1999, NEUROSCI LETT, V269, P52, DOI 10.1016/S0304-3940(99)00406-1
   Tong LY, 2011, FREE RADICAL BIO MED, V50, P1717, DOI 10.1016/j.freeradbiomed.2011.03.032
   Torres M, 2015, VIRUS RES, V207, P69, DOI 10.1016/j.virusres.2014.12.018
   Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139
   Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436
   Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873
   Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106
   Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782
   Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664
   Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110
   Walker FR, 2013, NEUROPHARMACOLOGY, V67, P304, DOI 10.1016/j.neuropharm.2012.10.002
   Wang J, 2015, J ALZHEIMERS DIS, V44, P385, DOI 10.3233/JAD-141506
   Xu NG, 2015, AM J ALZHEIMERS DIS, V30, P313, DOI 10.1177/1533317514545616
   Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188
   Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017
   Yamazaki T, 2006, NEUROPHARMACOLOGY, V50, P558, DOI 10.1016/j.neuropharm.2005.10.016
   Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
   Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040
   Zschocke J, 2011, NEUROPSYCHOPHARMACOL, V36, P1754, DOI 10.1038/npp.2011.57
NR 189
TC 20
Z9 21
U1 1
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3908
EI 1873-7064
J9 NEUROPHARMACOLOGY
JI Neuropharmacology
PD JUL 1
PY 2018
VL 136
SI SI
BP 350
EP 360
DI 10.1016/j.neuropharm.2017.11.016
PN B
PG 11
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GO6CL
UT WOS:000440121600022
PM 29129774
DA 2020-09-29
ER

PT J
AU Souza, IND
   Frost, PS
   Franca, JV
   Nascimento-Viana, JB
   Neris, RLS
   Freitas, L
   Pinheiro, DJLL
   Nogueira, CO
   Neves, G
   Chimelli, L
   De Felice, FG
   Cavalheiro, EA
   Ferreira, ST
   Assuncao-Miranda, I
   Figueiredo, CP
   Da Poian, AT
   Clarke, JR
AF de Oliveira Souza, Isis Nem
   Frost, Paula S.
   Franca, Julia V.
   Nascimento-Viana, Jessica B.
   Neris, Romulo L. S.
   Freitas, Leandro
   Pinheiro, Daniel J. L. L.
   Nogueira, Clara O.
   Neves, Gilda
   Chimelli, Leila
   De Felice, Fernanda G.
   Cavalheiro, Esper A.
   Ferreira, Sergio T.
   Assuncao-Miranda, Iranaia
   Figueiredo, Claudia P.
   Da Poian, Andrea T.
   Clarke, Julia R.
TI Acute and chronic neurological consequences of early-life Zika virus
   infection in mice
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID NEUROPSYCHIATRIC DISORDERS; OXIDATIVE STRESS; CASE SERIES; BRAZIL;
   BRAIN; SEIZURES; INFANTS; GROWTH; HIPPOCAMPUS; INDUCTION
AB Although congenital Zika virus (ZIKV) exposure has been associated with microcephaly and other neurodevelopmental disorders, long-term consequences of perinatal infection are largely unknown. We evaluated short-and long-term neuropathological and behavioral consequences of neonatal ZIKV infection in mice. ZIKV showed brain tropism, causing postnatal-onset microcephaly and several behavioral deficits in adulthood. During the acute phase of infection, mice developed frequent seizures, which were reduced by tumor necrosis factor-alpha (TNF-alpha) inhibition. During adulthood, ZIKV replication persisted in neonatally infected mice, and the animals showed increased susceptibility to chemically induced seizures, neurodegeneration, and brain calcifications. Altogether, the results show that neonatal ZIKV infection has long-term neuropathological and behavioral complications in mice and suggest that early inhibition of TNF-alpha-mediated neuroinflammation might be an effective therapeutic strategy to prevent the development of chronic neurological abnormalities.
C1 [de Oliveira Souza, Isis Nem; Frost, Paula S.; Nascimento-Viana, Jessica B.; Nogueira, Clara O.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Frost, Paula S.; Franca, Julia V.; Neves, Gilda] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Freitas, Leandro; Pinheiro, Daniel J. L. L.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, BR-04023062 Sao Paulo, SP, Brazil.
   [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, Brazil.
   [De Felice, Fernanda G.; Ferreira, Sergio T.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM iranaiamiranda@micro.ufrj.br; claufig@gmail.com;
   dapoian@bioqmed.ufrj.br; juliaclarke@pharma.ufrj.br
RI Clarke, Julia/AAF-9434-2019; de Oliveira Souza, Isis Nem/AAA-3423-2019;
   Cavalheiro, Esper A/I-3084-2016; Figueiredo, Claudia P/F-8424-2012;
   Cavalheiro, Esper/N-3985-2019; Neves, Gilda A./K-7573-2012; Ferreira,
   Sergio/AAZ-1576-2020; Da Poian, Andrea T./V-1699-2019
OI de Oliveira Souza, Isis Nem/0000-0002-0335-2541; Cavalheiro, Esper
   A/0000-0002-0854-3582; Cavalheiro, Esper/0000-0002-0854-3582; Neves,
   Gilda A./0000-0002-7027-3851; Ferreira, Sergio/0000-0001-7160-9866;
   Figueiredo, Claudia/0000-0001-9467-9891; Freitas,
   Leandro/0000-0002-0249-2948; Neris, Romulo/0000-0002-7436-1680; da Silva
   Frost, Paula/0000-0002-3814-999X; Pinheiro, Daniel/0000-0003-0078-993X
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Institutos
   Nacionais de Pesquisa-Instituto Nacional de Neurociencia Translacional;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Institutos
   Nacionais de Pesquisa-Inovacao em Medicamentos e Identificacao de Novos
   Alvos Terapeuticos; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP)
FX Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to F.G.D.F.,
   S.T.F., A.T.D.P., I.A.-M., C.P.F., and J.R.C.), Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (to E.A.C.), Institutos Nacionais de
   Pesquisa-Instituto Nacional de Neurociencia Translacional (to F.G.D.F.,
   E.A.C., and S.T.F.), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (to P.S.F., G.N., F.G.D.F., E.A.C., S.T.F., A.T.D.P.,
   C.P.F., I.A.-M., and J.R.C.), Institutos Nacionais de Pesquisa-Inovacao
   em Medicamentos e Identificacao de Novos Alvos Terapeuticos (to C.P.F.),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (to
   I.N.O.S., J.V.F., L.F., and D.J.L.L.P.), and Financiadora de Estudos e
   Projetos (to A.T.D.P.).
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Balosso S, 2013, EXP NEUROL, V247, P267, DOI 10.1016/j.expneurol.2013.05.010
   Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Dalman C, 2008, AM J PSYCHIAT, V165, P59, DOI 10.1176/appi.ajp.2007.07050740
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Edwards MJJ, 2002, NEUROLOGY, V59, P1447, DOI 10.1212/WNL.59.9.1447
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Ho YH, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0157-8
   Jiang PF, 2012, BRAIN RES, V1459, P1, DOI 10.1016/j.brainres.2012.03.058
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x
   KOVAC S, 2016, REACT OXYGEN SPECIES, V1, P38, DOI DOI 10.20455/ROS.2016.807
   Kramer AH, 2008, CURR TREAT OPTION NE, V10, P201, DOI 10.1007/s11940-008-0022-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Libbey JE, 2008, EPILEPSIA, V49, P1066, DOI 10.1111/j.1528-1167.2008.01535.x
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Smith R, 2006, PEDIATRICS, V117, P851, DOI 10.1542/peds.2005-0804
   Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Zhao K, 2010, BIOSCIENCE REP, V30, P233, DOI 10.1042/BSR20090048
NR 51
TC 29
Z9 29
U1 0
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JUN 6
PY 2018
VL 10
IS 444
AR eaar2749
DI 10.1126/scitranslmed.aar2749
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA GI5IG
UT WOS:000434403600003
PM 29875203
OA Bronze
DA 2020-09-29
ER

PT J
AU Batista, AF
   Forny-Germano, L
   Clarke, JR
   Silva, NMLE
   Brito-Moreira, J
   Boehnke, SE
   Winterborn, A
   Coe, BC
   Lablans, A
   Vital, JF
   Marques, SA
   Martinez, AMB
   Gralle, M
   Holscher, C
   Klein, WL
   Houzel, JC
   Ferreira, ST
   Munoz, DP
   De Felice, FG
AF Batista, Andre F.
   Forny-Germano, Leticia
   Clarke, Julia R.
   Lyra e Silva, Natalia M.
   Brito-Moreira, Jordano
   Boehnke, Susan E.
   Winterborn, Andrew
   Coe, Brian C.
   Lablans, Ann
   Vital, Juliana F.
   Marques, Suelen A.
   Martinez, Ana M. B.
   Gralle, Matthias
   Holscher, Christian
   Klein, William L.
   Houzel, Jean-Christophe
   Ferreira, Sergio T.
   Munoz, Douglas P.
   De Felice, Fernanda G.
TI The diabetes drug liraglutide reverses cognitive impairment in mice and
   attenuates insulin receptor and synaptic pathology in a non-human
   primate model of Alzheimer's disease
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE Alzheimer's disease; liraglutide; synapse damage; insulin receptors; PKA
   signaling; non-human primates; diabetes; GLP-1; tau pathology;
   neurodegeneration
ID GLUCAGON-LIKE PEPTIDE-1; AMYLOID-BETA OLIGOMERS; MODULATING TAU
   HYPERPHOSPHORYLATION; CENTRAL-NERVOUS-SYSTEM; A-BETA; INTRANASAL
   INSULIN; MEMORY IMPAIRMENT; IMPROVES MEMORY; PROTEIN-KINASE; MOUSE MODEL
AB Alzheimer's disease (AD) is a devastating neurological disorder that still lacks an effective treatment, and this has stimulated an intense pursuit of disease-modifying therapeutics. Given the increasingly recognized link between AD and defective brain insulin signaling, we investigated the actions of liraglutide, a glucagon-like peptide-1 (GLP-1) analog marketed for treatment of type 2 diabetes, in experimental models of AD. Insulin receptor pathology is an important feature of AD brains that impairs the neuroprotective actions of central insulin signaling. Here, we show that liraglutide prevented the loss of brain insulin receptors and synapses, and reversed memory impairment induced by AD-linked amyloid- oligomers (AOs) in mice. Using hippocampal neuronal cultures, we determined that the mechanism of neuroprotection by liraglutide involves activation of the PKA signaling pathway. Infusion of AOs into the lateral cerebral ventricle of non-human primates (NHPs) led to marked loss of insulin receptors and synapses in brain regions related to memory. Systemic treatment of NHPs with liraglutide provided partial protection, decreasing AD-related insulin receptor, synaptic, and tau pathology in specific brain regions. Synapse damage and elimination are amongst the earliest known pathological changes and the best correlates of memory impairment in AD. The results illuminate mechanisms of neuroprotection by liraglutide, and indicate that GLP-1 receptor activation may be harnessed to protect brain insulin receptors and synapses in AD. (c) 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
C1 [Batista, Andre F.; Forny-Germano, Leticia; Lyra e Silva, Natalia M.; Brito-Moreira, Jordano; Vital, Juliana F.; Gralle, Matthias; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
   [Boehnke, Susan E.; Coe, Brian C.; Lablans, Ann; Munoz, Douglas P.; De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Winterborn, Andrew] Queens Univ, Anim Care Serv, Kingston, ON, Canada.
   [Marques, Suelen A.] Fluminense Fed Univ, Dept Neurobiol, Niteroi, RJ, Brazil.
   [Martinez, Ana M. B.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Fac Med, Dept Pathol, Rio de Janeiro, Brazil.
   [Holscher, Christian] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA.
   [Houzel, Jean-Christophe] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Fed Univ Rio deJaneiro, CCS, Inst Med Biochem, Room H2-019, BR-21944590 Rio De Janeiro, RJ, Brazil.; Munoz, DP (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
EM doug.munoz@queensu.ca; felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Forny-Germano, Leticia/L-6639-2019;
   Boehnke, Susan/P-4952-2019; Clarke, Julia/AAF-9434-2019; Houzel, Jean
   Christophe/M-7936-2019; MARTINEZ, Ana/AAE-8358-2019; Forny-Germano,
   Leticia/D-1342-2017
OI Ferreira, Sergio/0000-0001-7160-9866; Forny-Germano,
   Leticia/0000-0001-8301-0711; Houzel, Jean
   Christophe/0000-0001-5128-438X; Forny-Germano,
   Leticia/0000-0001-8301-0711; Boehnke, Susan/0000-0002-0726-6659; Coe,
   Brian/0000-0002-3985-0163; Holscher, Christian/0000-0002-8159-3260
FU Alzheimer Society Canada; Human Frontiers Science Program (HFSP)Human
   Frontier Science Program; John Simon Guggenheim Memorial Foundation;
   Canadian Institutes for Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); Canada Research Chair ProgramCanada Research
   Chairs; Brain Canada; National Institute for Translational Neuroscience
   (INNT/Brazil); Brazilian funding agency Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Brazilian funding
   agency Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPq pre-doctoral fellowships;
   FAPERJ/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX We thank Drs Claudia P Figueiredo and Olavo B Amaral (Federal University
   of Rio de Janeiro) for technical advice on immunohistochemical and
   statistical analysis, respectively. The CP13 antibody was a generous
   gift from Dr Peter Davies (Albert Einstein College of Medicine, Bronx,
   NY, USA). This work was supported by grants from Alzheimer Society
   Canada, Human Frontiers Science Program (HFSP), and the John Simon
   Guggenheim Memorial Foundation (to FGF); Canadian Institutes for Health
   Research (CIHR) (to DPM and FDF); and Canada Research Chair Program and
   Brain Canada (to DPM). It was further supported by the National
   Institute for Translational Neuroscience (INNT/Brazil) (to STF and FGF)
   and the Brazilian funding agencies Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) (to STF and FGF). NLS, AFB, JF, and
   JBM were or are supported by CNPq pre-doctoral fellowships. LFG is
   supported by a post-doctoral fellowship from FAPERJ/Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035
   Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999
   Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7
   Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x
   Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x
   Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4
   Athauda D, 2017, J PARKINSON DIS, V7, P451, DOI 10.3233/JPD-171192
   Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013
   Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011
   Bartolotti N, 2016, MOL PSYCHIATR, V21, P1158, DOI 10.1038/mp.2016.111
   Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Cha DS, 2016, CURR MOL MED, V16, P465, DOI 10.2174/1566524016666160429121737
   Chen SH, 2017, COGN SYST RES, V42, P1, DOI 10.1016/j.cogsys.2016.11.001
   Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7
   Cholerton Brenna, 2016, Diabetes Spectr, V29, P210
   Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791
   Cork SC, 2015, MOL METAB, V4, P718, DOI 10.1016/j.molmet.2015.07.008
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Dailey MJ, 2013, TRENDS ENDOCRIN MET, V24, P85, DOI 10.1016/j.tem.2012.11.008
   DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, CURR ALZHEIMER RES, V4, P263
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2016, AGEING RES REV, V26, P112, DOI 10.1016/j.arr.2016.01.006
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101
   DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502
   Diniz LP, 2017, J NEUROSCI, V37, P6797, DOI 10.1523/JNEUROSCI.3351-16.2017
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1
   Fa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19393
   Fadel JR, 2016, CURR OPIN BEHAV SCI, V9, P47, DOI 10.1016/j.cobeha.2015.12.004
   Ferris HA, 2016, DIABETES, V65, P1481, DOI 10.2337/dbi16-0010
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8
   Gancheva S, 2015, DIABETES, V64, P1966, DOI 10.2337/db14-0892
   Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231
   Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025
   Gejl M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00108
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Guerrero-Munoz MJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00464
   Hansen HH, 2015, J ALZHEIMERS DIS, V46, P877, DOI 10.3233/JAD-143090
   Heppner KM, 2015, ENDOCRINOLOGY, V156, P255, DOI 10.1210/en.2014-1675
   Holscher C, 2012, CNS DRUGS, V26, P871, DOI 10.2165/11635890-000000000-00000
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Hsu TM, 2015, NEUROPSYCHOPHARMACOL, V40, P327, DOI 10.1038/npp.2014.175
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14
   Kim SH, 2001, J NEURAL TRANSM-SUPP, P263
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014
   Lee HK, 2017, J ALZHEIMERS DIS, V56, P1015, DOI 10.3233/JAD-161029
   Lee Sarah, 2013, J Alzheimers Dis Parkinsonism, V3, P128
   Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314
   Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x
   Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x
   Long-Smith CM, 2013, NEUROMOL MED, V15, P102, DOI 10.1007/s12017-012-8199-5
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Mansur RB, 2017, J AFFECT DISORDERS, V207, P114, DOI 10.1016/j.jad.2016.09.056
   Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452
   Mattson MP, 2003, NAT MED, V9, P1113, DOI 10.1038/nm0903-1113
   McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4
   Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504
   Norambuena A, 2017, ALZHEIMERS DEMENT, V13, P152, DOI 10.1016/j.jalz.2016.08.015
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974
   Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611
   Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481
   Qi LQ, 2017, AM J TRANSL RES, V9, P247
   Qi LQ, 2016, EUR J PHARMACOL, V783, P23, DOI 10.1016/j.ejphar.2016.04.052
   Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309
   Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440
   Rosenberger AFN, 2016, J ALZHEIMERS DIS, V49, P927, DOI 10.3233/JAD-150429
   Sandoval D, 2008, PHYSIOL BEHAV, V94, P670, DOI 10.1016/j.physbeh.2008.04.018
   SCHEFF SW, 1993, ANN NEUROL, V33, P190, DOI 10.1002/ana.410330209
   Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002
   Scheff SW, 1998, J NEUROPATH EXP NEUR, V57, P1146, DOI 10.1097/00005072-199812000-00006
   Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Sengupta U, 2017, ANN CLIN TRANSL NEUR, V4, P226, DOI 10.1002/acn3.382
   Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004
   Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   van der Harg JM, 2017, NEUROBIOL DIS, V103, P163, DOI 10.1016/j.nbd.2017.04.005
   Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375
   Vilsboll T, 2003, REGUL PEPTIDES, V114, P115, DOI 10.1016/S0167-0115(03)00111-3
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wang QW, 2009, NEUROBIOL AGING, V30, P1608, DOI 10.1016/j.neurobiolaging.2007.12.004
   Winnay JN, 2016, J CLIN INVEST, V126, P1401, DOI 10.1172/JCI84005
   Yang Y, 2013, J ALZHEIMERS DIS, V37, P637, DOI 10.3233/JAD-130491
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 117
TC 51
Z9 51
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD MAY
PY 2018
VL 245
IS 1
BP 85
EP 100
DI 10.1002/path.5056
PG 16
WC Oncology; Pathology
SC Oncology; Pathology
GA GC9JO
UT WOS:000430113500010
PM 29435980
OA Other Gold, Green Published
DA 2020-09-29
ER

PT J
AU de Godoy, MA
   Saraiva, LM
   de Carvalho, LRP
   Vasconcelos-dos-Santos, A
   Beiral, HJV
   Ramos, AB
   Silva, LRD
   Leal, RB
   Monteiro, VHS
   Braga, CV
   de Araujo-Silva, CA
   Sinis, LC
   Bodart-Santos, V
   Kasai-Brunswick, TH
   Alcantara, CD
   Lima, APCA
   da Cunha-e Silva, NL
   Galina, A
   Vieyra, A
   De Felice, FG
   Mendez-Otero, R
   Ferreira, ST
AF de Godoy, Mariana A.
   Saraiva, Leonardo M.
   de Carvalho, Luiza R. P.
   Vasconcelos-dos-Santos, Andreia
   Beiral, Hellen J. V.
   Ramos, Alane Bernardo
   de Paula Silva, Livian R.
   Leal, Renata B.
   Monteiro, Victor H. S.
   Braga, Carolina V.
   de Araujo-Silva, Carlla A.
   Sinis, Leandro C.
   Bodart-Santos, Victor
   Kasai-Brunswick, Tais Hanae
   Alcantara, Carolina de Lima
   Lima, Ana Paula C. A.
   da Cunha-e Silva, Narcisa L.
   Galina, Antonio
   Vieyra, Adalberto
   De Felice, Fernanda G.
   Mendez-Otero, Rosalia
   Ferreira, Sergio T.
TI Mesenchymal stem cells and cell-derived extracellular vesicles protect
   hippocampal neurons from oxidative stress and synapse damage induced by
   amyloid- oligomers
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Alzheimer's disease; catalase; cytokine action; endocytosis;
   extracellular vesicles; hippocampus; mesenchymal stem cells (MSCs);
   oxidative stress; synapse; amyloid-; oligomers
ID A-BETA OLIGOMERS; CENTRAL-NERVOUS-SYSTEM; RENAL TUBULAR CELLS;
   ALZHEIMERS-DISEASE; STROMAL CELLS; IN-VITRO; PRION PROTEIN;
   NEUROVASCULAR PLASTICITY; TAU-HYPERPHOSPHORYLATION; COGNITIVE IMPAIRMENT
AB Alzheimer's disease (AD) is a disabling and highly prevalent neurodegenerative condition, for which there are no effective therapies. Soluble oligomers of the amyloid- peptide (AOs) are thought to be proximal neurotoxins involved in early neuronal oxidative stress and synapse damage, ultimately leading to neurodegeneration and memory impairment in AD. The aim of the current study was to evaluate the neuroprotective potential of mesenchymal stem cells (MSCs) against the deleterious impact of AOs on hippocampal neurons. To this end, we established transwell cocultures of rat hippocampal neurons and MSCs. We show that MSCs and MSC-derived extracellular vesicles protect neurons against AO-induced oxidative stress and synapse damage, revealed by loss of pre- and postsynaptic markers. Protection by MSCs entails three complementary mechanisms: 1) internalization and degradation of AOs; 2) release of extracellular vesicles containing active catalase; and 3) selective secretion of interleukin-6, interleukin-10, and vascular endothelial growth factor to the medium. Results support the notion that MSCs may represent a promising alternative for cell-based therapies in AD.
C1 [de Godoy, Mariana A.; de Carvalho, Luiza R. P.; Vasconcelos-dos-Santos, Andreia; Beiral, Hellen J. V.; Ramos, Alane Bernardo; de Paula Silva, Livian R.; Leal, Renata B.; Monteiro, Victor H. S.; Braga, Carolina V.; de Araujo-Silva, Carlla A.; Sinis, Leandro C.; Kasai-Brunswick, Tais Hanae; Alcantara, Carolina de Lima; Lima, Ana Paula C. A.; da Cunha-e Silva, Narcisa L.; Vieyra, Adalberto; Mendez-Otero, Rosalia; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Saraiva, Leonardo M.; Bodart-Santos, Victor; Galina, Antonio; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Vieyra, Adalberto] Fed Univ Rio Janeiro, Natl Ctr Struct Biol & Bioimaging, CENABIO, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Mendez-Otero, R; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM rmotero@biof.ufrj.br; ferreira@bioqmed.ufrj.br
RI Kasai-Brunswick, Tais Hanae/AAK-9905-2020; Lima, Ana Paula
   CA/G-4122-2012; Mendez-Otero, Rosalia/AAL-7551-2020; de Godoy, Mariana
   Araya/S-3528-2019; Ferreira, Sergio/AAZ-1576-2020
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; Ferreira,
   Sergio/0000-0001-7160-9866; Kasai-Brunswick, Tais
   Hanae/0000-0002-6361-5980
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); National
   Institute for Translational Neuroscience; Departamento de Ciencia e
   Tecnologia do Ministerio da Saude (DECIT/MS)
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),
   National Institute for Translational Neuroscience, and Departamento de
   Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS) (to S. T. F., R.
   M. O., F. G. D. F., A. V., A. G., N. L. C. S., and A. P. C. A. L.). The
   authors declare that they have no conflicts of interest with the
   contents of this article.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004
   Asselineau D, 2015, J ALZHEIMERS DIS, V46, P837, DOI 10.3233/JAD-142832
   Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626
   Blazquez R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00556
   Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754
   Chi Y, 2014, CELL TISSUE BANK, V15, P397, DOI 10.1007/s10561-013-9404-y
   Choi M, 2014, MOL CELLS, V37, P133, DOI 10.14348/molcells.2014.2317
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635
   Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803
   Danielyan L, 2014, CELL TRANSPLANT, V23, pS123, DOI 10.3727/096368914X684970
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078
   dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094
   Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679
   Farinazzo A, 2015, CYTOTHERAPY, V17, P571, DOI 10.1016/j.jcyt.2015.01.005
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Frenkel D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3030
   Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X
   Garcia KO, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00030
   Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010
   Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033
   He J, 2012, NEPHROLOGY, V17, P493, DOI 10.1111/j.1440-1797.2012.01589.x
   Heiskanen M, 2010, ATHEROSCLEROSIS, V208, P190, DOI 10.1016/j.atherosclerosis.2009.06.032
   Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003
   Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3
   Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197
   Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140
   Kim JY, 2010, FEBS LETT, V584, P3601, DOI 10.1016/j.febslet.2010.07.028
   Kowal EJK, 2017, METHODS MOL BIOL, V1660, P143, DOI 10.1007/978-1-4939-7253-1_12
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024
   Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045
   Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125
   Lee JK, 2009, NEUROSCI LETT, V450, P136, DOI 10.1016/j.neulet.2008.11.059
   Lindoso RS, 2016, PROTEOMICS, V16, P328, DOI 10.1002/pmic.201500341
   Lindoso RS, 2014, STEM CELLS DEV, V23, P1809, DOI 10.1089/scd.2013.0618
   Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   MARGOLIASH E, 1962, J BIOL CHEM, V237, P2359
   Montemurro T, 2016, EUR J CELL BIOL, V95, P228, DOI 10.1016/j.ejcb.2016.04.003
   Moraes L, 2012, STEM CELL RES, V9, P143, DOI 10.1016/j.scr.2012.05.005
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Naaldijk Y, 2017, NEUROPATH APPL NEURO, V43, P299, DOI 10.1111/nan.12319
   Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018
   Noda Mariko, 2012, Int J Alzheimers Dis, V2012, P891087, DOI 10.1155/2012/891087
   Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009
   Ramos TL, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0124-8
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Shin JY, 2014, AUTOPHAGY, V10, P32, DOI 10.4161/auto.26508
   Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022
   Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013
   Song MS, 2015, NEUROSCIENCE, V307, P37, DOI 10.1016/j.neuroscience.2015.08.011
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465
   Tang X, 2016, P NATL ACAD SCI USA, V113, P751, DOI 10.1073/pnas.1524013113
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093
   van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244
   Vargas-Alarcon G, 2016, IMMUNOL LETT, V177, P47, DOI 10.1016/j.imlet.2016.07.011
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092
   Xie ZH, 2016, CLIN EXP MED, V16, P89, DOI 10.1007/s10238-015-0375-0
   Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152
   Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129
   Yang H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt227
   Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213
   Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479
   Zhang GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092129
   Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770
   Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194
NR 94
TC 32
Z9 32
U1 0
U2 23
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 9
PY 2018
VL 293
IS 6
BP 1957
EP 1975
DI 10.1074/jbc.M117.807180
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FV9YR
UT WOS:000424948000011
PM 29284679
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Selles, MC
   Oliveira, MM
   Ferreira, ST
AF Clara Selles, M.
   Oliveira, Mauricio M.
   Ferreira, Sergio T.
TI Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in
   Alzheimer's Disease
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Review
DE Alzheimer; depression; amyloid-beta; inflammation; microglia; TNF-alpha
ID AMYLOID-BETA OLIGOMERS; HIPPOCAMPAL SYNAPTIC PLASTICITY;
   CENTRAL-NERVOUS-SYSTEM; FRONTAL-LOBE HYPOPERFUSION; DEPRESSIVE-LIKE
   BEHAVIOR; GENOME-WIDE ASSOCIATION; LONG-TERM POTENTIATION;
   HIGH-MOLECULAR-WEIGHT; GLUTAMATE-RECEPTOR 5; LATE-LIFE DEPRESSION
AB Alzheimer's disease (AD) is the main form of dementia in the elderly and affects greater than 47 million people worldwide. Care for AD patients poses very significant personal and economic demands on individuals and society, and the situation is expected to get even more dramatic in the coming decades unless effective treatments are found to halt the progression of the disease. Although AD is most commonly regarded as a disease of the memory, the entire brain is eventually affected by neuronal dysfunction or neurodegeneration, which brings about a host of other behavioral disturbances. AD patients often present with apathy, depression, eating and sleeping disorders, aggressive behavior, and other non-cognitive symptoms, which deeply affect not only the patient but also the caregiver's health. These symptoms are usually associated with AD pathology but are often neglected as part of disease progression due to the early and profound impact of disease on memory centers such as the hippocampus and entorhinal cortex. Yet, a collection of findings offers biochemical insight into mechanisms underlying non-cognitive symptoms in AD, and indicate that, at the molecular level, such symptoms share common mechanisms. Here, we review evidence indicating mechanistic links between memory loss and non-cognitive symptoms of AD. We highlight the central role of the pro-inflammatory activity of microglia in behavioral alterations in AD patients and in experimental models of the disease. We suggest that a deeper understanding of non-cognitive symptoms of AD may illuminate a new beginning in AD research, offering a fresh approach to elucidate mechanisms involved in disease progression and potentially unveiling yet unexplored therapeutic targets.
C1 [Clara Selles, M.; Oliveira, Mauricio M.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Selles, Maria
   Clara/0000-0002-0008-6081
FU National Institute for Translational Science/Brazil; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ)
FX Work in the authors' laboratory is supported by National Institute for
   Translational Science/Brazil, Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) (to STF). MCS and MMO are pre-doctoral
   fellows supported by CNPq and FAPERJ, respectively.
CR Adebakin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045179
   Alosco ML, 2017, J ALZHEIMERS DIS, V57, P953, DOI 10.3233/JAD-161205
   Alzheimer A, 1995, Clin Anat, V8, P429
   Alzheimer's Disease International, 2015, WORLD ALZH REP GLOB
   Association A., 2017, ALZHEIMERS DEMENT, V13, P325, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]
   Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848
   Beckman D, 2013, J NEUROSCI, V33, P14283, DOI 10.1523/JNEUROSCI.2911-13.2013
   Bedard A, 2011, AGING MENT HEALTH, V15, P855, DOI 10.1080/13607863.2011.569480
   Beeri MS, 2002, INT J GERIATR PSYCH, V17, P403, DOI 10.1002/gps.490
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Benoit M, 2012, J ALZHEIMERS DIS, V31, P325, DOI 10.3233/JAD-2012-112003
   Beraldo FH, 2016, J BIOL CHEM, V291, P21945, DOI 10.1074/jbc.M116.738286
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Borroni B, 2010, CURR ALZHEIMER RES, V7, P158, DOI 10.2174/156720510790691173
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Brodaty H, 2012, J ALZHEIMERS DIS, V31, P411, DOI 10.3233/JAD-2012-120169
   Businaro R, 2018, CURR ALZHEIMER RES, V15, P363, DOI 10.2174/1567205014666170829100100
   Callen DJA, 2004, NEUROBIOL AGING, V25, P761, DOI 10.1016/j.neurobiolaging.2003.08.011
   Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669
   Casement MD, 2006, BIOL PSYCHOL, V72, P208, DOI 10.1016/j.biopsycho.2005.11.002
   Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200
   Chen ZH, 2016, J NEUROCHEM, V136, P10, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]
   Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Cohen-Mansfield J, 2000, SOC SCI MED, V51, P381, DOI 10.1016/S0277-9536(99)00471-2
   Cohen-Mansfield Jiska, 2016, Evid Based Nurs, V19, P31, DOI 10.1136/eb-2015-102059
   Cohen-Mansfield J, 2012, J CLIN PSYCHIAT, V73, P1255, DOI 10.4088/JCP.12m07918
   Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de Vugt ME, 2004, INT J GERIATR PSYCH, V19, P85, DOI 10.1002/gps.1044
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Dinamarca MC, 2015, BIOCHEM BIOPH RES CO, V466, P66, DOI 10.1016/j.bbrc.2015.08.107
   Diniz LP, 2017, J NEUROSCI, V37, P6797, DOI 10.1523/JNEUROSCI.3351-16.2017
   Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842
   Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48
   Dougherty JJ, 2003, J NEUROSCI, V23, P6740
   Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082
   Fan Z, 2017, BRAIN, V140, P792, DOI 10.1093/brain/aww349
   Feldman HH, 2005, NEUROLOGY, V65, pS10, DOI 10.1212/WNL.65.6_suppl_3.S10
   Fernandes A, 2014, CELL MOL LIFE SCI, V71, P3969, DOI 10.1007/s00018-014-1670-8
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K
   Finkel S I, 1996, Int Psychogeriatr, V8 Suppl 3, P497
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Fronczek R, 2012, NEUROBIOL AGING, V33, P1642, DOI 10.1016/j.neurobiolaging.2011.03.014
   Garcia-Osta A, 2009, LEARN MEMORY, V16, P267, DOI 10.1101/lm.1310209
   Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803
   Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753
   Haas LT, 2016, J BIOL CHEM, V291, P17112, DOI 10.1074/jbc.M116.720664
   Hall AM, 2008, ALZHEIMERS DEMENT, V4, P271, DOI 10.1016/j.jalz.2008.04.005
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102
   Holthoff VA, 2005, BIOL PSYCHIAT, V57, P412, DOI 10.1016/j.biopsych.2004.11.035
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207
   Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010
   Ishii M, 2014, J NEUROSCI, V34, P9096, DOI 10.1523/JNEUROSCI.0872-14.2014
   Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322
   Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008
   Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108
   Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kales HC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h369
   Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7
   Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962
   Kang NR, 2012, J AFFECT DISORDERS, V136, P485, DOI 10.1016/j.jad.2011.11.002
   Kataoka K, 2010, PSYCHIAT CLIN NEUROS, V64, P293, DOI 10.1111/j.1440-1819.2010.02083.x
   KENT S, 1992, P NATL ACAD SCI USA, V89, P9117, DOI 10.1073/pnas.89.19.9117
   Kincheski GC, 2017, BRAIN BEHAV IMMUN, V64, P140, DOI 10.1016/j.bbi.2017.04.007
   Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093
   Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008
   Kolanowski AM, 2011, RES GERONTOL NURS, V4, P161, DOI 10.3928/19404921-20101001-98
   Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577
   Kotilinek LA, 2002, J NEUROSCI, V22, P6331
   Krstic D, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-62
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lalonde R, 2012, NEUROSCI BIOBEHAV R, V36, P1357, DOI 10.1016/j.neubiorev.2012.02.011
   Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Landes AM, 2005, J NEUROPSYCH CLIN N, V17, P342, DOI 10.1176/appi.neuropsych.17.3.342
   Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Lawlor B, 2002, BRIT J PSYCHIAT, V181, P463, DOI 10.1192/bjp.181.6.463
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4
   Lee HCB, 2003, BIOL PSYCHIAT, V54, P353, DOI 10.1016/S0006-3223(03)00543-2
   Lee L, 2014, J ALZHEIMERS DIS, V38, P49, DOI 10.3233/JAD-130740
   Levy-Cooperman N, 2008, J PSYCHIATR NEUROSCI, V33, P218
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Lim MM, 2014, NEURODEGENER DIS MAN, V4, P351, DOI [10.2217/nmt.14.33, 10.2217/NMT.14.33]
   Loskutova N, 2010, J ALZHEIMERS DIS, V20, P313, DOI 10.3233/JAD-2010-1364
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006
   Lyketsos Constantine G, 2011, Alzheimers Dement, V7, P532, DOI 10.1016/j.jalz.2011.05.2410
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856
   Martorana A, 2013, NEUROPHARMACOLOGY, V64, P108, DOI 10.1016/j.neuropharm.2012.07.015
   MASLIAH E, 1990, AM J PATHOL, V137, P1293
   Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8
   McCurry SM, 1999, J GERIATR PSYCH NEUR, V12, P53, DOI 10.1177/089198879901200203
   Mokhber N, 2014, PHARMACOPSYCHIATRY, V47, P131, DOI 10.1055/s-0034-1377041
   Moran M, 2005, SLEEP MED, V6, P347, DOI 10.1016/j.sleep.2004.12.005
   Mowla A, 2007, J CLIN PSYCHOPHARM, V27, P484, DOI 10.1097/jcp.0b013e31814b98c1
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508
   Murman DL, 2002, AM J GERIAT PSYCHIAT, V10, P328, DOI 10.1176/appi.ajgp.10.3.328
   Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0
   Nie LL, 2017, BIOFACTORS, V43, P593, DOI 10.1002/biof.1369
   Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647
   Niwa K, 2002, NEUROBIOL DIS, V9, P61, DOI 10.1006/nbdi.2001.0460
   Nobili A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14727
   OGOMORI K, 1989, AM J PATHOL, V134, P243
   Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001
   Oshima E, 2014, PSYCHIAT RES-NEUROIM, V224, P319, DOI 10.1016/j.pscychresns.2014.10.008
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Palmqvist S, 2011, DEMENT GERIATR COGN, V32, P417, DOI 10.1159/000335778
   Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13
   Peters ME, 2015, AM J PSYCHIAT, V172, P460, DOI 10.1176/appi.ajp.2014.14040480
   Peters ME, 2015, AM J GERIAT PSYCHIAT, V23, P115, DOI 10.1016/j.jagp.2014.11.002
   Petracca GM, 2001, INT PSYCHOGERIATR, V13, P233, DOI 10.1017/S104161020100761X
   Pitt J, 2017, MOL BIOL CELL, V28, P2623, DOI 10.1091/mbc.E17-06-0416
   Porta-Etessam J, 2011, ALZ DIS ASSOC DIS, V25, P317, DOI 10.1097/WAD.0b013e31820e7c45
   Prince TM, 2014, NEUROBIOL LEARN MEM, V109, P122, DOI 10.1016/j.nlm.2013.11.021
   Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044
   Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313
   Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008
   Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   Ricciarelli R, 2014, ANN NEUROL, V75, P602, DOI 10.1002/ana.24130
   Richard E, 2013, JAMA NEUROL, V70, P383, DOI 10.1001/jamaneurol.2013.603
   Roh JH, 2014, J EXP MED, V211, P2487, DOI 10.1084/jem.20141788
   Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291
   Romano A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu020
   Roumestan C, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-35
   RUDELLI RD, 1984, ACTA NEUROPATHOL, V64, P273, DOI 10.1007/BF00690393
   Salazar SV, 2017, J NEUROSCI, V37, P9207, DOI 10.1523/JNEUROSCI.0722-17.2017
   Santos LE, 2016, BRAIN BEHAV IMMUN, V55, P151, DOI 10.1016/j.bbi.2015.11.011
   Schneider F, 2014, PHYSIOL BEHAV, V135, P25, DOI 10.1016/j.physbeh.2014.05.041
   Schulz E, 2004, HEALTH POLICY, V67, P57, DOI 10.1016/S0168-8510(03)00083-6
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Sheng JG, 1996, NEUROPATH APPL NEURO, V22, P334, DOI 10.1111/j.1365-2990.1996.tb01112.x
   Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295
   Son JH, 2013, NEUROSCI LETT, V548, P15, DOI 10.1016/j.neulet.2013.05.021
   STANDAERT DG, 1991, AM J PATHOL, V139, P681
   Stefani A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00067
   Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810
   STRAUSS S, 1992, LAB INVEST, V66, P223
   Tagariello P, 2009, ARCH GERONTOL GERIAT, V49, P246, DOI 10.1016/j.archger.2008.09.002
   Tanzi RE, 2016, NEW ENGL J MED, V372, P2564
   Taragano FE, 1997, PSYCHOSOMATICS, V38, P246, DOI 10.1016/S0033-3182(97)71461-0
   Teng E, 2008, AM J GERIAT PSYCHIAT, V16, P469, DOI 10.1097/JGP.0b013e318165dbae
   Terada S, 2014, PSYCHIAT RES-NEUROIM, V221, P86, DOI 10.1016/j.pscychresns.2013.11.002
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754
   Trzepacz Paula T, 2013, Alzheimers Dement, V9, pS95, DOI 10.1016/j.jalz.2012.10.005
   Tuglu C, 2003, PSYCHOPHARMACOLOGY, V170, P429, DOI 10.1007/s00213-003-1566-z
   Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X
   Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042
   Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036
   Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178
   United Nations Department of Economic and Social Affairs Population Division, 2015, ESAPWP241 UN POP DIV
   Velasco PT, 2012, ACS CHEM NEUROSCI, V3, P972, DOI 10.1021/cn300122k
   Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004
   Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3
   Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307
   Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049
   White H, 1998, J AM GERIATR SOC, V46, P1223, DOI 10.1111/j.1532-5415.1998.tb04537.x
   White H, 1996, J AM GERIATR SOC, V44, P265, DOI 10.1111/j.1532-5415.1996.tb00912.x
   Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600
   Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018
   Wolf-Klein G P, 1992, Int Psychogeriatr, V4, P103, DOI 10.1017/S1041610292000930
   World Health Organization, 2017, 10 FACTS ON DEM
   Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484
   Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001
   Yohn CN, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0306-y
   Zarros AC, 2005, ACTA NEUROBIOL EXP, V65, P277
   Zhang B, 2005, AM J PATHOL, V167, P1361, DOI 10.1016/S0002-9440(10)61223-0
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
   Zhu WL, 2006, LIFE SCI, V79, P749, DOI 10.1016/j.lfs.2006.02.015
NR 197
TC 9
Z9 9
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PY 2018
VL 64
SU 1
BP S313
EP S327
DI 10.3233/JAD-179925
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA GJ0MX
UT WOS:000434949600020
PM 29710716
DA 2020-09-29
ER

PT J
AU Neves, FS
   Marques, PT
   Barros-Aragao, F
   Nunes, JB
   Venancio, AM
   Cozachenco, D
   Frozza, RL
   Passos, GF
   Costa, R
   de Oliveira, J
   Engel, DF
   De Bem, AF
   Benjamim, CF
   De Felice, FG
   Ferreira, ST
   Clarke, JR
   Figueiredo, CP
AF Neves, Fernanda S.
   Marques, Patricia T.
   Barros-Aragao, Fernanda
   Nunes, Jose Bruno
   Venancio, Aline M.
   Cozachenco, Danielle
   Frozza, Rudimar L.
   Passos, Giselle F.
   Costa, Robson
   de Oliveira, Jade
   Engel, Daiane F.
   De Bem, Andreza F.
   Benjamim, Claudia F.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
   Clarke, Julia R.
   Figueiredo, Claudia P.
TI Brain-Defective Insulin Signaling Is Associated to Late Cognitive
   Impairment in Post-Septic Mice
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Sepsis survivors; Cognitive impairment; Insulin receptor substrate-1
   (IRS-1) inhibition; Glycogen synthase kinase 3 beta (GSK3 beta);
   Liraglutide; TDZD-8; Late cognitive impairment
ID A-BETA OLIGOMERS; GLYCOGEN-SYNTHASE KINASE-3; ALZHEIMERS-DISEASE; SEPSIS
   SURVIVORS; OBJECT RECOGNITION; RECEPTOR SUBSTRATE; AMYLOID OLIGOMERS;
   MEMORY IMPAIRMENT; CRITICAL ILLNESS; NERVOUS-SYSTEM
AB Sepsis survivors frequently develop late cognitive impairment. Because little is known on the mechanisms of post-septic memory deficits, there are no current effective approaches to prevent or treat such symptoms. Here, we subjected mice to severe sepsis induced by cecal ligation and puncture (CLP) and evaluated the sepsis-surviving animals in the open field, novel object recognition (NOR), and step-down inhibitory avoidance (IA) task at different times after surgery. Post-septic mice (30 days post-surgery) failed in the NOR and IA tests but exhibited normal performance when re-evaluated 45 days after surgery. Cognitive impairment in post-septic mice was accompanied by reduced hippocampal levels of proteins involved in synaptic plasticity, including synaptophysin, cAMP response element-binding protein (CREB), CREB phosphorylated at serine residue 133 (CREBpSer(133)), and GluA1 phosphorylated at serine residue 845 (GluA1pSer(845)). Expression of tumor necrosis factor alpha (TNF-alpha) was increased and brain insulin signaling was disrupted, as indicated by increased hippocampal IRS-1 phosphorylation at serine 636 (IRS-1pSer(636)) and decreased phosphorylation of IRS-1 at tyrosine 465 (IRS-1pTyr(465)), in the hippocampus 30 days after CLP. Phosphorylation of Akt at serine 473 (AktpSer(473)) and of GSK3 at serine 9 (GSK3 beta pSer(9)) were also decreased in hippocampi of post-septic animals, further indicating that brain insulin signaling is disrupted by sepsis. We then treated post-septic mice with liraglutide, a GLP-1 receptor agonist with insulinotropic activity, or TDZD-8, a GSK3 beta inhibitor, which rescued NOR memory. In conclusion, these results establish that hippocampal inflammation and disrupted insulin signaling are induced by sepsis and are linked to late memory impairment in sepsis survivors.
C1 [Neves, Fernanda S.; Marques, Patricia T.; Barros-Aragao, Fernanda; Cozachenco, Danielle; Passos, Giselle F.; Costa, Robson; Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Barros-Aragao, Fernanda; Nunes, Jose Bruno; Benjamim, Claudia F.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Venancio, Aline M.; de Oliveira, Jade; Engel, Daiane F.; De Bem, Andreza F.] Univ Fed Santa Catarina, Ctr Biol Sci, Florianopolis, SC, Brazil.
   [Frozza, Rudimar L.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Clarke, JR; Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM juclarke@gmail.com; claufig@gmail.com
RI Figueiredo, Claudia P/F-8424-2012; de Oliveira, Jade/AAJ-6849-2020;
   Engel, Daiane F./AAN-9044-2020; Ferreira, Sergio/AAZ-1576-2020; Clarke,
   Julia/AAF-9434-2019; Benjamim, Claudia/T-5090-2019; de,
   Andreza/AAA-1523-2019; Neves, Fernanda/AAW-9638-2020; da Costa,
   Robson/D-7822-2015; SILVA, JOSE BRUNO/G-7569-2015
OI de Oliveira, Jade/0000-0003-1454-2866; Engel, Daiane
   F./0000-0002-1950-196X; Ferreira, Sergio/0000-0001-7160-9866; Benjamim,
   Claudia/0000-0001-6247-9596; de, Andreza/0000-0003-1090-5244; da Costa,
   Robson/0000-0002-1675-4742; Figueiredo, Claudia/0000-0001-9467-9891;
   Gomes de Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; SILVA,
   JOSE BRUNO/0000-0003-4398-3943; Frozza, Rudimar Luiz/0000-0003-0918-4128
FU Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro; Brazilian funding agency Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Brazilian funding agency
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX This work was supported by grants from Brazilian funding agencies
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (F.S.N.,
   C.F.B., F.G.D.F, S.T.F, J.R.C., C.P.F.), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (R.L.F., F.B.A., C.F.B.,
   A.F.D.B., F.G.D.F., S.T.F.,, J.R.C., C.P.F.), and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (J.D.O, D.F.E., C.P.F.). We
   thank Maira Oliveira, Katia Laia, and Mariangela M. Viana for the
   technical support, and Ana Claudia Rangel for the competent lab and
   project management.
CR Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1
   Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2
   Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194
   Barichello T, 2005, CRIT CARE MED, V33, P1671, DOI 10.1097/01.CCM.0000170192.54682.C1
   Barichello T, 2005, CRIT CARE MED, V33, P221, DOI 10.1097/01.CCM.0000150741.12906.BD
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107
   Comim CM, 2011, NEUROCHEM RES, V36, P304, DOI 10.1007/s11064-010-0320-2
   CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0
   DaRocha-Souto B, 2012, NEUROBIOL DIS, V45, P425, DOI 10.1016/j.nbd.2011.09.002
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2013, EXPERT REV NEUROTHER, V13, P1297, DOI 10.1586/14737175.2013.864824
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475
   Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Fu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106331
   Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340
   Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1
   Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183
   Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0
   Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025
   Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830
   Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553
   Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017
   Lamar CD, 2011, J NEUROPSYCH CLIN N, V23, P236, DOI 10.1176/appi.neuropsych.23.3.237
   Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037
   Long-Smith CM, 2013, NEUROMOL MED, V15, P102, DOI 10.1007/s12017-012-8199-5
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005
   McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633
   Moraes CA, 2015, MOL NEUROBIOL, V52, P653, DOI 10.1007/s12035-014-8868-5
   Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200
   Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372
   Ritter C, 2004, CRIT CARE MED, V32, P342, DOI 10.1097/01.CCM.0000109454.13145.CA
   Ryan GJ, 2011, J CLIN PHARM THER, V36, P260, DOI 10.1111/j.1365-2710.2010.01180.x
   Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883
   Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48
   Sharshar T, 2014, LANCET NEUROL, V13, P534, DOI 10.1016/S1474-4422(14)70064-X
   Singer BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149136
   Steckert AV, 2013, SYNAPSE, V67, P786, DOI 10.1002/syn.21686
   Sui DM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1045657
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009
   Widmann CN, 2014, LANCET NEUROL, V13, P630, DOI 10.1016/S1474-4422(14)70017-1
   Yarchoan M, 2014, ACTA NEUROPATHOL, V128, P679, DOI 10.1007/s00401-014-1328-5
   Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723
NR 53
TC 14
Z9 14
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JAN
PY 2018
VL 55
IS 1
BP 435
EP 444
DI 10.1007/s12035-016-0307-3
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA FV6PC
UT WOS:000424702600042
PM 27966074
DA 2020-09-29
ER

PT J
AU Pitt, J
   Wilcox, KC
   Tortelli, V
   Diniz, LP
   Oliveira, MS
   Dobbins, C
   Yu, XW
   Nandamuri, S
   Gomes, FCA
   DiNunno, N
   Viola, KL
   De Felice, FG
   Ferreira, ST
   Klein, WL
AF Pitt, Jason
   Wilcox, Kyle C.
   Tortelli, Vanessa
   Diniz, Luan Pereira
   Oliveira, Maira S.
   Dobbins, Cassandra
   Yu, Xiao-Wen
   Nandamuri, Sathwik
   Gomes, Flvia C. A.
   DiNunno, Nadia
   Viola, Kirsten L.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
   Klein, William L.
TI Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1
   stimulates endocytic processing and extracellular release of
   neuron-bound A beta oligomers
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID INHIBITORY SYNAPSE FORMATION; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA;
   ALZHEIMERS-DISEASE; MOUSE MODEL; INSULIN-RESISTANCE; TAU
   PHOSPHORYLATION; DEFECTIVE INSULIN; SIGNALING PATHWAY; CELL-DEATH
AB Synaptopathy underlying memory deficits in Alzheimer's disease (AD) is increasingly thought to be instigated by toxic oligomers of the amyloid beta peptide (A beta Os). Given the long latency and incomplete penetrance of AD dementia with respect to A beta pathology, we hypothesized that factors present in the CNS may physiologically protect neurons from the deleterious impact of A beta Os. Here we employed physically separated neuron-astrocyte cocultures to investigate potential non-cell autonomous neuroprotective factors influencing A beta O toxicity. Neurons cultivated in the absence of an astrocyte feeder layer showed abundant A beta O binding to dendritic processes and associated synapse deterioration. In contrast, neurons in the presence of astrocytes showed markedly reduced A beta O binding and synaptopathy. Results identified the protective factors released by astrocytes as insulin and insulinlike growth factor-1 (IGF1). The protective mechanism involved release of newly bound A beta Os into the extracellular medium dependent upon trafficking that was sensitive to exosome pathway inhibitors. Delaying insulin treatment led to A beta O binding that was no longer releasable. The neuroprotective potential of astrocytes was itself sensitive to chronic A beta O exposure, which reduced insulin/IGF1 expression. Our findings support the idea that physiological protection against synaptotoxic A beta Os can be mediated by astrocyte-derived insulin/IGF1, but that this protection itself is vulnerable to A beta O buildup.
C1 [Pitt, Jason; Wilcox, Kyle C.; Dobbins, Cassandra; DiNunno, Nadia; Viola, Kirsten L.; Klein, William L.] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Neurobiol, Evanston, IL 60208 USA.
   [Pitt, Jason; Yu, Xiao-Wen] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.
   [Tortelli, Vanessa; Diniz, Luan Pereira; Gomes, Flvia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Oliveira, Maira S.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
RP Klein, WL (corresponding author), Northwestern Univ, Weinberg Coll Arts & Sci, Dept Neurobiol, Evanston, IL 60208 USA.
EM wklein@northwestern.edu
RI Ferreira, Sergio/AAZ-1576-2020; Diniz, Luan/AAN-6788-2020; Gomes,
   Flavia/C-5383-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Diniz, Luan/0000-0002-2986-4043;
   Gomes, Flavia/0000-0003-2966-0638
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [1F31AG039216];
   Alzheimer's AssociationAlzheimer's Association [ZEN09133875]; National
   Institute for Translational Neuroscience/Brazil; CNPq/BrazilNational
   Council for Scientific and Technological Development (CNPq);
   FAPERJ/BrazilCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); CCSG [P30 CA060553]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1S10OD016342-01]; NCIUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [CCSG P30 CA060553]
FX This research was funded by the National Institutes of Health (NIH)
   (grant 1F31AG039216 to J.P.); the Alzheimer's Association (grant
   ZEN09133875 to W.L.K.); and the National Institute for Translational
   Neuroscience/Brazil, CNPq/Brazil, and FAPERJ/Brazil (to S.T.F.,
   F.G.D.F., and F.C.A.G.).Imaging work with the N-SIM and A1R microscopes
   was performed at the Northwestern University Center for Advanced
   Microscopy, generously supported by National Cancer Institute (NCI)
   grant CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive
   Cancer Center.Structured illumination microscopy was performed on a
   Nikon N-SIM system, purchased through the support of NIH
   1S10OD016342-01.Wide-field fluorescent imaging was performed at the
   Northwestern University HighThroughput Analysis Laboratory generously
   supported by NCI grant CCSG P30 CA060553 awarded to the Robert H.Lurie
   Comprehensive Cancer Center.
CR Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059
   Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29
   Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479
   Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x
   Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107
   Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859
   Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801
   Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131
   Chang L, 2003, J MOL NEUROSCI, V20, P305, DOI 10.1385/JMN:20:3:305
   CHERNAUSEK SD, 1993, J NEUROSCI RES, V34, P189, DOI 10.1002/jnr.490340206
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   DiChiara T, 2017, YALE J BIOL MED, V90, P45
   Diniz LP, 2017, J NEUROSCI, V37, P6797, DOI 10.1523/JNEUROSCI.3351-16.2017
   Diniz LP, 2014, GLIA, V62, P1917, DOI 10.1002/glia.22713
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012
   Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287
   Fernandes MLDA, 2001, ENDOCRINE, V16, P227
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fogel H, 2014, CELL REP, V7, P1560, DOI 10.1016/j.celrep.2014.04.024
   Gault VA, 2008, J NEUROPHYSIOL, V99, P1590, DOI 10.1152/jn.01161.2007
   Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P405, DOI 10.3233/JAD-2010-100795
   Gomes FCA, 1999, GLIA, V25, P247, DOI 10.1002/(SICI)1098-1136(19990201)25:3<247::AID-GLIA5>3.3.CO;2-U
   Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x
   HAVRANKOVA J, 1979, J CLIN INVEST, V64, P636, DOI 10.1172/JCI109504
   Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673
   Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f
   Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228
   Hu SH, 2013, EXP CLIN ENDOCR DIAB, V121, P220, DOI 10.1055/s-0032-1333277
   Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0
   Jack CR, 2010, ALZHEIMERS DEMENT, V6, P212, DOI 10.1016/j.jalz.2010.03.004
   Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103
   Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668
   Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010
   Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787
   Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283
   Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356
   Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834
   Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3
   Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009
   Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004
   Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Launer Lenore J, 2005, Curr Diab Rep, V5, P59, DOI 10.1007/s11892-005-0069-1
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Spohr TCLDE, 2011, J NEUROCHEM, V119, P113, DOI 10.1111/j.1471-4159.2011.07421.x
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Long-Smith CM, 2013, NEUROMOL MED, V15, P102, DOI 10.1007/s12017-012-8199-5
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Malikova M, 2004, AM J PHYSIOL-ENDOC M, V287, pE547, DOI 10.1152/ajpendo.00571.2003
   Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012
   Martinez R, 2002, J BIOL CHEM, V277, P49311, DOI 10.1074/jbc.M209284200
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623
   Modrego Pedro J., 2006, Current Alzheimer Research, V3, P161, DOI 10.2174/156720506776383103
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Muller G, 2009, CELL SIGNAL, V21, P324, DOI 10.1016/j.cellsig.2008.10.021
   Nimmrich V, 2010, BRIT J PHARMACOL, V159, P1523, DOI 10.1111/j.1476-5381.2010.00652.x
   Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022
   PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0
   Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015
   Pitt J, 2013, FASEB J, V27, P199, DOI 10.1096/fj.12-211896
   Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018
   Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x
   Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X
   Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730
   Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247
   Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x
   Schmitt LI, 2012, J NEUROSCI, V32, P4417, DOI 10.1523/JNEUROSCI.5689-11.2012
   SEALS JR, 1980, J BIOL CHEM, V255, P6529
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323
   Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123
   Sivanesan S, 2013, CURR ALZHEIMER RES, V10, P316, DOI 10.2174/1567205011310030011
   Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008
   Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003
   Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321
   Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010
   Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200
   Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015
   Velasco PT, 2012, ACS CHEM NEUROSCI, V3, P972, DOI 10.1021/cn300122k
   VIDAL MJ, 1993, EUR J CELL BIOL, V60, P261
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   Wilcox KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125263
   Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4
   Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006
   Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616
   ZAFRA F, 1992, J NEUROSCI, V12, P4793
   Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010
   Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
   Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015
NR 123
TC 30
Z9 30
U1 1
U2 8
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD OCT 1
PY 2017
VL 28
IS 20
BP 2623
EP +
DI 10.1091/mbc.E17-06-0416
PG 19
WC Cell Biology
SC Cell Biology
GA FI6OE
UT WOS:000412115100004
PM 28963439
OA Green Published, Other Gold
DA 2020-09-29
ER

PT J
AU Sebollela, A
   Cline, EN
   Popova, I
   Luo, K
   Sun, XX
   Ahn, J
   Barcelos, MA
   Bezerra, VN
   Silva, NMLE
   Patel, J
   Pinheiro, NR
   Qin, LA
   Kamel, JM
   Weng, A
   DiNunno, N
   Bebenek, AM
   Velasco, PT
   Viola, KL
   Lacor, PN
   Ferreira, ST
   Klein, WL
AF Sebollela, Adriano
   Cline, Erika N.
   Popova, Izolda
   Luo, Kevin
   Sun, Xiaoxia
   Ahn, Jay
   Barcelos, Milena A.
   Bezerra, Vanessa N.
   Lyra e Silva, Natalia M.
   Patel, Jason
   Pinheiro, Nathalia R.
   Qin, Lei A.
   Kamel, Josette M.
   Weng, Anthea
   DiNunno, Nadia
   Bebenek, Adrian M.
   Velasco, Pauline T.
   Viola, Kirsten L.
   Lacor, Pascale N.
   Ferreira, Sergio T.
   Klein, William L.
TI A human scFv antibody that targets and neutralizes high molecular weight
   pathogenic amyloid-beta oligomers
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE Alzheimer's disease; amyloid beta oligomers; conformational antibodies;
   scFvs
ID PHAGE DISPLAY TECHNOLOGY; LONG-TERM POTENTIATION; A-BETA;
   ALZHEIMERS-DISEASE; TAU-HYPERPHOSPHORYLATION; MEMORY LOSS; IN-VIVO;
   FRAGMENTS; BRAIN; MECHANISM
AB Brain accumulation of soluble oligomers of the amyloid-beta peptide (A beta Os) is increasingly considered a key early event in the pathogenesis of Alzheimer's disease (AD). Avariety of A beta O species have been identified, both in vitro and in vivo, ranging from dimers to 24mers and higher order oligomers. However, there is no consensus in the literature regarding which A beta O species are most germane to AD pathogenesis. Antibodies capable of specifically recognizing defined subpopulations of AbOs would be a valuable asset in the identification, isolation, and characterization of AD-relevant AbO species. Here, we report the characterization of a human single chain antibody fragment (scFv) denoted NUsc1, one of a number of scFvs we have identified that stringently distinguish A beta Os from both monomeric and fibrillar A beta. NUsc1 readily detected A beta Ospreviously bound to dendrites in cultured hippocampal neurons. In addition, NUsc1 blocked AbO binding and reduced A beta O-induced neuronal oxidative stress and tau hyperphosphorylation in cultured neurons. NUsc1 further distinguished brain extracts from AD-transgenicmice from wild type (WT) mice, and detected endogenous A beta Os in fixed AD brain tissue and AD brain extracts. Biochemical analyses indicated that NUsc1 targets a subpopulation of A beta Os with apparent molecular mass greater than 50 kDa. Results indicate that NUsc1 targets a particular A beta O species relevant to AD pathogenesis, and suggest that NUsc1 may constitute an effective tool for AD diagnostics and therapeutics.
C1 [Sebollela, Adriano; Cline, Erika N.; Luo, Kevin; Sun, Xiaoxia; Ahn, Jay; Patel, Jason; Qin, Lei A.; Kamel, Josette M.; Weng, Anthea; DiNunno, Nadia; Bebenek, Adrian M.; Velasco, Pauline T.; Viola, Kirsten L.; Lacor, Pascale N.; Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [Sebollela, Adriano; Barcelos, Milena A.; Bezerra, Vanessa N.; Lyra e Silva, Natalia M.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
   [Sebollela, Adriano; Pinheiro, Nathalia R.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.
   [Popova, Izolda] Northwestern Univ, Recombinant Prot Prod Core rPPC, Evanston, IL 60208 USA.
   [Bebenek, Adrian M.] Illinois Math & Sci Acad, Aurora, IL USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
RP Sebollela, A (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
EM sebollela@fmrp.usp.br
RI Sebollela, Adriano/O-4385-2014; Ferreira, Sergio/AAZ-1576-2020
OI Sebollela, Adriano/0000-0002-7444-9156; Ferreira,
   Sergio/0000-0001-7160-9866; Qin, Lei/0000-0002-1754-7083
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AG22547, AG29460];
   Alzheimer's AssociationAlzheimer's Association [ZEN-09-133875];
   Nanoscale Science and Engineering Initiative of the National Science
   FoundationNational Science Foundation (NSF) [EEC-06475560]; Sao Paulo
   Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2014/25681-3]; FAEPA; Brazilian National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq); Rio de Janeiro State
   Funding Agency (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq) [560556/2010-1]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [4T32AG020506-15]; Northwestern University Robert H. Lurie
   Comprehensive Cancer Center
FX This work was supported by National Institutes of Health Grants AG22547
   and AG29460 (WLK), Alzheimer's Association Zenith Award #ZEN-09-133875
   (WLK), the Nanoscale Science and Engineering Initiative of the National
   Science Foundation Award EEC-06475560 (WLK), and Sao Paulo Research
   Foundation (FAPESP) grant 2014/25681-3 (AS). It was also supported by
   grants from FAEPA (AS), the Brazilian National Council for Scientific
   and Technological Development (CNPq) and the Rio de Janeiro State
   Funding Agency (FAPERJ) (AS and STF). AS was recipient of a postdoctoral
   fellowship from CNPq (#560556/2010-1). ENC was recipient of a
   postdoctoral fellowship from the NIH (4T32AG020506-15). A portion of the
   confocal imaging was performed at the Northwestern University High
   Throughput Analysis Core, supported by the Northwestern University
   Robert H. Lurie Comprehensive Cancer Center. The DA31 antibody was a
   generous gift from Dr. Peter Davies. The authors have no conflicts of
   interest to disclose.
CR Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010
   Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250
   Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0
   Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003
   Barbas III CF, 2004, PHAGE DISPLAY LAB MA
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Brichta J, 2003, VET MED-CZECH, V48, P237, DOI 10.17221/5776-VETMED
   Cheng M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1168557
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Farlow MR, 2013, NEUROL CLIN, V31, P869, DOI 10.1016/j.ncl.2013.03.012
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Frenkel D, 2000, J NEUROIMMUNOL, V106, P23, DOI 10.1016/S0165-5728(99)00232-5
   Frenkel D, 2002, P NATL ACAD SCI USA, V99, P5675, DOI 10.1073/pnas.072027199
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Goure WF, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt272
   GRIFFITHS AD, 1993, EMBO J, V12, P725, DOI 10.1002/j.1460-2075.1993.tb05706.x
   Grimm K. M., 2007, METHOD PREPARING COV
   Hayden EY, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt226
   Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010
   Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019
   Kasturirangan S, 2013, BIOTECHNOL PROGR, V29, P463, DOI 10.1002/btpr.1698
   Kasturirangan S, 2012, NEUROBIOL AGING, V33, P1320, DOI 10.1016/j.neurobiolaging.2010.09.020
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200
   Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Liu P, 2015, CELL REP, V11, P1760, DOI 10.1016/j.celrep.2015.05.021
   Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o
   Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313
   Mc Donald JM, 2015, ALZHEIMERS DEMENT, V11, P1286, DOI 10.1016/j.jalz.2015.01.005
   Medecigo M, 2010, J NEUROIMMUNOL, V223, P104, DOI 10.1016/j.jneuroim.2010.03.023
   Meli G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4867
   Meli G, 2009, J MOL BIOL, V387, P584, DOI 10.1016/j.jmb.2009.01.061
   Murakami K, 2014, BIOSCI BIOTECH BIOCH, V78, P1293, DOI 10.1080/09168451.2014.940275
   NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x
   Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208
   Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006
   Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974
   Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010
   Rivera-Hernandez G, 2013, MABS-AUSTIN, V5, P678, DOI 10.4161/mabs.25382
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Savioz A, 2016, NEURODEGENER DIS, V16, P398, DOI 10.1159/000446283
   Sebollela A, 2014, ACS CHEM NEUROSCI, V5, P1238, DOI 10.1021/cn500156r
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323
   Solomon B, 2002, J NEURAL TRANSM-SUPP, P321
   Solomon B, 2008, J ALZHEIMERS DIS, V15, P193
   Solorzano-Vargas RS, 2008, MOL IMMUNOL, V45, P881, DOI 10.1016/j.molimm.2007.08.008
   Teplow DB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt203
   Vandersteen A, 2012, FEBS LETT, V586, P4088, DOI 10.1016/j.febslet.2012.10.022
   Velasco PT, 2012, ACS CHEM NEUROSCI, V3, P972, DOI 10.1021/cn300122k
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3
   Viola KL, 2015, NAT NANOTECHNOL, V10, P91, DOI [10.1038/nnano.2014.254, 10.1038/NNANO.2014.254]
   Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005
   Wang J, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/6138251
   Wang XP, 2009, FEBS LETT, V583, P579, DOI 10.1016/j.febslet.2008.12.064
   Ward SM, 2013, J ALZHEIMERS DIS, V37, P593, DOI 10.3233/JAD-131235
   Williams SM, 2016, EUR J NEUROSCI, V43, P3, DOI 10.1111/ejn.13056
   Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265
   Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068
   Zhang Y, 2015, MOL NEUROBIOL, V52, P1269, DOI 10.1007/s12035-014-8910-7
NR 76
TC 11
Z9 11
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD SEP
PY 2017
VL 142
IS 6
BP 934
EP 947
DI 10.1111/jnc.14118
PG 14
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FG5YB
UT WOS:000410431800012
PM 28670737
OA Green Accepted, Bronze
DA 2020-09-29
ER

PT J
AU Almeida, DS
   Santos, RS
   Anjos, MJ
   Ferreira, ST
   Souza, AS
   Lopes, RT
AF Almeida, D. S.
   Santos, R. S.
   Anjos, M. J.
   Ferreira, S. T.
   Souza, A. S.
   Lopes, R. T.
TI Multielement concentration analysis of Swiss mice brains on experimental
   model of Alzheimer's disease induced by beta-amyloid oligomers
SO X-RAY SPECTROMETRY
LA English
DT Article; Proceedings Paper
CT 17th European Conference on X-Ray Spectrometry (EXRS)
CY JUN 19-24, 2016
CL Univ Gothenburg, Gothenburg, SWEDEN
SP Int Atom Energy Agcy
HO Univ Gothenburg
ID CENTRAL-NERVOUS-SYSTEM; COGNITIVE IMPAIRMENT; SUBSTANTIA-NIGRA; IRON
   ACCUMULATION; OXIDATIVE STRESS; METAL-IONS; HIPPOCAMPUS; COPPER; ZINC;
   MECHANISMS
AB Alzheimer's disease (AD) is an insidious, progressive, and irreversible brain disorder that leads to memory loss and severe cognitive decline. However, the discovery that soluble beta-amyloid oligomers are potent central nervous system neurotoxins has led to a new view of AD pathogenesis. Metals, such as zinc, iron, and copper, are all increased in the aged brain, and the contents of those metals in the brain of AD patients are higher than non-AD people. So, altered homeostasis of metal may result in the development of AD. Total reflection X-ray fluorescence analysis (TXRF) is a multielement analytical technique, which can be used for elemental trace analysis. In this work, TXRF was used to evaluate the elemental concentration and distribution on mice brain regions. Three groups were studied: control, AD10, and AD100, being the two latter were given a single intracerebroventricular injection of 10 pmol and 100 pmol (beta-amyloid oligomers), respectively, to induce experimental AD. All samples were submitted to acid digestion. The TXRF measurements were performed at the X-Ray Fluorescence Beamline at Brazilian National Synchrotron Light Laboratory, using amonochromatic beam (11.5 keV) for the excitation. It was possible to determine the concentrations of the following elements: P, S, K, Fe, Cu, and Zn. Results showed differences in the elemental concentration in some brain regions between the AD groups and the control group. Furthermore, the difference in the hypothalamus in AD10 groups, both female and male, suggests an association between AD and changes in these elements. Copyright (C) 2017 John Wiley & Sons, Ltd.
C1 [Ferreira, S. T.; Souza, A. S.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Almeida, D. S.; Lopes, R. T.] Univ Fed Rio de Janeiro, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
   [Santos, R. S.; Anjos, M. J.] Univ Estado Rio De Janeiro, Inst Phys, Rio De Janeiro, Brazil.
   [Ferreira, S. T.; Souza, A. S.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Souza, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Lopes, RT (corresponding author), Univ Fed Rio de Janeiro, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
EM amandass@bioqmed.ufrj.br; ricardo@lin.ufrj.br
RI Lopes, Ricardo T/O-8840-2014; Anjos, Marcelino Jose dos/R-3566-2019;
   Ferreira, Sergio/AAZ-1576-2020
OI Lopes, Ricardo T/0000-0001-7250-824X; Ferreira,
   Sergio/0000-0001-7160-9866
FU National Council for Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)National
   Council for Scientific and Technological Development (CNPq); Foundation
   for Research Support of the State of Rio de Janeiro (Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro - FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Brazilian Synchrotron Light Laboratory (Laboratorio Nacional de Luz
   Sincrotron - LNLS) [XRF-20150100]
FX This work was supported by the National Council for Scientific and
   Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq), Foundation for Research Support of the
   State of Rio de Janeiro (Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro - FAPERJ), and Brazilian Synchrotron Light Laboratory
   (Laboratorio Nacional de Luz Sincrotron - LNLS - Project XRF-20150100).
CR Abrams ZR, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00011
   Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003
   Andersen K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.013
   Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4
   Antharam V, 2012, NEUROIMAGE, V59, P1249, DOI 10.1016/j.neuroimage.2011.08.019
   Apostolova LG, 2011, DEMENT GERIATR COGN, V32, P118, DOI 10.1159/000330471
   Banerjee P, 2014, NEUROMOL MED, V16, P787, DOI 10.1007/s12017-014-8328-4
   Baumann O, 2014, CEREBELLUM, V13, P46, DOI 10.1007/s12311-013-0519-2
   Bherer Louis, 2004, Psychol Neuropsychiatr Vieil, V2, P181
   Biran J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00047
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Brar S, 2009, ARCH NEUROL-CHICAGO, V66, P371, DOI 10.1001/archneurol.2008.586
   Brass Steven D, 2006, Top Magn Reson Imaging, V17, P31, DOI 10.1097/01.rmr.0000245459.82782.e4
   Bussiere T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760
   Chen S, 2012, NEUROCHEM RES, V37, P2805, DOI 10.1007/s11064-012-0874-2
   Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005
   Chong-Bo Z., 2004, NEUROSCI LETT, V373, P99
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Collingwood JF, 2008, J ALZHEIMERS DIS, V14, P235
   Eskici G, 2012, BIOCHEMISTRY-US, V51, P6289, DOI 10.1021/bi3006169
   Faller P, 2013, INORG CHEM, V52, P12193, DOI 10.1021/ic4003059
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215
   Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01
   Guo CC, 2016, BRAIN, V139, P1527, DOI 10.1093/brain/aww003
   House MJ, 2006, AM J NEURORADIOL, V27, P430
   Inan SY, 2000, EUR J PHARMACOL, V407, P159, DOI 10.1016/S0014-2999(00)00736-6
   Jones LC, 2008, HIPPOCAMPUS, V18, P398, DOI 10.1002/hipo.20399
   Klein W. L., 2006, PROTEIN MISFOLDING A
   Krebs N, 2014, J TRACE ELEM MED BIO, V28, P1, DOI 10.1016/j.jtemb.2013.09.006
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021
   Leskovjan AC, 2011, NEUROIMAGE, V55, P32, DOI 10.1016/j.neuroimage.2010.11.073
   Lopes RT, 2011, PRAMANA-J PHYS, V76, P271, DOI 10.1007/s12043-011-0043-1
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Mavroudis IA, 2010, AM J ALZHEIMERS DIS, V25, P585, DOI 10.1177/1533317510382892
   Moon WJ, 2016, KOREAN J RADIOL, V17, P633, DOI 10.3348/kjr.2016.17.5.633
   Morbelli S, 2012, NEUROBIOL AGING, V33, P2533, DOI 10.1016/j.neurobiolaging.2012.01.005
   Mundy WR, 2000, NEUROTOXICOLOGY, V21, P1135
   Pan YP, 2004, J NEUROSCI RES, V77, P94, DOI 10.1002/jnr.20134
   Popescu BFG, 2009, CEREBELLUM, V8, P74, DOI 10.1007/s12311-008-0091-3
   Porte D, 2005, DIABETES, V54, P1264, DOI 10.2337/diabetes.54.5.1264
   Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209
   Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909
   Ruiz HH, 2016, ALZHEIMERS DEMENT, V12, P851, DOI 10.1016/j.jalz.2016.01.008
   Schroder N, 2013, J ALZHEIMERS DIS, V34, P797, DOI 10.3233/JAD-121996
   Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823
   Viles JH, 2012, COORDIN CHEM REV, V256, P2271, DOI 10.1016/j.ccr.2012.05.003
   Zainchick V., 2016, CANC RES ONCOL, V1, P1
   Zatta P, 2009, TRENDS PHARMACOL SCI, V30, P346, DOI 10.1016/j.tips.2009.05.002
   Zhu WZ, 2009, RADIOLOGY, V253, P497, DOI 10.1148/radiol.2532082324
NR 56
TC 2
Z9 2
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0049-8246
EI 1097-4539
J9 X-RAY SPECTROM
JI X-Ray Spectrom.
PD SEP-OCT
PY 2017
VL 46
IS 5
SI SI
BP 397
EP 402
DI 10.1002/xrs.2753
PG 6
WC Spectroscopy
SC Spectroscopy
GA FF8DX
UT WOS:000409246400017
OA Bronze
DA 2020-09-29
ER

PT J
AU Fortuna, JTS
   Gralle, M
   Beckman, D
   Neves, FS
   Diniz, LP
   Frost, PS
   Barros-Aragao, F
   Santos, LE
   Goncalves, RA
   Romao, L
   Zamberlan, DC
   Soares, FAA
   Braga, C
   Foguel, D
   Gomes, FCA
   De Felice, FG
   Ferreira, ST
   Clarke, JR
   Figueiredo, CP
AF Fortuna, Juliana T. S.
   Gralle, Matthias
   Beckman, Danielle
   Neves, Fernanda S.
   Diniz, Luan P.
   Frost, Paula S.
   Barros-Aragao, Fernanda
   Santos, Luis E.
   Goncalves, Rafaella A.
   Romao, Luciana
   Zamberlan, Daniele C.
   Soares, Felix A. A.
   Braga, Carolina
   Foguel, Debora
   Gomes, Flavia C. A.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
   Clarke, Julia R.
   Figueiredo, Claudia P.
TI Brain infusion of alpha-synuclein oligomers induces motor and non-motor
   Parkinson's disease-like symptoms in mice
SO BEHAVIOURAL BRAIN RESEARCH
LA English
DT Article
DE Intracerebroventricular (i.c.v.) infusion; Olfactory dysfunction;
   Anxiety-like behavior; Olfactory bulb; Dopamine; Tyrosine hydroxylase;
   Parkinson's disease
ID DEPRESSIVE-LIKE BEHAVIOR; COGNITIVE IMPAIRMENT; MOUSE MODEL;
   SUBSTANTIA-NIGRA; ANIMAL-MODELS; DYSFUNCTION; MPTP; DEFICITS; ANXIETY;
   RATS
AB Parkinson's disease (PD) is characterized by motor dysfunction, which is preceded by a number of non-motor symptoms including olfactory deficits. Aggregation of alpha-synuclein (alpha-syn) gives rise to Lewy bodies in dopaminergic neurons and is thought to play a central role in PD pathology. However, whether amyloid fibrils or soluble oligomers of alpha-syn are the main neurotoxic species in PD remains controversial. Here, we performed a single intracerebroventricular (i.c.v.) infusion of a-syn oligomers (alpha-SYOs) in mice and evaluated motor and non-motor symptoms. Familiar bedding and vanillin essence discrimination tasks showed that alpha-SYOs impaired olfactory performance of mice, and decreased TH and dopamine levels in the olfactory bulb early after infusion. The olfactory deficit persisted until 45 days post-infusion (dpi). alpha-SYO-infused mice behaved normally in the object recognition and forced swim tests, but showed increased anxiety-like behavior in the open field and elevated plus maze tests 20 dpi. Finally, administration of alpha-SYOs induced late motor impairment in the pole test and rotarod paradigms, along with reduced TH and dopamine content in the caudate putamen, 45 dpi. Reduced number of TH-positive cells was also seen in the substantii nigra of alpha-SYO-injected mice compared to control. In conclusion, i.c.v. infusion of alpha-SYOs recapitulated some of PD-associated non-motor symptoms, such as increased anxiety and olfactory dysfunction, but failed to recapitulate memory impairment and depressive-like behavior typical of the disease. Moreover, alpha-SY0s i.c.v. administration induced motor deficits and loss of TH and dopamine levels, key features of PD. Results point to alpha-syn oligomers as the proximal neurotoxins responsible for early non-motor and motor deficits in PD and suggest that the i.c.v. infusion model characterized here may comprise a useful tool for identification of PD novel therapeutic targets and drug screening.
C1 [Fortuna, Juliana T. S.; Neves, Fernanda S.; Frost, Paula S.; Barros-Aragao, Fernanda; Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Gralle, Matthias; Beckman, Danielle; Santos, Luis E.; Goncalves, Rafaella A.; Braga, Carolina; Foguel, Debora; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Diniz, Luan P.; Frost, Paula S.; Barros-Aragao, Fernanda; Romao, Luciana; Gomes, Flavia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Santos, Luis E.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Romao, Luciana; Braga, Carolina] Univ Fed Rio de Janeiro, Campus Xerem, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Zamberlan, Daniele C.; Soares, Felix A. A.] Univ Fed Santa Maria, Dept Toxicol Biochem, Santa Maria, RS, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
RP Clarke, JR; Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM juclarke@gmail.com; claufig@gmail.com
RI Ferreira, Sergio/AAZ-1576-2020; Neves, Fernanda/AAW-9638-2020; Santos,
   Luis/B-4961-2015; Soares, Felix AA/K-7611-2012; Soares,
   Felix/AAE-6251-2020; Diniz, Luan/AAN-6788-2020; Beckman,
   Danielle/J-5331-2015; Figueiredo, Claudia P/F-8424-2012; Clarke,
   Julia/AAF-9434-2019; Beckman, Danielle/AAA-1016-2019; Gomes,
   Flavia/C-5383-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Santos, Luis/0000-0002-0694-733X;
   Soares, Felix AA/0000-0002-6453-7902; Soares, Felix/0000-0002-6453-7902;
   Diniz, Luan/0000-0002-2986-4043; Beckman, Danielle/0000-0002-9584-4411;
   Beckman, Danielle/0000-0002-9584-4411; Foguel,
   Debora/0000-0001-7312-7115; Gomes de Queiroz Barros-Aragao,
   Fernanda/0000-0002-1663-8346; da Silva Frost, Paula/0000-0002-3814-999X;
   Figueiredo, Claudia/0000-0001-9467-9891; Gomes,
   Flavia/0000-0003-2966-0638
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; National Institute for Translational Neuroscience (INNT)
FX This work was supported by grants from Brazilian funding agencies
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (F.S.N.,
   C.F.B., L.R., F.C.A.G., F.G.D.F, S.T.F, J.R.C., C.P.F., M.G.), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (R.L.F., F.B.A.,
   C.F.B., A.F.D.B., L.P.D., F.C.A.G., F.G.D.F., S.T.F., J.R.C., C.P.F.,
   M.G.), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (J.D.O, D.F.E.), and National Institute for Translational Neuroscience
   (INNT) (STF). We thank Maira Oliveira, Katia Laia and Mariangela M.
   Viana for technical support, and Ana Claudia Rangel for competent lab
   and project management.
CR Aarsland D, 2016, PARKINSONISM RELAT D, V22, pS144, DOI 10.1016/j.parkreldis.2015.09.034
   Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014
   Amschl D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-6
   Antony PMA, 2011, MAMM GENOME, V22, P401, DOI 10.1007/s00335-011-9330-x
   Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313
   Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7
   Beckman D, 2015, J BIOL CHEM, V290, P20488, DOI 10.1074/jbc.M115.666156
   Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618
   Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y
   Bonito-Oliva A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00290
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Braak H, 2002, J NEUROL S3, V249, P1, DOI DOI 10.1007/S00415-002-1301-4
   Branchi I, 2008, J NEUROSCI RES, V86, P2050, DOI 10.1002/jnr.21642
   Caudal D, 2015, EXP NEUROL, V273, P243, DOI 10.1016/j.expneurol.2015.09.002
   Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7
   Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8
   Chiavegatto S, 2009, MOL PSYCHIATR, V14, P894, DOI 10.1038/mp.2008.43
   Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311
   Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3
   Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   Dissanayaka NNW, 2010, MOVEMENT DISORD, V25, P838, DOI 10.1002/mds.22833
   Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725
   Farrell KF, 2014, J NEUROCHEM, V128, P536, DOI 10.1111/jnc.12481
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x
   Follmer C, 2007, BIOCHEMISTRY-US, V46, P472, DOI 10.1021/bi061871+
   Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564
   Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555
   Goldberg NRS, 2015, STEM CELL REP, V5, P791, DOI 10.1016/j.stemcr.2015.09.008
   Graham DR, 2010, J NEUROSCI RES, V88, P1777, DOI 10.1002/jnr.22331
   Haehner A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/450939
   Hansen C, 2013, NEUROBIOL DIS, V56, P145, DOI 10.1016/j.nbd.2013.04.017
   Hisahara S, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/951709
   Jackson-Lewis Vernice, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS183, DOI 10.1016/S1353-8020(11)70057-8
   Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kim BW, 2015, NEUROPHARMACOLOGY, V97, P46, DOI 10.1016/j.neuropharm.2015.04.037
   Kim BW, 2015, J ETHNOPHARMACOL, V164, P388, DOI 10.1016/j.jep.2014.11.004
   LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003
   Lindgren HS, 2012, EUR J NEUROSCI, V35, P1894, DOI 10.1111/j.1460-9568.2012.08162.x
   LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180
   Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157
   Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457
   Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001
   Moretti M, 2015, NEUROTOX RES, V28, P222, DOI 10.1007/s12640-015-9540-1
   Mori A, 2005, NEUROSCI RES, V51, P265, DOI 10.1016/j.neures.2004.11.008
   Neuner J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4915
   Neuner J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03931
   OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435
   Ozawa T, 2011, NEUROSCI LETT, V497, P37, DOI 10.1016/j.neulet.2011.04.022
   Pagonabarraga J, 2012, NEUROBIOL DIS, V46, P590, DOI 10.1016/j.nbd.2012.03.029
   Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003
   Pena-Oliver Y, 2010, BEHAV BRAIN RES, V209, P234, DOI 10.1016/j.bbr.2010.01.049
   Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002
   Petit GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060691
   Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197
   PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0
   Prediger RDS, 2006, EXP NEUROL, V202, P391, DOI 10.1016/j.expneurol.2006.07.001
   Prediger RDS, 2012, NEUROTOX RES, V21, P90, DOI 10.1007/s12640-011-9281-8
   Prediger RDS, 2010, NEUROTOX RES, V17, P114, DOI 10.1007/s12640-009-9087-0
   Pruszak J., 2009, CURR PROTOC STEM CEL, V2, P5, DOI DOI 10.1002/
   Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X
   Qi C, 2017, EXP NEUROBIOL, V26, P97, DOI 10.5607/en.2017.26.2.97
   Rial D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114216
   Santiago RM, 2010, PROG NEURO-PSYCHOPH, V34, P1104, DOI 10.1016/j.pnpbp.2010.06.004
   Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178
   Schintu N, 2012, J PARKINSON DIS, V2, P87, DOI 10.3233/JPD-2012-12076
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stebbins GT, 1999, NEUROPSYCHOLOGIA, V37, P503, DOI 10.1016/S0028-3932(98)00068-2
   Tadaiesky MT, 2008, NEUROSCIENCE, V156, P830, DOI 10.1016/j.neuroscience.2008.08.035
   Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009
   Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006
   Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135
   Vuckovic MG, 2008, NEUROBIOL DIS, V32, P319, DOI 10.1016/j.nbd.2008.07.015
   Walsh K, 2001, POSTGRAD MED J, V77, P89, DOI 10.1136/pmj.77.904.89
   Watson GS, 2010, BRAIN PATHOL, V20, P640, DOI 10.1111/j.1750-3639.2010.00373.x
   Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108
   Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118
   Zhang SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119928
   Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200
NR 88
TC 11
Z9 11
U1 1
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-4328
EI 1872-7549
J9 BEHAV BRAIN RES
JI Behav. Brain Res.
PD AUG 30
PY 2017
VL 333
BP 150
EP 160
DI 10.1016/j.bbr.2017.06.047
PG 11
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA FE5ZK
UT WOS:000408289600019
PM 28668282
DA 2020-09-29
ER

PT J
AU Lourenco, M
   Ferreira, S
   Felice, FD
AF Lourenco, M.
   Ferreira, S.
   Felice, F. D.
TI FNDC5/irisin corrects memory deficits in animal models of Alzheimer's
   disease
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Lourenco, M.; Ferreira, S.; Felice, F. D.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA YMS04-04
BP 71
EP 71
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300126
DA 2020-09-29
ER

PT J
AU Diniz, L
   MAtias, I
   Tortelli, V
   Morgado, J
   Araujo, AP
   Melo, H
   de Silva, G
   Ferreira, S
   de Felice, F
   Gomes, F
AF Diniz, L.
   MAtias, I.
   Tortelli, V.
   Morgado, J.
   Araujo, A. P.
   Melo, H.
   de Silva, G.
   Ferreira, S.
   de Felice, F.
   Gomes, F.
TI Astrocytic transforming growth factor beta 1 protects synapses against
   Ab oligomers in Alzheimer's disease model
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Diniz, L.; MAtias, I.; Tortelli, V.; Morgado, J.; Araujo, A. P.; Gomes, F.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio de Janeiro, Brazil.
   [Melo, H.; de Silva, G.; Ferreira, S.; de Felice, F.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio de Janeiro, Brazil.
RI Diniz, Luan/AAN-6788-2020; Ferreira, Sergio/AAZ-1576-2020
OI Diniz, Luan/0000-0002-2986-4043; Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA MTU01-01
BP 78
EP 78
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300143
DA 2020-09-29
ER

PT J
AU Silva, CD
   Forny-Germano, L
   Mendonca, M
   Donato, J
   Houzel, J
   Ferreira, S
   Felice, FD
AF Silva, C. D.
   Forny-Germano, L.
   Mendonca, M.
   Donato, J.
   Houzel, J.
   Ferreira, S.
   Felice, F. D.
TI Obesity leads to impairment in neurogenesis and reduces brain size
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Silva, C. D.; Forny-Germano, L.; Mendonca, M.; Donato, J.; Houzel, J.; Ferreira, S.; Felice, F. D.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RI Houzel, Jean Christophe/M-7936-2019; Ferreira, Sergio/AAZ-1576-2020
OI Houzel, Jean Christophe/0000-0001-5128-438X; Ferreira,
   Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA MTU09-05
BP 138
EP 138
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300311
DA 2020-09-29
ER

PT J
AU Ribeiro, F
   Ferreira, D
   Fortuna, J
   Braga, G
   de Felice, F
   Ferreira, S
AF Ribeiro, F.
   Ferreira, D.
   Fortuna, J.
   Braga, G.
   de Felice, F.
   Ferreira, S.
TI The effects of abeta oligomers on regulators of protein synthesis
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Ribeiro, F.; Ferreira, D.; Fortuna, J.; Braga, G.; de Felice, F.; Ferreira, S.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA WTH06-13
BP 210
EP 210
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300506
DA 2020-09-29
ER

PT J
AU da Silva, RAG
   Lyra e Silva, LD
   Peny, JA
   Lima, RA
   Clarke, JR
   Munoz, DP
   Ferreira, ST
   Fraser, P
   De Felice, FG
AF da Silva, R. A. Goncalves
   Lyra e Silva, N. de Menezes
   Peny, J. A.
   Lima Filho, R. A.
   Clarke, J. R.
   Munoz, D. P.
   Ferreira, S. T.
   Fraser, P.
   De Felice, F. G.
TI Hypothalamic dysfunction and metabolic dysregulation in AD animal models
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [da Silva, R. A. Goncalves; Lyra e Silva, N. de Menezes; Peny, J. A.; Lima Filho, R. A.; Clarke, J. R.; Ferreira, S. T.; De Felice, F. G.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Munoz, D. P.; De Felice, F. G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Fraser, P.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.
RI Ferreira, Sergio/AAZ-1576-2020; Clarke, Julia/AAF-9434-2019
OI Ferreira, Sergio/0000-0001-7160-9866; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA WTH07-03
BP 214
EP 214
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300514
DA 2020-09-29
ER

PT J
AU Sebollela, A
   Mendes, N
   Fernandes, A
   Almeida, G
   Santos, L
   Lyra-Silva, N
   Assirati, J
   Ferreira, S
   Garcia-Cairasco, N
   Neder, L
AF Sebollela, A.
   Mendes, N.
   Fernandes, A.
   Almeida, G.
   Santos, L.
   Lyra-Silva, N.
   Assirati, J., Jr.
   Ferreira, S.
   Garcia-Cairasco, N.
   Neder, L.
TI Validation of histocultures from adult human brain as a tool to study
   age-associated neurodegenerative diseases
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Sebollela, A.; Mendes, N.; Fernandes, A.; Almeida, G.] Univ Sao Paulo, Biochem & Immunol, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Mendes, N.; Neder, L.] Univ Sao Paulo, Pathol, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Fernandes, A.; Garcia-Cairasco, N.] Univ Sao Paulo, Physiol, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Santos, L.; Lyra-Silva, N.; Ferreira, S.] Univ Fed Rio de Janeiro, Med Biochem, Rio De Janeiro, Brazil.
   [Assirati, J., Jr.] Gen Hosp, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA WTH07-42
BP 227
EP 227
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300553
DA 2020-09-29
ER

PT J
AU Freitas, G
   Lourenco, M
   de Felice, F
   Ferreira, S
   Gralle, M
AF Freitas, G.
   Lourenco, M.
   de Felice, F.
   Ferreira, S.
   Gralle, M.
TI Investigating neuroprotective actions of irisin in the central nervous
   system
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Freitas, G.; Lourenco, M.; de Felice, F.; Ferreira, S.; Gralle, M.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA WTH09-07
BP 240
EP 240
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300587
DA 2020-09-29
ER

PT J
AU Santos, LE
   Figueiredo-Freitas, C
   Ferreira, ST
   De Mello, FG
AF Santos, Luis Eduardo
   Figueiredo-Freitas, Cicero
   Ferreira, Sergio Teixeira
   De Mello, Fernando Garcia
TI An oxidative mechanism for cholinergic dysfunction in neurons exposed to
   Alzheimer's-linked A beta-oligomers
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 15th International Symposium on Cholinergic Mechanisms (ISCM)
CY OCT, 2016
CL Marseille, FRANCE
C1 [Santos, Luis Eduardo; Figueiredo-Freitas, Cicero; Ferreira, Sergio Teixeira] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio de Janeiro, Brazil.
   [Ferreira, Sergio Teixeira; De Mello, Fernando Garcia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 2
SI SI
BP 219
EP 219
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3IF
UT WOS:000407426000102
DA 2020-09-29
ER

PT J
AU Kincheski, GC
   Valentim, IS
   Clarke, JR
   Cozachenco, D
   Castelo-Branco, MTL
   Ramos-Lobo, AM
   Rumjanek, VMBD
   Donato, J
   De Felice, FG
   Ferreira, ST
AF Kincheski, Grasielle C.
   Valentim, Isabela S.
   Clarke, Julia R.
   Cozachenco, Danielle
   Castelo-Branco, Morgana T. L.
   Ramos-Lobo, Angela M.
   Rumjanek, Vivian M. B. D.
   Donato, Jose, Jr.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Chronic sleep restriction promotes brain inflammation and synapse loss,
   and potentiates memory impairment induced by amyloid-beta oligomers in
   mice
SO BRAIN BEHAVIOR AND IMMUNITY
LA English
DT Article
DE Sleep; Chronic sleep restriction; Alzheimer's disease; Amyloid-beta
   oligomers; Cytokines; TNF-alpha; IL-1 beta; IL-6; Hippocampus; Synaptic
   proteins; Synaptophysin; PSD-95; Inflammation
ID OBJECT RECOGNITION MEMORY; DEPRESSIVE-LIKE BEHAVIOR;
   CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE;
   TNF-ALPHA; COGNITIVE IMPAIRMENT; GENE-EXPRESSION; DEPRIVATION;
   HIPPOCAMPUS
AB It is increasingly recognized that sleep disturbances and Alzheimer's disease (AD) share a bidirectional relationship. AD patients exhibit sleep problems and alterations in the regulation of circadian rhythms; conversely, poor quality of sleep increases the risk of development of AD. The aim of the current study was to determine whether chronic sleep restriction potentiates the brain impact of amyloid-beta oligomers (ABOs), toxins that build up in AD brains and are thought to underlie synapse damage and memory impairment. We further investigated whether alterations in levels of pro-inflammatory mediators could play a role in memory impairment in sleep-restricted mice. We found that a single intracerebroventricular (i.c.v.) infusion of A beta Os disturbed sleep pattern in mice. Conversely, chronically sleep-restricted mice exhibited higher brain expression of pro-inflammatory mediators, reductions in levels of pre- and post-synaptic marker proteins, and exhibited increased susceptibility to the impact of i.c.v. infusion of a sub-toxic dose of ABOs (1 pmol) on performance in the novel object recognition memory task. Sleep-restricted mice further exhibited an increase in brain TNF-alpha levels in response to A beta Os. Interestingly, memory impairment in sleep-restricted A beta O-infused mice was prevented by treatment with the TNF-alpha neutralizing monoclonal antibody, infliximab. Results substantiate the notion of a dual relationship between sleep and AD, whereby A beta Os disrupt sleep/wake patterns and chronic sleep restriction increases brain vulnerability to A beta Os, and point to a key role of brain inflammation in increased susceptibility to A beta Os in sleep-restricted mice. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Kincheski, Grasielle C.; Valentim, Isabela S.; Cozachenco, Danielle; Rumjanek, Vivian M. B. D.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, RJ, Brazil.
   [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, RJ, Brazil.
   [Castelo-Branco, Morgana T. L.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
   [Ramos-Lobo, Angela M.; Donato, Jose, Jr.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Rumjanek, Vivian Mary/V-8741-2019;
   Donato, Jose/A-9662-2010; Clarke, Julia/AAF-9434-2019
OI Ferreira, Sergio/0000-0001-7160-9866; Donato, Jose/0000-0002-4166-7608;
   Kincheski, Grasielle Clotildes/0000-0002-7392-3602
FU National Institute for Translational Neuroscience; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Fundacao de Amparo a
   Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [2014/50140-6]
FX We thank Ana Claudia Rangel, Maira Oliveira and Mariangela Viana for
   administrative and technical support. This work was supported by grants
   from National Institute for Translational Neuroscience (to STF),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to STF,
   FGF, JRC), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to
   STF, FGF and JRC), and Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (to JD, # 2014/50140-6).
CR Alzheimer's Association, 2013, ALZHEIMERS DEMENT, V9, P110, DOI 10.1016/j.jalz.2013.02.003
   Ambree O, 2006, NEUROBIOL AGING, V27, P955, DOI 10.1016/j.neurobiolaging.2005.05.009
   Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8
   Baxter MG, 2010, BEHAV NEUROSCI, V124, P706, DOI 10.1037/a0021029
   Bedrosian TA, 2011, P NATL ACAD SCI USA, V108, P11686, DOI 10.1073/pnas.1103098108
   Benedict C, 2015, ALZHEIMERS DEMENT, V11, P1090, DOI 10.1016/j.jalz.2014.08.104
   Benedict C, 2014, SLEEP, V37, P195, DOI 10.5665/sleep.3336
   BLIWISE DL, 1989, BIOL PSYCHIAT, V25, P320, DOI 10.1016/0006-3223(89)90179-0
   BREDER CD, 1993, J COMP NEUROL, V337, P543, DOI 10.1002/cne.903370403
   Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011
   Bruunsgaard H., 2003, IMMUNOL ALLERGY CLIN
   Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x
   Cedernaes J., 2015, SLEEP MED REV
   Chen J, 2013, NEUROSCI LETT, V541, P275, DOI 10.1016/j.neulet.2013.02.005
   Chen WR, 2005, P SOC PHOTO-OPT INS, V5771, P1, DOI 10.1117/12.634654
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Czirr E., 2012, J CLIN INVEST
   D'Almeida V, 1998, NEUROREPORT, V9, P2853, DOI 10.1097/00001756-199808240-00031
   Dang-Vu T T, 2006, Pediatr Rehabil, V9, P98, DOI 10.1080/13638490500138702
   De Felice F.G., 2014, DIABETES
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x
   Duncan MJ, 2012, EXP NEUROL, V236, P249, DOI 10.1016/j.expneurol.2012.05.011
   Ehrlich I., 2009, NEURON
   Ferreira S.T., 2011, NEUROBIOL LEARN MEM
   Ferreira S.T., 2014, ALZHEIMERS DEMENT
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Frank MG, 1998, AM J PHYSIOL-REG I, V275, pR148
   Fronczek R, 2012, NEUROBIOL AGING, V33, P1642, DOI 10.1016/j.neurobiolaging.2011.03.014
   Goel N., 2009, SEMIN NEUROL
   Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6
   Gruol DL, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020019
   Gruol DL, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ricel.2014.00234, 10.3389/fncel.2014.00234]
   Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]
   Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748
   INOUE S, 1995, BEHAV BRAIN RES, V69, P91, DOI 10.1016/0166-4328(95)00014-K
   Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962
   Kaushal N, 2012, AM J PHYSIOL-REG I, V303, pR19, DOI 10.1152/ajpregu.00025.2012
   Kim DH, 2016, BEHAV BRAIN RES, V311, P384, DOI 10.1016/j.bbr.2016.06.001
   KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905
   Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281
   KRUEGER JM, 1984, AM J PHYSIOL, V246, pR994
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez J, 2008, NEUROSCIENCE, V153, P44, DOI 10.1016/j.neuroscience.2008.01.072
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Lucey B.P., 2016, JAMA NEUROL
   Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575
   Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239
   McCoy J.G., 2011, NEUROBIOL LEARN MEM
   McCurry SM, 1999, J GERIATR PSYCH NEUR, V12, P53, DOI 10.1177/089198879901200203
   McDermott CM, 2003, J NEUROSCI, V23, P9687
   MCGINTY D, 1990, TRENDS NEUROSCI, V13, P480, DOI 10.1016/0166-2236(90)90081-K
   Medzhitov R., 2010, CELL
   Mignot E., 2008, PLOS BIOL
   Millers D.A., 2010, CEREB CORTEX
   Moran M, 2005, SLEEP MED, V6, P347, DOI 10.1016/j.sleep.2004.12.005
   Mucke L., 2012, COLD SPRING HARB PER, V2
   Mullington J.M., 2010, BEST PRACT RES CLIN
   Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968
   Novati A, 2012, J SLEEP RES, V21, P3, DOI 10.1111/j.1365-2869.2011.00932.x
   Nowakowski S., 2015, SLEEP MED RES, V4, P1
   Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255
   Ooms S., 2014, JAMA NEUROL
   Osorio R.S., 2011, J AM GERIATR SOC
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006
   Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17
   Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827
   Platt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027068
   Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437
   Radulovic J, 2010, REV NEUROSCIENCE, V21, P1
   Ramanathan L, 2002, NEUROREPORT, V13, P1387, DOI 10.1097/00001756-200208070-00007
   Reitz C., 2014, BIOCH PHARM
   Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291
   Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270
   SIEGEL JM, 1995, BEHAV BRAIN RES, V69, P29, DOI 10.1016/0166-4328(95)00023-M
   Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
   Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013
   Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011
   Stickgold R, 2006, NATURE, V444, P559, DOI 10.1038/nature05309
   SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011
   Takeshita M, 2015, CYTOKINE, V75, P222, DOI 10.1016/j.cyto.2015.04.011
   Tononi G., 2006, SLEEP MED REV
   VANHULZEN ZJM, 1980, PHYSIOL BEHAV, V25, P807, DOI 10.1016/0031-9384(80)90298-X
   Wadhwa M, 2015, BEHAV BRAIN RES, V294, P95, DOI 10.1016/j.bbr.2015.08.002
   Walker MP, 2008, SLEEP MED, V9, pS29, DOI 10.1016/S1389-9457(08)70014-5
   Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x
   Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018
   Wilson RS, 2007, PSYCHOSOM MED, V69, P47, DOI 10.1097/01.psy.0000250264.25017.21
   Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224
   Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098
   ZEPELIN H, 1994, PRINCIPLES PRACTICE, P69
   Zhang J, 2014, J NEUROSCI, V34, P4418, DOI 10.1523/JNEUROSCI.5025-12.2014
   Zielinski MR, 2014, NEUROSCI LETT, V580, P27, DOI 10.1016/j.neulet.2014.07.043
NR 109
TC 39
Z9 39
U1 1
U2 45
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1591
EI 1090-2139
J9 BRAIN BEHAV IMMUN
JI Brain Behav. Immun.
PD AUG
PY 2017
VL 64
BP 140
EP 151
DI 10.1016/j.bbi.2017.04.007
PG 12
WC Immunology; Neurosciences; Psychiatry
SC Immunology; Neurosciences & Neurology; Psychiatry
GA EZ1XR
UT WOS:000404504600015
PM 28412140
DA 2020-09-29
ER

PT J
AU Diniz, LP
   Tortelli, V
   Matias, I
   Morgado, J
   Araujo, APB
   Melo, HM
   da Silva, GSS
   Alves-Leon, SV
   de Souza, JM
   Ferreira, ST
   De Felice, FG
   Gomes, FCA
AF Diniz, Luan Pereira
   Tortelli, Vanessa
   Matias, Isadora
   Morgado, Juliana
   Bergamo Araujo, Ana Paula
   Melo, Helen M.
   Seixas da Silva, Gisele S.
   Alves-Leon, Soniza V.
   de Souza, Jorge M.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
   Alcantara Gomes, Flavia Carvalho
TI Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against A
   beta Oligomers in Alzheimer's Disease Model
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE Alzheimer's disease; astrocyte; synapse loss; TGF-beta 1
ID RECEPTOR-DEPENDENT MECHANISM; TRANSGENIC ANIMAL-MODEL; TGF-BETA;
   SYNAPTIC PLASTICITY; CNS SYNAPTOGENESIS; MEMORY LOSS;
   HIPPOCAMPAL-NEURONS; SECRETED PROTEINS; AMPA RECEPTORS; MOUSE MODEL
AB Alzheimer's disease (AD) is characterized by progressive cognitive decline, increasingly attributed to neuronal dysfunction induced by amyloid-beta oligomers (A beta Os). Although the impact of A beta Os on neurons has been extensively studied, only recently have the possible effects ofA beta Os on astrocytes begun to be investigated. Given the key roles of astrocytes in synapse formation, plasticity, and function, we sought to investigate the impact ofA beta Os on astrocytes, and to determine whether this impact is related to the deleterious actions ofA beta Os on synapses. Wefound thatA beta Os interact with astrocytes, cause astrocyte activation and trigger abnormal generation of reactive oxygen species, which is accompanied by impairment of astrocyte neuroprotective potential in vitro. We further show that both murine and human astrocyte conditioned media (CM) increase synapse density, reduce A beta Os binding, and prevent A beta O-induced synapse loss in cultured hippocampal neurons. Both a neutralizing anti-transforming growth factor-beta 1 (TGF-beta 1) antibody and siRNA-mediated knockdown of TGF-beta 1, previously identified as an important synaptogenic factor secreted by astrocytes, abrogated the protective action of astrocyteCMagainstA beta O-induced synapse loss. Notably, TGF-beta 1 prevented hippocampal dendritic spine loss and memory impairment in mice that received an intracerebroventricular infusion of A beta Os. Results suggest that astrocyte-derived TGF-beta 1 is part of an endogenous mechanism that protects synapses against A eta Os. By demonstrating that A beta Os decrease astrocyte ability to protect synapses, our results unravel a new mechanism underlying the synaptotoxic action of A beta Os in AD.
C1 [Diniz, Luan Pereira; Tortelli, Vanessa; Matias, Isadora; Morgado, Juliana; Bergamo Araujo, Ana Paula; Alcantara Gomes, Flavia Carvalho] Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Melo, Helen M.; Seixas da Silva, Gisele S.; Ferreira, Sergio T.; De Felice, Fernanda G.] Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.; de Souza, Jorge M.] Hosp Univ Clementino Fraga Filho, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Seixas da Silva, Gisele S.] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.
RP Gomes, FCA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM fgomes@icb.ufrj.br
RI Diniz, Luan/AAN-6788-2020; Leon, Soniza V Alves/J-7786-2012; Ferreira,
   Sergio/AAZ-1576-2020; Gomes, Flavia/C-5383-2013
OI Diniz, Luan/0000-0002-2986-4043; Ferreira, Sergio/0000-0001-7160-9866;
   Gomes, Flavia/0000-0003-2966-0638; Marcondes desouza,
   Jorge/0000-0003-2412-8239
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Ministerio da Saude, Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Ministerio da Saude,
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ). We thank Marcelo Meloni and Grasiela Ventura for
   technical assistance.
CR Abbott A, 2011, NATURE, V475, pS2, DOI 10.1038/475S2a
   Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5
   Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010
   Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059
   Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6
   Bae James J, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P9
   BEACH TG, 1988, BRAIN RES, V463, P357, DOI 10.1016/0006-8993(88)90410-6
   Beauquis J, 2013, EXP NEUROL, V239, P28, DOI 10.1016/j.expneurol.2012.09.009
   Beraldo FH, 2016, J BIOL CHEM, V291, P21945, DOI 10.1074/jbc.M116.738286
   Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Caraci F, 2015, SCI REP-UK, V5, DOI 10.1038/srep11252
   Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93
   Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116549
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Ding MZ, 1998, J IMMUNOL, V160, P2560
   Diniz LP, 2014, NEUROCHEM INT, V78, P18, DOI 10.1016/j.neuint.2014.07.008
   Diniz LP, 2014, GLIA, V62, P1917, DOI 10.1002/glia.22713
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fisichella V, 2016, EUR J PHARMACOL, V787, P72, DOI 10.1016/j.ejphar.2016.02.002
   Fong SW, 2010, P NATL ACAD SCI USA, V107, P13515, DOI 10.1073/pnas.1001695107
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Fukushima T, 2007, HIPPOCAMPUS, V17, P5, DOI 10.1002/hipo.20243
   Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005
   Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015
   Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25
   Hippius Hanns, 2003, Dialogues Clin Neurosci, V5, P101
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639
   Juraskova B, 2010, J NUTR HEALTH AGING, V14, P758, DOI 10.1007/s12603-010-0325-1
   Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002
   Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108
   Kulijewicz-Nawrot M, 2012, J ANAT, V221, P252, DOI 10.1111/j.1469-7580.2012.01536.x
   Lacmann A, 2007, NEUROSCIENCE, V150, P647, DOI 10.1016/j.neuroscience.2007.09.046
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Matsunaga W, 2003, NEUROSCI LETT, V342, P129, DOI 10.1016/S0304-3940(03)00240-4
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   Mocali A, 2004, EXP GERONTOL, V39, P1555, DOI 10.1016/j.exger.2004.07.007
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8
   Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967
   Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004
   Osborn LM, 2016, PROG NEUROBIOL, V144, P121, DOI 10.1016/j.pneurobio.2016.01.001
   Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036
   Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583
   Qiao JP, 2016, GLIA, V64, P240, DOI 10.1002/glia.22926
   Rao KVR, 2013, J NEUROPATH EXP NEUR, V72, P735, DOI 10.1097/NEN.0b013e31829bd082
   Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007
   Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010
   Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341
   Tichauer JE, 2014, BRAIN BEHAV IMMUN, V37, P187, DOI 10.1016/j.bbi.2013.12.018
   Ueberham U, 2006, EUR J NEUROSCI, V24, P2327, DOI 10.1111/j.1460-9568.2006.05109.x
   Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017
   Vivien D, 2006, CYTOKINE GROWTH F R, V17, P121, DOI 10.1016/j.cytogfr.2005.09.011
   von Bernhardi R, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00426
   Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838
   Yeh CY, 2011, ASN NEURO, V3, DOI 10.1042/AN20110025
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
NR 83
TC 51
Z9 52
U1 1
U2 11
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUL 12
PY 2017
VL 37
IS 28
BP 6797
EP 6809
DI 10.1523/JNEUROSCI.3351-16.2017
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA FA2VZ
UT WOS:000405300600018
PM 28607171
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Brito-Moreira, J
   Lourenco, MV
   Oliveira, MM
   Ribeiro, FC
   Ledo, JH
   Diniz, LP
   Vital, JFS
   Magdesian, MH
   Melo, HM
   Barros-Aragao, F
   de Souza, JM
   Alves-Leon, SV
   Gomes, FCA
   Clarke, JR
   Figueiredo, CP
   De Felice, FG
   Ferreira, ST
AF Brito-Moreira, Jordano
   Lourenco, Mychael V.
   Oliveira, Mauricio M.
   Ribeiro, Felipe C.
   Ledo, Jose Henrique
   Diniz, Luan P.
   Vital, Juliana F. S.
   Magdesian, Margaret H.
   Melo, Helen M.
   Barros-Aragao, Fernanda
   de Souza, Jorge M.
   Alves-Leon, Soniza V.
   Gomes, Flavia C. A.
   Clarke, Julia R.
   Figueiredo, Claudia P.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Interaction of amyloid- (A) oligomers with neurexin 2 and neuroligin 1
   mediates synapse damage and memory loss in mice
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Alzheimer disease; amyloid (A); brain; neuron; synapse; amyloid
   oligomers; memory; neurexin; neuroligin
ID A-BETA OLIGOMERS; DEPRESSIVE-LIKE BEHAVIOR; LONG-TERM POTENTIATION;
   ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; BRAIN; RECOGNITION;
   INHIBITION; ADHESION; DYSFUNCTION
AB Brain accumulation of the amyloid- protein (A) and synapse loss are neuropathological hallmarks of Alzheimer disease (AD). A oligomers (AOs) are synaptotoxins that build up in the brains of patients and are thought to contribute to memory impairment in AD. Thus, identification of novel synaptic components that are targeted by AOs may contribute to the elucidation of disease-relevant mechanisms. Trans-synaptic interactions between neurexins (Nrxs) and neuroligins (NLs) are essential for synapse structure, stability, and function, and reduced NL levels have been associated recently with AD. Here we investigated whether the interaction of AOs with Nrxs or NLs mediates synapse damage and cognitive impairment in AD models. We found that AOs interact with different isoforms of Nrx and NL, including Nrx2 and NL1. Anti-Nrx2 and anti-NL1 antibodies reduced AO binding to hippocampal neurons and prevented AO-induced neuronal oxidative stress and synapse loss. Anti-Nrx2 and anti-NL1 antibodies further blocked memory impairment induced by AOs in mice. The results indicate that Nrx2 and NL1 are targets of AOs and that prevention of this interaction reduces the deleterious impact of AOs on synapses and cognition. Identification of Nrx2 and NL1 as synaptic components that interact with AOs may pave the way for development of novel approaches aimed at halting synapse failure and cognitive loss in AD.
C1 [Brito-Moreira, Jordano; Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ledo, Jose Henrique; Vital, Juliana F. S.; Magdesian, Margaret H.; Melo, Helen M.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Diniz, Luan P.; Barros-Aragao, Fernanda; Gomes, Flavia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurosurg, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurol, Epilepsy Program, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Clarke, Julia/AAF-9434-2019; Lourenco,
   Mychael/G-2614-2014; Leon, Soniza V Alves/J-7786-2012; Figueiredo,
   Claudia P/F-8424-2012; Ribeiro, Felipe Campos/W-9758-2019; Lourenco,
   Mychael/AAG-9732-2020; Gomes, Flavia/C-5383-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Lourenco,
   Mychael/0000-0002-1078-0296; Ribeiro, Felipe Campos/0000-0003-3028-3307;
   Lourenco, Mychael/0000-0002-1078-0296; Figueiredo,
   Claudia/0000-0001-9467-9891; Gomes, Flavia/0000-0003-2966-0638; Gomes de
   Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346
FU National Institute for Translational Neuroscience (INNT/Brazil);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Human Frontiers Science ProgramHuman
   Frontier Science Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); CAPES
   (Brazil)CAPES
FX This work was supported by grants from National Institute for
   Translational Neuroscience (INNT/Brazil) (to S. T. F.), the Brazilian
   funding agencies Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (to S. T. F. and F. G. F.), and the Human Frontiers
   Science Program (to F. G. F.). The authors declare that they have no
   conflicts of interest with the contents of this article.; Supported by
   predoctoral fellowships from CNPq, FAPERJ, or CAPES (Brazil).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011
   Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159
   Bemben MA, 2015, TRENDS NEUROSCI, V38, P496, DOI 10.1016/j.tins.2015.06.004
   Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101
   Chen GQ, 2000, NATURE, V408, P975
   Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016
   Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Dachtler J, 2015, BEHAV NEUROSCI, V129, P765, DOI 10.1037/bne0000108
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Dinamarca MC, 2015, BIOCHEM BIOPH RES CO, V466, P66, DOI 10.1016/j.bbrc.2015.08.107
   Dinamarca MC, 2011, BIOCHEMISTRY-US, V50, P8127, DOI 10.1021/bi201246t
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Jiang M, 2017, MOL PSYCHIATR, V22, P375, DOI 10.1038/mp.2016.80
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234
   Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Liu A, 2016, J CELL BIOL, V212, P449, DOI 10.1083/jcb.201509023
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464
   Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102
   Nery AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067194
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304
   SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Shen HT, 2015, STROKE, V46, P2607, DOI 10.1161/STROKEAHA.115.009729
   Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x
   Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0
   Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108
   Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Tristan-Clavijo E, 2015, NEUROBIOL AGING, V36, P3171, DOI 10.1016/j.neurobiolaging.2015.09.004
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010
NR 64
TC 38
Z9 39
U1 1
U2 18
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 5
PY 2017
VL 292
IS 18
BP 7327
EP 7337
DI 10.1074/jbc.M116.761189
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EU1FY
UT WOS:000400761300005
PM 28283575
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU da Silva, GSS
   Melo, HM
   Lourenco, MV
   Silva, NMLE
   de Carvalho, MB
   Alves-Leon, SV
   de Souza, JM
   Klein, WL
   da-Silva, WS
   Ferreira, ST
   De Felice, FG
AF Seixas da Silva, Gisele S.
   Melo, Helen M.
   Lourenco, Mychael V.
   Lyra e Silva, Natalia M.
   de Carvalho, Marcelo B.
   Alves-Leon, Soniza V.
   de Souza, Jorge M.
   Klein, William L.
   da-Silva, Wagner S.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Amyloid- oligomers transiently inhibit AMP-activated kinase and cause
   metabolic defects in hippocampal neurons
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Alzheimer disease; AMP-activated kinase (AMPK); ATP; energy metabolism;
   N-methyl-d-aspartate receptor (NMDA receptor; NMDAR); GLUTs; amyloid-
   oligomers
ID A-BETA OLIGOMERS; GROWTH-FACTOR-I; RECEPTOR-DEPENDENT MECHANISM;
   ALZHEIMERS-DISEASE; PROTEIN-KINASE; INSULIN-RESISTANCE;
   TAU-HYPERPHOSPHORYLATION; GLUCOSE TRANSPORTERS; HYBRID RECEPTORS;
   OXIDATIVE STRESS
AB AMP-activated kinase (AMPK) is a key player in energy sensing and metabolic reprogramming under cellular energy restriction. Several studies have linked impaired AMPK function to peripheral metabolic diseases such as diabetes. However, the impact of neurological disorders, such as Alzheimer disease (AD), on AMPK function and downstream effects of altered AMPK activity on neuronal metabolism have been investigated only recently. Here, we report the impact of A oligomers (AOs), synaptotoxins that accumulate in AD brains, on neuronal AMPK activity. Short-term exposure of cultured rat hippocampal neurons or ex vivo human cortical slices to AOs transiently decreased intracellular ATP levels and AMPK activity, as evaluated by its phosphorylation at threonine residue 172 (AMPK-Thr(P)(172)). The AO-dependent reduction in AMPK-Thr(P)(172) levels was mediated by glutamate receptors of the N-methyl-d-aspartate (NMDA) subtype and resulted in removal of glucose transporters (GLUTs) from the surfaces of dendritic processes in hippocampal neurons. Importantly, insulin prevented the AO-induced inhibition of AMPK. Our results establish a novel toxic impact of AOs on neuronal metabolism and suggest that AO-induced, NMDA receptor-mediated AMPK inhibition may play a key role in early brain metabolic defects in AD.
C1 [Seixas da Silva, Gisele S.; Melo, Helen M.; Lourenco, Mychael V.; Lyra e Silva, Natalia M.; de Carvalho, Marcelo B.; da-Silva, Wagner S.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Lourenco, Mychael V.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Div Neurol, Epilepsy Program, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge M.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Div Neurosurg, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM felice@bioqmed.ufrj.br
RI Leon, Soniza V Alves/J-7786-2012; Lourenco, Mychael/G-2614-2014;
   Ferreira, Sergio/AAZ-1576-2020; da Silva, Wagner/A-7835-2008; Lourenco,
   Mychael/AAG-9732-2020
OI Lourenco, Mychael/0000-0002-1078-0296; Ferreira,
   Sergio/0000-0001-7160-9866; da Silva, Wagner/0000-0002-0001-0386;
   Lourenco, Mychael/0000-0002-1078-0296
FU Human Frontiers Science Program (HFSP)Human Frontier Science Program;
   John Simon Guggenheim Foundation; National Institute for Translational
   Neuroscience (INNT/Brazil); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); CNPqNational
   Council for Scientific and Technological Development (CNPq);
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX This work was supported by grants from Human Frontiers Science Program
   (HFSP) and John Simon Guggenheim Foundation (to F.G.F.), the National
   Institute for Translational Neuroscience (INNT/Brazil), the Brazilian
   funding agencies Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (to S. T. F. and F. G. F.), and pre doctoral
   fellowships from CNPq or FAPERJ (to G. S. S., H. M. M., M. V. L, and N.
   L. S.). W. L. K. is co-founder of Acumen Pharmaceuticals, which has been
   licensed by Northwestern University to develop ADDL technology for AD
   therapeutics and diagnostics.
CR Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Ashrafi G, 2017, NEURON, V93, P606, DOI 10.1016/j.neuron.2016.12.020
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Dineley KT, 2010, J NEUROSCI RES, V88, P2923, DOI 10.1002/jnr.22445
   Dixon-Salazar TJ, 2014, J NEUROSCI, V34, P11844, DOI 10.1523/JNEUROSCI.4642-12.2014
   Duarte AI, 2006, DIABETES, V55, P2863, DOI 10.2337/db06-0030
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Ghasemi R, 2013, MOL NEUROBIOL, V47, P1045, DOI 10.1007/s12035-013-8404-z
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005
   Guerrieri D, 2015, ONCOTARGET, V6, P18293, DOI 10.18632/oncotarget.4715
   Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049
   Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108
   Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054
   Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904
   Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035
   Lopez-Lopez C, 2007, J NEUROSCI, V27, P824, DOI 10.1523/JNEUROSCI.4345-06.2007
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma T, 2014, J NEUROSCI, V34, P12230, DOI 10.1523/JNEUROSCI.1694-14.2014
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849
   Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930
   Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200
   Park H, 2012, HUM MOL GENET, V21, P2725, DOI 10.1093/hmg/dds100
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Ramamurthy Santosh, 2012, Exp Neurobiol, V21, P52, DOI 10.5607/en.2012.21.2.52
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Saez-Orellana F, 2016, NEUROPHARMACOLOGY, V100, P116, DOI 10.1016/j.neuropharm.2015.04.005
   Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870
   Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507
   Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200
   Son SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.039
   SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110
   Terni B, 2010, BRAIN PATHOL, V20, P222, DOI 10.1111/j.1750-3639.2009.00266.x
   Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900
   Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485
   Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010
   Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x
   Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315
   Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010
   Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
NR 76
TC 24
Z9 26
U1 0
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 5
PY 2017
VL 292
IS 18
BP 7395
EP 7406
DI 10.1074/jbc.M116.753525
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EU1FY
UT WOS:000400761300011
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Gomez-A, A
   Fiorenza, AM
   Boschen, SL
   Sugi, AH
   Beckman, D
   Ferreira, ST
   Lee, K
   Blaha, CD
   Da Cunha, C
AF Gomez-A, Alexander
   Fiorenza, Amanda M.
   Boschen, Suelen L.
   Sugi, Adam H.
   Beckman, Danielle
   Ferreira, Sergio T.
   Lee, Kendall
   Blaha, Charles D.
   Da Cunha, Claudio
TI Diazepam Inhibits Electrically Evoked and Tonic Dopamine Release in the
   Nucleus Accumbens and Reverses the Effect of Amphetamine
SO ACS CHEMICAL NEUROSCIENCE
LA English
DT Article
DE Dopaminergic neurons; Electrochemistry; Ventral tegmental area; Nucleus
   accumbens core; GABA; Anxiolytic; Anticonvulsant
ID INDUCED PLACE PREFERENCE; IN-VIVO MICRODIALYSIS; EXTRACELLULAR DOPAMINE;
   BASAL GANGLIA; RAT-BRAIN; BENZODIAZEPINE; STRIATUM; COCAINE; MIDAZOLAM;
   STRESS
AB Diazepam is a benzodiazepine receptor agonist with anxiolytic and addictive properties. Although most drugs of abuse increase the level of release of dopamine in the nucleus accumbens, here we show that diazepam not only causes the opposite effect but also prevents amphetamine from enhancing dopamine release. We used 20 min sampling in vivo microdialysis and subsecond fast-scan cyclic voltammetry recordings at carbon-fiber microelectrodes to show that diazepam caused a dose-dependent decrease in the level of tonic and electrically evoked dopamine release in the nucleus accumbens of urethane-anesthetized adult male Swiss mice. In fast scan cyclic voltammetry assays, dopamine release was evoked by electrical stimulation of the ventral tegmental area. We observed that 2 and 3 mg of diazepam/kg reduced the level of electrically evoked dopamine release, and this effect was reversed by administration of the benzodiazepine receptor antagonist flumazenil in doses of 2.5 and 5 mg/kg, respectively. No significant effects on measures of dopamine re-uptake were observed. Cyclic voltammetry experiments further showed that amphetamine (5 mg/kg, intraperitoneally) caused a significant increase in the level of dopamine release and in the half-life for dopamine re-uptake. Diazepam (2 mg/kg) significantly weakened the effect of amphetamine on dopamine release without affecting dopamine re-uptake. These results suggest that the pharmacological effects of benzodiazepines have a dopaminergic component. In addition, our findings challenge the classic view that all drugs of abuse cause dopamine release in the nucleus accumbens and suggest that benzodiazepines could be useful in the treatment of addiction to other drugs that increase the level of dopamine release, such as cocaine, amphetamines, and nicotine.
C1 [Gomez-A, Alexander; Fiorenza, Amanda M.; Boschen, Suelen L.; Sugi, Adam H.; Da Cunha, Claudio] Univ Fed Parana, Dept Farmacol, BR-81530980 Curitiba, PR, Brazil.
   [Boschen, Suelen L.; Beckman, Danielle; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Boschen, Suelen L.; Beckman, Danielle; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, Brazil.
   [Lee, Kendall; Blaha, Charles D.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
RP Da Cunha, C (corresponding author), Univ Fed Parana, Dept Farmacol, BR-81530980 Curitiba, PR, Brazil.
EM dacunha.claudio@gmail.com
RI Da Cunha, Claudio/I-5272-2014; Da Cunha, Claudio/X-7903-2019; Beckman,
   Danielle/J-5331-2015; Gomez-A, Alexander/Q-7913-2019; Beckman,
   Danielle/AAA-1016-2019; Ferreira, Sergio/AAZ-1576-2020; Boschen,
   Suelen/O-8906-2014
OI Da Cunha, Claudio/0000-0001-6920-8561; Da Cunha,
   Claudio/0000-0001-6920-8561; Beckman, Danielle/0000-0002-9584-4411;
   Beckman, Danielle/0000-0002-9584-4411; Ferreira,
   Sergio/0000-0001-7160-9866; Boschen, Suelen/0000-0002-7694-920X
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); FINEPCiencia Tecnologia
   e Inovacao (FINEP)
FX A.G.-A, A.M.F., S.L.B., A.H.S., D.B., S.T.F., and C.D.C. were supported
   by CAPES, CNPq, FAPERJ, and FINEP.
CR Bentue-Ferrer D, 2001, EUR NEUROPSYCHOPHARM, V11, P41, DOI 10.1016/S0924-977X(00)00137-1
   BROGDEN RN, 1988, DRUGS, V35, P448, DOI 10.2165/00003495-198835040-00004
   Bucher ES, 2015, ANNU REV ANAL CHEM, V8, P239, DOI 10.1146/annurev-anchem-071114-040426
   Chu TF, 1996, NEUROSCI LETT, V218, P169, DOI 10.1016/S0304-3940(96)13155-4
   Creed MC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00008
   Da Cunha C, 2015, NEUROSCI BIOBEHAV R, V58, P186, DOI 10.1016/j.neubiorev.2015.02.003
   Da Cunha C, 2012, REV NEUROSCIENCE, V23, P747, DOI 10.1515/revneuro-2012-0063
   DAZZI L, 1995, J PHARMACOL EXP THER, V273, P241
   Easton N, 2007, NEUROPHARMACOLOGY, V52, P405, DOI 10.1016/j.neuropharm.2006.07.035
   Engin E, 2014, NEUROPSYCHOPHARMACOL, V39, P1805, DOI 10.1038/npp.2014.41
   FINLAY JM, 1992, PSYCHOPHARMACOLOGY, V106, P202, DOI 10.1007/BF02801973
   FINLAY JM, 1995, NEUROSCIENCE, V64, P619, DOI 10.1016/0306-4522(94)00331-X
   Fordahl SC, 2016, NEUROPHARMACOLOGY, V109, P170, DOI 10.1016/j.neuropharm.2016.06.006
   GRUEN RJ, 1992, BRAIN RES, V599, P51, DOI 10.1016/0006-8993(92)90851-Y
   HEGARTY AA, 1995, PHARMACOL BIOCHEM BE, V52, P771, DOI 10.1016/0091-3057(95)00177-X
   Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102
   HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7
   Ikemoto S, 2015, BEHAV BRAIN RES, V290, P17, DOI 10.1016/j.bbr.2015.04.018
   INVERNIZZI R, 1991, NEUROPHARMACOLOGY, V30, P575, DOI 10.1016/0028-3908(91)90075-M
   Jones SR, 1998, J NEUROSCI, V18, P1979
   Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102
   Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8
   Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110
   Leggio GM, 2015, EUR NEUROPSYCHOPHARM, V25, P1427, DOI 10.1016/j.euroneuro.2014.11.004
   Meririnne E, 1999, PHARMACOL BIOCHEM BE, V62, P159, DOI 10.1016/S0091-3057(98)00139-7
   Motzo C, 1997, PSYCHOPHARMACOLOGY, V131, P34, DOI 10.1007/s002130050262
   MURAI T, 1994, EUR J PHARMACOL, V261, P65, DOI 10.1016/0014-2999(94)90301-8
   Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578
   NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227, DOI 10.1016/0006-3223(93)90288-O
   O'Brien CP, 2005, J CLIN PSYCHIAT, V66, P28
   Paxinos G., 2005, MOUSE BRAIN STEREOTA
   Rada P, 2005, EUR J PHARMACOL, V508, P131, DOI 10.1016/j.ejphar.2004.12.016
   Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244
   Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4
   Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502
   Rush CR, 2004, J CLIN PSYCHOPHARM, V24, P410, DOI 10.1097/01.jcp.0000130553.55630.ad
   Schneier FR, 2000, AM J PSYCHIAT, V157, P457, DOI 10.1176/appi.ajp.157.3.457
   Shibasaki M, 2013, J NEUROCHEM, V125, P747, DOI 10.1111/jnc.12258
   Straub CJ, 2010, BEHAV BRAIN RES, V206, P17, DOI 10.1016/j.bbr.2009.08.025
   SUZUKI T, 1995, EUR J PHARMACOL, V280, P327, DOI 10.1016/0014-2999(95)00249-K
   TAKADA K, 1993, BRIT J ANAESTH, V70, P181, DOI 10.1093/bja/70.2.181
   Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758
   Woo SH, 2001, PHARMACOL RES, V44, P467, DOI 10.1006/phrs.2001.0888
   YANG XM, 1992, PHARMACOL BIOCHEM BE, V41, P643, DOI 10.1016/0091-3057(92)90386-T
   Yoshida Y, 1999, NEUROSCI RES COMMUN, V25, P121
   ZETTERSTROM T, 1990, NEUROPHARMACOLOGY, V29, P129, DOI 10.1016/0028-3908(90)90052-S
   Zhang T, 2009, J NEUROSCI, V29, P4035, DOI 10.1523/JNEUROSCI.0261-09.2009
NR 47
TC 7
Z9 7
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-7193
J9 ACS CHEM NEUROSCI
JI ACS Chem. Neurosci.
PD FEB
PY 2017
VL 8
IS 2
SI SI
BP 300
EP 309
DI 10.1021/acschemneuro.6b00358
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences
   & Neurology
GA EL2XH
UT WOS:000394483300012
PM 28038309
DA 2020-09-29
ER

PT J
AU Vieira, MNN
   Silva, NMLE
   Ferreira, ST
   De Felice, FG
AF Vieira, Marcelo N. N.
   Lyra e Silva, Natalia M.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for
   Alzheimer's Therapy?
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Article
DE Alzheimer's disease; protein tyrosine phosphatase 1B; diabetes; synaptic
   plasticity; neuroinflammation; insulin signaling; leptin signaling;
   endoplasmic reticulum stress
ID AMYLOID-BETA OLIGOMERS; ENDOPLASMIC-RETICULUM STRESS; DEPRESSIVE-LIKE
   BEHAVIOR; LIVER-SPECIFIC DELETION; OPERATED CALCIUM-ENTRY; RECEPTOR
   MESSENGER-RNA; NECROSIS-FACTOR-ALPHA; NEUROTROPHIC FACTOR; TAU
   PHOSPHORYLATION; INSULIN SENSITIVITY
AB Despite significant advances in current understanding of mechanisms of pathogenesis in Alzheimer's disease (AD), attempts at drug development based on those discoveries have failed to translate into effective, disease-modifying therapies. AD is a complex and multifactorial disease comprising a range of aberrant cellular/molecular processes taking part in different cell types and brain regions. As a consequence, therapeutics for AD should be able to block or compensate multiple abnormal pathological events. Here, we examine recent evidence that inhibition of protein tyrosine phosphatase 1B (PTP1B) may represent a promising strategy to combat a variety of AD-related detrimental processes. Besides its well described role as a negative regulator of insulin and leptin signaling, PTB1B recently emerged as a modulator of various other processes in the central nervous system (CNS) that are also implicated in AD. These include signaling pathways germane to learning and memory, regulation of synapse dynamics, endoplasmic reticulum (ER) stress and microglia-mediated neuroinflammation. We propose that PTP1B inhibition may represent an attractive and yet unexplored therapeutic approach to correct aberrant signaling pathways linked to AD.
C1 [Vieira, Marcelo N. N.; Lyra e Silva, Natalia M.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Vieira, Marcelo N. N.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
RP Vieira, MNN; De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Vieira, MNN (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.; De Felice, FG (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
EM mnunes@bioqmed.ufrj.br; felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Vieira,
   Marcelo/0000-0003-2178-9218
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); National Institute for Translational
   Neuroscience; Canadian Institutes of Health Research (CIHR)Canadian
   Institutes of Health Research (CIHR); International Society for
   Neurochemistry (ISN); Committee for Aid and Education in Neurosciences
   (CAEN)
FX Work in the authors' laboratoryis funded by grants from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), National
   Institute for Translational Neuroscience (to FGF and STF) and Canadian
   Institutes of Health Research (CIHR; to FGF). MNNV is a former
   postdoctoral fellow of CNPq and a current fellow of FAPERJ. Studies on
   PTPIB inhibition as a therapy to Alzheimer's disesase are funded by the
   International Society for Neurochemistry (ISN) Committee for Aid and
   Education in Neurosciences (CAEN) Career Interruption, Re-entry Grant
   (to MNNV). NMLS is a pre-doctoral fellow of CNPq.
CR Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373
   Ahima RS, 2002, DIABETES, V51, P2099, DOI 10.2337/diabetes.51.7.2099
   Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012
   Bakke J, 2015, SEMIN CELL DEV BIOL, V37, P58, DOI 10.1016/j.semcdb.2014.09.020
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bonda DJ, 2014, J NEUROCHEM, V128, P162, DOI 10.1111/jnc.12380
   Bornemann KD, 2001, AM J PATHOL, V158, P63, DOI 10.1016/S0002-9440(10)63945-4
   Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2
   Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1
   Chiarreotto-Ropelle EC, 2013, AM J PHYSIOL-ENDOC M, V305, pE649, DOI 10.1152/ajpendo.00272.2013
   Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3
   Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2013, EXPERT REV NEUROTHER, V13, P1297, DOI 10.1586/14737175.2013.864824
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913
   Di Filippo M, 2013, NEUROBIOL DIS, V52, P229, DOI 10.1016/j.nbd.2012.12.009
   Doherty GH, 2013, NEUROBIOL AGING, V34, P226, DOI 10.1016/j.neurobiolaging.2012.08.003
   Echeverria V, 2007, CURR ALZHEIMER RES, V4, P518, DOI 10.2174/156720507783018190
   Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001
   Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544
   Erion JR, 2014, J NEUROSCI, V34, P2618, DOI 10.1523/JNEUROSCI.4200-13.2014
   Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204
   Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com
   Frautschy SA, 1998, AM J PATHOL, V152, P307
   Fuentes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041536
   Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283
   Gomes S, 2014, J NEUROENDOCRINOL, V26, P176, DOI 10.1111/jne.12138
   Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796
   Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026
   Greco SJ, 2009, NEUROSCI LETT, V455, P191, DOI 10.1016/j.neulet.2009.03.066
   Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041
   Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200
   Gum RJ, 2003, DIABETES, V52, P21, DOI 10.2337/diabetes.52.1.21
   Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327
   Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566
   Hakim F, 2015, SLEEP, V38, P31, DOI 10.5665/sleep.4320
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   Hansen TH, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0160-7
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Huang XF, 1996, NEUROREPORT, V7, P2635, DOI 10.1097/00001756-199611040-00045
   Iida M, 1996, BIOCHEM BIOPH RES CO, V222, P19, DOI 10.1006/bbrc.1996.0691
   Irving AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0155
   Ito Y, 2012, REGUL PEPTIDES, V174, P58, DOI 10.1016/j.regpep.2011.11.010
   Johnston JM, 2014, CURR ALZHEIMER RES, V11, P165, DOI 10.2174/1567205010666131212114156
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827
   Koss DJ, 2013, CELL CALCIUM, V53, P125, DOI 10.1016/j.ceca.2012.11.004
   Krishnan N, 2015, J CLIN INVEST, V125, P3163, DOI 10.1172/JCI80323
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lantz KA, 2010, OBESITY, V18, P1516, DOI 10.1038/oby.2009.444
   Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lindtner C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005123
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Maioli S, 2015, AGING CELL, V14, P122, DOI 10.1111/acel.12281
   Malamas MS, 2000, J MED CHEM, V43, P995, DOI 10.1021/jm990476x
   Marwarha G, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-41
   Marwarha G, 2010, J NEUROCHEM, V115, P373, DOI 10.1111/j.1471-4159.2010.06929.x
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5
   Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026
   Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Owen C, 2013, DIABETOLOGIA, V56, P2286, DOI 10.1007/s00125-013-2992-z
   Ozek C, 2014, J BIOL CHEM, V289, P31682, DOI 10.1074/jbc.M114.603621
   Pandey NR, 2014, BIOCHEM BIOPH RES CO, V450, P666, DOI 10.1016/j.bbrc.2014.06.026
   Pandey NR, 2013, J NEUROSCI, V33, P12647, DOI 10.1523/JNEUROSCI.0746-13.2013
   Panzhinskiy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077228
   PEI JJ, 1994, BRAIN RES, V655, P70, DOI 10.1016/0006-8993(94)91598-9
   Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x
   PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3
   Popov D, 2012, BIOCHEM BIOPH RES CO, V422, P535, DOI 10.1016/j.bbrc.2012.05.048
   Qi ZG, 2016, PHARM BIOL, V54, P882, DOI 10.3109/13880209.2015.1089295
   Qin ZH, 2015, NEURON, V85, P1319, DOI 10.1016/j.neuron.2015.02.015
   Qin ZH, 2015, BIOCHEM BIOPH RES CO, V458, P21, DOI 10.1016/j.bbrc.2015.01.040
   Rafii MS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0297-4
   Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590
   Santos LE, 2016, BRAIN BEHAV IMMUN, V55, P151, DOI 10.1016/j.bbi.2015.11.011
   Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Song GJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0545-3
   Soontornniyomkij V, 1999, ACTA NEUROPATHOL, V98, P345, DOI 10.1007/s004010051092
   Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Tamrakar AK, 2014, EXPERT OPIN THER PAT, V24, DOI 10.1517/13543776.2014.947268
   Tautz L, 2015, J CLIN INVEST, V125, P2931, DOI 10.1172/JCI83192
   Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004
   Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang N, 2009, MOL CELL ENDOCRINOL, V307, P89, DOI 10.1016/j.mce.2009.03.001
   Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49
   Wes PD, 2016, GLIA, V64, P1710, DOI 10.1002/glia.22988
   Xu HX, 2016, J NEUROSCI, V36, P9041, DOI 10.1523/JNEUROSCI.1023-16.2016
   Yamada T, 2013, BRAIN RES, V1524, P12, DOI 10.1016/j.brainres.2013.06.007
   Yu IC, 2013, DIABETES, V62, P411, DOI 10.2337/db12-0135
   Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200
   Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X
   Zhang H, 2015, J NEUROSCI, V35, P13275, DOI 10.1523/JNEUROSCI.1034-15.2015
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhang ZY, 2015, TRENDS PHARMACOL SCI, V36, P661, DOI 10.1016/j.tips.2015.07.003
   Zhang ZY, 2003, EXPERT OPIN INV DRUG, V12, P223, DOI 10.1517/eoid.12.2.223.21411
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199
NR 119
TC 31
Z9 31
U1 0
U2 21
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD JAN 31
PY 2017
VL 9
AR 7
DI 10.3389/fnagi.2077.00007
PG 9
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA EJ0QQ
UT WOS:000392915600001
PM 28197094
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Ferreira, ST
AF De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Getting a "GRiP" on Hypothalamic Endoplasmic Reticulum Stress to Combat
   Obesity
SO DIABETES
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; ER STRESS; DISEASE; ACTIVATION; INSULIN;
   DYSFUNCTION; RESISTANCE; OLIGOMERS; GRP78; MICE
C1 [De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, Brazil.; De Felice, FG (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
EM felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU CIHRCanadian Institutes of Health Research (CIHR) [MOP-38854] Funding
   Source: Medline
CR Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010
   Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010
   Contreras C, 2017, DIABETES, V66, P87, DOI 10.2337/db15-1547
   Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003
   Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108
   Ramirez S, 2015, FEBS LETT, V589, P1678, DOI 10.1016/j.febslet.2015.04.025
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002
   Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041
   Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079
   Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755
   Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200
   Zhu GY, 2015, J CELL PHYSIOL, V230, P1413, DOI 10.1002/jcp.24923
NR 22
TC 3
Z9 3
U1 0
U2 5
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD JAN
PY 2017
VL 66
IS 1
BP 17
EP 19
DI 10.2337/dbi16-0057
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EG2AA
UT WOS:000390834300005
PM 27999102
OA Bronze
DA 2020-09-29
ER

PT J
AU Ledo, JH
   Azevedo, EP
   Beckman, D
   Ribeiro, FC
   Santos, LE
   Razolli, DS
   Kincheski, GC
   Melo, HM
   Bellio, M
   Teixeira, AL
   Velloso, LA
   Foguel, D
   De Felice, FG
   Ferreira, ST
AF Ledo, Jose Henrique
   Azevedo, Estefania P.
   Beckman, Danielle
   Ribeiro, Felipe C.
   Santos, Luis E.
   Razolli, Daniela S.
   Kincheski, Grasielle C.
   Melo, Helen M.
   Bellio, Maria
   Teixeira, Antonio L.
   Velloso, Licio A.
   Foguel, Debora
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Cross Talk Between Brain Innate Immunity and Serotonin Signaling
   Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-beta
   Oligomers in Mice
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE Alzheimer's; depression; inflammation; microglia; serotonin
ID TOLL-LIKE RECEPTOR-4; DISEASE; INFLAMMATION; MODEL; TRYPTOPHAN;
   IMPAIRMENT; SYSTEM; RISK; NEUROBIOLOGY; METAANALYSIS
AB Considerable clinical and epidemiological evidence links Alzheimer's disease (AD) and depression. However, the molecular mechanisms underlying this connection are largely unknown. We reported recently that soluble A beta oligomers (A beta Os), toxins that accumulate in AD brains and are thought to instigate synapse damage and memory loss, induce depressive-like behavior in mice. Here, we report that the mechanism underlying this action involves A beta O-induced microglial activation, aberrant TNF-alpha signaling, and decreased brain serotonin levels. Inactivation or ablation of microglia blocked the increase in brain TNF-alpha and abolished depressive-like behavior induced by A beta Os. Significantly, we identified serotonin as a negative regulator of microglial activation. Finally, A beta Os failed to induce depressive-like behavior in Toll-like receptor 4-deficient mice and in mice harboring a nonfunctional TLR4 variant in myeloid cells. Results establish that A beta Os trigger depressive-like behavior via a double impact on brain serotonin levels and microglial activation, unveiling a cross talk between brain innate immunity and serotonergic signaling as a key player in mood alterations in AD.
C1 [Ledo, Jose Henrique; Azevedo, Estefania P.; Beckman, Danielle; Ribeiro, Felipe C.; Kincheski, Grasielle C.; Melo, Helen M.; Foguel, Debora; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.
   [Santos, Luis E.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
   [Bellio, Maria] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941902 Rio De Janeiro, Brazil.
   [Razolli, Daniela S.; Velloso, Licio A.] Univ Estadual Campinas, Fac Med Sci, BR-13083887 Campinas, SP, Brazil.
   [Teixeira, Antonio L.] Univ Fed Minas Gerais, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci, Kingston, ON K7L 3N6, Canada.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Beckman, Danielle/AAA-1016-2019; Teixeira, Antonio L/N-3315-2014;
   Ferreira, Sergio/AAZ-1576-2020; Beckman, Danielle/J-5331-2015; Ribeiro,
   Felipe Campos/W-9758-2019; Razolli, Daniela S/B-1630-2014; Velloso,
   Licio/AAJ-3778-2020; BELLIO, MARIA/N-8525-2018
OI Beckman, Danielle/0000-0002-9584-4411; Teixeira, Antonio
   L/0000-0002-9621-5422; Ferreira, Sergio/0000-0001-7160-9866; Beckman,
   Danielle/0000-0002-9584-4411; Ribeiro, Felipe
   Campos/0000-0003-3028-3307; Razolli, Daniela S/0000-0002-2217-0946;
   Foguel, Debora/0000-0001-7312-7115; BELLIO, MARIA/0000-0002-3360-2740;
   Kincheski, Grasielle Clotildes/0000-0002-7392-3602
FU National Institute for Translational Neuroscience; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Human Frontiers Science
   ProgramHuman Frontier Science Program
FX This work was supported by grants from National Institute for
   Translational Neuroscience (STF), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (S.T.F. and F.G.D.F.), Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (S.T.F. and F.G.D.F.), and the
   Human Frontiers Science Program (F.G.D.F.). This study is dedicated to
   the memory of Prof. Leopoldo de Meis (1938 - 2014), founder of the
   Institute for Medical Biochemistry at the Federal University of Rio de
   Janeiro.
CR Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130
   Azevedo EP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.325
   Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166
   Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bonaccorso S, 1998, AGING-CLIN EXP RES, V10, P316, DOI 10.1007/BF03339794
   Caramelli P, 2011, ARQ NEURO-PSIQUIAT, V69, P579, DOI 10.1590/S0004-282X2011000500002
   Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108
   Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Frye CA, 2009, AGE, V31, P143, DOI 10.1007/s11357-009-9091-6
   Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1
   Geldenhuys WJ, 2011, CNS DRUGS, V25, P765, DOI 10.2165/11590190-000000000-00000
   Grassi-Oliveira R, 2009, PSYCHIAT CLIN NEUROS, V63, P202, DOI 10.1111/j.1440-1819.2008.01918.x
   Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753
   Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102
   Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705
   Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010
   Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886
   Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103
   Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54
   Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lezoualc'h F, 2007, EXP NEUROL, V205, P325, DOI 10.1016/j.expneurol.2007.02.001
   Lorke DE, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-36
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Lyketsos CG, 2002, BIOL PSYCHIAT, V52, P243, DOI 10.1016/S0006-3223(02)01348-3
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Nau F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075426
   Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0
   Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0
   Romano A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu020
   Sachs BD, 2015, P NATL ACAD SCI USA, V112, P2557, DOI 10.1073/pnas.1416866112
   Santos LE, 2016, BRAIN BEHAV IMMUN, V55, P151, DOI 10.1016/j.bbi.2015.11.011
   Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457
   Starkstein Sergio E, 2006, Expert Rev Neurother, V6, P887, DOI 10.1586/14737175.6.6.887
   Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571
   Svenningsson P, 2013, NAT REV NEUROSCI, V14, P673, DOI 10.1038/nrn3564
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014
   Trotta T, 2014, J NEUROIMMUNOL, V268, P1, DOI 10.1016/j.jneuroim.2014.01.014
   Tuglu C, 2003, PSYCHOPHARMACOLOGY, V170, P429, DOI 10.1007/s00213-003-1566-z
   Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X
   van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13
   Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455
   Warner-Schmidt JL, 2011, P NATL ACAD SCI USA, V108, P9262, DOI 10.1073/pnas.1104836108
   Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600
   Wirleitner B, 2003, CURR MED CHEM, V10, P1581, DOI 10.2174/0929867033457179
   Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8
   Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346
   Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461
   Zarros AC, 2005, ACTA NEUROBIOL EXP, V65, P277
   Zhu CB, 2006, NEUROPSYCHOPHARMACOL, V31, P2121, DOI 10.1038/sj.npp.1301029
NR 65
TC 64
Z9 66
U1 0
U2 12
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD NOV 30
PY 2016
VL 36
IS 48
BP 12106
EP 12116
DI 10.1523/JNEUROSCI.1269-16.2016
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA EG6FQ
UT WOS:000391140400005
PM 27903721
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Santos, LE
   Beckman, D
   Ferreira, ST
AF Santos, Luis Eduardo
   Beckman, Danielle
   Ferreira, Sergio T.
TI Microglial dysfunction connects depression and Alzheimer's disease
SO BRAIN BEHAVIOR AND IMMUNITY
LA English
DT Article
DE Alzheimer's disease; Microglia; Major depressive disorder;
   Neuroinflammation
ID GROWTH-FACTOR-I; MILD COGNITIVE IMPAIRMENT; ADULT HIPPOCAMPAL
   NEUROGENESIS; SEROTONIN REUPTAKE INHIBITORS; FRONTAL-LOBE HYPOPERFUSION;
   INDUCED SICKNESS BEHAVIOR; BRAIN INSULIN-RESISTANCE;
   TUMOR-NECROSIS-FACTOR; LATE-LIFE DEPRESSION; STAR-ASTERISK-D
AB Alzheimer's disease (AD) and major depressive disorder (MDD) are highly prevalent neuropsychiatric conditions with intriguing epidemiological overlaps. Depressed patients are at increased risk of developing late-onset AD, and around one in four AD patients are co-diagnosed with MDD. Microglia are the main cellular effectors of innate immunity in the brain, and their activation is central to neuroinflammation - a ubiquitous process in brain pathology, thought to be a causal factor of both AD and MDD. Microglia serve several physiological functions, including roles in synaptic plasticity and neurogenesis, which may be disrupted in neuroinflammation. Following early work on the 'sickness behavior' of humans and other animals, microglia-derived inflammatory cytokines have been shown to produce depressive-like symptoms when administered exogenously or released in response to infection. MDD patients consistently show increased circulating levels of pro-inflammatory cytokines, and anti-inflammatory drugs show promise for treating depression. Activated microglia are abundant in the AD brain, and concentrate around senile plaques, hallmark lesions composed of aggregated amyloid-beta peptide (A beta). The A beta burden in affected brains is regulated largely by microglial clearance, and the complex activation state of microglia may be crucial for AD progression. Intriguingly, recent reports have linked soluble A beta oligomers, toxins that accumulate in AD brains and are thought to cause memory impairment, to increased brain cytokine production and depressive-like behavior in mice. Here, we review recent findings supporting the inflammatory hypotheses of AD and MDD, focusing on microglia as a common player and therapeutic target linking these devastating disorders. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Santos, Luis Eduardo; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Beckman, Danielle; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Santos, Luis/B-4961-2015; Beckman,
   Danielle/AAA-1016-2019; Beckman, Danielle/J-5331-2015
OI Ferreira, Sergio/0000-0001-7160-9866; Santos, Luis/0000-0002-0694-733X;
   Beckman, Danielle/0000-0002-9584-4411; Beckman,
   Danielle/0000-0002-9584-4411
FU National Institute for Translational Neuroscience/Brazil; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX Work in the authors' laboratory is supported by grants from the National
   Institute for Translational Neuroscience/Brazil, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
   L.E.S. and D.B. are pre-doctoral fellows supported by CNPq.
CR Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100
   Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005
   Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014
   Akhondzadeh S, 2009, DEPRESS ANXIETY, V26, P607, DOI 10.1002/da.20589
   Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667
   Allegri Ricardo F, 2006, Neuropsychiatr Dis Treat, V2, P105
   Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012
   Anisman H, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003579
   Apostolova LG, 2008, DEMENT GERIATR COGN, V25, P115, DOI 10.1159/000112509
   Baalman K, 2015, J NEUROSCI, V35, P2283, DOI 10.1523/JNEUROSCI.3751-14.2015
   Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1
   Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149
   Beckman D, 2013, J NEUROSCI, V33, P14283, DOI 10.1523/JNEUROSCI.2911-13.2013
   Benoit M, 2012, J ALZHEIMERS DIS, V31, P325, DOI 10.3233/JAD-2012-112003
   Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846
   Bluthe RM, 2006, BRAIN BEHAV IMMUN, V20, P57, DOI 10.1016/j.bbi.2005.02.003
   Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319
   Bockaert J, 2008, NEUROPHARMACOLOGY, V55, P922, DOI 10.1016/j.neuropharm.2008.05.013
   Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5
   Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bonda DJ, 2010, REDOX REP, V15, P161, DOI 10.1179/174329210X12650506623645
   Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115
   Bufalino C, 2013, BRAIN BEHAV IMMUN, V31, P31, DOI 10.1016/j.bbi.2012.04.009
   BURNS A, 1990, BRIT J PSYCHIAT, V157, P81, DOI 10.1192/bjp.157.1.81
   BURNS A, 1990, BRIT J PSYCHIAT, V157, P86, DOI 10.1192/bjp.157.1.86
   Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345
   Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4
   Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793
   Carro Eva, 2004, Expert Rev Neurother, V4, P79, DOI 10.1586/14737175.4.1.79
   Carvalho AF, 2014, CNS NEUROL DISORD-DR, V13, P1819
   Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018
   Cassilhas RC, 2010, PERCEPT MOTOR SKILL, V110, P265, DOI 10.2466/PMS.110.1.265-276
   Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020
   Chang KA, 2012, NEUROCHEM INT, V61, P885, DOI 10.1016/j.neuint.2012.03.017
   Chemerinski E, 2001, AM J PSYCHIAT, V158, P68, DOI 10.1176/appi.ajp.158.1.68
   Chen SY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-21
   Chen ZH, 2016, J NEUROCHEM, V136, P10, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]
   Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98
   Chi S, 2015, CURR ALZHEIMER RES, V12, P189, DOI 10.2174/1567205012666150204124310
   Chi S, 2014, J ALZHEIMERS DIS, V42, P739, DOI 10.3233/JAD-140324
   Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52
   Chow Tiffany W, 2007, Neuropsychiatr Dis Treat, V3, P627
   Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108
   Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008
   Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106
   Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176
   COPPEN A, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237
   CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308
   Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350
   Curtis C, 2015, JAMA NEUROL, V72, P287, DOI 10.1001/jamaneurol.2014.4144
   Dai LM, 2012, J NEUROL, V259, P414, DOI 10.1007/s00415-011-6164-0
   Dantzer R, 1999, NEUROREPORT, V10, P289, DOI 10.1097/00001756-199902050-00015
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Dantzer R, 2014, J NEURAL TRANSM, V121, P925, DOI 10.1007/s00702-014-1187-1
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   Dean OM, 2012, CNS DRUGS, V26, P391, DOI 10.2165/11632000-000000000-00000
   Dean OM, 2014, CLIN PSYCHOPHARM NEU, V12, P180, DOI 10.9758/cpn.2014.12.3.180
   Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387
   DENICOFF KD, 1987, ANN INTERN MED, V107, P293, DOI 10.7326/0003-4819-107-2-293
   Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1318, DOI 10.1001/archneurol.2012.1282
   Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48
   Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318
   Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033
   Dunger DB, 2003, HORM RES, V60, P131, DOI 10.1159/000074514
   Dwivedi Y, 2013, AM J GERIAT PSYCHIAT, V21, P433, DOI 10.1016/j.jagp.2012.10.026
   Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100
   El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Eyre HA, 2013, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00003
   Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060
   Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621
   Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710
   Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5
   Geldenhuys WJ, 2011, CNS DRUGS, V25, P765, DOI 10.2165/11590190-000000000-00000
   Gemma C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00229
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Glebov K, 2015, GLIA, V63, P626, DOI 10.1002/glia.22772
   Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041
   Gong CY, 2011, MED HYPOTHESES, V77, P383, DOI 10.1016/j.mehy.2011.05.022
   Grassi-Oliveira R, 2009, PSYCHIAT CLIN NEUROS, V63, P202, DOI 10.1111/j.1440-1819.2008.01918.x
   Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753
   Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851
   Guillot-Sestier M.V., 2015, NEURON, V85, P1
   Gulaj E, 2010, ADV MED SCI-POLAND, V55, P204, DOI 10.2478/v10039-010-0023-6
   HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6
   Hauser PS, 2013, CURR ALZHEIMER RES, V10, P809
   Hellwig S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00071
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102
   Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705
   Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008
   Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95
   Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1
   Holthoff VA, 2005, BIOL PSYCHIAT, V57, P412, DOI 10.1016/j.biopsych.2004.11.035
   Holtzheimer PE, 2011, TRENDS NEUROSCI, V34, P1, DOI 10.1016/j.tins.2010.10.004
   Hoshaw BA, 2008, EUR J PHARMACOL, V594, P109, DOI 10.1016/j.ejphar.2008.07.023
   Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x
   Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207
   Hurt C, 2008, DEMENT GERIATR COGN, V26, P138, DOI 10.1159/000149584
   Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010
   Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712
   Janzing JGE, 2002, INT J GERIATR PSYCH, V17, P1, DOI 10.1002/gps.526
   Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322
   Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100
   Johansson JU, 2015, J CLIN INVEST, V125, P350, DOI 10.1172/JCI77487
   Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103
   Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42
   Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010
   Kales HC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h369
   Kang JY, 2012, ALZ DIS ASSOC DIS, V26, P217, DOI 10.1097/WAD.0b013e318231e5fc
   Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041
   Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7
   Kataoka K, 2010, PSYCHIAT CLIN NEUROS, V64, P293, DOI 10.1111/j.1440-1819.2010.02083.x
   Katon W, 2015, JAMA PSYCHIAT, V72, P612, DOI 10.1001/jamapsychiatry.2015.0082
   Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6
   Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x
   KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U
   Khemka VK, 2014, AGING DIS, V5, P170, DOI 10.14336/AD.2014.0500170
   Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318
   Kim HJ, 2013, ARCH PHARM RES, V36, P1279, DOI 10.1007/s12272-013-0238-8
   Klempin F, 2013, J NEUROSCI, V33, P8270, DOI 10.1523/JNEUROSCI.5855-12.2013
   Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009
   KNESEVICH JW, 1983, AM J PSYCHIAT, V140, P233
   Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54
   Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611
   Kohman RA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-114
   Kohman RA, 2012, BRAIN BEHAV IMMUN, V26, P803, DOI 10.1016/j.bbi.2011.10.006
   Kolodziejczak M, 2015, ACS CHEM NEUROSCI, V6, P1219, DOI 10.1021/cn5003489
   Kopczak A, 2015, EUR NEUROPSYCHOPHARM, V25, P864, DOI 10.1016/j.euroneuro.2014.12.013
   Krabbe G, 2012, BRAIN BEHAV IMMUN, V26, P419, DOI 10.1016/j.bbi.2011.12.002
   Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155
   Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236
   Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007
   LAPCHAK PA, 1993, NEUROSCIENCE, V53, P297, DOI 10.1016/0306-4522(93)90196-M
   Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014
   Laws SM, 2005, HUM MUTAT, V26, P29, DOI 10.1002/humu.20180
   Lazarov O, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00043
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee HCB, 2003, BIOL PSYCHIAT, V54, P353, DOI 10.1016/S0006-3223(03)00543-2
   Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422
   Leo J., 2005, PLOS MED
   Levy-Cooperman N, 2008, J PSYCHIATR NEUROSCI, V33, P218
   Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027
   Lin F, 2014, PSYCHONEUROENDOCRINO, V42, P118, DOI 10.1016/j.psyneuen.2014.01.006
   Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505
   Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12
   Lyketsos C.G., 2011, NEUROPSYCHIATRIC SYM
   Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708
   Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475
   Lyketsos CG, 2003, ARCH GEN PSYCHIAT, V60, P737, DOI 10.1001/archpsyc.60.7.737
   Lyketsos CG, 2002, BIOL PSYCHIAT, V52, P243, DOI 10.1016/S0006-3223(02)01348-3
   Lynch MA, 2014, IMMUNOLOGY, V141, P292, DOI 10.1111/imm.12156
   Macchi F, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-116
   Maddison DC, 2015, SEMIN CELL DEV BIOL, V40, P134, DOI 10.1016/j.semcdb.2015.03.002
   Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017
   Malberg JE, 2007, NEUROPSYCHOPHARMACOL, V32, P2360, DOI 10.1038/sj.npp.1301358
   Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466
   MARTENSSON U, 1993, TOXICOL IN VITRO, V7, P241, DOI 10.1016/0887-2333(93)90007-R
   Martinez A, 1998, J NEUROSCI, V18, P7336
   Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001
   Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623
   MERRIAM AE, 1988, J AM GERIATR SOC, V36, P7, DOI 10.1111/j.1532-5415.1988.tb03427.x
   Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009
   Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032
   Mittelbronn M, 2014, NEUROL-NEUROIMMUNOL, V1, P6, DOI DOI 10.4103/2347-8659.135567
   Modrego PJ, 2004, ARCH NEUROL-CHICAGO, V61, P1290, DOI 10.1001/archneur.61.8.1290
   Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Mondelli V, 2011, J CLIN PSYCHIAT, V72, P1677, DOI 10.4088/JCP.10m06745
   Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417
   Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112
   Morgan SC, 2004, J NEUROCHEM, V90, P89, DOI 10.1111/j.1471-4159.2004.02461.x
   Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85
   Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006
   Muller N, 2010, CURR OPIN INVEST DR, V11, P31
   Myint AM, 2003, MED HYPOTHESES, V61, P519, DOI 10.1016/S0306-9877(03)00207-X
   Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x
   Naranjo DM, 2011, ANN FAM MED, V9, P115, DOI 10.1370/afm.1212
   Nelson JC, 2011, J AM GERIATR SOC, V59, P577, DOI 10.1111/j.1532-5415.2011.03355.x
   Nelson JC, 2001, J CLIN PSYCHIAT, V62, P18
   Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401
   Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647
   Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028
   O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148
   Okereke OI, 2006, J CLIN ENDOCR METAB, V91, P4306, DOI 10.1210/jc.2006-1325
   Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125
   Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004
   Oshima E, 2014, PSYCHIAT RES-NEUROIM, V224, P319, DOI 10.1016/j.pscychresns.2014.10.008
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Palmqvist S, 2011, DEMENT GERIATR COGN, V32, P417, DOI 10.1159/000335778
   Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13
   Paolicelli RC, 2011, NEURON GLIA BIOL, V7, P77, DOI 10.1017/S1740925X12000105
   Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529
   Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006
   Park SE, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-12
   Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030
   Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008
   Pascoe MC, 2011, INT J STROKE, V6, P128, DOI 10.1111/j.1747-4949.2010.00565.x
   Paslakis G, 2012, MED HYPOTHESES, V79, P222, DOI 10.1016/j.mehy.2012.04.045
   Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x
   Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015
   Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38
   Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007
   Porta-Etessam J, 2011, ALZ DIS ASSOC DIS, V25, P317, DOI 10.1097/WAD.0b013e31820e7c45
   Powell TR, 2013, EUR NEUROPSYCHOPHARM, V23, P1105, DOI 10.1016/j.euroneuro.2012.09.009
   Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722
   Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445
   RENAULT PF, 1987, ARCH INTERN MED, V147, P1577, DOI 10.1001/archinte.147.9.1577
   Richard E, 2013, JAMA NEUROL, V70, P383, DOI 10.1001/jamaneurol.2013.603
   Rivest S, 2015, CELL RES, V25, P535, DOI 10.1038/cr.2015.37
   Roberts KF, 2014, ANN NEUROL, V76, P837, DOI 10.1002/ana.24270
   Roberts R, 2013, CLIN GERIATR MED, V29, P753, DOI 10.1016/j.cger.2013.07.003
   Roumestan C, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-35
   Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949
   Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905
   Sabri O, 2015, CLIN TRANSL IMAGING, V3, P13, DOI 10.1007/s40336-015-0102-6
   Sacre S, 2010, ARTHRITIS RHEUM-US, V62, P683, DOI 10.1002/art.27304
   Sadovnick A.D., 1997, EUR PSYCHIAT J ASS E, V46, P628
   SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467
   SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509
   Sciacca FL, 2003, NEUROBIOL AGING, V24, P927, DOI 10.1016/S0197-4580(03)00011-3
   Sepehry AA, 2012, DRUG AGING, V29, P793, DOI 10.1007/s40266-012-0012-5
   Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427
   Sheline YI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008169
   SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z
   Soczynska JK, 2012, BEHAV BRAIN RES, V235, P302, DOI 10.1016/j.bbr.2012.07.026
   Son JH, 2013, NEUROSCI LETT, V548, P15, DOI 10.1016/j.neulet.2013.05.021
   Sonntag WE, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00027
   Starkstein SE, 2005, AM J PSYCHIAT, V162, P2086, DOI 10.1176/appi.ajp.162.11.2086
   Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858
   Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94
   Su F, 2015, NEUROSCIENCE, V294, P60, DOI 10.1016/j.neuroscience.2015.02.028
   Sun LY, 2006, AGE, V28, P181, DOI 10.1007/s11357-006-9009-5
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Szczesny E, 2013, PHARMACOL REP, V65, P1622, DOI 10.1016/S1734-1140(13)71523-8
   Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Taraz M, 2013, INT IMMUNOPHARMACOL, V17, P917, DOI 10.1016/j.intimp.2013.09.020
   Teng E, 2008, AM J GERIAT PSYCHIAT, V16, P469, DOI 10.1097/JGP.0b013e318165dbae
   Terada S, 2014, PSYCHIAT RES-NEUROIM, V221, P86, DOI 10.1016/j.pscychresns.2013.11.002
   Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28
   Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520
   Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011
   Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358
   Ulrich JD, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-20
   Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793
   Ventriglia M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/901082
   Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957
   Vilalta-Franch J, 2006, AM J GERIAT PSYCHIAT, V14, P589, DOI 10.1097/01.JGP.0000209396.15788.9d
   Viola KL, 2015, NAT NANOTECHNOL, V10, P91, DOI [10.1038/nnano.2014.254, 10.1038/NNANO.2014.254]
   von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x
   Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012
   Walker FR, 2013, NEUROPHARMACOLOGY, V67, P304, DOI 10.1016/j.neuropharm.2012.10.002
   Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419
   Wang TF, 2015, ARCH MED RES, V46, P24, DOI 10.1016/j.arcmed.2014.12.006
   Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049
   Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x
   Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382
   Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11
   Wilcock D.M., 2012, INT J ALZHEIMERS DIS, V2012, P1
   Wolkowitz OM, 2011, PROG NEURO-PSYCHOPH, V35, P1623, DOI 10.1016/j.pnpbp.2011.06.013
   Xavier ALR, 2015, J NEUROSCI, V35, P11848, DOI 10.1523/JNEUROSCI.1217-15.2015
   Yasutake C, 2006, EUR ARCH PSY CLIN N, V256, P402, DOI [10.1007/s00406-006-0652-8, 10.1007/s00406-006-0702-2]
   Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
   Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2
   Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001
   Yu D, 2015, J ALZHEIMERS DIS, V43, P291, DOI 10.3233/JAD-140414
   Yu H, 2011, ACTA PHARMACOL SIN, V32, P3, DOI 10.1038/aps.2010.184
   Yuan HH, 2015, MOL NEUROBIOL, V51, P512, DOI 10.1007/s12035-014-8717-6
   Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641
   Zhang Feng, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS213, DOI 10.1016/S1353-8020(11)70066-9
   Zheng LS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00005
   Zheng LS, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.015
   Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016
   Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629
   Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006
   Zubenko GS, 2003, AM J PSYCHIAT, V160, P857, DOI 10.1176/appi.ajp.160.5.857
NR 290
TC 37
Z9 39
U1 0
U2 37
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1591
EI 1090-2139
J9 BRAIN BEHAV IMMUN
JI Brain Behav. Immun.
PD JUL
PY 2016
VL 55
SI SI
BP 151
EP 165
DI 10.1016/j.bbi.2015.11.011
PG 15
WC Immunology; Neurosciences; Psychiatry
SC Immunology; Neurosciences & Neurology; Psychiatry
GA DO8FT
UT WOS:000378019100015
PM 26612494
DA 2020-09-29
ER

PT J
AU Ribeiro, FC
   Santos, LE
   Ferreira, ST
AF Ribeiro, Felipe C.
   Santos, Luis E.
   Ferreira, Sergio T.
TI USP46: a new piece of the memory puzzle?
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Editorial Material
ID UBIQUITINATION
C1 [Ribeiro, Felipe C.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Ribeiro, Felipe C.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Santos, Luis E.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Santos, Luis/B-4961-2015; Ribeiro, Felipe Campos/W-9758-2019; Ferreira,
   Sergio/AAZ-1576-2020
OI Santos, Luis/0000-0002-0694-733X; Ribeiro, Felipe
   Campos/0000-0003-3028-3307; Ferreira, Sergio/0000-0001-7160-9866
CR Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003
   Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769
   Dong CG, 2008, LEARN MEMORY, V15, P335, DOI 10.1101/lm.984508
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025
   Huo YD, 2015, J NEUROCHEM, V134, P1067, DOI 10.1111/jnc.13194
   Imai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058566
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kowalski JR, 2011, J NEUROSCI, V31, P1341, DOI 10.1523/JNEUROSCI.4765-10.2011
   Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x
   Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x
   Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008
   Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003
   Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129
   Widagdo J, 2015, CELL REP, V10, P783, DOI 10.1016/j.celrep.2015.01.015
NR 15
TC 2
Z9 2
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD SEP
PY 2015
VL 134
IS 6
BP 979
EP 981
DI 10.1111/jnc.13227
PG 3
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA CT5DK
UT WOS:000362827600001
PM 26237995
DA 2020-09-29
ER

PT J
AU Lourenco, M
   Madeira, C
   Vargas-Lopes, C
   Suemoto, C
   Brandao, CO
   Reis, T
   Leite, R
   Laks, J
   Jacob, W
   Pasquallucci, C
   Grinberg, L
   Ferreira, S
   Panizzutti, R
AF Lourenco, M.
   Madeira, C.
   Vargas-Lopes, C.
   Suemoto, C.
   Brandao, C. O.
   Reis, T.
   Leite, R.
   Laks, J.
   Jacob-Filho, W.
   Pasquallucci, C.
   Grinberg, L.
   Ferreira, S.
   Panizzutti, R.
TI D-serine levels in Alzheimer's disease: implications for novel biomarker
   development
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 25th Biennial Meeting of the International-Society-for-Neurochemistry
   Jointly with the 13th Meeting of the
   Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th
   Meeting of the Australasian-Neuroscience-Society
CY AUG 23-27, 2015
CL Cairns, AUSTRALIA
SP Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc
C1 [Lourenco, M.; Madeira, C.; Vargas-Lopes, C.; Brandao, C. O.; Reis, T.; Laks, J.; Ferreira, S.; Panizzutti, R.] Univ Fed Rio de Janeiro, Ctr Hlth Sci, Rio De Janeiro, Brazil.
   [Suemoto, C.; Leite, R.; Jacob-Filho, W.; Pasquallucci, C.; Grinberg, L.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Grinberg, L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.
RI Suemoto, Claudia Kimie/AAC-7238-2019; Junior, Taylor R.
   Silva/M-3748-2016; Ferreira, Sergio/AAZ-1576-2020; Suemoto, Claudia
   K/C-7218-2012
OI Junior, Taylor R. Silva/0000-0002-1779-7226; Ferreira,
   Sergio/0000-0001-7160-9866; Suemoto, Claudia K/0000-0002-5942-4778
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2015
VL 134
SU 1
SI SI
MA WTH12-14
BP 325
EP 325
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA CP9IA
UT WOS:000360206300828
DA 2020-09-29
ER

PT J
AU Lourenco, MV
   Ferreira, ST
   De Felice, FG
AF Lourenco, Mychael V.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Neuronal stress signaling and eIF2 alpha phosphorylation as molecular
   links between Alzheimer's disease and diabetes
SO PROGRESS IN NEUROBIOLOGY
LA English
DT Review
DE Alzheimer's disease; eIF2 alpha phosphorylation; Diabetes; Brain insulin
   signaling; Amyloid-beta oligomers; Stress kinases
ID UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; A-BETA
   OLIGOMERS; GLUCAGON-LIKE PEPTIDE-1; BLOOD-BRAIN-BARRIER;
   INSULIN-RECEPTOR SUBSTRATE; MILD COGNITIVE IMPAIRMENT; LONG-TERM
   POTENTIATION; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA
AB Mounting evidence from clinical, epidemiological, neuropathology and preclinical studies indicates that mechanisms similar to those leading to peripheral metabolic deregulation in metabolic disorders, such as diabetes and obesity, take place in the brains of Alzheimer's disease (AD) patients. These include pro-inflammatory mechanisms, brain metabolic stress and neuronal insulin resistance. From a molecular and cellular perspective, recent progress has been made in unveiling novel pathways that act in an orchestrated way to cause neuronal damage and cognitive decline in AD. These pathways converge to the activation of neuronal stress-related protein kinases and excessive phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha-P), which plays a key role in control of protein translation, culminating in synapse dysfunction and memory loss. eIF2 alpha-P signaling thus links multiple neuronal stress pathways to impaired neuronal function and neurodegeneration. Here, we present a critical analysis of recently discovered molecular mechanisms underlying impaired brain insulin signaling and metabolic stress, with emphasis on the role of stress kinase/eIF2 alpha-P signaling as a hub that promotes brain and behavioral impairments in AD. Because very similar mechanisms appear to operate in peripheral metabolic deregulation in T2D and in brain defects in AD, we discuss the concept that targeting defective brain insulin signaling and neuronal stress mechanisms with anti-diabetes agents may be an attractive approach to fight memory decline in AD. We conclude by raising core questions that remain to be addressed toward the development of much needed therapeutic approaches for AD. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Lourenco, Mychael V.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Lourenco, MV (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM mychael@bioqmed.ufrj.br; felice@bioqmed.ufrj.br
RI Lourenco, Mychael/G-2614-2014; Lourenco, Mychael/AAG-9732-2020;
   Ferreira, Sergio/AAZ-1576-2020
OI Lourenco, Mychael/0000-0002-1078-0296; Lourenco,
   Mychael/0000-0002-1078-0296; Ferreira, Sergio/0000-0001-7160-9866
FU Human Frontiers Science Program (HFSP)Human Frontier Science Program;
   National Institute for Translational Neuroscience (INNT/Brazil);
   Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Brazilian funding agency Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ); CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX Work in the authors' laboratories was supported by grants from Human
   Frontiers Science Program (HFSP) (to FGF), National Institute for
   Translational Neuroscience (INNT/Brazil) (to STF), the Brazilian funding
   agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ) (to STF and FGF). MVL is supported by a CNPq predoctoral
   fellowship.
CR Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035
   Abisambra JF, 2013, J NEUROSCI, V33, P9498, DOI 10.1523/JNEUROSCI.5397-12.2013
   Agrawal R, 2011, EUR NEUROPSYCHOPHARM, V21, P261, DOI 10.1016/j.euroneuro.2010.11.009
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Apostolatos A, 2012, J BIOL CHEM, V287, P9299, DOI 10.1074/jbc.M111.313080
   Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735
   Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658
   Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295
   Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e
   Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s
   Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555
   Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225
   Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001
   Banks WA, 2006, OBESITY, V14, P234
   Banks WA, 2012, ANN NY ACAD SCI, V1264, P13, DOI 10.1111/j.1749-6632.2012.06568.x
   Barbero-Camps E, 2014, AM J PATHOL, V184, P2066, DOI 10.1016/j.ajpath.2014.03.014
   BARONDES SH, 1968, SCIENCE, V160, P556, DOI 10.1126/science.160.3827.556
   BASKIN DG, 1994, ENDOCRINOLOGY, V134, P1952, DOI 10.1210/en.134.4.1952
   Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5
   Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005
   Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007
   Bell KFS, 2013, BIOCHEM SOC T, V41, P1541, DOI 10.1042/BST20130245
   Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003
   Benedict C, 2011, EXP GERONTOL, V46, P112, DOI 10.1016/j.exger.2010.08.026
   Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714
   Bjorklund NL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-23
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042
   Bosco D, 2012, J NEUROL SCI, V315, P39, DOI 10.1016/j.jns.2011.12.008
   Bose A, 2011, BRAIN PATHOL, V21, P189, DOI 10.1111/j.1750-3639.2010.00437.x
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381
   Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102
   Bruehl H, 2010, J CLIN EXP NEUROPSYC, V32, P487, DOI 10.1080/13803390903224928
   Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003
   Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100
   Miranda FC, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00438
   Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014
   Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057
   Caccamo A, 2011, J BIOL CHEM, V286, P8924, DOI 10.1074/jbc.M110.180638
   Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420
   Carrero I, 2012, EXP NEUROL, V236, P215, DOI 10.1016/j.expneurol.2012.05.004
   Carret-Rebillat AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08489
   Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100
   Chabrier MA, 2012, J NEUROSCI, V32, P17345, DOI 10.1523/JNEUROSCI.0172-12.2012
   Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797
   Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011
   Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x
   Checler F, 2013, NAT MED, V19, P1088, DOI 10.1038/nm.3332
   Chen J, 2014, J MOL NEUROSCI, V53, P677, DOI 10.1007/s12031-014-0236-4
   Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106
   Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7
   Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791
   Combs CK, 2009, J NEUROIMMUNE PHARM, V4, P380, DOI 10.1007/s11481-009-9165-3
   Costa RO, 2012, AGING CELL, V11, P823, DOI 10.1111/j.1474-9726.2012.00848.x
   Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897
   Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050
   Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72
   Couturier J, 2012, CURR ALZHEIMER RES, V9, P344, DOI 10.2174/156720512800107582
   Couturier J, 2010, J ALZHEIMERS DIS, V21, P1217, DOI 10.3233/JAD-2010-100258
   Couturier J, 2010, J BIOL CHEM, V285, P1272, DOI 10.1074/jbc.M109.041954
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740
   Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-13
   de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101
   De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012
   DEVASKAR SU, 1994, J BIOL CHEM, V269, P8445
   Devi L, 2014, NEUROBIOL AGING, V35, P2272, DOI 10.1016/j.neurobiolaging.2014.04.031
   Devi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032792
   Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974
   Di Carlo M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/147835
   Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754
   Dineley KT, 2010, J NEUROSCI RES, V88, P2923, DOI 10.1002/jnr.22445
   Dixon-Salazar TJ, 2014, J NEUROSCI, V34, P11844, DOI 10.1523/JNEUROSCI.4642-12.2014
   Duarte AI, 2006, DIABETES, V55, P2863, DOI 10.2337/db06-0030
   Dumurgier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053587
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Eckert A, 2014, BBA-MOL BASIS DIS, V1842, P1258, DOI 10.1016/j.bbadis.2013.08.013
   Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   FLEXNER LB, 1964, P NATL ACAD SCI USA, V52, P1165, DOI 10.1073/pnas.52.5.1165
   FLOOD JF, 1973, PHYSIOL BEHAV, V10, P555, DOI 10.1016/0031-9384(73)90221-7
   Foltynie T, 2014, ALZHEIMERS DEMENT, V10, pS38, DOI 10.1016/j.jalz.2013.12.005
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288
   Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8
   Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639
   Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010
   Gardoni F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-14
   Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025
   Gejl M, 2012, J CEREBR BLOOD F MET, V32, P2146, DOI 10.1038/jcbfm.2012.118
   Gengler S, 2012, NEUROBIOL AGING, V33, P265, DOI 10.1016/j.neurobiolaging.2010.02.014
   Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102
   Ghasemi R, 2013, MOL NEUROBIOL, V47, P145, DOI 10.1007/s12035-012-8339-9
   Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P405, DOI 10.3233/JAD-2010-100795
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x
   Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005
   Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x
   Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033
   Haj-ali V, 2009, BEHAV NEUROSCI, V123, P1309, DOI 10.1037/a0017722
   Hamilton A, 2011, J NEUROSCI RES, V89, P481, DOI 10.1002/jnr.22565
   Hamilton A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-40
   Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003
   Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5
   Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Harrington C, 2011, CURR ALZHEIMER RES, V8, P592, DOI 10.2174/156720511796391935
   Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729
   Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689
   Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Hetz Claudio, 2008, Current Immunology Reviews, V4, P1
   Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003
   Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS47, DOI 10.1016/j.jalz.2013.12.009
   Holscher C, 2010, NEUROBIOL AGING, V31, P1495, DOI 10.1016/j.neurobiolaging.2008.08.023
   Hokama M, 2014, CEREB CORTEX, V24, P2476, DOI 10.1093/cercor/bht101
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   HOYER S, 1988, J NEUROL, V235, P143, DOI 10.1007/BF00314304
   HOYER S, 1989, J NEURAL TRANSM, V75, P227, DOI 10.1007/BF01258634
   HOYER S, 1986, PROG NEURO-PSYCHOPH, V10, P447, DOI 10.1016/0278-5846(86)90018-7
   Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106
   Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33
   Ill-Raga G., 2015, ANTIOXID RE IN PRESS
   Ill-Raga G, 2013, HIPPOCAMPUS, V23, P431, DOI 10.1002/hipo.22113
   Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456
   Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311
   Jahrling JB, 2014, J NEUROSCI, V34, P4054, DOI 10.1523/JNEUROSCI.4024-13.2014
   Jian M, 2014, J NEUROSCI, V34, P10010, DOI 10.1523/JNEUROSCI.0934-14.2014
   Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010
   Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kazakos K, 2011, DIABETES RES CLIN PR, V93, pS32, DOI 10.1016/S0168-8227(11)70011-0
   Kerti L, 2013, NEUROLOGY, V81, P1746, DOI 10.1212/01.wnl.0000435561.00234.ee
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107
   Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032
   Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853
   Kishida KT, 2007, ANTIOXID REDOX SIGN, V9, P233, DOI 10.1089/ars.2007.9.233
   Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112
   Kobayashi K, 2013, BRAIN RES, V1505, P1, DOI 10.1016/j.brainres.2013.01.012
   Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041
   Korol SV, 2015, DIABETES, V64, P79, DOI 10.2337/db14-0668
   Kuwabara T, 2011, EMBO MOL MED, V3, P742, DOI 10.1002/emmm.201100177
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476
   Lalic NM, 2010, MOVEMENT DISORD, V25, P1976, DOI 10.1002/mds.23176
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108
   Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4
   Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003
   Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014
   Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010489
   Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449
   Leitman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090803
   Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008
   Leuner K, 2012, ANTIOXID REDOX SIGN, V16, P1421, DOI 10.1089/ars.2011.4173
   Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x
   Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314
   Lima RH, 2009, NEUROBIOL LEARN MEM, V91, P466, DOI 10.1016/j.nlm.2008.12.009
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013
   Lund A, 2014, EUR J INTERN MED, V25, P407, DOI 10.1016/j.ejim.2014.03.005
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Ma T, 2014, J NEUROSCI, V34, P12230, DOI 10.1523/JNEUROSCI.1694-14.2014
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Ma T, 2012, J NEUROSCI, V32, P13701, DOI 10.1523/JNEUROSCI.2107-12.2012
   Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845
   Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003
   Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012
   Manolopoulos KN, 2010, MOL PSYCHIATR, V15, P1046, DOI 10.1038/mp.2010.17
   Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f
   Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007
   Maurin AC, 2014, CELL REP, V6, P438, DOI 10.1016/j.celrep.2014.01.006
   MAZZIOTTA JC, 1985, ANN NY ACAD SCI, V444, P269, DOI 10.1111/j.1749-6632.1985.tb37596.x
   McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006
   McClean PL, 2014, NEUROPHARMACOLOGY, V86, P241, DOI 10.1016/j.neuropharm.2014.07.015
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005
   McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002
   McNeilly AD, 2012, DIABETOLOGIA, V55, P3061, DOI 10.1007/s00125-012-2686-y
   Medeiros R, 2007, J NEUROSCI, V27, P5394, DOI 10.1523/JNEUROSCI.5047-06.2007
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229
   Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767
   Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058
   Morris JK, 2014, NEUROBIOL AGING, V35, P585, DOI 10.1016/j.neurobiolaging.2013.09.033
   Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009
   Mouton-Liger F, 2012, BIOL PSYCHIAT, V71, P829, DOI 10.1016/j.biopsych.2011.11.031
   Mucke L, 2012, COLD SPRING HARBOR P, V2, P1
   Nakamura T, 2014, DIABETES, V63, P526, DOI 10.2337/db13-1019
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Nenov MN, 2014, J NEUROSCI, V34, P1028, DOI 10.1523/JNEUROSCI.3413-13.2014
   Nistico R, 2012, NEUROMOL MED, V14, P262, DOI 10.1007/s12017-012-8184-z
   Nosyreva E, 2010, J NEUROSCI, V30, P7358, DOI 10.1523/JNEUROSCI.5358-09.2010
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Ohno H, 2014, SCIENCE, V345, P313, DOI 10.1126/science.1250709
   Okereke OI, 2008, J AM GERIATR SOC, V56, P1028, DOI 10.1111/j.1532-5415.2008.01686.x
   Okereke OI, 2010, NEUROEPIDEMIOLOGY, V34, P200, DOI 10.1159/000289351
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ounallah-Saad H, 2014, J NEUROSCI, V34, P14624, DOI 10.1523/JNEUROSCI.2117-14.2014
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Page G, 2006, NEUROSCIENCE, V139, P1343, DOI 10.1016/j.neuroscience.2006.01.047
   Paquet C, 2012, BRAIN PATHOL, V22, P219, DOI 10.1111/j.1750-3639.2011.00520.x
   Park JY, 2014, J KOREAN RELIG, V5, P5, DOI 10.1353/jkr.2014.0003
   Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099
   Parthsarathy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058784
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Picone P, 2011, AGING CELL, V10, P832, DOI 10.1111/j.1474-9726.2011.00724.x
   Pietri M, 2013, NAT MED, V19, P1124, DOI 10.1038/nm.3302
   Porter DW, 2010, DIABETES OBES METAB, V12, P891, DOI 10.1111/j.1463-1326.2010.01259.x
   Porter WD, 2013, INT J OBESITY, V37, P678, DOI 10.1038/ijo.2012.91
   Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
   Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7
   Quintanilla RA, 2014, NEUROBIOL DIS, V71, P260, DOI 10.1016/j.nbd.2014.08.016
   Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057
   Ramirez AE, 2014, BBA-MOL BASIS DIS, V1842, P1495, DOI 10.1016/j.bbadis.2014.04.019
   Ramser EM, 2013, MOL BIOL CELL, V24, P2494, DOI 10.1091/mbc.E12-12-0858
   Raven JF, 2008, CELL CYCLE, V7, P1146, DOI 10.4161/cc.7.9.5811
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016
   Rhee YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.295
   Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883
   Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369
   Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885
   Roffe M, 2013, J BIOL CHEM, V288, P10860, DOI 10.1074/jbc.M113.461970
   Rosenberg T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00086
   Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607
   Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086
   Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109
   SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901
   Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009
   Sayre LM, 1997, J NEUROCHEM, V68, P2092
   Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6
   Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6
   Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101
   Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344
   Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824
   Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498
   Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060
   Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007
   Smith MA, 1997, J NEUROSCI, V17, P2653
   Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x
   Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0
   Son SM, 2012, DIABETES, V61, P3126, DOI 10.2337/db11-1735
   Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867
   Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010
   Stern E, 2013, J NEUROSCI, V33, P2517, DOI 10.1523/JNEUROSCI.2322-12.2013
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Takach O, 2015, NEUROBIOL AGING, V36, P1378, DOI 10.1016/j.neurobiolaging.2014.11.018
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200
   Trinh MA, 2014, LEARN MEMORY, V21, P298, DOI 10.1101/lm.032219.113
   Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010
   Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036
   Valdes P, 2014, P NATL ACAD SCI USA, V111, P6804, DOI 10.1073/pnas.1321845111
   van der Harg JM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.354
   van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x
   Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298
   Vilsboll T, 2003, REGUL PEPTIDES, V114, P115, DOI 10.1016/S0167-0115(03)00111-3
   Viola KL, 2015, NAT NANOTECHNOL, V10, P91, DOI [10.1038/nnano.2014.254, 10.1038/NNANO.2014.254]
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950
   White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952
   White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001
   Willette A.A., 2014, ALZHEIMERS IN PRESS
   Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121
   Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756
   Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565
   Xing B, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-84
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012
   Yamato E, 1997, HORM METAB RES, V29, P56, DOI 10.1055/s-2007-978985
   Yau PL, 2010, DIABETOLOGIA, V53, P2298, DOI 10.1007/s00125-010-1857-y
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Yu SW, 2008, STEM CELLS, V26, P2602, DOI 10.1634/stemcells.2008-0153
   Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015
   Zhao WC, 2010, NEUROSIGNALS, V18, P236, DOI 10.1159/000324040
   Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045
   Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293
   Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 334
TC 40
Z9 41
U1 0
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0301-0082
EI 1873-5118
J9 PROG NEUROBIOL
JI Prog. Neurobiol.
PD JUN
PY 2015
VL 129
BP 37
EP 57
DI 10.1016/j.pneurobio.2015.03.003
PG 21
WC Neurosciences
SC Neurosciences & Neurology
GA CK9FB
UT WOS:000356544900002
PM 25857551
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   Lourenco, MV
   Oliveira, MM
   De Felice, FG
AF Ferreira, Sergio T.
   Lourenco, Mychael V.
   Oliveira, Mauricio M.
   De Felice, Fernanda G.
TI Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive
   impairment in Alzheimer's disease
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Review
DE Alzheimer's disease; amyloid-beta oligomers; synapse failure; neuronal
   dysfunction; memory loss
ID HIPPOCAMPAL SYNAPTIC PLASTICITY; LONG-TERM DEPRESSION; UNFOLDED PROTEIN
   RESPONSE; RECEPTOR-DEPENDENT MECHANISM; BRAIN INSULIN-RESISTANCE;
   A-BETA; PRION PROTEIN; MOUSE MODEL; TAU PATHOLOGY; IN-VIVO
AB Alzheimer's disease (AD) is the most common form of dementia in the elderly, and affects millions of people worldwide. As the number of AD cases continues to increase in both developed and developing countries, finding therapies that effectively halt or reverse disease progression constitutes a major research and public health challenge. Since the identification of the arnyloid-beta peptide (A beta) as the major component of the amyloid plaques that are characteristically found in AD brains, a major effort has aimed to determine whether and how A/beta leads to memory loss and cognitive impairment. A large body of evidence accumulated in the past 15 years supports a pivotal role of soluble A beta oligomers (A beta Os) in synapse failure and neuronal dysfunction in AD. Nonetheless, a number of basic questions, including the exact molecular composition of the synaptotoxic oligomers, the identity of the receptor(s) to which they bind, and the signaling pathways that ultimately lead to synapse failure, remain to be definitively answered. Here, we discuss recent advances that have illuminated our understanding of the chemical nature of the toxic species and the deleterious impact they have on synapses, and have culminated in the proposal of an A beta oligomer hypothesis for Alzheimer's pathogenesis. We also highlight outstanding questions and challenges in AD research that should be addressed to allow translation of research findings into effective AD therapies.
C1 [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.; Lourenco, Mychael V.; Oliveira, Mauricio M.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Av Carlos Chagas 373,Bloco C,Sala C1-031, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Lourenco, Mychael/AAG-9732-2020; Lourenco, Mychael/G-2614-2014;
   Ferreira, Sergio/AAZ-1576-2020
OI Lourenco, Mychael/0000-0002-1078-0296; Lourenco,
   Mychael/0000-0002-1078-0296; Ferreira, Sergio/0000-0001-7160-9866
FU National Institute for Translational Neuroscience/Brazil; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Human Frontier Science Program (HFSP)Human Frontier Science
   Program; CNPqNational Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino
   Superior (CAPES)CAPES
FX Work in the authors' laboratory has been supported by grants from
   National Institute for Translational Neuroscience/Brazil (to STF),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to
   STF and FGF), and Human Frontier Science Program (HFSP) (to FGF). MVL
   and MMO are pre-doctoral fellows supported by CNPq and Coordenacao de
   Aperfeicoamento de Pessoal de Ensino Superior (CAPES), respectively.
CR Abisambra JF, 2013, J NEUROSCI, V33, P9498, DOI 10.1523/JNEUROSCI.5397-12.2013
   Alzheimer A, 1995, Clin Anat, V8, P429
   Alzheimer A, 1907, ALLG Z PSYCHIAT, V64, P146, DOI DOI 10.1002/CA.980080612
   Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003
   An K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-47
   Anker JN, 2009, J PHYS CHEM C, V113, P5891, DOI 10.1021/jp900266k
   ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573
   Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710
   Baker-Nigh A, 2015, BRAIN, V138, P1722, DOI 10.1093/brain/awv024
   Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107
   Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001
   Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Benilova I, 2011, NAT NEUROSCI, V14, P949, DOI 10.1038/nn.2871
   Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653
   Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]
   Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618
   Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699
   Bjorklund NL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-23
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Brodaty H, 2011, J AM GERIATR SOC, V59, P923, DOI 10.1111/j.1532-5415.2011.03365.x
   Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012
   Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100
   Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x
   Calamai M, 2013, FEBS LETT, V587, P1385, DOI 10.1016/j.febslet.2013.03.014
   Cameron B, 2012, J NEUROSCI, V32, P15112, DOI 10.1523/JNEUROSCI.1729-12.2012
   Canale C, 2013, BIOPHYS CHEM, V182, P23, DOI 10.1016/j.bpc.2013.07.010
   Carrero I, 2012, EXP NEUROL, V236, P215, DOI 10.1016/j.expneurol.2012.05.004
   Chabrier MA, 2012, J NEUROSCI, V32, P17345, DOI 10.1523/JNEUROSCI.0172-12.2012
   Chacon MA, 2008, J CELL PHYSIOL, V217, P215, DOI 10.1002/jcp.21497
   Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797
   Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011
   Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372
   Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013
   Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897
   Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050
   Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Desikan RS, 2011, ANN NEUROL, V70, P657, DOI 10.1002/ana.22509
   Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754
   Di Scala C, 2014, BIOCHEMISTRY-US, V53, P4489, DOI 10.1021/bi500373k
   Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769
   DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5
   Dinamarca MC, 2011, BIOCHEMISTRY-US, V50, P8127, DOI 10.1021/bi201246t
   Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Ferretti MT, 2011, CURR ALZHEIMER RES, V8, P4
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016
   Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954
   Forloni G, 2011, PRION, V5, P10, DOI 10.4161/pri.5.1.14367
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014
   Frandemiche ML, 2014, J NEUROSCI, V34, P6084, DOI 10.1523/JNEUROSCI.4261-13.2014
   Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639
   Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111
   Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511
   Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359
   Gan KJ, 2015, MOL BIOL CELL, V26, P1058, DOI 10.1091/mbc.E14-12-1612
   Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110
   Garcia-Osta A, 2009, LEARN MEMORY, V16, P267, DOI 10.1101/lm.1310209
   Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102
   Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013
   Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068
   Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q
   Hamilton A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-40
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042
   Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v
   Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010
   Herskovits AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067898
   Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008
   Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228
   Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035
   Hu NW, 2008, BRAIN, V131, P2414, DOI 10.1093/brain/awn174
   Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374
   Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008
   Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821
   Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036
   Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111898
   Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111899
   Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0
   Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217
   Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234
   Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008
   Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25
   Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106
   Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041
   Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009
   KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247
   Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012
   Kuo YM, 1996, J BIOL CHEM, V271, P4077
   Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009
   LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee J, 2014, BIOCHEMISTRY-US, V53, P4704, DOI 10.1021/bi500587p
   Lee L, 2014, J ALZHEIMERS DIS, V38, P49, DOI 10.3233/JAD-130740
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247
   MASLIAH E, 1990, AM J PATHOL, V137, P1293
   MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192
   MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x
   Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313
   Matsuno M, 2015, J NEUROSCI, V35, P5557, DOI 10.1523/JNEUROSCI.3865-14.2015
   McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006
   McDonald JM, 2012, BRAIN RES, V1450, P138, DOI 10.1016/j.brainres.2012.02.041
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504
   Morrison JH, 2014, JAMA PSYCHIAT, V71, P835, DOI 10.1001/jamapsychiatry.2014.380
   Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000
   Narayan P, 2014, BIOCHEMISTRY-US, V53, P2442, DOI 10.1021/bi401606f
   Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004
   O'Malley TT, 2014, BIOCHEM J, V461, P413, DOI 10.1042/BJ20140219
   O'Nuallain B, 2011, J NEUROCHEM, V119, P189, DOI 10.1111/j.1471-4159.2011.07389.x
   O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010
   Ogawa M, 2011, J NEUROCHEM, V116, P851, DOI 10.1111/j.1471-4159.2010.06997.x
   Overk CR, 2014, P NATL ACAD SCI USA, V111, P13680, DOI 10.1073/pnas.1414554111
   Patel AN, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002134
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171
   Peters C, 2015, NEUROBIOL AGING, V36, P1369, DOI 10.1016/j.neurobiolaging.2014.11.019
   PIKE CJ, 1993, J NEUROSCI, V13, P1676
   PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564
   Poling A, 2008, BEHAV BRAIN RES, V193, P230, DOI 10.1016/j.bbr.2008.06.001
   Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x
   Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313
   Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008
   Ramser EM, 2013, MOL BIOL CELL, V24, P2494, DOI 10.1091/mbc.E12-12-0858
   Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s
   Rasool S, 2013, J NEUROCHEM, V126, P473, DOI 10.1111/jnc.12305
   Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   Ricciarelli R, 2014, ANN NEUROL, V75, P602, DOI 10.1002/ana.24130
   Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883
   Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229
   Rios JA, 2014, PROG NEUROBIOL, V121, P125, DOI 10.1016/j.pneurobio.2014.07.004
   Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Rowan MJ, 2005, BIOCHEM SOC T, V33, P563, DOI 10.1042/BST0330563
   Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086
   SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2
   Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783
   Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021
   Silva-Alvarez C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00097
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003
   Takach O, 2015, NEUROBIOL AGING, V36, P1378, DOI 10.1016/j.neurobiolaging.2014.11.018
   Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004
   Takamura A, 2012, LIFE SCI, V91, P1177, DOI 10.1016/j.lfs.2012.04.038
   Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7
   Tarczyluk M. A., 2015, J CEREB BLOOD FLOW M, DOI [10.1038/jcbfm.2015.58, DOI 10.1038/JCBFM.2015.58.[]
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Tofoleanu F, 2012, PRION, V6, P339, DOI 10.4161/pri.21022
   Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72
   Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010
   Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754
   Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200
   Tsigelny IF, 2014, J ALZHEIMERS DIS, V39, P583, DOI 10.3233/JAD-131589
   Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036
   Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178
   Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100
   Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014
   Velasco PT, 2012, ACS CHEM NEUROSCI, V3, P972, DOI 10.1021/cn300122k
   Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3
   Viola KL, 2015, NAT NANOTECHNOL, V10, P91, DOI [10.1038/nnano.2014.254, 10.1038/NNANO.2014.254]
   Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002
   Williams TL, 2011, BIOCHEM J, V439, P67, DOI 10.1042/BJ20110750
   Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010
   Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565
   Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394
   Yamamoto N, 2014, J NEUROCHEM, V131, P323, DOI 10.1111/jnc.12828
   Yamamoto N, 2012, J NEUROCHEM, V121, P619, DOI 10.1111/j.1471-4159.2012.07668.x
   Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012
   Yates EA, 2013, J MOL BIOL, V425, P1915, DOI 10.1016/j.jmb.2013.03.022
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207
   Zempel H, 2012, NEURODEGENER DIS, V10, P64, DOI 10.1159/000332816
   Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010
   Zhang QH, 2015, GENE, V561, P76, DOI 10.1016/j.gene.2015.02.011
   Zhang YJ, 2012, J BIOL CHEM, V287, P748, DOI 10.1074/jbc.M111.281295
   Zhang YF, 2011, J NEUROCHEM, V119, P664, DOI 10.1111/j.1471-4159.2011.07450.x
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
   Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045
   Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5
   Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029
NR 246
TC 157
Z9 161
U1 1
U2 63
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD MAY 26
PY 2015
VL 9
AR 191
DI 10.3389/fncel.2015.00191
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA CM2OR
UT WOS:000357521400001
PM 26074767
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Madeira, C
   Lourenco, MV
   Vargas-Lopes, C
   Suemoto, CK
   Brandao, CO
   Reis, T
   Leite, REP
   Laks, J
   Jacob, W
   Pasqualucci, CA
   Grinberg, LT
   Ferreira, ST
   Panizzutti, R
AF Madeira, C.
   Lourenco, M. V.
   Vargas-Lopes, C.
   Suemoto, C. K.
   Brandao, C. O.
   Reis, T.
   Leite, R. E. P.
   Laks, J.
   Jacob-Filho, W.
   Pasqualucci, C. A.
   Grinberg, L. T.
   Ferreira, S. T.
   Panizzutti, R.
TI D-serine levels in Alzheimer's disease: implications for novel biomarker
   development
SO TRANSLATIONAL PSYCHIATRY
LA English
DT Article
ID LONG-TERM DEPRESSION; CEREBROSPINAL-FLUID; ASSOCIATION WORKGROUPS;
   DIAGNOSTIC GUIDELINES; COGNITIVE DEFICITS; NATIONAL INSTITUTE; AMYLOID
   OLIGOMERS; GLUTAMATE RELEASE; GENE-EXPRESSION; SYNAPSE FAILURE
AB Alzheimer's disease (AD) is a severe neurodegenerative disorder still in search of effective methods of diagnosis. Altered levels of the NMDA receptor co-agonist, D-serine, have been associated with neurological disorders, including schizophrenia and epilepsy. However, whether D-serine levels are deregulated in AD remains elusive. Here, we first measured D-serine levels in post-mortem hippocampal and cortical samples from nondemented subjects (n = 8) and AD patients (n = 14). We next determined D-serine levels in experimental models of AD, including wild-type rats and mice that received intracerebroventricular injections of amyloid-beta oligomers, and APP/PS1 transgenic mice. Finally, we assessed D-serine levels in the cerebrospinal fluid (CSF) of 21 patients with a diagnosis of probable AD, as compared with patients with normal pressure hydrocephalus (n = 9), major depression (n = 9) and healthy controls (n = 10), and results were contrasted with CSF amyloid-beta/tau AD biomarkers. D-serine levels were higher in the hippocampus and parietal cortex of AD patients than in control subjects. Levels of both D-serine and serine racemase, the enzyme responsible for D-serine production, were elevated in experimental models of AD. Significantly, D-serine levels were higher in the CSF of probable AD patients than in non-cognitively impaired subject groups. Combining D-serine levels to the amyloid/tau index remarkably increased the sensitivity and specificity of diagnosis of probable AD in our cohort. Our results show that increased brain and CSF D-serine levels are associated with AD. CSF D-serine levels discriminated between nondemented and AD patients in our cohort and might constitute a novel candidate biomarker for early AD diagnosis.
C1 [Madeira, C.; Vargas-Lopes, C.; Panizzutti, R.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Lourenco, M. V.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Suemoto, C. K.; Jacob-Filho, W.] Univ Sao Paulo, Sch Med, Discipline Geriatr, Sao Paulo, Brazil.
   [Brandao, C. O.; Reis, T.; Laks, J.; Panizzutti, R.] Univ Fed Rio de Janeiro, Inst Psychiat, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Leite, R. E. P.; Pasqualucci, C. A.; Grinberg, L. T.] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil.
   [Grinberg, L. T.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA.
   [Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Predio CCS, Sala H2-019,Cidade Univ, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br; rogerio@icb.ufrj.br
RI Suemoto, Claudia Kimie/AAC-7238-2019; Lourenco, Mychael/G-2614-2014;
   Ferreira, Sergio/AAZ-1576-2020; Lourenco, Mychael/AAG-9732-2020;
   Suemoto, Claudia/C-7218-2012
OI Lourenco, Mychael/0000-0002-1078-0296; Ferreira,
   Sergio/0000-0001-7160-9866; Lourenco, Mychael/0000-0002-1078-0296; Reis
   da silva junior, Taylor/0000-0002-1779-7226; Suemoto,
   Claudia/0000-0002-5942-4778
FU DECIT/SCTIE/MS; SESDC; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Instituto Nacional de
   Ciencia e Tecnologia de Biologia Estrutural e Bioimagem; Instituto
   Nacional de Neurociencia Translacional; Human Frontier Science
   ProgramHuman Frontier Science Program; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); LIM05-FMUSP; Hospital Albert Einstein-Sao Paulo; FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CAPESCAPES
FX Research was supported by grants from DECIT/SCTIE/MS, SESDC and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to RP and STF;
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to
   RP, STF and JL; Instituto Nacional de Ciencia e Tecnologia de Biologia
   Estrutural e Bioimagem to RP; and Instituto Nacional de Neurociencia
   Translacional to STF. RP is a recipient of a Long-Term Fellowship from
   the Human Frontier Science Program. CM, MVL and CVL were supported by
   fellowships from FAPERJ and CNPq. The Brain Bank of the Brazilian Aging
   Brain Study Group is funded by LIM05-FMUSP, Hospital Albert Einstein-Sao
   Paulo, FAPESP, CNPq and CAPES. We thank all sample donors and their
   families/caregivers for contributing to this study. We thank AC Rangel
   for secretarial support and A Fantinatti for technical support.
CR Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
   Armstrong RA, 2000, NEUROPATHOLOGY, V20, P31, DOI 10.1046/j.1440-1789.2000.00284.x
   Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4
   Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014
   CHOUINARD ML, 1993, J NEUROCHEM, V61, P1561, DOI 10.1111/j.1471-4159.1993.tb13657.x
   Dauvilliers YA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00119
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Dumurgier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053587
   Esposito S, 2012, AGING CELL, V11, P588, DOI 10.1111/j.1474-9726.2012.00822.x
   Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011
   Filali M, 2013, EUR J PHARMACOL, V701, P152, DOI 10.1016/j.ejphar.2012.12.018
   Fisher G, 1998, AMINO ACIDS, V15, P263, DOI 10.1007/BF01318865
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z
   Guercio GD, 2014, NEUROPHARMACOLOGY, V86, P1, DOI 10.1016/j.neuropharm.2014.06.021
   Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006
   Harari O, 2014, BIOL PSYCHIAT, V75, P723, DOI 10.1016/j.biopsych.2013.11.032
   Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911
   HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y
   Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555
   Hynd MR, 2004, J NEUROCHEM, V89, P240, DOI 10.1111/j.1471-4159.2003.02330.x
   Ikonemevic MD, 1999, EXP NEUROL, V160, P194, DOI 10.1006/exnr.1999.7196
   Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   KUMASHIRO S, 1995, BRAIN RES, V681, P117, DOI 10.1016/0006-8993(95)00307-C
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lehmann S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt267
   Lehmann S, 2014, ALZHEIMERS DEMENT, V10, pS390, DOI 10.1016/j.jalz.2013.06.008
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   McKhann GM, 2011, JAMA-J AM MED ASSOC, V305, P2458, DOI 10.1001/jama.2011.810
   McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
   Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016
   MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
   Mouton-Liger F, 2012, BIOL PSYCHIAT, V71, P829, DOI 10.1016/j.biopsych.2011.11.031
   Mucke L, 2012, COLD SPRING HARBOR P, V2, P1
   Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010
   NAGATA Y, 1995, BRAIN RES BULL, V38, P181, DOI 10.1016/0361-9230(95)00087-U
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298
   Parsons CG, 2013, NEUROTOX RES, V24, P358, DOI 10.1007/s12640-013-9398-z
   Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304
   Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009
   Radzishevsky I, 2013, CURR OPIN CLIN NUTR, V16, P72, DOI 10.1097/MCO.0b013e32835a3466
   Reis T, 2012, CNS NEUROSCI THER, V18, P524, DOI 10.1111/j.1755-5949.2012.00311.x
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106
   Tabaraud F, 2012, ACTA NEUROL SCAND, V125, P416, DOI 10.1111/j.1600-0404.2011.01592.x
   Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110
   Tarawneh R, 2012, COLD SPRING HARB PER, V2, P1, DOI DOI 10.1101/CSHPERSPECT.A006148
   Vargas-Lopes C, 2011, J NEUROCHEM, V116, P281, DOI 10.1111/j.1471-4159.2010.07102.x
   Wilson RS, 2002, NEUROLOGY, V59, P364, DOI 10.1212/WNL.59.3.364
   Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721
   Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x
   Wolosker H, 2013, BIOCHEM SOC T, V41, P1546, DOI 10.1042/BST20130220
   Wolosker H, 2012, AMINO ACIDS, V43, P1895, DOI 10.1007/s00726-012-1370-3
   Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2
   Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565
NR 77
TC 80
Z9 81
U1 1
U2 16
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 2158-3188
J9 TRANSL PSYCHIAT
JI Transl. Psychiatr.
PD MAY 5
PY 2015
VL 5
AR e561
DI 10.1038/tp.2015.52
PG 9
WC Psychiatry
SC Psychiatry
GA DA2WF
UT WOS:000367657000003
PM 25942042
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Acquarone, M
   de Melo, TM
   Meireles, F
   Brito-Moreiras, J
   Oliveira, G
   Ferreira, ST
   Castro, NG
   Tovar-Moil, F
   Houzel, JC
   Rehen, SK
AF Acquarone, Mariana
   de Melo, Thiago M.
   Meireles, Fernanda
   Brito-Moreiras, Jordano
   Oliveira, Gabriel
   Ferreira, Sergio T.
   Castro, Newton G.
   Tovar-Moil, Fernanda
   Houzel, Jean-Christophe
   Rehen, Stevens K.
TI Mitomycin-treated undifferentiated embryonic stem cells as a safe and
   effective therapeutic strategy in a mouse model of Parkinson's disease
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Article
DE embryonic stem cell; stem cell therapy; Parkinson model; mitomycin C;
   contrast-enhanced MRI
ID DOPAMINERGIC-NEURONS; PRIMATE MODEL; IN-VITRO; TRANSPLANTATION;
   DIFFERENTIATION; IMMUNOGENICITY; IDENTIFICATION; PLURIPOTENT;
   PROGENITORS; PROTOCOLS
AB Parkinsons disease (PD) is an incurable progressive neurodegenerative disorder. Clinical presentation of PD stems largely from the loss of dopaminergic neurons in the nigrostriatal dopaminergic pathway, motivating experimental strategies of replacement based on cell therapy. Transplantation of dopaminergic neurons derived from embryonic stem cells significantly improves motor functions in rodent and non-human primate models of PD. However, protocols to generate dopaminergic neurons from embryonic stem cells generally meet with low efficacy and high risk of teratoma formation upon transplantation. To address these issues, we have pre-treated undifferentiated mouse embryonic stem cells (mESCs) with the DNA alkylating agent mitomycin C (MMC) before transplantation. MMC treatment of cultures prevented tumorigenesis in a 12 week follow-up after mESCs were injected in nude mice. In 6-OH-dopamine-lesioned mice, intrastriatal injection of MMC-treated mESCs markedly improved motor function without tumor formation for as long as 15 months. Furthermore, we show that halting mitotic activity of undifferentiated mESCs induces a four-fold increase in dopamine release following in vitro differentiation. Our findings indicate that treating mESCs with MMC prior to intrastriatal transplant is an effective to strategy that could be further investigated as a novel alternative for treatment of PD.
C1 [Acquarone, Mariana; de Melo, Thiago M.; Castro, Newton G.; Tovar-Moil, Fernanda; Houzel, Jean-Christophe; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Meireles, Fernanda; Tovar-Moil, Fernanda; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Brito-Moreiras, Jordano; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, Brazil.
   [Oliveira, Gabriel] Inst Oswaldo Cruz, Oswaido Cruz Fdn, BR-20001 Rio De Janeiro, Brazil.
RP Houzel, JC (corresponding author), Inst Ciencias Biomed, Cidade Univ Itha Fundao,Av Carlos Chagas Filho, BR-21941920 Rio De Janeiro, RJ, Brazil.
EM jchouzel@lcb.ufrj.br; srehen@lance-ufrj.arg
RI Houzel, Jean Christophe/G-3723-2010; Rehen, Stevens K/J-5874-2012;
   Ferreira, Sergio/AAZ-1576-2020; Castro, Newton G/C-3263-2009; Houzel,
   Jean Christophe/M-7936-2019
OI Houzel, Jean Christophe/0000-0001-5128-438X; Rehen, Stevens
   K/0000-0003-4216-9501; Ferreira, Sergio/0000-0001-7160-9866; Castro,
   Newton G/0000-0001-9570-7428; Houzel, Jean
   Christophe/0000-0001-5128-438X
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); BNDES; CAPESCAPES
FX This work is part of the PhD Thesis of MA. We thank Dr. Liisa Tremere
   for comments on an earlier version of the manuscript. Funding agencies:
   FAPERJ, CNPq, BNDES, CAPES.
CR Akhlaghpoor S, 2012, WORLD J GASTROENTERO, V18, P5249, DOI 10.3748/wjg.v18.i37.5249
   Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807
   Arenas E, 2010, BIOCHEM BIOPH RES CO, V396, P152, DOI 10.1016/j.bbrc.2010.04.037
   Arita DY, 2002, J CELL BIOCHEM, V87, P58, DOI 10.1002/jcb.10277
   Bernstein HS, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt108
   Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099
   Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022
   Chung S, 2011, P NATL ACAD SCI USA, V108, P9703, DOI 10.1073/pnas.1016443108
   da Conceicao Fabio S L, 2010, J Vis Exp, DOI 10.3791/1376
   Deacon T, 1998, EXP NEUROL, V149, P28, DOI 10.1006/exnr.1997.6674
   Emre N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012148
   FDA, 2002, EXPERT REV ANTICANC, V2, P618
   Felfly H, 2011, AM J PHYSIOL-REG I, V301, pR727, DOI 10.1152/ajpregu.00217.2011
   Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775
   Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002
   Hayashi H, 2008, EUR J NEUROSCI, V27, P261, DOI 10.1111/j.1460-9568.2008.06027.x
   Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023
   Kahan B, 2011, STEM CELL RES, V6, P143, DOI 10.1016/j.scr.2010.10.003
   Khoo MLM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019025
   Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Kriks S, 2009, ADV EXP MED BIOL, V651, P101
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Lindvall O, 2012, NAT BIOTECHNOL, V30, P56, DOI 10.1038/nbt.2077
   Mesentier-Louro LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110722
   Mine Y, 2009, NEUROSURGERY, V65, P741, DOI 10.1227/01.NEU.0000351281.45986.76
   Muramatsu SI, 2009, SYNAPSE, V63, P541, DOI 10.1002/syn.20634
   Marinho PAN, 2013, TISSUE ENG PART C-ME, V19, P146, DOI [10.1089/ten.tec.2012.0141, 10.1089/ten.TEC.2012.0141]
   Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165
   Park CH, 2006, FASEB J, V20, P2553, DOI 10.1096/fj.06-6159fje
   Paulsen BS, 2011, STEM CELLS DEV, V20, P1711, DOI 10.1089/scd.2010.0446
   Paulsen JS, 2013, PROG NEUROBIOL, V110, P2, DOI 10.1016/j.pneurobio.2013.08.003
   Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060
   Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744
   Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8
   Stelling MP, 2013, GLYCOBIOLOGY, V23, P337, DOI 10.1093/glycob/cws133
   Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415
   Sykova Eva, 2013, Laser Ther, V22, P87, DOI 10.3136/islsm.22.87
   Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137
   Vinoth KJ, 2008, STEM CELLS DEV, V17, P599, DOI 10.1089/scd.2007.0088
   Werner D, 2013, CANCER MED-US, V2, P325, DOI 10.1002/cam4.77
   White RB, 2011, TRANSL RES, V157, P53, DOI 10.1016/j.trsl.2010.12.001
   Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019
NR 43
TC 18
Z9 18
U1 0
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD APR 8
PY 2015
VL 9
AR 97
DI 10.3389/fncel.2015.00097
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA CF7IL
UT WOS:000352729600001
PM 25904842
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Clarke, JR
   Silva, NMLE
   Figueiredo, CP
   Frozza, RL
   Ledo, JH
   Beckman, D
   Katashima, CK
   Razolli, D
   Carvalho, BM
   Frazao, R
   Silveira, MA
   Ribeiro, FC
   Bomfim, TR
   Neves, FS
   Klein, WL
   Medeiros, R
   LaFerla, FM
   Carvalheira, JB
   Saad, MJ
   Munoz, DP
   Velloso, LA
   Ferreira, ST
   De Felice, FG
AF Clarke, Julia R.
   Lyra e Silva, Natalia M.
   Figueiredo, Claudia P.
   Frozza, Rudimar L.
   Ledo, Jose H.
   Beckman, Danielle
   Katashima, Carlos K.
   Razolli, Daniela
   Carvalho, Bruno M.
   Frazao, Renata
   Silveira, Marina A.
   Ribeiro, Felipe C.
   Bomfim, Theresa R.
   Neves, Fernanda S.
   Klein, William L.
   Medeiros, Rodrigo
   LaFerla, Frank M.
   Carvalheira, Jose B.
   Saad, Mario J.
   Munoz, Douglas P.
   Velloso, Licio A.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Alzheimer-associated A beta oligomers impact the central nervous system
   to induce peripheral metabolic deregulation
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE Alzheimer's disease; ER stress; hypothalamus; inflammation; insulin
   resistance
ID ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE;
   NECROSIS-FACTOR-ALPHA; D-ASPARTATE RECEPTOR; MOUSE MODEL; TNF-ALPHA;
   COGNITIVE IMPAIRMENT; GLUCOSE-HOMEOSTASIS; AMYLOID OLIGOMERS; LONG-TERM
AB Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological data indicate increased risk of diabetes in AD patients. Here, we show that intracerebroventricular infusion of AD-associated A beta oligomers (A beta Os) in mice triggered peripheral glucose intolerance, a phenomenon further verified in two transgenic mouse models of AD. Systemically injected A beta Os failed to induce glucose intolerance, suggesting A beta Os target brain regions involved in peripheral metabolic control. Accordingly, we show that A beta Os affected hypothalamic neurons in culture, inducing eukaryotic translation initiation factor 2 alpha phosphorylation (eIF2 alpha-P). A beta Os further induced eIF2 alpha-P and activated proinflammatory IKK beta/NF-kappa B signaling in the hypothalamus of mice and macaques. A beta Os failed to trigger peripheral glucose intolerance in tumor necrosis factor-alpha (TNF-alpha) receptor 1 knockout mice. Pharmacological inhibition of brain inflammation and endoplasmic reticulum stress prevented glucose intolerance in mice, indicating that A beta Os act via a central route to affect peripheral glucose homeostasis. While the hypothalamus has been largely ignored in the AD field, our findings indicate that A beta Os affect this brain region and reveal novel shared molecular mechanisms between hypothalamic dysfunction in metabolic disorders and AD.
C1 [Clarke, Julia R.; Lyra e Silva, Natalia M.; Frozza, Rudimar L.; Ledo, Jose H.; Beckman, Danielle; Ribeiro, Felipe C.; Bomfim, Theresa R.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
   [Clarke, Julia R.; Figueiredo, Claudia P.; Neves, Fernanda S.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, RJ, Brazil.
   [Katashima, Carlos K.; Razolli, Daniela; Carvalho, Bruno M.; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Campinas, SP, Brazil.
   [Frazao, Renata; Silveira, Marina A.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, SP, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA.
   [Medeiros, Rodrigo; LaFerla, Frank M.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA.
   [Munoz, Douglas P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
EM felice@bioqmed.ufrj.br
RI Carvalheira, Jose B.C./E-8562-2013; Clarke, Julia/AAF-9434-2019;
   Beckman, Danielle/J-5331-2015; Razolli, Daniela S/B-1630-2014; Beckman,
   Danielle/AAA-1016-2019; Frazao, Renata/D-1374-2012; Carvalho,
   Bruno/G-1255-2012; Ribeiro, Felipe Campos/W-9758-2019; Ferreira,
   Sergio/AAZ-1576-2020; Neves, Fernanda/AAW-9638-2020; Figueiredo, Claudia
   P/F-8424-2012; Katashima, Carlos Kiyoshi K/I-5616-2018; Velloso,
   Licio/AAJ-3778-2020
OI Carvalheira, Jose B.C./0000-0002-0136-0943; Beckman,
   Danielle/0000-0002-9584-4411; Razolli, Daniela S/0000-0002-2217-0946;
   Beckman, Danielle/0000-0002-9584-4411; Carvalho,
   Bruno/0000-0002-6792-0288; Ribeiro, Felipe Campos/0000-0003-3028-3307;
   Ferreira, Sergio/0000-0001-7160-9866; Katashima, Carlos Kiyoshi
   K/0000-0002-3908-127X; Frazao, Renata/0000-0002-0877-8453; Frozza,
   Rudimar Luiz/0000-0003-0918-4128; Medeiros, Rodrigo/0000-0002-9399-7852
FU Human Frontiers Science Program (HFSP)Human Frontier Science Program;
   National Institute for Translational Neuroscience (INNT/Brazil);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de
   Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [FAPESP2012/12202-4]; Canadian Institutes for Health Research
   (CIHR)Canadian Institutes of Health Research (CIHR); Canada Research
   Chair ProgramCanada Research Chairs; CAPESCAPES; CNPqNational Council
   for Scientific and Technological Development (CNPq)
FX This study is dedicated to the memory of Prof. Leopoldo de Meis
   (1938-2014), founder of the Institute of Medical Biochemistry of the
   Federal University of Rio de Janeiro. This work was supported by grants
   from Human Frontiers Science Program (HFSP) (to FGF), National Institute
   for Translational Neuroscience (INNT/Brazil) (to STF), the Brazilian
   funding agencies Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (to STF, FGF, CPF and JRC), Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to STF, FGF, CPF and
   JRC), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP2012/12202-4 to RF), Canadian Institutes for Health Research
   (CIHR) and Canada Research Chair Program (to DPM). MAS, JRC, NMLS, RLF,
   JHL, DB, FCR, TRB and FSN received fellowships from Brazilian agencies
   CAPES or CNPq. We thank Drs. Matthias Gralle and Jordano Brito-Moreira
   for performing A beta O injections in macaques, Drs. Brito-Moreira and
   Adriano Sebollela for chromatographic characterization of oligomer
   preparations, Dr. Leonardo M. Saraiva for help with hypothalamic
   neuronal cultures and ROS assays, Maira S. Oliveira, Mariangela M.
   Viana, Sandra Bambrilla and Dioze Guadagnini for technical support,
   Prof. Carla Tasca (Federal University of Santa Catarina) for the
   hippocampal sections used as positive controls in Fluorojade staining
   experiments and Ana Claudia Rangel for secretarial and accounting
   support.
CR Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Chhatwal JP, 2012, J ALZHEIMERS DIS, V31, pS155, DOI 10.3233/JAD-2012-120730
   Costa RO, 2012, AGING CELL, V11, P823, DOI 10.1111/j.1474-9726.2012.00848.x
   CRAFT S, 1992, J CLIN EXP NEUROPSYC, V14, P253, DOI 10.1080/01688639208402827
   Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Denis RG, 2010, NEUROSCIENCE, V170, P1035, DOI 10.1016/j.neuroscience.2010.08.013
   El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Frazao R, 2013, J NEUROSCI, V33, P2807, DOI 10.1523/JNEUROSCI.1610-12.2013
   Fronczek R, 2012, NEUROBIOL AGING, V33, P1642, DOI 10.1016/j.neurobiolaging.2011.03.014
   Gomes S, 2014, J NEUROENDOCRINOL, V26, P176, DOI 10.1111/jne.12138
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Hahn TM, 1998, NAT NEUROSCI, V1, P271
   Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002
   Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474
   Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807
   Jimenez-Palomares M, 2012, AM J PHYSIOL-ENDOC M, V302, pE1373, DOI 10.1152/ajpendo.00500.2011
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0
   Le Beyec J, 2014, INT J OBESITY, V38, P1357, DOI 10.1038/ijo.2014.14
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194
   Loskutova N, 2010, J ALZHEIMERS DIS, V20, P313, DOI 10.3233/JAD-2010-1364
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   OGOMORI K, 1989, AM J PATHOL, V134, P243
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108
   Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874
   Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465
   Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958
   Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002
   Schwartz MW, 2000, NATURE, V404, P661
   Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Shi JQ, 2011, J AM GERIATR SOC, V59, P1142, DOI 10.1111/j.1532-5415.2011.03445.x
   Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053
   Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130
   STANDAERT DG, 1991, AM J PATHOL, V139, P681
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Thaler JP, 2013, DIABETES, V62, P2629, DOI 10.2337/db12-1605
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043
   Zhang Y, 2012, DIABETES, V61, P1434, DOI 10.2337/db11-0499
   Zhang YongJie, 2012, Mycology - An International Journal on Fungal Biology, V3, P2
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021
NR 84
TC 107
Z9 109
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD FEB
PY 2015
VL 7
IS 2
BP 190
EP 210
DI 10.15252/emmm.201404183
PG 21
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CD0MG
UT WOS:000350767300006
PM 25617315
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Ostapchenko, VG
   Beraldo, FH
   Mohammad, AH
   Xie, YF
   Hirata, PHF
   Magalhaes, AC
   Lamour, G
   Li, HB
   Maciejewski, A
   Belrose, JC
   Teixeira, BL
   Fahnestock, M
   Ferreira, ST
   Cashman, NR
   Hajj, GNM
   Jackson, MF
   Choy, WY
   MacDonald, JF
   Martins, VR
   Prado, VF
   Prado, MAM
AF Ostapchenko, Valeriy G.
   Beraldo, Flavio H.
   Mohammad, Amro H.
   Xie, Yu-Feng
   Hirata, Pedro H. F.
   Magalhaes, Ana C.
   Lamour, Guillaume
   Li, Hongbin
   Maciejewski, Andrzej
   Belrose, Jullian C.
   Teixeira, Bianca L.
   Fahnestock, Margaret
   Ferreira, Sergio T.
   Cashman, Neil R.
   Hajj, Glaucia N. M.
   Jackson, Michael F.
   Choy, Wing-Yiu
   MacDonald, John F.
   Martins, Vilma R.
   Prado, Vania F.
   Prado, Marco A. M.
TI The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates
   Amyloid-beta Oligomer Toxicity (October, 16552, 2013)
SO JOURNAL OF NEUROSCIENCE
LA English
DT Correction
RI Lamour, Guillaume/D-6758-2015; Prado, Marco Antonio Maximo/K-7638-2013;
   Ferreira, Sergio/AAZ-1576-2020; Choy, Wing-Yiu/O-7608-2017; Teixeira,
   Bianca Luise/AAM-5328-2020; Prado, Vania/K-7630-2013
OI Lamour, Guillaume/0000-0002-9331-5532; Prado, Marco Antonio
   Maximo/0000-0002-3028-5778; Ferreira, Sergio/0000-0001-7160-9866; Choy,
   Wing-Yiu/0000-0002-2124-7278; Prado, Vania/0000-0003-4994-6393
CR OSTAPCHENKO VG, 2013, J NEUROSCIENCE   OCT, P16552
NR 1
TC 0
Z9 0
U1 0
U2 8
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JAN 28
PY 2015
VL 35
IS 4
BP 1816
EP 1816
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA CB5LU
UT WOS:000349669600044
DA 2020-09-29
ER

PT J
AU Forny-Germano, L
   Silva, NMLE
   Batista, AF
   Brito-Moreira, J
   Gralle, M
   Boehnke, SE
   Coe, BC
   Lablans, A
   Marques, SA
   Martinez, AMB
   Klein, WL
   Houzel, JC
   Ferreira, ST
   Munoz, DP
   De Felice, FG
AF Forny-Germano, Leticia
   Lyra e Silva, Natalia M.
   Batista, Andre F.
   Brito-Moreira, Jordano
   Gralle, Matthias
   Boehnke, Susan E.
   Coe, Brian C.
   Lablans, Ann
   Marques, Suelen A.
   Martinez, Ana Maria B.
   Klein, William L.
   Houzel, Jean-Christophe
   Ferreira, Sergio T.
   Munoz, Douglas P.
   De Felice, Fernanda G.
TI Alzheimer's Disease-Like Pathology Induced by Amyloid-beta Oligomers in
   Nonhuman Primates
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE Alzheimer's disease; amyloid-beta oligomers; nonhuman primate; synapse
   loss; tau pathology
ID PAIRED HELICAL FILAMENTS; TRIPLE-TRANSGENIC MODEL; A-BETA;
   TAU-PATHOLOGY; COGNITIVE IMPAIRMENT; SYNAPTIC DYSFUNCTION; MEMORY
   IMPAIRMENT; TANGLE FORMATION; MOLECULAR-BASIS; TRUNCATED TAU
AB Alzheimer's disease (AD) is a devastating neurodegenerative disorder and a major medical problem. Here, we have investigated the impact of amyloid-beta (A beta) oligomers, AD-related neurotoxins, in the brains of rats and adult nonhuman primates (cynomolgus macaques). Soluble A beta oligomers are known to accumulate in the brains of AD patients and correlate with disease-associated cognitive dysfunction. When injected into the lateral ventricle of rats and macaques, A beta oligomers diffused into the brain and accumulated in several regions associated with memory and cognitive functions. Cardinal features of AD pathology, including synapse loss, tau hyper-phosphorylation, astrocyte and microglial activation, were observed in regions of the macaque brain where A beta oligomers were abundantly detected. Most importantly, oligomer injections induced AD-type neurofibrillary tangle formation in the macaque brain. These outcomes were specifically associated with A beta oligomers, as fibrillar amyloid deposits were not detected in oligomer-injected brains. Human and macaque brains share significant similarities in terms of overall architecture and functional networks. Thus, generation of a macaque model of AD that links A beta oligomers to tau and synaptic pathology has the potential to greatly advance our understanding of mechanisms centrally implicated in AD pathogenesis. Furthermore, development of disease-modifying therapeutics for AD has been hampered by the difficulty in translating therapies that work in rodents to humans. This new approach may be a highly relevant nonhuman primate model for testing therapeutic interventions for AD.
C1 [Forny-Germano, Leticia; Lyra e Silva, Natalia M.; Batista, Andre F.; Brito-Moreira, Jordano; Gralle, Matthias; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Forny-Germano, Leticia; Martinez, Ana Maria B.; Houzel, Jean-Christophe] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Boehnke, Susan E.; Coe, Brian C.; Lablans, Ann; Munoz, Douglas P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
   [Marques, Suelen A.] Univ Fed Fluminense, Inst Biol, Dept Neurobiol, BR-24020140 Niteroi, RJ, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, CCS, Inst Med Biochem, Room H2-019, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM doug.munoz@queensu.ca; felice@bioqmed.ufrj.br
RI Gralle, Matthias/B-9005-2014; MARTINEZ, Ana/AAE-8358-2019;
   Forny-Germano, Leticia/L-6639-2019; Houzel, Jean Christophe/M-7936-2019;
   Forny-Germano, Leticia/D-1342-2017; Ferreira, Sergio/AAZ-1576-2020;
   Boehnke, Susan/P-4952-2019; Houzel, Jean Christophe/G-3723-2010
OI Forny-Germano, Leticia/0000-0001-8301-0711; Houzel, Jean
   Christophe/0000-0001-5128-438X; Forny-Germano,
   Leticia/0000-0001-8301-0711; Ferreira, Sergio/0000-0001-7160-9866;
   Houzel, Jean Christophe/0000-0001-5128-438X; Coe,
   Brian/0000-0002-3985-0163; Boehnke, Susan/0000-0002-0726-6659
FU Human Frontiers Science ProgramHuman Frontier Science Program; John
   Simon Guggenheim Memorial Foundation; National Institute for
   Translational Neuroscience (Brazil); Brazilian funding agencies
   ConselhoNacional de DesenvolvimentoCientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Canadian Institutes for Health
   ResearchCanadian Institutes of Health Research (CIHR) [MOP-38854];
   Canada Research Chair ProgramCanada Research Chairs; CNPq predoctoral
   fellowships; FAPERJ/Coordenacaode Aperfeicoamentode Pessoal de Nivel
   Superior
FX This work was supported by grants from Human Frontiers Science Program
   and the John Simon Guggenheim Memorial Foundation (to FGF), National
   Institute for Translational Neuroscience (Brazil; to S.T.F. and
   F.G.D.F.), the Brazilian funding agencies ConselhoNacional de
   DesenvolvimentoCientifico e Tecnologico (CNPq) and Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ; to S.T.F. and F.G.D.F.),
   Canadian Institutes for Health Research (Grant MOP-38854 to D.P.M. and
   F.G.D.F.) and Canada Research Chair Program (D.P.M.). NLS and AFB are
   supported by CNPq predoctoral fellowships. J.B.M. was supported by a
   CNPq predoctoral fellowship. LFG is supported by a postdoctoral
   fellowship from FAPERJ/Coordenacaode Aperfeicoamentode Pessoalde Nivel
   Superior. We thank Edil Saturato da Silva Filho, and Dr. Claudia P.
   Figueiredo (Federal University of Rio de Janeiro, Brazil) for technical
   advice on macaque brain processing and advice on immunohistochemical
   analysis, respectively. The following anti-tau antibodies were a
   generous gift from Dr Peter Davies (Albert Einstein College of Medicine,
   Bronx, NY): ALZ-50, MC-1, CP13, and PHF-1.
CR Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379
   BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X
   Chabrier MA, 2012, J NEUROSCI, V32, P17345, DOI 10.1523/JNEUROSCI.0172-12.2012
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013
   Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841
   CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4
   DaRocha-Souto B, 2011, J NEUROPATH EXP NEUR, V70, P360, DOI 10.1097/NEN.0b013e318217a118
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   Dolgin E, 2012, NAT MED, V18, P1003, DOI 10.1038/nm0712-1003
   Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Filipcik P, 2012, NEUROBIOL AGING, V33, P1448, DOI 10.1016/j.neurobiolaging.2010.10.015
   Finch CE, 2012, AGE, V34, P1075, DOI 10.1007/s11357-011-9355-9
   Fisher M, 2009, STROKE, V40, P1947, DOI 10.1161/STROKEAHA.109.548131
   Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827
   Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420
   Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1
   GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827
   Grinberg LT, 2009, NEUROPATH APPL NEURO, V35, P406, DOI [10.1111/j.1365-2990.2008.00997.x, 10.1111/j.1365-2990.2009.00997.x]
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Heuer E, 2012, CURR PHARM DESIGN, V18, P1159, DOI 10.2174/138161212799315885
   Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E
   Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108
   Kaas JH, 2013, AM J PRIMATOL, V75, P407, DOI 10.1002/ajp.22065
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009
   LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168
   LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Leung E, 2011, NEUROBIOL AGING, V32, P387, DOI 10.1016/j.neurobiolaging.2009.02.025
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Martin RF, 1996, NEUROIMAGE, V4, P119, DOI 10.1006/nimg.1996.0036
   Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452
   Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007
   Merrick SE, 1996, J BIOL CHEM, V271, P5589, DOI 10.1074/jbc.271.10.5589
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9
   Negash S, 2011, CURR ALZHEIMER RES, V8, P336, DOI 10.2174/156720511795745302
   Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504
   NOVAK M, 1994, ACTA VIROL, V38, P173
   NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012
   Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x
   Oikawa N, 2010, BRAIN RES, V1315, P137, DOI 10.1016/j.brainres.2009.12.005
   Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009
   Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974
   PAXINOS G, 1997, RAT BRAIN STEREOTAXI
   Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171
   Philip M, 2009, STROKE, V40, P577, DOI 10.1161/STROKEAHA.108.524330
   PODLISNY MB, 1991, AM J PATHOL, V138, P1423
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005
   Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640
   Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f
   Schultz C, 2000, NEUROBIOL AGING, V21, P905, DOI 10.1016/S0197-4580(00)00176-7
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014
   Serrano-Pozo A, 2011, AM J PATHOL, V179, P1373, DOI 10.1016/j.ajpath.2011.05.047
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737
   Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033
   Thal DR, 2008, J CELL MOL MED, V12, P1848, DOI 10.1111/j.1582-4934.2008.00411.x
   Thorpe JR, 2001, J HISTOCHEM CYTOCHEM, V49, P97, DOI 10.1177/002215540104900110
   Toledano A, 2014, NEUROLOGIA, V29, P42, DOI 10.1016/j.nrl.2011.05.004
   Van Essen DC, 2013, NEURON, V80, P775, DOI 10.1016/j.neuron.2013.10.027
   Van Hoesen GW, 2000, CEREB CORTEX, V10, P243, DOI 10.1093/cercor/10.3.243
   WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506
   WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509
   Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010
   Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029
NR 85
TC 103
Z9 107
U1 0
U2 34
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD OCT 8
PY 2014
VL 34
IS 41
BP 13629
EP 13643
DI 10.1523/JNEUROSCI.1353-14.2014
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA AQ9DF
UT WOS:000343142100007
PM 25297091
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Ferreira, ST
AF De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction
   as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer
   Disease
SO DIABETES
LA English
DT Article
ID DEPENDENT PROTEIN-KINASE; BETA-AMYLOID OLIGOMERS; INTRANASAL INSULIN;
   MOUSE MODEL; OXIDATIVE STRESS; GLUCOSE-LEVELS; FAT INTAKE; INCIDENT
   DEMENTIA; IMPAIRED INSULIN; RISK-FACTORS
AB A growing body of evidence supports an intriguing clinical/epidemiological connection between Alzheimer disease (AD) and type 2 diabetes (T2D). T2D patients have significantly increased risk of developing AD and vice versa. Recent studies have begun to reveal common pathogenic mechanisms shared by AD and metabolic disorders, notably obesity and T2D. In T2D and obesity, low-grade chronic inflammation is a key mechanism leading to peripheral insulin resistance, which progressively causes tissue deterioration and overall health decline. In the brain, proinflammatory signaling was recently found to mediate impaired neuronal insulin signaling, synapse deterioration, and memory loss. Here, we review evidence indicating that inflammation, insulin resistance, and mitochondrial dysfunction are common features in AD and T2D. We further propose the hypothesis that dementia and its underlying neuronal dysfunction are exacerbated or driven by peripheral inflammation. Identification of central and peripheral inflammation as potential mediators of brain dysfunction in AD may lead to the development of effective treatments for this devastating disease.
C1 [De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU Human Frontiers Science ProgramHuman Frontier Science Program; National
   Institute for Translational Neuroscience (Brazil); Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX Work in the authors' laboratory was supported by grants from the Human
   Frontiers Science Program (to F. G. D. F.), the National Institute for
   Translational Neuroscience (Brazil) (to S. T. F.), and the Brazilian
   funding agencies Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico and Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (to F. G. D. F. and S.T.F.).
CR Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035
   Acharya NK, 2013, J ALZHEIMERS DIS, V35, P179, DOI 10.3233/JAD-122254
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659
   Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225
   Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684
   Benedict C, 2012, DIABETES CARE, V35, P488, DOI 10.2337/dc11-2075
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x
   Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723
   Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571
   Bjorklund NL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-23
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Calay ES, 2013, NAT MED, V19, P265, DOI 10.1038/nm.3114
   Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x
   Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727
   De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Eskelinen MH, 2008, INT J GERIATR PSYCH, V23, P741, DOI 10.1002/gps.1969
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288
   Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8
   Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359
   Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103
   GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7
   Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027
   Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Haj-ali V, 2009, BEHAV NEUROSCI, V123, P1309, DOI 10.1037/a0017722
   Hassing LB, 2009, INT J OBESITY, V33, P893, DOI 10.1038/ijo.2009.104
   Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje
   Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   International Diabetes Federation, 2013, IDF DIABETES ATLAS
   Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514
   Kerti L, 2013, NEUROLOGY, V81, P1746, DOI 10.1212/01.wnl.0000435561.00234.ee
   Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001
   Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836
   Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f
   Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012
   Mattson MP, 2003, NAT MED, V9, P1113, DOI 10.1038/nm0903-1113
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Negash S, 2011, CURR ALZHEIMER RES, V8, P336, DOI 10.2174/156720511795745302
   Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Pandini G, 2013, ENDOCRINOLOGY, V154, P375, DOI 10.1210/en.2012-1661
   Patrone C, 2014, LANCET DIABETES ENDO, V2, P256, DOI 10.1016/S2213-8587(13)70125-6
   Paz G, 2010, INT J CLIN PRACT, V64, P1808, DOI 10.1111/j.1742-1241.2010.02536.x
   Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018
   Perez-Gonzalez R, 2011, J ALZHEIMERS DIS, V24, P17, DOI 10.3233/JAD-2011-102070
   Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17
   Peters SAE, 2014, LANCET
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Picone P, 2011, AGING CELL, V10, P832, DOI 10.1111/j.1474-9726.2011.00724.x
   Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008
   Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070
   Salvioli S, 2006, CURR PHARM DESIGN, V12, P3161, DOI 10.2174/138161206777947470
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101
   Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344
   Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Smith QR, 2001, J MOL NEUROSCI, V16, P167, DOI 10.1385/JMN:16:2-3:167
   Sonnen JA, 2009, ARCH NEUROL-CHICAGO, V66, P315, DOI 10.1001/archneurol.2008.579
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906
   Takeda S, 2013, NEUROBIOL AGING, V34, P2064, DOI 10.1016/j.neurobiolaging.2013.02.010
   Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003
   THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993
   Une K, 2011, EUR J NEUROL, V18, P1006, DOI 10.1111/j.1468-1331.2010.03194.x
   Velloso LA, 2011, INT J OBESITY, V35, P1455, DOI 10.1038/ijo.2011.56
   Vilsboll T, 2003, REGUL PEPTIDES, V114, P115, DOI 10.1016/S0167-0115(03)00111-3
   Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29
   Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792
   White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705
   Yang Y, 2013, J ALZHEIMERS DIS, V33, P329, DOI 10.3233/JAD-2012-121294
   Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1
   Yin F, 2013, BIOCHEM SOC T, V41, P101, DOI 10.1042/BST20120260
   Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001
   Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5
NR 133
TC 286
Z9 290
U1 1
U2 76
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD JUL
PY 2014
VL 63
IS 7
BP 2262
EP 2272
DI 10.2337/db13-1954
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AJ7YO
UT WOS:000337918200017
PM 24931033
OA Other Gold
DA 2020-09-29
ER

PT J
AU Blair, JA
   Siedlak, SL
   Wolfram, JA
   Nunomura, A
   Castellani, RJ
   Ferreira, ST
   Klein, WL
   Wang, Y
   Casadesus, G
   Smith, MA
   Perry, G
   Zhu, XW
   Lee, HG
AF Blair, Jeffrey A.
   Siedlak, Sandra L.
   Wolfram, Julie A.
   Nunomura, Akihiko
   Castellani, Rudy J.
   Ferreira, Sergio T.
   Klein, William L.
   Wang, Yang
   Casadesus, Gemma
   Smith, Mark A.
   Perry, George
   Zhu, Xiongwei
   Lee, Hyoung-gon
TI Accumulation of Intraneuronal Amyloid-beta is Common in Normal Brain
SO CURRENT ALZHEIMER RESEARCH
LA English
DT Article
DE Aging; Alzheimer disease; amyloid-beta; amyloid-beta protein precursor;
   immunohistochemistry; neuropathology
ID A-BETA; ALZHEIMERS-DISEASE; SYNAPTIC DYSFUNCTION; NEURON LOSS;
   PREDICTOR; TRANSPORT; PROTEIN; TARGET; MODEL; APP
AB Intraneuronal amyloid-beta (iA beta) accumulation has been demonstrated in Alzheimer disease (AD). Although extracellular amyloid plaques composed primarily of aggregated amyloid-beta are one of the main pathological features of AD, functional characterization of iA beta is still lacking. In this study, we identified the normal distribution of iA beta through an analysis of hippocampal sections from a series of over 90 subjects with diverse antemortem clinical findings. In addition to AD cases, iA beta in pyramidal neurons was readily and reproducibly demonstrated in the majority of control cases. Similar findings for controls were made across all ages, spanning from infants to the elderly. There was no correlation of iA beta between gender, postmortem interval, or age. While the possible pathophysiological significance of iA beta accumulation in AD remains to be elucidated, careful examination of iA beta found in the normal brain may be informative for determining the biological role of iA beta and how this function changes during disease. Current findings support a physiological role for iA beta in neuronal function over the entire lifespan.
C1 [Blair, Jeffrey A.; Siedlak, Sandra L.; Wolfram, Julie A.; Wang, Yang; Smith, Mark A.; Zhu, Xiongwei; Lee, Hyoung-gon] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Blair, Jeffrey A.; Casadesus, Gemma] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Nunomura, Akihiko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neuropsychiat, Chuo Ku, Kofu, Yamanashi, Japan.
   [Castellani, Rudy J.] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA.
   [Perry, George] Univ Texas San Antonio, Coll Sci, San Antonio, TX USA.
RP Lee, HG (corresponding author), Case Western Reserve Univ, Dept Pathol, 2103 Cornell Rd, Cleveland, OH 44106 USA.
EM hyoung-gon.lee@case.edu
RI Perry, George/A-8611-2009; Ferreira, Sergio/AAZ-1576-2020
OI Perry, George/0000-0002-6547-0172; Ferreira, Sergio/0000-0001-7160-9866;
   Casadesus, Gemma/0000-0002-5206-5637
FU Alzheimer's AssociationAlzheimer's Association [IIRG-11-205527]
FX Human tissue was obtained from the NICHD Brain and Tissue Bank for
   Developmental Disorders at the University of Maryland, Baltimore, MD,
   contact HHSN2752 00900011C, Ref. No. N01-H0-9-0011. Work in the authors'
   laboratories was funded by the Alzheimer's Association (IIRG-11-205527).
CR Achim CL, 2009, J NEUROIMMUNE PHARM, V4, P190, DOI 10.1007/s11481-009-9152-8
   Aho L, 2010, J ALZHEIMERS DIS, V20, P1015, DOI 10.3233/JAD-2010-091681
   Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008
   Christensen DZ, 2010, ACTA NEUROPATHOL, V119, P555, DOI 10.1007/s00401-010-0666-1
   Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2
   Ginsberg SD, 1999, J NEUROPATH EXP NEUR, V58, P815, DOI 10.1097/00005072-199908000-00004
   Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1
   Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Ohyagi Y, 2008, CURR ALZHEIMER RES, V5, P555, DOI 10.2174/156720508786898514
   Ohyagi Y, 2007, J NEUROSCI METH, V159, P134, DOI 10.1016/j.jneumeth.2006.06.010
   Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106
   Smith MA, 1998, INT REV NEUROBIOL, V42, P1, DOI 10.1016/S0074-7742(08)60607-8
   Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009
   Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4
   Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011
NR 18
TC 13
Z9 13
U1 1
U2 11
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2050
EI 1875-5828
J9 CURR ALZHEIMER RES
JI Curr. Alzheimer Res.
PD MAY
PY 2014
VL 11
IS 4
BP 317
EP 324
DI 10.2174/1567205011666140302200902
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AF8ZN
UT WOS:000335004600002
PM 24597504
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Lourenco, MV
   Ferreira, ST
AF De Felice, Fernanda G.
   Lourenco, Mychael V.
   Ferreira, Sergio T.
TI How does brain insulin resistance develop in Alzheimer's disease?
SO ALZHEIMERS & DEMENTIA
LA English
DT Article
DE Alzheimer's disease; Amyloid-beta oligomers; Insulin resistance; Insulin
   therapy; GLP-IR agonists
ID CENTRAL-NERVOUS-SYSTEM; DIABETES-MELLITUS; COGNITIVE IMPAIRMENT;
   RECEPTOR SUBSTRATE; GLUCOSE-METABOLISM; PROTEIN OLIGOMERS; MEMORY;
   PATHOLOGY; MECHANISMS; EXPRESSION
AB Compelling preclinical and clinical evidence supports a pathophysiological connection between Alzheimer's disease (AD) and diabetes. Altered metabolism, inflammation, and insulin resistance are key pathological features of both diseases. For many years, it was generally considered that the brain was insensitive to insulin, but it is now accepted that this hormone has central neuromodulatory functions, including roles in learning and memory, that are impaired in AD. However, until recently, the molecular mechanisms accounting for brain insulin resistance in AD have remained elusive. Here, we review recent evidence that sheds light on how brain insulin dysfunction is initiated at a molecular level and why abnormal insulin signaling culminates in synaptic failure and memory decline. We also discuss the cellular basis underlying the beneficial effects of stimulation of brain insulin signaling on cognition. Discoveries summarized here provide pathophysiological background for identification of novel molecular targets and for development of alternative therapeutic approaches in AD. (C) 2014 The Alzheimer's Association. All rights reserved.
C1 [De Felice, Fernanda G.; Lourenco, Mychael V.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Lourenco, Mychael/AAG-9732-2020;
   Lourenco, Mychael/G-2614-2014
OI Ferreira, Sergio/0000-0001-7160-9866; Lourenco,
   Mychael/0000-0002-1078-0296; Lourenco, Mychael/0000-0002-1078-0296
FU Human Frontiers Science ProgramHuman Frontier Science Program; National
   Institute for Translational Neuroscience (INNT/Brazil); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX This work was supported by grants from the Human Frontiers Science
   Program (to FGF), National Institute for Translational Neuroscience
   (INNT/Brazil; to STF), and the Brazilian funding agencies Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (to FGF and STF). MVL
   is supported by a CNPq predoctoral fellowship.
CR Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035
   Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x
   Al-Mubarak B, 2009, CHANNELS, V3, P233
   Apostolatos A, 2012, J BIOL CHEM, V287, P9299, DOI 10.1074/jbc.M111.313080
   Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225
   Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009
   Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869
   Craft S, SNIFF STUDY NASAL IN
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   EGEFJORD L, 2012, DAN MED J, V59, P1
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Freiherr J., 2013, CNS DRUGS IN PRESS
   Ghasemi R, 2013, MOL NEUROBIOL, V47, P1045, DOI 10.1007/s12035-013-8404-z
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Haj-ali V, 2009, BEHAV NEUROSCI, V123, P1309, DOI 10.1037/a0017722
   Han W-N., 2012, NEUROBIOL AGING
   Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hoyer S, 1996, ANN NY ACAD SCI, V777, P374, DOI 10.1111/j.1749-6632.1996.tb34448.x
   Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33
   Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005
   Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2012, MOL PSYCHIA IN PRESS
   Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003
   Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014
   Lee YH, 2004, ARCH PHARM RES, V27, P361, DOI 10.1007/BF02980074
   Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Manolopoulos KN, 2010, MOL PSYCHIATR, V15, P1046, DOI 10.1038/mp.2010.17
   MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464
   Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005
   Mochizuki A, 1996, EXP NEUROL, V142, P89, DOI 10.1006/exnr.1996.0181
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Okereke OI, 2008, J AM GERIATR SOC, V56, P1028, DOI 10.1111/j.1532-5415.2008.01686.x
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Riederer P, 2011, NEUROTOX RES, V19, P253, DOI 10.1007/s12640-010-9203-1
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Schioth HB, 2011, MOL NEUROHI IN PRESS
   Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Son S. M., 2012, DIABETES IN PRESS
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200
   van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003
   van Es MA, 2009, NAT GENET, V41, P1047, DOI 10.1038/ng1009-1047
   Vilsboll T, 2003, REGUL PEPTIDES, V114, P115, DOI 10.1016/S0167-0115(03)00111-3
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wang X, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-46
   White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952
   Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4
   Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565
   Yamamoto N, 2012, J NEUROCHEM, V121, P619, DOI 10.1111/j.1471-4159.2012.07668.x
   Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001
   Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015
   Zhao WC, 2010, NEUROSIGNALS, V18, P236, DOI 10.1159/000324040
   Zheng WH, 2009, J BIOL CHEM, V284, P855, DOI 10.1074/jbc.M807914200
NR 90
TC 174
Z9 178
U1 3
U2 43
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1552-5260
EI 1552-5279
J9 ALZHEIMERS DEMENT
JI Alzheimers. Dement.
PD FEB
PY 2014
VL 10
SU 1
BP S26
EP S32
DI 10.1016/j.jalz.2013.12.004
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA CN6OW
UT WOS:000358555100004
PM 24529521
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   Clarke, JR
   Bomfim, TR
   De Felice, FG
AF Ferreira, Sergio T.
   Clarke, Julia R.
   Bomfim, Theresa R.
   De Felice, Fernanda G.
TI Inflammation, defective insulin signaling, and neuronal dysfunction in
   Alzheimer's disease
SO ALZHEIMERS & DEMENTIA
LA English
DT Article
DE Inflammation; Alzheimer's disease; Diabetes; Obesity; Insulin signaling;
   Aging
ID NECROSIS-FACTOR-ALPHA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS;
   ENDOPLASMIC-RETICULUM STRESS; TRANSGENIC MOUSE MODEL; ADIPOSE-TISSUE;
   TNF-ALPHA; PERISPINAL ETANERCEPT; COGNITIVE IMPROVEMENT; RECEPTOR
   SUBSTRATE-1; AMYLOID DEPOSITION
AB A link between Alzheimer's disease (AD) and metabolic disorders has been established, with patients with type 2 diabetes at increased risk of developing AD and vice versa. The incidence of metabolic disorders, including insulin resistance and type 2 diabetes is increasing at alarming rates worldwide, primarily as a result of poor lifestyle habits. In parallel, as the world population ages, the prevalence of AD, the most common form of dementia in the elderly, also increases. In addition to their epidemiologic and clinical association, mounting recent evidence indicates shared mechanisms of pathogenesis between metabolic disorders and AD. We discuss the concept that peripheral and central nervous system inflammation link the pathogenesis of AD and metabolic diseases. We also explore the contribution of brain inflammation to defective insulin signaling and neuronal dysfunction. Last, we review recent evidence indicating that targeting neuroinflammation may provide novel therapeutic avenues for AD. (C) 2014 The Alzheimer's Association. All rights reserved.
C1 [Ferreira, Sergio T.; Clarke, Julia R.; Bomfim, Theresa R.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Clarke, Julia/AAF-9434-2019; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU National Institute for Translational Neuroscience (INNT/Brazil); Human
   Frontiers Science ProgramHuman Frontier Science Program; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); CNPqNational Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino
   SuperiorCAPES
FX Work in our laboratory was supported by grants from the National
   Institute for Translational Neuroscience (INNT/Brazil) (STF), the Human
   Frontiers Science Program (FGF), and the Brazilian funding agencies
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (FGF,
   STF, and JRC). TRB is supported by a CNPq predoctoral fellowship and JRC
   is recipient of a postdoctoral fellowship from Coordenacao de
   Aperfeicoamento de Pessoal de Ensino Superior.
CR Acharya NK, 2013, J ALZHEIMERS DIS, V35, P179, DOI 10.3233/JAD-122254
   Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901
   Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8
   Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819
   Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050
   Arvanitakis Z, 2008, NEUROLOGY, V70, P2219, DOI 10.1212/01.wnl.0000313813.48505.86
   Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012
   Baggio G, 1998, FASEB J, V12, P433
   Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684
   Bate C, 2003, NEUROREPORT, V14, P2099, DOI 10.1097/00001756-200311140-00018
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Bikman BT, 2012, CELL MOL LIFE SCI, V69, P2135, DOI 10.1007/s00018-012-0917-5
   Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000
   Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691
   Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Calay ES, 2013, NAT MED, V19, P265, DOI 10.1038/nm.3114
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850
   Combs CK, 2009, J NEUROIMMUNE PHARM, V4, P380, DOI 10.1007/s11481-009-9165-3
   Costello DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031124
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740
   Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798
   Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99
   Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200
   Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292
   Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7
   Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026
   Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866
   Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178
   Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23
   Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200
   KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780
   Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7
   Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620
   Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008
   Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4
   Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045
   Li YK, 2003, J NEUROSCI, V23, P1605
   Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012
   MCGEER PL, 1992, NEUROLOGY, V42, P447, DOI 10.1212/WNL.42.2.447
   McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425
   Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010
   Pasqualetti P, 2009, AGING CLIN EXP RES, V21, P102, DOI 10.1007/BF03325217
   Paz G, 2010, INT J CLIN PRACT, V64, P1808, DOI 10.1111/j.1742-1241.2010.02536.x
   Perez-Gonzalez R, 2011, J ALZHEIMERS DIS, V24, P17, DOI 10.3233/JAD-2011-102070
   Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17
   Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002
   Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082
   Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66
   Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070
   Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934
   Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975
   Ryu JK, 2008, NEUROBIOL DIS, V29, P254, DOI 10.1016/j.nbd.2007.08.019
   Salvioli S, 2006, CURR PHARM DESIGN, V12, P3161, DOI 10.2174/138161206777947470
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Samad F, 1999, P NATL ACAD SCI USA, V96, P6902, DOI 10.1073/pnas.96.12.6902
   Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197
   Shi JQ, 2011, J AM GERIATR SOC, V59, P1142, DOI 10.1111/j.1532-5415.2011.03445.x
   Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053
   Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460
   Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130
   Smith QR, 2001, J MOL NEUROSCI, V16, P167, DOI 10.1385/JMN:16:2-3:167
   Sonnen JA, 2009, ARCH NEUROL-CHICAGO, V66, P315, DOI 10.1001/archneurol.2008.579
   Sourris KC, 2009, DIABETES, V58, P1259, DOI 10.2337/db08-1725
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48
   Szekely CA, 2010, CNS NEUROL DISORD-DR, V9, P132, DOI 10.2174/187152710791012026
   Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906
   Takeda S, 2013, NEUROBIOL AGING, V34, P2064, DOI 10.1016/j.neurobiolaging.2013.02.010
   THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993
   Tobar N, 2011, ENDOCRINOLOGY, V152, P4080, DOI 10.1210/en.2011-0249
   Tobinick E, 2007, CURR ALZHEIMER RES, V4, P550, DOI 10.2174/156720507783018217
   Tobinick Edward, 2006, MedGenMed, V8, P25
   Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2
   Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873
   Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106
   Une K, 2011, EUR J NEUROL, V18, P1006, DOI 10.1111/j.1468-1331.2010.03194.x
   van Himbergen TM, 2012, ARCH NEUROL-CHICAGO, V69, P594, DOI 10.1001/archneurol.2011.670
   Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29
   Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428
   Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591
   White MF, 1998, CURR TOP MICROBIOL, V228, P179
   White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001
   Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yan Q, 2003, J NEUROSCI, V23, P7504
   Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008
   Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1
   Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620
   Zandi PP, 2002, NEUROLOGY, V59, P880, DOI 10.1212/WNL.59.6.880
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045
   Zhu XX, 2003, J MED CHEM, V46, P5222, DOI 10.1021/jm030152f
NR 123
TC 170
Z9 179
U1 1
U2 45
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1552-5260
EI 1552-5279
J9 ALZHEIMERS DEMENT
JI Alzheimers. Dement.
PD FEB
PY 2014
VL 10
SU 1
BP S76
EP S83
DI 10.1016/j.jalz.2013.12.010
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA CN6OW
UT WOS:000358555100010
PM 24529528
DA 2020-09-29
ER

PT J
AU Lourenco, MV
   Clarke, JR
   Frozza, RL
   Bomfim, TR
   Forny-Germano, L
   Batista, AF
   Sathler, LB
   Brito-Moreira, J
   Amaral, OB
   Silva, CA
   Freitas-Correa, L
   Espirito-Santo, S
   Campello-Costa, P
   Houzel, JC
   Klein, WL
   Holscher, C
   Carvalheira, JB
   Silva, AM
   Velloso, LA
   Munoz, DP
   Ferreira, ST
   De Felice, FG
AF Lourenco, Mychael V.
   Clarke, Julia R.
   Frozza, Rudimar L.
   Bomfim, Theresa R.
   Forny-Germano, Leticia
   Batista, Andre F.
   Sathler, Luciana B.
   Brito-Moreira, Jordano
   Amaral, Olavo B.
   Silva, Cesar A.
   Freitas-Correa, Leo
   Espirito-Santo, Sheila
   Campello-Costa, Paula
   Houzel, Jean-Christophe
   Klein, William L.
   Holscher, Christian
   Carvalheira, Jose B.
   Silva, Aristobolo M.
   Velloso, Licio A.
   Munoz, Douglas P.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI TNF-alpha Mediates PKR-Dependent Memory Impairment and Brain IRS-1
   Inhibition Induced by Alzheimer's beta-Amyloid Oligomers in Mice and
   Monkeys
SO CELL METABOLISM
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TYROSINE
   KINASE-ACTIVITY; D-ASPARTATE RECEPTOR; INSULIN-RESISTANCE; COGNITIVE
   IMPAIRMENT; SYNAPTIC PLASTICITY; INTRANASAL INSULIN; MOUSE MODEL;
   MOLECULAR-BASIS
AB Alzheimer's disease (AD) and type 2 diabetes appear to share similar pathogenic mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin resistance in metabolic disorders. PKR phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2 alpha-P), and AD brains exhibit elevated phospho-PKR and eIF2 alpha-P levels. Whether and how PKR and eIF2 alpha-P participate in defective brain insulin signaling and cognitive impairment in AD are unknown. We report that beta-amyloid oligomers, AD-associated toxins, activate PKR in a tumor necrosis factor alpha (TNF-alpha)dependent manner, resulting in eIF2 alpha-P, neuronal insulin receptor substrate (IRS-1) inhibition, synapse loss, and memory impairment. Brain phospho-PKR and eIF2 alpha-P were elevated in AD animal models, including monkeys given intracerebroventricular oligomer infusions. Oligomers failed to trigger eIF2 alpha-P and cognitive impairment in PKR-/- and TNFR1(-/-) mice. Bolstering insulin signaling rescued phospho-PKR and eIF2 alpha-P. Results reveal pathogenic mechanisms shared by AD and diabetes and establish that proinflammatory signaling mediates oligomer-induced IRS-1 inhibition and PKR-dependent synapse and memory loss.
C1 [Lourenco, Mychael V.; Clarke, Julia R.; Frozza, Rudimar L.; Bomfim, Theresa R.; Forny-Germano, Leticia; Batista, Andre F.; Sathler, Luciana B.; Brito-Moreira, Jordano; Amaral, Olavo B.; Silva, Cesar A.; Freitas-Correa, Leo; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Houzel, Jean-Christophe] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Espirito-Santo, Sheila; Campello-Costa, Paula] Univ Fed Fluminense, Inst Biol, BR-24001970 Niteroi, RJ, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [Holscher, Christian] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England.
   [Carvalheira, Jose B.] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, BR-13084761 Campinas, SP, Brazil.
   [Silva, Aristobolo M.] Univ Fed Minas Gerais, Inst Biol Sci, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva, Aristobolo M.] Fiocruz MS, Rene Rachou Res Ctr, BR-30190002 Belo Horizonte, MG, Brazil.
   [Velloso, Licio A.] Univ Estadual Campinas, DCM FCM UNICAMP, Obes & Comorbid Res Ctr, Lab Cell Signalling, BR-13084761 Campinas, SP, Brazil.
   [Munoz, Douglas P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br; felice@bioqmed.ufrj.br
RI Campello-Costa, Paula/J-3251-2012; Lourenco, Mychael/G-2614-2014;
   Clarke, Julia/AAF-9434-2019; Forny-Germano, Leticia/L-6639-2019; Houzel,
   Jean Christophe/G-3723-2010; Forny-Germano, Leticia/D-1342-2017;
   Carvalheira, Jose B.C./E-8562-2013; Velloso, Licio/AAJ-3778-2020;
   Houzel, Jean Christophe/M-7936-2019; Lourenco, Mychael/AAG-9732-2020;
   Amaral, Olavo/B-2874-2009; Silva, Aristobolo AMS/F-7326-2016;
   Campello-Costa, Paula/V-7013-2019; Ferreira, Sergio/AAZ-1576-2020
OI Lourenco, Mychael/0000-0002-1078-0296; Forny-Germano,
   Leticia/0000-0001-8301-0711; Houzel, Jean
   Christophe/0000-0001-5128-438X; Forny-Germano,
   Leticia/0000-0001-8301-0711; Carvalheira, Jose B.C./0000-0002-0136-0943;
   Houzel, Jean Christophe/0000-0001-5128-438X; Lourenco,
   Mychael/0000-0002-1078-0296; Amaral, Olavo/0000-0002-4299-8978;
   Ferreira, Sergio/0000-0001-7160-9866; Campello-Costa,
   Paula/0000-0001-5086-4972; Holscher, Christian/0000-0002-8159-3260;
   Frozza, Rudimar Luiz/0000-0003-0918-4128
FU Human Frontiers Science Program (HFSP)Human Frontier Science Program;
   National Institute for Translational Neuroscience (INNT/Brazil);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Canadian Institutes for Health Research
   (CIHR)Canadian Institutes of Health Research (CIHR); Canada Research
   Chair ProgramCanada Research Chairs; CNPq predoctoral fellowships
FX This work was supported by grants from Human Frontiers Science Program
   (HFSP) (to F. G. D. F.), National Institute for Translational
   Neuroscience (INNT/Brazil), the Brazilian funding agencies Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to S. T. F.
   and F. G. D. F.), Canadian Institutes for Health Research (CIHR), and
   Canada Research Chair Program (to D. P. M.). M. V. L., L. B. S., L.
   F.-G., A. F. B., T. R. B., J.B.-M., and L. F.-C. were supported by CNPq
   predoctoral fellowships. We thank Drs. Matthias Gralle, Wagner Seixas,
   and Claudio A. Masuda (Federal University of Rio de Janeiro, Brazil) for
   insightful discussions and Dr. Claudia P. Figueiredo (Federal University
   of Rio de Janeiro, Brazil) for advice on immunohistochemical analysis of
   monkey brains. W. L. K. is a cofounder of Acumen Pharmaceuticals, which
   has been licensed by Northwestern University to develop ADDL technology
   for Alzheimer's therapeutics and diagnostics.
CR Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003
   Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003
   Birkenfeld AL, 2011, J BIOL CHEM, V286, P36163, DOI 10.1074/jbc.M111.228817
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850
   Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gkogkas C, 2010, J BIOL CHEM, V285, P31913, DOI 10.1074/jbc.R110.154476
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006
   Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Nistico R, 2012, NEUROMOL MED, V14, P262, DOI 10.1007/s12017-012-8184-z
   O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C
   Raven JF, 2008, CELL CYCLE, V7, P1146, DOI 10.4161/cc.7.9.5811
   Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016
   Ryan GJ, 2011, J CLIN PHARM THER, V36, P260, DOI 10.1111/j.1365-2710.2010.01180.x
   Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010
   van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x
   Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121
   Xu J, 2014, AGING CELL, V13, P19, DOI 10.1111/acel.12145
   Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029
NR 63
TC 193
Z9 196
U1 0
U2 37
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD DEC 3
PY 2013
VL 18
IS 6
BP 831
EP 843
DI 10.1016/j.cmet.2013.11.002
PG 13
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 265HJ
UT WOS:000327940800009
PM 24315369
OA Bronze
DA 2020-09-29
ER

PT J
AU Freitas-Correa, L
   Lourenco, MV
   Acquarone, M
   da Costa, RFM
   Galina, A
   Rehen, SK
   Ferreira, ST
AF Freitas-Correa, Leo
   Lourenco, Mychael V.
   Acquarone, Mariana
   Madeiro da Costa, Rodrigo F.
   Galina, Antonio
   Rehen, Stevens K.
   Ferreira, Sergio T.
TI 2,4-dinitrophenol induces neural differentiation of murine embryonic
   stem cells
SO STEM CELL RESEARCH
LA English
DT Article
ID A-BETA OLIGOMERIZATION; NEURONAL DIFFERENTIATION; ALZHEIMERS-DISEASE;
   NEURODEGENERATIVE DISEASES; APOPTOSIS; NEUROTOXICITY; PLURIPOTENCY;
   INDUCTION; THERAPIES; PATHWAY
AB 2,4-Dinitrophenol (DNP) is a neuroprotective compound previously shown to promote neuronal differentiation in a neuroblastoma cell line and neurite outgrowth in primary neurons. Here, we tested the hypothesis that DNP could induce neurogenesis in embryonic stem cells (ESCs). Murine ESCs, grown as embryoid bodies (EBs), were exposed to 20 mu M DNP (or vehicle) for 4 days. Significant increases in the proportion of nestin- and beta-tubulin III-positive cells were detected after EB exposure to DNP, accompanied by enhanced glial fibrillary acidic protein (GFAP), phosphorylated extracellular signal-regulated kinase (p-ERK) and ATP-linked oxygen consumption, thought to mediate DNP-induced neural differentiation. DNP further protected ESCs from cell death, as indicated by reduced caspase-3 positive cells, and increased proliferation. Cell migration from EBs was significantly higher in DNP-treated EBs, and migrating cells were positive for nestin, beta-tubulin III and MAP2, similar to that observed with retinoic acid (RA)-treated EBs. Compared to RA, however, DNP exerted a marked neuritogenic effect on differentiating ESCs, increasing the average length and number of neurites per cell. Results establish that DNP induces neural differentiation of ESCs, accompanied by cell proliferation, migration and neuritogenesis, suggesting that DNP may be a novel tool to induce neurogenesis in embryonic stem cells. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Freitas-Correa, Leo; Lourenco, Mychael V.; Galina, Antonio; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Acquarone, Mariana; Madeiro da Costa, Rodrigo F.; Rehen, Stevens K.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Rehen, SK (corresponding author), Univ Fed Rio de Janeiro, Natl Lab Embryon Stem Cells, Univ Hosp HUCFF, CEPEDIP, Rua Rodolpho Paulo Rocco,255-4th Floor, BR-21941913 Rio De Janeiro, RJ, Brazil.
EM srehen@lance-ufrj.org; ferreira@bioqmed.ufrj.br
RI Madeiro, Rodrigo/M-6433-2017; Ferreira, Sergio/AAZ-1576-2020; Lourenco,
   Mychael/AAG-9732-2020; Rehen, Stevens K/J-5874-2012; Lourenco,
   Mychael/G-2614-2014; Acquarone, Mariana/D-8862-2015
OI Madeiro, Rodrigo/0000-0001-5646-8858; Ferreira,
   Sergio/0000-0001-7160-9866; Lourenco, Mychael/0000-0002-1078-0296;
   Rehen, Stevens K/0000-0003-4216-9501; Lourenco,
   Mychael/0000-0002-1078-0296; Acquarone, Mariana/0000-0002-7477-6018
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); National Institute of Translational
   Neuroscience (INNT)
FX This work was supported by grants from Brazilian agencies Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to STF and
   SKR) and National Institute of Translational Neuroscience (INNT) (to
   STF).
CR Abramoff M, 2004, BIOPHOTON INT, P1
   Akanuma Hiromi, 2012, Frontiers in Genetics, V3, P141, DOI 10.3389/fgene.2012.00141
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272
   Bull ND, 2011, STEM CELLS, V29, P1170, DOI 10.1002/stem.676
   Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8
   De Felice FG, 2007, CURR ALZHEIMER RES, V4, P263
   De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891
   Dottori M, 2011, J CELL BIOCHEM, V112, P1955, DOI 10.1002/jcb.23116
   Faustino GM, 2011, INTEGR COMPUT-AID E, V18, P91, DOI 10.3233/ICA-2011-0359
   Giordano G, 2011, METHODS MOL BIOL, V758, P171, DOI 10.1007/978-1-61779-170-3_11
   Hernandez-Garcia D, 2008, EXP CELL RES, V314, P2090, DOI 10.1016/j.yexcr.2008.03.005
   Huang FJ, 2013, ENVIRON TOXICOL, V28, P190, DOI 10.1002/tox.20709
   Kudin A, 1999, BRAIN RES PROTOC, V4, P329, DOI 10.1016/S1385-299X(99)00037-9
   Li ZG, 2006, DEV GROWTH DIFFER, V48, P513, DOI 10.1111/j.1440-169x.2006.00889.x
   Lopez-Gonzalez R, 2012, ARCH MED RES, V43, P1, DOI 10.1016/j.arcmed.2012.01.007
   da Costa RFM, 2010, J NEUROTRAUM, V27, P829, DOI 10.1089/neu.2009.1189
   Maragos WF, 2003, BRAIN RES, V966, P312, DOI 10.1016/S0006-8993(02)04225-7
   Marinho PAN, 2010, BIOTECHNOL PROGR, V26, P548, DOI 10.1002/btpr.328
   Moon BS, 2009, EXP MOL MED, V41, P116, DOI 10.3858/emm.2009.41.2.014
   Mutoh T, 2012, STEM CELLS, V30, P561, DOI 10.1002/stem.1019
   Nikoletopoulou V, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200040
   Nones J, 2010, CELL BIOL INT, V34, P399, DOI 10.1042/CBI20090036
   Nuttall JR, 2012, NEUROTOX RES, V21, P128, DOI 10.1007/s12640-011-9291-6
   Okazawa H, 1996, J CELL BIOL, V132, P955, DOI 10.1083/jcb.132.5.955
   Osakada F, 2011, CNS NEUROL DISORD-DR, V10, P419, DOI 10.2174/187152711795563958
   Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673
   Paulsen BS, 2011, STEM CELLS DEV, V20, P1711, DOI 10.1089/scd.2010.0446
   Pfahl M, 2003, ONCOGENE, V22, P9058, DOI 10.1038/sj.onc.1207109
   Platel JC, 2008, J PHYSIOL-LONDON, V586, P3739, DOI 10.1113/jphysiol.2008.155325
   Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012
   Sarkar SA, 2002, CELL BIOL TOXICOL, V18, P243, DOI 10.1023/A:1016003027850
   Sebollela A, 2010, NEUROTOX RES, V18, P112, DOI 10.1007/s12640-009-9133-y
   Tomaskovic-Crook E, 2011, CNS NEUROL DISORD-DR, V10, P440, DOI 10.2174/187152711795564001
   Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   Visan A, 2012, NEUROTOXICOLOGY, V33, P1135, DOI 10.1016/j.neuro.2012.06.006
   Wang ZQ, 2009, CHEM-BIOL INTERACT, V179, P375, DOI 10.1016/j.cbi.2008.12.007
   Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com
   Wu JY, 2013, NEUROCHEM INT, V62, P92, DOI 10.1016/j.neuint.2012.09.016
   Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100
NR 44
TC 4
Z9 6
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1873-5061
EI 1876-7753
J9 STEM CELL RES
JI Stem Cell Res.
PD NOV
PY 2013
VL 11
IS 3
BP 1407
EP 1416
DI 10.1016/j.scr.2013.09.016
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 264UA
UT WOS:000327905300036
PM 24148244
OA Bronze
DA 2020-09-29
ER

PT J
AU Ostapchenko, VG
   Beraldo, FH
   Mohammad, AH
   Xie, YF
   Hirata, PHF
   Magalhaes, AC
   Lamour, G
   Li, HB
   Maciejewski, A
   Belrose, JC
   Teixeira, BL
   Fahnestock, M
   Ferreira, ST
   Cashman, NR
   Hajj, GNM
   Jackson, MF
   Choy, WY
   MacDonald, JF
   Martins, VR
   Prado, VF
   Prado, MAM
AF Ostapchenko, Valeriy G.
   Beraldo, Flavio H.
   Mohammad, Amro H.
   Xie, Yu-Feng
   Hirata, Pedro H. F.
   Magalhaes, Ana C.
   Lamour, Guillaume
   Li, Hongbin
   Maciejewski, Andrzej
   Belrose, Jillian C.
   Teixeira, Bianca L.
   Fahnestock, Margaret
   Ferreira, Sergio T.
   Cashman, Neil R.
   Hajj, Glaucia N. M.
   Jackson, Michael F.
   Choy, Wing-Yiu
   MacDonald, John F.
   Martins, Vilma R.
   Prado, Vania F.
   Prado, Marco A. M.
TI The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates
   Amyloid-beta Oligomer Toxicity
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID ALPHA-7 NICOTINIC ACETYLCHOLINE; CELLULAR PRION; ALZHEIMERS-DISEASE;
   A-BETA; SYNAPTIC PLASTICITY; COGNITIVE DEFICITS; SECRETED OLIGOMERS;
   MICE DEFICIENT; MOUSE MODEL; IN-VIVO
AB In Alzheimer's disease (AD), soluble amyloid-beta oligomers (A beta Os) trigger neurotoxic signaling, at least partially, via the cellular prion protein (PrPC). However, it is unknown whether other ligands of PrPC can regulate this potentially toxic interaction. Stress-inducible phosphoprotein 1 (STI1), an Hsp90 cochaperone secreted by astrocytes, binds to PrPC in the vicinity of the A beta O binding site to protect neurons against toxic stimuli. Here, we investigated a potential role of STI1 in A beta O toxicity. We confirmed the specific binding of A beta Os and STI1 to the PrP and showed that STI1 efficiently inhibited A beta O binding to PrP in vitro (IC50 of similar to 70 nM) and also decreased A beta O binding to cultured mouse primary hippocampal neurons. Treatment with STI1 prevented A beta O-induced synaptic loss and neuronal death in mouse cultured neurons and long-term potentiation inhibition in mouse hippocampal slices. Interestingly, STI1-haploinsufficient neurons were more sensitive to A beta O-induced cell death and could be rescued by treatment with recombinant STI1. Noteworthy, both A beta O binding to PrPC and PrPC-dependent A beta O toxicity were inhibited by TPR2A, the PrPC-interacting domain of STI1. Additionally, PrPC-STI1 engagement activated alpha 7 nicotinic acetylcholine receptors, which participated in neuroprotection against A beta O-induced toxicity. We found an age-dependent upregulation of cortical STI1 in the APPswe/PS1dE9 mouse model of AD and in the brains of AD-affected individuals, suggesting a compensatory response. Our findings reveal a previously unrecognized role of the PrPC ligand STI1 in protecting neurons in AD and suggest a novel pathway that may help to offset A beta O-induced toxicity.
C1 [Ostapchenko, Valeriy G.; Beraldo, Flavio H.; Mohammad, Amro H.; Xie, Yu-Feng; Hirata, Pedro H. F.; Magalhaes, Ana C.; Belrose, Jillian C.; Jackson, Michael F.; MacDonald, John F.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada.
   [Ostapchenko, Valeriy G.; Beraldo, Flavio H.; Xie, Yu-Feng; Jackson, Michael F.; MacDonald, John F.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada.
   [Mohammad, Amro H.; Magalhaes, Ana C.; Belrose, Jillian C.; MacDonald, John F.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5K8, Canada.
   [Maciejewski, Andrzej; Choy, Wing-Yiu] Univ Western Ontario, Dept Biochem, London, ON N6A 5K8, Canada.
   [Hirata, Pedro H. F.; Teixeira, Bianca L.; Hajj, Glaucia N. M.; Martins, Vilma R.] AC Camargo Canc Ctr, Dept Mol & Cell Biol, Int Res Ctr, BR-01508010 Sao Paulo, Brazil.
   [Hirata, Pedro H. F.; Teixeira, Bianca L.; Hajj, Glaucia N. M.; Martins, Vilma R.] Natl Inst Translat Neurosci, BR-01508010 Sao Paulo, Brazil.
   [Lamour, Guillaume; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada.
   [Lamour, Guillaume; Cashman, Neil R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z4, Canada.
   [Fahnestock, Margaret] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8S 4K1, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21941590 Rio De Janeiro, Brazil.
RP Prado, MAM (corresponding author), Robarts Res Inst, 100 Perth Dr, London, ON N6A 5K8, Canada.
EM mprado@robarts.ca
RI Lamour, Guillaume/D-6758-2015; Teixeira, Bianca Luise/AAM-5328-2020;
   XIE, YU-FENG/K-1041-2013; Hajj, Glaucia N N M M/I-8176-2015; Martins,
   Vilma R/E-2547-2012; Fahnestock, Margaret/I-3578-2017; Ferreira,
   Sergio/AAZ-1576-2020; Prado, Vania Ferreira/K-7630-2013; Prado, Marco
   Antonio Maximo/K-7638-2013; Choy, Wing-Yiu/O-7608-2017; Li,
   Hongbin/G-2949-2012; Martins, Vilma/N-5446-2019
OI Lamour, Guillaume/0000-0002-9331-5532; XIE, YU-FENG/0000-0001-8384-4177;
   Hajj, Glaucia N N M M/0000-0003-2342-7384; Martins, Vilma
   R/0000-0002-2909-8502; Fahnestock, Margaret/0000-0002-6815-0529;
   Ferreira, Sergio/0000-0001-7160-9866; Prado, Vania
   Ferreira/0000-0003-4994-6393; Prado, Marco Antonio
   Maximo/0000-0002-3028-5778; Choy, Wing-Yiu/0000-0002-2124-7278; Li,
   Hongbin/0000-0001-7813-1332; Mohammad, Amro/0000-0001-7230-9195;
   Ostapchenko, Valeriy/0000-0002-3629-7702
FU Alzheimer's AssociationAlzheimer's Association; PrioNet-Canada; Canadian
   Institutes of Health ResearchCanadian Institutes of Health Research
   (CIHR) [MOP 93651]; Sao Paulo State Foundation (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/14027-2,
   2012/04370-4]; National Institute for Translational Neuroscience;
   Canadian Foundation for InnovationCanada Foundation for Innovation;
   Ontario Research Fund; Master's Program Ontario Graduate Scholarship;
   FAPESP fellowshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX This work was supported by the Alzheimer's Association, PrioNet-Canada,
   Canadian Institutes of Health Research Grant MOP 93651, Sao Paulo State
   Foundation (FAPESP) Grants 2009/14027-2 (V. R. M.) and 2012/04370-4
   (G.N.M.H.), National Institute for Translational Neuroscience, Canadian
   Foundation for Innovation, and Ontario Research Fund. A. H. M. and A. M.
   were recipients of Master's Program Ontario Graduate Scholarship. B. L.
   T. received an FAPESP fellowship. We thank PrP<SUP>5</SUP>, a
   PrioNet-Canada facility, and David Wishart for the gift of PrP 112-231.
CR Ambegaokar SS, 2011, HUM MOL GENET, V20, P4947, DOI 10.1093/hmg/ddr432
   Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107
   Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011
   Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724
   Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088
   Beraldo FH, 2013, FASEB J, V27, P3594, DOI 10.1096/fj.13-232280
   Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653
   Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263
   Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200
   Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008
   Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x
   Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516
   Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324
   Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001
   Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3
   Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341
   Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010
   Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026
   Hajj GNM, 2013, CELL MOL LIFE SCI, V70, P3211, DOI 10.1007/s00018-013-1328-y
   Hernandez CM, 2012, CURR DRUG TARGETS, V13, P613, DOI 10.2174/138945012800398973
   Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010
   Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008
   Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217
   KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029
   Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x
   Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007
   Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63
   Martyn AC, 2012, P NATL ACAD SCI USA, V109, P17651, DOI 10.1073/pnas.1215381109
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2
   Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   OrrUrtreger A, 1997, J NEUROSCI, V17, P9165
   Ostapchenko VG, 2008, J MOL BIOL, V383, P1210, DOI 10.1016/j.jmb.2008.08.073
   Ostapchenko VG, 2013, J NEUROCHEM, DOI [10.1111/jnc.12296, DOI 10.1111/JNC.12296.CR0SSREF]
   Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Resenberger UK, 2012, J BIOL CHEM, V287, P43765, DOI 10.1074/jbc.M112.389007
   Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86
   Roffe M, 2013, J BIOL CHEM, V288, P10860, DOI 10.1074/jbc.M113.461970
   Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107
   Romano SA, 2009, FASEB J, V23, P4308, DOI 10.1096/fj.09-138974
   Santos TG, 2013, J NEUROCHEM, V124, P210, DOI 10.1111/jnc.12091
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Shen H, 2010, BRIT J PHARMACOL, V161, P127, DOI 10.1111/j.1476-5381.2010.00894.x
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273
   Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023
   Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754
   Tsutsui S, 2008, AM J PATHOL, V173, P1029, DOI 10.2353/ajpath.2008.071062
   Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang HY, 2012, J NEUROSCI, V32, P9773, DOI 10.1523/JNEUROSCI.0354-12.2012
   Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009
   Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626
   Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002
   You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109
   Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325
   Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030
NR 78
TC 43
Z9 43
U1 0
U2 29
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD OCT 16
PY 2013
VL 33
IS 42
BP 16552
EP 16564
DI 10.1523/JNEUROSCI.3214-13.2013
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA 236OY
UT WOS:000325809800013
PM 24133259
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Ledo, JH
   Azevedo, EP
   Clarke, JR
   Ribeiro, FC
   Figueiredo, CP
   Foguel, D
   De Felice, FG
   Ferreira, ST
AF Ledo, J. H.
   Azevedo, E. P.
   Clarke, J. R.
   Ribeiro, F. C.
   Figueiredo, C. P.
   Foguel, D.
   De Felice, F. G.
   Ferreira, S. T.
TI Amyloid-beta oligomers link depressive-like behavior and cognitive
   deficits in mice
SO MOLECULAR PSYCHIATRY
LA English
DT Letter
ID ALZHEIMER-DISEASE; A-BETA; RISK; HYPOTHESIS; RECEPTORS; SYMPTOMS
C1 [Ledo, J. H.; Azevedo, E. P.; Clarke, J. R.; Ribeiro, F. C.; Foguel, D.; De Felice, F. G.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Figueiredo, C. P.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Azevedo, Estefania/I-3807-2012; Clarke, Julia/AAF-9434-2019; Ribeiro,
   Felipe Campos/W-9758-2019; Ferreira, Sergio/AAZ-1576-2020; Figueiredo,
   Claudia P/F-8424-2012
OI Ribeiro, Felipe Campos/0000-0003-3028-3307; Ferreira,
   Sergio/0000-0001-7160-9866; Foguel, Debora/0000-0001-7312-7115;
   Figueiredo, Claudia/0000-0001-9467-9891
CR Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1
   Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lorke DE, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-36
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600
   Zhu CB, 2006, NEUROPSYCHOPHARMACOL, V31, P2121, DOI 10.1038/sj.npp.1301029
NR 11
TC 82
Z9 84
U1 1
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD OCT
PY 2013
VL 18
IS 10
BP 1053
EP 1054
DI 10.1038/mp.2012.168
PG 2
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA 222JJ
UT WOS:000324726700003
PM 23183490
OA Green Published
DA 2020-09-29
ER

PT J
AU Azevedo, EP
   Ledo, JH
   Barbosa, G
   Sobrinho, M
   Diniz, L
   Fonseca, ACC
   Gomes, F
   Romao, L
   Lima, FRS
   Palhano, FL
   Ferreira, ST
   Foguel, D
AF Azevedo, E. P.
   Ledo, J. H.
   Barbosa, G.
   Sobrinho, M.
   Diniz, L.
   Fonseca, A. C. C.
   Gomes, F.
   Romao, L.
   Lima, F. R. S.
   Palhano, F. L.
   Ferreira, S. T.
   Foguel, D.
TI Activated microglia mediate synapse loss and short-term memory deficits
   in a mouse model of transthyretin-related oculoleptomeningeal
   amyloidosis
SO CELL DEATH & DISEASE
LA English
DT Article
DE microglia; transthyretin; amyloid fibril; neurodegeneration
ID LEPTOMENINGEAL AMYLOIDOSIS; LIVER-TRANSPLANTATION; CEREBRAL-HEMORRHAGE;
   ALZHEIMERS-DISEASE; BETA; VARIANT; NEUROTOXICITY; PATIENT; INHIBITION;
   EXPRESSION
AB Oculoleptomeningeal amyloidosis (OA) is a fatal and untreatable hereditary disease characterized by the accumulation of transthyretin (TTR) amyloid within the central nervous system. The mechanisms underlying the pathogenesis of OA, and in particular how amyloid triggers neuronal damage, are still unknown. Here, we show that amyloid fibrils formed by a mutant form of TTR, A25T, activate microglia, leading to the secretion of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and nitric oxide. Further, we found that A25T amyloid fibrils induce the activation of Akt, culminating in the translocation of NF kappa B to the nucleus of microglia. While A25T fibrils were not directly toxic to neurons, the exposure of neuronal cultures to media conditioned by fibril-activated microglia caused synapse loss that culminated in extensive neuronal death via apoptosis. Finally, intracerebroventricular (i.c.v.) injection of A25T fibrils caused microgliosis, increased brain TNF-alpha and IL-6 levels and cognitive deficits in mice, which could be prevented by minocycline treatment. These results indicate that A25T fibrils act as pro-inflammatory agents in OA, activating microglia and causing neuronal damage.
C1 [Azevedo, E. P.; Ledo, J. H.; Palhano, F. L.; Ferreira, S. T.; Foguel, D.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Barbosa, G.; Sobrinho, M.; Diniz, L.; Fonseca, A. C. C.; Gomes, F.; Romao, L.; Lima, F. R. S.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Romao, L.] Univ Fed Rio de Janeiro, BR-27930560 Macae, RJ, Brazil.
RP Foguel, D (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, CCS Bloco E Sala 42,Ave Carlos Chagas Filho 373, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM palhano@bioqmed.ufrj.br; foguel@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; da Fonseca, Anna Carolina
   Carvalho/AAQ-7440-2020; Azevedo, Estefania/I-3807-2012; Palhano,
   Fernando/C-2586-2008; da Fonseca, Anna Carolina Carvalho/C-5825-2015;
   Romao, Luciana/I-4291-2015; Gomes, Flavia/C-5383-2013
OI Ferreira, Sergio/0000-0001-7160-9866; da Fonseca, Anna Carolina
   Carvalho/0000-0002-8366-3146; Palhano, Fernando/0000-0001-5336-632X; da
   Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; Foguel,
   Debora/0000-0001-7312-7115; Gomes, Flavia/0000-0003-2966-0638; Souza
   Lima, Flavia Regina/0000-0003-0799-9235
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Coordena a
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This research was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and
   Coordena a Aperfeicoamento de Pessoal de Nivel Superior (CAPES). We are
   also very grateful to Dr. Andre Gomes (Federal University of Rio de
   Janeiro) for two-photon assistance, Dr. Evan Powers (The Scripps
   Research Institute) for guidance on statistical analysis, and to ER
   Goncalves and S Alonso for competent technical assistance.
CR ANDO Y, 1995, BIOCHEM BIOPH RES CO, V211, P354, DOI 10.1006/bbrc.1995.1820
   Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942
   Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r
   Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859
   Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3
   Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0
   De Carolis P, 2006, NEUROL SCI, V27, P352, DOI 10.1007/s10072-006-0709-5
   Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Greenberg SM, 1997, STROKE, V28, P1418, DOI 10.1161/01.STR.28.7.1418
   Hagiwara K, 2009, NEUROLOGY, V72, P1358, DOI 10.1212/WNL.0b013e3181a0fe74
   He ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035926
   Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54
   Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+
   Li XY, 2011, J NEUROSCI, V31, P12483, DOI 10.1523/JNEUROSCI.2417-11.2011
   Liepnieks JJ, 2011, AMYLOID, V18, P160, DOI 10.3109/13506129.2011.574354060
   Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001
   Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121
   Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Mitrasinovic OM, 2002, J BIOL CHEM, V277, P29889, DOI 10.1074/jbc.M200868200
   Mitsuhashi S, 2005, AMYLOID, V12, P216, DOI 10.1080/13506120500352404
   Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2
   Nakagawa K, 2008, J NEUROL SCI, V272, P186, DOI 10.1016/j.jns.2008.05.014
   Nelson TE, 2012, BRAIN BEHAV IMMUN, V26, P959, DOI 10.1016/j.bbi.2012.05.005
   NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0
   Nishimori JH, 2012, INFECT IMMUN, V80, P4398, DOI 10.1128/IAI.00911-12
   Owa M, 2001, INTERNAL MED, V40, P259, DOI 10.2169/internalmedicine.40.259
   Palhano FL, 2009, J BIOL CHEM, V284, P1443, DOI 10.1074/jbc.M807100200
   Paxinos G, 2001, MOUSE BRAIN STEREOTA
   Peuralinna T, 2011, J ALZHEIMERS DIS, V26, P377, DOI 10.3233/JAD-2011-102049
   Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006
   Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8
   Rinaldi L, 2006, TRANSPLANTATION, V81, P134, DOI 10.1097/01.tp.0000189714.12889.ae
   Roe Richard H, 2007, Ophthalmology, V114, pe33, DOI 10.1016/j.ophtha.2007.07.007
   Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Shen E, 2008, J CELL BIOCHEM, V104, P329, DOI 10.1002/jcb.21629
   Shimizu Y, 2006, AMYLOID, V13, P37, DOI 10.1080/13506120600551814
   Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1
   Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4
   Yates PA, 2011, NEUROLOGY, V77, P48, DOI 10.1212/WNL.0b013e318221ad36
NR 45
TC 24
Z9 26
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD SEP
PY 2013
VL 4
AR e789
DI 10.1038/cddis.2013.325
PG 9
WC Cell Biology
SC Cell Biology
GA 230VC
UT WOS:000325370300006
PM 24008733
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Ramser, EM
   Gan, KJ
   Decker, H
   Fan, EY
   Suzuki, MM
   Ferreira, ST
   Silverman, MA
AF Ramser, Elisa M.
   Gan, Kathlyn J.
   Decker, Helena
   Fan, Emily Y.
   Suzuki, Matthew M.
   Ferreira, Sergio T.
   Silverman, Michael A.
TI Amyloid-beta oligomers induce tau-independent disruption of BDNF axonal
   transport via calcineurin activation in cultured hippocampal neurons
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GLYCOGEN-SYNTHASE KINASE-3-BETA; RECEPTOR-DEPENDENT MECHANISM;
   ALZHEIMERS-DISEASE; CASPASE ACTIVATION; MOUSE MODEL; KINESIN; PROTEIN;
   PHOSPHORYLATION; HYPOTHESIS; IMPAIRMENT
AB Disruption of fast axonal transport (FAT) is an early pathological event in Alzheimer's disease (AD). Soluble amyloid-beta oligomers (A beta Os), increasingly recognized as proximal neurotoxins in AD, impair organelle transport in cultured neurons and transgenic mouse models. A beta Os also stimulate hyperphosphorylation of the axonal microtubule-associated protein, tau. However, the role of tau in FAT disruption is controversial. Here we show that A beta Os reduce vesicular transport of brain-derived neurotrophic factor (BDNF) in hippocampal neurons from both wild-type and tau-knockout mice, indicating that tau is not required for transport disruption. FAT inhibition is not accompanied by microtubule destabilization or neuronal death. Significantly, inhibition of calcineurin (CaN), a calcium-dependent phosphatase implicated in AD pathogenesis, rescues BDNF transport. Moreover, inhibition of protein phosphatase 1 and glycogen synthase kinase 3 beta, downstream targets of CaN, prevents BDNF transport defects induced by A beta Os. We further show that A beta Os induce CaN activation through nonexcitotoxic calcium signaling. Results implicate CaN in FAT regulation and demonstrate that tau is not required for A beta O-induced BDNF transport disruption.
C1 [Ramser, Elisa M.; Decker, Helena; Fan, Emily Y.; Suzuki, Matthew M.; Silverman, Michael A.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.
   [Gan, Kathlyn J.; Silverman, Michael A.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.
   [Decker, Helena; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Decker, Helena] Univ Fed Rio de Janeiro, Inst Biomed Sci, Morphol Sci Program, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Silverman, MA (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.
EM masilver@sfu.ca
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Silverman, Michael
   A./0000-0001-6967-4917
FU National Science and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada [327100-06];
   Canadian Foundation for InnovationCanada Foundation for Innovation
   [12793]; Canadian Institutes of Health ResearchCanadian Institutes of
   Health Research (CIHR) [90396]; C.D. Nelson Memorial Graduate
   Scholarship from Simon Fraser University; National Science and
   Engineering Research Council of CanadaNatural Sciences and Engineering
   Research Council of Canada; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel SuperiorCAPES; National Institute of Translational Neuroscience;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX This research was supported by grants from the National Science and
   Engineering Research Council of Canada (327100-06), the Canadian
   Foundation for Innovation (12793), and the Canadian Institutes of Health
   Research (90396) to M.A.S. We thank Lesley Chen and Cathleen Pfefferkorn
   for their expert technical assistance, C. D. Link and T. Tomiyama for
   their critical reading of the manuscript, and V. Gelfand for essential
   discussions. K.J.G. is funded by a C.D. Nelson Memorial Graduate
   Scholarship from Simon Fraser University and a National Science and
   Engineering Research Council of Canada Postgraduate Scholarship. H.D.
   thanks the Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior for fellowship support. S.T.F. is supported by grants
   from the National Institute of Translational Neuroscience, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil). We also thank
   the Simon Fraser University Animal Care Services staff for their
   essential assistance in our experiments.
CR Abney JR, 1999, BIOPHYS J, V77, P2887, DOI 10.1016/S0006-3495(99)77120-1
   Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Berridge MJ, 2011, NEUROCHEM RES, V36, P1149, DOI 10.1007/s11064-010-0371-4
   Black MM, 1996, J NEUROSCI, V16, P3601
   Braithwaite SP, 2012, PROG MOL BIOL TRANSL, V106, P343, DOI 10.1016/B978-0-12-396456-4.00012-2
   Castellani RJ, 2008, J ALZHEIMERS DIS, V14, P377
   D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709
   de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890
   de Calignon A, 2009, J NEUROPATH EXP NEUR, V68, P757, DOI 10.1097/NEN.0b013e3181a9fc66
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895
   Diniz BS, 2011, NEUROMOL MED, V13, P217, DOI 10.1007/s12017-011-8154-x
   Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Goldstein LSB, 2012, PROG NEUROBIOL, V99, P186, DOI 10.1016/j.pneurobio.2012.03.006
   Henriques AG, 2010, J NEUROCHEM, V113, P761, DOI 10.1111/j.1471-4159.2010.06643.x
   Hiruma H, 2003, J NEUROSCI, V23, P8967
   Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x
   Hyman BT, 2011, NAT NEUROSCI, V14, P5, DOI 10.1038/nn0111-5
   Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036
   Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001
   Jolly AL, 2011, BIOCHEM SOC T, V39, P1126, DOI 10.1042/BST0391126
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356
   Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011
   Kim J, 2011, NEUROIMAGE, V56, P1286, DOI 10.1016/j.neuroimage.2011.02.039
   King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187
   Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012
   Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850
   Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200
   Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200
   Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018
   Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x
   Mandell JW, 1996, J NEUROSCI, V16, P5727
   Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380
   Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281
   Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237
   Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009
   MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0
   Park JJ, 2008, MOL CELL NEUROSCI, V39, P63, DOI 10.1016/j.mcn.2008.05.016
   Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2
   Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029
   Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106
   Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199
   Reese LC, 2011, CURR NEUROPHARMACOL, V9, P685, DOI 10.2174/157015911798376316
   Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674
   Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006
   Schlager MA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-25
   SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J
   Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503
   Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011
   STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701
   Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730
   Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014
   Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200
   Tang Y, 2012, TRAFFIC, V13, P681, DOI 10.1111/j.1600-0854.2012.01340.x
   Uchida A, 2009, MOL BIOL CELL, V20, P4997, DOI 10.1091/mbc.E09-04-0304
   Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168
   Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653
   Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046
   Weaver C, 2013, TRAFFIC, V14, P295, DOI 10.1111/tra.12037
   Welte MA, 2010, CURR BIOL, V20, pR410, DOI 10.1016/j.cub.2010.03.018
   Wu HY, 2012, J NEUROSCI, V32, P5298, DOI 10.1523/JNEUROSCI.0227-12.2012
   Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008
   Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200
NR 74
TC 36
Z9 38
U1 0
U2 15
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD AUG 15
PY 2013
VL 24
IS 16
BP 2494
EP 2505
DI 10.1091/mbc.E12-12-0858
PG 12
WC Cell Biology
SC Cell Biology
GA 219FZ
UT WOS:000324492900002
PM 23783030
OA Green Published, Other Gold
DA 2020-09-29
ER

PT J
AU Nery, AA
   Magdesian, MH
   Trujillo, CA
   Sathler, LB
   Juliano, MA
   Juliano, L
   Ulrich, H
   Ferreira, ST
AF Nery, Arthur A.
   Magdesian, Margaret H.
   Trujillo, Cleber A.
   Sathler, Luciana B.
   Juliano, Maria A.
   Juliano, Luiz
   Ulrich, Henning
   Ferreira, Sergio T.
TI Rescue of Amyloid-Beta-Induced Inhibition of Nicotinic Acetylcholine
   Receptors by a Peptide Homologous to the Nicotine Binding Domain of the
   Alpha 7 Subtype
SO PLOS ONE
LA English
DT Article
ID ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; LIGAND-BINDING; AMINO-ACIDS;
   IN-VITRO; BETA-AMYLOID(1-42); AGONIST; COCAINE; PROTEIN; IDENTIFICATION
AB Alzheimer's disease (AD) is characterized by brain accumulation of the neurotoxic amyloid-beta peptide (A beta) and by loss of cholinergic neurons and nicotinic acetylcholine receptors (nAChRs). Recent evidence indicates that memory loss and cognitive decline in AD correlate better with the amount of soluble A beta than with the extent of amyloid plaque deposits in affected brains. Inhibition of nAChRs by soluble A beta 40 is suggested to contribute to early cholinergic dysfunction in AD. Using phage display screening, we have previously identified a heptapeptide, termed IQ, homologous to most nAChR subtypes, binding with nanomolar affinity to soluble A beta 40 and blocking A beta-induced inhibition of carbamylcholine-induced currents in PC12 cells expressing alpha 7 nAChRs. Using alanine scanning mutagenesis and whole-cell current recording, we have now defined the amino acids in IQ essential for reversal of A beta 40 inhibition of carbamylcholine-induced responses in PC12 cells, mediated by alpha 7 subtypes and other endogenously expressed nAChRs. We further investigated the effects of soluble A beta, IQ and analogues of IQ on alpha 3 beta 4 nAChRs recombinantly expressed in HEK293 cells. Results show that nanomolar concentrations of soluble A beta 40 potently inhibit the function of alpha 3 beta 4 nAChRs, and that subsequent addition of IQ or its analogues does not reverse this effect. However, co-application of IQ makes the inhibition of alpha 3 beta 4 nAChRs by A beta 40 reversible. These findings indicate that A beta 40 inhibits different subtypes of nAChRs by interacting with specific receptor domains homologous to the IQ peptide, suggesting that IQ may be a lead for novel drugs to block the inhibition of cholinergic function in AD.
C1 [Nery, Arthur A.; Trujillo, Cleber A.; Ulrich, Henning] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
   [Magdesian, Margaret H.; Sathler, Luciana B.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, RJ, Brazil.
   [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.
RP Ulrich, H (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
EM henning@iq.usp.br; ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Ulrich, Henning/C-5245-2013; Juliano,
   Luiz/D-7204-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Ulrich,
   Henning/0000-0002-2114-3815; Juliano, Luiz/0000-0002-5589-2822
FU National Institute for Translational Neuroscience/Brazil; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Fundacao
   Universitaria Jose Bonifacio; Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2006/61285-9, 2012/50880-4]
FX This work was supported by grants from National Institute for
   Translational Neuroscience/Brazil (STF), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (STF and HU), Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (STF and MHM), Fundacao
   Universitaria Jose Bonifacio (MHM), and Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) (HU) (project No. 2006/61285-9 and
   2012/50880-4). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Alzheimer's A., 2010, ALZHEIMERS DEMENT, V6, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2014.02.001]
   Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0
   Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47
   Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011
   Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562
   Cheffer A, 2012, J NEUROSCI RES, V90, P1607, DOI 10.1002/jnr.23047
   Cheffer A, 2011, BIOCHEMISTRY-US, V50, P1763, DOI 10.1021/bi101789y
   Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940
   Clementi F, 2000, EUR J PHARMACOL, V393, P3, DOI 10.1016/S0014-2999(00)00066-2
   CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749
   Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431
   D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224
   DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016
   Dineley KT, 2007, FRONT BIOSCI-LANDMRK, V12, P5030, DOI 10.2741/2445
   Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200
   Dougherty JJ, 2003, J NEUROSCI, V23, P6740
   Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   FU DX, 1994, J BIOL CHEM, V269, P26152
   Fu W, 2003, J NEUROPHYSIOL, V90, P3130, DOI 10.1152/jn.00616.2003
   GALZI JL, 1990, J BIOL CHEM, V265, P10430
   Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005
   Grassi F, 2003, J PHYSIOL-LONDON, V547, P147, DOI 10.1113/jphysiol.2002.035436
   Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009
   Hess GP, 2000, P NATL ACAD SCI USA, V97, P13895, DOI 10.1073/pnas.240459497
   HO PL, 1992, J CELL PHYSIOL, V150, P647, DOI 10.1002/jcp.1041500326
   Jurgensen S, 2010, J MOL NEUROSCI, V40, P221, DOI 10.1007/s12031-009-9237-0
   Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7
   Krivoshein AV, 2004, BIOCHEMISTRY-US, V43, P481, DOI 10.1021/bi034838l
   Lamb PW, 2005, J MOL NEUROSCI, V27, P13, DOI 10.1385/JMN:27:1:013
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007
   Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   Martin-Ruiz CM, 1999, J NEUROCHEM, V73, P1635, DOI 10.1046/j.1471-4159.1999.0731635.x
   Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2
   Moaddel R, 2004, J CHROMATOGR B, V813, P235, DOI 10.1016/j.jchromb.2004.09.042
   Mura E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029661
   Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2
   Nery AA, 2010, J MOL NEUROSCI, V41, P329, DOI 10.1007/s12031-010-9369-2
   Niu L, 1995, P NATL ACAD SCI USA, V92, P12008, DOI 10.1073/pnas.92.26.12008
   Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2
   Nunes-Alves A, 2013, J MOL NEUROSCI, V49, P52, DOI 10.1007/s12031-012-9859-5
   Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001
   Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008
   Pym L, 2005, BRIT J PHARMACOL, V146, P964, DOI 10.1038/sj.bjp.0706403
   Riek R, 2006, NATURE, V444, P429, DOI 10.1038/444429a
   Salas R, 2004, NEUROPHARMACOLOGY, V47, P401, DOI 10.1016/j.neuropharm.2004.05.002
   Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016
   Small DH, 2007, J NEUROCHEM, V101, P1527, DOI 10.1111/j.1471-4159.2006.04444.x
   Tayeb HO, 2013, EXPERT OPIN BIOL THE
   UDGAONKAR JB, 1987, P NATL ACAD SCI USA, V84, P8758, DOI 10.1073/pnas.84.24.8758
   Ulrich H, 2008, J NEUROSCI RES, V86, P93, DOI 10.1002/jnr.21468
   Ulrich H, 1998, P NATL ACAD SCI USA, V95, P14051, DOI 10.1073/pnas.95.24.14051
   Wang H., 2000, ADV IND CON
   Wang HY, 2010, BIOL PSYCHIAT, V67, P522, DOI 10.1016/j.biopsych.2009.09.031
   Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626
   Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225
   Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200
   Wu JL, 2007, BRAIN RES, V1182, P82, DOI 10.1016/j.brainres.2007.08.079
   Xiao YX, 1998, MOL PHARMACOL, V54, P322
   Zappettini S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00146
NR 63
TC 9
Z9 9
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 22
PY 2013
VL 8
IS 7
AR e67194
DI 10.1371/journal.pone.0067194
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 187PW
UT WOS:000322132100009
PM 23894286
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Guillot-Sestier, MV
   Sunyach, C
   Ferreira, ST
   Marzolo, MP
   Bauer, C
   Thevenet, A
   Checler, F
AF Guillot-Sestier, Marie-Victoire
   Sunyach, Claire
   Ferreira, Sergio T.
   Marzolo, Maria-Paz
   Bauer, Charlotte
   Thevenet, Aurelie
   Checler, Frederic
TI alpha-Secretase-derived fragment of cellular prion, N1, protects against
   monomeric and oligomeric amyloid beta (A beta)-associated cell death
   (vol 287, pg 5021, 2012)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Correction
RI Checler, Frederic/C-1241-2009; Ferreira, Sergio/AAZ-1576-2020
OI Checler, Frederic/0000-0003-2098-1750; Ferreira,
   Sergio/0000-0001-7160-9866
CR Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 19
PY 2013
VL 288
IS 29
BP 21210
EP 21210
DI 10.1074/jbc.A111.323626
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 186AU
UT WOS:000322014400042
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Paula-Lima, AC
   Brito-Moreira, J
   Ferreira, ST
AF Paula-Lima, Andrea C.
   Brito-Moreira, Jordano
   Ferreira, Sergio T.
TI Deregulation of excitatory neurotransmission underlying synapse failure
   in Alzheimer's disease
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Review
DE A oligomers; AMPA receptors; d-serine; GABA receptors; NMDA receptors;
   synapse dysfunction
ID METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; A-BETA OLIGOMERS; CELLULAR
   PRION PROTEIN; METABOTROPIC GLUTAMATE RECEPTORS; RAT NUCLEUS BASALIS;
   AMYLOID-BETA; D-SERINE; NMDA RECEPTORS; HIPPOCAMPAL-NEURONS
AB Alzheimers disease (AD) is the most common form of dementia in the elderly. Memory loss in AD is increasingly attributed to soluble oligomers of the amyloid- peptide (AOs), toxins that accumulate in AD brains and target particular synapses. Glutamate receptors appear to be centrally involved in synaptic targeting by AOs. Once bound to neurons, AOs dysregulate the activity and reduce the surface expression of both N-methyl-d-aspartate (NMDA) and 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) types of glutamate receptors, impairing signaling pathways involved in synaptic plasticity. In the extracellular milieu, AOs promote accumulation of the excitatory amino acids, glutamate and d-serine. This leads to overactivation of glutamate receptors, triggering abnormal calcium signals with noxious impacts on neurons. Here, we review key findings linking AOs to deregulated glutamate neurotransmission and implicating this as a primary mechanism of synapse failure in AD. We also discuss strategies to counteract the impact of AOs on excitatory neurotransmission. In particular, we review evidence showing that inducing neuronal hyperpolarization via activation of inhibitory GABA(A) receptors prevents AO-induced excitotoxicity, suggesting that this could comprise a possible therapeutic approach in AD.
C1 [Paula-Lima, Andrea C.] Univ Chile, Fac Dent, Dept Basic Sci, Santiago, Chile.
   [Brito-Moreira, Jordano; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM apaula@med.uchile.cl; ferreira@bioqmed.ufrj.br
RI Paula-Lima, Andrea C./I-2537-2013; Ferreira, Sergio/AAZ-1576-2020
OI Paula-Lima, Andrea C./0000-0002-0466-7561; Ferreira,
   Sergio/0000-0001-7160-9866
FU FondecytComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT FONDECYT [11110322]; ConicytComision Nacional de
   Investigacion Cientifica y Tecnologica (CONICYT) [79090021]; BNI
   [P-09-015F]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); National Institute of
   Translational Neuroscience; FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX Work in the authors' laboratories has been funded by grants from
   Fondecyt 11110322, Conicyt 79090021 and BNI P-09-015F (to APL), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and National
   Institute of Translational Neuroscience (to STF). JBM is recipient of a
   pre-doctoral fellowship from FAPERJ. The authors have no conflict of
   interest to disclose.
CR Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799
   Aronica E, 1998, NEUROSCIENCE, V82, P979
   Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4
   Ballard TM, 2002, J NEUROSCI, V22, P6713
   Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653
   Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014
   Chin JH, 2007, J NEUROSCI, V27, P9262, DOI 10.1523/JNEUROSCI.1843-07.2007
   Choi SH, 2011, CURR MED RES OPIN, V27, P1375, DOI 10.1185/03007995.2011.582484
   Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635
   Clerici F, 2012, NEUROL SCI, V33, P23, DOI 10.1007/s10072-011-0618-0
   Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556
   Csernansky JG, 1996, NEUROLOGY, V46, P1715, DOI 10.1212/WNL.46.6.1715
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P7678, DOI 10.1073/pnas.0902058106
   De Miranda J, 2000, GENE, V256, P183, DOI 10.1016/S0378-1119(00)00356-5
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1
   Eleuteri S, 2009, NEUROTOX RES, V15, P127, DOI 10.1007/s12640-009-9013-5
   Emre M, 2008, J ALZHEIMERS DIS, V14, P193
   Esposito E, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-31
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo C. P., 2013, J NEUROSCI IN PRESS, P33
   Frasca A, 2011, NEUROBIOL DIS, V43, P507, DOI 10.1016/j.nbd.2011.04.024
   Fujimoto S, 2004, NEUROSCI RES, V50, P179, DOI 10.1016/j.neures.2004.06.013
   GEDDES JW, 1986, BRAIN RES, V399, P156, DOI 10.1016/0006-8993(86)90611-6
   Gillessen T, 2002, ADV EXP MED BIOL, V513, P3
   Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010
   Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005
   GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051
   Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001
   HAMBERGER A, 1984, NEUROCHEM RES, V9, P1181, DOI 10.1007/BF00973033
   Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x
   Harris ME, 1996, J NEUROCHEM, V67, P277
   Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673
   Herrmann N, 2011, CNS DRUGS, V25, P425, DOI 10.2165/11588160-000000000-00000
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101
   Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kakuda N, 2012, EMBO MOL MED, V4, P344, DOI 10.1002/emmm.201200214
   Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200
   Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912
   Khosravani Houman, 2008, J Gen Physiol, V131, pi5, DOI 10.1085/JGP1316OIA5
   Kim SH, 2010, J NEUROSCI, V30, P3870, DOI 10.1523/JNEUROSCI.4717-09.2010
   Korpi ER, 2002, PROG NEUROBIOL, V67, P113, DOI 10.1016/S0301-0082(02)00013-8
   Koutsilleri E, 2007, PARKINSONISM RELAT D, V13, pS329, DOI 10.1016/S1353-8020(08)70025-7
   Kristensen BW, 2003, BRAIN RES, V973, P303, DOI 10.1016/S0006-8993(03)02550-2
   Kurup P, 2010, CHANNELS, V4, P347, DOI [10.4161/chan.4.5.12910, 10.1523/JNEUROSCI.0157-10.2010]
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lanctot KL, 2004, CAN J PSYCHIAT, V49, P439
   Lapchak PA, 2000, STROKE, V31, P1953, DOI 10.1161/01.STR.31.8.1953
   Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Ledo J. H., 2012, MOL PSYCHIAT
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Lima ACP, 2003, NEUROTOX RES, V5, P323, DOI 10.1007/BF03033152
   Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958
   Liu SJ, 2010, J ALZHEIMERS DIS, V21, P655, DOI 10.3233/JAD-2010-091654
   Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com
   Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3
   Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007
   Martina M, 2003, J PHYSIOL-LONDON, V548, P411, DOI 10.1113/jphysiol.2002.037127
   Masters C. L., 2012, COLD SPRING HARB PER, V2, P1
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   MATSUI T, 1995, J NEUROCHEM, V65, P454
   Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x
   Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65
   Mohler H, 2011, NEUROPHARMACOLOGY, V60, P1042, DOI 10.1016/j.neuropharm.2010.10.020
   Morimoto K, 2003, NEUROSCI LETT, V340, P242, DOI 10.1016/S0304-3940(03)00130-7
   Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926
   Muller WEG, 1997, ARCH GERONTOL GERIAT, V25, P41, DOI 10.1016/S0167-4943(96)00770-4
   Nagata Y, 1998, MECH AGEING DEV, V104, P115, DOI 10.1016/S0047-6374(98)00059-1
   Nakamura S, 2006, EUR J PHARMACOL, V548, P115, DOI 10.1016/j.ejphar.2006.07.049
   Nemeth H, 2005, CURR NEUROVASC RES, V2, P249, DOI 10.2174/1567202054368326
   Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497
   Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029
   Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023
   ParpuraGill A, 1997, BRAIN RES, V754, P65, DOI 10.1016/S0006-8993(97)00043-7
   PASANTESMORALES H, 1987, NEUROPHARMACOLOGY, V26, P1721, DOI 10.1016/0028-3908(87)90123-7
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   PERRY TL, 1981, NEUROLOGY, V31, P872, DOI 10.1212/WNL.31.7.872
   Pisani F, 2006, EXP BRAIN RES, V171, P511, DOI 10.1007/s00221-005-0298-1
   Priller C, 2009, NEUROBIOL AGING, V30, P1227, DOI 10.1016/j.neurobiolaging.2007.10.016
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   Rissman RA, 2011, J NEUROCHEM, V117, P613, DOI 10.1111/j.1471-4159.2011.07237.x
   Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736
   Rodriguez MJ, 2005, J NEUROCHEM, V95, P651, DOI 10.1111/j.1471-4159.2005.03394.x
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013
   Ruiz A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.31
   Russell CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043201
   Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109
   SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Saransaari P, 1997, MECH AGEING DEV, V99, P219, DOI 10.1016/S0047-6374(97)00101-2
   Saransaari P, 2007, AMINO ACIDS, V32, P439, DOI 10.1007/s00726-006-0375-1
   Sattler R, 2006, HANDB EXP PHARM, V175, P277
   Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P58, DOI 10.1001/archneurol.2010.343
   Schulz JB, 2011, J ALZHEIMERS DIS, V25, P463, DOI 10.3233/JAD-2011-101929
   Schwartz-Bloom RD, 2000, NEUROSCIENCE, V98, P471, DOI 10.1016/S0306-4522(00)00144-5
   Scott HL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0004.2002
   Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005
   Small DH, 2012, NEURODEGENER DIS, V10, P76, DOI 10.1159/000333126
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648
   Steinmetz RD, 2002, J NEUROSCI METH, V113, P99, DOI 10.1016/S0165-0270(01)00482-4
   Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100
   Tannenberg RK, 2004, CURR ALZHEIMER RES, V1, P11, DOI 10.2174/1567205043480591
   Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008
   Texido L, 2011, CELL CALCIUM, V49, P184, DOI 10.1016/j.ceca.2011.02.001
   Thal DR, 2002, BRAIN PATHOL, V12, P405
   ULAS J, 1994, J NEUROSCI, V14, P6317
   Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178
   Velasco I, 2002, J NEUROSCI RES, V67, P406, DOI 10.1002/jnr.10114
   Vignes M, 2001, NEUROPHARMACOLOGY, V40, P737, DOI 10.1016/S0028-3908(00)00213-6
   Wallace SJ, 2001, BRAIN DEV-JPN, V23, P277, DOI 10.1016/S0387-7604(01)00230-3
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4
   Williams SM, 2006, GLIA, V53, P401, DOI 10.1002/glia.20300
   Winblad B, 2007, DEMENT GERIATR COGN, V24, P20, DOI 10.1159/000102568
   Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2
   Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007
   Yasuda E, 2001, NEUROSCI LETT, V299, P162, DOI 10.1016/S0304-3940(01)01502-6
   You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109
   Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
   Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015
   Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356
NR 146
TC 104
Z9 107
U1 0
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUL
PY 2013
VL 126
IS 2
BP 191
EP 202
DI 10.1111/jnc.12304
PG 12
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 175DY
UT WOS:000321211700006
PM 23668663
DA 2020-09-29
ER

PT J
AU Figueiredo, CP
   Clarke, JR
   Ledo, JH
   Ribeiro, FC
   Costa, CV
   Melo, HM
   Mota-Sales, AP
   Saraiva, LM
   Klein, WL
   Sebollela, A
   De Felice, FG
   Ferreira, ST
AF Figueiredo, Claudia P.
   Clarke, Julia R.
   Ledo, Jose Henrique
   Ribeiro, Felipe C.
   Costa, Carine V.
   Melo, Helen M.
   Mota-Sales, Axa P.
   Saraiva, Leonardo M.
   Klein, William L.
   Sebollela, Adriano
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Memantine Rescues Transient Cognitive Impairment Caused by
   High-Molecular-Weight A beta Oligomers But Not the Persistent Impairment
   Induced by Low-Molecular-Weight Oligomers
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID LONG-TERM POTENTIATION; RECEPTOR-DEPENDENT MECHANISM; SOLUBLE-PROTEIN
   OLIGOMERS; AMYLOID-BETA; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; NMDA
   RECEPTORS; MOUSE HIPPOCAMPUS; PEPTIDE OLIGOMERS; MEMORY LOSS
AB Brain accumulation of soluble amyloid-beta oligomers (A beta Os) has been implicated in synapse failure and cognitive impairment in Alzheimer's disease (AD). However, whether and how oligomers of different sizes induce synapse dysfunction is a matter of controversy. Here, we report that low-molecular-weight (LMW) and high-molecular-weight (HMW) A beta oligomers differentially impact synapses and memory. A single intracerebroventricular injection of LMW A beta Os (10 pmol) induced rapid and persistent cognitive impairment in mice. On the other hand, memory deficit induced by HMW A beta Os (10 pmol) was found to be reversible. While memory impairment in LMW oligomer-injected mice was associated with decreased hippocampal synaptophysin and GluN2B immunoreactivities, synaptic pathology was not detected in the hippocampi of HMW oligomer-injected mice. On the other hand, HMW oligomers, but not LMW oligomers, induced oxidative stress in hippocampal neurons. Memantine rescued both neuronal oxidative stress and the transient memory impairment caused by HMW oligomers, but did not prevent the persistent cognitive deficit induced by LMW oligomers. Results establish that different A beta oligomer assemblies act in an orchestrated manner, inducing different pathologies and leading to synapse dysfunction. Furthermore, results suggest a mechanistic explanation for the limited efficacy of memantine in preventing memory loss in AD.
C1 [Figueiredo, Claudia P.; Ribeiro, Felipe C.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Figueiredo, Claudia P.; Clarke, Julia R.; Ledo, Jose Henrique; Costa, Carine V.; Melo, Helen M.; Mota-Sales, Axa P.; Saraiva, Leonardo M.; Sebollela, Adriano; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM felice@bioqmed.ufrj.br; ferreira@bioqmed.ufrj.br
RI Clarke, Julia/AAF-9434-2019; Ribeiro, Felipe Campos/W-9758-2019;
   Ferreira, Sergio/AAZ-1576-2020; Figueiredo, Claudia P/F-8424-2012;
   Sebollela, Adriano/O-4385-2014
OI Ribeiro, Felipe Campos/0000-0003-3028-3307; Ferreira,
   Sergio/0000-0001-7160-9866; Sebollela, Adriano/0000-0002-7444-9156;
   Figueiredo, Claudia/0000-0001-9467-9891
FU National Institute for Translational Neuroscience (Brazil); Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Human Frontier
   Science ProgramHuman Frontier Science Program; John Simon Guggenheim
   Memorial Foundation
FX This work was supported by grants from the National Institute for
   Translational Neuroscience (Brazil) (S.T.F.), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (A.S., C.P.F., J.R.C., S.T.F.,
   F.G.D.F.), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (C.P.F., J.R.C., S.T.F., F.G.D.F.), Human Frontier Science Program
   (F.G.D.F.), and John Simon Guggenheim Memorial Foundation (F.G.D.F.). We
   thank Maira S. Oliveira and Mariangela M. Viana for technical support
   and Ana Claudia Rangel for competent lab and project management.
CR ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8
   BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Benilova I, 2011, NAT NEUROSCI, V14, P949, DOI 10.1038/nn.2871
   Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]
   Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110
   Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012
   CHEN HSV, 1992, J NEUROSCI, V12, P4427
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107
   Creeley C, 2006, J NEUROSCI, V26, P3923, DOI 10.1523/JNEUROSCI.4883-05.2006
   da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Drever BD, 2007, J ALZHEIMERS DIS, V12, P319
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kervern M, 2012, J ALZHEIMERS DIS, V32, P183, DOI 10.3233/JAD-2012-120394
   Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012
   Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x
   LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x
   LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Murphy KPSJ, 1997, J PHYSIOL-LONDON, V504, P379, DOI 10.1111/j.1469-7793.1997.379be.x
   MURPHY TH, 1990, DEV BRAIN RES, V57, P146, DOI 10.1016/0165-3806(90)90195-5
   Pacifici R, 2011, PLOS CURR, V3
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754
   Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087
   Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x
   Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010
NR 56
TC 95
Z9 97
U1 0
U2 18
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUN 5
PY 2013
VL 33
IS 23
BP 9626
EP U317
DI 10.1523/JNEUROSCI.0482-13.2013
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 158IS
UT WOS:000319963300006
PM 23739959
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Ferreira, ST
AF Ferreira, S. T.
TI Inhibition of choline acetyltransferase as a mechanism for cholinergic
   dysfunction induced by amyloid-beta peptide oligomers
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 24th Biennial Meeting of the International-Society-for-Neurochemistry
   and the American-Society-for-Neurochemistry
CY APR 20-24, 2013
CL Cancun, MEXICO
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 1
Z9 1
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD MAY
PY 2013
VL 125
SU 1
SI SI
BP 84
EP 84
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 117OB
UT WOS:000316961700163
DA 2020-09-29
ER

PT J
AU Santos, LE
   Figueiredo-Freitas, C
   Nunes-Tavares, N
   Ferreira, ST
   de Mello, FG
AF Santos, L. E.
   Figueiredo-Freitas, C.
   Nunes-Tavares, N.
   Ferreira, S. T.
   de Mello, F. G.
TI Loss of choline acetyltransferase activity caused by oxidative damage:
   Mechanism and possible implications for Alzheimer's disease
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 24th Biennial Meeting of the International-Society-for-Neurochemistry
   and the American-Society-for-Neurochemistry
CY APR 20-24, 2013
CL Cancun, MEXICO
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Santos, L. E.; Nunes-Tavares, N.; de Mello, F. G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil.
   [Figueiredo-Freitas, C.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil.
RI Santos, Luis/B-4961-2015; Ferreira, Sergio/AAZ-1576-2020
OI Santos, Luis/0000-0002-0694-733X; Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD MAY
PY 2013
VL 125
SU 1
SI SI
BP 238
EP 239
PG 2
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 117OB
UT WOS:000316961700549
DA 2020-09-29
ER

PT J
AU Calcia, MA
   Madeira, C
   Alheira, FV
   Silva, TCS
   Tannos, FM
   Vargas-Lopes, C
   Goldenstein, N
   Brasil, MA
   Ferreira, ST
   Panizzutti, R
AF Calcia, Marilia A.
   Madeira, Caroline
   Alheira, Flavio V.
   Silva, Thuany C. S.
   Tannos, Filippe M.
   Vargas-Lopes, Charles
   Goldenstein, Nelson
   Brasil, Marco Antonio
   Ferreira, Sergio T.
   Panizzutti, Rogerio
TI Plasma levels of D-serine in Brazilian individuals with schizophrenia
SO SCHIZOPHRENIA RESEARCH
LA English
DT Article
DE D-serine; Schizophrenia; NMDA receptor; Negative symptoms; Aging
ID AMINO-ACID OXIDASE; NEUROMODULATOR D-SERINE; D-ASPARTATE RECEPTOR;
   RAT-BRAIN; RACEMASE GENE; GLYCINE SITE; SERUM-LEVELS; MEMORY;
   SUSCEPTIBILITY; METAANALYSIS
AB Changes in D-serine availability in the brain may contribute to the hypofunction of NMDA-glutamate receptors in schizophrenia; however, measurements of blood levels of D-serine in individuals with schizophrenia have not been consistent amongst previous studies. Here we studied plasma levels of D-serine and L-serine in 84 Brazilian individuals with schizophrenia and 75 gender-and age-matched controls. Plasma levels of D-serine and the ratio of plasma D-serine to total serine were significantly lower in individuals with schizophrenia as compared to the control group. Levels of D-serine were significantly and negatively correlated to the severity of negative symptoms of schizophrenia. We also observed that plasma levels of D-serine significantly decreased with aging in healthy controls. Our results suggest that the possible role of D-serine in the pathophysiology of schizophrenia should be further investigated, with possible implications for the drug treatment of this disorder. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Predio CCS, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Calcia, Marilia A.; Alheira, Flavio V.; Silva, Thuany C. S.; Goldenstein, Nelson; Brasil, Marco Antonio; Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Psiquiatria & Psicol Med, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Panizzutti, R (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Predio CCS, Sala F1-03,Cidade Univ, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM Rogerio@icb.ufrj.br
RI Neurociencia, Inct/I-1011-2013; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Cristine Santos da Silva,
   Thuany/0000-0001-8152-0056; Calcia, Marilia/0000-0001-8488-9342
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ,
   Brazil)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Brazil)National Council for Scientific
   and Technological Development (CNPq); Long-Term Fellowship from the
   Human Frontier Science ProgramHuman Frontier Science Program;
   DECIT/SCTIE/MS; SESDC
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ, Brazil) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil). RP is a
   recipient of the Long-Term Fellowship from the Human Frontier Science
   Program. CM and CVL were supported by pre-doctoral fellowships from CNPq
   and FAPERJ. These institutes had no further role in the study design,
   collection, analysis, interpretation of data, writing of the report, or
   the decision by the authors to submit the paper for publication.; We
   thank Ana Claudia Rangel and Andrea Fantinatti for their technical
   support. This research was supported by grants from DECIT/SCTIE/MS,
   SESDC, FAPERJ and CNPq to RP.RP is a recipient of the Long-Term
   Fellowship from the Human Frontier Science Program.
CR Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4
   Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130
   BECH P, 1988, PSYCHOPHARMACOL BULL, V24, P118
   Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010
   Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499
   De Miranda J, 2000, GENE, V256, P183, DOI 10.1016/S0378-1119(00)00356-5
   Friedman M, 1999, J AGR FOOD CHEM, V47, P3457, DOI 10.1021/jf990080u
   Goltsov AY, 2006, MOL PSYCHIATR, V11, P325, DOI 10.1038/sj.mp.4001801
   Habl G, 2009, J NEURAL TRANSM, V116, P1657, DOI 10.1007/s00702-009-0312-z
   HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F
   Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P767, DOI 10.1016/j.pnpbp.2005.04.023
   Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572
   Heresco-Levy U, 2005, BIOL PSYCHIAT, V57, P577, DOI 10.1016/j.biopsych.2004.12.037
   Hons J, 2008, NEUROENDOCRINOL LETT, V29, P485
   HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2
   Kapoor R, 2006, BRAIN RES, V1106, P205, DOI 10.1016/j.brainres.2006.05.082
   Labrie V, 2012, NEUROPHARMACOLOGY, V62, P1484, DOI 10.1016/j.neuropharm.2011.01.030
   Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261
   LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011
   Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002
   Matsuda S, 2010, PROG NEURO-PSYCHOPH, V34, P895, DOI 10.1016/j.pnpbp.2010.04.013
   Morita Y, 2007, BIOL PSYCHIAT, V61, P1200, DOI 10.1016/j.biopsych.2006.07.025
   Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x
   Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926
   Ohnuma T, 2008, PROG NEURO-PSYCHOPH, V32, P1905, DOI 10.1016/j.pnpbp.2008.07.022
   OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998
   Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051
   Panizzutti R, 2005, NEUROSCI LETT, V380, P111, DOI 10.1016/j.neulet.2005.01.062
   Potier B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.001.2010
   Sacchi S, 2008, J BIOL CHEM, V283, P22244, DOI 10.1074/jbc.M709153200
   Sagud M, 2009, PSYCHIAT DANUB, V21, P371
   Sakurai S, 2004, J NEUROCHEM, V90, P1378, DOI 10.1111/j.1471-4159.2004.02592.x
   SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948
   Singh SP, 2011, CNS DRUGS, V25, P859, DOI 10.2165/11586650-000000000-00000
   Steffek AE, 2006, NEUROREPORT, V17, P1181, DOI 10.1097/01.wnr.0000230512.01339.72
   Targum SD, 1999, J CLIN PSYCHIAT, V60, P4
   Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0
   Tuominen HJ, 2005, SCHIZOPHR RES, V72, P225, DOI 10.1016/j.schres.2004.05.005
   Verrall L, 2007, EUR J NEUROSCI, V26, P1657, DOI 10.1111/j.1460-9568.2007.05769.x
   Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721
   Yamada K, 2005, BIOL PSYCHIAT, V57, P1493, DOI 10.1016/j.biopsych.2005.03.018
   Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008
NR 42
TC 48
Z9 48
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0920-9964
J9 SCHIZOPHR RES
JI Schizophr. Res.
PD DEC
PY 2012
VL 142
IS 1-3
BP 83
EP 87
DI 10.1016/j.schres.2012.09.014
PG 5
WC Psychiatry
SC Psychiatry
GA 039CR
UT WOS:000311220900012
PM 23063707
DA 2020-09-29
ER

PT J
AU Ferreira, ST
AF Ferreira, S. T.
TI Synapse failure induced by Alzheimer's toxic A beta oligomers
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 5th Special Conference of the International-Society-for-Neurochemistry
   on Synapses and Dendritic Spines in Health and Disease
CY SEP 12-15, 2012
CL Buenos Aires, ARGENTINA
SP Int Soc Neurochem
C1 [Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD SEP
PY 2012
VL 122
SU 1
SI SI
BP 4
EP 4
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 003BI
UT WOS:000308582800012
DA 2020-09-29
ER

PT J
AU Godoy, MA
   Saraiva, L
   Vasconcelos-dos-Santos, A
   Monteiro, VL
   Sinis, LC
   Silva, LRP
   Braga, CV
   Leal, RB
   De Felice, FG
   Ferreira, ST
   Mendez-Otero, R
AF Godoy, M. A.
   Saraiva, L.
   Vasconcelos-dos-Santos, A.
   Monteiro, V. L.
   Sinis, L. C.
   Silva, L. R. P.
   Braga, C. V.
   Leal, R. B.
   De Felice, F. G.
   Ferreira, S. T.
   Mendez-Otero, R.
TI Treatment with bone marrow mesenchymal stem cells in an in vitro model
   of Alzheimer's disease
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 5th Special Conference of the International-Society-for-Neurochemistry
   on Synapses and Dendritic Spines in Health and Disease
CY SEP 12-15, 2012
CL Buenos Aires, ARGENTINA
SP Int Soc Neurochem
C1 [Godoy, M. A.; Vasconcelos-dos-Santos, A.; Monteiro, V. L.; Sinis, L. C.; Silva, L. R. P.; Braga, C. V.; Leal, R. B.; Mendez-Otero, R.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Saraiva, L.; De Felice, F. G.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RI Mendez-Otero, Rosalia/AAL-7551-2020; Ferreira, Sergio/AAZ-1576-2020
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; Ferreira,
   Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD SEP
PY 2012
VL 122
SU 1
SI SI
BP 18
EP 18
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 003BI
UT WOS:000308582800053
DA 2020-09-29
ER

PT J
AU Ramella, NA
   Schinella, GR
   Ferreira, ST
   Prieto, ED
   Vela, ME
   Rios, JL
   Tricerri, MA
   Rimoldi, OJ
AF Ramella, Nahuel A.
   Schinella, Guillermo R.
   Ferreira, Sergio T.
   Prieto, Eduardo D.
   Vela, Maria E.
   Luis Rios, Jose
   Alejandra Tricerri, M.
   Rimoldi, Omar J.
TI Human Apolipoprotein A-I Natural Variants: Molecular Mechanisms
   Underlying Amyloidogenic Propensity
SO PLOS ONE
LA English
DT Article
ID SYSTEMIC AMYLOIDOSIS; HEREDITARY AMYLOIDOSIS; HYDROSTATIC-PRESSURE;
   ALZHEIMERS-DISEASE; CHOLESTEROL EFFLUX; BUNDLE PROTEIN; HUMAN LYSOZYME;
   MUTATION; BETA; FLUORESCENCE
AB Human apolipoprotein A-I (apoA-I)-derived amyloidosis can present with either wild-type (Wt) protein deposits in atherosclerotic plaques or as a hereditary form in which apoA-I variants deposit causing multiple organ failure. More than 15 single amino acid replacement amyloidogenic apoA-I variants have been described, but the molecular mechanisms involved in amyloid-associated pathology remain largely unknown. Here, we have investigated by fluorescence and biochemical approaches the stabilities and propensities to aggregate of two disease-associated apoA-I variants, apoA-IGly26Arg, associated with polyneuropathy and kidney dysfunction, and apoA-ILys107-0, implicated in amyloidosis in severe atherosclerosis. Results showed that both variants share common structural properties including decreased stability compared to Wt apoA-I and a more flexible structure that gives rise to formation of partially folded states. Interestingly, however, distinct features appear to determine their pathogenic mechanisms. ApoA-ILys107-0 has an increased propensity to aggregate at physiological pH and in a pro-inflammatory microenvironment than Wt apoA-I, whereas apoA-IGly26Arg elicited macrophage activation, thus stimulating local chronic inflammation. Our results strongly suggest that some natural mutations in apoA-I variants elicit protein tendency to aggregate, but in addition the specific interaction of different variants with macrophages may contribute to cellular stress and toxicity in hereditary amyloidosis.
C1 [Ramella, Nahuel A.; Prieto, Eduardo D.; Alejandra Tricerri, M.; Rimoldi, Omar J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.
   [Schinella, Guillermo R.] Univ Nacl La Plata, Fac Ciencias Med, Catedra Farmacol Basica, La Plata, Buenos Aires, Argentina.
   [Schinella, Guillermo R.] Pcia Buenos Aires, Comis Invest Cient, La Plata, Buenos Aires, Argentina.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Program Biochem & Cellular Biophys, Rio De Janeiro, Brazil.
   [Vela, Maria E.] Univ Nacl La Plata, CONICET, Inst Invest Fis Quim Teor & Aplicadas INIFTA, La Plata, Buenos Aires, Argentina.
   [Luis Rios, Jose] Univ Valencia, Fac Farm, Dept Farmacol, E-46010 Valencia, Spain.
RP Ramella, NA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.
EM aletricerri@yahoo.com
RI Schinella, Guillermo/V-9937-2018; Ferreira, Sergio/AAZ-1576-2020;
   Neurociencia, Inct/I-1011-2013
OI Schinella, Guillermo/0000-0001-9541-9688; Ferreira,
   Sergio/0000-0001-7160-9866; Vela, Maria Elena/0000-0003-4502-5618
FU Agencia Nacional de Promocion Cientifica y Tecnologica, ArgentinaANPCyT
   [2106-2008, 26228]; Universidad Nacional de La PlataNational University
   of La Plata [M158]; Consejo Nacional de Investigaciones Cientificas y
   TecnicasConsejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET) [PIP 112-200801-00953]; Spanish government (MICIIN)
   [SAF2009-10059-C03-01]; National Institute of Translational Neuroscience
   (Brazil); Conselho Nacional de Pesquisas (CNPq/Brazil)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Spanish government (FEDER)European Union (EU)
   [SAF2009-10059-C03-01]
FX The work presented here was supported by the Agencia Nacional de
   Promocion Cientifica y Tecnologica, Argentina, grants Numbers 2106-2008
   to MAT, and Number 26228 to Horacio Garda; Universidad Nacional de La
   Plata (grant Number M158 to MAT); Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (PIP 112-200801-00953 to MAT and HG); and grant
   SAF2009-10059-C03-01 from the Spanish government (MICIIN and FEDER) to
   JLR. STF is supported by grants from National Institute of Translational
   Neuroscience (Brazil), Conselho Nacional de Pesquisas (CNPq/Brazil) and
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ/Brazil). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amarzguioui M, 1998, BIOCHEM BIOPH RES CO, V242, P534, DOI 10.1006/bbrc.1997.8005
   ARAKI K, 1994, BBA-LIPID LIPID MET, V1214, P272
   Booth DR, 1996, J CLIN INVEST, V97, P2714, DOI 10.1172/JCI118725
   Botelho MG, 2003, J BIOL CHEM, V278, P34259, DOI 10.1074/jbc.M303189200
   Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a
   Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h
   De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Eriksson M, 2009, J MOL DIAGN, V11, P257, DOI 10.2353/jmoldx.2009.080161
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539
   Gonzalez MC, 2008, ARCH BIOCHEM BIOPHYS, V473, P34, DOI 10.1016/j.abb.2008.02.021
   Gregorini G, 2005, J AM SOC NEPHROL, V16, P3680, DOI 10.1681/ASN.2005040382
   Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991
   Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014
   Hamidi Asl K, 1999, BIOCHEM BIOPH RES CO, V257, P584, DOI DOI 10.1006/BBRC.1999.0518
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9
   Jaureguiberry MS, 2010, J MEMBRANE BIOL, V234, P183, DOI 10.1007/s00232-010-9245-6
   Kazama JJ, 2001, NEPHROL DIAL TRANSPL, V16, P31, DOI 10.1093/ndt/16.suppl_4.31
   Klabunde T, 2000, NAT STRUCT BIOL, V7, P312
   Lachmann HJ, 2002, NEW ENGL J MED, V346, P1786, DOI 10.1056/NEJMoa013354
   Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493
   Lakowicz J. R., 1986, PRINCIPLES FLUORESCE
   LeVine H, 1999, METHOD ENZYMOL, V309, P274
   Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   Martins SM, 2002, EUR J BIOCHEM, V269, P5484, DOI 10.1046/j.1432-1033.2002.03248.x
   Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144
   Miettinen HE, 1997, ARTERIOSCL THROM VAS, V17, P3021, DOI 10.1161/01.ATV.17.11.3021
   Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S
   Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015
   NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4
   NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6
   Obici L, 1999, AM J PATHOL, V155, P695, DOI 10.1016/S0002-9440(10)65167-X
   Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883
   RADER DJ, 1992, J LIPID RES, V33, P755
   Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532
   Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5
   Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2
   Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b
   SOUTAR AK, 1992, P NATL ACAD SCI USA, V89, P7389, DOI 10.1073/pnas.89.16.7389
   TAKADA Y, 1990, BIOCHIM BIOPHYS ACTA, V1043, P169, DOI 10.1016/0005-2760(90)90292-6
   Testro AG, 2007, LIVER TRANSPLANT, V13, P1028, DOI 10.1002/lt.21176
   TillyKiesi M, 1997, ARTERIOSCL THROM VAS, V17, P873, DOI 10.1161/01.ATV.17.5.873
   Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251
   Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q
   VANALLEN MW, 1969, NEUROLOGY, V19, P10, DOI 10.1212/WNL.19.1.10
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   VIGUSHIN DM, 1994, Q J MED, V87, P149
   VOLLMER E, 1991, VIRCHOWS ARCH A, V419, P79, DOI 10.1007/BF01600220
   Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923
   Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com
NR 58
TC 23
Z9 24
U1 2
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2012
VL 7
IS 8
AR e43755
DI 10.1371/journal.pone.0043755
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 998CA
UT WOS:000308213600040
PM 22952757
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Nunes-Tavares, N
   Santos, LE
   Stutz, B
   Brito-Moreira, J
   Klein, WL
   Ferreira, ST
   de Mello, FG
AF Nunes-Tavares, Nilson
   Santos, Luis Eduardo
   Stutz, Bernardo
   Brito-Moreira, Jordano
   Klein, William L.
   Ferreira, Sergio T.
   de Mello, Fernando G.
TI Inhibition of Choline Acetyltransferase as a Mechanism for Cholinergic
   Dysfunction Induced by Amyloid-beta Peptide Oligomers
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RECEPTOR-DEPENDENT MECHANISM; EMBRYONIC AVIAN RETINA;
   CENTRAL-NERVOUS-SYSTEM; D-ASPARTATE RECEPTOR; A-BETA;
   ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; OXIDATIVE STRESS; CHICKEN
   RETINA; ACTIVATION
AB Dysregulated cholinergic signaling is an early hallmark of Alzheimer disease (AD), usually ascribed to degeneration of cholinergic neurons induced by the amyloid-beta peptide (A beta). It is now generally accepted that neuronal dysfunction and memory deficits in the early stages of AD are caused by the neuronal impact of soluble A beta oligomers (A beta Os). A beta Os build up in AD brain and specifically attach to excitatory synapses, leading to synapse dysfunction. Here, we have investigated the possibility that A beta Os could impact cholinergic signaling. The activity of choline acetyltransferase (ChAT, the enzyme that carries out ACh production) was inhibited by similar to 50% in cultured cholinergic neurons exposed to low nanomolar concentrations of A beta Os. 3-(4,5-Dimethylthiazol-2-yl)-2,5-di-phenyltetrazoliumbromide (MTT) reduction, lactatedehydrogenase release, and [H-3] choline uptake assays showed no evidence of neuronal damage or loss of viability that could account for reduced ChAT activity under these conditions. Glutamate receptor antagonists fully blocked ChAT inhibition and oxidative stress induced by A beta Os. Antioxidant polyunsaturated fatty acids had similar effects, indicating that oxidative damage may be involved in ChAT inhibition. Treatment with insulin, previously shown to down-regulate neuronal A beta O binding sites, fully prevented A beta O-induced inhibition of ChAT. Interestingly, we found that A beta Os selectively bind to similar to 50% of cultured cholinergic neurons, suggesting that ChAT is fully inhibited in A beta O-targeted neurons. Reduction in ChAT activity instigated by A beta Os may thus be a relevant event in early stage AD pathology, preceding the loss of cholinergic neurons commonly observed in AD brains.
C1 [Nunes-Tavares, Nilson; Santos, Luis Eduardo; Stutz, Bernardo; de Mello, Fernando G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Brito-Moreira, Jordano; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Klein, William L.] Northwestern Univ, Evanston, IL 60208 USA.
RP de Mello, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM fgmello@biof.ufrj.br
RI Santos, Luis/B-4961-2015; Neurociencia, Inct/I-1011-2013; Ferreira,
   Sergio/AAZ-1576-2020
OI Santos, Luis/0000-0002-0694-733X; Ferreira, Sergio/0000-0001-7160-9866
FU Conselho Nacional de Desenvolvi-mento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   National Institute of Translational Neuroscience
FX This work was supported by grants from Conselho Nacional de
   Desenvolvi-mento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro, and National Institute of Translational
   Neuroscience (to F.G.d.M. and S.T.F.).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051
   Bate C, 2010, NEUROTOX RES, V17, P203, DOI 10.1007/s12640-009-9093-2
   BAUGHMAN RW, 1977, BRAIN RES, V138, P469, DOI 10.1016/0006-8993(77)90684-9
   Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030
   Blasina MF, 2000, CELL TISSUE RES, V299, P173, DOI 10.1007/s004419900117
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Contestabile A, 2011, BEHAV BRAIN RES, V221, P334, DOI 10.1016/j.bbr.2009.12.044
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   DEMELLO FG, 1991, CELL MOL NEUROBIOL, V11, P485, DOI 10.1007/BF00734811
   DEMELLO FG, 1990, J NEUROCHEM, V54, P886, DOI 10.1111/j.1471-4159.1990.tb02334.x
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kim SJ, 2010, NEUROSCI LETT, V479, P292, DOI 10.1016/j.neulet.2010.05.083
   Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Loureiro-dos-Santos NE, 2002, CELL MOL NEUROBIOL, V22, P727, DOI 10.1023/A:1021809124814
   Loureiro-dos-Santos NE, 2001, J NEUROCHEM, V77, P1136, DOI 10.1046/j.1471-4159.2001.00330.x
   Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com
   Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASLAND R H, 1980, Neurochemistry International, V1, P501, DOI 10.1016/0197-0186(80)90083-2
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   SPIRA AW, 1987, J COMP NEUROL, V260, P526, DOI 10.1002/cne.902600406
   STRADA O, 1992, P NATL ACAD SCI USA, V89, P9549, DOI 10.1073/pnas.89.20.9549
   VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899
   Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587
   Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4
   WILLIAMS K, 1993, MOL PHARMACOL, V44, P851
   Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
NR 47
TC 54
Z9 54
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 1
PY 2012
VL 287
IS 23
BP 19377
EP 19385
DI 10.1074/jbc.M111.321448
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 974EF
UT WOS:000306411900052
PM 22505713
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Bomfim, TR
   Forny-Germano, L
   Sathler, LB
   Brito-Moreira, J
   Houzel, JC
   Decker, H
   Silverman, MA
   Kazi, H
   Melo, HM
   McClean, PL
   Holscher, C
   Arnold, SE
   Talbot, K
   Klein, WL
   Munoz, DP
   Ferreira, ST
   De Felice, FG
AF Bomfim, Theresa R.
   Forny-Germano, Leticia
   Sathler, Luciana B.
   Brito-Moreira, Jordano
   Houzel, Jean-Christophe
   Decker, Helena
   Silverman, Michael A.
   Kazi, Hala
   Melo, Helen M.
   McClean, Paula L.
   Holscher, Christian
   Arnold, Steven E.
   Talbot, Konrad
   Klein, William L.
   Munoz, Douglas P.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI An anti-diabetes agent protects the mouse brain from defective insulin
   signaling caused by Alzheimer's disease-associated A beta oligomers
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID CULTURED HIPPOCAMPAL-NEURONS; RECEPTOR-DEPENDENT MECHANISM;
   AMYLOID-BETA; TNF-ALPHA; SYNAPTIC PLASTICITY; AXONAL-TRANSPORT;
   TRANSGENIC MICE; INTRANASAL INSULIN; PEPTIDE OLIGOMERS; MAMMALIAN TARGET
AB Defective brain insulin signaling has been suggested to contribute to the cognitive deficits in patients with Alzheimer's disease (AD). Although a connection between AD and diabetes has been suggested, a major unknown is the mechanism(s) by which insulin resistance in the brain arises in individuals with AD. Here, we show that serine phosphorylation of IRS-1 (IRS-1pSer) is common to both diseases. Brain tissue from humans with AD had elevated levels of IRS-1pSer and activated JNK, analogous to what occurs in peripheral tissue in patients with diabetes. We found that amyloid-beta peptide (A beta) oligomers, synaptotoxins that accumulate in the brains of AD patients, activated the JNK/TNF-alpha pathway, induced IRS-1 phosphorylation at multiple serine residues, and inhibited physiological IRS-1pTyr in mature cultured hippocarnpal neurons. Impaired IRS-1 signaling was also present in the hippocampi of Tg mice with a brain condition that models AD. Importantly, intracerebroventricular injection of A beta oligomers triggered hippocampal IRS-1pSer and JNK activation in cynomolgus monkeys. The oligomer-induced neuronal pathologies observed in vitro, including impaired axonal transport, were prevented by exposure to exendin-4 (exenatide), an anti-diabetes agent. In Tg mice, exendin-4 decreased levels of hippocampal IRS-1pSer and activated JNK and improved behavioral measures of cognition. By establishing molecular links between the dysregulated insulin signaling in AD and diabetes, our results open avenues for the investigation of new therapeutics in AD.
C1 [De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem, CCS, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Forny-Germano, Leticia; Houzel, Jean-Christophe] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Decker, Helena; Silverman, Michael A.] Simon Fraser Univ, Dept Biol Sci, Vancouver, BC, Canada.
   [Kazi, Hala; Arnold, Steven E.; Talbot, Konrad] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.
   [McClean, Paula L.; Holscher, Christian] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
   [Munoz, Douglas P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, CCS, Room H2-019, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM felice@bioqmed.ufrj.br
RI Houzel, Jean Christophe/G-3723-2010; Forny-Germano, Leticia/L-6639-2019;
   Forny-Germano, Leticia/D-1342-2017; Arnold, Steven/J-7546-2012;
   Ferreira, Sergio/AAZ-1576-2020; Neurociencia, Inct/I-1011-2013; Houzel,
   Jean Christophe/M-7936-2019
OI Houzel, Jean Christophe/0000-0001-5128-438X; Forny-Germano,
   Leticia/0000-0001-8301-0711; Forny-Germano, Leticia/0000-0001-8301-0711;
   Ferreira, Sergio/0000-0001-7160-9866; Houzel, Jean
   Christophe/0000-0001-5128-438X; Silverman, Michael
   A./0000-0001-6967-4917; Holscher, Christian/0000-0002-8159-3260
FU Human Frontier Science Program (HFSP)Human Frontier Science Program;
   John Simon Guggenheim Memorial Foundation; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Instituto Nacional de Neurociencia Translacional (INNT); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico and Coordenacao de
   Aperfeicoamento de Pessoal de Ensino Superior; Canadian Institutes of
   Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-77734,
   90396]; HFSPHuman Frontier Science Program; Canada Research ChairNatural
   Resources CanadaCanadian Forest ServiceCanada Research Chairs; American
   Health Assistance FoundationBrightFocus Foundation; Alzheimer's
   AssociationAlzheimer's Association; NIH-National Institute on
   AgingUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [R01-AG18877, R01-AG22547]; Temple Foundation; National Science and
   Engineering Research CouncilNatural Sciences and Engineering Research
   Council of Canada [327100-06]; Canadian Foundation for InnovationCanada
   Foundation for Innovation [12793]
FX This work was supported by the Human Frontier Science Program (HFSP) and
   the John Simon Guggenheim Memorial Foundation (FGF). F.G. De Felice and
   S.T. Ferreira are also funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ), and Instituto Nacional de Neurociencia
   Translacional (INNT). T.R. Bomfim, L. Forny-Germano, L.B. Sathler, H.M.
   Melo, and J. Brito-Moreira are supported by predoctoral fellowships from
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and
   Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior.
   Experiments on monkeys were funded by a grant (MOP-77734) from the
   Canadian Institutes of Health Research (to D.P. Munoz) and by HFSP (to
   F.G. De Felice). DR Munoz was also supported by the Canada Research
   Chair Program. W.L. Klein is funded by grants from the American Health
   Assistance Foundation, Alzheimer's Association, and NIH-National
   Institute on Aging grants R01-AG18877 and R01-AG22547. K. Talbot and
   S.E. Arnold were supported by a Temple Foundation Discovery award and by
   the Alzheimer's Association. M.A. Silverman is funded by the National
   Science and Engineering Research Council (no. 327100-06), the Canadian
   Foundation for Innovation (12793), and the Canadian Institutes of Health
   Research (no. 90396). We thank G. Banker (Oregon Health State
   University) for the gift of DN JNK and L. Veloso (University of
   Campinas, Campinas, Brazil) for the gift of infliximab.
CR Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200
   Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047
   AMARAL DG, 1988, J NEUROSCI, V8, P3306
   Araujo EP, 2007, ENDOCRINOLOGY, V148, P5991, DOI 10.1210/en.2007-0132
   Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378
   Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002
   Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319
   Brewer GJ, 2008, J NEUROSCI METH, V170, P181, DOI 10.1016/j.jneumeth.2008.01.009
   Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420
   Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009
   Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003
   Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Dhamoon MS, 2009, NEUROLOGY, V72, P292, DOI 10.1212/01.wnl.0000344246.91081.2c
   Dou JT, 2005, LEARN MEMORY, V12, P646, DOI 10.1101/lm.88005
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32
   Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Fisher TL, 2004, CURR BIOL, V14, pR1005, DOI 10.1016/j.cub.2004.11.024
   Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043
   Gengler S, 2012, NEUROBIOL AGING, V33, P265, DOI 10.1016/j.neurobiolaging.2010.02.014
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854
   Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955
   Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311
   Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474
   Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032
   Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234
   Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845
   Mattson MP, 2003, NAT MED, V9, P1113, DOI 10.1038/nm0903-1113
   McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Morel M, 2009, J CELL MOL MED, V13, P1476, DOI 10.1111/j.1582-4934.2009.00849.x
   Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009
   Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Natalicchio A, 2010, ENDOCRINOLOGY, V151, P2019, DOI 10.1210/en.2009-1166
   Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298
   Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021
   Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533
   Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425
   Tobinick E, 2010, EXPERT REV NEUROTHER, V10, P985, DOI [10.1586/ern.10.52, 10.1586/ERN.10.52]
   Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72
   Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200
   Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335
   White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001
   Wiedmann Marcus W., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P295
   Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 75
TC 476
Z9 494
U1 1
U2 122
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD APR
PY 2012
VL 122
IS 4
BP 1339
EP 1353
DI 10.1172/JCI57256
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 918WJ
UT WOS:000302281800028
PM 22476196
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Sebollela, A
   Freitas-Correa, L
   Oliveira, FF
   Paula-Lima, AC
   Saraiva, LM
   Martins, SM
   Mota, LD
   Torres, C
   Alves-Leon, S
   de Souza, JM
   Carraro, DM
   Brentani, H
   De Felice, FG
   Ferreira, ST
AF Sebollela, Adriano
   Freitas-Correa, Leo
   Oliveira, Fabio F.
   Paula-Lima, Andrea C.
   Saraiva, Leonardo M.
   Martins, Samantha M.
   Mota, Louise D.
   Torres, Cesar
   Alves-Leon, Soniza
   de Souza, Jorge M.
   Carraro, Dirce M.
   Brentani, Helena
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Amyloid-beta Oligomers Induce Differential Gene Expression in Adult
   Human Brain Slices
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RECEPTOR-DEPENDENT MECHANISM; SOLUBLE-PROTEIN OLIGOMERS; D-ASPARTATE
   RECEPTORS; LONG-TERM DEPRESSION; NERVE-CELL LINE; ALZHEIMERS-DISEASE;
   A-BETA; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; SYNAPTOPHYSIN MESSAGE
AB Cognitive decline in Alzheimer disease (AD) is increasingly attributed to the neuronal impact of soluble oligomers of the amyloid-beta peptide (A beta Os). Current knowledge on the molecular and cellular mechanisms underlying the toxicity of A beta Os stems largely from rodent-derived cell/tissue culture experiments or from transgenic models of AD, which do not necessarily recapitulate the complexity of the human disease. Here, we used DNA microarray and RT-PCR to investigate changes in transcription in adult human cortical slices exposed to sublethal doses of A beta Os. The results revealed a set of 27 genes that showed consistent differential expression upon exposure of slices from three different donors to A beta Os. Functional classification of differentially expressed genes revealed that A beta Os impact pathways important for neuronal physiology and known to be dysregulated in AD, including vesicle trafficking, cell adhesion, actin cytoskeleton dynamics, and insulin signaling. Most genes (70%) were down-regulated by A beta O treatment, suggesting a predominantly inhibitory effect on the corresponding pathways. Significantly, A beta Os induced down-regulation of synaptophysin, a presynaptic vesicle membrane protein, suggesting a mechanism by which oligomers cause synapse failure. The results provide insight into early mechanisms of pathogenesis of AD and suggest that the neuronal pathways affected by A beta Os may be targets for the development of novel diagnostic or therapeutic approaches.
C1 [Sebollela, Adriano; Freitas-Correa, Leo; Oliveira, Fabio F.; Paula-Lima, Andrea C.; Saraiva, Leonardo M.; Martins, Samantha M.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Mota, Louise D.; Torres, Cesar; Carraro, Dirce M.; Brentani, Helena] AC Camargo Hosp, Int Ctr Educ & Res, BR-01509 Sao Paulo, Brazil.
   [de Souza, Jorge M.] Univ Fed Rio de Janeiro, Div Neurosurg, Clementino Fraga Filho Univ Hosp, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurol, Epilepsy Program, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Paula-Lima, Andrea C.] Univ Chile, Ctr Mol Studies Cell, Fac Dent, Santiago, Chile.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Brentani, Helena/G-6839-2011; Paula-Lima, Andrea C./I-2537-2013; Leon,
   Soniza V Alves/J-7786-2012; Ferreira, Sergio/AAZ-1576-2020; Sebollela,
   Adriano/O-4385-2014; Neurociencia, Inct/I-1011-2013; carraro,
   dirce/C-9179-2009
OI Brentani, Helena/0000-0001-5192-4682; Paula-Lima, Andrea
   C./0000-0002-0466-7561; Ferreira, Sergio/0000-0001-7160-9866; Sebollela,
   Adriano/0000-0002-7444-9156; carraro, dirce/0000-0001-5667-1418
FU Human Frontiers Science ProgramHuman Frontier Science Program; The John
   Simon Guggenheim Foundation; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio
   de JaneiroNational Council for Scientific and Technological Development
   (CNPq)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); National Institute for Translational
   Neuroscience; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by grants from the Human Frontiers Science
   Program and The John Simon Guggenheim Foundation (to F. G. D.-F.) and
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and National
   Institute for Translational Neuroscience (to S. T. F. and F. G. D.-F.).;
   Recipient of a postdoctoral fellowship from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico. To whom correspondence may be
   addressed. E-mail: sebollela@bioqmed.ufrj.br.
CR Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107
   Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9
   Billuart P, 2003, NEURON, V38, P843, DOI 10.1016/S0896-6273(03)00362-3
   Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006
   Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100
   Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258
   Brentani RR, 2005, CRIT REV ONCOL HEMAT, V54, P95, DOI 10.1016/j.critrevonc.2004.12.006
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Callahan LM, 1999, J NEUROPATH EXP NEUR, V58, P275, DOI 10.1097/00005072-199903000-00007
   Callahan LM, 2002, J NEUROPATH EXP NEUR, V61, P384, DOI 10.1093/jnen/61.5.384
   Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157
   Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351
   Cox WG, 2004, BIOTECHNIQUES, V36, P114, DOI 10.2144/04361RR02
   Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Dickey CA, 2003, J NEUROSCI, V23, P5219
   Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10
   ELFERINK LA, 1993, J CELL SCI, P75
   Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004
   Ferreira EN, 2010, DIAGN MOL PATHOL, V19, P45, DOI 10.1097/PDM.0b013e3181ae8186
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016
   Heinitz K, 2006, J NEUROCHEM, V98, P1930, DOI 10.1111/j.1471-4159.2006.04015.x
   Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035
   Ishibashi KI, 2006, J NEUROSCI RES, V84, P632, DOI 10.1002/jnr.20952
   Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200
   Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845
   Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298
   Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000
   Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140
   Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X
   SABO S, 1995, NEUROSCI LETT, V184, P25, DOI 10.1016/0304-3940(94)11159-G
   Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vencio RZN, 2005, DNA RES, V12, P211, DOI 10.1093/dnares/dsi007
   Verwer RWH, 2002, FASEB J, V16, P54, DOI 10.1096/fj.01-0504com
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4
   Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004
   Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x
   Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004
   Zhang C, 1996, NEUROSCI LETT, V211, P187, DOI 10.1016/0304-3940(96)12761-0
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 76
TC 51
Z9 51
U1 0
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 2
PY 2012
VL 287
IS 10
BP 7436
EP 7445
DI 10.1074/jbc.M111.298471
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 902SL
UT WOS:000301060200044
PM 22235132
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Guillot-Sestier, MV
   Sunyach, C
   Ferreira, ST
   Marzolo, MP
   Bauer, C
   Thevenet, A
   Checler, F
AF Guillot-Sestier, Marie-Victoire
   Sunyach, Claire
   Ferreira, Sergio T.
   Marzolo, Maria-Paz
   Bauer, Charlotte
   Thevenet, Aurelie
   Checler, Frederic
TI alpha-Secretase-derived Fragment of Cellular Prion, N1, Protects against
   Monomeric and Oligomeric Amyloid beta (A beta)-associated Cell Death
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RECEPTOR-RELATED PROTEIN; HEK293 HUMAN-CELLS; PRECURSOR PROTEIN;
   ALZHEIMERS-DISEASE; WILD-TYPE; MUSCARINIC RECEPTORS; SYNAPTIC
   PLASTICITY; P53; PRESENILIN-1; CLEAVAGE
AB In physiological conditions, both beta-amyloid precursor protein (beta APP) and cellular prion (PrPc) undergo similar disintegrin-mediated alpha-secretase cleavage yielding N-terminal secreted products referred to as soluble amyloid precursor protein-alpha (sAPP alpha) and N1, respectively. We recently demonstrated that N1 displays neuroprotective properties by reducing p53-dependent cell death both in vitro and in vivo. In this study, we examined the potential of N1 as a neuroprotector against amyloid beta (A beta)-mediated toxicity. We first show that both recombinant sAPP alpha and N1, but not its inactive parent fragment N2, reduce staurosporine-stimulated caspase-3 activation and TUNEL-positive cell death by lowering p53 promoter transactivation and activity in human cells. We demonstrate that N1 also lowers toxicity, cell death, and p53 pathway exacerbation triggered by Swedish mutated beta APP overexpression in human cells. We designed a CHO cell line overexpressing the London mutated beta APP (APP(LDN)) that yields A beta oligomers. N1 protected primary cultured neurons against toxicity and cell death triggered by oligomer-enriched APP(LDN)-derived conditioned medium. Finally, we establish that N1 also protects neurons against oligomers extracted from Alzheimer disease-affected brain tissues. Overall, our data indicate that a cellular prion catabolite could interfere with A beta-associated toxicity and that its production could be seen as a cellular protective mechanism aimed at compensating for an sAPP alpha deficit taking place at the early asymptomatic phase of Alzheimer disease.
C1 [Guillot-Sestier, Marie-Victoire; Sunyach, Claire; Bauer, Charlotte; Thevenet, Aurelie; Checler, Frederic] Univ Nice Sophia Antipolis UNSA, Inst Pharmacol Mol & Cellulaire, CNRS, UMR6097, F-06560 Valbonne, France.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Lab Traf Intracelular & Senalizac, Dept Biol Celular & Mol, Santiago 6513492, Chile.
RP Checler, F (corresponding author), Univ Nice Sophia Antipolis UNSA, Inst Pharmacol Mol & Cellulaire, CNRS, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.
EM checler@ipmc.cnrs.fr
RI Neurociencia, Inct/I-1011-2013; Ferreira, Sergio/AAZ-1576-2020; Checler,
   Frederic/C-1241-2009
OI Ferreira, Sergio/0000-0001-7160-9866; Checler,
   Frederic/0000-0003-2098-1750
FU Fondation pour la Recherche MedicaleFondation pour la Recherche
   Medicale; Conseil general des Alpes MaritimesRegion Provence-Alpes-Cote
   d'Azur; FondecytComision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT)CONICYT FONDECYT [1110382]; Millennium Nucleus
   [P-07-011-F]
FX This work was supported in part by the Fondation pour la Recherche
   Medicale and by the Conseil general des Alpes Maritimes.; Supported by
   Fondecyt Grant 1110382 and Millennium Nucleus Grant P-07-011-F.
CR Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36
   Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200
   Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030
   Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708
   Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088
   Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200
   Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020
   Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x
   Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082
   CHECLER F, 1995, J NEUROCHEM, V65, P1431
   Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516
   Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920
   Chevallier N, 1997, BRIT J PHARMACOL, V121, P556, DOI 10.1038/sj.bjp.0701151
   Cisse M, 2011, J BIOL CHEM, V286, P29192, DOI 10.1074/jbc.M110.208249
   Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011
   Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008
   Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007
   da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200
   da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006
   da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899
   Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030
   GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0
   GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107
   Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4
   Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086
   HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E
   Heber S, 2000, J NEUROSCI, V20, P7951
   Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748
   Herreman A, 2000, NAT CELL BIOL, V2, P461
   Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228
   Huber G, 1997, NEUROSCIENCE, V80, P313, DOI 10.1016/S0306-4522(97)00120-6
   Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010
   Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718
   Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217
   KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Lefranc-Jullien S, 2005, BRIT J PHARMACOL, V145, P228, DOI 10.1038/sj.bjp.0706183
   Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059
   Ma L, 2009, J ALZHEIMERS DIS, V16, P565, DOI 10.3233/JAD-2009-0990
   MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I
   MENSAWILMOT K, 1994, J CELL BIOL, V124, P935, DOI 10.1083/jcb.124.6.935
   Morel M, 2009, NEUROBIOL DIS, V36, P151, DOI 10.1016/j.nbd.2009.07.004
   Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223
   Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje
   Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200
   Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816
   Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864
   Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0
   Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864
   Sevalle J, 2009, J NEUROCHEM, V110, P275, DOI 10.1111/j.1471-4159.2009.06131.x
   Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3
   STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4
   Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200
   Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736
   Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200
   Vincent B, 2001, J BIOL CHEM, V276, P37743
   Vincent B, 1996, J NEUROSCI, V16, P5049
   Vincent B, 2008, CURR ALZHEIMER RES, V5, P202, DOI 10.2174/156720508783954749
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x
   Xu X, 1999, P NATL ACAD SCI USA, V96, P7547, DOI 10.1073/pnas.96.13.7547
   Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119
NR 69
TC 57
Z9 57
U1 0
U2 9
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 10
PY 2012
VL 287
IS 7
BP 5021
EP 5032
DI 10.1074/jbc.M111.323626
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 896YX
UT WOS:000300608500061
PM 22184125
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   Klein, WL
AF Ferreira, Sergio T.
   Klein, William L.
TI The A beta oligomer hypothesis for synapse failure and memory loss in
   Alzheimer's disease
SO NEUROBIOLOGY OF LEARNING AND MEMORY
LA English
DT Review
DE Alzheimer's disease; Oligomer; Neurodegeneration; Diabetes; Fragile X
ID AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; GROWTH-FACTOR
   EXPRESSION; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM;
   ENDOPLASMIC-RETICULUM STRESS; RECEPTOR-DEPENDENT MECHANISM; MILD
   COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPE; TYPE-2
   DIABETES-MELLITUS
AB Alzheimer's disease (AD) is the 3rd most costly disease and the leading cause of dementia. It can linger for many years, but ultimately is fatal, the 6th leading cause of death. Alzheimer's disease (AD) is fatal and affected individuals can sometimes linger many years. Current treatments are palliative and transient, not disease modifying. This article reviews progress in the search to identify the primary AD-causing toxins. We summarize the shift from an initial focus on amyloid plaques to the contemporary concept that AD memory failure is caused by small soluble oligomers of the A beta peptide, toxins that target and disrupt particular synapses. Evidence is presented that links A beta oligomers to pathogenesis in animal models and humans, with reference to seminal discoveries from cell biology and new ideas concerning pathogenic mechanisms, including relationships to diabetes and Fragile X. These findings have established the oligomer hypothesis as a new molecular basis for the cause, diagnosis, and treatment of AD. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Klein, William L.] Northwestern Univ, Dept Neurobiol, Cognit Neurol & Alzheimers Dis Ctr, Evanston, IL 60208 USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21941590 Rio De Janeiro, Brazil.
RP Klein, WL (corresponding author), Northwestern Univ, Dept Neurobiol, Cognit Neurol & Alzheimers Dis Ctr, Evanston, IL 60208 USA.
EM ferreira@bioqmed.ufrj.br; wklein@northwestern.edu
RI Ferreira, Sergio/AAZ-1576-2020; Neurociencia, Inct/I-1011-2013
OI Ferreira, Sergio/0000-0001-7160-9866; 
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; NSFNational Science Foundation (NSF);
   American Health Assistance Foundation; Alzheimer's
   AssociationAlzheimer's Association; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo 'a Pesquisa do
   Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); National Institute of
   Translational Neuroscience
FX WLK is co-founder of Acumen Pharmaceuticals, which has been licensed by
   Northwestern University to target A beta oligomers for Alzheimer's
   therapeutics and diagnostics. Work in the authors' laboratories has been
   funded by grants from NIH, NSF, the American Health Assistance
   Foundation, and the Alzheimer's Association (WLK), and by the Brazilian
   agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Fundacao de Amparo 'a Pesquisa do Estado do Rio de Janeiro and National
   Institute of Translational Neuroscience (STF). We wish to acknowledge
   Kirsten L Viola for her assistance with preparation of this manuscript.
CR Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999
   Ajit D, 2009, BIOCHEMISTRY-US, V48, P9011, DOI 10.1021/bi9003777
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Allain H, 2007, HUM PSYCHOPHARM CLIN, V22, P189, DOI 10.1002/hup.838
   ALLSOP D, 1988, P NATL ACAD SCI USA, V85, P2790, DOI 10.1073/pnas.85.8.2790
   Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008
   Alzheimer's Association, 2010, 2010 ALZH DIS FACTS
   Alzheimer's Association, 2011, WHAT IS ALZH
   ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0
   Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3
   ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573
   Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7
   ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567
   Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031
   Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107
   Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x
   Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011
   Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009
   Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]
   Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013
   Bhatia R, 2000, FASEB J, V14, P1233
   Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699
   Blaabjerg M, 2001, BRAIN RES, V898, P91, DOI 10.1016/S0006-8993(01)02148-5
   Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5
   Boutaud O, 2006, J NEUROCHEM, V96, P917, DOI 10.1111/j.1471-4159.2005.03586.x
   Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102
   Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001
   Butterfield DA, 2001, CURR MED CHEM, V8, P815, DOI 10.2174/0929867013373048
   Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x
   Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082
   Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013
   Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200
   Carlsson CM, 2010, J ALZHEIMERS DIS, V20, P711, DOI 10.3233/JAD-2010-100012
   Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3
   Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797
   Chang L, 2003, J MOL NEUROSCI, V20, P305, DOI 10.1385/JMN:20:3:305
   Chauhan N. B., 2008, ICV ANTIADDL ANTIBOD
   Chauhan NB, 2007, J NEUROSCI RES, V85, P451, DOI 10.1002/jnr.21110
   Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200
   Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107
   Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028
   Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635
   Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67
   CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0
   Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372
   Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   Craft S, 1999, NEUROENDOCRINOLOGY, V70, P146, DOI 10.1159/000054469
   Craft S, 1996, NEUROBIOL AGING, V17, P123, DOI 10.1016/0197-4580(95)02002-0
   Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x
   Cullen WK, 1997, NEUROREPORT, V8, P3213, DOI 10.1097/00001756-199710200-00006
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45
   de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475
   De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   DEKEYSER J, 1990, ARCH NEUROL-CHICAGO, V47, P761, DOI 10.1001/archneur.1990.00530070055011
   Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200
   Dineley KT, 2010, J NEUROSCI RES, V88, P2923, DOI 10.1002/jnr.22445
   Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842
   Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418
   Dougherty JJ, 2003, J NEUROSCI, V23, P6740
   Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009
   Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019
   Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32
   Fa M., 2010, J VISUALIZED EXPT
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3
   Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200
   Finch CE, 2001, CONTEMPORARY CLIN NE, P87
   FRACKOWIAK J, 1994, J NEUROPATH EXP NEUR, V53, P637, DOI 10.1097/00005072-199411000-00011
   Freir DB, 2001, J NEUROPHYSIOL, V85, P708
   Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x
   Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068
   Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359
   Gao CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015725
   Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102
   GEROZISSIS K, 1993, BRAIN RES, V611, P258, DOI 10.1016/0006-8993(93)90511-K
   GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9
   Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010
   Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009
   Gleckman AM, 2000, ARCH PATHOL LAB MED, V124, P251
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0
   Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Goto Y, 2006, BIOCHEM BIOPH RES CO, V351, P259, DOI 10.1016/j.bbrc.2006.10.030
   Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001
   Guzowski JF, 2000, J NEUROSCI, V20, P3993
   Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440
   HAVRANKOVA J, 1981, DIABETOLOGIA, V20, P268, DOI 10.1007/BF00254492
   Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119
   Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f
   Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010
   Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje
   Hoyer S, 1998, J NEURAL TRANSM-SUPP, P187
   Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035
   Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI [10.1073/pnas.0710991105, 10.1073/pnas.0803737105]
   Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703
   Jin M., 2011, P NATL ACAD SCI US
   Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI 10.1089/neu.2008-0843
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kaiyala KJ, 2000, DIABETES, V49, P1525, DOI 10.2337/diabetes.49.9.1525
   Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104
   Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200
   Kelly MP, 2003, J NEUROSCI, V23, P6443
   Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042
   Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750
   Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694
   Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217
   Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517
   Kim SH, 2008, P NATL ACAD SCI USA, V105, P4429, DOI 10.1073/pnas.0800257105
   Klein W. L, 2006, PROTEIN MISFOLDING A, P289
   Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008
   Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009
   KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561
   Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011
   Kotilinek LA, 2002, J NEUROSCI, V22, P6331
   KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247
   Labak M, 2010, ACTA NEUROCHIR SUPPL, V106, P177, DOI 10.1007/978-3-211-98811-4_32
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 2009, CNS NEUROL DISORD-DR, V8, P65, DOI 10.2174/187152709787601876
   Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200
   Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014
   Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003
   Leon WC, 2010, J ALZHEIMERS DIS, V20, P113, DOI 10.3233/JAD-2010-1349
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com
   Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Luchsinger JA, 2008, EUR J PHARMACOL, V585, P119, DOI 10.1016/j.ejphar.2008.02.048
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3
   MARKS JL, 1990, ENDOCRINOLOGY, V127, P3234, DOI 10.1210/endo-127-6-3234
   Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200
   Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63
   Marx J, 2007, SCIENCE, V318, P384, DOI 10.1126/science.318.5849.384
   Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f
   Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623
   Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Moroz N, 2008, J ALZHEIMERS DIS, V15, P29
   Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000
   Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008
   Nishitsuji K, 2009, AM J PATHOL, V174, P957, DOI 10.2353/ajpath.2009.080480
   Nogalska A., 2010, NOVEL DEMONSTRATION
   O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010
   Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006
   ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080
   ODA T, 1994, BIOCHEM BIOPH RES CO, V204, P1131, DOI 10.1006/bbrc.1994.2580
   Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010
   Origlia N, 2010, J NEUROSCI, V30, P11414, DOI 10.1523/JNEUROSCI.2127-10.2010
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Park CR, 2000, PHYSIOL BEHAV, V68, P509, DOI 10.1016/S0031-9384(99)00220-6
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Pedersen WA, 2004, NEUROBIOL DIS, V17, P500, DOI 10.1016/j.nbd.2004.08.003
   Peng S, 2009, J NEUROSCI, V29, P9321, DOI 10.1523/JNEUROSCI.4736-08.2009
   Perez JL, 2010, EXP NEUROL, V223, P410, DOI 10.1016/j.expneurol.2009.10.013
   Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106
   PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D
   PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9
   Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018
   Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270
   Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008
   PODLISNY MB, 1987, SCIENCE, V238, P669, DOI 10.1126/science.2960019
   Poon W. W., 2009, NEUROBIOLOGY AGING
   Pratchayasakul W., 2011, LIFE SCI
   Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008
   Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051
   RAZAY G, 1994, AGE AGEING, V23, P396, DOI 10.1093/ageing/23.5.396
   Reagan LP, 2007, CURR OPIN PHARMACOL, V7, P633, DOI 10.1016/j.coph.2007.10.012
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   Riederer P, 2011, NEUROTOX RES, V19, P253, DOI 10.1007/s12640-010-9203-1
   Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247
   Ronicke R., 2010, NEUROBIOLOGY AGING
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Schaeffer EL, 2009, PSYCHOPHARMACOLOGY, V202, P37, DOI 10.1007/s00213-008-1351-0
   SCHEIBEL ME, 1975, EXP NEUROL, V47, P392, DOI 10.1016/0014-4886(75)90072-2
   Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864
   SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649
   SCHWARTZ MW, 1990, PEPTIDES, V11, P467, DOI 10.1016/0196-9781(90)90044-6
   Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2
   SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0
   Shimizu E, 2008, J IMMUNOL, V181, P6503, DOI 10.4049/jimmunol.181.9.6503
   Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011
   SIEKEVITZ P, 1985, P NATL ACAD SCI USA, V82, P3494, DOI 10.1073/pnas.82.10.3494
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002
   Sponne I, 2004, FASEB J, V18, P836, DOI 10.1096/fj.03-0372fje
   Sponne I, 2003, J BIOL CHEM, V278, P3437, DOI 10.1074/jbc.M206745200
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977
   Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008
   Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X
   Takamura A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-20
   TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7
   Terry R. D., 1994, ALZHEIMERS DIS
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78
   Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010
   Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200
   Tong M, 2009, J ALZHEIMERS DIS, V17, P827, DOI 10.3233/JAD-2009-1115
   Toro P, 2009, J ALZHEIMERS DIS, V16, P687, DOI 10.3233/JAD-2009-0981
   Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754
   Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014
   Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640
   Unger JW, 1998, HISTOL HISTOPATHOL, V13, P1215, DOI 10.14670/HH-13.1215
   van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558
   Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107
   Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41
   Varghese K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008643
   Varvel NH, 2008, J NEUROSCI, V28, P10786, DOI 10.1523/JNEUROSCI.2441-08.2008
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004
   Wang X, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-46
   Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003
   Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052
   Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007
   White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952
   Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004
   Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006
   Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2
   Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5
   Zhang T, 2009, NEUROSCIENCE, V161, P1045, DOI 10.1016/j.neuroscience.2009.04.032
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
   Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015
   Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045
   Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5
   Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2
NR 265
TC 260
Z9 268
U1 4
U2 72
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1074-7427
EI 1095-9564
J9 NEUROBIOL LEARN MEM
JI Neurobiol. Learn. Mem.
PD NOV
PY 2011
VL 96
IS 4
SI SI
BP 529
EP 543
DI 10.1016/j.nlm.2011.08.003
PG 15
WC Behavioral Sciences; Neurosciences; Psychology; Psychology,
   Multidisciplinary
SC Behavioral Sciences; Neurosciences & Neurology; Psychology
GA 859UD
UT WOS:000297900400004
PM 21914486
OA Green Accepted
DA 2020-09-29
ER

PT J
AU Brito-Moreira, J
   Paula-Lima, AC
   Bomfim, TR
   Oliveira, FF
   Sepulveda, FJ
   De Mello, FG
   Aguayo, LG
   Panizzutti, R
   Ferreira, ST
AF Brito-Moreira, J.
   Paula-Lima, A. C.
   Bomfim, T. R.
   Oliveira, F. F.
   Sepulveda, F. J.
   De Mello, F. G.
   Aguayo, L. G.
   Panizzutti, R.
   Ferreira, S. T.
TI A beta Oligomers Induce Glutamate Release from Hippocampal Neurons
SO CURRENT ALZHEIMER RESEARCH
LA English
DT Article
DE A beta oligomers; Alzheimer's disease; D-serine; glutamate; taurine
AB Soluble oligomers of the amyloid-beta peptide (A beta Os) accumulate in Alzheimer's disease (AD) brain and have been implicated in mechanisms of pathogenesis. The neurotoxicity of A beta Os appears to be, at least in part, due to dysregulation of glutamate signaling. Here, we show that A beta Os promote extracellular accumulation of glutamate and D-serine, a co-agonist at glutamate receptors of the N-methyl-D-aspartate subtype (NMDARs), in hippocampal neuronal cultures. The increase in extracellular glutamate levels induced by A beta Os was blocked by the sodium channel blocker tetrodotoxin (TTX), by the NMDAR blocker (+)-5-methyl-10,11-dihydro-5H-dibenzo[a, d] cyclohepten-5,10-imine maleate (MK-801) and by removal of Ca2+ from the extracellular medium, indicating dependence on excitatory neuronal activity. A beta Os enhanced the release of pre-synaptic vesicles labeled by FM1-43 as well as spontaneous post-synaptic activity measured by whole-cell patch-clamp. Activation of inhibitory GABA(A) receptors by taurine blocked the increase in extracellular glutamate levels, suggesting that selective pharmacological inhibition of neuronal activity can counteract the impact of A beta Os on glutamate dyshomeostasis. Results reveal a novel mechanism by which A beta oligomers promote abnormal release of glutamate from hippocampal neurons, which may contribute to dysregulation of excitatory signaling in the brain.
C1 [Brito-Moreira, J.; Paula-Lima, A. C.; Bomfim, T. R.; Oliveira, F. F.; Panizzutti, R.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
   [De Mello, F. G.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, Brazil.
   [Panizzutti, R.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Program Basic & Clin Neurosci, Inst Biomed Sci, BR-21944590 Rio De Janeiro, Brazil.
   [Sepulveda, F. J.; Aguayo, L. G.] Univ Concepcion, Neurophysiol Lab, Dept Physiol, Concepcion, Chile.
RP Panizzutti, R (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
EM rogerio@anato.ufrj.br; ferreira@bioqmed.ufrj.br
RI Paula-Lima, Andrea C./I-2537-2013; Ferreira, Sergio/AAZ-1576-2020
OI Paula-Lima, Andrea C./0000-0002-0466-7561; Ferreira,
   Sergio/0000-0001-7160-9866
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Rede de Diagnostico em Doencas
   Neurodegenerativas (SUS/FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Instituto
   Nacional de Neurociencia Translacional (INCT/CNPq)National Council for
   Scientific and Technological Development (CNPq); Conicyt-FONDAPComision
   Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT
   FONDAP [79090021]; Ring of Research PBCTComision Nacional de
   Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT
   [ACT-04]
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Rede de Diagnostico em
   Doencas Neurodegenerativas (SUS/FAPERJ) and Instituto Nacional de
   Neurociencia Translacional (INCT/CNPq). ACPL was supported by Bolsa Nota
   10 (FAPERJ) and is currently funded by Conicyt-FONDAP 79090021. LGA and
   FJS were supported by Ring of Research PBCT ACT-04 grant.
CR Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x
   Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130
   BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497
   Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821
   Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005
   Bobich JA, 2004, J ALZHEIMERS DIS, V6, P243
   Cheng L, 2009, SYNAPSE, V63, P206, DOI 10.1002/syn.20599
   de Ceballos ML, 2001, CLIN CHEM LAB MED, V39, P317
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009
   Fernandez-Tome P, 2004, NEUROBIOL DIS, V15, P580, DOI 10.1016/j.nbd.2003.12.006
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Harkany T, 1999, NEUROREPORT, V10, P1693, DOI 10.1097/00001756-199906030-00013
   Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x
   Harris ME, 1996, J NEUROCHEM, V67, P277
   HASHIMOTO A, 1992, J CHROMATOGR, V1, P41
   HASHIMOTO A, 1992, J CHROMATOGR, V41, P1
   IKEMATSU K, 2002, FORENSIC SCI INT, V83, P2
   Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008
   Jia F, 2008, J NEUROSCI, V28, P106, DOI 10.1523/JNEUROSCI.3996-07.2008
   Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Lima ACP, 2003, NEUROTOX RES, V5, P323, DOI 10.1007/BF03033152
   Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958
   Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com
   Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X
   Mattson MP, 2006, ANTIOXID REDOX SIGN, V8, P1997, DOI 10.1089/ars.2006.8.1997
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   Mennerick S, 1999, J NEUROSCI, V19, P9242
   Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x
   Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926
   NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V
   Noda M, 1999, NEUROSCIENCE, V92, P1465, DOI 10.1016/S0306-4522(99)00036-6
   OERTEL WH, 1981, NEUROSCIENCE, V6, P2689, DOI 10.1016/0306-4522(81)90113-5
   Palmada Monica, 1998, Frontiers in Bioscience, V3, pD701
   Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025
   Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298
   Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023
   ParpuraGill A, 1997, BRAIN RES, V754, P65, DOI 10.1016/S0006-8993(97)00043-7
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967
   Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011
   SanchezPrieto J, 1996, TRENDS NEUROSCI, V19, P235, DOI 10.1016/0166-2236(96)10031-X
   Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Shi C, 2010, NEUROCHEM INT, V56, P893, DOI 10.1016/j.neuint.2010.03.016
   Shigeri Y, 2001, J NEUROCHEM, V79, P297, DOI 10.1046/j.1471-4159.2001.00588.x
   Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005
   Vargas-Lopes C, 2011, J NEUROCHEM, V116, P281, DOI 10.1111/j.1471-4159.2010.07102.x
   Velasco I, 1996, J NEUROSCI RES, V44, P551, DOI 10.1002/(SICI)1097-4547(19960615)44:6<551::AID-JNR5>3.0.CO;2-A
   Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x
   Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085
   Williams SM, 2006, GLIA, V53, P401, DOI 10.1002/glia.20300
   Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721
   Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2
   Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100
   Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004
NR 69
TC 44
Z9 45
U1 0
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2050
EI 1875-5828
J9 CURR ALZHEIMER RES
JI Curr. Alzheimer Res.
PD AUG
PY 2011
VL 8
IS 5
BP 552
EP 562
DI 10.2174/156720511796391917
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 813BD
UT WOS:000294340100010
PM 21244351
DA 2020-09-29
ER

PT J
AU Hajj, GN
   Roffe, M
   Beraldo, FH
   Wasilewska-Sampaio, AP
   Hirata, PH
   Vorberg, I
   Castilho, BA
   Prado, MA
   Ferreira, S
   Martins, VR
AF Hajj, G. N.
   Roffe, M.
   Beraldo, F. H.
   Wasilewska-Sampaio, A. P.
   Hirata, P. H.
   Vorberg, I
   Castilho, B. A.
   Prado, M. A.
   Ferreira, S.
   Martins, V. R.
TI THE CONTROL OF PROTEIN SYNTHESIS IN PRION AND ALZHEIMER DISEASES
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 [Hajj, G. N.; Wasilewska-Sampaio, A. P.; Hirata, P. H.; Martins, V. R.] Fundacao Antonio Prudente, CIPE, Sao Paulo, Brazil.
   [Roffe, M.; Castilho, B. A.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Beraldo, F. H.; Prado, M. A.] Robarts Res Inst, London, ON, Canada.
   [Vorberg, I] Deutsch Zentrum Neurodegenerat Erkrankungen, Bonn, Germany.
   [Ferreira, S.] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
RI Martins, Vilma/N-5446-2019; Prado, Marco Antonio Maximo/K-7638-2013;
   Castilho, Beatriz A/C-2503-2012; Ferreira, Sergio/AAZ-1576-2020
OI Prado, Marco Antonio Maximo/0000-0002-3028-5778; Castilho, Beatriz
   A/0000-0003-4509-5237; Ferreira, Sergio/0000-0001-7160-9866
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Alzheimer's AssociationAlzheimer's Association
FX Supported by FAPESP, CNPq and Alzheimer's Association.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2011
VL 118
SU 1
SI SI
MA YIC03-03
BP 106
EP 107
PG 2
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA VC1UN
UT WOS:000431628300262
DA 2020-09-29
ER

PT J
AU Bomfim, TR
   Forny-Germano, L
   Sathler, LB
   Decker, H
   Brito-Moreira, J
   Christophe-Houzel, J
   Silverman, MA
   Kazi, H
   Arnold, SE
   Talbot, K
   Klein, WL
   Munoz, DP
   Ferreira, ST
   De Felice, FG
AF Bomfim, T. R.
   Forny-Germano, L.
   Sathler, L. B.
   Decker, H.
   Brito-Moreira, J.
   Christophe-Houzel, J.
   Silverman, M. A.
   Kazi, H.
   Arnold, S. E.
   Talbot, K.
   Klein, W. L.
   Munoz, D. P.
   Ferreira, S. T.
   De Felice, F. G.
TI IRS-1 INHIBITION LINKS IMPAIRED INSULIN SIGNALING IN ALZHEIMER'S AND
   TYPE-2 DIABETES: PROTECTION BY ANTI-DIABETIC DRUGS
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 [Bomfim, T. R.; Sathler, L. B.; Decker, H.; Brito-Moreira, J.; Ferreira, S. T.; De Felice, F. G.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Forny-Germano, L.; Christophe-Houzel, J.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Decker, H.; Silverman, M. A.] Simon Fraser Univ, Dept Biol Sci, Vancouver, BC, Canada.
   [Kazi, H.; Arnold, S. E.; Talbot, K.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.
   [Klein, W. L.; De Felice, F. G.] Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.
   [Munoz, D. P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2011
VL 118
SU 1
SI SI
MA TU04-01
BP 134
EP 134
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA VC1UN
UT WOS:000431628300333
DA 2020-09-29
ER

PT J
AU Lourenco, MV
   Silva, CA
   Bomfim, TR
   Ferreira, ST
   De Felice, FG
AF Lourenco, M., V
   Silva, C. A.
   Bomfim, T. R.
   Ferreira, S. T.
   De Felice, F. G.
TI ALZHEIMER'S TOXIC AMYLOID-BETA OLIGOMERS INDUCE ENDOPLASMIC RETICULUM
   STRESS IN MATURE HIPPOCAMPAL NEURONAL CULTURES
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 [Lourenco, M., V; Silva, C. A.; Bomfim, T. R.; Ferreira, S. T.; De Felice, F. G.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2011
VL 118
SU 1
SI SI
MA TU04-17
BP 139
EP 139
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA VC1UN
UT WOS:000431628300349
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Bomfim, TR
   Forny-Germano, L
   Brito-Moreira, J
   Ferreira, ST
AF De Felice, F. G.
   Bomfim, T. R.
   Forny-Germano, L.
   Brito-Moreira, J.
   Ferreira, S. T.
TI ALZHEIMER'S DISEASE AS A NEW FORM OF BRAIN SPECIFIC DIABETES INSTIGATED
   BY ABETA OLIGOMERS
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 [De Felice, F. G.; Bomfim, T. R.; Forny-Germano, L.; Brito-Moreira, J.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2011
VL 118
SU 1
SI SI
MA YIC06-01
BP 189
EP 189
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA VC1UN
UT WOS:000431628300463
DA 2020-09-29
ER

PT J
AU Forny-Germano, L
   Bomfim, TR
   Brito-Moreira, J
   Houzel, JC
   Klein, WL
   Munoz, DP
   Ferreira, ST
   De Felice, FG
AF Forny-Germano, L.
   Bomfim, T. R.
   Brito-Moreira, J.
   Houzel, J. C.
   Klein, W. L.
   Munoz, D. P.
   Ferreira, S. T.
   De Felice, F. G.
TI IMPAIRED INSULIN SIGNALING IN A PRIMATE MODEL OF ALZHEIMER'S DISEASE:
   LINK WITH TYPE-2 DIABETES
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 [Forny-Germano, L.; Houzel, J. C.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Forny-Germano, L.; Bomfim, T. R.; Brito-Moreira, J.; Ferreira, S. T.; De Felice, F. G.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Klein, W. L.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
   [Munoz, D. P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
RI Ferreira, Sergio/AAZ-1576-2020; Houzel, Jean Christophe/M-7936-2019
OI Ferreira, Sergio/0000-0001-7160-9866; Houzel, Jean
   Christophe/0000-0001-5128-438X
CR Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2011
VL 118
SU 1
SI SI
MA WE02-06
BP 197
EP 198
PG 2
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA VC1UN
UT WOS:000431628300486
DA 2020-09-29
ER

PT J
AU Brito-Moreira, J
   Paula-Lima, AC
   Bomfim, TR
   Oliveira, FF
   Sepulveda, FJ
   De Mello, FG
   Aguayo, LG
   Panizzutti, R
   Ferreira, ST
AF Brito-Moreira, J.
   Paula-Lima, A. C.
   Bomfim, T. R.
   Oliveira, F. F.
   Sepulveda, F. J.
   De Mello, F. G.
   Aguayo, L. G.
   Panizzutti, R.
   Ferreira, S. T.
TI A beta OLIGOMERS INDUCE GLUTAMATE RELEASE FROM HIPPOCAMPAL NEURONS
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 [Brito-Moreira, J.; Paula-Lima, A. C.; Bomfim, T. R.; Oliveira, F. F.; De Mello, F. G.; Panizzutti, R.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Sepulveda, F. J.; Aguayo, L. G.] Univ Concepcion, Concepcion, Chile.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2011
VL 118
SU 1
SI SI
MA WE03-05
BP 203
EP 203
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA VC1UN
UT WOS:000431628300501
DA 2020-09-29
ER

PT J
AU Caetano, FA
   Beraldo, FH
   Hajj, GN
   Guimaraes, AL
   Jurgensen, S
   Wasilewska-Sampaio, AP
   Hirata, PH
   Sousa, I
   Machado, CF
   Wong, DL
   De Felice, FG
   Ferreira, S
   Prado, VF
   Rylett, RJ
   Martins, VR
   Prado, MM
AF Caetano, F. A.
   Beraldo, F. H.
   Hajj, G. N.
   Guimaraes, A. L.
   Jurgensen, S.
   Wasilewska-Sampaio, A. P.
   Hirata, P. H.
   Sousa, I
   Machado, C. F.
   Wong, D. L.
   De Felice, F. G.
   Ferreira, S.
   Prado, V. F.
   Rylett, R. J.
   Martins, V. R.
   Prado, M. M.
TI AMYLOID-BETA ALTERS CONSTITUTIVE TRAFFICKING OF PRION PROTEIN
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 [Caetano, F. A.; Beraldo, F. H.; Sousa, I; Wong, D. L.; Prado, V. F.; Rylett, R. J.; Prado, M. M.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada.
   [Caetano, F. A.; Sousa, I] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Hajj, G. N.; Wasilewska-Sampaio, A. P.; Hirata, P. H.; Machado, C. F.; Martins, V. R.] Int Ctr Res & Educ, Sao Paulo, Brazil.
   [Guimaraes, A. L.] Fed Univ Montes Claros, Montes Claros, Brazil.
   [Jurgensen, S.; De Felice, F. G.; Ferreira, S.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Guimaraes, Andre Luiz Sena/D-8122-2011; Martins, Vilma/N-5446-2019;
   Ferreira, Sergio/AAZ-1576-2020
OI Guimaraes, Andre Luiz Sena/0000-0002-3162-3206; Ferreira,
   Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2011
VL 118
SU 1
SI SI
MA WE03-06
BP 203
EP 204
PG 2
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA VC1UN
UT WOS:000431628300502
DA 2020-09-29
ER

PT J
AU Magdesian, MH
   Gralle, M
   Guerreiro, LH
   Beltrao, PJI
   Carvalho, MMVF
   Santos, LED
   de Mello, FG
   Reis, RAM
   Ferreira, ST
AF Magdesian, Margaret H.
   Gralle, Matthias
   Guerreiro, Luiz H.
   Beltrao, Paulo Jose I.
   Carvalho, Milena M. V. F.
   Santos, Luis Eduardo da S.
   de Mello, Fernando G.
   Reis, Ricardo A. M.
   Ferreira, Sergio T.
TI Secreted Human Amyloid Precursor Protein Binds Semaphorin 3a and
   Prevents Semaphorin-Induced Growth Cone Collapse
SO PLOS ONE
LA English
DT Article
ID ALZHEIMERS-DISEASE; BETA; DOMAIN; APP; MECHANISMS; RECEPTORS; MIGRATION;
   OLIGOMERS; SURVIVAL; REGION
AB The amyloid precursor protein (APP) is well known for giving rise to the amyloid-beta peptide and for its role in Alzheimer's disease. Much less is known, however, on the physiological roles of APP in the development and plasticity of the central nervous system. We have used phage display of a peptide library to identify high-affinity ligands of purified recombinant human sAPP alpha(695) (the soluble, secreted ectodomain from the main neuronal APP isoform). Two peptides thus selected exhibited significant homologies with the conserved extracellular domain of several members of the semaphorin (Sema) family of axon guidance proteins. We show that sAPP alpha(695) binds both purified recombinant Sema3A and Sema3A secreted by transfected HEK293 cells. Interestingly, sAPP alpha(695) inhibited the collapse of embryonic chicken (Gallus gallus domesticus) dorsal root ganglia growth cones promoted by Sema3A (K-d <= 8.10(-9) M). Two Sema3A-derived peptides homologous to the peptides isolated by phage display blocked sAPP alpha binding and its inhibitory action on Sema3A function. These two peptides are comprised within a domain previously shown to be involved in binding of Sema3A to its cellular receptor, suggesting a competitive mechanism by which sAPP alpha modulates the biological action of semaphorins.
C1 [Magdesian, Margaret H.; Gralle, Matthias; Guerreiro, Luiz H.; Beltrao, Paulo Jose I.; Carvalho, Milena M. V. F.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Program Biochem & Cellular Biophys, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Santos, Luis Eduardo da S.; de Mello, Fernando G.; Reis, Ricardo A. M.] Univ Fed Rio de Janeiro, Program Neurobiol, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Magdesian, MH (corresponding author), Univ Fed Rio de Janeiro, Program Biochem & Cellular Biophys, Inst Med Biochem, Rio De Janeiro, Brazil.
EM magdesian@bioqmed.ufrj.br; gralle@bioqmed.ufrj.br
RI Santos, Luis/B-4961-2015; Neurociencia, Inct/I-1011-2013; Reis,
   Ricardo/E-9962-2011; Gralle, Matthias/B-9005-2014; Ferreira,
   Sergio/AAZ-1576-2020; Rosado, Luiz L H/N-1472-2015
OI Santos, Luis/0000-0002-0694-733X; Reis, Ricardo/0000-0001-9689-4085;
   Ferreira, Sergio/0000-0001-7160-9866; Rosado, Luiz L
   H/0000-0002-9390-8397
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute;
   Instituto Nacional de Neurociencia Translacional; Pronex-FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)
FX This work was supported by grants from the Howard Hughes Medical
   Institute (www.hhmi.org) to STF; Instituto Nacional de Neurociencia
   Translacional (www.cnpq.br) and Pronex-FAPERJ (www.faperj.br) to STF and
   FGdM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (www.cnpq.br) to STF, RAMR, and MG; and Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (www.faperj.br) to MHM, MG, and STF. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077
   ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6
   Bagri A, 2002, ADV EXP MED BIOL, V515, P13
   Bates D., 2009, LME4 LINEAR MIXED EF
   Ben-Zvi A, 2008, J NEUROSCI, V28, P12427, DOI 10.1523/JNEUROSCI.3573-08.2008
   Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x
   Calissano P, 2010, DEV NEUROBIOL, V70, P372, DOI 10.1002/dneu.20759
   de Wit J, 2006, TRAFFIC, V7, P1060, DOI 10.1111/j.1600-0854.2006.00442.x
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2
   Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282
   Goshima Y, 1999, J NEUROBIOL, V39, P579, DOI 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9
   Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4
   Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001
   Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200
   Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   HE Z, 2002, SCI STKE, V119, pRE1, DOI DOI 10.1126/STKE.2002.119.RE1
   Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200
   Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009
   HUNG AY, 1992, P NATL ACAD SCI USA, V89, P9439, DOI 10.1073/pnas.89.20.9439
   Ikin AF, 2007, MOL CELL NEUROSCI, V35, P57, DOI 10.1016/j.mcn.2007.02.003
   JIN LW, 1994, J NEUROSCI, V14, P5461
   Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005
   KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561
   Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   LEBLANC AC, 1992, J NEUROSCI RES, V31, P635, DOI 10.1002/jnr.490310407
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891
   MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6
   MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055
   Osterfield M, 2008, DEVELOPMENT, V135, P1189, DOI 10.1242/dev.007401
   Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Pawlik M, 2007, BIOCHEM BIOPH RES CO, V355, P907, DOI 10.1016/j.bbrc.2007.02.047
   Perez RG, 1997, J NEUROSCI, V17, P9407
   R Development Core Team, 2009, R LANG ENV STAT COMP
   Reis RADM, 2008, BRAIN RES, V1205, P1, DOI 10.1016/j.brainres.2008.02.035
   Rusu P, 2007, EUR J NEUROSCI, V25, P1079, DOI 10.1111/j.1460-9568.2007.05341.x
   Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005
   Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063
   SMALL DH, 1994, J NEUROSCI, V14, P2117
   Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596
   Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009
   YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510
   Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009
   Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007
   YOUNGPEARSE TL, 2008, NEURAL DEV, V23, P3
   Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006
NR 56
TC 10
Z9 9
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 29
PY 2011
VL 6
IS 7
AR e22857
DI 10.1371/journal.pone.0022857
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 799KV
UT WOS:000293286500040
PM 21829538
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Ramella, NA
   Rimoldi, OJ
   Prieto, ED
   Schinella, GR
   Sanchez, SA
   Jaureguiberry, MS
   Vela, ME
   Ferreira, ST
   Tricerri, MA
AF Ramella, Nahuel A.
   Rimoldi, Omar J.
   Prieto, Eduardo D.
   Schinella, Guillermo R.
   Sanchez, Susana A.
   Jaureguiberry, Maria S.
   Vela, Maria E.
   Ferreira, Sergio T.
   Alejandra Tricerri, M.
TI Human Apolipoprotein A-I-Derived Amyloid: Its Association with
   Atherosclerosis
SO PLOS ONE
LA English
DT Article
ID REVERSE CHOLESTEROL TRANSPORT; DENSITY-LIPOPROTEIN DISKS;
   COLONY-STIMULATING FACTOR; HYDROSTATIC-PRESSURE; HUMAN NEUTROPHILS;
   TERMINAL DOMAIN; PRION PROTEIN; OLIGOMERS; FIBRILS; BETA
AB Amyloidoses constitute a group of diseases in which soluble proteins aggregate and deposit extracellularly in tissues. Nonhereditary apolipoprotein A-I (apoA-I) amyloid is characterized by deposits of nonvariant protein in atherosclerotic arteries. Despite being common, little is known about the pathogenesis and significance of apoA-I deposition. In this work we investigated by fluorescence and biochemical approaches the impact of a cellular microenvironment associated with chronic inflammation on the folding and pro-amyloidogenic processing of apoA-I. Results showed that mildly acidic pH promotes misfolding, aggregation, and increased binding of apoA-I to extracellular matrix elements, thus favoring protein deposition as amyloid like-complexes. In addition, activated neutrophils and oxidative/proteolytic cleavage of the protein give rise to pro amyloidogenic products. We conclude that, even though apoA-I is not inherently amyloidogenic, it may produce non hereditary amyloidosis as a consequence of the pro-inflammatory microenvironment associated to atherogenesis.
C1 [Ramella, Nahuel A.; Rimoldi, Omar J.; Prieto, Eduardo D.; Jaureguiberry, Maria S.; Alejandra Tricerri, M.] Consejo Nacl Invest Cient & Tecn, CCT, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.
   [Ramella, Nahuel A.; Rimoldi, Omar J.; Prieto, Eduardo D.; Schinella, Guillermo R.; Jaureguiberry, Maria S.; Alejandra Tricerri, M.] Univ Nacl La Plata, Fac Ciencias Med, La Plata, Buenos Aires, Argentina.
   [Sanchez, Susana A.] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA USA.
   [Sanchez, Susana A.] Ctr Nacl Invest Cardiovasc, Fdn CNIC Carlos III, Microscopy Unit, Madrid, Spain.
   [Vela, Maria E.] Univ Nacl La Plata, Inst Invest Fisicoquim Teor & Aplicadas INIFTA, CCT, CONICET, La Plata, Buenos Aires, Argentina.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Program Biochem & Cellular Biophys, Rio De Janeiro, Brazil.
RP Ramella, NA (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.
EM aletricerri@yahoo.com
RI Schinella, Guillermo/V-9937-2018; Neurociencia, Inct/I-1011-2013;
   Ferreira, Sergio/AAZ-1576-2020
OI Schinella, Guillermo/0000-0001-9541-9688; Ferreira,
   Sergio/0000-0001-7160-9866; Vela, Maria Elena/0000-0003-4502-5618
FU Agencia Nacional de Promocion Cientifica y Tecnologica, ArgentinaANPCyT
   [2106-2008, 26228]; Universidad Nacional de La PlataNational University
   of La Plata [M126, M158]; Consejo Nacional de Investigaciones
   Cientificas y TecnicasConsejo Nacional de Investigaciones Cientificas y
   Tecnicas (CONICET) [PIP 112-200801-00953]; National Institutes of
   Health, USUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [PHS 5 P41 RR-03155]; Instituto
   Nacional de Neurociencia Translacional; Conselho Nacional de Pesquisas;
   Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX The work presented here was supported by the Agencia Nacional de
   Promocion Cientifica y Tecnologica, Argentina, grants # 2106-2008 to MAT
   and # 26228 to Horacio Garda, Universidad Nacional de La Plata (grants #
   M126 and M158 to MAT), and Consejo Nacional de Investigaciones
   Cientificas y Tecnicas, (PIP 112-200801-00953 to MAT and HG). SS
   acknowledges support from the National Institutes of Health (grant PHS 5
   P41 RR-03155, US). STF is supported by grants from Instituto Nacional de
   Neurociencia Translacional, Conselho Nacional de Pesquisas and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200
   Benson MD, 2005, AMYLOID, V12, P75, DOI 10.1080/13506120500106925
   Bergt C, 2001, EUR J BIOCHEM, V268, P3523, DOI 10.1046/j.1432-1327.2001.02253.x
   Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chen Y, 1999, METHODS, V19, P234, DOI 10.1006/meth.1999.0854
   Coakley RJ, 2002, BLOOD, V100, P3383, DOI 10.1182/blood.V100.9.3383
   Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s
   Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a
   DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342
   Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h
   De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje
   Eberini I, 2002, BIOCHEM J, V362, P627, DOI 10.1042/0264-6021:3620627
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539
   Gharavi NM, 2007, ARTERIOSCL THROM VAS, V27, P1346, DOI 10.1161/ATVBAHA.107.141283
   Gongora L, 2002, LIFE SCI, V71, P2995, DOI 10.1016/S0024-3205(02)02167-7
   Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991
   HAREL A, 1990, J NEUROCHEM, V55, P1237, DOI 10.1111/j.1471-4159.1990.tb03130.x
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044
   Jaureguiberry MS, 2010, J MEMBRANE BIOL, V234, P183, DOI 10.1007/s00232-010-9245-6
   Jerlich A, 2000, EUR J BIOCHEM, V267, P4137, DOI 10.1046/j.1432-1327.2000.01449.x
   JOHNSON KH, 1992, AM J PATHOL, V141, P1013
   JONAS A, 1989, J BIOL CHEM, V264, P4818
   Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222
   Lakowicz J. R., 1986, PRINCIPLES FLUORESCE
   LeVine H, 1999, METHOD ENZYMOL, V309, P274
   Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627
   Liz MA, 2007, J LIPID RES, V48, P2385, DOI 10.1194/jlr.M700158-JLR200
   Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S
   Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298
   Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399
   Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245
   Nofer Jerzy-Roch, 2005, Expert Rev Cardiovasc Ther, V3, P1071, DOI 10.1586/14779072.3.6.1071
   Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488
   Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5
   Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5
   Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5
   Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027
   Sanchez SA, 2001, BIOCHEMISTRY-US, V40, P6903, DOI 10.1021/bi001599i
   Sanchez SA, 2007, J LIPID RES, V48, P1689, DOI 10.1194/jlr.M600457-JLR200
   Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107
   Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2
   Sebollela A, 2005, J BIOL CHEM, V280, P31949, DOI 10.1074/jbc.M505314200
   Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105
   Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200
   Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16
   Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201
   Thompson N. L., 1991, FLUORESCENCE CORRELA
   Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q
   Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x
   VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0
   VOLLMER E, 1991, VIRCHOWS ARCH A, V419, P79, DOI 10.1007/BF01600220
   Wettreich A, 1999, J BIOL CHEM, V274, P31468, DOI 10.1074/jbc.274.44.31468
   WINROW VR, 1993, BRIT MED BULL, V49, P506, DOI 10.1093/oxfordjournals.bmb.a072627
NR 61
TC 38
Z9 39
U1 1
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 19
PY 2011
VL 6
IS 7
AR e22532
DI 10.1371/journal.pone.0022532
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 794VN
UT WOS:000292929500075
PM 21811627
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Baez, MV
   Adrover, M
   Decker, H
   Melendez, ME
   Aguirre, AI
   Cheli, VT
   Ferreira, S
   Jerusalinsky, DA
   Epstein, A
AF Baez, Maria-Veronica
   Adrover, Martin
   Decker, Helena
   Melendez, Matias E.
   Aguirre, Alejandra I.
   Cheli, Veronica T.
   Ferreira, Sergio
   Jerusalinsky, Diana A.
   Epstein, Alberto
TI Silencing of NMDA receptor NR1 subunit using HSV-1-derived amplicon
   vectors impairs cognitive functions in rats and reduces amyloid-beta
   oligomers binding and toxicity in cultured neurons
SO HUMAN GENE THERAPY
LA English
DT Meeting Abstract
CT 10th Annual Congress of the French-Society-of-Cell-and-Gene-Therapy
   (SFTCG)
CY JUN 06-08, 2011
CL Nantes, FRANCE
SP Aviesan, AFM, ThermoFisher Sci, Clinigene, CellGenix, AMT Biopharma, GenoSafe, PeproTech, Sigma, Genethon, Taxcell, Cleancells, Plasmid Factory, Beckman Coulter, Miltenyi Biotec, Agilebio, French Soc Cell & Gene Therapy
C1 [Baez, Maria-Veronica; Adrover, Martin; Aguirre, Alejandra I.; Cheli, Veronica T.; Jerusalinsky, Diana A.] Univ Buenos Aires, Inst Cellular Biol & Neurosci, RA-1053 Buenos Aires, DF, Argentina.
   [Decker, Helena; Ferreira, Sergio] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
   [Melendez, Matias E.; Epstein, Alberto] Univ Lyon 1, CNRS, CGphiMC, UMR5534, F-69622 Villeurbanne, France.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1043-0342
J9 HUM GENE THER
JI Hum. Gene Ther.
PD JUN
PY 2011
VL 22
IS 6
BP A11
EP A12
PG 2
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 774LS
UT WOS:000291388300029
DA 2020-09-29
ER

PT J
AU Caetano, FA
   Beraldo, FH
   Hajj, GNM
   Guimaraes, AL
   Jurgensen, S
   Wasilewska-Sampaio, AP
   Hirata, PHF
   Souza, I
   Machado, CF
   Wong, DYL
   De Felice, FG
   Ferreira, ST
   Prado, VF
   Rylett, RJ
   Martins, VR
   Prado, MAM
AF Caetano, Fabiana A.
   Beraldo, Flavio H.
   Hajj, Glaucia N. M.
   Guimaraes, Andre L.
   Juergensen, Sofia
   Wasilewska-Sampaio, Ana Paula
   Hirata, Pedro H. F.
   Souza, Ivana
   Machado, Cleiton F.
   Wong, Daisy Y. -L.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
   Prado, Vania F.
   Rylett, R. Jane
   Martins, Vilma R.
   Prado, Marco A. M.
TI Amyloid-beta oligomers increase the localization of prion protein at the
   cell surface
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE Abeta; Alzheimer's disease; amyloid; endocytosis; prion protein; TIRF
   microscopy
ID STRESS-INDUCIBLE PROTEIN-1; NICOTINIC ACETYLCHOLINE-RECEPTORS;
   ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; IN-VITRO; TRAFFICKING; LAMININ;
   ENDOCYTOSIS; IMPAIRMENT; BINDS
AB P>In Alzheimer's disease, the amyloid-beta peptide (A beta) interacts with distinct proteins at the cell surface to interfere with synaptic communication. Recent data have implicated the prion protein (PrPC) as a putative receptor for A beta. We show here that A beta oligomers signal in cells in a PrPC-dependent manner, as might be expected if A beta oligomers use PrPC as a receptor. Immunofluorescence, flow cytometry and cell surface protein biotinylation experiments indicated that treatment with A beta oligomers, but not monomers, increased the localization of PrPC at the cell surface in cell lines. These results were reproduced in hippocampal neuronal cultures by labeling cell surface PrPC. In order to understand possible mechanisms involved with this effect of A beta oligomers, we used live cell confocal and total internal reflection microscopy in cell lines. A beta oligomers inhibited the constitutive endocytosis of PrPC, but we also found that after A beta oligomer-treatment PrPC formed more clusters at the cell surface, suggesting the possibility of multiple effects of A beta oligomers. Our experiments show for the first time that A beta oligomers signal in a PrPC-dependent way and that they can affect PrPC trafficking, increasing its localization at the cell surface.
C1 [Caetano, Fabiana A.; Beraldo, Flavio H.; Guimaraes, Andre L.; Souza, Ivana; Wong, Daisy Y. -L.; Prado, Vania F.; Rylett, R. Jane; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, London, ON N6A 5K8, Canada.
   [Caetano, Fabiana A.; Souza, Ivana; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.
   [Caetano, Fabiana A.; Juergensen, Sofia; Souza, Ivana; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Minas Gerais, Fac Med, Program Mol Pharmacol, Belo Horizonte, MG, Brazil.
   [Beraldo, Flavio H.; Guimaraes, Andre L.; Prado, Vania F.; Rylett, R. Jane; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.
   [Hajj, Glaucia N. M.; Wasilewska-Sampaio, Ana Paula; Hirata, Pedro H. F.; Machado, Cleiton F.; Martins, Vilma R.] AC Camargo Hosp, Int Ctr Res & Educ, Antonio Prudente Fdn, Sao Paulo, Brazil.
   [Guimaraes, Andre L.] Univ Estadual Montes Claros, Dept Dent, Montes Claros, MG, Brazil.
   [Juergensen, Sofia; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RP Prado, MAM (corresponding author), Univ Western Ontario, Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, 100 Perth Dr, London, ON N6A 5K8, Canada.
EM mprado@robarts.ca
RI Prado, Marco Antonio Maximo/K-7638-2013; Rylett, Rebecca
   Jane/K-3597-2013; Prado, Vania Ferreira/K-7630-2013; Hajj, Glaucia N N M
   M/I-8176-2015; Machado, Cleiton/I-5907-2014; Neurociencia,
   Inct/I-1011-2013; Ferreira, Sergio/AAZ-1576-2020; Martins,
   Vilma/N-5446-2019; Guimaraes, Andre Luiz Sena/D-8122-2011; Martins,
   Vilma R/E-2547-2012
OI Prado, Marco Antonio Maximo/0000-0002-3028-5778; Rylett, Rebecca
   Jane/0000-0002-9158-9599; Prado, Vania Ferreira/0000-0003-4994-6393;
   Hajj, Glaucia N N M M/0000-0003-2342-7384; Machado,
   Cleiton/0000-0002-3313-3868; Ferreira, Sergio/0000-0001-7160-9866;
   Guimaraes, Andre Luiz Sena/0000-0002-3162-3206; Martins, Vilma
   R/0000-0002-2909-8502
FU Alzheimer's Association (USA)Alzheimer's Association; Canadian
   Foundation for Innovation (CFI)Canada Foundation for Innovation; Ontario
   Research Fund; PrioNet-Canada; CIHRCanadian Institutes of Health
   Research (CIHR); FAPESP-BrazilFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2009/14027-2, 2008/00390-5]; Instituto Nacionais de
   Neurociencia Translacional (INNT/MCT-Brazil); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); DFAIT-Canada; CAPESCAPES; DFAIT; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Human Frontier Science ProgramHuman Frontier Science Program
FX This work was supported by the Alzheimer's Association (USA), the
   Canadian Foundation for Innovation (CFI) and the Ontario Research Fund
   (M.A.M.P and V.F.P.), PrioNet-Canada (M.A.M.P., V.R.M. and V.F.P), CIHR
   (R.J.R, V.F.P and M.A.M.P.), FAPESP-Brazil (V.R.M., G.N.M.H. and
   M.A.M.P.; 2009/14027-2 and 2008/00390-5) and Instituto Nacionais de
   Neurociencia Translacional (INNT/MCT-Brazil, V.R.M. and S.T.F.). S.T.F
   and F.G.F. are supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ). P.H.F.H, F.A.C. and
   A.L.G. received a fellowships from CNPq. F.H.B received a fellowship
   from DFAIT-Canada. I.S. and A.P.W-S. were supported by a CAPES
   fellowship and I.S. also received a training fellowship from DFAIT (ELAP
   program) for a visit to Canada. S.J. received a fellowship from FAPERJ.
   V.R.M. is an International Scholar of the Howard Hughes Medical
   Institute. F.G.F. is a John Simon Guggenheim Memorial Foundation Fellow
   and is supported by a grant from the Human Frontier Science Program. We
   are indebted to Drs. Stephen Ferguson (University of Western Ontario)
   for the Rab5 construct, Roger Morris (King's College London) for the
   original PrP-3F4 constructs and Suzette A. Priola (NIAID-RML) for CF-10
   cells. We would like to acknowledge the help of Lianne Dale from the
   London Regional Cell & In Vitro Molecular Imaging Facility for initial
   help with TIRF microscopy.
CR Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008
   Baier M, 2008, INT J DEV NEUROSCI, V26, P821, DOI 10.1016/j.ijdevneu.2008.07.001
   Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107
   Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653
   Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263
   Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x
   Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008
   Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082
   CAUGHEY B, 1991, J BIOL CHEM, V266, P18217
   Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294
   Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516
   Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324
   Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200
   Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372
   Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x
   Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660
   Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005
   Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001
   Ferguson Stephen S. G., 2003, V237, P121
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ghribi O, 2003, MOL BRAIN RES, V119, P201, DOI 10.1016/j.molbrainres.2003.09.001
   Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957
   Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4
   Graner E, 2000, FEBS LETT, V482, P257, DOI 10.1016/S0014-5793(00)02070-6
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459
   Hooper NM, 2008, TRENDS BIOCHEM SCI, V33, P151, DOI 10.1016/j.tibs.2008.01.004
   Jen A, 2010, J CELL SCI, V123, P246, DOI 10.1242/jcs.058099
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Jurgensen S, 2010, J MOL NEUROSCI, V40, P221, DOI 10.1007/s12031-009-9237-0
   Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217
   Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5
   Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x
   Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007
   Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005
   Ma QL, 2007, J NEUROCHEM, V103, P1594, DOI 10.1111/j.1471-4159.2007.04869.x
   Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005
   Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662
   Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426
   Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63
   Martins VR, 2002, FEBS LETT, V512, P25, DOI 10.1016/S0014-5793(02)02291-3
   Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218
   Maxfield FR, 1997, ADV EXP MED BIOL, V419, P355
   MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582
   Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010
   Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104
   Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816
   Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107
   Prado MAM, 2004, J NEUROCHEM, V88, P769, DOI 10.1046/j.1471-4159.2003.02199.x
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107
   Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127
   Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016
   Selkoe DJ, 2006, NAT MED, V12, P758, DOI 10.1038/nm0706-758
   Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248
   SHYNG SL, 1993, J BIOL CHEM, V268, P15922
   SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003
   Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200
   Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6
   Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344
   Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736
   Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626
   Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3
   Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011
   Young KF, 2009, NEUROCHEM INT, V55, P796, DOI 10.1016/j.neuint.2009.08.002
   Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 80
TC 57
Z9 57
U1 1
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD MAY
PY 2011
VL 117
IS 3
BP 538
EP 553
DI 10.1111/j.1471-4159.2011.07225.x
PG 16
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 749KJ
UT WOS:000289464500017
PM 21352228
DA 2020-09-29
ER

PT J
AU Wasilewska-Sampaio, AP
   Hirata, P
   Prado, M
   Brito-Moreira, J
   Ferreira, S
   Hajj, G
   Martins, VR
AF Wasilewska-Sampaio, Ana Paula
   Hirata, Pedro
   Prado, Marco
   Brito-Moreira, Jordano
   Ferreira, Sergio
   Hajj, Glucia
   Martins, Vilma Regina
TI PrPC-STI1 Interaction Protects Against Synapse Damage Caused by Soluble
   A beta Oligomers
SO PRION
LA English
DT Meeting Abstract
C1 [Wasilewska-Sampaio, Ana Paula; Hirata, Pedro; Hajj, Glucia; Martins, Vilma Regina] Fundacao Antonio Prudente, Sao Paulo, Brazil.
   [Prado, Marco] Robarts Res Inst, London, ON N6A 5C1, Canada.
   [Prado, Marco] Univ Western Ontario, London, ON, Canada.
   [Brito-Moreira, Jordano; Ferreira, Sergio] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
EM asampaio@cipe.accamargo.org.br
RI Martins, Vilma/N-5446-2019; Ferreira, Sergio/AAZ-1576-2020; Martins,
   Vilma R/E-2547-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Martins, Vilma
   R/0000-0002-2909-8502
NR 0
TC 1
Z9 1
U1 0
U2 0
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1933-6896
EI 1933-690X
J9 PRION
JI Prion
PD APR-JUN
PY 2011
VL 5
SU S
MA PPPM.24
BP 121
EP 122
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA V34DE
UT WOS:000209066300276
DA 2020-09-29
ER

PT J
AU Paula-Lima, AC
   Adasme, T
   SanMartin, C
   Sebollela, A
   Hetz, C
   Carrasco, MA
   Ferreira, ST
   Hidalgo, C
AF Paula-Lima, Andrea C.
   Adasme, Tatiana
   SanMartin, Carol
   Sebollela, Adriano
   Hetz, Claudio
   Angelica Carrasco, M.
   Ferreira, Sergio T.
   Hidalgo, Cecilia
TI Amyloid beta-Peptide Oligomers Stimulate RyR-Mediated Ca2+ Release
   Inducing Mitochondrial Fragmentation in Hippocampal Neurons and Prevent
   RyR-Mediated Dendritic Spine Remodeling Produced by BDNF
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article
ID LONG-TERM POTENTIATION; DISEASE-LINKED MUTATIONS; RAT-BRAIN CORTEX;
   ALZHEIMERS-DISEASE; RYANODINE RECEPTORS; SYNAPTIC PLASTICITY;
   TAU-HYPERPHOSPHORYLATION; CREB PHOSPHORYLATION; SOLUBLE OLIGOMERS;
   PROTEIN-SYNTHESIS
AB Soluble amyloid beta-peptide oligomers (A beta Os), increasingly recognized as causative agents of Alzheimer's disease (AD), disrupt neuronal Ca2+ homeostasis and synaptic function. Here, we report that A beta Os at sublethal concentrations generate prolonged Ca2+ signals in primary hippocampal neurons; incubation in Ca2+-free solutions, inhibition of ryanodine receptors (RyRs) or N-methyl-d-aspartate receptors (NMDARs), or preincubation with N-acetyl-L-cysteine abolished these signals. A beta Os decreased (6 h) RyR2 and RyR3 mRNA and RyR2 protein, and promoted mitochondrial fragmentation after 24 h. NMDAR inhibition abolished the RyR2 decrease, whereas RyR inhibition prevented significantly the RyR2 protein decrease and mitochondrial fragmentation induced by A beta Os. Incubation with A beta Os (6 h) eliminated the RyR2 increase induced by brain-derived nerve factor (BDNF) and the dendritic spine remodeling induced within minutes by BDNF or the RyR agonist caffeine. Addition of BDNF to neurons incubated with A beta Os for 24 h, which had RyR2 similar to and slightly higher RyR3 protein content than those of controls, induced dendritic spine growth but at slower rates than in controls. These combined effects of sublethal A beta Os concentrations (which include redox-sensitive stimulation of RyR-mediated Ca2+ release, decreased RyR2 protein expression, mitochondrial fragmentation, and prevention of RyR-mediated spine remodeling) may contribute to impairing the synaptic plasticity in AD. Antioxid. Redox Signal. 14, 1209-1223.
C1 [Paula-Lima, Andrea C.; Adasme, Tatiana; SanMartin, Carol; Hetz, Claudio; Angelica Carrasco, M.; Hidalgo, Cecilia] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Inst Ciencias Biomed, Santiago 8380453, Chile.
   [Sebollela, Adriano; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21941 Rio De Janeiro, Brazil.
   [Hetz, Claudio] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Biol Celular & Mol, Santiago 8380453, Chile.
   [Angelica Carrasco, M.; Hidalgo, Cecilia] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 8380453, Chile.
RP Hidalgo, C (corresponding author), Univ Chile, Fac Med, Ctr Estudios Mol Celula, Inst Ciencias Biomed, Independencia 1027, Santiago 8380453, Chile.
EM chidalgo@med.uchile.cl
RI Ferreira, Sergio/AAZ-1576-2020; Sebollela, Adriano/O-4385-2014; Hetz,
   Claudio/I-1900-2013; Paula-Lima, Andrea C./I-2537-2013; Neurociencia,
   Inct/I-1011-2013; Adasme, Tatiana/I-2828-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Sebollela,
   Adriano/0000-0002-7444-9156; Hetz, Claudio/0000-0001-7724-1767;
   Paula-Lima, Andrea C./0000-0002-0466-7561; Adasme,
   Tatiana/0000-0002-0840-1912
FU FondecytComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT FONDECYT [3085025, 1060177, 1100176];
   CONICYT-FONDAPComision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT)CONICYT FONDAP [79090021]; Fondecyt-FONDAPComision
   Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT
   FONDECYTCONICYT FONDAP [15010006]; Millennium Nucleus [P07-048-F];
   CHDI-HighQ Foundation; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Instituto Nacional de Neurociencia Translacional
FX This work was supported by Fondecyt postdoctoral project 3085025 and by
   CONICYT-FONDAP 79090021 to A. C. Paula-Lima, by Fondecyt grants 1060177
   and 1100176, and by Fondecyt-FONDAP 15010006. C. Hetz also acknowledges
   support from Millennium Nucleus P07-048-F and CHDI-HighQ Foundation, and
   S. T. Ferreira from Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   and Instituto Nacional de Neurociencia Translacional. The authors
   gratefully acknowledge Drs. J. Hidalgo, P. Donoso and G. Sanchez for
   their thoughtful comments and support, and thank N. Leal and P.
   Fernandez for their skilful professional assistance.
CR ADASME T, 2008, 2008 NEUR M PLANN
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008
   Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804
   Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264
   Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008
   BARONDES SH, 1964, J NEUROCHEM, V11, P187, DOI 10.1111/j.1471-4159.1964.tb06128.x
   Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1
   Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005
   Bull R, 2008, J NEUROSCI, V28, P9463, DOI 10.1523/JNEUROSCI.2286-08.2008
   Bull R, 2007, AM J PHYSIOL-CELL PH, V293, pC162, DOI 10.1152/ajpcell.00518.2006
   Celsi F, 2007, NEUROBIOL DIS, V26, P342, DOI 10.1016/j.nbd.2006.12.022
   Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015
   Danzer SC, 2002, J NEUROSCI, V22, P9754
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200
   DeToledo-Morrell L, 2007, PROG BRAIN RES, V163, P741, DOI 10.1016/S0079-6123(07)63040-4
   Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2
   Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011
   FLEXNER JB, 1962, J NEUROCHEM, V9, P595, DOI 10.1111/j.1471-4159.1962.tb04216.x
   Galeotti N, 2008, LEARN MEMORY, V15, P315, DOI 10.1101/lm.929008
   Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007
   GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893
   Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009
   Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Haeger P, 2010, NEUROTOX RES, V17, P238, DOI 10.1007/s12640-009-9096-z
   Hayrapetyan V, 2008, CELL CALCIUM, V44, P507, DOI 10.1016/j.ceca.2008.03.004
   Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051
   Huddleston AT, 2008, J NEUROPHYSIOL, V99, P1565, DOI 10.1152/jn.00659.2007
   Kaddour-Djebbar I, 2010, INT J ONCOL, V36, P1437, DOI 10.3892/ijo_00000629
   Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5
   Kelliher M, 1999, NEUROSCIENCE, V92, P499, DOI 10.1016/S0306-4522(99)00042-1
   Kemmerling U, 2007, CELL CALCIUM, V41, P491, DOI 10.1016/j.ceca.2006.10.001
   Kitanishi T, 2009, CEREB CORTEX, V19, P2572, DOI 10.1093/cercor/bhp012
   Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068
   Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Lu YF, 2002, J NEUROPHYSIOL, V88, P1270, DOI 10.1152/jn.2002.88.3.1270
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   Muller M, 2011, ANTIOXID REDOX SIGN, V14, P1225, DOI 10.1089/ars.2010.3421
   Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447
   Nguyen PV, 1996, J NEUROSCI, V16, P3189
   Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150
   Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Peng S, 2009, J NEUROSCI, V29, P9321, DOI 10.1523/JNEUROSCI.4736-08.2009
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x
   Resende R, 2008, J NEUROSCI RES, V86, P2091, DOI 10.1002/jnr.21648
   Riquelme D, 2011, ANTIOXID REDOX SIGN, V14, P1245, DOI 10.1089/ars.2010.3238
   Sanz-Blasco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002718
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   SHARP AH, 1993, J NEUROSCI, V13, P3051
   Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006
   Supnet C, 2006, J BIOL CHEM, V281, P38440, DOI 10.1074/jbc.M606736200
   Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864
   Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004
   Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200
   Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059
   Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577
   Zhao WQ, 2000, FASEB J, V14, P290
   Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359
NR 78
TC 82
Z9 86
U1 0
U2 7
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD APR
PY 2011
VL 14
IS 7
BP 1209
EP 1223
DI 10.1089/ars.2010.3287
PG 15
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 732BN
UT WOS:000288157300004
PM 20712397
OA Green Published
DA 2020-09-29
ER

PT J
AU Jurgensen, S
   Antonio, LL
   Mussi, GEA
   Brito-Moreira, J
   Bomfim, TR
   De Felice, FG
   Garrido-Sanabria, ER
   Cavalheiro, EA
   Ferreira, ST
AF Juergensen, Sofia
   Antonio, Leandro L.
   Mussi, Gabriela E. A.
   Brito-Moreira, Jordano
   Bomfim, Theresa R.
   De Felice, Fernanda G.
   Garrido-Sanabria, Emilio R.
   Cavalheiro, Esper A.
   Ferreira, Sergio T.
TI Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse
   Dysfunction Induced by Amyloid-beta Oligomers
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID LONG-TERM POTENTIATION; AMPA-RECEPTORS; DEPENDENT MECHANISM;
   PERISYNAPTIC SITES; SURFACE EXPRESSION; ALZHEIMERS-DISEASE; SECRETED
   OLIGOMERS; PLASTICITY; TRAFFICKING; GLUR1
AB Soluble oligomers of the amyloid-beta peptide (A beta Os) accumulate in the brains of Alzheimer disease (AD) patients and are implicated in synapse failure and early memory loss in AD. A beta Os have been shown to impact synapse function by inhibiting long term potentiation, facilitating the induction of long term depression and inducing internalization of both AMPA and NMDA glutamate receptors, critical players in plasticity mechanisms. Because activation of dopamine D1/D5 receptors plays important roles in memory circuits by increasing the insertion of AMPA and NMDA receptors at synapses, we hypothesized that selective activation of D1/D5 receptors could protect synapses from the deleterious action of A beta Os. We show that SKF81297, a selective D1/D5 receptor agonist, prevented the reduction in surface levels of AMPA and NMDA receptors induced by A beta Os in hippocampal neurons in culture. Protection by SKF81297 was abrogated by the specific D1/D5 antagonist, SCH23390. Levels of AMPA receptor subunit GluR1 phosphorylated at Ser(845), which regulates AMPA receptor association with the plasma membrane, were reduced in a calcineurin-dependent manner in the presence of A beta Os, and treatment with SKF81297 prevented this reduction. Establishing the functional relevance of these findings, SKF81297 blocked the impairment of long term potentiation induced by A beta Os in hippocampal slices. Results suggest that D1/D5 receptors may be relevant targets for development of novel pharmacological approaches to prevent synapse failure in AD.
C1 [Juergensen, Sofia; Mussi, Gabriela E. A.; Brito-Moreira, Jordano; Bomfim, Theresa R.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-1944590 Rio De Janeiro, Brazil.
   [Antonio, Leandro L.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Dept Expt Neurol, BR-04023900 Sao Paulo, Brazil.
   [Garrido-Sanabria, Emilio R.] Univ Texas Brownsville, Ctr Biomed Studies, Dept Biol Sci, Brownsville, TX 78520 USA.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, CCS IBqM, BR-21941590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Cavalheiro, Esper A/I-3084-2016; Ferreira, Sergio/AAZ-1576-2020;
   Neurociencia, Inct/I-1011-2013; Cavalheiro, Esper A/F-4325-2014;
   Cavalheiro, Esper/N-3985-2019
OI Cavalheiro, Esper A/0000-0002-0854-3582; Ferreira,
   Sergio/0000-0001-7160-9866; Cavalheiro, Esper A/0000-0002-0854-3582;
   Cavalheiro, Esper/0000-0002-0854-3582
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5SC1NS063950-04,
   3SC1NS063950-03S1]; Conselho Nacional de Desenvolvimento Cientifico
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Neurociencia Translacional; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); Human Frontier Science ProgramHuman
   Frontier Science Program
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants 5SC1NS063950-04 and 3SC1NS063950-03S1 (to E. R. G.-S.).
   This work was also supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico Tecnologico, Instituto Nacional de
   Neurociencia Translacional, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior, and Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (to S. T. F.); Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (to E. A. C.); and Human Frontier Science Program (to F. G. D.
   F.).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008
   Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381
   Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002
   Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3
   Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x
   Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018
   Chen QS, 2002, NEUROBIOL LEARN MEM, V77, P354, DOI 10.1006/nlme.2001.4034
   Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010
   Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   DEKEYSER J, 1990, BRAIN RES, V528, P308, DOI 10.1016/0006-8993(90)91672-4
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x
   Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220
   Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026
   Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9
   Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106
   Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035
   Ikonemevic MD, 1999, EXP NEUROL, V160, P194, DOI 10.1006/exnr.1999.7196
   Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8
   Knobloch M, 2007, J NEUROSCI, V27, P7648, DOI 10.1523/JNEUROSCI.0395-07.2007
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003
   Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009
   Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012
   Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001
   Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104
   Missale C, 1998, PHYSIOL REV, V78, P189
   Missale C, 2006, CURR TOP MED CHEM, V6, P801, DOI 10.2174/156802606777057562
   Mockett BG, 2007, J NEUROSCI, V27, P2918, DOI 10.1523/JNEUROSCI.0838-06.2007
   Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008
   Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Rui YF, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-10
   Sanabria ERG, 2002, BRAIN RES BULL, V59, P47, DOI 10.1016/S0361-9230(02)00837-7
   Schaeffer EL, 2009, PROG NEURO-PSYCHOPH, V33, P1087, DOI 10.1016/j.pnpbp.2009.06.024
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516
   Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Snyder GL, 1998, J NEUROSCI, V18, P10297
   Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1
   Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754
   van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   WALS P, 1998, P NATL ACAD SCI USA, V95, P6448
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015
   Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010
   Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998
   Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105
   YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
NR 63
TC 61
Z9 63
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 4
PY 2011
VL 286
IS 5
BP 3270
EP 3276
DI 10.1074/jbc.M110.177790
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 712GE
UT WOS:000286653200012
PM 21115476
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Vargas-Lopes, C
   Madeira, C
   Kahn, SA
   do Couto, IA
   Bado, P
   Houzel, JC
   De Miranda, J
   de Freitas, MS
   Ferreira, ST
   Panizzutti, R
AF Vargas-Lopes, Charles
   Madeira, Caroline
   Kahn, Suzana A.
   do Couto, Ingrid Albino
   Bado, Patricia
   Houzel, Jean Christophe
   De Miranda, Joari
   de Freitas, Marta S.
   Ferreira, Sergio T.
   Panizzutti, Rogerio
TI Protein kinase C activity regulates d-serine availability in the brain
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE brain; d-serine; NMDAR function; phosphorylation; protein kinase C;
   serine racemase
ID NEUROMODULATOR D-SERINE; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE;
   MESSENGER-RNA; RAT-BRAIN; RACEMASE; INHIBITION; NEUROTRANSMISSION;
   CULTURES; NEUROTOXICITY
AB P>d-Serine is a co-agonist of NMDA receptor (NMDAR) and plays important roles in synaptic plasticity mechanisms. Serine racemase (SR) is a brain-enriched enzyme that converts l-serine to d-serine. SR interacts with the protein interacting with C-kinase 1 (PICK1), which is known to direct protein kinase C (PKC) to its targets in cells. Here, we investigated whether PKC activity regulates SR activity and d-serine availability in the brain. In vitro, PKC phosphorylated SR and decreased its activity. PKC activation increased SR phosphorylation in serine residues and reduced d-serine levels in astrocyte and neuronal cultures. Conversely, PKC inhibition decreased basal SR phosphorylation and increased cellular d-serine levels. In vivo modulation of PKC activity regulated both SR phosphorylation and d-serine levels in rat frontal cortex. Finally, rats that completed an object recognition task showed decreased SR phosphorylation and increased d-serine/total serine ratios, which was markedly correlated with decreased PKC activity in both cortex and hippocampus. Results indicate that PKC phosphorylates SR in serine residues and regulates d-serine availability in the brain. This interaction may be relevant for the regulation of physiological and pathological mechanisms linked to NMDAR function.
C1 [Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, CCS, Lab Fronteiras Neurociencias, BR-21941590 Rio De Janeiro, Brazil.
   [De Miranda, Joari] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY USA.
   [de Freitas, Marta S.] Univ Estado Rio de Janeiro, Dept Farmacol, Inst Biol, BR-20550011 Rio De Janeiro, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Lab Doencas Neurodegenerat, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Panizzutti, R (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, CCS, Lab Fronteiras Neurociencias, Sala F1-03, BR-21941590 Rio De Janeiro, Brazil.
EM rogerio@anato.ufrj.br
RI Houzel, Jean Christophe/G-3723-2010; Ferreira, Sergio/AAZ-1576-2020;
   Houzel, Jean Christophe/M-7936-2019; Neurociencia, Inct/I-1011-2013
OI Houzel, Jean Christophe/0000-0001-5128-438X; Ferreira,
   Sergio/0000-0001-7160-9866; Houzel, Jean Christophe/0000-0001-5128-438X;
   
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio
   (FUJB); Instituto Nacional de Neurociencia Translacional (INNP);
   International Society for Neurochemistry; Human Frontier Science Program
   (HFSP)Human Frontier Science Program; CAPESCAPES; ICB, UFRJ
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Universitaria
   Jose Bonifacio (FUJB), Instituto Nacional de Neurociencia Translacional
   (INNP), and International Society for Neurochemistry. RP is recipient of
   a Long-Term Fellowship from the Human Frontier Science Program (HFSP).
   CVL and CM were supported by pre-doctoral fellowships from CNPq. SAK was
   supported by a pre-doctoral fellowship from CAPES. CVL, CM, SAK, JCH,
   and RP are from the Programa em Ciencias Morfologicas, ICB, UFRJ. The
   authors declare no conflict of interest.
CR Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106
   Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130
   Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021
   Brennan AR, 2009, NEUROBIOL AGING, V30, P782, DOI 10.1016/j.neurobiolaging.2007.08.020
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   de Miranda J, 2002, P NATL ACAD SCI USA, V99, P14542, DOI 10.1073/pnas.222421299
   Dumin E, 2006, J BIOL CHEM, V281, P20291, DOI 10.1074/jbc.M601971200
   ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X
   FLINT AJ, 1990, SCIENCE, V249, P408, DOI 10.1126/science.2377895
   Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200
   Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776
   GOMEZA J, 1991, BIOCHEM J, V275, P435, DOI 10.1042/bj2750435
   Gustafson EC, 2007, J NEUROPHYSIOL, V98, P122, DOI 10.1152/jn.00057.2006
   HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F
   Hikida T, 2008, BIOL PSYCHIAT, V63, P997, DOI 10.1016/j.biopsych.2007.09.025
   Holub O, 2006, COMPUT PHYS COMMUN, V175, P620, DOI 10.1016/j.cpc.2006.06.014
   Junjaud G, 2006, J NEUROCHEM, V98, P1159, DOI 10.1111/j.1471-4159.2006.03944.x
   Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200
   KATSUKI H, 1971, ANAL BIOCHEM, V43, P349, DOI 10.1016/0003-2697(71)90263-6
   Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102
   KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822
   Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x
   Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926
   Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104
   Mustafaa AK, 2009, P NATL ACAD SCI USA, V106, P2921, DOI 10.1073/pnas.0813105106
   Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051
   Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298
   Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496
   Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847
   Runyan JD, 2005, LEARN MEMORY, V12, P103, DOI 10.1101/lm.89405
   Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005
   Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004
   Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409
   Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x
   Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6
   Yang S, 2005, NEUROSCI LETT, V379, P7, DOI 10.1016/j.neulet.2004.12.033
   Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100
   Yoshikawa M, 2007, ARCH HISTOL CYTOL, V70, P127, DOI 10.1679/aohc.70.127
   Yoshikawa M, 2006, EUR J PHARMACOL, V548, P74, DOI 10.1016/j.ejphar.2006.07.029
   Zhou Y, 2001, NEUROPHARMACOLOGY, V41, P601, DOI 10.1016/S0028-3908(01)00106-X
NR 43
TC 25
Z9 26
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JAN
PY 2011
VL 116
IS 2
BP 281
EP 290
DI 10.1111/j.1471-4159.2010.07102.x
PG 10
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 695TF
UT WOS:000285394800012
PM 21070240
DA 2020-09-29
ER

PT J
AU Oliveira, LT
   Louzada, PR
   de Mello, FG
   Ferreira, ST
AF Oliveira, Leandro T.
   Louzada, Paulo Roberto
   de Mello, Fernando G.
   Ferreira, Sergio T.
TI Amyloid-beta Decreases Nitric Oxide Production in Cultured Retinal
   Neurons: A Possible Mechanism for Synaptic Dysfunction in Alzheimer's
   Disease?
SO NEUROCHEMICAL RESEARCH
LA English
DT Article
DE Amyloid-beta; Alzheimer's disease; Neurotoxicity; Nitric oxide; Nitric
   oxide syntase; Retina
ID LONG-TERM POTENTIATION; SOLUBLE-PROTEIN OLIGOMERS; NMDA RECEPTOR
   BLOCKADE; IN-VIVO; NEUROTOXICITY; SYNTHASE; HIPPOCAMPAL; INHIBITION;
   PEPTIDE; RAT
AB The neurotoxicity of the amyloid-beta peptide (A beta) appears to be, at least in part, related to pathological activation of glutamate receptors by A beta aggregates. However, the downstream signaling pathways leading to neurodegeneration are still incompletely understood. Hyperactivation of nitric oxide synthase (NOS) and increased nitric oxide (NO) production have been implicated in excitotoxic neuronal damage caused by overactivation of glutamate receptors, and it has been suggested that increased NO levels might also play a role in neurotoxicity in Alzheimer's disease. We have examined the effect of blockade of NO production on the neurotoxicity instigated by A beta(42) and by elevated concentrations of glutamate in chick embryo retinal neurons in culture. Results showed that L-nitroarginine methyl ester, a potent inhibitor of all NOS isoforms, had no protective effect against neuronal death induced by either A beta(42) (20 mu M) or glutamate (1 mM). Surprisingly, at short incubation times both A beta and glutamate decreased NO production in retinal neuronal cultures in the absence of neuronal death. Thus, excitotoxic insults induced by A beta and glutamate cause inhibition rather than activation of NO synthase in retinal neurons, suggesting that cell death induced by A beta or glutamate is not related to increased NO production. On the other hand, considering the role of NO in long term potentiation and synaptic plasticity, the decrease in NO levels instigated by A beta and glutamate suggests a possible mechanism leading to synaptic failure in AD.
C1 [Louzada, Paulo Roberto] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, Brazil.
   [Oliveira, Leandro T.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   [de Mello, Fernando G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chages Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Louzada, PR (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, Brazil.
EM louzada@rocketmail.com
RI Neurociencia, Inct/I-1011-2013; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Oliveira,
   Leandro/0000-0001-8441-5163
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Programa de Nucleos de Excelencia and Instituto Nacional de Neurociencia
   Translacional; Howard Hughes Medical InstituteHoward Hughes Medical
   Institute
FX Supported by grants from Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro, Programa de Nucleos de Excelencia and Instituto Nacional de
   Neurociencia Translacional (to STF and FGM) and Howard Hughes Medical
   Institute (to STF).
CR Araujo IM, 2003, J NEUROCHEM, V85, P791, DOI 10.1046/j.1471-4159.2003.01731.x
   BECKMAN JS, 1996, AM J PHYS, V71, P1424
   Bisel BE, 2007, ANN NY ACAD SCI, V1097, P58, DOI 10.1196/annals.1379.020
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Dentchev T, 2003, MOL VIS, V9, P184
   Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   GALASSO JM, 1995, NEUROREPORT, V6, P1505, DOI 10.1097/00001756-199507310-00010
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hashiguchi A, 2004, J CEREBR BLOOD F MET, V24, P271, DOI 10.1097/01.WCB.0000110539.96047.FC
   Hawkins RD, 1998, PROG BRAIN RES, V118, P155
   Holscher C, 1997, TRENDS NEUROSCI, V20, P298, DOI 10.1016/S0166-2236(97)01065-5
   Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006
   Hossain S, 2009, J NEUROCHEM, V111, P568, DOI 10.1111/j.1471-4159.2009.06336.x
   Huang EP, 1997, CURR BIOL, V7, pR141, DOI 10.1016/S0960-9822(97)70073-3
   Yun SH, 2006, NEUROSCI LETT, V403, P162, DOI 10.1016/j.neulet.2006.04.065
   Ju TC, 2005, FREE RADICAL BIO MED, V38, P938, DOI 10.1016/j.freeradbiomed.2004.12.019
   Keil U, 2004, POL J PHARMACOL, V56, P631
   Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200
   KOWALL NW, 1992, NEUROBIOL AGING, V13, P537, DOI 10.1016/0197-4580(92)90053-Z
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lahiri DK, 2003, ANN NY ACAD SCI, V1010, P639, DOI 10.1196/annals.1299.117
   Lima ACP, 2003, NEUROTOX RES, V5, P323, DOI 10.1007/BF03033152
   Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958
   Lopez-Colome AM, 2003, DEV NEUROSCI-BASEL, V25, P293, DOI 10.1159/000073505
   Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com
   Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3
   Margaill I, 1997, BRIT J PHARMACOL, V120, P160, DOI 10.1038/sj.bjp.0700889
   Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   McCarthy HO, 2008, J PHARM PHARMACOL, V60, P999, DOI 10.1211/jpp.60.8.0007
   Moncada S, 2006, V176
   Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x
   Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529
   Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849
   O'Mahony S, 1998, BRAIN RES BULL, V45, P405, DOI 10.1016/S0361-9230(97)00405-X
   Origlia N, 2009, J ALZHEIMERS DIS, V17, P59, DOI 10.3233/JAD-2009-1045
   Patel NJ, 2010, EUR J PHARMACOL, V633, P1, DOI 10.1016/j.ejphar.2010.01.012
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Perez-Severiano F, 1998, NEUROCHEM RES, V23, P1297, DOI 10.1023/A:1020700401678
   PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D
   Puzzo Daniela, 2006, Current Alzheimer Research, V3, P179, DOI 10.2174/156720506777632871
   Romano C, 1998, PROG RETIN EYE RES, V17, P465, DOI 10.1016/S1350-9462(98)00008-1
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741
   Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037
   Thatcher Gregory R. J., 2006, Current Alzheimer Research, V3, P237, DOI 10.2174/156720506777632925
   Venturini G, 2002, FASEB J, V16, P1970, DOI 10.1096/fj.02-0186fje
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Xie Z, 2002, J NEUROSCI, V22, P3484
   Yin HB, 2008, MED HYPOTHESES, V71, P77, DOI 10.1016/j.mehy.2008.01.030
   Zhang JM, 2006, SYNAPSE, V60, P307, DOI 10.1002/syn.20302
   Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249
   Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147
NR 59
TC 13
Z9 13
U1 0
U2 3
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-3190
EI 1573-6903
J9 NEUROCHEM RES
JI Neurochem. Res.
PD JAN
PY 2011
VL 36
IS 1
BP 163
EP 169
DI 10.1007/s11064-010-0287-z
PG 7
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 711KA
UT WOS:000286589000020
PM 20936504
DA 2020-09-29
ER

PT J
AU Saraiva, LM
   da Silva, GSS
   Galina, A
   da-Silva, WS
   Klein, WL
   Ferreira, ST
   De Felice, FG
AF Saraiva, Leonardo M.
   Seixas da Silva, Gisele S.
   Galina, Antonio
   da-Silva, Wagner S.
   Klein, William L.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Amyloid-beta Triggers the Release of Neuronal Hexokinase 1 from
   Mitochondria
SO PLOS ONE
LA English
DT Article
ID SOLUBLE-PROTEIN OLIGOMERS; A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS;
   TAU-HYPERPHOSPHORYLATION; GLUCOSE-METABOLISM; NEUROTOXICITY;
   HIPPOCAMPAL; DEPOSITION; MECHANISM
AB Brain accumulation of the amyloid-beta peptide (A beta) and oxidative stress underlie neuronal dysfunction and memory loss in Alzheimer's disease (AD). Hexokinase (HK), a key glycolytic enzyme, plays important pro-survival roles, reducing mitochondrial reactive oxygen species (ROS) generation and preventing apoptosis in neurons and other cell types. Brain isozyme HKI is mainly associated with mitochondria and HK release from mitochondria causes a significant decrease in enzyme activity and triggers oxidative damage. We here investigated the relationship between A beta-induced oxidative stress and HK activity. We found that A beta triggered HKI detachment from mitochondria decreasing HKI activity in cortical neurons. A beta oligomers further impair energy metabolism by decreasing neuronal ATP levels. A beta-induced HKI cellular redistribution was accompanied by excessive ROS generation and neuronal death. 2-deoxyglucose blocked A beta-induced oxidative stress and neuronal death. Results suggest that A beta-induced cellular redistribution and inactivation of neuronal HKI play important roles in oxidative stress and neurodegeneration in AD.
C1 [Saraiva, Leonardo M.; Seixas da Silva, Gisele S.; Galina, Antonio; da-Silva, Wagner S.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.
   [Klein, William L.; De Felice, Fernanda G.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
RP Saraiva, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br
RI da Silva, Wagner/A-7835-2008; Galina, Antonio/A-9292-2008; Ferreira,
   Sergio/AAZ-1576-2020
OI da Silva, Wagner/0000-0002-0001-0386; Ferreira,
   Sergio/0000-0001-7160-9866
FU Human Frontier Science Program (HFSP)Human Frontier Science Program;
   John Simon Guggenheim Memorial Foundation; Howard Hughes Medical
   InstituteHoward Hughes Medical Institute; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/BrazilNational Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro/BrazilCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Instituto Nacional de Neurociencia Translacional/Brazil; American Health
   Assistance Foundation; Alzheimer's AssociationAlzheimer's Association;
   National Institutes of Health-National Institute on AgingUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [RO1-AG18877, RO1-AG22547]
FX This work was supported by grants from the Human Frontier Science
   Program (HFSP) and The John Simon Guggenheim Memorial Foundation (FGF),
   Howard Hughes Medical Institute (STF), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/Brazil, Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro/Brazil and Instituto Nacional de
   Neurociencia Translacional/Brazil (FGF and STF). WLK is supported by
   grants from the American Health Assistance Foundation, Alzheimer's
   Association, National Institutes of Health-National Institute on Aging
   Grants RO1-AG18877 and RO1-AG22547. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Andersson CX, 2005, BIOCHEM J, V387, P377, DOI 10.1042/BJ20041387
   Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465
   Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006
   Bigl M, 2003, J NEURAL TRANSM, V110, P77, DOI 10.1007/s00702-002-0772-x
   Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005
   da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Huang TJ, 2005, MOL CELL NEUROSCI, V28, P42, DOI 10.1016/j.mcn.2004.08.009
   Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9
   Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009
   Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014
   Mark RJ, 1997, J NEUROSCI, V17, P1046
   Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200
   Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010
   MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1333.062
   Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059
   Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200
   ROSE IA, 1967, J BIOL CHEM, V242, P1635
   Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com
   Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x
   Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005
   Skaff DA, 2005, J BIOL CHEM, V280, P38403, DOI 10.1074/jbc.M506943200
   Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang Z, 2008, NEUROSCI LETT, V434, P6, DOI 10.1016/j.neulet.2008.01.057
   Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241
   Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147
NR 52
TC 57
Z9 59
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 16
PY 2010
VL 5
IS 12
AR e15230
DI 10.1371/journal.pone.0015230
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 695OI
UT WOS:000285381200018
PM 21179577
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Decker, H
   Jurgensen, S
   Adrover, MF
   Brito-Moreira, J
   Bomfim, TR
   Klein, WL
   Epstein, AL
   De Felice, FG
   Jerusalinsky, D
   Ferreira, ST
AF Decker, Helena
   Juergensen, Sofia
   Adrover, Martin F.
   Brito-Moreira, Jordano
   Bomfim, Theresa R.
   Klein, William L.
   Epstein, Alberto L.
   De Felice, Fernanda G.
   Jerusalinsky, Diana
   Ferreira, Sergio T.
TI N-Methyl-d-aspartate receptors are required for synaptic targeting of
   Alzheimer's toxic amyloid-beta peptide oligomers
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE A beta oligomers; Alzheimer's disease; insulin; NMDA receptor; synapse
   dysfunction
ID LONG-TERM POTENTIATION; CELLULAR PRION PROTEIN; A-BETA;
   INSULIN-RECEPTORS; IN-VIVO; TAU-HYPERPHOSPHORYLATION;
   HIPPOCAMPAL-NEURONS; DEPENDENT MECHANISM; SOLUBLE OLIGOMERS;
   MOLECULAR-BASIS
AB P>Soluble amyloid-beta peptide (A beta) oligomers, known to accumulate in Alzheimer's disease brains, target excitatory post-synaptic terminals. This is thought to trigger synapse deterioration, a mechanism possibly underlying memory loss in early stage Alzheimer's disease. A major unknown is the identity of the receptor(s) targeted by oligomers at synapses. Because oligomers have been shown to interfere with N-methyl-d-aspartate receptor (NMDAR) function and trafficking, we hypothesized that NMDARs might be required for oligomer binding to synapses. An amplicon vector was used to knock-down NMDARs in mature hippocampal neurons in culture, yielding 90% reduction in dendritic NMDAR expression and blocking neuronal oxidative stress induced by A beta oligomers, a pathological response that has been shown to be mediated by NMDARs. Remarkably, NMDAR knock-down abolished oligomer binding to dendrites, indicating that NMDARs are required for synaptic targeting of oligomers. Nevertheless, oligomers do not appear to bind directly to NMDARs as indicated by the fact that both oligomer-attacked and non-attacked neurons exhibit similar surface levels of NMDARs. Furthermore, pre-treatment of neurons with insulin down-regulates oligomer-binding sites in the absence of a parallel reduction in surface levels of NMDARs. Establishing that NMDARs are key components of the synaptic oligomer binding complex may illuminate the development of novel approaches to prevent synapse failure triggered by A beta oligomers.
C1 [Decker, Helena; Juergensen, Sofia; Brito-Moreira, Jordano; Bomfim, Theresa R.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
   [Decker, Helena] Univ Fed Rio de Janeiro, Program Morphol Sci, BR-21944590 Rio De Janeiro, Brazil.
   [Adrover, Martin F.; Jerusalinsky, Diana] Univ Buenos Aires, Inst Cellular Biol & Neurosci Prof Eduardo de Rob, Sch Med, Buenos Aires, DF, Argentina.
   [Adrover, Martin F.; Jerusalinsky, Diana] Univ Buenos Aires, CBC, Buenos Aires, DF, Argentina.
   [Adrover, Martin F.; Jerusalinsky, Diana] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
   [Epstein, Alberto L.] Univ Lyon 1, CNRS, Ctr Genet Mol & Cellulaire, Villeurbanne, France.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Neurociencia, Inct/I-1011-2013; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute; Human
   Frontier Science ProgramHuman Frontier Science Program; John Simon
   Guggenheim Memorial Foundation; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Pronex-FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Instituto Nacional de Neurociencia Translacional;
   CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET); CNRSCentre National de la Recherche Scientifique (CNRS);
   Brazilian agency CAPESCAPES
FX This work was supported by grants from Howard Hughes Medical Institute
   (STF), Human Frontier Science Program and The John Simon Guggenheim
   Memorial Foundation (FGF), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro, Pronex-FAPERJ and Instituto Nacional de Neurociencia
   Translacional (STF and FGF), CONICET (DJ) and CNRS (ALE). We thank the
   Program for Technological Development of Tools for Health Research
   (PDTIS/FIOCRUZ) for use of the confocal microscope. HD thanks the
   Brazilian agency CAPES for fellowship support.
CR Adrover MF, 2003, GENES BRAIN BEHAV, V2, P103, DOI 10.1034/j.1601-183X.2003.00015.x
   Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107
   BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0
   Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082
   Cheli V, 2006, J NEUROCHEM, V97, P68, DOI 10.1111/j.1471-4159.2005.03592.x
   COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102
   Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   HEIDENREICH KA, 1983, J BIOL CHEM, V258, P8527
   HEIDENREICH KA, 1988, MOL CELL ENDOCRINOL, V56, P255, DOI 10.1016/0303-7207(88)90068-8
   Hu NW, 2009, P NATL ACAD SCI USA, V106, P20504, DOI 10.1073/pnas.0908083106
   Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200
   Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217
   Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003
   Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010
   Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009
   Krisky DM, 1998, GENE THER, V5, P1517, DOI 10.1038/sj.gt.3300755
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   MACHUCA I, 1986, VIROLOGY, V150, P117, DOI 10.1016/0042-6822(86)90271-0
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   MATSUMOTO H, 1990, J NEUROCHEM, V54, P347, DOI 10.1111/j.1471-4159.1990.tb13321.x
   Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945
   MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0
   Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029
   RONICKE R, 2010, NEUROBIOL AGING
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Zaupa C, 2003, HUM GENE THER, V14, P1049, DOI 10.1089/104303403322124774
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
   Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893
   Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5
NR 53
TC 117
Z9 117
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD DEC
PY 2010
VL 115
IS 6
BP 1520
EP 1529
DI 10.1111/j.1471-4159.2010.07058.x
PG 10
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 688ME
UT WOS:000284852600020
PM 20950339
DA 2020-09-29
ER

PT J
AU Sebollela, A
   Freitas-Correa, L
   Oliveira, FF
   Mendes, CT
   Wasilewska-Sampaio, AP
   Camacho-Pereira, J
   Galina, A
   Brentani, H
   Passetti, F
   De Felice, FG
   Dias-Neto, E
   Ferreira, ST
AF Sebollela, Adriano
   Freitas-Correa, Leo
   Oliveira, Fabio F.
   Mendes, Camila T.
   Wasilewska-Sampaio, Ana Paula
   Camacho-Pereira, Juliana
   Galina, Antonio
   Brentani, Helena
   Passetti, Fabio
   De Felice, Fernanda G.
   Dias-Neto, Emmanuel
   Ferreira, Sergio T.
TI Expression Profile of Rat Hippocampal Neurons Treated with the
   Neuroprotective Compound 2,4-Dinitrophenol: Up-Regulation of cAMP
   Signaling Genes
SO NEUROTOXICITY RESEARCH
LA English
DT Article
DE Neuronal cultures; Hippocampus; Neuroprotection; DNP; Gene expression;
   Cyclic AMP
ID A-BETA OLIGOMERIZATION; METHYL-D-ASPARTATE; ALZHEIMERS-DISEASE;
   MITOCHONDRIAL-FUNCTION; AMYLOID AGGREGATION; CORTICAL-NEURONS; MEMORY
   STORAGE; PROTEIN; NEUROTOXICITY; MECHANISMS
AB 2,4-Dinitrophenol (DNP) is classically known as a mitochondrial uncoupler and, at high concentrations, is toxic to a variety of cells. However, it has recently been shown that, at subtoxic concentrations, DNP protects neurons against a variety of insults and promotes neuronal differentiation and neuritogenesis. The molecular and cellular mechanisms underlying the beneficial neuroactive properties of DNP are still largely unknown. We have now used DNA microarray analysis to investigate changes in gene expression in rat hippocampal neurons in culture treated with low micromolar concentrations of DNP. Under conditions that did not affect neuronal viability, high-energy phosphate levels or mitochondrial oxygen consumption, DNP induced up-regulation of 275 genes and down-regulation of 231 genes. Significantly, several up-regulated genes were linked to intracellular cAMP signaling, known to be involved in neurite outgrowth, synaptic plasticity, and neuronal survival. Differential expression of specific genes was validated by quantitative RT-PCR using independent samples. Results shed light on molecular mechanisms underlying neuroprotection by DNP and point to possible targets for development of novel therapeutics for neurodegenerative disorders.
C1 [Sebollela, Adriano; Freitas-Correa, Leo; Oliveira, Fabio F.; Wasilewska-Sampaio, Ana Paula; Camacho-Pereira, Juliana; Galina, Antonio; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
   [Mendes, Camila T.; Dias-Neto, Emmanuel] Univ Sao Paulo, Fac Med, Inst Psiquiatria, Lab Neurociencias LIM27, BR-05403010 Sao Paulo, Brazil.
   [Brentani, Helena] Hosp Canc AC Camargo, Lab Bioinformat, Sao Paulo, Brazil.
   [Passetti, Fabio] INCA, Lab Bioinformat & Biol Computac, Serv Pesquisa Clin, BR-20231050 Rio De Janeiro, Brazil.
   [Dias-Neto, Emmanuel] Hosp Canc, Ctr Pesquisas, BR-01509900 Sao Paulo, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Dias-Neto, Emmanuel/AAA-6701-2019;
   Brentani, Helena/G-6839-2011; Dias-Neto, Emmanuel/A-5869-2008;
   Sebollela, Adriano/O-4385-2014; Passetti, Fabio/D-2422-2009; Galina,
   Antonio/A-9292-2008; Dias-Neto, Emmanuel/AAE-9147-2020; Neurociencia,
   Inct/I-1011-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Brentani,
   Helena/0000-0001-5192-4682; Dias-Neto, Emmanuel/0000-0001-5670-8559;
   Sebollela, Adriano/0000-0002-7444-9156; Passetti,
   Fabio/0000-0001-5672-7848; Camacho-Pereira, Juliana/0000-0002-4247-2140
FU Howard Hughes Medical Institute, Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq/Brazil)National Council for Scientific
   and Technological Development (CNPq)Howard Hughes Medical Institute;
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ/Brazil)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Instituto Nacional de Neurociencia
   Translacional (INNT/Brazil); Associacao Beneficente Alzira Denise
   Hertzog Silva (ABADHS); Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX This article was supported by grants from Howard Hughes Medical
   Institute, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ/Brazil) and Instituto Nacional de Neurociencia Translacional
   (INNT/Brazil) (to STF). We thank Lorena Chavez Gonzalez, Simon Guzman
   Leon, Jose Luis Santillan Torres and Jorge Ramirez for expert assistance
   with microarray analysis, and Gerardo Coello, Gustavo Corral and Ana
   Patricia Gomez for genArise software assistance. CTM and EDN acknowledge
   the support of Associacao Beneficente Alzira Denise Hertzog Silva
   (ABADHS) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP).
CR Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7
   Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200
   Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006
   Bourtchouladze R, 2006, LEARN MEMORY, V13, P745, DOI 10.1101/lm.354106
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com
   Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005
   da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x
   De Felice FG, 2007, CURR ALZHEIMER RES, V4, P263
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Leite MDS, 2007, EXP PARASITOL, V115, P315, DOI 10.1016/j.exppara.2006.09.002
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   DUGAN LL, 1995, J NEUROSCI, V15, P6377
   Flajolet M, 2003, P NATL ACAD SCI USA, V100, P16006, DOI 10.1073/pnas.2136600100
   Han YH, 2008, TOXICOL IN VITRO, V22, P659, DOI 10.1016/j.tiv.2007.12.005
   HANSTEIN WG, 1976, BIOCHIM BIOPHYS ACTA, V456, P129, DOI 10.1016/0304-4173(76)90010-0
   HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S
   Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6
   Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381
   Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396
   Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Korde AS, 2005, J NEUROTRAUM, V22, P1142, DOI 10.1089/neu.2005.22.1142
   Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x
   Kudin A, 1999, BRAIN RES PROTOC, V4, P329, DOI 10.1016/S1385-299X(99)00037-9
   Li DJ, 2005, J NEUROSCI, V25, P1914, DOI 10.1523/JNEUROSCI.4790-04.2005
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Luna-Moreno D, 2007, COMP BIOCHEM PHYS A, V146, P632, DOI 10.1016/j.cbpa.2006.02.039
   Maragos WF, 2003, BRAIN RES, V966, P312, DOI 10.1016/S0006-8993(02)04225-7
   Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903
   Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65
   Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   PARASCANDOLA J, 1974, MOL CELL BIOCHEM, V5, P69, DOI 10.1007/BF01874175
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Paula-Lima AC, 2008, BIOL RES, V41, P129, DOI [10.4067/S0716-97602008000200001, /S0716-97602008000200001]
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9
   Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779
   Sanchez S, 2004, NEUROCHEM INT, V44, P231, DOI 10.1016/S0197-0186(03)00150-5
   Shen LJ, 2006, HIPPOCAMPUS, V16, P875, DOI 10.1002/hipo.20218
   Shoichet SA, 2005, HUM GENET, V117, P536, DOI 10.1007/s00439-005-1310-3
   Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292
   Takahashi M, 2009, ENVIRON TOXICOL, V24, P74, DOI 10.1002/tox.20398
   Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x
   Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x
   Vieira MNN, 2006, CELL BIOCHEM BIOPHYS, V44, P549, DOI 10.1385/CBB:44:3:549
   Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com
NR 53
TC 11
Z9 13
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1029-8428
EI 1476-3524
J9 NEUROTOX RES
JI Neurotox. Res.
PD AUG
PY 2010
VL 18
IS 2
BP 112
EP 123
DI 10.1007/s12640-009-9133-y
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 607AR
UT WOS:000278471100002
PM 19949915
DA 2020-09-29
ER

PT J
AU Decker, H
   Lo, KY
   Unger, SM
   Ferreira, ST
   Silverman, MA
AF Decker, Helena
   Lo, Karen Y.
   Unger, Sandra M.
   Ferreira, Sergio T.
   Silverman, Michael A.
TI Amyloid-beta Peptide Oligomers Disrupt Axonal Transport through an NMDA
   Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase
   Kinase 3 beta in Primary Cultured Hippocampal Neurons
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; TAU; NEUROTOXICITY;
   MICROTUBULE; PLASTICITY; SYNAPSES; VESICLES; POLARITY; MOTILITY
AB Disruption of axonal transport is a hallmark of several neurodegenerative diseases, including Alzheimer's disease (AD). Even though defective transport is considered an early pathologic event, the mechanisms by which neurodegenerative insults impact transport are poorly understood. We show that soluble oligomers of the amyloid-beta peptide (A beta Os), increasingly recognized as the proximal neurotoxins in AD pathology, induce disruption of organelle transport in primary hippocampal neurons in culture. Live imaging of fluorescent protein-tagged organelles revealed a marked decrease in axonal trafficking of dense-core vesicles and mitochondria in the presence of 0.5 mu M A beta Os. NMDA receptor (NMDAR) antagonists, including D-AP5, MK-801, and memantine, prevented the disruption of trafficking, thereby identifying signals for A beta O action at the cell membrane. Significantly, both pharmacological inhibition of glycogen synthase kinase-3 beta (GSK-3 beta) and transfection of neurons with a kinase-dead form of GSK-3 beta prevented the transport defect. Finally, we demonstrate by biochemical and immunocytochemical means that A beta Os do not affect microtubule stability, indicating that disruption of transport involves a more subtle mechanism than microtubule destabilization, likely the dysregulation of intracellular signaling cascades. Results demonstrate that A beta Os negatively impact axonal transport by a mechanism that is initiated by NMDARs and mediated by GSK-3 beta and establish a new connection between toxic A beta oligomers and AD pathology.
C1 [Decker, Helena; Lo, Karen Y.; Unger, Sandra M.; Silverman, Michael A.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.
   [Decker, Helena; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
   [Decker, Helena] Univ Fed Rio de Janeiro, Inst Biomed Sci, Morphol Sci Program, BR-21944590 Rio De Janeiro, Brazil.
RP Silverman, MA (corresponding author), Simon Fraser Univ, Dept Biol Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.
EM masilver@sfu.ca
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Silverman, Michael
   A./0000-0001-6967-4917; Lo, Karen/0000-0003-4301-5846
FU National Science and Engineering Research CouncilNatural Sciences and
   Engineering Research Council of Canada [327100-06]; Canadian Foundation
   for InnovationCanada Foundation for Innovation [12793]; Canadian
   Institutes of Health ResearchCanadian Institutes of Health Research
   (CIHR) [90396]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (Brazil)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (Brazil)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Instituto Nacional de Neurociencia
   Translacional (Brazil); Coordenacao de Aperfeicoamento de Pessoal de
   Nivel SuperiorCAPES
FX This research was supported by grants from the National Science and
   Engineering Research Council (327100-06), the Canadian Foundation for
   Innovation (12793), and the Canadian Institutes of Health Research
   (90396) (to M. A. S.). S. T. F. is supported by grants from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro, and Instituto Nacional de
   Neurociencia Translacional (Brazil). We thank Cheng Fang (Oregon Health
   & Science University) for the p beta-actin-BDNF-mRFP plasmid and H.
   Hutter and V. Gelfand for critical reading of this manuscript. H. D.
   thanks the Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior for fellowship support.
CR Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075
   Black MM, 1996, J NEUROSCI, V16, P3601
   Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242
   BRADY ST, 1984, NATURE, V310, P56, DOI 10.1038/310056a0
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Giese KP, 2009, IUBMB LIFE, V61, P516, DOI 10.1002/iub.187
   Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009
   Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007
   Hiruma H, 2003, J NEUROSCI, V23, P8967
   Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100
   Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356
   Kempf M, 1996, J NEUROSCI, V16, P5583
   King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187
   Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003
   Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010
   Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281
   Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009
   Muresan V, 2009, FUTUR NEUROL, V4, P761, DOI 10.2217/FNL.09.54
   Park JJ, 2008, MOL CELL NEUROSCI, V39, P63, DOI 10.1016/j.mcn.2008.05.016
   Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2
   Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029
   Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Rui YF, 2006, CELL BIOL INT, V30, P733, DOI 10.1016/j.cellbi.2006.05.005
   Schlager MA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-25
   Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x
   Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681
   Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046
   Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057
   Wong MY, 2009, J MOL NEUROSCI, V37, P146, DOI 10.1007/s12031-008-9080-8
NR 39
TC 149
Z9 150
U1 0
U2 14
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUL 7
PY 2010
VL 30
IS 27
BP 9166
EP 9171
DI 10.1523/JNEUROSCI.1074-10.2010
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA 621MA
UT WOS:000279581700015
PM 20610750
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU da Costa, RFM
   Martinez, AMB
   Ferreira, ST
AF Madeiro da Costa, Rodrigo F.
   Blanco Martinez, Ana M.
   Ferreira, Sergio T.
TI 2,4-Dinitrophenol Blocks Neurodegeneration and Preserves Sciatic Nerve
   Function after Trauma
SO JOURNAL OF NEUROTRAUMA
LA English
DT Article
DE peripheral nervous system; nerve degeneration; neuroprotection; amyloid
   precursor protein; neuregulin
ID AMYLOID PRECURSOR PROTEIN; SPINAL-CORD-INJURY; A-BETA OLIGOMERIZATION;
   CYCLIC-AMP; ALZHEIMERS-DISEASE; WALLERIAN DEGENERATION;
   N-ACETYLCYSTEINE; AXONAL GROWTH; IN-VITRO; REGENERATION
AB Preventing the harm caused by nerve degeneration is a major challenge in neurodegenerative diseases and in various forms of trauma to the nervous system. The aim of the current work was to investigate the effects of systemic administration of 2,4-dinitrophenol (DNP), a compound with newly recognized neuroprotective properties, on sciatic-nerve degeneration following a crush injury. Sciatic-nerve injury was induced by unilateral application of an aneurism clip. Four groups of mice were used: uninjured, injured treated with vehicle (PBS), injured treated with two intraperitoneal doses of DNP (0.06mg DNP/kg every 24 h), and injured treated with four doses of DNP (every 12 h). Animals were sacrificed 48 h post injury and both injured and uninjured (contralateral) sciatic nerves were processed for light and electron microscopy. Morphometric, ultrastructural, and immunohistochemical analysis of injured nerves established that DNP prevented axonal degeneration, blocked cytoskeletal disintegration, and preserved the immunoreactivity of amyloid precursor protein (APP) and Neuregulin 1 (Nrg1), proteins implicated in neuronal survival and myelination. Functional tests revealed preservation of limb function following injury in DNP-treated animals. Results indicate that DNP prevents nerve degeneration and suggest that it may be a useful small-molecule adjuvant in the development of novel therapeutic approaches in nerve injury.
C1 [Madeiro da Costa, Rodrigo F.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21941590 Rio De Janeiro, Brazil.
   [Blanco Martinez, Ana M.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Neurobiol Basica & Clin, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21941590 Rio De Janeiro, Brazil.
EM martinez@histo.ufrj.br; ferreira@bioqmed.ufrj.br
RI Martinez, Ana/C-6318-2014; Madeiro, Rodrigo/M-6433-2017; Neurociencia,
   Inct/I-1011-2013; Ferreira, Sergio/AAZ-1576-2020
OI Madeiro, Rodrigo/0000-0001-5646-8858; Ferreira,
   Sergio/0000-0001-7160-9866
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq);
   Co-ordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES;
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Instituto Nacional de Neurociencia
   Translacional
FX We thank Ms. Diana Pontes for her contribution to morphometry and
   immunofluorescence experiments, Dr. Paulo R. Louzada for suggestions and
   valuable insight into the nerve injury model and Dr. Fernanda G. De
   Felice for critical reading of this manuscript. This study was supported
   by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Co-ordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and
   Instituto Nacional de Neurociencia Translacional.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6
   Bozkurt A, 2008, J NEUROSCI METH, V170, P117, DOI 10.1016/j.jneumeth.2008.01.006
   BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109
   Bregman BS, 2002, PROG BRAIN RES, V137, P257
   Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705
   Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001
   Camins A, 2006, CNS DRUG REV, V12, P135, DOI 10.1111/j.1527-3458.2006.00135.x
   Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5
   Couto LA, 2004, J NEUROSCI RES, V77, P410, DOI 10.1002/jnr.20170
   De Felice FG, 2007, CURR ALZHEIMER RES, V4, P263
   De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5
   Dijkstra JR, 2000, J NEUROSCI METH, V96, P89, DOI 10.1016/S0165-0270(99)00174-0
   DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739
   DYCK PJ, 1984, PERIPHERAL NEUROPATH, P660
   Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7
   GILLESPIE MJ, 1983, BRAIN RES, V259, P41, DOI 10.1016/0006-8993(83)91065-X
   Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001
   Hanson MG, 1998, J NEUROSCI, V18, P7361
   Hattori T, 2008, J CLIN NEUROSCI, V15, P185, DOI 10.1016/j.jocn.2006.12.009
   Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee RKK, 1997, P NATL ACAD SCI USA, V94, P5422, DOI 10.1073/pnas.94.10.5422
   Lopes FRP, 2006, EXP NEUROL, V198, P457, DOI 10.1016/j.expneurol.2005.12.019
   Maragos WF, 2003, BRAIN RES, V966, P312, DOI 10.1016/S0006-8993(02)04225-7
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862
   Moschou M, 2008, TOXICOL IN VITRO, V22, P267, DOI 10.1016/j.tiv.2007.09.005
   Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673
   PARASCANDOLA J, 1974, MOL CELL BIOCHEM, V5, P69, DOI 10.1007/BF01874175
   Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056
   Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4
   Reid AJ, 2009, NEUROSCI RES, V65, P148, DOI 10.1016/j.neures.2009.06.008
   SEBOLLELA A, 2009, NEUROTOX RES
   Tainter ML, 1935, J AMER MED ASSOC, V105, P0332, DOI 10.1001/jama.1935.02760310006002
   Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833
   Varejao ASP, 2001, J NEUROSCI METH, V108, P1, DOI 10.1016/S0165-0270(01)00378-8
   WALLACE W, 1993, P NATL ACAD SCI USA, V90, P8712, DOI 10.1073/pnas.90.18.8712
   Waller J., 1850, PHILOS T R SOC LOND, V140, P423, DOI DOI 10.1098/RSTL.1850.0021
   Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com
   WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858
   West CA, 2007, ACTA NEUROCHIR SUPPL, V100, P29
   Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X
NR 48
TC 17
Z9 17
U1 0
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
EI 1557-9042
J9 J NEUROTRAUM
JI J. Neurotrauma
PD MAY
PY 2010
VL 27
IS 5
BP 829
EP 841
DI 10.1089/neu.2009.1189
PG 13
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA 599LX
UT WOS:000277915400005
PM 20143955
DA 2020-09-29
ER

PT J
AU Jurgensen, S
   Ferreira, ST
AF Juergensen, Sofia
   Ferreira, Sergio T.
TI Nicotinic Receptors, Amyloid-beta, and Synaptic Failure in Alzheimer's
   Disease
SO JOURNAL OF MOLECULAR NEUROSCIENCE
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Cholinergic Mechanisms
CY AUG 16-20, 2008
CL Foz do Iguacu, BRAZIL
DE Alzheimer's disease; Nicotinic receptors; Amyloid-beta
ID LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; SOLUBLE-PROTEIN
   OLIGOMERS; REGION IN-VIVO; ACETYLCHOLINE-RECEPTORS; HIPPOCAMPAL-NEURONS;
   RAT HIPPOCAMPUS; NMDA RECEPTOR; BETA-AMYLOID(1-42) PEPTIDE;
   CHOLINESTERASE-INHIBITORS
AB Dysfunctional cholinergic transmission is thought to underlie, at least in part, memory impairment and cognitive deficits in Alzheimer's disease (AD). However, it is still unclear whether this is a consequence of the loss of cholinergic neurons and elimination of nicotinic acetycholine receptors (nAChRs) in AD brain or of a direct impact of molecular interactions of the amyloid-beta (A beta) peptide with nAChRs, leading to dysregulation of receptor function. This review examines recent progress in our understanding of the roles of nicotinic receptors in mechanisms of synaptic plasticity, molecular interactions of A beta with nAChRs, and how A beta-induced dysregulation of nicotinic receptor function may underlie synaptic failure in AD.
C1 [Juergensen, Sofia; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Neurociencia, Inct/I-1011-2013
OI Ferreira, Sergio/0000-0001-7160-9866; 
CR ABDULLA FA, 1993, PSYCHOPHARMACOLOGY, V111, P508, DOI 10.1007/BF02253544
   Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008
   Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008
   Bennett MR, 2000, PROG NEUROBIOL, V60, P109, DOI 10.1016/S0301-0082(99)00006-4
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381
   Buhler AV, 2002, J NEUROPHYSIOL, V87, P548, DOI 10.1152/jn.00316.2001
   Chen L, 2006, NEUROPHARMACOLOGY, V50, P254, DOI 10.1016/j.neuropharm.2005.09.018
   Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214
   DAVIES P, 1976, LANCET, V2, P1403
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055
   Dineley KT, 2007, FRONT BIOSCI-LANDMRK, V12, P5030, DOI 10.2741/2445
   Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200
   Dougherty JJ, 2003, J NEUROSCI, V23, P6740
   Fabian-Fine R, 2001, J NEUROSCI, V21, P7993
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Fisher A, 2008, NEUROTHERAPEUTICS, V5, P433, DOI 10.1016/j.nurt.2008.05.002
   Freir DB, 2003, J NEUROPHYSIOL, V89, P2917, DOI 10.1152/jn.00996.2002
   FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210
   Fu W, 2003, J NEUROPHYSIOL, V90, P3130, DOI 10.1152/jn.00616.2003
   Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Goto Y, 2006, BIOCHEM BIOPH RES CO, V351, P259, DOI 10.1016/j.bbrc.2006.10.030
   Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001
   Grassi F, 2003, J PHYSIOL-LONDON, V547, P147, DOI 10.1113/jphysiol.2002.035436
   Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035
   Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490
   Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4
   Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8
   Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731
   KELLAR KJ, 1987, BRAIN RES, V436, P62, DOI 10.1016/0006-8993(87)91556-3
   Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003
   Krall WJ, 1999, ANN PHARMACOTHER, V33, P441, DOI 10.1345/aph.18211
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lamb PW, 2005, J MOL NEUROSCI, V27, P13, DOI 10.1385/JMN:27:1:013
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153
   Lena C, 1997, J NEUROSCI, V17, P576
   LENA C, 1993, J NEUROSCI, V13, P2680
   Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541
   Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009
   Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083
   Matsuyama S, 2003, J PHARMACOL SCI, V93, P180, DOI 10.1254/jphs.93.180
   Mckay BE, 2007, BIOCHEM PHARMACOL, V74, P1120, DOI 10.1016/j.bcp.2007.07.001
   Mousavi M, 2003, NEUROSCIENCE, V122, P515, DOI 10.1016/S0306-4522(03)00460-3
   Munoz-Torrero D, 2008, CURR MED CHEM, V15, P2433, DOI 10.2174/092986708785909067
   Nordberg A, 1998, DRUG SAFETY, V19, P465, DOI 10.2165/00002018-199819060-00004
   NORDBERG A, 1993, ACTA NEUROL SCAND, V88, P62
   Perry E, 2000, EUR J PHARMACOL, V393, P215, DOI 10.1016/S0014-2999(00)00064-9
   PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457
   Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001
   Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004
   Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008
   Pym L, 2005, BRIT J PHARMACOL, V146, P964, DOI 10.1038/sj.bjp.0706403
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   SEGUELA P, 1993, J NEUROSCI, V13, P596
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Small DH, 2002, J ALZHEIMERS DIS, V4, P349, DOI 10.3233/JAD-2002-4502
   SMITH CM, 1978, ANN NEUROL, V3, P471, DOI 10.1002/ana.410030602
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   SVENSSON AL, 1992, BRAIN RES, V596, P142, DOI 10.1016/0006-8993(92)91541-L
   Terzano S, 1998, MOL BRAIN RES, V63, P72, DOI 10.1016/S0169-328X(98)00260-5
   WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang BW, 2006, SYNAPSE, V59, P491, DOI 10.1002/syn.20267
   Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x
   Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x
   WARBURTON DM, 1992, PSYCHOPHARMACOLOGY, V108, P443, DOI 10.1007/BF02247418
   Welsby P, 2006, EUR J NEUROSCI, V24, P3109, DOI 10.1111/j.1460-9568.2006.05187.x
   Wevers A, 1999, EUR J NEUROSCI, V11, P2551, DOI 10.1046/j.1460-9568.1999.00676.x
   Wevers A, 1999, J Alzheimers Dis, V1, P207
   Wooltorton JRA, 2003, J NEUROSCI, V23, P3176
   Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200
   Wu JL, 2007, BRAIN RES, V1182, P82, DOI 10.1016/j.brainres.2007.08.079
   Wu MN, 2008, BRAIN RES BULL, V77, P84, DOI 10.1016/j.brainresbull.2008.06.005
   Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006
   Zarei MM, 1999, NEUROSCIENCE, V88, P755, DOI 10.1016/S0306-4522(98)00246-2
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 91
TC 40
Z9 40
U1 0
U2 12
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0895-8696
EI 1559-1166
J9 J MOL NEUROSCI
JI J. Mol. Neurosci.
PD JAN
PY 2010
VL 40
IS 1-2
BP 221
EP 229
DI 10.1007/s12031-009-9237-0
PG 9
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 545RG
UT WOS:000273753500032
PM 19690986
DA 2020-09-29
ER

PT J
AU Chapeaurouge, A
   Martins, SM
   Holub, O
   Rocha, SLG
   Valente, RH
   Neves-Ferreira, AGC
   Ferreira, ST
   Domont, GB
   Perales, J
AF Chapeaurouge, Alex
   Martins, Samantha M.
   Holub, Oliver
   Rocha, Surza L. G.
   Valente, Richard H.
   Neves-Ferreira, Ana G. C.
   Ferreira, Sergio T.
   Domont, Gilberto B.
   Perales, Jonas
TI Conformational plasticity of DM43, a metalloproteinase inhibitor from
   Didelphis marsupialis: Chemical and pressure-induced equilibrium
   (un)folding studies
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE Snake venom inhibitor; Protein folding; Intermediate; Conformational
   plasticity
ID 3-HELIX BUNDLE PROTEIN; ALPHA-LACTALBUMIN; DISSOCIATION; STABILITY;
   NEURODEGENERATION; ENERGETICS; KINETICS; DIMERS
AB We have investigated the folding of DM43, a homodimeric metallo proteinase inhibitor isolated from the serum of the South American opossum Didelphis marsupialis. Denaturation of the protein induced by GdnHCl (guanidine hydrochloride) was monitored by extrinsic and intrinsic fluorescence spectroscopy. While the equilibrium (un)folding of DM43 followed by tryptophan fluorescence was well described by a cooperative two-state transition, bis-ANS (4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid) fluorescence measurements revealed an intensity maximum at the midpoint of the unfolding transition (2 M GdnHCl), indicating a partially folded intermediate state. We further investigated the DM43 intermediate stabilized at 2 M GdnHCl using size exclusion chromatography. This analysis revealed that the folding intermediate can be best described as partially folded DM43 monomers. Thermodynamic analysis of the GdnHCl-induced denaturation of DM43 revealed Gibbs free-energy changes of 13.57 kcal/mol for dimer dissociation and 1.86 kcal/mol for monomer unfolding, pointing to a critical role of dimerization as a determinant of the structure and stability of this protein. In addition, by using hydrostatic pressure (up to 3.5 kbar) we were able to stabilize partially folded states different from those stabilized in the presence of GdnHCl. Taken together, these results indicate that the conformational plasticity of DM43 could provide this protein with the ability to adapt its conformation to a variety of different environments and biological partners during its biological lifetime. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Chapeaurouge, Alex; Rocha, Surza L. G.; Valente, Richard H.; Neves-Ferreira, Ana G. C.; Perales, Jonas] Fiocruz MS, Inst Oswaldo Cruz, Lab Toxinol, BR-21045900 Rio De Janeiro, Brazil.
   [Martins, Samantha M.; Holub, Oliver; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   [Rocha, Surza L. G.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Dept Bioquim, Inst Quim, BR-21949900 Rio De Janeiro, Brazil.
RP Chapeaurouge, A (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Toxinol, BR-21045900 Rio De Janeiro, Brazil.
EM henk@ioc.fiocruz.br
RI Ferreira, Sergio/AAZ-1576-2020; Neves-Ferreira, Ana Gisele
   C./N-3596-2013; Valente, Richard Hemmi/I-5300-2012; Neurociencia,
   Inct/I-1011-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Neves-Ferreira, Ana Gisele
   C./0000-0002-7863-9512; Valente, Richard Hemmi/0000-0002-6562-7571; 
FU Fundacao de Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Howard Hughes Medical InstituteHoward Hughes Medical
   Institute
FX This work was supported by grants from the Fundacao de Amparo A Pesquisa
   do Estado do Rio de Janeiro (FAPERJ) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (to J.P. and S.T.F.) and
   the Howard Hughes Medical Institute (to S.T.F.). SMM was recipient of
   fellowship from FAPERJ.
CR BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910
   Betts S, 1997, ADV PROTEIN CHEM, V50, P243, DOI 10.1016/S0065-3233(08)60323-X
   BIERI O, 1999, BIOCHEMISTRY-US, V38, P11270
   Botelho MG, 2006, BIOPHYS J, V91, P2826, DOI 10.1529/biophysj.106.089706
   Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t
   Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   Doyle SM, 2000, BIOCHEMISTRY-US, V39, P11667, DOI 10.1021/bi000299y
   Faure G, 2000, BIOCHIMIE, V82, P833, DOI 10.1016/S0300-9084(00)01175-5
   Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539
   Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020
   Golbik R, 1998, J MOL BIOL, V276, P505, DOI 10.1006/jmbi.1997.1538
   GOROVITS BM, 1995, BIOCHEMISTRY-US, V34, P13928, DOI 10.1021/bi00042a026
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9
   JURGILAS PB, 2005, Patent No. 2005000036
   Kamen DE, 2001, PROTEIN SCI, V10, P2123, DOI 10.1110/ps.19801
   KIM J, 1986, BIOCHEMISTRY-US, V25, P7867, DOI 10.1021/bi00372a012
   Levenberg K., 1944, Quarterly of Applied Mathematics, V2, P164
   Lizano S, 2003, TOXICON, V42, P963, DOI 10.1016/j.toxicon.2003.11.007
   Lopes DHJ, 2004, J BIOL CHEM, V279, P10991, DOI 10.1074/jbc.M308174200
   Louzada PR, 2003, BIOPHYS J, V85, P3255, DOI 10.1016/S0006-3495(03)74743-2
   MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   Martins SM, 2002, EUR J BIOCHEM, V269, P5484, DOI 10.1046/j.1432-1033.2002.03248.x
   Mei G, 2005, FEBS J, V272, P16, DOI 10.1111/j.1432-1033.2004.04407.x
   Morais ACS, 2005, INT J BIOCHEM CELL B, V37, P1890, DOI 10.1016/j.biocel.2005.04.007
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202
   NEUMAN RC, 1973, J PHYS CHEM-US, V77, P2687, DOI 10.1021/j100640a025
   Neves-Ferreira AGC, 2002, J BIOL CHEM, V277, P13129, DOI 10.1074/jbc.M200589200
   Neves-Ferreira AGC, 2000, BBA-GEN SUBJECTS, V1474, P309, DOI 10.1016/S0304-4165(00)00022-2
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Panick G, 1998, J MOL BIOL, V275, P389, DOI 10.1006/jmbi.1997.1454
   Perez JC, 1999, TOXICON, V37, P703, DOI 10.1016/S0041-0101(98)00205-0
   Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
NR 44
TC 2
Z9 3
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD OCT
PY 2009
VL 1794
IS 10
BP 1379
EP 1386
DI 10.1016/j.bbapap.2009.03.010
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 499XB
UT WOS:000270259000001
PM 19332153
DA 2020-09-29
ER

PT J
AU Jurgensen, S
   Mussi, GE
   Brito-Moreira, J
   Ferreira, ST
AF Jurgensen, S.
   Mussi, G. E.
   Brito-Moreira, J.
   Ferreira, S. T.
TI D1 RECEPTOR STIMULATION PREVENTS LOSS OF AMPA AND NMDA RECEPTORS INDUCED
   BY AEPTOR STIMULATION PREVENT LOSS OF AMPA AND NMDA RECEPTORS INDUCED BY
   A beta OLIGOMERS
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 22nd Biennial Meeting of the
   International-Society-of-Neurochemistry/Asian-Pacific-Society-for-Neuroc
   hemistry
CY AUG 23-29, 2009
CL Busan, SOUTH KOREA
SP Int Soc Neurochem, Asian Pacific Soc
C1 [Jurgensen, S.; Mussi, G. E.; Brito-Moreira, J.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD SEP
PY 2009
VL 110
BP 59
EP 59
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 477WT
UT WOS:000268550400165
DA 2020-09-29
ER

PT J
AU Paula-Lima, AC
   Tricerri, MA
   Brito-Moreira, J
   Bomfim, TR
   Oliveira, FF
   Magdesian, MH
   Grinberg, LT
   Panizzutti, R
   Ferreira, ST
AF Paula-Lima, Andrea C.
   Tricerri, M. Alejandra
   Brito-Moreira, Jordano
   Bomfim, Theresa R.
   Oliveira, Fabio F.
   Magdesian, Margaret H.
   Grinberg, Lea T.
   Panizzutti, Rogerio
   Ferreira, Sergio T.
TI Human apolipoprotein A-I binds amyloid-beta and prevents A beta-induced
   neurotoxicity
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Amyloid-beta peptide; Human apolipoprotein A-I; Alzheimer's disease;
   Neurotoxicity
ID HIGH-DENSITY-LIPOPROTEIN; SOLUBLE-PROTEIN OLIGOMERS; HUMAN
   CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; OXIDATIVE STRESS;
   HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; THIOFLAVIN-T; MOUSE MODEL;
   EARLY-ONSET
AB Aggregates of the amyloid-P peptide (A beta) play a central role in the pathogenesis of Alzheimer's disease (AD). Identification of proteins that physiologically bind A beta and modulate its aggregation and neurotoxicity could lead to the development of novel disease-modifying approaches in AD. By screening a phage display peptide library for high affinity ligands of aggregated A beta(1-42), We isolated a peptide homologous to a highly conserved amino acid sequence present in the N-terminus of apolipoprotein A-I (apoA-I). We show that purified human apoA-I and A beta form non-covalent complexes and that interaction with apoA-I affects the morphology of amyloid aggregates formed by A beta. Significantly, A beta/apoA-I complexes were also detected in cerebrospinal fluid from AD patients. Interestingly, apoA-I and apoA-I-containing reconstituted high density lipoprotein particles protect hippocampal neuronal cultures from A beta-induced oxidative stress and neurodegeneration. These results suggest that human apoA-I modulates A beta aggregation and A beta-induced neuronal damage and that the A beta-binding domain in apoA-I may constitute a novel framework for the design of inhibitors of A beta toxicity. (C) 2009 Published by Elsevier Ltd.
C1 [Paula-Lima, Andrea C.; Brito-Moreira, Jordano; Bomfim, Theresa R.; Oliveira, Fabio F.; Magdesian, Margaret H.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   [Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, Brazil.
   [Tricerri, M. Alejandra] Univ Nacl La Plata, Inst Invest Bioquim La Plata, La Plata, Argentina.
   [Grinberg, Lea T.] Univ Sao Paulo, Fac Med, Dept Patol, Sao Paulo, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Paula-Lima, Andrea C./I-2537-2013;
   Neurociencia, Inct/I-1011-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Paula-Lima, Andrea
   C./0000-0002-0466-7561; grinberg, lea/0000-0002-6809-0618
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX This work was supported by grants from Howard Hughes Medical Institute,
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and
   Fundacao de Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to
   S.T.F.). S.T.F. was a Howard Hughes International Scholar and M.A.T. was
   a CNPq (and FAPERJ) postdoctoral fellow. We are grateful to Drs. Luis
   Juliano and Maria Aparecida Juliano (Federal University of Sao Paulo -
   Escola Paulista de Medicina, Brazil) for synthesis of the GN peptide.
CR Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   BORGHINI I, 1995, BBA-LIPID LIPID MET, V1255, P192, DOI 10.1016/0005-2760(94)00232-N
   Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291
   Bruce AJ, 1996, P NATL ACAD SCI USA, V93, P2312, DOI 10.1073/pnas.93.6.2312
   BURDICK D, 1992, J BIOL CHEM, V267, P546
   Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844
   Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035
   CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599
   Cecchi C, 2002, FREE RADICAL BIO MED, V33, P1372, DOI 10.1016/S0891-5849(02)01049-3
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398
   Dimopoulos N, 2007, J GERIATR PSYCH NEUR, V20, P138, DOI 10.1177/0891988707301867
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0
   FIELDING CJ, 1995, J LIPID RES, V36, P211
   Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z
   Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Harr SD, 1996, J NEUROCHEM, V66, P2429
   HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270
   Huang THJ, 1997, J MOL BIOL, V269, P214
   Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f
   Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835
   JONAS A, 1986, METHOD ENZYMOL, V128, P553
   Kaufmann SH, 1998, METH MOL B, V80, P223
   Klein WL, 2007, RES PER NEUROSCI, P155, DOI 10.1007/978-3-540-45702-2_11
   Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003
   KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510
   KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1293, DOI 10.1177/37.8.2666512
   Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k
   Kontush A, 2004, BRAIN PATHOL, V14, P433
   KOUDINOV A, 1994, BIOCHEM BIOPH RES CO, V205, P1164, DOI 10.1006/bbrc.1994.2788
   Koudinov AR, 1996, BIOCHEM BIOPH RES CO, V223, P592, DOI 10.1006/bbrc.1996.0940
   Koudinov AR, 1997, CELL BIOL INT, V21, P265, DOI 10.1006/cbir.1996.0126
   Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002
   Kuo YM, 1996, J BIOL CHEM, V271, P4077
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lauderback CM, 2002, BRAIN RES, V924, P90, DOI 10.1016/S0006-8993(01)03228-0
   LEROY A, 1994, BBA-LIPID LIPID MET, V1212, P285, DOI 10.1016/0005-2760(94)90202-X
   LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312
   Liu HC, 2006, DEMENT GERIATR COGN, V21, P155, DOI 10.1159/000090676
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7
   MOCKEL B, 1994, J NEUROCHEM, V62, P788
   Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005
   Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288
   ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080
   ODA T, 1994, BIOCHEM BIOPH RES CO, V204, P1131, DOI 10.1006/bbrc.1994.2580
   Okon M, 2001, FEBS LETT, V487, P390, DOI 10.1016/S0014-5793(00)02375-9
   Olesen OF, 2000, BIOCHEM BIOPH RES CO, V270, P62, DOI 10.1006/bbrc.2000.2372
   Panzenboeck U, 2002, J BIOL CHEM, V277, P42781, DOI 10.1074/jbc.M207601200
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D
   Praprotnik D, 1996, ACTA NEUROPATHOL, V91, P1
   Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027
   SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467
   Sayre LM, 1997, J NEUROCHEM, V68, P2092
   SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470
   Smith MA, 1995, J NEUROL SCI, V134, P92, DOI 10.1016/0022-510X(95)00213-L
   Song H, 1997, NEUROSCI LETT, V231, P175, DOI 10.1016/S0304-3940(97)00558-2
   Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3
   SOREGHAN B, 1994, J BIOL CHEM, V269, P28551
   Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200
   TRICERRI MA, 1994, INT J BIOCHROMATOGR, V1, P159
   Vollbach H, 2005, ANN NEUROL, V58, P436, DOI 10.1002/ana.20593
   WILBUR KM, 1949, ARCH BIOCHEM, V24, P305
   WISNIEWSKI T, 1995, AM J PATHOL, V147, P238
NR 78
TC 67
Z9 70
U1 1
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD JUN
PY 2009
VL 41
IS 6
BP 1361
EP 1370
DI 10.1016/j.biocel.2008.12.003
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 425WU
UT WOS:000264669300019
PM 19130896
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Vieira, MNN
   Bomfim, TR
   Decker, H
   Velasco, PT
   Lambert, MP
   Viola, KL
   Zhao, WQ
   Ferreira, ST
   Klein, WL
AF De Felice, Fernanda G.
   Vieira, Marcelo N. N.
   Bomfim, Theresa R.
   Decker, Helena
   Velasco, Pauline T.
   Lambert, Mary P.
   Viola, Kirsten L.
   Zhao, Wei-Qin
   Ferreira, Sergio T.
   Klein, William L.
TI Protection of synapses against Alzheimer's-linked toxins: Insulin
   signaling prevents the pathogenic binding of A beta oligomers (vol 106,
   pg 1971, 2009)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Correction
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
NR 1
TC 2
Z9 2
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 5
PY 2009
VL 106
IS 18
BP 7678
EP 7678
DI 10.1073/pnas.0902058106
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 441QI
UT WOS:000265783600077
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Vieira, MNN
   Bomfim, TR
   Decker, H
   Velasco, PT
   Lambert, MP
   Viola, KL
   Zhao, WQ
   Ferreira, ST
   Klein, WL
AF De Felice, Fernanda G.
   Vieira, Marcelo N. N.
   Bomfim, Theresa R.
   Decker, Helena
   Velasco, Pauline T.
   Lambert, Mary P.
   Viola, Kirsten L.
   Zhao, Wei-Qin
   Ferreira, Sergio T.
   Klein, William L.
TI Protection of synapses against Alzheimer's-linked toxins: Insulin
   signaling prevents the pathogenic binding of A beta oligomers
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE therapeutics; diabetes; aging; receptors; plasticity
ID SOLUBLE-PROTEIN OLIGOMERS; TRANSGENIC MOUSE MODEL; AMYLOID-BETA;
   SYNAPTIC PLASTICITY; IN-VIVO; COGNITIVE IMPAIRMENT; MEMORY DEFICITS;
   MOLECULAR-BASIS; TAU-PROTEIN; DISEASE
AB Synapse deterioration underlying severe memory loss in early Alzheimer's disease ( AD) is thought to be caused by soluble amyloid beta (A beta) oligomers. Mechanistically, soluble A beta oligomers, also referred to as A beta-derived diffusible ligands (ADDLs), act as highly specific pathogenic ligands, binding to sites localized at particular synapses. This binding triggers oxidative stress, loss of synaptic spines, and ectopic redistribution of receptors critical to plasticity and memory. We report here the existence of a protective mechanism that naturally shields synapses against ADDL-induced deterioration. Synapse pathology was investigated in mature cultures of hippocampal neurons. Before spine loss, ADDLs caused major downregulation of plasma membrane insulin receptors (IRs), via a mechanism sensitive to calcium calmodulin-dependent kinase II (CaMKII) and casein kinase II (CK2) inhibition. Most significantly, this loss of surface IRs, and ADDL-induced oxidative stress and synaptic spine deterioration, could be completely prevented by insulin. At submaximal insulin doses, protection was potentiated by rosiglitazone, an insulin-sensitizing drug used to treat type 2 diabetes. The mechanism of insulin protection entailed a marked reduction in pathogenic ADDL binding. Surprisingly, insulin failed to block ADDL binding when IR tyrosine kinase activity was inhibited; in fact, a significant increase in binding was caused by IR inhibition. The protective role of insulin thus derives from IR signaling-dependent downregulation of ADDL binding sites rather than ligand competition. The finding that synapse vulnerability to ADDLs can be mitigated by insulin suggests that bolstering brain insulin signaling, which can decline with aging and diabetes, could have significant potential to slow or deter AD pathogenesis.
C1 [De Felice, Fernanda G.; Velasco, Pauline T.; Lambert, Mary P.; Viola, Kirsten L.; Zhao, Wei-Qin; Klein, William L.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
   [De Felice, Fernanda G.; Vieira, Marcelo N. N.; Bomfim, Theresa R.; Decker, Helena; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
   [Vieira, Marcelo N. N.; Decker, Helena] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21944590 Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.
EM felice@bioqmed.ufrj.br; wklein@northwestern.edu
RI Ferreira, Sergio/AAZ-1576-2020; Neurociencia, Inct/I-1011-2013
OI Ferreira, Sergio/0000-0001-7160-9866; 
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding
   Source: Medline; NIA NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) [R01 AG022547, R01 AG018877, R01-AG18877, R01-AG22547]
   Funding Source: Medline
CR Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193
   Boyer C, 1998, J NEUROSCI, V18, P5294
   Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200
   Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004
   Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485
   Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009
   Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102
   Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje
   Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035
   Huang CC, 2003, MOL CELL NEUROSCI, V24, P831, DOI 10.1016/S1044-7431(03)00238-0
   Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Landreth G, 2007, CURR ALZHEIMER RES, V4, P159, DOI 10.2174/156720507780362092
   LEE CC, 2007, NEUROBIOL AGING
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   MOLONEY AM, 2008, NEUROBIOL AGING
   Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   RELKIN NR, 2008, NEUROBIOL AGING
   Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626
   SCHEIBEL ME, 1975, EXP NEUROL, P47392
   Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893
   Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5
NR 51
TC 448
Z9 454
U1 1
U2 46
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 10
PY 2009
VL 106
IS 6
BP 1971
EP 1976
DI 10.1073/pnas.0809158106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 405VO
UT WOS:000263252500055
PM 19188609
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Ramella, N
   Tricerri, MA
   Sanchez, SA
   Ferreira, ST
   Rimoldi, OJ
AF Ramella, Nahuel
   Alejandra Tricerri, M.
   Sanchez, Susana A.
   Ferreira, Sergio T.
   Rimoldi, Omar J.
TI Amyloid-like Aggregation Of A Human Apolipoprotein A-I Variant
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Ramella, Nahuel; Alejandra Tricerri, M.; Rimoldi, Omar J.] Inst Invest Bioquim La Plata, INIBIOLP, La Plata, Buenos Aires, Argentina.
   [Sanchez, Susana A.] UCI, LFD, Irvine, CA USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Lab Neurodegenerat Dis, Rio de Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 1
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 2009
VL 96
IS 3
SU 1
MA 458-Pos
BP 89A
EP 89A
PG 1
WC Biophysics
SC Biophysics
GA VC0ME
UT WOS:000426275900455
DA 2020-09-29
ER

PT J
AU Cardoso, LA
   Ferreira, ST
   Hemes-Lima, M
AF Cardoso, Luciano A.
   Ferreira, Sergio T.
   Hemes-Lima, Marcelo
TI Reductive inactivation of yeast glutathione reductase by Fe(II) and
   NADPH
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE
   PHYSIOLOGY
LA English
DT Article
DE Glutathione reductase; Iron; Free radicals; Oxygen; NADPH
ID REDOX INTERCONVERSION; ESCHERICHIA-COLI; ANTIOXIDATIVE DEFENSE;
   OXIDATIVE DAMAGE; FERROUS-IONS; IRON; LIVER; ENZYME; PURIFICATION;
   INHIBITION
AB Glutathione reductase (GR) carries out the enzymatic reduction of glutathione disulfide (GSSG) to its reduced form (GSH) at the expense of the reducing power of NADPH. Previous studies have shown that GR from several species is progressively inactivated in the presence of NADPH, but that the mechanism of inactivation (especially in the presence of metals) has not been fully elucidated. We have investigated the involvement of iron ions in the inactivation of yeast (Saccharomyces cerevisiae) GR in the presence of NADPH. Even in the absence of added iron, inactivation of GR was partly blocked by the iron chelators, deferoxamine and ortho-phenanthroline, suggesting the involvement of trace amounts of contaminating iron in the mechanism of inhibition. Exogenously added antioxidants including ethanol, dimethylsulfoxide and 2-deoxyribose did not protect GR against NADPH-induced inactivation, whilst addition of exogenous Fe(II) (but not Fe(III)) potentiated the inactivation. Moreover, removal of oxygen from the medium led to increased inhibition of GR, whereas pre-incubation of the Fe(II)-containing medium for 30 min under normoxic conditions prior to the addition of GR abolished the enzyme inactivation by NADPH. Under these pre-incubation conditions, Fe(II) is fully oxidized to Fe(III) within I min. Furthermore, GR that had been previously inactivated in the presence of Fe(II) plus NADPH could be partially reactivated by treatment with ortho-phenanthroline and deferoxamine. In contrast, Fe(III) had no effect on GR reactivation. Together, these results indicate that yeast GR is inactivated by a reductive mechanism mediated by NADPH and Fe(II). According to this mechanism, GR is diverted from its normal redox cycling by the generation of an inactive reduced enzyme form in which both the FAD and thiol groups at the active site are likely in a reduced state. (C) 2007 Elsevier Inc. All rights reserved.
C1 [Cardoso, Luciano A.; Hemes-Lima, Marcelo] Univ Brasilia, Dept Biol Celular, Oxyrad Res Grp, BR-70910900 Brasilia, DF, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
RP Hemes-Lima, M (corresponding author), Univ Brasilia, Dept Biol Celular, Oxyrad Res Grp, BR-70910900 Brasilia, DF, Brazil.
EM hermes@unb.br
RI Neurociencia, Inct/I-1011-2013; Hermes-Lima, Marcelo/AAP-1167-2020;
   Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Hermes-Lima,
   Marcelo/0000-0003-1732-0927
CR Allen T, 2004, BIOL TRACE ELEM RES, V100, P39, DOI 10.1385/BTER:100:1:039
   ARSCOTT LD, 1989, BIOCHEMISTRY-US, V28, P3591, DOI 10.1021/bi00434a066
   Bagnyukova TV, 2005, COMP BIOCHEM PHYS B, V142, P335, DOI 10.1016/j.cbpb.2005.08.003
   BECKER K, 1995, EUR J BIOCHEM, V234, P472, DOI 10.1111/j.1432-1033.1995.472_b.x
   Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767
   BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074
   CARDOSO LS, 2001, THESIS U FEDERAL RIO
   Colak E, 2005, ANN MED, V37, P613, DOI 10.1080/07853890500330193
   de Avelar IGJ, 2004, BBA-GEN SUBJECTS, V1675, P46, DOI 10.1016/j.bbagen.2004.08.006
   Erat M, 2005, APPL BIOCHEM BIOTECH, V125, P127, DOI 10.1385/ABAB:125:2:127
   Erat M, 2003, PREP BIOCHEM BIOTECH, V33, P283, DOI 10.1081/PB-120025371
   Francescutti D, 1996, PROTEIN ENG, V9, P189, DOI 10.1093/protein/9.2.189
   GARCIAALFONSO C, 1993, INT J BIOCHEM, V25, P513, DOI 10.1016/0020-711X(93)90658-2
   Geetha A, 2002, J Biochem Mol Biol Biophys, V6, P427, DOI 10.1080/1025814021000036179
   Gutierrez-Correa J, 1997, FREE RADICAL RES, V27, P543, DOI 10.3109/10715769709097858
   Hassan MQ, 2001, J APPL TOXICOL, V21, P69, DOI 10.1002/jat.736
   Hermes-Lima M, 1999, BBA-GEN SUBJECTS, V1426, P475, DOI 10.1016/S0304-4165(98)00167-6
   Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7
   Hermes-Lima M, 2004, FUNCTIONAL METABOLIS, P319, DOI DOI 10.1002/047167558X.CH12
   HERMESLIMA M, 1994, MOL CELL BIOCHEM, V137, P65, DOI 10.1007/BF00926041
   Keese MA, 1997, BIOCHEM PHARMACOL, V54, P1307, DOI 10.1016/S0006-2952(97)00348-1
   Kim CY, 1998, TOHOKU J EXP MED, V186, P205, DOI 10.1620/tjem.186.205
   KLEBANOFF SJ, 1989, J BIOL CHEM, V264, P19765
   Kulak W, 2005, LIFE SCI, V77, P3031, DOI 10.1016/j.lfs.2005.02.031
   LEE TS, 1948, J AM CHEM SOC, V70, P2348, DOI 10.1021/ja01187a012
   LOPEZBAREA J, 1979, EUR J BIOCHEM, V98, P487, DOI 10.1111/j.1432-1033.1979.tb13210.x
   MATA AM, 1985, MOL CELL BIOCHEM, V68, P121
   MATA AM, 1985, MOL CELL BIOCHEM, V67, P65
   MATA AM, 1984, Z NATURFORSCH C, V39, P908
   Morgan PE, 2002, ARCH BIOCHEM BIOPHYS, V403, P259, DOI 10.1016/S0003-9861(02)00222-9
   MOROFF G, 1975, BIOCHIM BIOPHYS ACTA, V410, P21, DOI 10.1016/0005-2744(75)90204-1
   MORTON D, 1982, COMP BIOCHEM PHYS A, V73, P421, DOI 10.1016/0300-9629(82)90178-5
   Ogino T, 1995, BBA-GEN SUBJECTS, V1245, P359, DOI 10.1016/0304-4165(95)00101-8
   PEINADO J, 1992, MOL CELL BIOCHEM, V110, P135, DOI 10.1007/BF02454190
   PEINADO J, 1991, MOL CELL BIOCHEM, V101, P175
   PINTO MC, 1985, EUR J BIOCHEM, V151, P275, DOI 10.1111/j.1432-1033.1985.tb09097.x
   PINTO MC, 1984, ARCH BIOCHEM BIOPHYS, V228, P1, DOI 10.1016/0003-9861(84)90040-7
   Qian SY, 1999, FREE RADICAL BIO MED, V26, P1447, DOI 10.1016/S0891-5849(99)00002-7
   REINKE LA, 1995, ARCH BIOCHEM BIOPHYS, V316, P758, DOI 10.1006/abbi.1995.1101
   REINKE LA, 1994, FREE RADICAL BIO MED, V16, P485, DOI 10.1016/0891-5849(94)90126-0
   RIETVELD P, 1994, BIOCHEMISTRY-US, V33, P13888, DOI 10.1021/bi00250a043
   Rizzo AM, 2007, COMP BIOCHEM PHYS B, V146, P94, DOI 10.1016/j.cbpb.2006.09.009
   ROCHE M, 1990, CHIMIE SOLUTIOONS CO
   Savvides SN, 2002, J BIOL CHEM, V277, P2779, DOI 10.1074/jbc.M108190200
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STARKE PE, 1985, J BIOL CHEM, V260, P86
   TABATABAIE T, 1994, ARCH BIOCHEM BIOPHYS, V314, P112, DOI 10.1006/abbi.1994.1418
   Terblanche SE, 2000, COMP BIOCHEM PHYS B, V127, P319, DOI 10.1016/S0305-0491(00)00269-8
   VanderJagt DL, 1997, BIOCHEM PHARMACOL, V53, P1133, DOI 10.1016/S0006-2952(97)00090-7
   Walther UI, 2003, ARCH TOXICOL, V77, P131, DOI 10.1007/s00204-002-0421-z
   Williams AC, 2004, BIOL REPROD, V71, P1309, DOI 10.1095/biolreprod.104.028407
   Yang SS, 2005, WORLD J GASTROENTERO, V11, P7272, DOI 10.3748/wjg.v11.i46.7272
   Zielinski S, 2000, COMP BIOCHEM PHYS B, V125, P147, DOI 10.1016/S0305-0491(99)00162-5
NR 53
TC 10
Z9 10
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1095-6433
EI 1531-4332
J9 COMP BIOCHEM PHYS A
JI Comp. Biochem. Physiol. A-Mol. Integr. Physiol.
PD NOV
PY 2008
VL 151
IS 3
SI SI
BP 313
EP 321
DI 10.1016/j.cbpa.2007.03.025
PG 9
WC Biochemistry & Molecular Biology; Physiology; Zoology
SC Biochemistry & Molecular Biology; Physiology; Zoology
GA 369AM
UT WOS:000260665000004
PM 17544307
DA 2020-09-29
ER

PT J
AU Magdesian, MH
   Carvalho, MMVF
   Mendes, FA
   Saraiva, LM
   Juliano, MA
   Juliano, L
   Garcia-Abreu, J
   Ferreira, ST
AF Magdesian, Margaret H.
   Carvalho, Milena M. V. F.
   Mendes, Fabio A.
   Saraiva, Leonardo M.
   Juliano, Maria A.
   Juliano, Luiz
   Garcia-Abreu, Jose
   Ferreira, Sergio T.
TI Amyloid-beta binds to the extracellular cysteine-rich domain of frizzled
   and inhibits wnt/beta-catenin signaling
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SOLUBLE-PROTEIN OLIGOMERS; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE;
   WNT PATHWAY; PEPTIDE NEUROTOXICITY; PHAGE DISPLAY; RECEPTOR;
   IDENTIFICATION; TRANSCRIPTION; TRANSDUCTION
AB The amyloid-beta peptide (A beta) plays a major role in neuronal dysfunction and neurotoxicity in Alzheimer disease. However, the signal transduction mechanisms involved in A beta-induced neuronal dysfunction remain to be fully elucidated. A major current unknown is the identity of the protein receptor(s) involved in neuronal A beta binding. Using phage display of peptide libraries, we have identified a number of peptides that bind A beta and are homologous to neuronal receptors putatively involved in A beta interactions. We report here on a cysteine-linked cyclic heptapeptide (denominated cSP5) that binds A beta with high affinity and is homologous to the extracellular cysteine-rich domain of several members of the Frizzled (Fz) family of Wnt receptors. Based on this homology, we investigated the interaction between A beta and Fz. The results show that A beta binds to the Fz cysteine-rich domain at or in close proximity to the Wnt-binding site and inhibits the canonical Wnt signaling pathway. Interestingly, the cSP5 peptide completely blocks A beta binding to Fz and prevents inhibition of Wnt signaling. These results indicate that the A beta- binding site in Fz is homologous to cSP5 and that this is a relevant target for A beta-instigated neurotoxicity. Furthermore, they suggest that blocking the interaction of A beta with Fz might lead to novel therapeutic approaches to prevent neuronal dysfunction in Alzheimer disease.
C1 [Magdesian, Margaret H.; Carvalho, Milena M. V. F.; Saraiva, Leonardo M.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim Biofis Celular, BR-21944 Rio De Janeiro, RJ, Brazil.
   [Mendes, Fabio A.; Garcia-Abreu, Jose] Univ Fed Rio de Janeiro, Dept Anat, BR-21944 Rio De Janeiro, RJ, Brazil.
   [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, BR-04044 Sao Paulo, SP, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim Biofis Celular, Bloco H,Sala 19,CCS, BR-21944 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Mendes, Fabio/J-6911-2015; Abreu, Jose
   GR/G-6159-2010; Complexos, INCT Fluidos/H-9172-2013; Neurociencia,
   Inct/I-1011-2013; Juliano, Luiz/D-7204-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Abreu, Jose
   GR/0000-0002-9875-7786; Juliano, Luiz/0000-0002-5589-2822
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding
   Source: Medline
CR Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797
   ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402
   Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028
   Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006
   Bhat RV, 2002, NEUROSIGNALS, V11, P251, DOI 10.1159/000067423
   Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004
   Caricasole A, 2003, TRENDS PHARMACOL SCI, V24, P233, DOI 10.1016/S0165-6147(03)00100-7
   Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200
   Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7
   DEFELICE FG, 2007, IN PRESS NEUROBIOL A
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Fradkin LG, 2005, J NEUROSCI, V25, P10376, DOI 10.1523/JNEUROSCI.3429-05.2005
   Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018
   Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje
   Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200
   Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117
   Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546
   Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490
   Kang CK, 2003, NEUROBIOL DIS, V14, P146, DOI 10.1016/S0969-9961(03)00105-0
   KLEIN WL, 2006, ALZHEIMERS DEMENT, P260
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x
   Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108
   Lima AR, 2004, PROTEIN J, V23, P287, DOI 10.1023/B:JOPC.0000027853.93513.34
   Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200
   Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2
   Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291
   Nishimura M, 1999, NAT MED, V5, P164
   Orner BP, 2006, J AM CHEM SOC, V128, P11882, DOI 10.1021/ja0619861
   Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200
   Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8
   Salins P, 2007, NEUROSCI LETT, V412, P211, DOI 10.1016/j.neulet.2006.07.045
   Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325
   Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042
   Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003
   Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4
NR 44
TC 159
Z9 165
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 4
PY 2008
VL 283
IS 14
BP 9359
EP 9368
DI 10.1074/jbc.M707108200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 280ZO
UT WOS:000254465800066
PM 18234671
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Paula-Lima, AC
   Arriagada, C
   Toro, R
   Cardenas, AM
   Caviedes, R
   Ferreira, ST
   Caviedes, P
AF Paula-Lima, Andrea C.
   Arriagada, Christian
   Toro, Rodrigo
   Maria Cardenas, Ana
   Caviedes, Raul
   Ferreira, Sergio T.
   Caviedes, Pablo
TI Small-molecule aggregation inhibitors reduce excess amyloid in a trisomy
   16 mouse cortical cell line
SO BIOLOGICAL RESEARCH
LA English
DT Article
DE Alzheimer's disease; Down syndrome; intracellular amyloid; murine
   trisomy 16; small molecule inhibitors
ID SOLUBLE-PROTEIN OLIGOMERS; A-BETA ACCUMULATION; ALZHEIMERS-DISEASE;
   PRECURSOR PROTEIN; CEREBRAL-CORTEX; DOWN-SYNDROME; CHOLINERGIC FUNCTION;
   ABNORMALITIES; DYSFUNCTION; HYPOTHESIS
AB We have previously characterized a number of small molecule organic compounds that prevent the a,aggregation of the beta-amyloid peptide and its neurotoxicity in hippocampal neuronal Cultures. We have now evaluated the effects of such compounds on amyloid precursor protein (APP) accumulation in the CTb immortalized cell line derived from the cerebral cortex of a trisomy 16 Mouse, an animal model of Down's syndrome. Compared to a non-trisomic cortical cell line (CNh), CTb cells overexpress APP and exhibit slightly elevated resting intracellular Ca2+, levels ([Ca2+](i)). Here. we show that the compounds 2,4-dinitrophenol. 3-nitrophenol and 4-anisidine decreased intracellular accumulation of APP in CTb cells. Those compounds were non-toxic to the cells, and slightly increased the basal [Ca2+](i). Results indicate that the compounds tested call be leads for the development of drugs to decrease intracellular vesicular accumulation of APP in trisomic cells.
C1 [Caviedes, Raul; Caviedes, Pablo] Univ Chile, Fac Med, ICBM, Program Mol & Clin Pharmacol, Santiago 1027, Chile.
   [Arriagada, Christian] Univ Chile, Fac Med, ICBM, Program Anat & Dev Biol, Santiago 1027, Chile.
   [Paula-Lima, Andrea C.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Program Cell Biophys & Biochem, BR-21941590 Rio De Janeiro, Brazil.
   [Toro, Rodrigo; Maria Cardenas, Ana] Univ Valparaiso, Fac Ciencias, Ctr Neurociencia Valparaiso, Valparaiso, Chile.
RP Caviedes, P (corresponding author), Univ Chile, Fac Med, ICBM, Program Mol & Clin Pharmacol, Clasif 7 Independencia, Santiago 1027, Chile.
EM pcaviede@med.uchile.cl
RI Ferreira, Sergio/AAZ-1576-2020; Paula-Lima, Andrea C./I-2537-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Paula-Lima, Andrea
   C./0000-0002-0466-7561
FU FondecytComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT FONDECYT [1040862]; Univ of Chile [ENL-02/11, ENL
   07/05]; Fondation Jerome Lejeune, Paris, France; Howard Hughes Medical
   Institute Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoHoward Hughes Medical Institute; Fundacao de Amparo A
   Pesquisa do Estado; FINEP/CT-Verde AmareloCiencia Tecnologia e Inovacao
   (FINEP)
FX This work was supported by grants from Fondecyt (1040862), Univ of Chile
   (VID ENL-02/11 and ENL 07/05) and Fondation Jerome Lejeune, Paris,
   France (to PC), Howard Hughes Medical Institute Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo A Pesquisa
   do Estado do RJ and FINEP/CT-Verde Amarelo (to STF).
CR Allen DD, 2000, EUR J NEUROSCI, V12, P3259, DOI 10.1046/j.1460-9568.2000.00221.x
   Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006
   Arriagada C, 2007, NEUROSCI LETT, V423, P172, DOI 10.1016/j.neulet.2007.06.054
   Begni B, 2003, NEUROSCI LETT, V343, P73, DOI 10.1016/S0304-3940(03)00260-X
   Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9
   Cardenas AM, 1999, NEUROREPORT, V10, P363, DOI 10.1097/00001756-199902050-00028
   Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5
   Cataldo AM, 2003, J NEUROSCI, V23, P6788
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   Echeverria V, 2002, MOL NEUROBIOL, V26, P299, DOI 10.1385/MN:26:2-3:299
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Galdzicki Z, 2003, GENES BRAIN BEHAV, V2, P167, DOI 10.1034/j.1601-183X.2003.00024.x
   Geller LN, 1999, NEUROBIOL DIS, V6, P167, DOI 10.1006/nbdi.1999.0236
   Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137
   Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1
   Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022
   Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Opazo P, 2006, J NEUROSCI RES, V84, P1303, DOI 10.1002/jnr.21035
   PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x
   Pollard HB, 1995, CELL MOL NEUROBIOL, V15, P513, DOI 10.1007/BF02071314
   PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693
   Saud K, 2006, J PHYSIOL-PARIS, V99, P201, DOI 10.1016/j.jphysparis.2005.12.013
   SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2
   Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X
   Vieira MNN, 2006, CELL BIOCHEM BIOPHYS, V44, P549, DOI 10.1385/CBB:44:3:549
   Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com
   Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6
NR 35
TC 4
Z9 4
U1 0
U2 8
PU SOC BIOLGIA CHILE
PI SANTIAGO
PA CASILLA 16164, SANTIAGO 9, CHILE
SN 0716-9760
EI 0717-6287
J9 BIOL RES
JI Biol. Res.
PY 2008
VL 41
IS 2
BP 129
EP 136
PG 8
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 353PB
UT WOS:000259578800001
PM 18949129
DA 2020-09-29
ER

PT J
AU Sebollela, A
   Dias-Neto, E
   Ferreira, ST
AF Sebollela, Adriano
   Dias-Neto, Emmanuel
   Ferreira, Sergio T.
TI Interrogating global gene expression in rat neuronal cultures using SAGE
SO NEUROTOXICITY RESEARCH
LA English
DT Editorial Material
DE SAGE; rat neuronal cultures; high-throughput analysis; neurotoxicity
   neuroprotection
ID SOLUBLE-PROTEIN OLIGOMERS; SERIAL ANALYSIS; HIPPOCAMPAL-NEURONS;
   ALZHEIMERS-DISEASE; 2,4-DINITROPHENOL; IDENTIFICATION; TRANSCRIPTOME;
   MARKERS; GENOME
AB The normal function of the mammalian brain is regulated by complex networks of interactions between cells and molecules, which are to a considerable extent dependent on mechanisms of transcriptional regulation. Disruption of such interactions by neurotoxic stimuli may lead to severe forms of dementia and to other neuropsychiatric disorders. Therefore, critical insight into mechanisms of neuronal dysfunction may be obtained by examining global patterns of gene expression in mammalian models of neurotoxicity. In this regard, the combined use of rat neuronal cultures and serial analysis of gene expression (SAGE) can be viewed as a general platform to enable the search for molecular targets involved in neurotoxic processes. Here, we discuss potential advantages of this approach, highlighting the need for generation of robust SAGE libraries from rat neuronal cultures. The availability and current limitations of bioinformatics tools for SAGE data derived from rat samples is also discussed.
C1 [Sebollela, Adriano; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Program Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
   [Dias-Neto, Emmanuel] Univ Sao Paulo, Fac Med, Inst Psiquiatria, Lab Neurociencias LIM27, BR-05403010 Sao Paulo, Brazil.
   [Dias-Neto, Emmanuel] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Program Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Dias-Neto, Emmanuel/AAE-9147-2020; Sebollela, Adriano/O-4385-2014;
   Dias-Neto, Emmanuel/A-5869-2008; Ferreira, Sergio/AAZ-1576-2020;
   Dias-Neto, Emmanuel/AAA-6701-2019
OI Sebollela, Adriano/0000-0002-7444-9156; Dias-Neto,
   Emmanuel/0000-0001-5670-8559; Ferreira, Sergio/0000-0001-7160-9866; 
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding
   Source: Medline
CR BANDEIRA FC, 2006, 36 ANN M SOC NEUR AT
   Boon K, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-39
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Buckhaults P, 2003, CANCER RES, V63, P4144
   Cai NS, 2006, ANN NY ACAD SCI, V1074, P13, DOI 10.1196/annals.1369.002
   Chang DTW, 2006, NEUROSCIENCE, V141, P727, DOI 10.1016/j.neuroscience.2006.01.034
   Dabrowski M, 2003, J NEUROCHEM, V85, P1279, DOI 10.1046/j.1471-4159.2003.01753.x
   Datson NA, 2001, HIPPOCAMPUS, V11, P430, DOI 10.1002/hipo.1058
   Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x
   De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   DOTTI CG, 1988, J NEUROSCI, V8, P1454
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426
   GILLIAM TC, 2000, PRINCIPLES NEURAL SC, P36
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hendriksen H, 2001, EUR J NEUROSCI, V14, P1475, DOI 10.1046/j.0953-816x.2001.01778.x
   KLEIN WL, 2006, ALZHEIMERS DEMENTIA, V2, P60
   Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051
   Ojopi EPB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-186
   Riggins GJ, 2001, DIS MARKERS, V17, P41, DOI 10.1155/2001/185929
   Ruijter JM, 2002, PHYSIOL GENOMICS, V11, P37, DOI 10.1152/physiolgenomics.00042.2002
   Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508
   Silva APM, 2004, NUCLEIC ACIDS RES, V32, P6104, DOI 10.1093/nar/gkh937
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   Wang SM, 2007, TRENDS GENET, V23, P42, DOI 10.1016/j.tig.2006.11.001
   Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com
   Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268
NR 29
TC 0
Z9 0
U1 0
U2 0
PU F P GRAHAM PUBLISHING CO
PI MOUNTAIN HOME
PA PO BOX 370, MOUNTAIN HOME, TN 37684 USA
SN 1029-8428
J9 NEUROTOX RES
JI Neurotox. Res.
PD DEC
PY 2007
VL 12
IS 4
BP 209
EP 214
DI 10.1007/BF03033905
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA 261HY
UT WOS:000253070900002
PM 18201949
DA 2020-09-29
ER

PT J
AU Vieira, MNN
   Fomy-Germano, L
   Saraiva, LM
   Sebollela, A
   Martinez, AMB
   Houzel, JC
   De Felice, FG
   Ferreira, ST
AF Vieira, Marcelo N. N.
   Fomy-Germano, Leticia
   Saraiva, Leonardo M.
   Sebollela, Adriano
   Martinez, Ana M. Blanco
   Houzel, Jean-Christophe
   De Felice, Fernanda G.
   Ferreira, Srgio T.
TI Soluble oligomers from a non-disease related protein mimic A
   beta-induced tau hyperphosphorylation and neurodegeneration
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE amyloid oligomers; cerebral cortex; hen egg white lysozyme; hippocampus;
   neurotoxicity; tau phosphorylation
ID AMYLOID FIBRIL FORMATION; LONG-TERM POTENTIATION; HUMAN LYSOZYME;
   ALZHEIMERS-DISEASE; WILD-TYPE; PHOSPHORYLATED TAU; COMMON MECHANISM;
   IN-VIVO; AGGREGATION; PROTOFIBRILS
AB Protein aggregation and amyloid accumulation in different tissues are associated with cellular dysfunction and toxicity in important human pathologies, including Alzheimer's disease and various forms of systemic amyloidosis. Soluble oligomers formed at the early stages of protein aggregation have been increasingly recognized as the main toxic species in amyloid diseases. To gain insight into the mechanisms of toxicity instigated by soluble protein oligomers, we have investigated the aggregation of hen egg white lysozyme (HEWL), a normally harmless protein. HEWL initially aggregates into P-sheet rich, roughly spherical oligomers which appear to convert with time into protofibrils and mature amyloid fibrils. HEWL oligomers are potently neurotoxic to rat cortical neurons in culture, while mature amyloid fibrils are little or non-toxic. Interestingly, when added to cortical neuronal cultures HEWL oligomers induce tau hyperphosphorylati on at epitopes that are characteristically phosphorylated in neurons exposed to soluble oligomers of the amyloid-P peptide. Furthermore, injection of HEWL oligomers in the cerebral cortices of adult rats induces extensive neuroclegeneration in different brain areas. These results show that soluble oligomers from a non-disease related protein can mimic specific neuronal pathologies thought to be induced by soluble amyloid-beta peptide oligomers in Alzheimer's disease and support the notion that amyloid oligomers from different proteins may share common structural determinants that would explain their generic cytotoxicities.
C1 Univ Fed Rio de Janeiro, Inst Med Biochem, Programa Bioquim Biofis Celular, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Programa Ciencias Morfologicas, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Anat, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embryol, Rio De Janeiro, Brazil.
   Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL USA.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21944 Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br; ferreira@bioqmed.uftj.br
RI Houzel, Jean Christophe/M-7936-2019; Houzel, Jean
   Christophe/G-3723-2010; Martinez, Ana/C-6318-2014; Ferreira,
   Sergio/AAZ-1576-2020; Forny-Germano, Leticia/D-1342-2017; Sebollela,
   Adriano/O-4385-2014; Forny-Germano, Leticia/L-6639-2019
OI Houzel, Jean Christophe/0000-0001-5128-438X; Houzel, Jean
   Christophe/0000-0001-5128-438X; Ferreira, Sergio/0000-0001-7160-9866;
   Forny-Germano, Leticia/0000-0001-8301-0711; Sebollela,
   Adriano/0000-0002-7444-9156; Forny-Germano, Leticia/0000-0001-8301-0711;
   Vieira, Marcelo/0000-0003-2178-9218
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   ARISPE N, 1994, ANN NY ACAD SCI, V747, P256
   Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003
   Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067
   Bautista MJ, 2006, VET MICROBIOL, V115, P293, DOI 10.1016/j.vetmic.2006.02.017
   Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0
   Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje
   DEFELICE FG, 2007, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROBIOLAFGING.2007.02.029
   Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539
   Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016
   Goedert M, 1999, PHILOS T ROY SOC B, V354, P1101, DOI 10.1098/rstb.1999.0466
   Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097
   Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hampel H, 2003, BRAIN RES BULL, V61, P243, DOI 10.1016/S0361-9230(03)00087-X
   Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100
   Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kelly JW, 2000, NAT STRUCT BIOL, V7, P824, DOI 10.1038/82815
   Klein WL, 2007, RES PER NEUROSCI, P155, DOI 10.1007/978-3-540-45702-2_11
   Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003
   Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010
   Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6
   Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700
   Maccioni RB, 2006, NEUROBIOL AGING, V27, P237, DOI 10.1016/j.neurobiolaging.2005.01.011
   Malisauskas M, 2005, J BIOL CHEM, V280, P6269, DOI 10.1074/jbc.M407273200
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Moreira Paula I, 2005, Curr Alzheimer Res, V2, P403
   Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264
   Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080
   Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200
   PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0
   Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5
   Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199
   Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r
   Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054
   Sirangelo I, 2004, J BIOL CHEM, V279, P13183, DOI 10.1074/jbc.M308207200
   Song MS, 2006, NEUROBIOL AGING, V27, P1224, DOI 10.1016/j.neurobiolaging.2005.06.007
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5
   Valleix S, 2002, KIDNEY INT, V61, P907, DOI 10.1046/j.1523-1755.2002.00205.x
   Vieira MNN, 2006, CELL BIOCHEM BIOPHYS, V44, P549, DOI 10.1385/CBB:44:3:549
   Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Yazaki M, 2003, KIDNEY INT, V63, P1652, DOI 10.1046/j.1523-1755.2003.00904.x
   Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x
NR 60
TC 66
Z9 66
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD OCT
PY 2007
VL 103
IS 2
BP 736
EP 748
DI 10.1111/j.1471-4159.2007.04809.x
PG 13
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 223PN
UT WOS:000250384500027
PM 17727639
OA Bronze
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Ferreira, ST
   Klein, WL
AF De Felice, F. G.
   Ferreira, S. T.
   Klein, W. L.
TI Soluble AE A beta oligomers induce tau hyperphosphorylation and NMDA
   receptor-mediated oxidative stress
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 21st Biennial Meeting of the
   International-Society-for-Neurochemistry/38th Annual Meeting of the
   American-Society-for-Neurochemistry
CY AUG 19-24, 2007
CL Cancun, MEXICO
SP Int Sco Neurochem, Amer Soc Neurochem
C1 Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 1
Z9 1
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2007
VL 102
SU 1
BP 19
EP 19
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 203RL
UT WOS:000248991600038
DA 2020-09-29
ER

PT J
AU Vieira, MN
   Germano, LF
   Saraiva, LM
   Sebollela, A
   Martinez, AB
   Houzel, JC
   De Felice, FG
   Ferreira, ST
AF Vieira, M. N.
   Germano, L. F.
   Saraiva, L. M.
   Sebollela, A.
   Martinez, A. B.
   Houzel, J. C.
   De Felice, F. G.
   Ferreira, S. T.
TI Soluble oligomers from a non-disease related protein mimic Abeta-induced
   tau hyperphosphorylation and neurodegeneration
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 21st Biennial Meeting of the
   International-Society-for-Neurochemistry/38th Annual Meeting of the
   American-Society-for-Neurochemistry
CY AUG 19-24, 2007
CL Cancun, MEXICO
SP Int Sco Neurochem, Amer Soc Neurochem
C1 Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21941 Rio De Janeiro, Brazil.
   Dept Neurobiol & Physiol, Evanston, IL USA.
RI Houzel, Jean Christophe/M-7936-2019; Ferreira, Sergio/AAZ-1576-2020
OI Houzel, Jean Christophe/0000-0001-5128-438X; Ferreira,
   Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2007
VL 102
SU 1
BP 74
EP 74
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 203RL
UT WOS:000248991600178
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Wasilewska-Sampaio, AP
   Barbosa, ACAP
   Gomes, FCA
   Klein, WL
   Ferreira, ST
AF De Felice, Fernanda G.
   Wasilewska-Sampaio, Ana Paula
   Barbosa, Anna Carolina A. P.
   Gomes, Flavia C. A.
   Klein, William L.
   Ferreira, Sergio T.
TI Cyclic AMP enhancers and A beta oligomerization blockers as potential
   therapeutic agents in Alzheimer's disease
SO CURRENT ALZHEIMER RESEARCH
LA English
DT Article
ID LONG-TERM POTENTIATION; PROMOTES AXONAL REGENERATION;
   SPINAL-CORD-INJURY; IN-VIVO; NEURONAL DIFFERENTIATION; SYNAPTIC
   PLASTICITY; AMYLOID AGGREGATION; PHOSPHODIESTERASE INHIBITOR;
   PRESYNAPTIC FACILITATION; ADENINE RIBONUCLEOTIDE
AB One of the earliest manifestations of Alzheimer's disease (AD) is the characteristic inability of affected individuals to form new memories. Memory impairment appears to significantly predate the death of nerve cells, implying that neuronal dysfunction is responsible for the pathophysiology of early stage AD. Mounting evidence now indicates that soluble oligomers of the amyloid-beta peptide (A beta) are the main neurotoxins that lead to early neuronal dysfunction and memory deficits in AD. Cyclic AMP (cAMP) is a central component of intracellular signaling pathways that regulate a wide range of biological functions, including memory. Among other actions, cAMP triggers the phosphorylation and activation of the cAMP responsive element binding protein (CREB), a transcription factor that regulates the expression of genes that are important for long-term memory. Here, we discuss recent evidence suggesting that cAMP enhancing compounds may find applications as neurocognitive enhancers in AD and in other neurological disorders, as well as possible roles of cAMP in the regulation of neuronal regeneration. In particular, we review recent results showing that low concentrations of 2,4-dinitrophenol (DNP) upregulate neuronal cAMP and tau levels, promote neurite outgrowth and neuronal differentiation and block the oligomerization and neurotoxicity of A beta. Possible implications of these findings in the development of novel therapeutic approaches in AD are discussed.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944 Rio De Janeiro, Brazil.
   Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Anat, BR-21944 Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944 Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Gomes, Flavia/C-5383-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Gomes, Flavia/0000-0003-2966-0638
CR Aujla H, 2001, BEHAV NEUROSCI, V115, P1204, DOI 10.1037//0735-7044.115.6.1204
   Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003
   Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067
   Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445
   Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020
   Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/eott.7.1.101.21163
   Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3
   Benitez-King G, 2004, CNS NEUROL DISORD-DR, V3, P515, DOI 10.2174/1568007043336761
   Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439
   Byrne JH, 1996, J NEUROSCI, V16, P425
   Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001
   Canals M, 2005, J NEUROCHEM, V92, P337, DOI 10.1111/j.1471-4159.2004.02856.x
   Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com
   Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005
   Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142
   Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x
   DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0
   Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632
   De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   DEFELICE FG, 2006, UNPUB ALZHEIMERS DIS
   Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001
   Dobson CM, 2006, NAT STRUCT MOL BIOL, V13, P295, DOI 10.1038/nsmb0406-295
   DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739
   Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x
   Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539
   Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030
   Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046
   Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101
   HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S
   Holub O, 2006, COMPUT PHYS COMMUN, V175, P620, DOI 10.1016/j.cpc.2006.06.014
   Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004
   Jacobs WB, 2003, NEUROSURGERY, V53, P943, DOI 10.1227/01.NEU.0000083592.74383.B1
   Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6
   Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381
   Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020
   KANDEL ER, 1975, COLD SPRING HARB SYM, V40, P465
   Kim SH, 2001, J NEURAL TRANSM-SUPP, P263
   KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   KLEIN WL, 2006, IN PRESS ALZHEIMERS
   KLEIN WL, 2006, IN PRESS FDN IPSEN
   Kresge N, 2005, J BIOL CHEM, V280
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Li H, 2000, NAT GENET, V25, P385
   Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004
   Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501
   Makhinson M, 2006, NEUROSCIENCE, V140, P415, DOI 10.1016/j.neuroscience.2006.02.018
   Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882
   Matsuzaki K, 2006, NEUROSCI LETT, V400, P230, DOI 10.1016/j.neulet.2006.02.077
   Monti B, 2006, NEUROPSYCHOPHARMACOL, V31, P278, DOI 10.1038/sj.npp.1300813
   Morais-de-Sa E, 2006, ACTA CRYSTALLOGR D, V62, P512, DOI 10.1107/S0907444906006962
   Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101
   Nishino N, 1993, Rev Neurosci, V4, P213
   Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056
   Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247
   Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005
   Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779
   RALL TW, 1958, J BIOL CHEM, V232, P1065
   Sanchez S, 2004, NEUROCHEM INT, V44, P231, DOI 10.1016/S0197-0186(03)00150-5
   Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515
   Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864
   Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200
   SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077
   Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x
   Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200
   Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552
   Vaudry D, 2002, J NEUROCHEM, V83, P1272, DOI 10.1046/j.1471-4159.2002.01242.x
   Vieira MNN, 2006, CELL BIOCHEM BIOPHYS, V44, P549, DOI 10.1385/CBB:44:3:549
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1
   Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174
   Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wang ZQ, 2004, J MED CHEM, V47, P3329, DOI 10.1021/jm034224e
   Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com
   WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858
   Yamamoto M, 2000, BBA-MOL BASIS DIS, V1535, P60, DOI 10.1016/S0925-4439(00)00083-1
   Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200
NR 85
TC 33
Z9 34
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2050
EI 1875-5828
J9 CURR ALZHEIMER RES
JI Curr. Alzheimer Res.
PD JUL
PY 2007
VL 4
IS 3
BP 263
EP 271
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 180JX
UT WOS:000247360300004
PM 17627483
DA 2020-09-29
ER

PT J
AU Gralle, M
   Ferreira, ST
AF Gralle, Matthias
   Ferreira, Sergio T.
TI Structure and functions of the human amyloid precursor protein: The
   whole is more than the sum of its parts
SO PROGRESS IN NEUROBIOLOGY
LA English
DT Review
DE Alzheimer's disease; amyloid precursor protein; adhesion protein;
   structural determination; dimerization; functions
ID LONG-TERM POTENTIATION; FAMILIAL ALZHEIMERS-DISEASE;
   CENTRAL-NERVOUS-SYSTEM; GAMMA-SECRETASE ACTIVITY; HEPARIN-BINDING
   DOMAIN; COAGULATION-FACTOR-XIA; APP-LIKE PROTEIN-2; BETA-PROTEIN;
   CELL-SURFACE; NEURITE OUTGROWTH
AB The amyloid precursor protein (APP) is a transmembrane protein that plays major roles in the regulation of several important cellular functions, especially in the nervous system, where it is involved in synaptogenesis and synaptic plasticity. The secreted extracellular domain of APP, sAPP alpha acts as a growth factor for many types of cells and promotes neuritogenesis in post-mitotic neurons. Alternative proteolytic processing of APP releases potentially neurotoxic species, including the amyloid-beta (A beta) peptide that is centrally implicated in the pathogenesis of Alzheimer's disease (AD). Reinforcing this biochemical link to neuronal dysfunction and neurodegeneration, APP is also genetically linked to AD. In this review, we discuss the biological functions of APP in the context of tissue morphogenesis and restructuring, where APP appears to play significant roles both as a contact receptor and as a diffusible factor. Structural investigation of APP, which is necessary for a deeper understanding of its roles at a molecular level, has also been advancing rapidly. We summarize recent progress in the determination of the structure of isolated APP fragments and of the conformations of full-length sAPP alpha in both monomeric and dimeric states. The potential role of APP dimerization for the regulation of its biological functions is also discussed. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Med Biochem, Programa Bioquim Biofis Celular, BR-21944 Rio De Janeiro, Brazil.
   European Neurosci Inst, Cell Biol Grp, Gottingen, Germany.
RP Gralle, M (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, Programa Bioquim Biofis Celular, BR-21944 Rio De Janeiro, Brazil.
EM mgralle@gwdg.de; ferreira@bioqmed.ufrj.br
RI Gralle, Matthias/B-9005-2014; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ALBERTS B, 2002, MOL BIOL CELL, P831
   ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919
   ALLINQUANT B, 1994, J NEUROSCI, V14, P6842
   Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030
   Ando K, 1999, J NEUROSCI, V19, P4421
   Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244
   ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3
   Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5
   Arendt T, 1998, NEUROSCIENCE, V83, P991, DOI 10.1016/S0306-4522(97)00509-5
   Arendt T, 1997, J NEUROSCI, V17, P516
   Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200
   Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613
   Berezovska O, 2003, J NEUROSCI, V23, P4560
   BLANGY A, 1995, J CELL SCI, V108, P675
   Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6
   Borg JP, 1996, MOL CELL BIOL, V16, P6229
   Botelho MG, 2003, J BIOL CHEM, V278, P34259, DOI 10.1074/jbc.M303189200
   BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109
   Brouillet E, 1999, J NEUROSCI, V19, P1717
   BUSH AI, 1993, J BIOL CHEM, V268, P16109
   Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103
   Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2
   Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783
   Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200
   Cappai R, 2005, J BIOL CHEM, V280, P13913, DOI 10.1074/jbc.M409179200
   Capsoni S, 2002, MOL CELL NEUROSCI, V21, P15, DOI 10.1006/mcne.2002.1163
   Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x
   Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667
   Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339
   CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2
   CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0
   Ciuculescu ED, 2005, CHEM-EUR J, V11, P903, DOI 10.1002/chem.200400786
   CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P
   CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180
   DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045
   Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2
   De la Fourniere-Bessueille L, 1997, EUR J BIOCHEM, V250, P705
   DE SB, 1999, NATURE, V398, P518
   De Strooper B, 2000, J CELL SCI, V113, P1857
   DePristo MA, 2004, STRUCTURE, V12, P831, DOI 10.1016/S0969-2126(04)00114-5
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004
   Dulubova I, 2004, BIOCHEMISTRY-US, V43, P9583, DOI 10.1021/bi049041o
   Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438
   Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960
   EDELMAN GM, 1990, COLD SH Q B, V55, P303
   Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200
   Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113
   Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978
   Esler WP, 2000, NAT CELL BIOL, V2, P428
   Fedorov AN, 1999, J MOL BIOL, V294, P579, DOI 10.1006/jmbi.1999.3281
   FERREIRA ST, 1994, BIOPHYS J, V66, P1185, DOI 10.1016/S0006-3495(94)80901-4
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x
   Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0
   Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103
   GEBBINK MFBG, 1995, J CELL BIOL, V131, P251, DOI 10.1083/jcb.131.1.251
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0
   Goda Y, 2002, NEURON, V35, P1, DOI 10.1016/S0896-6273(02)00765-1
   Goldsbury C, 2006, TRAFFIC, V7, P873, DOI 10.1111/j.1600-0854.2006.00434.x
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Goo JH, 2004, DNA CELL BIOL, V23, P59, DOI 10.1089/104454904322745934
   Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053
   Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4
   Hashimoto Y, 2003, J PHARMACOL EXP THER, V306, P889, DOI 10.1124/jpet.103.051383
   Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200
   Heber S, 2000, J NEUROSCI, V20, P7951
   Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704
   HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324
   Heidemann SR, 1996, INT REV CYTOL, V165, P235, DOI 10.1016/S0074-7696(08)62224-X
   Herard AS, 2006, NEUROBIOL AGING, V27, P1740, DOI 10.1016/j.neurobiolaging.2005.10.020
   Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390
   Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200
   HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X
   Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100
   Huber G, 1997, NEUROSCIENCE, V80, P313, DOI 10.1016/S0306-4522(97)00120-6
   HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002
   Ikezu T, 1996, EMBO J, V15, P2468, DOI 10.1002/j.1460-2075.1996.tb00604.x
   Isacson O, 2002, TRENDS NEUROSCI, V25, P79, DOI 10.1016/S0166-2236(02)02037-4
   Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376
   Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012
   Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X
   JIN LW, 1994, J NEUROSCI, V14, P5461
   Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200
   Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0
   Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7
   KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0
   Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891
   KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150
   Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005
   Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100
   Kirfel G, 2002, EUR J CELL BIOL, V81, P664, DOI 10.1078/0171-9335-00284
   KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0
   KLEIN WL, 2006, MEMORIES MOL CIRCUIT
   Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998
   Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041
   KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561
   KOO EH, 1994, J BIOL CHEM, V269, P17386
   KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8
   Kroenke CD, 1997, BIOCHEMISTRY-US, V36, P8145, DOI 10.1021/bi9705669
   Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005
   LEBLANC AC, 1992, J NEUROSCI RES, V31, P635, DOI 10.1002/jnr.490310407
   Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757
   Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449
   Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199
   Loewer A, 2004, EMBO REP, V5, P405, DOI 10.1038/sj.embor.7400122
   LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x
   Lorenzo A, 2000, NAT NEUROSCI, V3, P460
   Lu CB, 2006, J NEUROCHEM, V97, P1104, DOI 10.1111/j.1471-4159.2006.03800.x
   Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761
   Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X
   Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100
   MAJOCHA RE, 1994, CELL MOL NEUROBIOL, V14, P425, DOI 10.1007/BF02088829
   MarquezSterling NR, 1997, J NEUROSCI, V17, P140
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   Matsuda S, 2001, J NEUROSCI, V21, P6597
   MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683
   MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6
   Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0
   Morimoto T, 1998, J NEUROSCI, V18, P9386
   Moss L., 2003, WHAT GENES CANT DO
   MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055
   MULTHAUP G, 1994, FEBS LETT, V355, P151, DOI 10.1016/0014-5793(94)01176-1
   Multhaup G, 1998, BIOCHEMISTRY-US, V37, P7224, DOI 10.1021/bi980022m
   NARINDRASORASAK S, 1992, LAB INVEST, V67, P643
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0
   Ohsawa I, 1997, BIOCHEM BIOPH RES CO, V236, P59, DOI 10.1006/bbrc.1997.6903
   Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x
   OKAMOTO T, 1995, J BIOL CHEM, V270, P4205, DOI 10.1074/jbc.270.9.4205
   OUIMET CC, 1994, J COMP NEUROL, V348, P244, DOI 10.1002/cne.903480207
   Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296
   PANGALOS MN, 1995, J BIOL CHEM, V270, P10388, DOI 10.1074/jbc.270.18.10388
   Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008
   Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543
   Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4
   Perez RG, 1997, J NEUROSCI, V17, P9407
   Pietrzik CU, 1998, P NATL ACAD SCI USA, V95, P1770, DOI 10.1073/pnas.95.4.1770
   PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D
   PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0
   Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864
   Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006
   Qahwash I, 2004, J BIOL CHEM, V279, P39010, DOI 10.1074/jbc.M407101200
   QIU WQ, 1995, J NEUROSCI, V15, P2157
   Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje
   Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m
   Rassoulzadegan M, 1998, EMBO J, V17, P4647, DOI 10.1093/emboj/17.16.4647
   Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102
   RICHARDS SJ, 1995, BRAIN RES BULL, V38, P305, DOI 10.1016/0361-9230(95)92758-8
   ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G
   Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327
   Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200
   Russo C, 2001, NEUROBIOL DIS, V8, P173, DOI 10.1006/nbdi.2000.0357
   Sabo SL, 2003, J NEUROSCI, V23, P5407
   Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403
   SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2
   Sakurai Y, 1999, NEUROSCI BIOBEHAV R, V23, P785, DOI 10.1016/S0149-7634(99)00017-2
   SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205
   SANDYSWINSCH DC, 1994, BIOCONTROL SCI TECHN, V4, P269, DOI 10.1080/09583159409355335
   Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024
   Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200
   SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066
   Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5
   Sester M, 2000, J BIOL CHEM, V275, P3645, DOI 10.1074/jbc.275.5.3645
   SISODIA SS, 1993, J NEUROSCI, V13, P3136
   SMALL DH, 1994, J NEUROSCI, V14, P2117
   SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x
   Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824
   Sondag CM, 2006, J NEUROCHEM, V97, P449, DOI 10.1111/j.1471-4159.2006.03759.x
   SPRECHER CA, 1993, BIOCHEMISTRY-US, V32, P4481, DOI 10.1021/bi00068a002
   Storey E, 1999, EUR J NEUROSCI, V11, P1779, DOI 10.1046/j.1460-9568.1999.00599.x
   STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098
   STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977
   Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7
   SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   Swanson TL, 2005, DEV BIOL, V288, P160, DOI 10.1016/j.ydbio.2005.09.029
   SZEPANSKI S, 1994, J GEN VIROL, V75, P1023, DOI 10.1099/0022-1317-75-5-1023
   TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0
   Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092
   Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200
   Tominaga-Yoshino K, 2001, BRAIN RES, V918, P121, DOI 10.1016/S0006-8993(01)02983-3
   TRAPP BD, 1994, J NEUROSCI RES, V37, P538, DOI 10.1002/jnr.490370413
   Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3
   Van Nostrand WE, 2002, J BIOL CHEM, V277, P36392, DOI 10.1074/jbc.M204676200
   VANNOSTRAND WE, 1995, THROMB RES, V78, P43, DOI 10.1016/0049-3848(95)00033-X
   VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384
   Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6
   WAGNER SL, 1992, BIOCHEM BIOPH RES CO, V186, P1138, DOI 10.1016/0006-291X(92)90865-I
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005
   Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037
   WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95
   WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758
   Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004
   WEBER G, 1992, PROTIEN INTERACTIONS
   Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215
   Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898
   Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077
   Wootton JC, 1996, METHOD ENZYMOL, V266, P554
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349
   Yamatsuji T, 1996, EMBO J, V15, P498, DOI 10.1002/j.1460-2075.1996.tb00382.x
   YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431
   Yang G, 2005, NEUROSCI LETT, V384, P66, DOI 10.1016/j.neulet.2005.04.040
   YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531
   YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N
   YOSHIKAI S, 1991, GENE, V102, P291, DOI 10.1016/0378-1119(91)90093-Q
   Zambrano N, 2001, J BIOL CHEM, V276, P19787, DOI 10.1074/jbc.M100792200
   Zhang Y, 1997, J BIOL CHEM, V272, P26139, DOI 10.1074/jbc.272.42.26139
   ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X
   Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102
NR 223
TC 122
Z9 124
U1 0
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0301-0082
J9 PROG NEUROBIOL
JI Prog. Neurobiol.
PD MAY
PY 2007
VL 82
IS 1
BP 11
EP 32
DI 10.1016/j.pneurobio.2007.02.001
PG 22
WC Neurosciences
SC Neurosciences & Neurology
GA 176YR
UT WOS:000247121300002
PM 17428603
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Velasco, PT
   Lambert, MP
   Viola, K
   Fernandez, SJ
   Ferreira, ST
   Klein, WL
AF De Felice, Fernanda G.
   Velasco, Pauline T.
   Lambert, Mary P.
   Viola, Kirsten
   Fernandez, Sara J.
   Ferreira, Sergio T.
   Klein, William L.
TI A beta oligomers induce neuronal oxidative stress through an
   N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the
   Alzheimer drug memantine
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FREE-RADICAL GENERATION; CENTRAL-NERVOUS-SYSTEM; HYDROGEN-PEROXIDE;
   MITOCHONDRIA; MEMORY; A-BETA(1-42); AGGREGATION; TRAFFICKING;
   PLASTICITY; IMBALANCE
AB Oxidative stress is a major aspect of Alzheimer disease ( AD) pathology. We have investigated the relationship between oxidative stress and neuronal binding of A beta oligomers ( also known as ADDLs). ADDLs are known to accumulate in brain tissue of AD patients and are considered centrally related to pathogenesis. Using hippocampal neuronal cultures, we found that ADDLs stimulated excessive formation of reactive oxygen species ( ROS) through a mechanism requiring N-methyl-D-aspartate receptor ( NMDA-R) activation. ADDL binding to neurons was reduced and ROS formation was completely blocked by an antibody to the extracellular domain of the NR1 subunit of NMDA-Rs. In harmony with a steric inhibition of ADDL binding by NR1 antibodies, ADDLs that were bound to detergent-extracted synaptosomal membranes co-immunoprecipitated with NMDA-R subunits. The NR1 antibody did not affect ROS formation induced by NMDA, showing that NMDA-Rs themselves remained functional. Memantine, an open channel NMDA-R antagonist prescribed as a memory-preserving drug for AD patients, completely protected against ADDL-induced ROS formation, as did other NMDA-R antagonists. Memantine and the anti-NR1 antibody also attenuated a rapid ADDL-induced increase in intraneuronal calcium, which was essential for stimulated ROS formation. These results show that ADDLs bind to or in close proximity to NMDA-Rs, triggering neuronal damage through NMDA-R-dependent calcium flux. This response provides a pathologically specific mechanism for the therapeutic action of memantine, indicates a role for ROS dysregulation in ADDL-induced cognitive impairment, and supports the unifying hypothesis that ADDLs play a central role in AD pathogenesis.
C1 Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
   Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.
EM ferreira@bioqmed.ufrj.br; wklein@northwestern.edu
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU NIA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [R01-AG22547, R01-AG11385, R01-AG18877] Funding Source: Medline
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200
   Butterfield DA, 2005, BBA-PROTEINS PROTEOM, V1703, P149, DOI 10.1016/j.bbapap.2004.10.014
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2
   Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200
   Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200
   DODD PR, 1981, BRAIN RES, V226, P107, DOI 10.1016/0006-8993(81)91086-6
   Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7
   Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FISKUM G, 1985, ANN EMERG MED, V14, P810, DOI 10.1016/S0196-0644(85)80063-9
   Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102
   Giasson BI, 2002, FREE RADICAL BIO MED, V32, P1264, DOI 10.1016/S0891-5849(02)00804-3
   Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   Kawai H, 2002, J NEUROSCI, V22, P7903
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200
   Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745
   Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5
   Moreira Paula I, 2005, Curr Alzheimer Res, V2, P403
   Moreira PI, 2006, BIOL RES, V39, P7, DOI 10.4067/S0716-97602006000100002
   Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945
   Multhaup G, 1997, BIOCHEM PHARMACOL, V54, P533, DOI 10.1016/S0006-2952(97)00062-2
   Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385
   Nicholls DG, 2000, PHYSIOL REV, V80, P315
   Pratico D, 2000, AM J MED, V109, P577, DOI 10.1016/S0002-9343(00)00547-7
   Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102
   Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128
   Rizzuto R, 2003, J CELL BIOL, V163, P441, DOI 10.1083/jcb.200309111
   Schmitt HP, 2005, MED HYPOTHESES, V65, P259, DOI 10.1016/j.mehy.2005.03.011
   Schmitt HP, 2005, PSYCHOPHARMACOLOGY, V179, P151, DOI 10.1007/s00213-004-2110-5
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005
   Skulachev VP, 2005, IUBMB LIFE, V57, P305, DOI 10.1080/15216540500092161
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2
   Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006
   Tabner BJ, 2005, BIOCHEM SOC T, V33, P548, DOI 10.1042/BST0330548
   Thiels E, 2002, PHYSIOL BEHAV, V77, P601, DOI 10.1016/S0031-9384(02)00900-9
   Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010
   Wilcock GK, 2003, LANCET NEUROL, V2, P503, DOI 10.1016/S1474-4422(03)00486-1
   Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147
   Zhu XW, 2005, MOL NEUROBIOL, V31, P205, DOI 10.1385/MN:31:1-3:205
NR 63
TC 611
Z9 616
U1 0
U2 65
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 13
PY 2007
VL 282
IS 15
BP 11590
EP 11601
DI 10.1074/jbc.M607483200
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 160LG
UT WOS:000245941500080
PM 17308309
OA Bronze
DA 2020-09-29
ER

PT J
AU Hermes-Lima, M
   Santos, NCF
   Alencastro, ACR
   Ferreira, ST
AF Hermes-Lima, Marcelo
   Santos, Natacha C. F.
   Alencastro, Antonieta C. R.
   Ferreira, Sergio T.
TI Whither Latin America? Trends and challenges of science in Latin America
SO IUBMB LIFE
LA English
DT Editorial Material
DE science; Latin America; biochemistry and molecular biology; scientific
   output
ID DEVELOPING-COUNTRIES; IMPACT FACTORS; PART
AB Science in Latin America has experienced vigorous growth in the past decade, as demonstrated by the fact that the Latin American share of the world's scientific publications increased from 1.8% in 1991 - 1995 to 3.4% in 1999 - 2003. Significant growth has also taken place in the numbers of PhDs in science and engineering (S&E) awarded in Latin American countries in recent years, including those in the natural sciences. Importantly, albeit at different rates, growth has been verified in almost all countries in the region, indicating a general effort to promote the development of S&E. In most research fields, however, the recognition or relative impact of Latin American science, as measured by the average number of citations received by published articles (CpP), is still below world averages and much lower than in developed nations. We show that average CpP values for a set of 34 representative developing and developed countries correlate significantly with gross expenditure in research and development (GERD), with gross domestic product ( GDP) per capita and with the number of researchers per million inhabitants (RpM). Among those countries, Latin American nations present some of the lowest average values of CpP (<6), GERD (<= 1% of GDP) and RpM (52,000). We also examined recent trends in scientific activity in Latin America, with focus on the natural sciences and on biochemistry and molecular biology (BMB). In terms of citation scores, publications in BMB compare favorably to those in other research fields within Latin America. At the same time, however, Latin American BMB is one of the areas for which relative impact compared to developed nations or normalized to world averages is lowest. These observations clearly indicate the need to establish effective policies to increase competitiveness in terms of the quality and international recognition of Latin American natural sciences in general, and BMB in particular, as opposed to merely increasing the absolute numbers of publications or the numbers of PhDs awarded in the region.
C1 Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
   Univ Brasilia, Dept Biol Celular, Oxyradical Res Grp, Brasilia, DF, Brazil.
   Univ Brasilia, Programa Posgrad Nutr Humana, Brasilia, DF, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Hermes-Lima, Marcelo/AAP-1167-2020; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Hermes-Lima,
   Marcelo/0000-0003-1732-0927
CR Adam D, 2002, NATURE, V415, P726, DOI 10.1038/415726a
   Barcinski MA, 2003, NATURE, V423, P480, DOI 10.1038/423480c
   Batista PD, 2006, SCIENTOMETRICS, V68, P179, DOI 10.1007/s11192-006-0090-4
   BRERETON A, 2005, RES DEV IRELAND 2005
   Colquhoun D, 2003, NATURE, V423, P479, DOI 10.1038/423479a
   CRUZ CHB, 1997, REFL DEB 1 C BRAS CI, pCH6
   de Meis L, 2003, BRAZ J MED BIOL RES, V36, P1135, DOI 10.1590/S0100-879X2003000900001
   de Meis L, 2003, NATURE, V424, P723, DOI 10.1038/424723b
   Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90
   Garfield E., 2005, INT C PEER REV BIOM
   Glanzel W, 2006, SCIENTOMETRICS, V67, P67, DOI 10.1556/Scient.67.2006.1.5
   Hermes-Lima M, 2006, COMP BIOCHEM PHYS C, V142, P157, DOI 10.1016/j.cbpc.2006.01.010
   HERMESLIMA M, 2007, IN PRESS COMP BIOCH
   HILL DL, 2004, 04336 NSF
   Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102
   Holmgren M, 2004, PLOS BIOL, V2, P10, DOI 10.1371/journal.pbio.0020001
   Hortale Virginia Alonso, 2003, Cad. Saúde Pública, V19, P1837, DOI 10.1590/S0102-311X2003000600027
   King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a
   Lawrence PA, 2003, NATURE, V422, P259, DOI 10.1038/422259a
   Leta J, 2002, SCIENTOMETRICS, V53, P325, DOI 10.1023/A:1014868928349
   MUNOZ E, 2000, CONVERGE PROJ WORKSH
   OECD, 2004, M OECD COMM SCI TECH
   OREIRA COF, 2004, REV BRASILEIRA POSGR, V1, P26
   *RICYT, 2004, EST CIENC
   ROCHE P, 2003, ED CONHECIMENTO EXPE, P255
   *SCI WATCH, 2001, LAT AM GROW PRES
   Soler J.M, 2006, RATIONAL INDICATOR S
   STAINER JE, 2005, ETUDOS AVANCADOS, V19, P341
   United Nations Educational Scientific and Cultural Organization-UNESCO Institute for Statistics (UIS), 2005, UIS B SCI TECHN STAT
   Velloso Jacques, 2004, Cad. Pesqui., V34, P583, DOI 10.1590/S0100-15742004000300005
   Zenteno-Savin T, 2007, COMP BIOCHEM PHYS A, V146, P463, DOI 10.1016/j.cbpa.2006.06.044
NR 31
TC 23
Z9 27
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1521-6543
J9 IUBMB LIFE
JI IUBMB Life
PY 2007
VL 59
IS 4-5
BP 199
EP 210
DI 10.1080/15216540701258751
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 171SX
UT WOS:000246756800003
PM 17505948
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   Vieira, MNN
   De Felice, FG
AF Ferreira, Sergio T.
   Vieira, Marcelo N. N.
   De Felice, Fernanda G.
TI Soluble protein oligomers as emerging toxins in Alzheimer's and other
   amyloid diseases
SO IUBMB LIFE
LA English
DT Article; Proceedings Paper
CT 10th IUBMB Conference 2007
CY MAY 21-25, 2007
CL Salvador, BRAZIL
DE amyloid disorders; Alzheimer's disease; soluble amyloid oligomers
ID CENTRAL-NERVOUS-SYSTEM; DESMIN-RELATED CARDIOMYOPATHY; ALPHA-SYNUCLEIN
   AGGREGATION; TRIPLE-TRANSGENIC MODEL; LONG-TERM POTENTIATION; REVERSIBLE
   MEMORY LOSS; A-BETA OLIGOMERS; PRION PROTEIN; PARKINSONS-DISEASE;
   IN-VITRO
AB Amyloid diseases are a group of degenerative disorders characterized by cell/tissue damage caused by toxic protein aggregates. Abnormal production, processing and/or clearance of misfolded proteins or peptides may lead to their accumulation and to the formation of amyloid aggregates. Early histopathological investigation of affected organs in different amyloid diseases revealed the ubiquitous presence of fibrillar protein aggregates forming large deposits known as amyloid plaques. Further in vitro biochemical and cell biology studies, as well as studies using transgenic animal models, provided strong support to what initially seemed to be a solid concept, namely that amyloid. brils played crucial roles in amyloid pathogenesis. However, recent studies describing tissue-specific accumulation of soluble protein oligomers and their strong impact on cell function have challenged the fibril hypothesis and led to the emergence of a new view: Fibrils are not the only toxins derived from amyloidogenic proteins and, quite possibly, not the most important ones with respect to disease etiology. Here, we review some of the recent findings and concepts in this rapidly developing field, with emphasis on the involvement of soluble oligomers of the amyloid-beta peptide in the pathogenesis of Alzheimer's disease. Recent studies suggesting that soluble oligomers from different proteins may share common mechanisms of cytotoxicity are also discussed. Increased understanding of the cellular toxic mechanisms triggered by protein oligomers may lead to the development of rational, effective treatments for amyloid disorders.
C1 Univ Fed Rio de Janeiro, Inst Ciencas Biomed, Programa Ciencias Morfol, Rio De Janeiro, Brazil.
   Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL USA.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21744590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Vieira,
   Marcelo/0000-0003-2178-9218
CR Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+
   Armstrong RA, 2003, J NEURAL TRANSM, V110, P1303, DOI 10.1007/s00702-003-0039-1
   Avila J, 2006, J ALZHEIMERS DIS, V9, P171
   Bagriantsev S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-32
   Bautista MJ, 2006, VET MICROBIOL, V115, P293, DOI 10.1016/j.vetmic.2006.02.017
   Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200
   Bobich JA, 2004, J ALZHEIMERS DIS, V6, P243
   Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0
   Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Budka H, 2003, BRIT MED BULL, V66, P121, DOI 10.1093/bmb/66.1.121
   Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509
   Buxbaum J, 1999, HEMATOL ONCOL CLIN N, V13, P1235, DOI 10.1016/S0889-8588(05)70123-4
   CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8
   Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433
   Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x
   Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r
   De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje
   DEFELICE FG, UNPUB ALZHEIMERS DIS
   DEFELICE FG, UNPUB ABETA OLIGOMER
   Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200
   Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842
   Dorandeu A, 1998, BRAIN PATHOL, V8, P531
   Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613
   Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q
   El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje
   Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0
   Florent S, 2006, J NEUROCHEM, V96, P385, DOI 10.1111/j.1471-4159.2005.03541.x
   FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0
   FRACKOWIAK J, 1994, J NEUROPATH EXP NEUR, V53, P637, DOI 10.1097/00005072-199411000-00011
   Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016
   Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102
   Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827
   Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01
   Gobbi M, 2006, J BIOL CHEM, V281, P843, DOI 10.1074/jbc.M506164200
   Goldberg MS, 2000, NAT CELL BIOL, V2, pE115
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Goto Y, 2006, BIOCHEM BIOPH RES CO, V351, P259, DOI 10.1016/j.bbrc.2006.10.030
   Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097
   Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022
   GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Hoffner G, 2005, J NEUROCHEM, V95, P125, DOI 10.1111/j.1471-4159.2005.03348.x
   Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100
   Hou X, 2007, J NEUROCHEM, V100, P446, DOI 10.1111/j.1471-4159.2006.04210.x
   Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035
   Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559
   Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491
   Karpuj MV, 1999, P NATL ACAD SCI USA, V96, P7388, DOI 10.1073/pnas.96.13.7388
   KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206
   Kawai-Noma S, 2006, GENES CELLS, V11, P1085, DOI 10.1111/j.1365-2443.2006.01004.x
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200
   King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   KLEIN WL, 2007, IN PRESS MEMORIES MO
   Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com
   Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x
   Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337
   Kotilinek LA, 2002, J NEUROSCI, V22, P6331
   Kuo YM, 1996, J BIOL CHEM, V271, P4077
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0
   Lee CH, 2006, J BIOL CHEM, V281, P3463, DOI 10.1074/jbc.M505307200
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189
   Lima ACP, 2003, NEUROTOX RES, V5, P323, DOI 10.1007/BF03033152
   Lopes DHJ, 2004, J BIOL CHEM, V279, P10991, DOI 10.1074/jbc.M308174200
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com
   Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3
   Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   MALOY AL, 1981, HUM PATHOL, V12, P917, DOI 10.1016/S0046-8177(81)80197-9
   MANDERLUH G, 2005, FEBS J, V272, P3042
   Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200
   Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Mazur-Kolecka B, 2006, NEUROBIOL AGING, V27, P1181, DOI 10.1016/j.neurobiolaging.2005.07.006
   Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102
   Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571
   Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200
   Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003
   Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012
   Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0
   Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001
   Piao YS, 2005, NEUROPATHOLOGY, V25, P144, DOI 10.1111/j.1440-1789.2005.00608.x
   Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u
   PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564
   POLLARD HB, 1993, ANN NY ACAD SCI, V695, P165, DOI 10.1111/j.1749-6632.1993.tb23046.x
   Pollard HB, 1995, CELL MOL NEUROBIOL, V15, P513, DOI 10.1007/BF02071314
   Pratico D, 2000, AM J MED, V109, P577, DOI 10.1016/S0002-9343(00)00547-7
   QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0
   Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199
   Redecke L, 2007, J STRUCT BIOL, V157, P308, DOI 10.1016/j.jsb.2006.06.013
   Relini A, 2004, BBA-MOL BASIS DIS, V1690, P33, DOI 10.1016/j.bbadis.2004.04.007
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102
   Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101
   SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9
   Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2
   Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200
   SHIMADA K, 1989, MOL BIOL MED, V6, P333
   Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989
   Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114
   Smith DP, 2001, PROTEIN SCI, V10, P1775, DOI 10.1110/ps.4901
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m
   Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200
   Sousa MM, 2001, AM J PATHOL, V159, P1993
   Sousa MM, 2001, J NEUROSCI, V21, P7576
   Sponne I, 2003, J BIOL CHEM, V278, P3437, DOI 10.1074/jbc.M206745200
   Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5
   TABATON M, 1994, BIOCHEM BIOPH RES CO, V200, P1598, DOI 10.1006/bbrc.1994.1634
   Tahiri-Alaoui A, 2006, J BIOL CHEM, V281, P34171, DOI 10.1074/jbc.M606606200
   Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X
   Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004
   Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7
   Teng MH, 2001, LAB INVEST, V81, P385, DOI 10.1038/labinvest.3780246
   TERRY RD, 1964, AM J PATHOL, V44, P269
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Tompkins MM, 1997, BRAIN RES, V775, P24, DOI 10.1016/S0006-8993(97)00874-3
   Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754
   Ulrih NP, 2006, BIOCHEM BIOPH RES CO, V344, P1320, DOI 10.1016/j.bbrc.2006.04.046
   Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200
   Vasan S, 2006, NEUROCHEM RES, V31, P629, DOI 10.1007/s11064-006-9063-5
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017
   Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492
   VIEIRA MN, SOLUBLE LYOZYME OLIG, P155
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626
   Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137
   WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036
   WIRAK DO, 1991, SCIENCE, V253, P323, DOI 10.1126/science.1857970
   Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c
   Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077
   Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200
   Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977
   YAGUI K, 1995, EUR J ENDOCRINOL, V132, P487, DOI 10.1530/eje.0.1320487
   Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a
   Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103
   Yu ZX, 2002, HUM MOL GENET, V11, P905, DOI 10.1093/hmg/11.8.905
   Zheng J, 2006, BIOPHYS J, V91, P824, DOI 10.1529/biophysj.106.083246
   Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147
   Zhu XW, 2005, MOL NEUROBIOL, V31, P205, DOI 10.1385/MN:31:1-3:205
NR 161
TC 246
Z9 252
U1 3
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PY 2007
VL 59
IS 4-5
BP 332
EP 345
DI 10.1080/15216540701283882
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 171SX
UT WOS:000246756800028
PM 17505973
DA 2020-09-29
ER

PT S
AU Klein, WL
   Lacor, PN
   De Felice, FG
   Ferreira, ST
AF Klein, William L.
   Lacor, Pascale N.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
BE Bontempi, B
   Silva, AJ
   Christen, Y
TI Molecules that disrupt memory circuits in Alzheimer's disease: The
   attack on synapses by A beta oligomers (ADDLs)
SO MEMORIES: MOLECULES AND CIRCUITS
SE Research and Perspectives in Neurosciences
LA English
DT Proceedings Paper
CT Conference on Memories Molecules and Circuits
CY APR 24, 2006
CL Fdn Ipsen, Paris, FRANCE
HO Fdn Ipsen
ID LONG-TERM POTENTIATION; AMYLOID-BETA; SYNAPTIC PLASTICITY; IN-VIVO;
   MOUSE MODEL; SYNTHASE KINASE-3-BETA; RECEPTOR TRAFFICKING; TRANSGENIC
   MODEL; PROTEIN-KINASE; PEPTIDE
AB Individuals with early Alzheimer's disease (AD) suffer from a selective and profound failure to form new memories. A novel molecular mechanism with implications for therapeutics and diagnostics is now emerging in which the specificity of AD for memory derives from disruption of plasticity at synapses targeted by neurologically active A beta oligomers. We have named these oligomers "ADDLs" (for pathogenic A beta-derived diffusible ligands). ADDLs constitute metastable alternatives to the disease-defining AP fibrils deposited in amyloid plaques. In AD brain, ADDLs accumulate primarily as AP 12-mers (similar to 54 kDa). The same size oligomers occur in tg-mouse AD models; in mice, these 12-mers appear concomitantly with memory failure, consistent with the ability of ADDLs to inhibit long-term potentiation (LTP) and block reversal of long-term depression (LTD). Mechanistically, ADDLs are gain-of-function ligands that bind with specificity to particular synapses, targeting synaptic spines. Binding leads to a rapid and ectopic expression of the memory-linked immediate early gene Arc. Such aberrant accumulation has been linked by others to memory dysfunction in tg-Arc mouse models. Consistent with the expected consequences of Arc overexpression, ADDLs promote loss of surface NMDA receptors and anomalous spine morphology, which are responses expected to contribute to plasticity failure and memory dysfunction. Importantly, the attack on synapses provides a putative mechanism that unifies AD memory dysfunction with major features of AD neuropathology. Recent findings show ADDL binding instigates synapse loss, AD-type tau hyperphosphorylation, and generation of reactive oxygen species (ROS). Binding sites for ADDLs are at or in the close vicinity of NMDA receptors. Antibodies against external domains of NMDA receptors reduce ADDL binding and inhibit ADDL-stimulated ROS formation. The ROS response also is inhibited by memantine, an open-channel blocker of NMDA receptors recently approved for AD therapeutics. The ability of memantine to contravene the impact of ADDLs offers a new mechanism to explain why an NMDA receptor antagonist should improve memory function in AD patients. Elimination of ADDLs by vaccines now under development could provide the first AD treatments that are truly disease-modifying. In addition to establishing a molecular mechanism of significant value for AD therapeutics and diagnostics, studies of ADDL interactions with synaptic pathways and control mechanisms ultimately may provide new insights into the extraordinary complexities of physiological synaptic information storage.
C1 [Klein, William L.; Lacor, Pascale N.; De Felice, Fernanda G.; Ferreira, Sergio T.] Northwestern Univ, Inst Neurosci, Cognit Neurol & Alzheimers Dis Ctr, Dept Neurobiol & Physiol, 2205 Tech Dr, Evanston, IL 60208 USA.
RP Klein, WL (corresponding author), Northwestern Univ, Inst Neurosci, Cognit Neurol & Alzheimers Dis Ctr, Dept Neurobiol & Physiol, 2205 Tech Dr, Evanston, IL 60208 USA.
EM wklein@northwestern.edu
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000
   ALZHEIMER A, 2006, LANCET, V349, P1546
   Bigio EH, 2005, J NEUROPATH EXP NEUR, V64, P440
   Boutaud O, 2006, J NEUROCHEM, V96, P917, DOI 10.1111/j.1471-4159.2005.03586.x
   Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304
   Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013
   Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008
   Chang L, 2003, J MOL NEUROSCI, V20, P305, DOI 10.1385/JMN:20:3:305
   Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q
   Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571
   Costello DA, 2005, NEUROPHARMACOLOGY, V49, P359, DOI 10.1016/j.neuropharm.2005.03.009
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842
   Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x
   Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3
   FRACKOWIAK J, 1994, J NEUROPATH EXP NEUR, V53, P637, DOI 10.1097/00005072-199411000-00011
   Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010
   Guzowski JF, 2000, J NEUROSCI, V20, P3993
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100
   Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8
   Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103
   KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kelly MP, 2003, J NEUROSCI, V23, P6443
   Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5
   Klein WL, 2001, CONTEMPORARY CLIN NE, P1
   KLEIN WL, 2005, PROTEIN MISFOLDING A
   Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009
   Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x
   Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234
   Kotilinek LA, 2002, J NEUROSCI, V22, P6331
   Kuo YM, 1996, J BIOL CHEM, V271, P4077
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   LACOR PN, 2004, 2004 ABSTRACT VIEWER
   LACOR PN, 2005, 2005 ABSTRACT VIEWER
   LACOR PN, 2007, IN PRESS J NEUROSCI
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LAMBERT MP, 2003, 2003 ABSTRACT VIEWER
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x
   LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G
   LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014
   MASLIAH E, 1993, MED HYPOTHESES, V41, P334, DOI 10.1016/0306-9877(93)90078-5
   Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5
   MONTALTO MC, 2004, Patent No. 10747715
   Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000
   Mukaetova-Ladinska EB, 2000, AM J PATHOL, V157, P623, DOI 10.1016/S0002-9440(10)64573-7
   Nomura I, 2005, NEUROSCI LETT, V391, P1, DOI 10.1016/j.neulet.2005.08.024
   ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080
   ODA T, 1994, BIOCHEM BIOPH RES CO, V204, P1131, DOI 10.1006/bbrc.1994.2580
   Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x
   Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005
   Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005
   Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101
   Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102
   Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004
   Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200
   Trommer BL, 2005, NEUROBIOL DIS, V18, P75, DOI 10.1016/j.nbd.2004.08.011
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang GJ, 2004, BIOMED MICRODEVICES, V6, P47, DOI 10.1023/B:BMMD.0000013365.99619.36
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004
   WESTERMAN MA, 2002, SOC NEUR ABSTR, V28
   Witt A, 2004, NAT REV DRUG DISCOV, V3, P109, DOI 10.1038/nrd1311
   Zhang C, 1996, NEUROSCI LETT, V211, P187, DOI 10.1016/0304-3940(96)12761-0
NR 83
TC 13
Z9 13
U1 0
U2 4
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0945-6082
EI 2196-3096
BN 978-3-540-45698-8
J9 RES PER NEUROSCI
JI Res. Perspect. Neurosci.
PY 2007
BP 155
EP +
DI 10.1007/978-3-540-45702-2_11
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA BGE11
UT WOS:000246253100011
DA 2020-09-29
ER

PT J
AU Holub, O
   Ferreira, ST
AF Holub, Oliver
   Ferreira, Sergio T.
TI Quantitative histogram analysis of images
SO COMPUTER PHYSICS COMMUNICATIONS
LA English
DT Article
DE histogram; image; microscopy; statistics
AB A routine for histogram analysis of images has been written in the object-oriented, graphical development environment LabVIEW. The program converts an RGB bitmap image into an intensity-linear greyscale image according to selectable conversion coefficients. This greyscale image is subsequently analysed by plots of the intensity histogram and probability distribution of brightness, and by calculation of various parameters, including average brightness, standard deviation, variance, minimal and maximal brightness, mode, skewness and kurtosis of the histogram and the median of the probability distribution. The program allows interactive selection of specific regions of interest (ROI) in the image and definition of lower and upper threshold levels (e.g., to permit the removal of a constant background signal). The results of the analysis of multiple images can be conveniently saved and exported for plotting in other programs, which allows fast analysis of relatively large sets of image data. The program file accompanies this manuscript together with a detailed description of two application examples: The analysis of fluorescence microscopy images, specifically of tau-immunofluorescence in primary cultures of rat cortical and hippocampal neurons, and the quantification of protein bands by Western-blot. The possibilities and limitations of this kind of analysis are discussed.
C1 Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Holub, O (corresponding author), Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM holub@bioqmed.ufrj.br; ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR DRAKOS N, 1993, TNIMAGE IMAGE ANAL M
   Haeberli P., 1993, MATRIX OPERATIONS IM
   Michielsen K, 2000, COMPUT PHYS COMMUN, V132, P94, DOI 10.1016/S0010-4655(00)00139-9
   Rasband W. S., 1997, IMAGEJ
   Ritley KA, 2001, COMPUT PHYS COMMUN, V137, P300, DOI 10.1016/S0010-4655(01)00155-2
   Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com
   Weisstein E. W., 1999, MATHWORLD WOLFRAM WE
   YOUNG I, 1995, FUNDAMENTALS IMAGE P
NR 8
TC 17
Z9 17
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0010-4655
J9 COMPUT PHYS COMMUN
JI Comput. Phys. Commun.
PD NOV 1
PY 2006
VL 175
IS 9
BP 620
EP 623
DI 10.1016/j.cpc.2006.06.014
PG 4
WC Computer Science, Interdisciplinary Applications; Physics, Mathematical
SC Computer Science; Physics
GA 101BK
UT WOS:000241713700005
DA 2020-09-29
ER

PT J
AU Botelho, MG
   Rietveld, AWM
   Ferreira, ST
AF Botelho, Michelle G.
   Rietveld, Alex W. M.
   Ferreira, Sergio T.
TI Long-lived conformational isomerism of protein dimers: The role of the
   free energy of subunit association
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID YEAST TRIOSEPHOSPHATE ISOMERASE; PRESSURE-INDUCED DISSOCIATION; TRIOSE
   PHOSPHATE ISOMERASE; EXTRACELLULAR HEMOGLOBIN; CONCENTRATION-DEPENDENCE;
   REVERSIBLE DISSOCIATION; HYDROSTATIC-PRESSURE; STABILITY; HETEROGENEITY;
   EQUILIBRIUM
AB The association of protein subunits to form N-mers (N >= 3) does not follow the dependence on the law of mass action predicted by the classical thermodynamic description used for the equilibrium of association of small molecules. For those anomalous cases, a so-called deterministic model has been previously proposed. The latter model was based on the empirical observation that the dynamics of subunit exchange between protein oligomers can be very slow, leading to the existence of long-lived conformational isomers and to a persistently heterogeneous ensemble of oligomers in solution. Contrary to the expectation for a protein dimer, we have recently shown that the subunit association of triosephosphate isomerase (TIM) could also be described as a deterministic process and that long-lived conformational isomers of TIM could be isolated in solution. Here we show that a), observation of hysteresis in pressure dissociation curves is an additional indicator of deterministic behavior; b), the extent of deviation from the classical thermodynamic behavior correlates with the free-energy change of subunit association; and c), experimental manipulation of the free energy of subunit association through the addition of a subdenaturing concentration of a chaotropic agent restores the concentration dependence of subunit association of TIM. A model that explains these features and its biological relevance is discussed.
C1 Fed Univ Rio De Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Fed Univ Rio De Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21941590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Botelho, Michael George/B-2131-2009; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Aparicio R, 2003, J MOL BIOL, V334, P1023, DOI 10.1016/j.jmb.2003.10.022
   BONAFE CFS, 1991, J BIOL CHEM, V266, P13210
   COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266
   DAPOIAN AT, 1993, J MOL BIOL, V231, P999, DOI 10.1006/jmbi.1993.1347
   ERIJMAN L, 1993, BIOCHEMISTRY-US, V32, P5187, DOI 10.1021/bi00070a030
   ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6609, DOI 10.1021/bi00480a009
   MATOUSCHEK A, 1995, BIOCHEMISTRY-US, V34, P13656, DOI 10.1021/bi00041a047
   Moreau VH, 2003, BIOCHEMISTRY-US, V42, P14831, DOI 10.1021/bi0343572
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Najera H, 2003, BIOCHEM J, V370, P785, DOI 10.1042/BJ20021439
   Pace C N, 1986, Methods Enzymol, V131, P266
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   SILVA JL, 1989, J BIOL CHEM, V264, P15863
   SILVA JL, 1988, J MOL BIOL, V199, P149, DOI 10.1016/0022-2836(88)90385-3
   SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.biochem.56.1.89
   SUN AW, 1992, ARCH BIOCHEM BIOPHYS, V293, P382, DOI 10.1016/0003-9861(92)90410-X
   Tellez-Valencia A, 2004, J MOL BIOL, V341, P1355, DOI 10.1016/j.jmb.2004.06.056
   WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165
   Weber G, 1996, BIOPHYS J, V70, P167, DOI 10.1016/S0006-3495(96)79557-7
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
NR 30
TC 6
Z9 6
U1 0
U2 3
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD OCT
PY 2006
VL 91
IS 8
BP 2826
EP 2832
DI 10.1529/biophysj.106.089706
PG 7
WC Biophysics
SC Biophysics
GA 086VI
UT WOS:000240700700010
PM 16861278
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Martins, SM
   Frosoni, DJ
   Martinez, AMB
   De Felice, FG
   Ferreira, ST
AF Martins, Samantha M.
   Frosoni, Doris J.
   Martinez, Ana M. Blanco
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Formation of soluble oligomers and amyloid fibrils with physical
   properties of the scrapie isoform of the prion protein from the
   C-terminal domain of recombinant murine prion protein mPrP-(121-231)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID IN-VITRO; MOLECULAR-BASIS; CONVERSION; PRPSC; PH; CONFORMATION;
   DISEASES; AGGREGATION; MODULATION; TRANSITION
AB Prion diseases are fatal neurodegenerative disorders associated with conformational conversion of the cellular prion protein, PrPC, into a misfolded, protease-resistant form, PrPSc. Here we show, for the first time, the oligomerization and fibrillization of the C-terminal domain of murine PrP, mPrP-(121-231), which lacks the entire unstructured N-terminal domain of the protein. In particular, the construct we used lacks amino acid residues 106-120 from the so-called amyloidogenic core of PrP (residues 106-126). Amyloid formation was accompanied by acquisition of resistance to proteinase K digestion. Aggregation of mPrP-(121-231) was investigated using a combination of biophysical and biochemical techniques at pH 4.0, 5.5, and 7.0 and at 37 and 65 degrees C. Under partially denaturing conditions (65 degrees C), aggregates of different morphologies ranging from soluble oligomers to mature amyloid fibrils of mPrP-(121-231) were formed. Transmission electron microscopy analysis showed that roughly spherical aggregates were readily formed when the protein was incubated at pH 5.5 and 65 degrees C for 1 h, whereas prolonged incubation led to the formation of mature amyloid fibrils. Samples incubated at 65 degrees C at pH 4.0 or 7.0 presented an initial mixture of oligomers and protofibrils or fibrils. Electrophoretic analysis of samples incubated at 65 degrees C revealed formation of sodium dodecyl sulfate-resistant oligomers (dimers, trimers, and tetramers) and higher molecular weight aggregates of mPrP-(121-231). These results demonstrate that formation of an amyloid form with physical properties of PrPSc can be achieved in the absence of the flexible N-terminal domain and, in particular, of residues 106-120 of PrP and does not require other cellular factors or a PrPSc template.
C1 Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Histol & Embryol, Inst Ciencias Biomed, BR-21944590 Rio De Janeiro, Brazil.
   Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
RP Martins, SM (corresponding author), Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Martinez, Ana/C-6318-2014
OI Ferreira, Sergio/0000-0001-7160-9866; 
CR Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6
   Alvarez-Martinez MT, 2003, BBA-PROTEINS PROTEOM, V1645, P228, DOI 10.1016/S1570-9639(02)00536-8
   Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200
   Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200
   Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353
   Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200
   BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994
   Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605
   BORCHELT DR, 1992, J BIOL CHEM, V267, P16188
   Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340
   Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011
   CAUGHEY B, 1991, J BIOL CHEM, V266, P18217
   Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142
   CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003
   CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A
   CHESLER M, 1990, PROG NEUROBIOL, V34, P401, DOI 10.1016/0301-0082(90)90034-E
   Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433
   COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959
   Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362
   Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   Hornemann S, 1996, J MOL BIOL, V261, P614, DOI 10.1006/jmbi.1996.0487
   Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010
   Jobling MF, 1999, J NEUROCHEM, V73, P1557, DOI 10.1046/j.1471-4159.1999.0731557.x
   Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010
   Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770
   KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923
   KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0
   Lawson VA, 2004, J BIOL CHEM, V279, P13689, DOI 10.1074/jbc.M303697200
   Lee RJ, 1996, BBA-MOL CELL RES, V1312, P237, DOI 10.1016/0167-4889(96)00041-9
   Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961
   Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g
   Lu BY, 2002, BIOCHEM J, V364, P81, DOI 10.1042/bj3640081
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q
   NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8
   Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7
   Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200
   PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102
   Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4
   Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0
   Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654
   Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200
   STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016
   Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m
   Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517
   Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010
   Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552
   Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174
   Weissmann C, 2005, CELL, V122, P165, DOI 10.1016/j.cell.2005.07.001
   Wildegger G, 1999, NAT STRUCT BIOL, V6, P550, DOI 10.1038/9323
   Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200
NR 54
TC 25
Z9 26
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 8
PY 2006
VL 281
IS 36
BP 26121
EP 26128
DI 10.1074/jbc.M605367200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 080LO
UT WOS:000240249500027
PM 16844683
OA Bronze
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Ferreira, ST
AF De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Novel neuroprotective, neuritogenic and anti-amyloidogenic properties of
   2,4-dinitrophenol: The gentle face of Janus
SO IUBMB LIFE
LA English
DT Review
DE 2,4-dinitrophenol; low concentrations; neuroprotection; amyloid-beta
   peptide
ID ALZHEIMERS-DISEASE; TAU-PROTEIN; LIFE-SPAN; DINITROPHENOL; AGGREGATION;
   UNCOUPLER; INHIBITION; MECHANISMS; DISORDERS; PATHOLOGY
AB In Roman mythology, Janus was the god of gates, doors, beginnings and endings. He was usually depicted with two faces looking in opposite directions. Janus was frequently used to symbolize change and transitions, such as the progression from past to future or from one viewpoint to another. 2,4-dinitrophenol (DNP) and other nitrophenols have long been known to be toxic at high concentrations (the `bad' face of DNP), an effect that appears essentially related to interference with cellular energy metabolism due to uncoupling of mitochondrial oxidative phosphorylation. Five years ago, however, we published the first report showing that low concentrations of DNP protect neurons against the toxicity of the amyloid-beta peptide [De Felice et al. (2001) FASEB J. 15: 1297-1299]. Since then, other studies have provided evidence of beneficial actions of DNP (at low concentrations), including neuroprotection against different types of insult, blockade of amyloid aggregation, stimulation of neurite outgrowth and neuronal differentiation, and even extension of lifespan in certain organisms. Some of these effects appear to be due to mild mitochondrial uncoupling and prevention of cellular oxidative stress, whereas other actions are related to activation of additional intracellular signaling pathways. Thus, a novel and `gentle' face of DNP is emerging from such studies. In this review, we discuss both toxic and beneficial actions of DNP. The evidence available so far suggests that DNP and other compounds with similar biological activities may be of significant interest to the development of novel therapeutic approaches for neurodegenerative diseases and other neurological disorders.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
   Northwestern Univ, Dept Physiol & Neurobiol, Evanston, IL 60208 USA.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003
   Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200
   Benitez-King G, 2004, CNS NEUROL DISORD-DR, V3, P515, DOI 10.2174/1568007043336761
   BETTMAN JW, 1946, AM J OPHTHALMOL, V29, P1388, DOI 10.1016/0002-9394(46)92034-X
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001
   Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com
   Czech C, 2000, PROG NEUROBIOL, V60, P363, DOI 10.1016/S0301-0082(99)00033-7
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   *DOW CHEM CO, 1940, IN SUBM TOX HLTH HAZ
   *DOW CHEM CO, 1950, IN SUBM COMP AC OR T
   DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739
   Ernst RL, 1997, ARCH NEUROL-CHICAGO, V54, P687, DOI 10.1001/archneur.1997.00550180013006
   Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539
   Harris M. O., 1995, TOXICOLOGICAL PROFIL
   Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008
   Jacobs WB, 2003, NEUROSURGERY, V53, P943, DOI 10.1227/01.NEU.0000083592.74383.B1
   Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396
   KAISER J A, 1964, Ther Ggw, V103, P232
   KLEIN WL, 2006, ALZHEIMERS DEMENTIA, V2, P60
   Korde AS, 2005, J NEUROTRAUM, V22, P1142, DOI 10.1089/neu.2005.22.1142
   Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x
   KURT TL, 1986, VET HUM TOXICOL, V28, P574
   LIPTON SA, 1994, NEW ENGL J MED, V330, P613
   LIPTON SA, 2006, NAT REV DRUG DISCOV, V20, P1
   Maragos WF, 2003, BRAIN RES, V966, P312, DOI 10.1016/S0006-8993(02)04225-7
   Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903
   Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65
   McFee RB, 2004, VET HUM TOXICOL, V46, P251
   Padalko VI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P986, DOI 10.1007/s10541-005-0213-1
   PARASCANDOLA J, 1974, MOL CELL BIOCHEM, V5, P69, DOI 10.1007/BF01874175
   Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779
   Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002
   Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515
   Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864
   SPENCER HC, 1948, J IND HYG TOXICOL, V30, P10
   Tainter ML, 1934, ARCH PATHOL, V18, P881
   Tainter ML, 1935, J AMER MED ASSOC, V105, P0332, DOI 10.1001/jama.1935.02760310006002
   Vieira MNN, 2006, CELL BIOCHEM BIOPHYS, V44, P549, DOI 10.1385/CBB:44:3:549
   Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com
   WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858
NR 44
TC 35
Z9 36
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD APR
PY 2006
VL 58
IS 4
BP 185
EP 191
DI 10.1080/15216540600702198
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 051YT
UT WOS:000238198300001
PM 16754295
DA 2020-09-29
ER

PT J
AU Gralle, M
   Oliveira, CLP
   Guerreiro, LH
   McKinstry, WJ
   Galatis, D
   Masters, CL
   Cappai, R
   Parker, MW
   Ramos, CHI
   Torriani, I
   Ferreira, ST
AF Gralle, M
   Oliveira, CLP
   Guerreiro, LH
   McKinstry, WJ
   Galatis, D
   Masters, CL
   Cappai, R
   Parker, MW
   Ramos, CHI
   Torriani, I
   Ferreira, ST
TI Solution conformation and heparin-induced dimerization of the
   full-length extracellular domain of the human amyloid precursor protein
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE analytical ultracentrifugation; modeling; signal transduction;
   small-angle X-ray scattering; structural domains
ID SOLUTION SCATTERING DATA; RAY SOLUTION SCATTERING; SMALL-ANGLE
   SCATTERING; ALZHEIMERS-DISEASE; MACROMOLECULAR COMPLEXES; CYTOPLASMIC
   DOMAIN; CRYSTAL-STRUCTURE; TRANSGENIC MICE; SECRETED FORMS; CELL-SURFACE
AB Proteolytic cleavage of the amyloid precursor protein (APP) by beta and gamma-secretases gives rise to the beta-amyloid peptide, considered to be a causal factor in Alzheimer's disease. Conversely, the soluble extracellular domain of APP (sAPP alpha), released upon its cleavage by alpha-secretase, plays a number of important physiological functions. Several APP fragments have been structurally characterized at atomic resolution, but the structures of intact APP and of full-length sAPP alpha have not been determined. Here, ab initio reconstruction of molecular models from high-resolution solution X-ray scattering (SAXS) data for the two main isoforms of sAPP alpha (sAPP alpha(695) and sAPP alpha(770)) provided models of sufficiently high resolution to identify distinct structural domains of APP. The fragments for which structures are known at atomic resolution were fitted within the solution models of full-length sAPPa, allowing localization of important functional sites (i.e. glycosylation, protease inhibitory and heparin-binding sites). Furthermore, combined results from SAXS, analytical ultracentrifugation (AUC) and size-exclusion chromatography (SEC) analysis indicate that both sAPP alpha isoforms are monomeric in solution. On the other hand, SEC, bis-ANS fluorescence, AUC and SAXS measurements showed that sAPPa forms a 2:1 complex with heparin. A conformational model for the sAPP alpha:heparin complex was also derived from the SAXS data. Possible implications of such complex formation for the physiological dimerization of APP and biological signaling are discussed in terms of the structural models proposed. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
   Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13084971 Campinas, SP, Brazil.
   Lab Nacl Luz Sincrotron, BR-13084970 Campinas, SP, Brazil.
   St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia.
   Univ Melbourne, Ctr Neurosci, Dept Pathol, Parkville, Vic 3010, Australia.
   Mental Hlth Res Inst, Parkville, Vic 3010, Australia.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Gralle, Matthias/B-9005-2014; Oliveira, Cristiano L P/B-4403-2008;
   Ferreira, Sergio/AAZ-1576-2020; Parker, Michael W/F-9069-2013; Rosado,
   Luiz L H/N-1472-2015; McKinstry, William J/D-2612-2013; Ramos,
   CH/C-1571-2012; Torriani, Iris L/E-5686-2010; Cappai,
   Roberto/B-3347-2010
OI Oliveira, Cristiano L P/0000-0002-3426-6507; Ferreira,
   Sergio/0000-0001-7160-9866; Parker, Michael W/0000-0002-3101-1138;
   Rosado, Luiz L H/0000-0002-9390-8397; McKinstry, William
   J/0000-0001-9668-9364; Ramos, CH/0000-0002-7246-9081; Cappai,
   Roberto/0000-0002-9505-8496; Torriani, Iris/0000-0002-7847-5108
CR Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200
   Botelho MG, 2003, J BIOL CHEM, V278, P34259, DOI 10.1074/jbc.M303189200
   Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103
   Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P561
   Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783
   Clarris HJ, 1997, J NEUROCHEM, V68, P1164
   DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045
   de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6
   Dulubova I, 2004, BIOCHEMISTRY-US, V43, P9583, DOI 10.1021/bi049041o
   Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113
   ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583
   Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101
   FARBER SA, 1995, J NEUROSCI, V15, P7442
   GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0
   Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4
   Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2
   Hashimoto Y, 2003, J PHARMACOL EXP THER, V306, P889, DOI 10.1124/jpet.103.051383
   Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100
   Hoffmann J, 1999, J HISTOCHEM CYTOCHEM, V47, P373, DOI 10.1177/002215549904700311
   HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002
   Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0
   Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829
   KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150
   Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643
   Konarev PV, 2001, J APPL CRYSTALLOGR, V34, P527, DOI 10.1107/S0021889801006100
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Kroenke CD, 1997, BIOCHEMISTRY-US, V36, P8145, DOI 10.1021/bi9705669
   Kwan CP, 2001, J BIOL CHEM, V276, P23421, DOI 10.1074/jbc.M010786200
   Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702
   Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I
   Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683
   Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0
   Morimoto T, 1998, J NEUROSCI, V18, P9386
   Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406
   Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x
   OLIVEIRA CLP, 1997, DATA TREATMENT PROGR
   Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289
   Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154
   Petoukhov MV, 2003, J APPL CRYSTALLOGR, V36, P540, DOI 10.1107/S0021889803000591
   Pietrzik CU, 1998, P NATL ACAD SCI USA, V95, P1770, DOI 10.1073/pnas.95.4.1770
   Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864
   Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje
   Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327
   Sabo SL, 2003, J NEUROSCI, V23, P5407
   Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X
   Stein TD, 2002, J NEUROSCI, V22, P7380
   Storey E, 1996, BRAIN RES, V735, P217, DOI 10.1016/0006-8993(96)00608-7
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   Svergun DI, 2000, J APPL CRYSTALLOGR, V33, P530, DOI 10.1107/S0021889800001370
   Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3
   Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037
   Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215
   Zhang Y, 1997, J BIOL CHEM, V272, P26139, DOI 10.1074/jbc.272.42.26139
   Zhuang P, 1997, J BIOL CHEM, V272, P6858, DOI 10.1074/jbc.272.11.6858
NR 63
TC 51
Z9 51
U1 0
U2 12
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAR 24
PY 2006
VL 357
IS 2
BP 493
EP 508
DI 10.1016/j.jmb.2005.12.053
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 023IL
UT WOS:000236120200013
PM 16436282
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   De Felice, FG
   Chapeaurouge, A
AF Ferreira, ST
   De Felice, FG
   Chapeaurouge, A
TI Metastable, partially folded states in the productive folding and in the
   misfolding and amyloid aggregation of proteins
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT 1st Latin-American-Protein-Society Meeting
CY NOV 08-12, 2004
CL Angra dos Reis, BRAZIL
SP Latin Amer Protein Soc
DE protein folding; misfolding; amyloid aggregates; hydrostatic pressure
ID 3-HELIX BUNDLE PROTEIN; HAMSTER PRION PROTEIN; HIGH-PRESSURE; HUMAN
   LYSOZYME; HYDROSTATIC-PRESSURE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE;
   STRUCTURAL-CHANGES; COLD DENATURATION; FIBRIL FORMATION
AB Understanding the energetic and structural basis of protein folding in a physiological context may represent an important step toward the elucidation of protein misfolding and aggregation events that take place in several pathological states. In particular, investigation of the structure and thermodynamic properties of partially folded intermediate states involved in productive folding or in misfolding/aggregation may provide insight into these processes and suggest novel approaches to prevent misfolding in living organisms. This goal, however, has remained elusive, because such intermediates are often transient and correspond to metastable states that are little populated under physiological conditions. Characterization of these states requires their stabilization by means of manipulation of the experimental conditions, involving changes in temperature, pH, or addition of different types of denaturants. In the past few years, hydrostatic pressure has been increasingly used as a thermodynamic variable in the study of both protein folding and misfolding/aggregation transitions. Compared with other chemical or physical denaturing agents, a unique feature of pressure is its ability to induce subtle changes in protein conformation, allowing the stabilization of partially folded states that are usually not significantly populated under more drastic conditions. Much of the recent work in this field has focused on the characterization of folding intermediates, because they seem to be involved in a variety of disease-causing protein misfolding and aggregation reactions. Here, we review recent examples of the use of hydrostatic pressure as a tool to gain insight into the forces and energetics governing the productive folding or the misfolding and amyloid aggregation of proteins.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.
   Fiocruz MS, Dept Fisiol & Farmacodinam, Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6
   Alvarez-Martinez MT, 2003, BBA-PROTEINS PROTEOM, V1645, P228, DOI 10.1016/S1570-9639(02)00536-8
   Balny C, 2002, BBA-PROTEIN STRUCT M, V1595, P3, DOI 10.1016/S0167-4838(01)00331-4
   BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801
   Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0
   Botelho MM, 2000, EUR J BIOCHEM, V267, P2235, DOI 10.1046/j.1432-1327.2000.01226.x
   Bridgman PW., 1931, PHYS HIGH PRESSURE
   Brown P, 2003, P NATL ACAD SCI USA, V100, P6093, DOI 10.1073/pnas.1031826100
   Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768
   Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t
   Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4
   Caughey B, 2003, NAT MED, V9, P819, DOI 10.1038/nm0703-819
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200
   Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752
   Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200
   De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   DeGrado WF, 1999, ANNU REV BIOCHEM, V68, P779, DOI 10.1146/annurev.biochem.68.1.779
   Dobson CM, 2004, METHODS, V34, P4, DOI 10.1016/j.ymeth.2004.03.002
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   Edelhoch H, 1976, Adv Protein Chem, V30, P183, DOI 10.1016/S0065-3233(08)60480-5
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200
   Foguel D, 1996, P NATL ACAD SCI USA, V93, P10642, DOI 10.1073/pnas.93.20.10642
   Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020
   GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0
   GAJDUSEK DC, 1967, SCIENCE, V155, P212
   Garcia AF, 2005, J BIOL CHEM, V280, P9842, DOI 10.1074/jbc.M410679200
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   HILL CP, 1990, SCIENCE, V249, P543, DOI 10.1126/science.2382133
   HONIG BH, 1986, ANNU REV BIOPHYS BIO, V15, P163
   Inoue K, 2000, NAT STRUCT BIOL, V7, P547
   Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k
   Jansen R, 2004, J MOL BIOL, V338, P203, DOI 10.1016/j.jmb.2004.02.056
   Johansson JS, 1998, J AM CHEM SOC, V120, P3881, DOI 10.1021/ja973538m
   Kamatari YO, 2001, EUR J BIOCHEM, V268, P1782, DOI 10.1046/j.1432-1327.2001.02050.x
   Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X
   Kuwata K, 2004, BIOCHEMISTRY-US, V43, P4439, DOI 10.1021/bi036123o
   Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y
   Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x
   Lopes DHJ, 2004, J BIOL CHEM, V279, P10991, DOI 10.1074/jbc.M308174200
   Macario AJL, 1999, GENETICS, V152, P1277
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   MASTERTO.WL, 1968, J PHYS CHEM-US, V72, P4257, DOI 10.1021/j100858a053
   MASTERTON WL, 1954, J CHEM PHYS, V22, P1830, DOI 10.1063/1.1739928
   McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8
   Morais ACS, 2005, INT J BIOCHEM CELL B, V37, P1890, DOI 10.1016/j.biocel.2005.04.007
   Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587
   PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0
   PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Refaee M, 2003, J MOL BIOL, V327, P857, DOI 10.1016/S0022-2836(03)00209-2
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   Royer CA, 2002, BBA-PROTEIN STRUCT M, V1595, P201, DOI 10.1016/S0167-4838(01)00344-2
   Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627
   Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1
   Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007
   Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3
   Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5
   Suarez MC, 2001, BIOCHEMISTRY-US, V40, P1300, DOI 10.1021/bi0020978
   Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919
   Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d
   Torrent J, 2003, BIOCHEMISTRY-US, V42, P1318, DOI 10.1021/bi0269916
   Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940
   ZIPP A, 1973, BIOCHEMISTRY-US, V12, P4217, DOI 10.1021/bi00745a028
NR 72
TC 24
Z9 25
U1 0
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PY 2006
VL 44
IS 3
BP 539
EP 548
DI 10.1385/CBB:44:3:539
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 040TR
UT WOS:000237403800025
PM 16679542
DA 2020-09-29
ER

PT J
AU Vieira, MNN
   Figueroa-Villar, JD
   Meirelles, MNL
   Ferreira, ST
   De Felice, FG
AF Vieira, MNN
   Figueroa-Villar, JD
   Meirelles, MNL
   Ferreira, ST
   De Felice, FG
TI Small molecule inhibitors of lysozyme amyloid aggregation
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT 1st Latin-American-Protein-Society Meeting
CY NOV 08-12, 2004
CL Angra dos Reis, BRAZIL
SP Latin Amer Protein Soc
DE protein amyloid aggregation; beta-amyloid peptide; hen egg white
   lysozyme; systemic amyloidosis
ID HEREDITARY RENAL AMYLOIDOSIS; ALZHEIMERS-DISEASE; FIBRIL FORMATION;
   ALPHA-SYNUCLEIN; TISSUE-CULTURE; HEN LYSOZYME; IN-VIVO; PROTEIN;
   OLIGOMERS; THERAPY
AB Protein amyloid aggregation is associated with a number of important human pathologies, but the precise mechanisms underlying the toxicity of amyloid aggregates are still incompletely understood. In this context, drugs capable of blocking or interfering with the aggregation of amyloidogenic proteins should be considered in strategies aimed at the development of novel therapeutic agents. Human lysozyme variants have been shown to form massive amyloid deposits in the livers and kidneys of individuals affected by hereditary systemic amyloidosis. Currently, there are no clinical treatments available to prevent or reverse formation of such amyloid deposits. We have recently described a number of di- and trisubstituted aromatic compounds that block the formation of soluble oligomers and amyloid fibrils of the beta-amyloid peptide (A beta) and protect hippocampal neurons in culture from A beta-induced toxicity. Here, we show that some of those compounds inhibit the formation and disrupt preformed amyloid fibrils from both human and hen egg white lysozyme. These results suggest that these small molecule compounds may serve as prototypes for the development of drugs for the prevention or treatment of different types of amyloidoses.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.
   Inst Mil Engn, Dept Quim Organ, Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Ultraestrutura & Biol Celular, BR-21045900 Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Vieira,
   Marcelo/0000-0003-2178-9218
CR Buxbaum Joel N., 2004, Current Opinion in Rheumatology, V16, P67, DOI 10.1097/00002281-200401000-00013
   Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t
   Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com
   Chamberlain AK, 2000, BIOPHYS J, V79, P3282, DOI 10.1016/S0006-3495(00)76560-X
   Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kisilevsky R, 2004, AM J PATHOL, V164, P2127, DOI 10.1016/S0002-9440(10)63771-6
   Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862
   Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707
   Matagne A, 1998, CELL MOL LIFE SCI, V54, P363, DOI 10.1007/s000180050165
   Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264
   Noppe W, 1996, J CHROMATOGR A, V719, P327, DOI 10.1016/0021-9673(95)00677-X
   Ohnishi S, 2004, CELL MOL LIFE SCI, V61, P511, DOI 10.1007/s00018-003-3264-8
   PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0
   Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779
   Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101
   Sirangelo I, 2004, J BIOL CHEM, V279, P13183, DOI 10.1074/jbc.M308207200
   Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5
   Strynadka N C, 1996, EXS, V75, P185
   Valleix S, 2002, KIDNEY INT, V61, P907, DOI 10.1046/j.1523-1755.2002.00205.x
   Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174
   Yazaki M, 2003, KIDNEY INT, V63, P1652, DOI 10.1046/j.1523-1755.2003.00904.x
NR 31
TC 48
Z9 49
U1 0
U2 14
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PY 2006
VL 44
IS 3
BP 549
EP 553
DI 10.1385/CBB:44:3:549
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 040TR
UT WOS:000237403800026
PM 16679543
DA 2020-09-29
ER

PT J
AU Paula-Lima, AC
   De Felice, FG
   Brito-Moreira, J
   Ferreira, ST
AF Paula-Lima, AC
   De Felice, FG
   Brito-Moreira, J
   Ferreira, ST
TI Activation of GABA(A) receptors by taurine and muscimol blocks the
   neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons
SO NEUROPHARMACOLOGY
LA English
DT Article
DE beta-amyloid peptide; taurine; muscimol; GABA(A) receptor;
   neurotoxicity; hippocampal neurons; cortical neurons
ID EXCITATORY AMINO-ACIDS; KAINATE-INDUCED NEUROTOXICITY;
   BLOOD-BRAIN-BARRIER; SERUM-FREE MEDIUM; ALZHEIMERS-DISEASE; A RECEPTORS;
   GLUTAMATE ANTAGONIST; CALCIUM HOMEOSTASIS; SUBUNIT COMPOSITION; IN-VITRO
AB The beta-amyloid peptide (A beta) is centrally related to the pathogenesis of Alzheimer's disease (AD) and is potently neurotoxic to central nervous system neurons. The neurotoxicity of A beta has been partially related to the over activation of glutamatergic transmission and excitotoxicity. Taurine is a naturally occurring beta-amino acid present in the mammalian brain. Due to its safety and tolerability, taurine has been clinically used in humans in the treatment of a number of non-neurological disorders. Here, we show that micromolar doses of taurine block the neurotoxicity of A beta to rat hippocampal and cortical neurons in culture. Moreover, taurine also rescues central neurons from the excitotoxicity induced by high concentrations of extracellular glutamate. Neuroprotection by taurine is abrogated by picrotoxin, a GABA(A) receptor antagonist. GABA and muscimol, an agonist of the GABA(A) receptor, also block neuronal death induced by A beta in rat hippocampal and cortical neurons. These results suggest that activation of GABA(A) receptors protects neurons against A beta toxicity in AD-affected regions of the mammalian brain and that taurine should be investigated as a novel therapeutic tool in the treatment of AD and of other neurological disorders in which excitotoxicity plays a relevant role. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, Bloco H 2andar Sala 019, BR-21941590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Paula-Lima, Andrea C./I-2537-2013; Ferreira, Sergio/AAZ-1576-2020
OI Paula-Lima, Andrea C./0000-0002-0466-7561; Ferreira,
   Sergio/0000-0001-7160-9866
CR Angehagen M, 2003, EPILEPSY RES, V54, P63, DOI 10.1016/S0920-1211(03)00039-1
   ARIAS C, 1995, J NEUROSCI RES, V41, P561, DOI 10.1002/jnr.490410416
   BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F
   Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920
   BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762
   BENEDETTI MS, 1991, J NEURAL TRANSM-GEN, V86, P191, DOI 10.1007/BF01250705
   BENRABH H, 1995, BRAIN RES, V692, P57, DOI 10.1016/0006-8993(95)00648-A
   Bickler PE, 2003, ANESTH ANALG, V97, P564, DOI 10.1213/01.ANE.0000068880.82739.7B
   Birdsall T C, 1998, Altern Med Rev, V3, P128
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   CHOI DW, 1987, J NEUROSCI, V7, P357
   Csernansky JG, 1996, NEUROLOGY, V46, P1715, DOI 10.1212/WNL.46.6.1715
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   DEFEUDIS FV, 1980, NEUROCHEM RES, V5, P1047, DOI 10.1007/BF00966163
   del Olmo N, 2000, BRAIN RES, V864, P298, DOI 10.1016/S0006-8993(00)02211-3
   El Idrissi A, 1999, J NEUROSCI, V19, P9459
   FISZMAN ML, 1993, DEV BRAIN RES, V73, P243, DOI 10.1016/0165-3806(93)90144-Y
   FISZMAN ML, 1990, DEV BRAIN RES, V53, P186, DOI 10.1016/0165-3806(90)90005-J
   FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362
   French E D, 1986, Adv Exp Med Biol, V203, P349
   Grachev ID, 2001, J NEUROCHEM, V76, P582, DOI 10.1046/j.1471-4159.2001.00026.x
   Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x
   Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101
   HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1
   Kovacs AD, 2001, EXP NEUROL, V168, P47, DOI 10.1006/exnr.2000.7576
   KOWALL NW, 1992, NEUROBIOL AGING, V13, P537, DOI 10.1016/0197-4580(92)90053-Z
   Kristensen BW, 2003, BRAIN RES, V973, P303, DOI 10.1016/S0006-8993(03)02550-2
   Lapchak PA, 2000, STROKE, V31, P1953, DOI 10.1161/01.STR.31.8.1953
   LAUNDERBACK CM, 1999, LIFE SCI, V650, P1977
   Lima ACP, 2003, NEUROTOX RES, V5, P323, DOI 10.1007/BF03033152
   LIMA L, 1993, J NEUROCHEM, V60, P2153, DOI 10.1111/j.1471-4159.1993.tb03500.x
   Lima L, 1998, J NEUROSCI RES, V53, P377, DOI 10.1002/(SICI)1097-4547(19980801)53:3<377::AID-JNR12>3.0.CO;2-2
   LIPTON SA, 1994, NEW ENGL J MED, V330, P613
   Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com
   Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3
   LYDEN PD, 1994, STROKE, V25, P189, DOI 10.1161/01.STR.25.1.189
   Lyden PD, 2000, EXP NEUROL, V163, P477, DOI 10.1006/exnr.2000.7394
   MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569
   MacGregor DG, 1997, EXP NEUROL, V148, P110, DOI 10.1006/exnr.1997.6625
   MADDEN KP, 1994, STROKE, V25, P2271, DOI 10.1161/01.STR.25.11.2271
   Matsuyama Y, 1983, Prog Clin Biol Res, V125, P461
   MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9
   O'Byrne MB, 2000, J NEUROCHEM, V74, P2087, DOI 10.1046/j.1471-4159.2000.0742087.x
   Oja SS, 1996, METAB BRAIN DIS, V11, P153, DOI 10.1007/BF02069502
   OJA SS, 1983, HDB NEUROCHEMISTRY, V3, P501
   OKAMOTO K, 1983, BRAIN RES, V259, P319, DOI 10.1016/0006-8993(83)91266-0
   PASANTESMORALES H, 1987, NEUROPHARMACOLOGY, V26, P1721, DOI 10.1016/0028-3908(87)90123-7
   PERRY TL, 1981, NEUROLOGY, V31, P872, DOI 10.1212/WNL.31.7.872
   PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D
   PIKE CJ, 1993, J NEUROSCI, V13, P1676
   POMARA N, 1992, AM J PSYCHIAT, V149, P251
   SARANSAARI P, 1992, PROG NEUROBIOL, V38, P455, DOI 10.1016/0301-0082(92)90046-H
   Saransaari P, 1997, NEUROSCIENCE, V79, P847, DOI 10.1016/S0306-4522(97)00038-9
   SCHURR A, 1987, LIFE SCI, V40, P2059, DOI 10.1016/0024-3205(87)90098-1
   Schwartz-Bloom RD, 2000, NEUROSCIENCE, V98, P471, DOI 10.1016/S0306-4522(00)00144-5
   SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4
   Sommer C, 2003, ACTA NEUROPATHOL, V105, P197, DOI 10.1007/s00401-002-0632-7
   STURMAN JA, 1993, PHYSIOL REV, V73, P119
   TADOLINI B, 1995, BIOCHEM BIOPH RES CO, V213, P820, DOI 10.1006/bbrc.1995.2203
   Tsuji A, 1996, ADV EXP MED BIOL, V403, P385
   Velasco I, 2002, J NEUROSCI RES, V67, P406, DOI 10.1002/jnr.10114
   Velasco I, 2003, J NEUROSCI RES, V71, P811, DOI 10.1002/jnr.10538
   VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6
   Vignes M, 2001, NEUROPHARMACOLOGY, V40, P737, DOI 10.1016/S0028-3908(00)00213-6
   Wu H, 2005, BRAIN RES, V1038, P123, DOI 10.1016/j.brainres.2005.01.058
   Yu K, 2003, BRAIN RES, V960, P25, DOI 10.1016/S0006-8993(02)03736-8
   Zhao P, 1999, NEUROSCI LETT, V268, P25, DOI 10.1016/S0304-3940(99)00373-0
NR 70
TC 57
Z9 60
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3908
EI 1873-7064
J9 NEUROPHARMACOLOGY
JI Neuropharmacology
PD DEC
PY 2005
VL 49
IS 8
BP 1140
EP 1148
DI 10.1016/j.neuropharm.2005.06.015
PG 9
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 989SZ
UT WOS:000233695400005
PM 16150468
DA 2020-09-29
ER

PT J
AU Oliveira, MF
   Kycia, SW
   Gomez, A
   Kosar, AJ
   Bohle, DS
   Hempelmann, E
   Menezes, D
   Vannier-Santos, MA
   Oliveira, PL
   Ferreira, ST
AF Oliveira, MF
   Kycia, SW
   Gomez, A
   Kosar, AJ
   Bohle, DS
   Hempelmann, E
   Menezes, D
   Vannier-Santos, MA
   Oliveira, PL
   Ferreira, ST
TI Structural and morphological characterization of hemozoin produced by
   Schistosoma mansoni and Rhodhius prolixus
SO FEBS LETTERS
LA English
DT Article
DE hemozoin; heme; X-ray diffraction; Rhodnius prolixus; Schistosoma
   mansoni
ID BETA-HEMATIN; HEME DETOXIFICATION; PLASMODIUM HEMOZOIN; CATTLE TICK;
   POLYMERIZATION; MECHANISM; AGGREGATION; HAEMOZOIN; MEMBRANE; CRYSTALS
AB Hemozoin (Hz) is a heme crystal produced upon the digestion of hemoglobin (Hb) by blood-feeding organisms as a main mechanism of heme disposal. The structure of Hz consists of heme dimers bound by reciprocal iron-carboxylate interactions and stabilized by hydrogen bonds. We have recently described heme crystals in the blood fluke, Schistosoma mansoni, and in the kissing bug, Rhodnius prolixus. Here, we characterized the structures and morphologies of the heme crystals from those two organisms and compared them to synthetic P-hematin (beta H). Synchrotron radiation X-ray powder diffraction showed that all heme crystals share the same unit cell and structure. The heme crystals isolated from S. mansoni and R. prolixus consisted of very regular units assembled in multicrystalline spherical structures exhibiting remarkably distinct surface morphologies compared to beta H. In both organisms, Hz formation occurs inside lipid droplet-like particles or in close association to phospholipid membranes. These results show, for the first time, the structural and morphological characterization of natural Hz samples obtained from these two blood-feeding organisms. Moreover, Hz formation occurring in close association to a hydrophobic environment seems to be a common trend for these organisms and may be crucial to produce very regular shaped phases, allowing the formation of multicrystalline assemblies in the guts of S. mansoni and R. prolixus. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programas Biol Mol & Biotecnol Bioquim & Biofis, BR-21941590 Rio De Janeiro, Brazil.
   Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada.
   McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada.
   Univ Tubingen, Inst Trop Med, Dept Parasitol, Tubingen, Germany.
   Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Lab Nucl Luz Sincrotron, Campinas, SP, Brazil.
RP Oliveira, MF (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programas Biol Mol & Biotecnol Bioquim & Biofis, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
EM maroli@bioqmed.ufrj.br
RI Oliveira, Marcus/G-3158-2011; Ferreira, Sergio/AAZ-1576-2020;
   Vannier-Santos, Marcos A/L-3649-2013; Vannier-Santos,
   Marcos/G-5517-2012; Oliveira, Pedro/A-9438-2010
OI Oliveira, Marcus/0000-0002-9890-8425; Ferreira,
   Sergio/0000-0001-7160-9866; Vannier-Santos, Marcos/0000-0001-9241-2261;
   Oliveira, Pedro/0000-0003-0307-354X
CR BENDRAT K, 1995, NATURE, V378, P138, DOI 10.1038/378138a0
   Blauer G, 2002, ARCH BIOCHEM BIOPHYS, V398, P7, DOI 10.1006/abbi.2001.2638
   Bohle DS, 1997, J BIOL CHEM, V272, P713, DOI 10.1074/jbc.272.2.713
   BOHLE DS, 1993, BIOCHEM BIOPH RES CO, V193, P504, DOI 10.1006/bbrc.1993.1652
   Bohle DS, 2002, ACTA CRYSTALLOGR D, V58, P1752, DOI 10.1107/S0907444902014294
   Chen MM, 2001, MOL BIOCHEM PARASIT, V113, P1, DOI 10.1016/S0166-6851(00)00365-0
   CHOU AC, 1981, J CLIN INVEST, V68, P672, DOI 10.1172/JCI110302
   DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893
   DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0
   Dorn A, 1998, BIOCHEM PHARMACOL, V55, P737, DOI 10.1016/S0006-2952(97)00509-1
   Egan TJ, 2002, J INORG BIOCHEM, V91, P19, DOI 10.1016/S0162-0134(02)00372-0
   Egan TJ, 2001, BIOCHEMISTRY-US, V40, P204, DOI 10.1021/bi0013501
   Favre-Nicolin V, 2002, J APPL CRYSTALLOGR, V35, P734, DOI 10.1107/S0021889802015236
   Fitch CD, 1999, BBA-MOL BASIS DIS, V1454, P31, DOI 10.1016/S0925-4439(99)00017-4
   Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97
   GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988
   Hempelmann E, 2003, TRENDS PARASITOL, V19, P23, DOI 10.1016/S1471-4922(02)00011-9
   Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334
   Larson A. C., 2000, 86748 LAUR LOS AL NA
   LAUGIER J, Patent No. 4638042
   Lynn A, 1999, FEBS LETT, V459, P267, DOI 10.1016/S0014-5793(99)01260-0
   Maya-Monteiro CM, 2000, J BIOL CHEM, V275, P36584, DOI 10.1074/jbc.M007344200
   Noland GS, 2003, MOL BIOCHEM PARASIT, V130, P91, DOI 10.1016/S0166-6851(03)00163-4
   Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5
   Oliveira MF, 2004, J INFECT DIS, V190, P843, DOI 10.1086/422759
   Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910
   Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3
   Oliveira MF, 2000, MOL BIOCHEM PARASIT, V111, P217, DOI 10.1016/S0166-6851(00)00299-1
   Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132
   Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004
   Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3
   SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566
   Shirley R., 2002, CRYSFIRE 2002 SYSTEM
   SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325
   SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248
   SODEMAN TM, 1972, ANN TROP MED PARASIT, V66, P475, DOI 10.1080/00034983.1972.11686849
   Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5
   Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219
   Thomas-Keprta KL, 2001, P NATL ACAD SCI USA, V98, P2164, DOI 10.1073/pnas.051500898
   WOLFF PM, 1968, J APPL CRYSTALLOGR, V1, P108
NR 40
TC 91
Z9 91
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD NOV 7
PY 2005
VL 579
IS 27
BP 6010
EP 6016
DI 10.1016/j.febslet.2005.09.035
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 982KT
UT WOS:000233157800002
PM 16229843
DA 2020-09-29
ER

PT J
AU Wasilewska-Sampaio, AP
   Silveira, MS
   Holub, O
   Goecking, R
   Gomes, FCA
   Neto, VM
   Linden, R
   Ferreira, ST
   De Felice, FG
AF Wasilewska-Sampaio, AP
   Silveira, MS
   Holub, O
   Goecking, R
   Gomes, FCA
   Neto, VM
   Linden, R
   Ferreira, ST
   De Felice, FG
TI Neuritogenesis and neuronal differentiation promoted by
   2,4-dinitrophenol, a novel anti-amyloidogenic compound
SO FASEB JOURNAL
LA English
DT Article
DE DNP; central neurons; cAMP; neuritogenesis; tau; differentiation
ID MICROTUBULE-ASSOCIATED PROTEIN; NERVE GROWTH-FACTOR; TAU-ANTISENSE
   OLIGONUCLEOTIDES; SPINAL-CORD-INJURY; ALZHEIMERS-DISEASE; CYCLIC-AMP;
   PC12 CELLS; HIPPOCAMPAL-NEURONS; AXONAL REGENERATION; FUNCTIONAL
   RECOVERY
AB Neurite outgrowth is a critical event in neuronal development, formation, and remodeling of synapses, response to injury, and regeneration. We examined the effects of 2,4-dinitrophenol (DNP), a recently described blocker of the aggregation and neurotoxicity of the beta-amyloid peptide, on neurite elongation of central neurons. Morphometric analysis of rat embryo hippocampal and cortical neuronal cultures showed that neurite outgrowth was stimulated by DNP. This effect was accompanied by increases in the neuronal levels of the microtubule-associated protein tau and of cyclic adenosine 3',5' monophosphate (cAMP). DNP also promoted cAMP accumulation, increased tau level, neurite outgrowth, and neuronal differentiation in the mouse neuroblastoma cell line N2A. We show that DNP-induced differentiation requires activation of the extracellular signal-regulated kinase (ERK). The finding that DNP promotes neuritogenesis and neuronal differentiation suggests that, in addition to its anti-amyloidogenic actions, it may be a useful lead compound in the development of novel therapeutic approaches targeting neurite dystrophy and synaptic dysfunction in neurodegenerative pathologies such as Alzheimer's disease.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Anat, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Silveira, Mariana/M-4865-2013; Ferreira, Sergio/AAZ-1576-2020; Linden,
   Rafael/F-2275-2011; Moura-Neto, VIVALDO/V-9913-2019; Gomes,
   Flavia/C-5383-2013
OI Silveira, Mariana/0000-0002-0496-1517; Ferreira,
   Sergio/0000-0001-7160-9866; Linden, Rafael/0000-0003-3287-336X;
   Moura-Neto, VIVALDO/0000-0002-6266-043X; Gomes,
   Flavia/0000-0003-2966-0638
CR Ambrosini A, 2000, MOL BRAIN RES, V75, P54, DOI 10.1016/S0169-328X(99)00294-6
   Ammer H, 1997, NEUROSCI LETT, V230, P143, DOI 10.1016/S0304-3940(97)00495-3
   Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003
   AVILA J, 1994, INT J DEV BIOL, V38, P13
   Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439
   BLACK MM, 1994, PROG BRAIN RES, V102, P61
   BOTELHO LHP, 1988, J BIOL CHEM, V263, P5301
   BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   CACERES A, 1991, J NEUROSCI, V11, P1515
   CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0
   Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001
   Chalasani SH, 2003, J NEUROSCI, V23, P4601
   Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200
   CONRAD MJ, 1979, P NATL ACAD SCI USA, V76, P5202, DOI 10.1073/pnas.76.10.5202
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Dehmelt L, 2003, J NEUROSCI, V23, P9479
   DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141
   DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739
   FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407
   FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   GREENE LA, 1983, J CELL BIOL, V96, P76, DOI 10.1083/jcb.96.1.76
   HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916
   Heidemann SR, 1996, INT REV CYTOL, V165, P235, DOI 10.1016/S0074-7696(08)62224-X
   HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8
   HO PL, 1992, J CELL PHYSIOL, V150, P647, DOI 10.1002/jcp.1041500326
   Iida N, 2001, J NEUROSCI, V21, P6459
   Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004
   KAHN JS, 1964, ANAL BIOCHEM, V9, P389, DOI 10.1016/0003-2697(64)90198-8
   Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8
   LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012
   LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x
   Lin SL, 2003, J NEUROCHEM, V87, P1076, DOI 10.1046/j.1471-4159.2003.02076.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004
   MACCIONI RB, 1989, ARCH BIOCHEM BIOPHYS, V275, P568, DOI 10.1016/0003-9861(89)90403-7
   MATUS A, 1991, J CELL SCI, P61
   Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200
   Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6
   Moreno-Flores MT, 2003, J NEUROCHEM, V87, P879, DOI 10.1046/j.1471-4159.2003.02051.x
   Nakagawa S, 2002, J NEUROSCI, V22, P3673
   Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101
   Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595
   PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585
   Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056
   Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5
   QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2
   REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015
   Sanchez S, 2004, NEUROCHEM INT, V44, P231, DOI 10.1016/S0197-0186(03)00150-5
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Selkoe DJ, 2002, SCIENCE, V298, P963
   SILVEIRA MS, 2004, IN PRESS BRAIN REPAR
   Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515
   Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864
   Spencer T, 2004, J ANAT, V204, P49, DOI 10.1111/j.1469-7580.2004.00259.x
   Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200
   TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E
   Tuszynski MH, 2002, LANCET NEUROL, V1, P51, DOI 10.1016/S1474-4422(02)00006-6
   Tuszynski MH, 2004, PROG BRAIN RES, V146, P441
   WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858
   WU DK, 1983, J CYCLIC NUCL PROT, V9, P59
NR 65
TC 34
Z9 37
U1 0
U2 14
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD OCT
PY 2005
VL 19
IS 12
BP 1627
EP 1636
DI 10.1096/fj.05-3812com
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 980CI
UT WOS:000232991100040
PM 16195371
DA 2020-09-29
ER

PT J
AU Sebollela, A
   Cagliari, TC
   Limaverde, GSCS
   Chapeaurouge, A
   Sorgine, MHF
   Coelho-Sampaio, T
   Ramos, CHI
   Ferreira, ST
AF Sebollela, A
   Cagliari, TC
   Limaverde, GSCS
   Chapeaurouge, A
   Sorgine, MHF
   Coelho-Sampaio, T
   Ramos, CHI
   Ferreira, ST
TI Heparin-binding sites in granulocyte-macrophage colony-stimulating
   factor - Localization and regulation by histidine ionization
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FACTOR GM-CSF; GROWTH-FACTOR; SULFATE PROTEOGLYCANS; NERVE REGENERATION;
   MITOGENIC ACTIVITY; ESCHERICHIA-COLI; CELL-LINES; RECEPTOR; ACTIVATION;
   GLYCOSAMINOGLYCANS
AB The biological activity of granulocyte-macrophage colony-stimulating factor (GM-CSF) is modulated by the sulfated glycosaminoglycans (GAGs) heparan sulfate and heparin. However, the molecular mechanisms involved in such interactions are still not completely understood. We have proposed previously that helix C, one of the four alpha-helices of human GM-CSF (hGM-CSF), contains a GAG-binding site in which positively charged residues are spatially positioned for interaction with the sulfate moieties of the GAGs (Wettreich, A., Sebollela, A., Carvalho, M. A., Azevedo, S. P., Borojevic, R., Ferreira, S. T., and Coelho-Sampaio, T. (1999) J. Biol. Chem. 274, 31468-31475). Protonation of two histidine residues ( His(83) and His(87)) in helix C of hGM-CSF appears to act as a pH-dependent molecular switch to control the interaction with GAGs. Based on these findings, we have now generated a triple mutant form of murine GM-CSF (mGM-CSF) in which three noncharged residues in helix C of the murine factor (Tyr(83), Gln(85), and Tyr(87)) were replaced by the corresponding basic residues present in hGM-CSF (His(83), Lys(85), and His87). Binding assays on heparin-Sepharose showed that, at acidic pH, the triple mutant mGM-CSF binds to immobilized heparin with significantly higher affinity than wild type (WT) mGM-CSF and that neither protein binds to the column at neutral pH. The fact that even WT mGM-CSF binds to heparin at acidic pH indicates the existence of a distinct, lower affinity heparin-binding site in the protein. Chemical modification of the single histidine residue (His(15)) located in helix A of WT mGM-CSF with diethyl pyrocarbonate totally abolished binding to immobilized heparin. Moreover, replacement of His(15) for an alanine residue significantly reduced the affinity of mGM-CSF for heparin at pH 5.0 and completely blocked heparin binding to a synthetic peptide corresponding to helix A of GM-CSF. These results indicate a major role of histidine residues in the regulation of the binding of GM-CSF to GAGs, supporting the notion that an acidic microenvironment is required for GM-CSF-dependent regulation of target cells. In addition, our results provide insight into the molecular basis of the strict species specificity of the biological activity of GM-CSF.
C1 Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21940590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Lab Modelagem & Dinam Mol, Inst Biofis Carlos Chagas Filho, BR-21940590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embriol, BR-21940590 Rio De Janeiro, Brazil.
   UNICAMP, Dept Bioquim, Inst Biol, BR-13084971 Campinas, SP, Brazil.
   Fiocruz MS, Dept Fisiol & Farmacodinam, BR-21045900 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21940590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Ramos, CH/C-1571-2012; Sebollela,
   Adriano/O-4385-2014
OI Ferreira, Sergio/0000-0001-7160-9866; Ramos, CH/0000-0002-7246-9081;
   Sebollela, Adriano/0000-0002-7444-9156
CR AlvarezSilva M, 1996, J LEUKOCYTE BIOL, V59, P435
   ALVAREZSILVA M, 1993, J CELL SCI, V104, P477
   Arcanjo K, 2002, J CELL BIOCHEM, V87, P160, DOI 10.1002/jcb.10293
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934
   Borojevic R, 2003, CELL TISSUE RES, V313, P55, DOI 10.1007/s00441-003-0726-0
   BURGESS AW, 1987, BLOOD, V69, P43
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200
   Carvalho MA, 2000, BIOL CELL, V92, P605, DOI 10.1016/S0248-4900(01)01113-3
   D'Andrea RJ, 2000, EXP HEMATOL, V28, P231, DOI 10.1016/S0301-472X(99)00159-9
   DECRISTAN G, 1990, J CELL PHYSIOL, V144, P505
   DELAMARTER JF, 1985, EMBO J, V4, P2575, DOI 10.1002/j.1460-2075.1985.tb03973.x
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036
   Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276
   Freire E, 2002, J CELL SCI, V115, P4867, DOI 10.1242/jcs.00173
   Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI200113713
   Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868
   Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031
   Harmer NJ, 2003, BIOPHYS CHEM, V100, P545, DOI 10.1016/S0301-4622(02)00305-8
   HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   KAUSHANSKY K, 1988, J CLIN INVEST, V81, P92, DOI 10.1172/JCI113316
   LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q
   LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, P105
   MARGALIT H, 1993, J BIOL CHEM, V268, P19228
   MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524
   MEOTNER M, 1991, J AM CHEM SOC, V113, P4448, DOI 10.1021/ja00012a012
   METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028
   Miles E W, 1977, Methods Enzymol, V47, P431
   Modrowski D, 1998, J CELL PHYSIOL, V177, P187, DOI 10.1002/(SICI)1097-4652(199810)177:1<187::AID-JCP19>3.3.CO;2-O
   Modrowski D, 2000, J BIOL CHEM, V275, P9178, DOI 10.1074/jbc.275.13.9178
   Monfardini C, 2002, CURR PHARM DESIGN, V8, P2185, DOI 10.2174/1381612023393198
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8
   Sasaki T, 1999, EMBO J, V18, P6240, DOI 10.1093/emboj/18.22.6240
   Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3
   Schnaar RL, 2004, ARCH BIOCHEM BIOPHYS, V426, P163, DOI 10.1016/j.abb.2004.02.019
   SCHRIMSHER JL, 1987, BIOCHEM J, V247, P195, DOI 10.1042/bj2470195
   THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006
   Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8
   Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699
   WALTER MR, 1992, J MOL BIOL, V224, P1075, DOI 10.1016/0022-2836(92)90470-5
   WANG HM, 1991, BIOCHEM J, V278, P689, DOI 10.1042/bj2780689
   Wettreich A, 1999, J BIOL CHEM, V274, P31468, DOI 10.1074/jbc.274.44.31468
   WINGFIELD P, 1988, EUR J BIOCHEM, V173, P65, DOI 10.1111/j.1432-1033.1988.tb13967.x
NR 47
TC 34
Z9 35
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 9
PY 2005
VL 280
IS 36
BP 31949
EP 31956
DI 10.1074/jbc.M505314200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 961LZ
UT WOS:000231665200074
PM 16027123
OA Bronze
DA 2020-09-29
ER

PT J
AU Magdesian, MH
   Nery, AA
   Martins, AHB
   Juliano, MA
   Juliano, L
   Ulrich, H
   Ferreira, ST
AF Magdesian, MH
   Nery, AA
   Martins, AHB
   Juliano, MA
   Juliano, L
   Ulrich, H
   Ferreira, ST
TI Peptide blockers of the inhibition of neuronal nicotinic acetylcholine
   receptors by amyloid beta
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ALZHEIMERS-DISEASE; PROTEIN; IDENTIFICATION; BETA-AMYLOID(1-42);
   NEUROTOXICITY; GENERATION; BINDING
AB Alzheimer disease ( AD) is characterized by accumulation of the neurotoxic amyloid beta peptide ( A beta) and by the loss of cholinergic neurons and nicotinic acetylcholine receptors ( nAChRs) throughout the brain. Direct inhibition of nAChRs by A beta has also been suggested to contribute to cholinergic dysfunction in AD. In an effort to find ligands capable of blocking A beta- induced inhibition of nAChRs, we have screened a phage display library to identify peptides that bind to A beta. Using this approach, we identified a heptapeptide denoted IQ, which binds with nanomolar affinity to A beta and is homologous to the acetylcholine- binding protein and to most subtypes of nAChRs. Rapid kinetic whole- cell current- recording measurements showed that A beta inhibits nAChR function in a dose- dependent manner in neuronal differentiated PC12 cells and that nanomolar concentrations of IQ completely block the inhibition by A beta. These results indicate that the A beta binding site in nAChRs is homologous to the IQ peptide and that this is a relevant target for A beta neurotoxicity in AD and, more generally, for the regulation of nAChR function by soluble A beta in a physiological context. Furthermore, the results suggest that the IQ peptide may be a lead for the development of novel drugs to block the inhibition of nAChRs in AD.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, RJ, Brazil.
   Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Dept Biofis, BR-04044020 Sao Paulo, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Av Brigadeiro Trompowsky S-N,Bloco H Sala 19,CCS, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Ulrich, Henning/C-5245-2013; Juliano,
   Luiz/D-7204-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Ulrich,
   Henning/0000-0002-2114-3815; Juliano, Luiz/0000-0002-5589-2822
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0
   Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011
   Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1
   CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200
   Espinoza-Fonseca LM, 2004, BIOCHEM BIOPH RES CO, V320, P587, DOI 10.1016/j.bbrc.2004.05.207
   Grassi F, 2003, J PHYSIOL-LONDON, V547, P147, DOI 10.1113/jphysiol.2002.035436
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999
   Hess GP, 2003, BIOCHEMISTRY-US, V42, P6106, DOI 10.1021/bi020677u
   HO PL, 1992, J CELL PHYSIOL, V150, P647, DOI 10.1002/jcp.1041500326
   JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x
   Kang CK, 2003, NEUROBIOL DIS, V14, P146, DOI 10.1016/S0969-9961(03)00105-0
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1
   Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598
   Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com
   Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200
   Martin SE, 2004, BRAIN RES, V1022, P254, DOI 10.1016/j.brainres.2004.07.016
   MIRZABEKOV T, 1994, BIOCHEM BIOPH RES CO, V202, P1142, DOI 10.1006/bbrc.1994.2047
   Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2
   Nishiki T, 1997, BIOCHEM BIOPH RES CO, V239, P57, DOI 10.1006/bbrc.1997.7427
   Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741
   Stephan A, 2001, J NEUROSCI, V21, P5703
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Tozaki H, 2002, BIOCHEM BIOPH RES CO, V294, P42, DOI 10.1016/S0006-291X(02)00429-1
   UDGAONKAR JB, 1987, P NATL ACAD SCI USA, V84, P8758, DOI 10.1073/pnas.84.24.8758
   Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626
   Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631
   Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200
   Ye CP, 2004, NEUROSCI LETT, V366, P320, DOI 10.1016/j.neulet.2004.05.060
NR 34
TC 42
Z9 43
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 2
PY 2005
VL 280
IS 35
BP 31085
EP 31090
DI 10.1074/jbc.M502406200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 958ZX
UT WOS:000231487800053
PM 15987688
OA Bronze
DA 2020-09-29
ER

PT J
AU Morais, ACS
   Chapeaurouge, A
   Ferreira, ST
AF Morais, ACS
   Chapeaurouge, A
   Ferreira, ST
TI Acid- and pressure-induced (un)folding of yeast glutathione reductase:
   Competition between protein oligomerization and aggregation
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE glutathione reductase; pH; CD; fluorescence; hydrostatic pressure;
   aggregation
ID 3-HELIX BUNDLE PROTEIN; MOLTEN-GLOBULE; ALPHA-LACTALBUMIN;
   STAPHYLOCOCCAL NUCLEASE; HYDROSTATIC-PRESSURE; CRYSTAL-STRUCTURE; DIMER;
   DISSOCIATION; BINDING; ENZYME
AB Glutathione reductase (GR) is a homodimeric flavoenzyme involved in cellular defense against oxidative stress. In the present study, we have used a combination of acidic pH and hydrostatic pressure to investigate the (un)folding transition of yeast GR. Our results indicate that at pH 2 a distinct partially folded state is stabilized, as judged by intrinsic fluorescence, bis ANS binding and circular dichroism (CD) analysis. Further characterization of this partially folded state by size exclusion chromatography revealed that it corresponds to expanded GR monomers. CD analysis at pH 2 showed a significant loss of secondary structure. The partially folded GR monomers stabilized at pH 2 were fully and reversibly unfolded using hydrostatic pressure (up to 3.5 kbar) as a thermodynamic perturbant. By contrast, return to physiological pH after exposure to acidic pH led to a competing reaction between refolding dimerization and aggregation of GR. These results support the notion that a partially folded intermediate state is not only critical for folding of GR but also appears to tie a seed for protein aggregation. (C) 2005 Elsevier Ltd. All rights reserved.
C1 Fiocruz MS, Dept Fisiol & Farmacodinam, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21941590 Rio De Janeiro, Brazil.
RP Chapeaurouge, A (corresponding author), Fiocruz MS, Dept Fisiol & Farmacodinam, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
EM henk@ioc.fiocruz.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ARSCOTT LD, 1989, BIOCHEMISTRY-US, V28, P3591, DOI 10.1021/bi00434a066
   BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910
   Barteri M, 2000, BBA-PROTEIN STRUCT M, V1479, P255, DOI 10.1016/S0167-4838(00)00021-2
   BASHIR A, 1995, BIOCHEM J, V312, P527, DOI 10.1042/bj3120527
   Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   Christensen K, 2001, J BIOL CHEM, V276, P17044, DOI 10.1074/jbc.M100903200
   De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje
   FINK AL, 1995, ANNU REV BIOPH BIOM, V24, P495, DOI 10.1146/annurev.biophys.24.1.495
   Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020
   Gee AC, 2001, MOL ENDOCRINOL, V15, P421, DOI 10.1210/me.15.3.421
   KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4
   KIM J, 1986, BIOCHEMISTRY-US, V25, P7867, DOI 10.1021/bi00372a012
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   Lopes DHJ, 2004, J BIOL CHEM, V279, P10991, DOI 10.1074/jbc.M308174200
   Louzada PR, 2003, BIOPHYS J, V85, P3255, DOI 10.1016/S0006-3495(03)74743-2
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289
   NEWMANN RC, 1973, J PHYS CHEM-US, V77, P2687
   NORDHOFF A, 1993, BIOCHEMISTRY-US, V32, P4060, DOI 10.1021/bi00066a029
   Nordhoff A, 1997, EUR J BIOCHEM, V245, P273, DOI 10.1111/j.1432-1033.1997.00273.x
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Panick G, 1998, J MOL BIOL, V275, P389, DOI 10.1006/jmbi.1997.1454
   Rendon JL, 2001, ARCH BIOCHEM BIOPHYS, V387, P265, DOI 10.1006/abbi.2000.2230
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   Sarma GN, 2003, J MOL BIOL, V328, P893, DOI 10.1016/S0022-2836(03)00347-4
   Savvides SN, 2002, J BIOL CHEM, V277, P2779, DOI 10.1074/jbc.M108190200
   SCHULZ GE, 1978, NATURE, V273, P120, DOI 10.1038/273120a0
   SCRUTTON NS, 1992, SCIENCE, V258, P1140, DOI 10.1126/science.1439821
   Sebollela A, 2004, INT J BIOCHEM CELL B, V36, P900, DOI 10.1016/j.biocel.2003.10.006
   SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065
   Smeller L, 1999, BIOCHEMISTRY-US, V38, P3816, DOI 10.1021/bi981693n
   Surendran R, 2004, BIOPHYS CHEM, V108, P101, DOI 10.1016/j.bpc.2003.10.013
   Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388
   Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5
   Temussi PA, 2003, EMBO J, V22, P355, DOI 10.1093/emboj/cdg044
   Thompson AJ, 2002, CURR MED CHEM, V9, P1751
   Uversky VN, 1999, PROTEIN SCI, V8, P161
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
NR 42
TC 5
Z9 5
U1 1
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD SEP
PY 2005
VL 37
IS 9
BP 1890
EP 1899
DI 10.1016/j.biocel.2005.04.007
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 953TN
UT WOS:000231103500016
PM 15964778
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   Chapeaurouge, A
   De Felice, FG
AF Ferreira, ST
   Chapeaurouge, A
   De Felice, FG
TI Stabilization of partially folded states in protein folding/misfolding
   transitions by hydrostatic pressure
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on High Pressure Bioscience and
   Biotechnology
CY SEP 27-30, 2004
CL Rio de Janeiro, BRAZIL
DE high pressure; protein folding; misfolding; amyloid; aggregation
ID 3-HELIX BUNDLE PROTEIN; PARTIAL MOLAL VOLUMES; HUMAN LYSOZYME; PRION
   PROTEIN; DISEASE; AGGREGATION; DENATURATION; TRANSMISSION; ENERGETICS;
   DYNAMICS
AB In the last few years, hydrostatic pressure has been extensively used in the study of both protein folding and misfolding/aggregation. Compared to other chemical or physical denaturing agents, a unique feature of pressure is its ability to induce subtle changes in protein conformation, which allow the stabilization of partially folded intermediate states that are usually not significantly populated under more drastic conditions (e.g., in the presence of chemical denaturants or at high temperatures). Much of the recent research in the field of protein folding has focused on the characterization of folding intermediates since these species appear to be involved in a variety of disease-causing protein misfolding and aggregation events. The exact mechanisms of these biological phenomena, however, are still poorly understood. Here, we review recent examples of the use of hydrostatic pressure as a tool to obtain insight into the forces and energetics governing the productive folding or the misfolding and aggregation of proteins.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Fisiol & Farmacodinam, BR-21045900 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Alvarez-Martinez MT, 2003, BBA-PROTEINS PROTEOM, V1645, P228, DOI 10.1016/S1570-9639(02)00536-8
   BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801
   Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0
   Bridgman PW., 1931, PHYS HIGH PRESSURE
   Brown P, 2003, P NATL ACAD SCI USA, V100, P6093, DOI 10.1073/pnas.1031826100
   Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768
   Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t
   Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752
   Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200
   De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   DeGrado WF, 1999, ANNU REV BIOCHEM, V68, P779, DOI 10.1146/annurev.biochem.68.1.779
   Dobson CM, 2004, METHODS, V34, P4, DOI 10.1016/j.ymeth.2004.03.002
   Edelhoch H, 1976, Adv Protein Chem, V30, P183, DOI 10.1016/S0065-3233(08)60480-5
   Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361
   Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200
   Foguel D, 1996, P NATL ACAD SCI USA, V93, P10642, DOI 10.1073/pnas.93.20.10642
   Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020
   GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0
   GAJDUSEK DC, 1967, SCIENCE, V155, P212
   Garcia AF, 2005, J BIOL CHEM, V280, P9842, DOI 10.1074/jbc.M410679200
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   HILL CP, 1990, SCIENCE, V249, P543, DOI 10.1126/science.2382133
   HONIG BH, 1986, ANNU REV BIOPHYS BIO, V15, P163
   Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l
   Inoue K, 2000, NAT STRUCT BIOL, V7, P547
   Johansson JS, 1998, J AM CHEM SOC, V120, P3881, DOI 10.1021/ja973538m
   Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244
   Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X
   Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6
   Kuwata K, 2004, BIOCHEMISTRY-US, V43, P4439, DOI 10.1021/bi036123o
   Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y
   Lopes DHJ, 2004, J BIOL CHEM, V279, P10991, DOI 10.1074/jbc.M308174200
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   MASTERTO.WL, 1968, J PHYS CHEM-US, V72, P4257, DOI 10.1021/j100858a053
   MASTERTON WL, 1954, J CHEM PHYS, V22, P1830, DOI 10.1063/1.1739928
   Morais AC, 2005, INT J BIOCHEM CELL B, V37, P1386, DOI 10.1016/j.biocel.2005.01.008
   Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0
   PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   Saraiva MJM, 2003, AMYLOID, V10, P13
   Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1
   Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007
   Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3
   Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002
   Suarez MC, 2001, BIOCHEMISTRY-US, V40, P1300, DOI 10.1021/bi0020978
   Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d
   Torrent J, 2003, BIOCHEMISTRY-US, V42, P1318, DOI 10.1021/bi0269916
   Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940
   ZIPP A, 1973, BIOCHEMISTRY-US, V12, P4217, DOI 10.1021/bi00745a028
NR 57
TC 7
Z9 7
U1 0
U2 8
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD AUG
PY 2005
VL 38
IS 8
BP 1215
EP 1222
DI 10.1590/S0100-879X2005000800009
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 954OO
UT WOS:000231164600009
PM 16082462
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Morais, AC
   Feffeira, ST
AF Morais, AC
   Feffeira, ST
TI Folding and stability of a coiled-coil investigated using chemical and
   physical denaturing agents: Comparative analysis of polymerized and
   non-polymerized forms of alpha-tropomyosin
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE tropomyosin; CD; fluorescence; guanidine; urea
ID 3-HELIX BUNDLE PROTEIN; F-ACTIN; ESCHERICHIA-COLI; SKELETAL-MUSCLE;
   AMINO-TERMINUS; TROPONIN-T; PRESSURE; BINDING; OVERLAP; DESIGN
AB alpha-Tropomyosin (Tm) is a two-stranded alpha-helical coiled-coil protein, which participates in the regulation of muscle contraction. Unlike Tin purified from vertebrate muscle, recombinant Tin expressed in Escherichia coli is not acetylated at the N-terminal residue and loses the capacity to undergo head-to-tail polymerization, to bind actin and to inhibit actomyosin ATPase activity. These functions are restored by fusion of an N-terminal Ala-Ser (AS) dipeptide tail to recombinant Tin. Here, we have employed chemical (guanidine hydrochloride and urea) and physical (elevated hydrostatic pressures and low temperatures) denaturing agents to compare the structural stabilities of polymeric alanine-serine-tropomyosin (ASTm, containing the AS dipeptide) and dimeric "non-fusion" Tin (nfTm, i.e., not containing the AS dipeptide). Binding of the hydrophobic fluorescent dye bis-ANS, circular dichroism and size-exclusion chromatography were used to monitor the stabilities and state of association of both proteins under different solution conditions. Bis-ANS binding was markedly decreased at low concentrations (< 1 M) of GdnHCl or urea, whereas the secondary structures of both ASTm and nfTm were essentially unaffected in the same range of denaturant concentrations. These results suggest local unfolding of bis-ANS binding domains prior to global unfolding of Tm. In contrast, increased bis-ANS binding was observed when Tin was submitted to high pressures or to low temperatures, implying increased exposure of hydrophobic domains in the protein. Taken together, the different sensitivities of ASTm and nfTm to different denaturing agents support the notion that, at close to physiological conditions, head-to-tail interactions in polymerized ASTm are predominantly stabilized by electrostatic interactions between adjacent Tin dimers, whereas non-polar interactions appear to play a major role in the stability of the coiled-coil structure of individual Tm dimers. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Morais, AC (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR BRIDGMAN PW, 1931, PHYS HIGH PRESSURE, P233
   Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   CHO YJ, 1990, J BIOL CHEM, V265, P538
   CHO YJ, 1991, P NATL ACAD SCI USA, V88, P10153, DOI 10.1073/pnas.88.22.10153
   COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102
   COHEN C, 1957, J AM CHEM SOC, V79, P248, DOI 10.1021/ja01558a066
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   DABROWSKA R, 1983, J MUSCLE RES CELL M, V4, P143, DOI 10.1007/BF00712027
   FARAH CS, 1995, FASEB J, V9, P755
   Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   HEALD RW, 1988, J BIOL CHEM, V263, P5254
   HEELEY DH, 1989, J BIOL CHEM, V264, P2424
   HITCHCOCKDEGREGORI SE, 1987, J BIOL CHEM, V262, P9730
   ISHII Y, 1990, BIOCHEMISTRY-US, V29, P1160, DOI 10.1021/bi00457a010
   ISHII Y, 1994, EUR J BIOCHEM, V221, P705, DOI 10.1111/j.1432-1033.1994.tb18783.x
   LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, pCH11
   LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902
   LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377
   Lopes DHJ, 2004, J BIOL CHEM, V279, P10991, DOI 10.1074/jbc.M308174200
   LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042
   MAK AS, 1981, BIOCHEM BIOPH RES CO, V101, P208, DOI 10.1016/S0006-291X(81)80032-0
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   Martins SM, 2002, EUR J BIOCHEM, V269, P5484, DOI 10.1046/j.1432-1033.2002.03248.x
   Maytum R, 2000, BIOCHEMISTRY-US, V39, P11913, DOI 10.1021/bi000977g
   MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7
   MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2
   MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461
   Moraczewska J, 2000, BIOCHEMISTRY-US, V39, P6891, DOI 10.1021/bi000242b
   Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   NOVY RE, 1993, BIOCHIM BIOPHYS ACTA, V1162, P255, DOI 10.1016/0167-4838(93)90289-4
   OBRIEN EJ, 1971, PHILOS T ROY SOC B, V261, P201, DOI 10.1098/rstb.1971.0051
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3
   PAN BS, 1989, J BIOL CHEM, V264, P8495
   PARDEE JD, 1982, METHOD CELL BIOL, V24, P271
   PARRY DAD, 1975, J MOL BIOL, V98, P519, DOI 10.1016/S0022-2836(75)80084-2
   PATO MD, 1981, J BIOL CHEM, V256, P593
   PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7
   PITTENGER MF, 1995, J CELL SCI, V108, P3253
   PRIVALOV PL, 1992, PROTEIN FOLFING, P87
   REINACH FC, 1982, J CELL BIOL, V95, P78, DOI 10.1083/jcb.95.1.78
   ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006
   Sano K, 2000, J BIOCHEM-TOKYO, V127, P1095
   SMILLIE LB, 1979, TIBS, P151
   Sousa AD, 2002, J BIOL CHEM, V277, P2081, DOI 10.1074/jbc.M109568200
   Suarez MC, 2001, BIOCHEMISTRY-US, V40, P1300, DOI 10.1021/bi0020978
   URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310
   WILLADSEN KA, 1992, J BIOL CHEM, V267, P23746
NR 52
TC 5
Z9 9
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD JUL
PY 2005
VL 37
IS 7
BP 1386
EP 1395
DI 10.1016/j.biocel.2005.01.008
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 926ZG
UT WOS:000229161600007
PM 15833271
DA 2020-09-29
ER

PT J
AU Ramos, CHI
   Ferreira, ST
AF Ramos, CHI
   Ferreira, ST
TI Protein folding, misfolding and aggregation: Evolving concepts and
   conformational diseases
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Review
DE protein folding; misfolding; aggregation; amyloid; amyloidoses
ID TRANSMEMBRANE CONDUCTANCE REGULATOR; HIGH HYDROSTATIC-PRESSURE; 3-HELIX
   BUNDLE PROTEIN; TRANSITION-STATE; PRION PROTEIN; TRIOSEPHOSPHATE
   ISOMERASE; RIBONUCLEASE-A; HUMAN LYSOZYME; CHYMOTRYPSIN INHIBITOR-2;
   KINETIC INTERMEDIATE
AB Proteins carry out many vital cellular functions determined by their precise 3-dimensional structures (the native conformations). Understanding how proteins fold has long been a major goal and can be of great therapeutic value. Failure to reach or maintain the correct folded structure can have serious consequences, as in the conformational diseases. The ultimate goal of folding studies is to predict structure from sequence, allowing the design of new functional proteins and prevention of aberrant disease-associated conformations.
C1 Ctr Biol Mol Estrutural, Lab Nacl Luz Sincrotron, BR-13084971 Campinas, SP, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Ramos, CHI (corresponding author), Ctr Biol Mol Estrutural, Lab Nacl Luz Sincrotron, POB 6192, BR-13084971 Campinas, SP, Brazil.
EM cramos@lnls.br
RI Ferreira, Sergio/AAZ-1576-2020; Ramos, CH/C-1571-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Ramos, CH/0000-0002-7246-9081
CR ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029
   Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348
   ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309
   Aparicio R, 2003, J MOL BIOL, V334, P1023, DOI 10.1016/j.jmb.2003.10.022
   Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200
   Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000
   BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002
   Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0
   BALDWIN RL, 1995, J BIOMOL NMR, V5, P103
   Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2
   Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200
   Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552
   Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0
   BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302
   BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524
   Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9
   Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796
   Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768
   Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t
   Carrio MM, 2002, J BIOTECHNOL, V96, P3, DOI 10.1016/S0168-1656(02)00032-9
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   Chiti F, 1999, NAT STRUCT BIOL, V6, P1005
   Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752
   COHEN ALAN S., 1965, INT REV EXP PATHOL, V4, P159
   Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265
   CREIGHTON TE, 1974, J MOL BIOL, V87, P579, DOI 10.1016/0022-2836(74)90105-3
   Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9
   Dalal S, 1997, NAT STRUCT BIOL, V4, P548, DOI 10.1038/nsb0797-548
   Dalby PA, 1998, J MOL BIOL, V276, P625, DOI 10.1006/jmbi.1997.1546
   Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257
   De Armond S J, 1989, Prog Clin Biol Res, V317, P601
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   DEFELICE FG, 2004, IN PRESS FASEB J
   Denisov VP, 1999, NAT STRUCT BIOL, V6, P253, DOI 10.1038/6692
   DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0
   DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942
   DILL KA, 1985, BIOCHEMISTRY-US, V24, P1501, DOI 10.1021/bi00327a032
   DIVRY PAUL, 1927, JOUR NEUROL ET PSYCHIATR, V27, P643
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452
   Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739
   Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4
   GAREL JR, 1973, P NATL ACAD SCI USA, V70, P3347, DOI 10.1073/pnas.70.12.3347
   GINSBURG ANN, 1965, BIOCHEMISTRY, V4, P2159, DOI 10.1021/bi00886a033
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408
   Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5
   Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h
   IKAI A, 1973, J MOL BIOL, V73, P165, DOI 10.1016/0022-2836(73)90321-5
   IKAI A, 1971, NATURE, V230, P100, DOI 10.1038/230100a0
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010
   KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075
   Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244
   KARPLUS M, 1976, NATURE, V260, P404, DOI 10.1038/260404a0
   KAUZMANN W, 1954, MECHANISM ENZYME ACT, P70
   Kay MS, 1999, P NATL ACAD SCI USA, V96, P2007, DOI 10.1073/pnas.96.5.2007
   Kaya H, 2002, J MOL BIOL, V315, P899, DOI 10.1006/jmbi.2001.5266
   KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331
   Klimov DK, 2001, PROTEINS, V43, P465, DOI 10.1002/prot.1058
   Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   Laurents DV, 1998, J MOL BIOL, V283, P669, DOI 10.1006/jmbi.1998.2118
   Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928
   Levinthal C., 1969, MOSSBAUER SPECTROSCO, P22
   LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0
   Lilie H, 1998, CURR OPIN BIOTECH, V9, P497, DOI 10.1016/S0958-1669(98)80035-9
   Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907
   Lopes DHJ, 2004, J BIOL CHEM, V279, P10991, DOI 10.1074/jbc.M308174200
   LUMRY R, 1966, BIOPOLYMERS, V4, P917, DOI 10.1002/bip.1966.360040808
   Marmorino JL, 1998, J MOL BIOL, V275, P379, DOI 10.1006/jmbi.1997.1450
   Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814
   MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253
   MILLA ME, 1995, BIOCHEMISTRY-US, V34, P13914, DOI 10.1021/bi00042a024
   Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0
   Moreau VH, 2003, BIOCHEMISTRY-US, V42, P14831, DOI 10.1021/bi0343572
   Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264
   MOULT J, 1991, BIOCHEMISTRY-US, V30, P3816, DOI 10.1021/bi00230a003
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4
   OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6
   Olah J, 2002, BIOCHEM SOC T, V30, P30, DOI 10.1042/bst0300030
   OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422
   Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j
   Pace C N, 1986, Methods Enzymol, V131, P266
   PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0
   Plakoutsi G, 2004, J BIOL CHEM, V279, P14111, DOI 10.1074/jbc.M312961200
   Plaxco KW, 1999, NAT STRUCT BIOL, V6, P554
   Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645
   POHL FM, 1969, FEBS LETT, V3, P60, DOI 10.1016/0014-5793(69)80097-9
   PTITSYN OB, 1991, FEBS LETT, V285, P176, DOI 10.1016/0014-5793(91)80799-9
   RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0
   Ramos CHI, 2004, ARCH BIOCHEM BIOPHYS, V427, P135, DOI 10.1016/j.abb.2004.05.002
   Ramos CHI, 2004, BIOCHEM MOL BIOL EDU, V32, P31, DOI 10.1002/bmb.2004.494032010309
   Ramos CHI, 2002, PROTEIN SCI, V11, P1771, DOI 10.1110/ps.0205902
   Ramos CHI, 1999, BIOCHEMISTRY-US, V38, P9783, DOI 10.1021/bi9828627
   Randolph TW, 2002, BBA-PROTEIN STRUCT M, V1595, P224, DOI 10.1016/S0167-4838(01)00346-6
   Ribeiro EA, 2004, ANAL BIOCHEM, V329, P300, DOI 10.1016/j.ab.2004.01.016
   Ribeiro EA, 2003, PROTEIN EXPRES PURIF, V28, P202, DOI 10.1016/S1046-5928(02)00651-4
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0
   SACHS DH, 1972, P NATL ACAD SCI USA, V69, P3790, DOI 10.1073/pnas.69.12.3790
   SALI A, 1994, J MOL BIOL, V235, P1614, DOI 10.1006/jmbi.1994.1110
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Schlieker C, 2002, J BIOTECHNOL, V96, P13, DOI 10.1016/S0168-1656(02)00033-0
   Schonbrun J, 2003, P NATL ACAD SCI USA, V100, P12678, DOI 10.1073/pnas.1735417100
   Schubert U, 2000, NATURE, V404, P770
   SHAKHNOVICH E, 1991, PHYS REV LETT, V67, P1665, DOI 10.1103/PhysRevLett.67.1665
   SHAKHNOVICH E, 1998, FOLDING DESIGN, V3, P108
   Shea JE, 1999, P NATL ACAD SCI USA, V96, P12512, DOI 10.1073/pnas.96.22.12512
   Shortle D, 1996, FASEB J, V10, P27
   Simons KT, 1999, PROTEINS, P171
   SKOLNICK J, 1990, J MOL BIOL, V212, P787, DOI 10.1016/0022-2836(90)90237-G
   SOSNICK TR, 1994, NAT STRUCT BIOL, V1, P149, DOI 10.1038/nsb0394-149
   Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007
   Springsteel MF, 2003, BIOORGAN MED CHEM, V11, P4113, DOI 10.1016/S0968-0896(03)00435-8
   Spudich GM, 2004, J MOL BIOL, V335, P609, DOI 10.1016/j.jmb.2003.10.052
   Stirling PC, 2003, EMBO REP, V4, P565, DOI 10.1038/sj.embor.embor869
   TANFORD C, 1968, ADV PROTEIN CHEM, V23, P123
   TSONG TY, 1971, P NATL ACAD SCI USA, V68, P2712, DOI 10.1073/pnas.68.11.2712
   UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0
   Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6
   Uversky VN, 2002, FEBS LETT, V515, P79, DOI 10.1016/S0014-5793(02)02441-9
   Viguera AR, 1996, NAT STRUCT BIOL, V3, P874, DOI 10.1038/nsb1096-874
   VIRCHOW R, 1854, VIRCHOWS ARCH, V6, P415
   Wagner C, 1999, P NATL ACAD SCI USA, V96, P6716, DOI 10.1073/pnas.96.12.6716
   WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031
   WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697
   Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030
   Wildegger G, 1999, NAT STRUCT BIOL, V6, P550, DOI 10.1038/9323
   WRIGHT PE, 2000, MECH PROTEIN FOLDING, P309
   Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55
   Zaidi FN, 1997, NAT STRUCT BIOL, V4, P1016, DOI 10.1038/nsb1297-1016
   Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940
NR 142
TC 31
Z9 31
U1 1
U2 20
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD APR
PY 2005
VL 12
IS 3
BP 213
EP 222
DI 10.2174/0929866053587156
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 907TI
UT WOS:000227740500002
PM 15777268
DA 2020-09-29
ER

PT J
AU Torriani, IL
   Oliveira, CLP
   Gralle, M
   Ramos, CHI
   Ferreira, ST
AF Torriani, Iris L.
   Oliveira, Cristiano L. P.
   Gralle, Matthias
   Ramos, Carlos H. I.
   Ferreira, Sergio T.
TI Structural SAXS Studies of the Human Amyloid Precursor Protein
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE SAXS; human amyloid precursor protein; molecular model reconstruction
C1 [Torriani, Iris L.; Oliveira, Cristiano L. P.] Univ Estadual Campinas, IFGW, Campinas, SP, Brazil.
   [Torriani, Iris L.; Oliveira, Cristiano L. P.; Ramos, Carlos H. I.; Ferreira, Sergio T.] Lab Nacl Luz Sincrotron, Campinas, SP, Brazil.
   [Gralle, Matthias; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil.
EM torriani@ifi.unicamp.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   LNLS; CNPqNational Council for Scientific and Technological Development
   (CNPq)
FX FAPESP, LNLS, CNPq
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2005
VL 61
SU S
MA P.12.07.7
BP C412
EP C412
DI 10.1107/S0108767305082565
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3UX
UT WOS:000478085802209
OA Bronze
DA 2020-09-29
ER

PT J
AU Dahabada, HJL
   Colin, C
   Degaki, TL
   de Sousa, ACV
   Vieira, MNN
   Sebollela, A
   Martinez, AMB
   Bloch, C
   Ferreira, ST
   Sogayar, MC
AF Dahabada, HJL
   Colin, C
   Degaki, TL
   de Sousa, ACV
   Vieira, MNN
   Sebollela, A
   Martinez, AMB
   Bloch, C
   Ferreira, ST
   Sogayar, MC
TI Amyloidogenicity and cytotoxicity of recombinant mature human islet
   amyloid polypeptide (rhIAPP)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; IN-VITRO; GLUTATHIONE-REDUCTASE; EXPRESSION
   SYSTEM; ESCHERICHIA-COLI; AMYLIN; AGGREGATION; PEPTIDE; PROTEINS;
   TOXICITY
AB Pancreatic amyloid plaques formed by the pancreatic islet amyloid polypeptide ( IAPP) are present in more than 95% of type II diabetes mellitus patients, and their abundance correlates with the severity of the disease. IAPP is currently considered the most amyloidogenic peptide known, but the molecular bases of its aggregation are still incompletely understood. Detailed characterization of the mechanisms of amyloid formation requires large quantities of pure material. Thus, availability of recombinant IAPP in sufficient amounts for such studies constitutes an important step toward elucidation of the mechanisms of amyloidogenicity. Here, we report, for the first time, the successful expression, purification and characterization of the amyloidogenicity and cytotoxicity of recombinant human mature IAPP. This approach is likely to be useful for the production of other amyloidogenic peptides or proteins that are difficult to obtain by chemical synthesis.
C1 Univ Sao Paulo, Inst Quim, BR-05513970 Sao Paulo, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Cenargen EMBRAPA, Lab Espectrometria Massa, BR-70770900 Brasilia, DF, Brazil.
   LNLS, Lab Nacl Luz Sincrotron, BR-13084971 Campinas, SP, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embriol, BR-21941590 Rio De Janeiro, Brazil.
RP Sogayar, MC (corresponding author), Univ Sao Paulo, Inst Quim, BR-05513970 Sao Paulo, Brazil.
EM mcsoga@iq.usp.br
RI Bloch, Carlos/S-8375-2019; Sebollela, Adriano/O-4385-2014; Ferreira,
   Sergio/AAZ-1576-2020; Sogayar, Mari C/B-3980-2017; Martinez,
   Ana/C-6318-2014
OI Sebollela, Adriano/0000-0002-7444-9156; Ferreira,
   Sergio/0000-0001-7160-9866; Sogayar, Mari C/0000-0003-4805-4609; Vieira,
   Marcelo/0000-0003-2178-9218; Bloch Jr, Carlos/0000-0003-2799-6883
CR Badman MK, 1996, FEBS LETT, V378, P227, DOI 10.1016/0014-5793(95)01460-8
   BURDICK D, 1992, J BIOL CHEM, V267, P546
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   Cooper G J, 1989, Prog Growth Factor Res, V1, P99, DOI 10.1016/0955-2235(89)90004-5
   COOPER GJS, 1988, P NATL ACAD SCI USA, V85, P7763, DOI 10.1073/pnas.85.20.7763
   DOBELI H, 1995, BIO-TECHNOL, V13, P988, DOI 10.1038/nbt0995-988
   EDWARDS BJA, 1992, LIFE SCI, V51, P1899, DOI 10.1016/0024-3205(92)90106-Y
   Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200
   Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268
   Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858
   HAYDEN MR, 2001, J PANCREAS, V2, P129
   Higham CE, 2000, EUR J BIOCHEM, V267, P4998, DOI 10.1046/j.1432-1327.2000.01548.x
   Hollenbach B, 1999, PHILOS T ROY SOC B, V354, P991, DOI 10.1098/rstb.1999.0450
   Janciauskiene S, 1998, BIOCHEM BIOPH RES CO, V251, P888, DOI 10.1006/bbrc.1998.9574
   Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491
   Kapurniotu A, 2001, BIOPOLYMERS, V60, P438, DOI 10.1002/1097-0282(2001)60:6<438::AID-BIP10182>3.0.CO;2-A
   Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244
   Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646
   Krampert M, 2000, CHEM BIOL, V7, P855, DOI 10.1016/S1074-5521(00)00034-X
   KULIOPULOS A, 1994, J AM CHEM SOC, V116, P4599, DOI 10.1021/ja00090a008
   LaVallie Edward R, 2003, Methods Mol Biol, V205, P119
   LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187
   LaVallie ER, 2000, METHOD ENZYMOL, V326, P322
   LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881
   LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0
   Louzada PR, 2003, BIOPHYS J, V85, P3255, DOI 10.1016/S0006-3495(03)74743-2
   Mazor Y, 2002, J MOL BIOL, V322, P1013, DOI 10.1016/S0022-2836(02)00887-2
   Naiki H, 1996, LAB INVEST, V74, P374
   Nilsson MR, 2001, ANAL BIOCHEM, V288, P76, DOI 10.1006/abio.2000.4887
   Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462
   Ramos OHP, 2003, PROTEIN EXPRES PURIF, V28, P34, DOI 10.1016/S1046-5928(02)00644-7
   RENDON JL, 1995, ARCH BIOCHEM BIOPHYS, V318, P264, DOI 10.1006/abbi.1995.1229
   Rhoades E, 2000, BBA-PROTEIN STRUCT M, V1476, P230, DOI 10.1016/S0167-4838(99)00248-4
   ROBERTS AN, 1989, P NATL ACAD SCI USA, V86, P9662, DOI 10.1073/pnas.86.24.9662
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Soeller WC, 1998, DIABETES, V47, P743, DOI 10.2337/diabetes.47.5.743
   Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5
   STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z
   Ueda EKM, 2003, J CHROMATOGR A, V988, P1, DOI 10.1016/S0021-9673(02)02057-5
   Wang J, 2001, DIABETES, V50, P534, DOI 10.2337/diabetes.50.3.534
   WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881
   Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40
NR 44
TC 11
Z9 11
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 8
PY 2004
VL 279
IS 41
BP 42803
EP 42810
DI 10.1074/jbc.M406108200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 858XQ
UT WOS:000224226400056
PM 15292167
OA Bronze
DA 2020-09-29
ER

PT J
AU Rangel, A
   Saraiva, K
   Schwengber, P
   Narciso, MS
   Domont, GB
   Ferreira, ST
   Pedrosa, C
AF Rangel, A
   Saraiva, K
   Schwengber, P
   Narciso, MS
   Domont, GB
   Ferreira, ST
   Pedrosa, C
TI Biological evaluation of a protein isolate from cowpea (Vigna
   unguiculata) seeds
SO FOOD CHEMISTRY
LA English
DT Article
DE Vigna unguiculata; protein quality; cowpea seeds; protein isolate
ID 7S STORAGE GLOBULIN; PEA PISUM-SATIVUM; TRYPSIN-INHIBITOR ACTIVITY;
   BEANS PHASEOLUS-VULGARIS; RAT SMALL-INTESTINE; FUNCTIONAL-PROPERTIES;
   NUTRITIONAL-EVALUATION; CONVERSION FACTORS; LEGUME SEEDS; AMINO-ACIDS
AB The present work was carried out to determine the nutritive quality of a protein isolate from cowpea (Vigna unguiculata) seeds. Previous data from our laboratory showed that cowpea protein isolate (CPI) presents good functional properties, including solubility, emulsifying and foaming activities. In this work, rats were divided into three groups that received, during 16 days, liquid diets containing casein or CPI as protein sources or a protein-free diet. The nutritional parameters measured for the diet containing CPI showed a positive nitrogen balance (NB = 0.5), a net protein retention (NPR) of 0.7 and digestibility of 87/0. Furthermore, CPI did not present detectable hemagglutinating activity and very low trypsin inhibitory activity (18 TIU/mg protein) after heat treatment. In terms of its essential amino acid content, CPI presented a better composition than purified cowpea vicilin. No significant histological differences were found in several internal organs of the rats that were fed a diet containing CPI when compared to the group fed with a casein-containing diet. Taken together, these results suggest that CPI may provide a new, inexpensive source of protein for use as a potential functional and nutritional agent in the food industry. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Nutr, Dept Expt & Basic Nutr, BR-21944590 Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Dept Biochem Med, BR-21944590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biomed Sci, Dept Histol & Embriol, BR-21944590 Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Pedrosa, C (corresponding author), Univ Fed Rio de Janeiro, Inst Nutr, Dept Expt & Basic Nutr, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM chana@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Alonso R, 1998, FOOD CHEM, V63, P505, DOI 10.1016/S0308-8146(98)00037-5
   Alonso R, 2000, J SCI FOOD AGR, V80, P397, DOI 10.1002/(SICI)1097-0010(200002)80:3<397::AID-JSFA542>3.0.CO;2-3
   AOAC, 1990, OFF METH AN, P2
   Armour JC, 1998, J SCI FOOD AGR, V78, P225, DOI 10.1002/(SICI)1097-0010(199810)78:2&lt;225::AID-JSFA109&gt;3.0.CO;2-1
   BANIEL A, 1992, J AGR FOOD CHEM, V40, P200, DOI 10.1021/jf00014a007
   BARDOCZ S, 1990, DIGESTION, V46, P360, DOI 10.1159/000200409
   BENDER AE, 1957, BIOL EVALUATION PROT
   DOMONEY C, 1985, NUCLEIC ACIDS RES, V13, P687, DOI 10.1093/nar/13.3.687
   ELKOWICZ K, 1982, J FOOD SCI, V47, P1301, DOI 10.1111/j.1365-2621.1982.tb07673.x
   Ezeagu IE, 2002, FOOD CHEM, V78, P105, DOI 10.1016/S0308-8146(02)00105-X
   *FAO, 1980, 26 FAOUN
   *FAO WHO, 1991, FOOD AGR ORG UN
   *FAO WHO UNO, 1985, TECHN REP SER, V724
   Gallaher D., 1984, Nutritional and toxicological aspects of food safety., P299
   GATEHOUSE JA, 1983, BIOCHEM J, V212, P427, DOI 10.1042/bj2120427
   GRANT G, 1995, BRIT J NUTR, V73, P17, DOI 10.1079/BJN19950005
   GRANT G, 1999, 2 PLANT PRODUCTS ANT, P71
   GRANT G, 1987, IRCS MED SCI RES BIO, V15, P1355
   GUMBMANN MR, 1986, NUTR TOXICOLOGICAL S, P33
   HANKINS CN, 1978, J BIOL CHEM, V253, P7791
   HIGUCHI M, 1983, AGR BIOL CHEM TOKYO, V47, P1879, DOI 10.1080/00021369.1983.10865872
   ISHIGURO M, 1992, CHEM PHARM BULL, V40, P441, DOI 10.1248/cpb.40.441
   JAFFE WG, 1950, P SOC EXP BIOL MED, V75, P219, DOI 10.3181/00379727-75-18150
   JINDAL S, 1984, NUTR REP INT, V29, P95
   KAKADE ML, 1974, CEREAL CHEM, V51, P376
   LIENER IE, 1994, CRIT REV FOOD SCI, V34, P31, DOI 10.1080/10408399409527649
   LIENER IE, 1976, J FOOD SCI, V41, P1076, DOI 10.1111/j.1365-2621.1976.tb14391.x
   LIENER IE, 1953, J NUTR, V49, P527
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYNCH CJ, 1977, J SCI FOOD AGR, V28, P971, DOI 10.1002/jsfa.2740281104
   MCGUINNESS EE, 1984, ENVIRON HEALTH PERSP, V56, P205, DOI 10.2307/3429846
   MOSSE J, 1990, J AGR FOOD CHEM, V38, P18, DOI 10.1021/jf00091a004
   MURRAY DR, 1984, SEED PHYSL, V1, P83
   Mwanjala A.M., 1999, FOOD CHEM, V67, P435
   NTI CA, 1996, FOOD CONTROL, V3, P129
   OKEZIE BO, 1988, J FOOD SCI, V53, P450, DOI 10.1111/j.1365-2621.1988.tb07728.x
   Onwuliri VA, 2002, FOOD CHEM, V78, P1, DOI 10.1016/S0308-8146(00)00293-4
   Oser B. L., 1959, PROTEIN AMINO ACID N, P295
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   PAREDESLOPEZ O, 1991, J FOOD SCI, V56, P726, DOI 10.1111/j.1365-2621.1991.tb05367.x
   Pedrosa C, 1997, J AGR FOOD CHEM, V45, P2025, DOI 10.1021/jf960815k
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   Pedrosa C, 2000, ARCH BIOCHEM BIOPHYS, V382, P203, DOI 10.1006/abbi.2000.2024
   PHILLIPS RD, 1987, J FOOD SCI, V52, P696, DOI 10.1111/j.1365-2621.1987.tb06705.x
   PROLL J, 1998, AM SOC NUTR SCI, P2014
   PUSZTAI A, 1990, DIGESTION, V46, P308, DOI 10.1159/000200402
   REEVES PG, 1993, J NUTR, V123, P1939
   RUBIO LA, 1991, BRIT J NUTR, V66, P533, DOI 10.1079/BJN19910053
   SATHE SK, 1981, J FOOD SCI, V46, P626, DOI 10.1111/j.1365-2621.1981.tb04926.x
   Seabra M, 2001, ANIM FEED SCI TECH, V89, P1, DOI 10.1016/S0377-8401(00)00230-3
   SGARBIERI VC, 1996, PROTEINAS ALIMENTOS
   Siddhuraju P, 1996, FOOD CHEM, V57, P385, DOI 10.1016/0308-8146(95)00238-3
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   STEINKE FH, 1980, J FOOD SCI, V45, P323, DOI 10.1111/j.1365-2621.1980.tb02606.x
   THOMPSON LU, 1986, J FOOD SCI, V51, P150, DOI 10.1111/j.1365-2621.1986.tb10857.x
   Udedibie ABI, 1998, ANIM FEED SCI TECH, V74, P179, DOI 10.1016/S0377-8401(98)00160-6
   VOSE JR, 1980, CEREAL CHEM, V57, P406
   WAGGLE DH, 1989, LEGUMES CHEM TECHNOL
   YEOH HH, 1994, FOOD CHEM, V49, P245, DOI 10.1016/0308-8146(94)90167-8
   Zarkadas CG, 1997, J AGR FOOD CHEM, V45, P1161, DOI 10.1021/jf9604201
NR 60
TC 33
Z9 38
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD OCT
PY 2004
VL 87
IS 4
BP 491
EP 499
DI 10.1016/j.foodchem.2003.12.023
PG 9
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 833YH
UT WOS:000222377100002
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Vieira, MNN
   Saraiva, LM
   Figueroa-Villar, JD
   Garcia-Abreu, J
   Liu, R
   Chang, L
   Klein, WL
   Ferreira, ST
AF De Felice, FG
   Vieira, MNN
   Saraiva, LM
   Figueroa-Villar, JD
   Garcia-Abreu, J
   Liu, R
   Chang, L
   Klein, WL
   Ferreira, ST
TI Targeting the neurotoxic species in Alzheimer's disease: inhibitors of A
   beta oligomerization
SO FASEB JOURNAL
LA English
DT Article
DE amyloid; oligomers; neuroprotection; small molecule inhibitors
ID LONG-TERM POTENTIATION; REVERSIBLE MEMORY LOSS; FIBRILS IN-VITRO;
   AMYLOID-BETA; NERVOUS-SYSTEM; PROTEIN; MODEL; NEURODEGENERATION;
   IMMUNIZATION; AGGREGATION
AB In the past two decades, a large body of evidence has established a causative role for the beta-amyloid peptide (Abeta) in Alzheimer's disease (AD). However, recent debate has focused on whether amyloid fibrils or soluble oligomers of Abeta are the main neurotoxic species that contribute to neurodegeneration and dementia. Considerable early evidence has indicated that amyloid fibrils are toxic, but some recent studies support the notion that Abeta oligomers are the primary neurotoxins. While this crucial aspect of AD pathogenesis remains controversial, effective therapeutic strategies should ideally target both oligomeric and fibrillar species of Abeta. Here, we describe the anti-amyloidogenic and neuroprotective actions of some di- and tri-substituted aromatic compounds. Inhibition of the formation of soluble Abeta oligomers was monitored using a specific antibody-based assay that discriminates between Abeta oligomers and monomers. Thioflavin T and electron microscopy were used to screen for inhibitors of fibril formation. Taken together, these results led to the identification of compounds that more effectively block Abeta oligomerization than fibrillization. It is significant that such compounds completely blocked the neurotoxicity of Abeta to rat hippocampal neurons in culture. These findings provide a basis for the development of novel small molecule Abeta inhibitors with potential applications in AD.
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, Inst Ciencias Biomed, BR-21944590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Anat, Inst Ciencias Biomed, BR-21944590 Rio De Janeiro, Brazil.
   Inst Mil Engn, Dept Quim Organ, Rio De Janeiro, Brazil.
   Northwestern Univ, Dept Neurobiol & Physiol, Cognit Neurol & Alzheimers Dis Ctr, Inst Neurosci, Evanston, IL USA.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, Inst Ciencias Biomed, BR-21944590 Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br; ferreira@bioqmed.ufrj.br
RI Abreu, Jose GR/G-6159-2010; Saraiva, Ligia/H-8537-2012; Ferreira,
   Sergio/AAZ-1576-2020
OI Abreu, Jose GR/0000-0002-9875-7786; Saraiva, Ligia/0000-0002-0675-129X;
   Ferreira, Sergio/0000-0001-7160-9866
CR Birmingham K, 2002, NAT MED, V8, P199, DOI 10.1038/nm0302-199b
   Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com
   Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142
   Chang L, 2003, J MOL NEUROSCI, V20, P305, DOI 10.1385/JMN:20:3:305
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5
   Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842
   Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Grace EA, 2002, NEUROSCIENCE, V114, P265, DOI 10.1016/S0306-4522(02)00241-5
   Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916
   Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   KIM HJ, 2003, FASEB J, V17, P118
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998
   Kotilinek LA, 2002, J NEUROSCI, V22, P6331
   Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200
   Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje
   Lin SJ, 2004, BIOORG MED CHEM LETT, V14, P1173, DOI 10.1016/j.bmcl.2003.12.086
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116
   Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025
   PIKE CJ, 1993, J NEUROSCI, V13, P1676
   Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779
   Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002
   Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977
   Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739
NR 42
TC 152
Z9 155
U1 0
U2 25
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD SEP
PY 2004
VL 18
IS 12
BP 1366
EP 1372
DI 10.1096/fj.04-1764com
PG 7
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 859DQ
UT WOS:000224243200055
PM 15333579
DA 2020-09-29
ER

PT J
AU Oliveira, MF
   d'Avila, JCP
   Tempone, AJ
   Soares, JBRC
   Rumjanek, FD
   Ferreira-Pereira, A
   Ferreira, ST
   Oliveira, PL
AF Oliveira, MF
   d'Avila, JCP
   Tempone, AJ
   Soares, JBRC
   Rumjanek, FD
   Ferreira-Pereira, A
   Ferreira, ST
   Oliveira, PL
TI Inhibition of heme aggregation by chloroquine reduces Schistosoma
   mansoni infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT 9th international Symposium on Schistosomiasis
CY NOV 02-05, 2003
CL Salvador, BRAZIL
ID FERRIPROTOPORPHYRIN-IX; BETA-HEMATIN; PLASMODIUM HEMOZOIN; MALARIA
   PIGMENT; POLYMERIZATION; RESISTANCE; HAEMOZOIN; PRAZIQUANTEL;
   ANTIMALARIAL; CHEMOTHERAPY
AB Adult Schistosoma mansoni digest large amounts of host hemoglobin and release potentially toxic heme inside their guts. We have previously demonstrated that free heme in S. mansoni is detoxified through aggregation, forming hemozoin (Hz). Possible mechanisms of heme aggregation and the effects of chloroquine (CLQ) on formation of Hz and on the viability of this parasite have now been investigated. Different fractions isolated from S. mansoni, such as crude whole-worm homogenates, total lipid extracts, and Hz itself promoted heme aggregation in vitro in a CLQ-sensitive manner. Treatment of S. mansoni-infected mice with CLQ led to remarkable decreases in total protein, Hz content, and viability of the worms, as well as in parasitemia and deposition of eggs in mouse livers. These results indicate that inhibition of formation of Hz in S. mansoni, by CLQ, led to an important decrease in the overall severity of experimental murine schistosomiasis. Taken together, the results presented here suggest that formation of Hz is a major mechanism of heme detoxification and a potential target for chemotherapy in S. mansoni.
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, Dept Microbiol Geral, Rio De Janeiro, Brazil.
RP Oliveira, MF (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
EM maroli@bioqmed.ufrj.br
RI Oliveira, Marcus/G-3158-2011; Tempone, Antonio J/E-5118-2011;
   Ferreira-Pereira, Antonio/A-2910-2011; d'Avila, Joana/L-8970-2013;
   Ferreira, Sergio/AAZ-1576-2020; Oliveira, Pedro/A-9438-2010
OI Oliveira, Marcus/0000-0002-9890-8425; Ferreira-Pereira,
   Antonio/0000-0002-0474-8388; d'Avila, Joana/0000-0002-2045-0813;
   Ferreira, Sergio/0000-0001-7160-9866; Oliveira,
   Pedro/0000-0003-0307-354X; Rumjanek, Franklin/0000-0002-6618-7096
CR AFT RL, 1983, J BIOL CHEM, V258, P2069
   AMADOR E, 1962, CLIN CHEM, V8, P343
   BENDRAT K, 1995, NATURE, V378, P138, DOI 10.1038/378138a0
   BOGITSH BJ, 1991, J PARASITOL, V77, P187, DOI 10.2307/3283078
   Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4
   BRUCKSTEIN AH, 1987, POSTGRAD MED, V82, P143, DOI 10.1080/00325481.1987.11699957
   CHEEVER A W, 1968, Bulletin of the World Health Organization, V39, P328
   Chen MM, 2001, MOL BIOCHEM PARASIT, V113, P1, DOI 10.1016/S0166-6851(00)00365-0
   CHOU AC, 1980, J CLIN INVEST, V66, P856, DOI 10.1172/JCI109925
   CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600
   Cioli D, 1998, PARASITOL TODAY, V14, P418, DOI 10.1016/S0169-4758(98)01323-4
   CIOLI D, 1993, PARASITOL TODAY, V9, P162, DOI 10.1016/0169-4758(93)90138-6
   COHEN SN, 1964, NATURE, V202, P805, DOI 10.1038/202805a0
   COLLEY DG, 1974, EXP PARASITOL, V35, P44, DOI 10.1016/0014-4894(74)90005-8
   Doenhoff MJ, 2002, T ROY SOC TROP MED H, V96, P465, DOI 10.1016/S0035-9203(02)90405-0
   DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0
   Dorn A, 1998, BIOCHEM PHARMACOL, V55, P737, DOI 10.1016/S0006-2952(97)00509-1
   ELSLAGER EF, 1969, J MED CHEM, V12, P970, DOI 10.1021/jm00306a002
   Fitch CD, 1999, BBA-MOL BASIS DIS, V1454, P31, DOI 10.1016/S0925-4439(99)00017-4
   GINSBURG H, 1983, BIOCHIM BIOPHYS ACTA, V732, P316, DOI 10.1016/0005-2736(83)90219-5
   Hempelmann E, 2003, TRENDS PARASITOL, V19, P23, DOI 10.1016/S1471-4922(02)00011-9
   HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0
   HOMEWOOD CA, 1972, COMP BIOCHEM PHYSIOL, V43, P517, DOI 10.1016/0305-0491(72)90135-6
   Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236
   Ismail M, 1996, AM J TROP MED HYG, V55, P214, DOI 10.4269/ajtmh.1996.55.214
   KLOETZEL K, 1966, AM J TROP MED HYG, V15, P28, DOI 10.4269/ajtmh.1966.15.28
   Kusel J, 1999, PARASITOL TODAY, V15, P352, DOI 10.1016/S0169-4758(99)01510-0
   LAWRENCE JD, 1973, J PARASITOL, V59, P60, DOI 10.2307/3278572
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NARE B, 1991, BIOCHEM PHARMACOL, V42, P1287, DOI 10.1016/0006-2952(91)90267-9
   O'Neill PM, 1998, PHARMACOL THERAPEUT, V77, P29, DOI 10.1016/S0163-7258(97)00084-3
   Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5
   Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910
   Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3
   Oliveira MF, 2000, MOL BIOCHEM PARASIT, V111, P217, DOI 10.1016/S0166-6851(00)00299-1
   Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132
   Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004
   Ridley RG, 1997, ANN TROP MED PARASIT, V91, P559, DOI 10.1080/00034989760932
   Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3
   SCHOENFELD C, 1974, EXP PARASITOL, V36, P265, DOI 10.1016/0014-4894(74)90066-6
   SHUHUA X, 1989, ANTIMICROB AGENTS CH, V33, P1557, DOI 10.1128/AAC.33.9.1557
   SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325
   SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0
   SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248
   Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219
   Utzinger J, 2000, LANCET, V355, P1320, DOI 10.1016/S0140-6736(00)02114-0
   Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237
   VINCENT SH, 1989, SEMIN HEMATOL, V26, P105
NR 48
TC 60
Z9 62
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2004
VL 190
IS 4
BP 843
EP 852
DI 10.1086/422759
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 841CP
UT WOS:000222907200024
PM 15272414
OA Green Published
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Vieira, MNN
   Meirelles, MNL
   Morozova-Roche, LA
   Dobson, CM
   Ferreira, ST
AF De Felice, FG
   Vieira, MNN
   Meirelles, MNL
   Morozova-Roche, LA
   Dobson, CM
   Ferreira, ST
TI Formation of amyloid aggregates from human lysozyme and its
   disease-associated variants using hydrostatic pressure
SO FASEB JOURNAL
LA English
DT Article
DE systemic amyloidosis; high pressure; oligomers; protofibrils; fibrils
ID FIBRIL FORMATION; EQUINE LYSOZYME; HIGH-RESOLUTION; WILD-TYPE; PROTEIN;
   TRANSTHYRETIN; NEUROTOXICITY; PROTOFIBRILS; DISSOCIATION; PORES
AB Formation of amyloid deposits from the Ile56Thr or Asp67His variants of human lysozyme is a hallmark of autosomal hereditary systemic amyloidosis. It has recently been shown that amyloid fibrils can be formed in vitro from wild-type (WT), I56T, or D67H lysozyme variants upon prolonged incubation at acidic pH and elevated temperatures ( 1). Here, we have used hydrostatic pressure as a tool to generate amyloidogenic states of WT and variant lysozymes at physiological pH. WT or variant lysozyme samples were initially compressed to 3.5 kbar ( at 57degreesC, pH 7.4). Decompression led to the formation of amyloid fibrils, protofibrils, or globular aggregates, as indicated by light scattering, thioflavin T fluorescence, and transmission electron microscopy analysis. Increased 1-anilinonaphthalene-8-sulfonate binding to the proteins was also observed, indicating exposure of hydrophobic surface area. Thus, pressure appears to induce a conformational state of lysozyme that aggregates readily upon decompression. These results support the notion that amyloid aggregation results from the formation of partially unfolded protein conformations and suggest that pressure may be a useful tool for the generation of the amyloidogenic conformations of lysozyme and other proteins.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Ultraestrutura & Biol Celular, BR-21045900 Rio De Janeiro, Brazil.
   Umea Univ, Dept Med Biochem & Biophys, SE-90741 Umea, Sweden.
   Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Vieira,
   Marcelo/0000-0003-2178-9218; Morozova-Roche, Ludmilla
   A./0000-0001-5886-2023
CR Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0
   Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768
   Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t
   CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589
   Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com
   Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142
   Chamberlain AK, 2001, PROTEIN SCI, V10, P2525, DOI 10.1110/ps.ps.28101
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752
   CHRYSSOMALLIS GS, 1981, BIOCHEMISTRY-US, V20, P3955, DOI 10.1021/bi00517a002
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013
   Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758
   ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589
   Jonas J, 1998, BIOPHYS J, V75, P445, DOI 10.1016/S0006-3495(98)77532-0
   JONAS J, 1994, ANNU REV BIOPH BIOM, V23, P287, DOI 10.1146/annurev.bb.23.060194.001443
   Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244
   Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6
   Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a
   Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Malisauskas M, 2003, J MOL BIOL, V330, P879, DOI 10.1016/S0022-2836(03)00551-5
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   Nash DP, 1997, BIOCHEMISTRY-US, V36, P14375, DOI 10.1021/bi970881v
   Noppe W, 1996, J CHROMATOGR A, V719, P327, DOI 10.1016/0021-9673(95)00677-X
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0
   Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5
   SAMARASINGHE SD, 1992, BIOCHEMISTRY-US, V31, P7773, DOI 10.1021/bi00149a005
   Sasahara K, 2001, PROTEINS, V44, P180, DOI 10.1002/prot.1083
   SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503
   Spencer A, 1999, PROTEIN EXPRES PURIF, V16, P171, DOI 10.1006/prep.1999.1036
   TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x
   Webb JN, 2000, BIOTECHNOL PROGR, V16, P630, DOI 10.1021/bp0000499
   WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031
   Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4
   Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739
NR 50
TC 61
Z9 61
U1 0
U2 18
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAY
PY 2004
VL 18
IS 7
BP 1099
EP +
DI 10.1096/fj.03-1072fje
PG 15
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 827EZ
UT WOS:000221883200003
PM 15155566
DA 2020-09-29
ER

PT J
AU Sebollela, A
   Louzada, PR
   Sola-Penna, M
   Sarone-Williams, V
   Coelho-Sampaio, T
   Ferreira, ST
AF Sebollela, A
   Louzada, PR
   Sola-Penna, M
   Sarone-Williams, V
   Coelho-Sampaio, T
   Ferreira, ST
TI Inhibition of yeast glutathione reductase by trehalose: possible
   implications in yeast survival and recovery from stress
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE trehalose; ethanol; stress; glutathione reductase; yeast
ID SACCHAROMYCES-CEREVISIAE; HEAT-SHOCK; ETHANOL TOLERANCE; OXIDATIVE
   STRESS; FISSION YEAST; STABILITY; ENZYME; THERMOTOLERANCE;
   PYROPHOSPHATASE; STABILIZATION
AB Accumulation of trehalose has been implicated in the tolerance of yeast cells to several forms of stress, including heat-shock and high ethanol levels. However, yeast lacking trehalase, the enzyme that degrades trehalose, exhibit poor survival after exposure to stress conditions. This suggests that optimal cell viability also depends on the capacity to rapidly degrade. the high levels of trehalose that build up under stress. Here, we initially examined the effects of trehalose on the activity of an important antioxidant enzyme, glutathione reductase (GR), from Saccharomyces cerevisiae. At 25 degreesC, GR was inhibited by trehalose in a dose-dependent manner, with 70% inhibition at.1.5 M trehalose. The inhibition was practically abolished at 40 degreesC, a temperature that induces a physiological response of trehalose accumulation in yeast. The inhibition of GR by trehalose was additive to the inhibition caused by ethanol, indicating that enzyme function is drastically affected upon ethanol-induced stress. Moreover, two other yeast enzymes, cytosolic pyrophosphatase and glucose 6-phosphate dehydrogenase, showed temperature dependences on inhibition by trehalose that were similar to the temperature dependence of GR inhibition. These results are discussed in terms of the apparent paradox represented by the induction of enzymes involved in both synthesis and degradation of trehalose under stress, and suggest that the persistence of high levels of trehalose after recovery from stress could lead to the inactivation of important yeast enzymes. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Farmacos, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM sebollela@bioqmed.ufrj.br; ferreira@bioqmed.ufrj.br
RI Sebollela, Adriano/O-4385-2014; Ferreira, Sergio/AAZ-1576-2020;
   Sola-Penna, Mauro/E-8221-2011
OI Sebollela, Adriano/0000-0002-7444-9156; Ferreira,
   Sergio/0000-0001-7160-9866; Sola-Penna, Mauro/0000-0001-9796-6829
CR ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5
   COELHOSAMPAIO T, 1994, EUR J BIOCHEM, V221, P1103, DOI 10.1111/j.1432-1033.1994.tb18830.x
   COSTA V, 1993, ARCH BIOCHEM BIOPHYS, V300, P608, DOI 10.1006/abbi.1993.1084
   Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353
   DAMORE T, 1990, CRIT REV BIOTECHNOL, V9, P287, DOI 10.3109/07388558909036740
   Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1111/j.1574-6976.2000.tb00551.x
   Fernandez J, 1998, FUNGAL GENET BIOL, V25, P79, DOI 10.1006/fgbi.1998.1084
   GOUNALAKI N, 1994, EMBO J, V13, P4036, DOI 10.1002/j.1460-2075.1994.tb06720.x
   Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x
   Gupta S, 1996, Acta Microbiol Immunol Hung, V43, P33
   HOTTIGER T, 1987, J BACTERIOL, V169, P5518, DOI 10.1128/jb.169.12.5518-5522.1987
   HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x
   KHOSHTARIYA DE, 1986, BIOFIZIKA+, V31, P220
   KYUSHIKI H, 1990, PROTEINS, V8, P287, DOI 10.1002/prot.340080310
   Lopes DHJ, 1999, Z NATURFORSCH C, V54, P186
   LOWRY OH, 1946, J BIOL CHEM, V162, P421
   MANSURE JJC, 1994, BBA-BIOMEMBRANES, V1191, P309, DOI 10.1016/0005-2736(94)90181-3
   MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V258, P356, DOI 10.1016/0003-9861(87)90355-9
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   NWAKA S, 1995, J BIOL CHEM, V270, P10193, DOI 10.1074/jbc.270.17.10193
   NWAKA S, 1995, FEBS LETT, V360, P286, DOI 10.1016/0014-5793(95)00105-I
   Parsegian VA, 1995, METHOD ENZYMOL, V259, P43
   Pesti M, 2002, J BASIC MICROB, V42, P408, DOI 10.1002/1521-4028(200212)42:6<408::AID-JOBM408>3.0.CO;2-8
   PIPER PW, 1995, FEMS MICROBIOL LETT, V134, P121, DOI 10.1016/0378-1097(95)00431-9
   Ribeiro MJS, 1999, ANTON LEEUW INT J G, V75, P245, DOI 10.1023/A:1001806012566
   Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7
   Sola-Penna M, 1998, ARCH BIOCHEM BIOPHYS, V360, P10, DOI 10.1006/abbi.1998.0906
   SolaPenna M, 1997, EUR J BIOCHEM, V248, P24, DOI 10.1111/j.1432-1033.1997.00024.x
   SOLAPENNA M, 1994, Z NATURFORSCH C, V49, P327
   SOMERO GN, 1986, AM J PHYSIOL, V251, P197
   TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435
   Wera S, 1999, BIOCHEM J, V343, P621, DOI 10.1042/0264-6021:3430621
   WIEMKEN A, 1990, ANTON LEEUW INT J G, V58, P209, DOI 10.1007/BF00548935
NR 33
TC 39
Z9 41
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD MAY
PY 2004
VL 36
IS 5
BP 900
EP 908
DI 10.1016/j.biocel.2003.10.006
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 806SP
UT WOS:000220453900018
PM 15006642
DA 2020-09-29
ER

PT J
AU Lopes, DHJ
   Chapeaurouge, A
   Manderson, GA
   Johansson, JS
   Ferreira, ST
AF Lopes, DHJ
   Chapeaurouge, A
   Manderson, GA
   Johansson, JS
   Ferreira, ST
TI Redesigning the folding energetics of a model three-helix bundle protein
   by site-directed mutagenesis
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID COLD DENATURATION; FREE-ENERGY; ACIDIC CONDITIONS; HYDROPHOBIC CORE;
   MOLTEN GLOBULE; HIGH-PRESSURE; EQUILIBRIUM; PATHWAY; INTERMEDIATE;
   MUTATIONS
AB Because of their limited size and complexity, de novo designed proteins are particularly useful for the detailed investigation of folding thermodynamics and mechanisms. Here, we describe how subtle changes in the hydrophobic core of a model three-helix bundle protein (GM-0) alter its folding energetics. To explore the folding tolerance of GM-0 toward amino acid sequence variability, two mutant proteins (GM-1 and GM-2) were generated. In the mutants, cavities were created in the hydrophobic core of the protein by either singly (GM-1; L35A variant) or doubly (GM-2; L35A/I39A variant) replacing large hydrophobic side chains by smaller Ala residues. The folding of GM-0 is characterized by two partially folded intermediate states exhibiting characteristics of molten globules, as evidenced by pressure-unfolding and pressure-assisted cold denaturation experiments. In contrast, the folding energetics of both mutants, GM-1 and GM-2, exhibit only one folding intermediate. Our results support the view that simple but biologically important folding motifs such as the three-helix bundle can reveal complex folding plasticity, and they point to the role of hydrophobic packing as a determinant of the overall stability and folding thermodynamic of the helix bundle.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Fisiol & Farmacodinam, BR-21045900 Rio De Janeiro, Brazil.
   Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA.
   Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.
RP Chapeaurouge, A (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM henk@ioc.fiocruz.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM65218] Funding Source: Medline
CR ANTONINO LC, 1991, P NATL ACAD SCI USA, V88, P7715, DOI 10.1073/pnas.88.17.7715
   BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103
   Boice JA, 1996, BIOCHEMISTRY-US, V35, P14480, DOI 10.1021/bi961831d
   Botelho MM, 2000, EUR J BIOCHEM, V267, P2235, DOI 10.1046/j.1432-1327.2000.01226.x
   BRIDGMAN PW, 1931, PHYS HIGH PRESSURE, P233
   Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   Eastwood MP, 2001, J CHEM PHYS, V114, P4702, DOI 10.1063/1.1315994
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020
   Godbole S, 1997, BIOCHEMISTRY-US, V36, P119, DOI 10.1021/bi961915m
   Gorski SA, 2001, J MOL BIOL, V312, P849, DOI 10.1006/jmbi.2001.5001
   Gruebele M, 2002, CURR OPIN STRUC BIOL, V12, P161, DOI 10.1016/S0959-440X(02)00304-4
   Hobart SA, 2002, BIOCHEMISTRY-US, V41, P13744, DOI 10.1021/bi0265224
   JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11259, DOI 10.1021/bi00093a001
   Johansson JS, 1998, J AM CHEM SOC, V120, P3881, DOI 10.1021/ja973538m
   KAUZMANN W, 1959, ADV PROTEIN CHEM, P1
   Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193
   Lassalle MW, 2003, PROTEIN SCI, V12, P66, DOI 10.1110/ps.0221303
   LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025
   Martins SM, 2002, EUR J BIOCHEM, V269, P5484, DOI 10.1046/j.1432-1033.2002.03248.x
   MASTERTO.WL, 1968, J PHYS CHEM-US, V72, P4257, DOI 10.1021/j100858a053
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638
   Nguyen H, 2003, P NATL ACAD SCI USA, V100, P3948, DOI 10.1073/pnas.0538054100
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612
   PTITSYN OB, 1995, TRENDS BIOCHEM SCI, V20, P376, DOI 10.1016/S0968-0004(00)89081-7
   RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1
   Sasahara K, 2002, PROTEINS, V49, P472, DOI 10.1002/prot.10215
   SEALE JW, 1995, BIOCHEMISTRY-US, V34, P7443, DOI 10.1021/bi00022a018
   Walsh STR, 2001, J MOL BIOL, V305, P361, DOI 10.1006/jmbi.2000.4184
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940
NR 35
TC 30
Z9 30
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 19
PY 2004
VL 279
IS 12
BP 10991
EP 10996
DI 10.1074/jbc.M308174200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 802IQ
UT WOS:000220157600021
PM 14701847
OA Bronze
DA 2020-09-29
ER

PT J
AU Louzada, PR
   Lima, ACP
   Mendonca-Silva, DL
   Noel, F
   De Mello, FG
   Ferreira, ST
AF Louzada, PR
   Lima, ACP
   Mendonca-Silva, DL
   Noel, F
   De Mello, FG
   Ferreira, ST
TI Taurine prevents the neurotoxicity of beta-amyloid and glutamate
   receptor agonists: activation of GABA receptors and possible
   implications for Alzheimer's disease and other neurological disorders
SO FASEB JOURNAL
LA English
DT Article
DE amyloid; neuroprotection
ID EXCITATORY AMINO-ACIDS; BLOOD-BRAIN-BARRIER; LIPID-PEROXIDATION;
   NEURONAL DEATH; HIPPOCAMPAL-NEURONS; CALCIUM HOMEOSTASIS; IN-VITRO;
   PEPTIDE; RETINA; EXCITOTOXICITY
AB Alzheimer's disease (AD) and several other neurological disorders have been linked to the overactivation of glutamatergic transmission and excitotoxicity as a common pathway of neuronal injury. The beta-amyloid peptide (Abeta) is centrally related to the pathogenesis of AD, and previous reports have demonstrated that the blockade of glutamate receptors prevents Abeta-induced neuronal death. We show that taurine, a beta-amino acid found at high concentrations in the brain, protects chick retinal neurons in culture against the neurotoxicity of Abeta and glutamate receptor agonists. The protective effect of taurine is not mediated by interaction with glutamate receptors, as demonstrated by binding studies using radiolabeled glutamate receptor ligands. The neuroprotective action of taurine is blocked by picrotoxin, an antagonist of GABA(A) receptors. GABA and the GABA(A) receptor agonists phenobarbital and melatonin also protect neurons against Abeta-induced neurotoxicity. These results suggest that activation of GABA receptors decreases neuronal vulnerability to excitotoxic damage and that pharmacological manipulation of the excitatory and inhibitory neurotransmitter tonus may protect neurons against a variety of insults. GABAergic transmission may represent a promising target for the treatment of AD and other neurological disorders in which excitotoxicity plays a relevant role.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Farmacol Basica & Clin, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.uf.br
RI Ferreira, Sergio/AAZ-1576-2020; nikkhah, elham/M-6142-2017; Noel,
   Francois/C-3402-2009; Paula-Lima, Andrea C./I-2537-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Noel,
   Francois/0000-0001-6813-1347; Paula-Lima, Andrea C./0000-0002-0466-7561
CR Abel KM, 2003, NEUROPHARMACOLOGY, V44, P729, DOI 10.1016/S0028-3908(03)00073-X
   Alvarez A, 1998, J NEUROSCI, V18, P3213
   ARIAS C, 1995, J NEUROSCI RES, V41, P561, DOI 10.1002/jnr.490410416
   Balla A, 2001, NEUROPSYCHOPHARMACOL, V25, P157, DOI 10.1016/S0893-133X(01)00230-5
   Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180
   BENRABH H, 1995, BRAIN RES, V692, P57, DOI 10.1016/0006-8993(95)00648-A
   Birdsall T C, 1998, Altern Med Rev, V3, P128
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Butterfield DA, 2002, NEUROBIOL AGING, V23, P655
   Cluskey S, 2001, J CLIN PATHOL-MOL PA, V54, P386
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   del Olmo N, 2000, BRAIN RES, V864, P298, DOI 10.1016/S0006-8993(00)02211-3
   DIFAZIO MC, 1992, NEUROLOGY, V42, P402, DOI 10.1212/WNL.42.2.402
   El Idrissi A, 1999, J NEUROSCI, V19, P9459
   FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153
   Forloni G, 1997, J NEUROCHEM, V68, P319
   FRANDSEN A, 1990, NEUROSCI LETT, V111, P233, DOI 10.1016/0304-3940(90)90374-I
   GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.ph.54.030192.002451
   Green AR, 2000, NEUROPHARMACOLOGY, V39, P1483, DOI 10.1016/S0028-3908(99)00233-6
   GUIDOTTI A, 1972, J NEUROCHEM, V19, P431, DOI 10.1111/j.1471-4159.1972.tb01352.x
   Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x
   Hassel B, 2001, EPILEPSY RES, V43, P153, DOI 10.1016/S0920-1211(00)00196-0
   Holden C, 2003, SCIENCE, V300, P1866, DOI 10.1126/science.300.5627.1866
   Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197
   Jevtovic-Todorovic V, 2001, BRAIN RES, V913, P185, DOI 10.1016/S0006-8993(01)02800-1
   JOHNSTON GAR, 1980, J NEUROCHEM, V34, P241, DOI 10.1111/j.1471-4159.1980.tb04650.x
   Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1
   KIEBURTZ KD, 1991, ARCH NEUROL-CHICAGO, V48, P1281, DOI 10.1001/archneur.1991.00530240087028
   KOWALL NW, 1992, NEUROBIOL AGING, V13, P537, DOI 10.1016/0197-4580(92)90053-Z
   LAUNDERBACK CM, 1999, LIFE SCI, V650, P1977
   Lima ACP, 2003, NEUROTOX RES, V5, P323, DOI 10.1007/BF03033152
   LIMA L, 1993, J NEUROCHEM, V60, P2153, DOI 10.1111/j.1471-4159.1993.tb03500.x
   Lima L, 1998, J NEUROSCI RES, V53, P377, DOI 10.1002/(SICI)1097-4547(19980801)53:3<377::AID-JNR12>3.0.CO;2-2
   LIPTON SA, 1994, NEW ENGL J MED, V330, P613
   Lombardini JB, 1996, ADV EXP MED BIOL, V403, P343
   Loureiro-dos-Santos NE, 2001, J NEUROCHEM, V77, P1136, DOI 10.1046/j.1471-4159.2001.00330.x
   Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3
   MARK RJ, 1995, NEUROBIOL AGING, V16, P187, DOI 10.1016/0197-4580(94)00150-2
   Matsuyama Y, 1983, Prog Clin Biol Res, V125, P461
   MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992
   Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65
   MCBRIDE WJ, 1980, FED PROC, V39, P2701
   Mills CD, 2002, EXP NEUROL, V173, P153, DOI 10.1006/exnr.2001.7828
   NAGELHUS EA, 1993, NEUROSCIENCE, V54, P615, DOI 10.1016/0306-4522(93)90233-6
   Noda M, 1999, NEUROSCIENCE, V92, P1465, DOI 10.1016/S0306-4522(99)00036-6
   O'Byrne MB, 2000, J NEUROCHEM, V74, P2087, DOI 10.1046/j.1471-4159.2000.0742087.x
   OKAMOTO K, 1983, BRAIN RES, V259, P319, DOI 10.1016/0006-8993(83)91266-0
   PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D
   POMARA N, 1992, AM J PSYCHIAT, V149, P251
   Rodrigues CMP, 2001, BIOCHEM BIOPH RES CO, V281, P468, DOI 10.1006/bbrc.2001.4370
   Saransaari P, 1997, NEUROSCIENCE, V79, P847, DOI 10.1016/S0306-4522(97)00038-9
   Schwartz-Bloom RD, 2000, NEUROSCIENCE, V98, P471, DOI 10.1016/S0306-4522(00)00144-5
   Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023
   TADOLINI B, 1995, BIOCHEM BIOPH RES CO, V213, P820, DOI 10.1006/bbrc.1995.2203
   Tamai I, 1995, BIOCHEM PHARMACOL, V50, P1783, DOI 10.1016/0006-2952(95)02046-2
   Velasco I, 2002, J NEUROSCI RES, V67, P406, DOI 10.1002/jnr.10114
   Zhao P, 1999, NEUROSCI LETT, V268, P25, DOI 10.1016/S0304-3940(99)00373-0
NR 57
TC 162
Z9 166
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAR
PY 2004
VL 18
IS 3
BP 511
EP 518
DI 10.1096/fj.03-0739com
PG 8
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 807TC
UT WOS:000220522800043
PM 15003996
DA 2020-09-29
ER

PT J
AU Moreau, VH
   Rietveld, AWM
   Ferreira, ST
AF Moreau, VH
   Rietveld, AWM
   Ferreira, ST
TI Persistent conformational heterogeneity of triosephosphate isomerase:
   Separation and characterization of conformational isomers in solution
SO BIOCHEMISTRY
LA English
DT Article
ID TRIOSE PHOSPHATE ISOMERASE; ACTIVE-SITE MODIFICATION;
   HYDROSTATIC-PRESSURE; SUPEROXIDE-DISMUTASE; CRYSTAL-STRUCTURE; REVERSE
   MICELLES; LIGAND-BINDING; PROTEIN; DISSOCIATION; FLUORESCENCE
AB Subunit dissociation of dimeric rabbit muscle triosephosphate isomerase (TIM) by hydrostatic pressure has previously been shown not to follow the expected dependence on protein concentration [Rietveld and Ferreira (1996) Biochemistry 35, 7743-7751]. This anomalous behavior was attributed to persistent conformational heterogeneity (i.e., the coexistence of long-lived conformational isomers) in the ensemble of TIM dimers. Here, we initially show that subunit dissociation/unfolding of TIM by guanidine hydrochloride (GdnHCl) also exhibits an anomalous dependence on protein concentration. Dissociation/unfolding of TIM by GdnHCl was investigated by intrinsic fluorescence and circular dichroism spectroscopies and was found to be a highly cooperative transition in which the tertiary and secondary structures of the protein were concomitantly lost. A procedure based on size-exclusion chromatography in the presence of intermediate (0.6 M) GdnHCl concentrations was developed to isolate two conformational isomers of TIM that exhibit significantly different stabilities and kinetics of unfolding by GdnHCl. Complete unfolding of the two isolated conformers at a high GdnHCl concentration (1.5 M), followed by refolding by removal of the denaturant, completely abolished the differences in their unfolding kinetics. These results indicate that such differences stem from conformational heterogeneity of TIM and are not related to any chemical modification of the protein. Furthermore, they add support to the notion that long-lived conformational isomers of TIM coexist in solution and provide a basis for the interpretation of the persistent heterogeneity of this protein.
C1 Univ Fed Rio de Janeiro, ICB, Dept Bioquim Med, BR-21994590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, ICB, Dept Bioquim Med, BR-21994590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Moreau, Vitor Hugo/B-8865-2009; Moreau,
   Vitor Hugo/J-4829-2015
OI Ferreira, Sergio/0000-0001-7160-9866; Moreau, Vitor
   Hugo/0000-0002-5393-0645
CR ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031
   ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032
   ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000
   AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021
   BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266
   DELBONI LF, 1995, PROTEIN SCI, V4, P2594, DOI 10.1002/pro.5560041217
   Dobo A, 2001, ANAL CHEM, V73, P4763, DOI 10.1021/ac010713f
   ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022
   FERNANDEZVELASCO DA, 1995, BIOCHEMISTRY-US, V34, P361, DOI 10.1021/bi00001a044
   FERREIRA ST, 1994, BIOPHYS J, V66, P1185, DOI 10.1016/S0006-3495(94)80901-4
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933
   Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298
   GARZARAMOS G, 1992, EUR J BIOCHEM, V208, P389, DOI 10.1111/j.1432-1033.1992.tb17199.x
   Hansson UB, 1997, BBA-PROTEIN STRUCT M, V1340, P53, DOI 10.1016/S0167-4838(97)00028-9
   KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0
   LODI PJ, 1994, BIOCHEMISTRY-US, V33, P2809, DOI 10.1021/bi00176a009
   LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6609, DOI 10.1021/bi00480a009
   MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510
   MEI G, 1992, BIOCHEMISTRY-US, V31, P7224, DOI 10.1021/bi00147a003
   Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708
   NOBLE MEM, 1993, ACTA CRYSTALLOGR D, V49, P403, DOI 10.1107/S0907444993002628
   Pace C N, 1986, Methods Enzymol, V131, P266
   Panda M, 2002, BIOCHEMISTRY-US, V41, P1869, DOI 10.1021/bi011794c
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201
   RHOLAM M, 1981, BIOCHEMISTRY-US, V20, P5837, DOI 10.1021/bi00523a029
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   RUAN KC, 1993, BIOCHEMISTRY-US, V32, P6295, DOI 10.1021/bi00075a025
   SAWYER TH, 1975, ARCH BIOCHEM BIOPHYS, V169, P51, DOI 10.1016/0003-9861(75)90315-X
   SCARLATA SF, 1986, BIOCHEMISTRY-US, V25, P4925, DOI 10.1021/bi00365a030
   Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463
   Schmitt L, 1999, P NATL ACAD SCI USA, V96, P6581, DOI 10.1073/pnas.96.12.6581
   SCHNACKERZ KD, 1991, EUR J BIOCHEM, V199, P231, DOI 10.1111/j.1432-1033.1991.tb16114.x
   SepulvedaBecerra MA, 1996, BIOCHEMISTRY-US, V35, P15915, DOI 10.1021/bi961548e
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SUN AQ, 1992, J BIOL CHEM, V267, P20168
   SUN AW, 1992, ARCH BIOCHEM BIOPHYS, V293, P382, DOI 10.1016/0003-9861(92)90410-X
   WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165
   Weber G, 1996, BIOPHYS J, V70, P167, DOI 10.1016/S0006-3495(96)79557-7
   WEBER G, 1987, NATO ASI SER C, V197, P401
   WIERENGA RK, 1992, J MOL BIOL, V224, P1115, DOI 10.1016/0022-2836(92)90473-W
   WIERENGA RK, 1991, J MOL BIOL, V220, P995, DOI 10.1016/0022-2836(91)90368-G
   ZABORI S, 1980, Z NATURFORSCH C, V35, P999
   Zhang DY, 2002, ARCH BIOCHEM BIOPHYS, V397, P99, DOI 10.1006/abbi.2001.2660
NR 51
TC 16
Z9 16
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD DEC 23
PY 2003
VL 42
IS 50
BP 14831
EP 14837
DI 10.1021/bi0343572
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 755KL
UT WOS:000187402000013
PM 14674757
DA 2020-09-29
ER

PT J
AU Aparicio, R
   Ferreira, ST
   Polikarpov, I
AF Aparicio, R
   Ferreira, ST
   Polikarpov, I
TI Closed conformation of the active site loop of rabbit muscle
   triosephosphate isomerase in the absence of substrate: Evidence of
   conformational heterogeneity
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE triosephosphate isomerase; TIM structure; lid loop conformation;
   conformational heterogeneity; protein crystallography
ID TRIOSE-PHOSPHATE ISOMERASE; X-RAY-DIFFRACTION; HINGED-LID MOTION;
   CRYSTAL-STRUCTURE; FLEXIBLE LOOP; PLASMODIUM-FALCIPARUM;
   PHOSPHOGLYCOLOHYDROXAMATE COMPLEX; ENZYME CATALYSIS; BINDING; RESOLUTION
AB The active site loop of triosephosphate isomerase (TIM) exhibits a hinged-lid motion, alternating between the two well defined "open" and "closed" conformations. Until now the closed conformation had only been observed in protein complexes with substrate analogues. Here, we present the first rabbit muscle apo TIM structure, refined to 1.5 Angstrom resolution, in which the active site loop is either in the open or in the closed conformation in different subunits of the enzyme. In the closed conformation described here, the lid loop residues participate in stabilizing hydrogen bonds characteristic of holo TIM structures, whereas chemical interactions observed in the open loop conformation are similar to those found in the apo structures of TIM. In the closed conformation, a number of water, molecules are observed at the projected ligand atom positions that are hydrogen bonded to the active site residues. Additives used during crystallization (DMSO and Tris molecules and magnesium atoms) were modeled in the electron density maps. However, no specific binding of these molecules is observed at, or close to, the active site-and the lid loop. To further investigate this unusual closed conformation of the apo enzyme, two more rabbit muscle TIM structures, one in the same and another in a different crystal form, were determined. These structures present the open lid conformation only, indicating that the closed conformation cannot be explained by crystal contact effects. To rationalize why the active site loop is closed in the absence of ligand in one of the subunits, extensive comparison with previously solved TIM structures was carried out, supported by the bulk of available experimental information about enzyme kinetics and reaction mechanism of TIM. The observation of both open and closed lid conformations in TIM crystals might be related to a persistent conformational heterogeneity of this protein in solution. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
   Lab Nacl Luz Sincrotron, Campinas, SP, Brazil.
   Univ Fed Rio de Janeiro, Depto Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
RP Polikarpov, I (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Av Trabalhador SaoCarlense,400, BR-13560970 Sao Carlos, SP, Brazil.
EM ipolikarpov@if.sc.usp.br
RI Ferreira, Sergio/AAZ-1576-2020; Polikarpov, Igor/D-2575-2012; Aparicio,
   Ricardo/G-5802-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Polikarpov,
   Igor/0000-0001-9496-4174
CR ALBER T, 1981, PHILOS T ROY SOC B, V293, P159, DOI 10.1098/rstb.1981.0069
   ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032
   Alvarez M, 1998, J BIOL CHEM, V273, P2199, DOI 10.1074/jbc.273.4.2199
   Aparicio R, 2000, ACTA CRYSTALLOGR D, V56, P1492, DOI 10.1107/S0907444900011380
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0
   BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013
   BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703, DOI 10.1111/j.1432-1033.1993.tb17599.x
   Branden C., 1991, INTRO PROTEIN STRUCT
   BRZOVIC PS, 1993, BIOCHEMISTRY-US, V32, P10404, DOI 10.1021/bi00090a016
   Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729
   DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903
   DAVENPORT RC, 1991, BIOCHEMISTRY-US, V30, P5821, DOI 10.1021/bi00238a002
   DELBONI LF, 1995, PROTEIN SCI, V4, P2594, DOI 10.1002/pro.5560041217
   Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4
   Doenhoff MJ, 1998, PARASITOL TODAY, V14, P105, DOI 10.1016/S0169-4758(97)01204-0
   ERIJMAN L, 1993, J BIOL CHEM, V268, P25914
   ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022
   FARBER GK, 1993, CURR OPIN STRUC BIOL, V3, P409, DOI 10.1016/S0959-440X(05)80114-9
   Garman EF, 1997, J APPL CRYSTALLOGR, V30, P211, DOI 10.1107/S0021889897002677
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636
   KISHAN KVR, 1994, PROTEIN SCI, V3, P779
   Kleywegt GJ, 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111
   KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0
   KNOWLES JR, 1977, ACCOUNTS CHEM RES, V10, P105, DOI 10.1021/ar50112a001
   Kohlhoff M, 1996, FEBS LETT, V383, P245, DOI 10.1016/0014-5793(96)00249-9
   KRIETSCH WK, 1970, EUR J BIOCHEM, V14, P289, DOI 10.1111/j.1432-1033.1970.tb00289.x
   Kursula I, 2003, J BIOL CHEM, V278, P9544, DOI 10.1074/jbc.M211389200
   Kursula I, 2001, EUR J BIOCHEM, V268, P5189, DOI 10.1046/j.0014-2956.2001.02452.x
   LEHMANN MS, 1989, BIOCHEMISTRY-US, V28, P7028, DOI 10.1021/bi00443a037
   LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6619, DOI 10.1021/bi00480a010
   LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6609, DOI 10.1021/bi00480a009
   LUNDQVIST T, 1991, J BIOL CHEM, V266, P12604
   Maes D, 1999, PROTEINS, V37, P441, DOI 10.1002/(SICI)1097-0134(19991115)37:3<441::AID-PROT11>3.3.CO;2-Z
   Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174
   Maldonado E, 1998, J MOL BIOL, V283, P193, DOI 10.1006/jmbi.1998.2094
   MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510
   McMillan FM, 2000, BIOCHEMISTRY-US, V39, P4533, DOI 10.1021/bi992645l
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081
   NICKBARG EB, 1988, BIOCHEMISTRY-US, V27, P5939, DOI 10.1021/bi00416a018
   NOBLE MEM, 1993, PROTEINS, V16, P311, DOI 10.1002/prot.340160402
   NOBLE MEM, 1993, ACTA CRYSTALLOGR D, V49, P403, DOI 10.1107/S0907444993002628
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Panda M, 2002, BIOCHEMISTRY-US, V41, P1869, DOI 10.1021/bi011794c
   Parthasarathy S, 2002, ACTA CRYSTALLOGR D, V58, P1992, DOI 10.1107/S0907444902015433
   Parthasarathy S, 2002, BIOCHEMISTRY-US, V41, P13178, DOI 10.1021/bi025783a
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   Plomp M, 2001, J PHYS CHEM B, V105, P542, DOI 10.1021/jp003007b
   RIEDER SV, 1959, J BIOL CHEM, V234, P1007
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   ROSE I A, 1962, Brookhaven Symp Biol, V15, P293
   Rozovsky S, 2001, J MOL BIOL, V310, P271, DOI 10.1006/jmbi.2001.4673
   RUAN K, 1989, BIOCHEMISTRY-US, V28, P2144, DOI 10.1021/bi00431a028
   RUAN KC, 1993, BIOCHEMISTRY-US, V32, P6295, DOI 10.1021/bi00075a025
   SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7
   Schliebs W, 1996, PROTEIN SCI, V5, P229
   Schliebs W, 1997, BIOCHEMISTRY-US, V36, P9655, DOI 10.1021/bi963086a
   SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718
   SCOPES RK, 1977, BIOCHEM J, V161, P253, DOI 10.1042/bj1610253
   SCOPES RK, 1977, BIOCHEM J, V161, P265, DOI 10.1042/bj1610265
   Shan SO, 1999, METHOD ENZYMOL, V308, P246
   Taylor JC, 2003, ARCH BIOCHEM BIOPHYS, V415, P164, DOI 10.1016/S0003-9861(03)00277-7
   Velanker SS, 1997, STRUCTURE, V5, P751, DOI 10.1016/S0969-2126(97)00230-X
   VERLINDE CLMJ, 1992, PROTEIN SCI, V1, P1578, DOI 10.1002/pro.5560011205
   Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Watanabe M, 1996, AM J HUM GENET, V58, P308
   Wiechmann M, 2001, ULTRAMICROSCOPY, V86, P159, DOI 10.1016/S0304-3991(00)00101-7
   WIERENGA RK, 1992, J MOL BIOL, V224, P1115, DOI 10.1016/0022-2836(92)90473-W
   WIERENGA RK, 1992, FEBS LETT, V307, P34, DOI 10.1016/0014-5793(92)80897-P
   WIERENGA RK, 1991, J MOL BIOL, V220, P995, DOI 10.1016/0022-2836(91)90368-G
   WIERENGA RK, 1991, PROTEINS, V10, P33, DOI 10.1002/prot.340100105
   WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012
   Williams JC, 1999, PROTEIN ENG, V12, P243, DOI 10.1093/protein/12.3.243
   Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736
   Xiang JY, 2001, J MOL BIOL, V307, P1103, DOI 10.1006/jmbi.2001.4536
   YUKSEL KU, 1994, J BIOL CHEM, V269, P5005
   YUKSEL KU, 1991, STUDY ENZYMES, V2, P457
   ZHANG ZD, 1994, BIOCHEMISTRY-US, V33, P2830, DOI 10.1021/bi00176a012
   Zhang ZD, 1999, BIOCHEMISTRY-US, V38, P4389, DOI 10.1021/bi9826759
NR 84
TC 42
Z9 44
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 12
PY 2003
VL 334
IS 5
BP 1023
EP 1041
DI 10.1016/j.jmb.2003.10.022
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 752GP
UT WOS:000187153000014
PM 14643664
DA 2020-09-29
ER

PT J
AU Louzada, PR
   Sebollela, A
   Scaramello, ME
   Ferreira, ST
AF Louzada, PR
   Sebollela, A
   Scaramello, ME
   Ferreira, ST
TI Predissociated dimers and molten globule monomers in the equilibrium
   unfolding of yeast glutathione reductase
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID ALPHA-LACTALBUMIN; GUANIDINE-HYDROCHLORIDE; PROTEIN-STRUCTURE; COMPACT
   STATE; HIGH-PRESSURE; STABILITY; DISSOCIATION; DYNAMICS; ENZYME;
   RECONSTITUTION
AB The equilibrium unfolding of dimeric yeast glutathione reductase (GR) by guanidine hydrochloride (GdnHCl) was investigated. Unfolding was monitored by a variety of techniques, including intrinsic fluorescence emission, anisotropy and iodide quenching measurements, far-ultraviolet circular dichroism and thiol reactivity measurements. At 1 M GdnHCl, one thiol group of GR became accessible to modification with 5,5'-dithiobis-(2-nitrobenzoic) acid (DTNB), whereas no changes could be detected in the spectroscopic properties (fluorescence, circular dichroism) of the protein. Between 2 and 3 M GdnHCl, two partially folded intermediate states possessing flexible tertiary structures (revealed by fluorescence data) but compact secondary structures (as indicated by circular dichroism measurements) were identified. The quaternary structure of GR in the presence of GdnHCl was also investigated by size-exclusion liquid chromatography. These results indicated the presence of an expanded predissociated dimer at 2.5 M GdnHCl and partially folded monomers at 3 M GdnHCl. Taken together, these results suggest the existence of two molten-globule-like intermediate species (one dimeric and one monomeric) in the unfolding of GR. The results are discussed in terms of the mechanism of GR folding and dimerization.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, Rio De Janeiro, Brazil.
RI Sebollela, Adriano/O-4385-2014; Ferreira, Sergio/AAZ-1576-2020
OI Sebollela, Adriano/0000-0002-7444-9156; Ferreira,
   Sergio/0000-0001-7160-9866
CR ARSCOTT LD, 1989, BIOCHEMISTRY-US, V28, P3591, DOI 10.1021/bi00434a066
   BASHIR A, 1995, BIOCHEM J, V312, P527, DOI 10.1042/bj3120527
   BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0
   BOLOTINA I A, 1987, Molekulyarnaya Biologiya (Moscow), V21, P1625
   BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X
   COLLIER HB, 1973, ANAL BIOCHEM, V56, P310, DOI 10.1016/0003-2697(73)90196-6
   COUTHON F, 1995, EUR J BIOCHEM, V234, P160, DOI 10.1111/j.1432-1033.1995.160_c.x
   Creighton T.E., 1992, PROTEIN FOLDING
   DOLGIKH DA, 1984, FEBS LETT, V165, P88, DOI 10.1016/0014-5793(84)80020-4
   DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4
   DOLGIKH DA, 1985, EUR BIOPHYS J BIOPHY, V13, P109, DOI 10.1007/BF00256531
   EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   Heremans K, 1998, BBA-PROTEIN STRUCT M, V1386, P353, DOI 10.1016/S0167-4838(98)00102-2
   KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4
   KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   NORDHOFF A, 1993, BIOCHEMISTRY-US, V32, P4060, DOI 10.1021/bi00066a029
   Nordhoff A, 1997, EUR J BIOCHEM, V245, P273, DOI 10.1111/j.1432-1033.1997.00273.x
   NOZAKA M, 1978, BIOCHEMISTRY-US, V17, P3753, DOI 10.1021/bi00611a013
   Pain R. H., 1994, MECH PROTEIN FOLDING
   PENG XD, 1994, BIOCHEMISTRY-US, V33, P8323, DOI 10.1021/bi00193a020
   PTITSYN OB, 1995, TRENDS BIOCHEM SCI, V20, P376, DOI 10.1016/S0968-0004(00)89081-7
   PTITSYN OB, 1992, PROTEIN FOLDING
   Rawat U, 1998, J BIOL CHEM, V273, P9415, DOI 10.1074/jbc.273.16.9415
   RENDON JL, 1995, ARCH BIOCHEM BIOPHYS, V318, P264, DOI 10.1006/abbi.1995.1229
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   RISSE B, 1992, PROTEIN SCI, V1, P1699, DOI 10.1002/pro.5560011218
   ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6
   SCHULZ GE, 1978, NATURE, V273, P120, DOI 10.1038/273120a0
   SCRUTTON NS, 1992, SCIENCE, V258, P1140, DOI 10.1126/science.1439821
   SILVA N, 1993, BIOPHYS CHEM, V48, P171, DOI 10.1016/0301-4622(93)85008-6
   Trevino RJ, 1999, J BIOL CHEM, V274, P13938, DOI 10.1074/jbc.274.20.13938
NR 39
TC 24
Z9 24
U1 1
U2 3
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD NOV 1
PY 2003
VL 85
IS 5
BP 3255
EP 3261
DI 10.1016/S0006-3495(03)74743-2
PG 7
WC Biophysics
SC Biophysics
GA 736UA
UT WOS:000186190500044
PM 14581225
OA Green Published
DA 2020-09-29
ER

PT J
AU Rangel, A
   Domont, GB
   Pedrosa, C
   Ferreira, ST
AF Rangel, A
   Domont, GB
   Pedrosa, C
   Ferreira, ST
TI Functional properties of purified vicilins from cowpea (Vigna
   unguiculata) and pea (Pisum sativum) and cowpea protein isolate
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Vigna unguiculata; Pisum sativum; vicilin; functional properties;
   protein isolates
ID 7S STORAGE GLOBULIN; LEGUME SEEDS; EMULSIFYING PROPERTIES;
   NUTRITIVE-VALUE; FLOUR; CLEAVAGE; L.
AB The major storage globulins (vicilins) of cowpea (Vigna unguiculata) and pea (Pisum sativum) seeds were purified by ammonium sulfate precipitation, and a semipurified cowpea protein isolate (CPI) was prepared by isoelectric precipitation. Some of the functional properties of these proteins, including solubility, foaming, and emulsifying capacities, were investigated and compared. The solubility of purified cowpea vicilin was reduced at pH 5.0, increasing markedly below and above this value. Pea vicilin exhibited poor solubility between pH 5.0 and pH 6.0, and CPI was little soluble in the pH range from 4.0 to 6.0. At neutral pH, the emulsifying activity indexes (EAI) of purified pea vicilin and CPI were 194 and 291 m(2)/g, respectively, which compare quite favorably to EAIs of 110 and 133 m(2)/g for casein and albumin, respectively. Remarkably, purified cowpea vicilin exhibited an EAI of 490 m(2)/g, indicating a very high emulsifying activity. Purified cowpea and pea vicilins exhibited lower foaming capacities and foam stablity indexes (FSI) than CPI. FSI values of 80 and 260 min were obtained for purified pea and cowpea vicilin, respectively, whereas a FSI value of 380 min was obtained for CPI. These results are discussed in terms of the possible utilization of purified vicilins or protein isolates from pea and cowpea in the food processing industry.
C1 Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Chem, BR-21944590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Nutr, BR-21944590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Alonso R, 2000, J AGR FOOD CHEM, V48, P2286, DOI 10.1021/jf000095o
   BADUI DS, 1994, QUIMICA ALIMENTOS, P160
   BANIEL A, 1992, J AGR FOOD CHEM, V40, P200, DOI 10.1021/jf00014a007
   Bressani R, 1985, COWPEA RES PRODUCTIO, P353
   Chau CF, 1997, J AGR FOOD CHEM, V45, P2500, DOI 10.1021/jf970047c
   Chavan UD, 2001, FOOD CHEM, V74, P177, DOI 10.1016/S0308-8146(01)00123-6
   Chel-Guerrero L, 2002, J AGR FOOD CHEM, V50, P584, DOI 10.1021/jf010778j
   COFFMANN CW, 1977, J FOOD TECHNOL, V12, P473, DOI 10.2174/0929866054395257
   DAGORNSCAVINER C, 1987, J FOOD SCI, V52, P335, DOI 10.1111/j.1365-2621.1987.tb06607.x
   DANIELSSON CE, 1949, BIOCHEM J, V44, P387, DOI 10.1042/bj0440387
   DEFELICE FG, 1995, PERSPECTIVES PROTEIN, P306
   DERBYSHIRE E, 1976, PHYTOCHEMISTRY, V15, P3, DOI 10.1016/S0031-9422(00)89046-9
   DOMONEY C, 1985, NUCLEIC ACIDS RES, V13, P687, DOI 10.1093/nar/13.3.687
   EKEPENGYONG TE, 1985, NUTR REP INT, V31, P561
   El-Adawy TA, 2001, FOOD CHEM, V74, P455, DOI 10.1016/S0308-8146(01)00163-7
   Enwere NJ, 1998, INT J FOOD SCI NUTR, V49, P365, DOI 10.3109/09637489809089411
   *FAO WHO UNU, 1985, TECHN REP SER, V724
   GATEHOUSE JA, 1983, BIOCHEM J, V212, P427, DOI 10.1042/bj2120427
   GATEHOUSE JA, 1984, CRC CR REV PLANT SCI, V1, P287, DOI 10.1080/07352688409382182
   GUEGUEN J, 1990, J AGR FOOD CHEM, V38, P61, DOI 10.1021/jf00091a013
   HALLING PJ, 1981, CRC CR REV FOOD SCI, V15, P155
   IDOURAINE A, 1997, J FOOD SCI, V56, P1316
   KATO A, 1983, J FOOD SCI, V48, P62, DOI 10.1111/j.1365-2621.1983.tb14788.x
   KEHINDE AT, 1998, TECHNOVATION, V18, P469
   KINSELLA JE, 1979, J AM OIL CHEM SOC, V56, P242, DOI 10.1007/BF02671468
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIENER IE, 1994, CRIT REV FOOD SCI, V34, P31, DOI 10.1080/10408399409527649
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Meng GT, 2001, FOOD CHEM, V73, P453, DOI 10.1016/S0308-8146(00)00329-0
   MNEMBUKA BV, 1995, PLANT FOOD HUM NUTR, V47, P333, DOI 10.1007/BF01088271
   MNEMBUKA BV, 1993, PLANT FOOD HUM NUTR, V44, P1, DOI 10.1007/BF01088477
   Mwanjala A.M., 1999, FOOD CHEM, V67, P435
   Onwuliri VA, 2002, FOOD CHEM, V78, P1, DOI 10.1016/S0308-8146(00)00293-4
   Osagie A. U., 1996, Tropical Science, V36, P109
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   PEARCE KN, 1978, J AGR FOOD CHEM, V26, P716, DOI 10.1021/jf60217a041
   Pedrosa C, 1997, J AGR FOOD CHEM, V45, P2025, DOI 10.1021/jf960815k
   Pedrosa C, 2000, ARCH BIOCHEM BIOPHYS, V382, P203, DOI 10.1006/abbi.2000.2024
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P6
   Prinyawiwatkul W, 1997, J AGR FOOD CHEM, V45, P480, DOI 10.1021/jf9603691
   Schwenke KD, 2001, NAHRUNG, V45, P377, DOI 10.1002/1521-3803(20011001)45:6<377::AID-FOOD377>3.0.CO;2-G
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   VOSE JR, 1980, CEREAL CHEM, V57, P406
   WRIGHT DJ, 1984, PHILOS T ROY SOC B, V304, P381, DOI 10.1098/rstb.1984.0033
   WRIGHT JR, 1985, J HEAT RECOV SYST, V5, P81, DOI 10.1016/0198-7593(85)90040-2
NR 45
TC 68
Z9 72
U1 2
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD SEP 10
PY 2003
VL 51
IS 19
BP 5792
EP 5797
DI 10.1021/jf0340052
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 719NQ
UT WOS:000185210100031
PM 12952435
DA 2020-09-29
ER

PT J
AU Botelho, MG
   Gralle, M
   Oliveira, CLP
   Torriani, I
   Ferreira, ST
AF Botelho, MG
   Gralle, M
   Oliveira, CLP
   Torriani, I
   Ferreira, ST
TI Folding and stability of the extracellular domain of the human amyloid
   precursor protein
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID X-RAY-SCATTERING; ALZHEIMERS-DISEASE; BETA-SECRETASE;
   GUANIDINE-HYDROCHLORIDE; INHIBITORY-ACTIVITY; CRYSTAL-STRUCTURE; BUNDLE
   PROTEIN; CELL; DENATURATION; CLEAVAGE
AB The beta-amyloid peptide (Abeta), the major component of the senile plaques found in the brains of Alzheimer's disease patients, is derived from proteolytic processing of a transmembrane glycoprotein known as the amyloid precursor protein (APP). Human APP exists in various isoforms, of which the major ones contain 695, 751, and 770 amino acids. Proteolytic cleavage of APP by alpha- or beta-secretases releases the extracellular soluble fragments sAPPalpha or sAPPbeta, respectively. Despite the fact that sAPPalpha plays important roles in both physiological and pathological processes in the brain, very little is known about its structure and stability. We have recently presented a structural model of sAPPalpha(695) obtained from small-angle x-ray scattering measurements (Gralle, M., Botelho, M. M., Oliveira, C. L. P., Torriani, I., and Ferreira, S. T. ( 2002) Biophys. J. 83, 3513 - 3524). We now report studies on the folding and stabilities of sAPPalpha(695) and sAPPalpha(770). The combined use of intrinsic fluorescence, 4-4'-Dianilino-1,1' binaphthyl-5,5'-disulfonic acid ( bis-ANS) fluorescence, circular dichroism, differential ultraviolet absorption, and small-angle x-ray scattering measurements of the equilibrium unfolding of sAPPalpha(695) and sAPPalpha(770) by GdnHCl and urea revealed multistep folding pathways for both sAPPalpha isoforms. Such stepwise folding processes may be related to the identification of distinct structural domains in the three-dimensional model of sAPPalpha. Furthermore, the relatively low stability of the native state of sAPPalpha suggests that conformational plasticity may play a role in allowing APP to interact with a number of distinct physiological ligands.
C1 Univ Fed Rio de Janeiro, Dept Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
   UNICAMP, Inst Fis Gleb Wataghin, BR-13084971 Campinas, SP, Brazil.
   Lab Nacl Luz Sincrotron, BR-13084970 Campinas, SP, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Dept Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
RI Torriani, Iris L/E-5686-2010; Ferreira, Sergio/AAZ-1576-2020; Gralle,
   Matthias/B-9005-2014; Oliveira, Cristiano L P/B-4403-2008
OI Ferreira, Sergio/0000-0001-7160-9866; Oliveira, Cristiano L
   P/0000-0002-3426-6507
CR Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200
   BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109
   Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200
   Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   De Strooper B, 2000, J CELL SCI, V113, P1857
   DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002
   DONIACH S, 1995, J MOL BIOL, V254, P960, DOI 10.1006/jmbi.1995.0668
   Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113
   Glatter O., 1982, SMALL ANGLE XRAY SCA
   Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4
   Guo J, 1998, INVEST OPHTH VIS SCI, V39, P292
   HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0
   Heber S, 2000, J NEUROSCI, V20, P7951
   Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200
   Hoffmann J, 1999, J HISTOCHEM CYTOCHEM, V47, P373, DOI 10.1177/002215549904700311
   HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002
   Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a
   KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0
   KATAOKA M, 1993, J MOL BIOL, V229, P591, DOI 10.1006/jmbi.1993.1064
   Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829
   KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0
   KOHN WD, 1995, J BIOL CHEM, V270, P25495, DOI 10.1074/jbc.270.43.25495
   KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106
   Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922
   LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004
   Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441
   Martins SM, 2002, EUR J BIOCHEM, V269, P5484, DOI 10.1046/j.1432-1033.2002.03248.x
   MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I
   MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110
   MORJANA NA, 1993, P NATL ACAD SCI USA, V90, P2107, DOI 10.1073/pnas.90.6.2107
   MUROGA Y, 1992, MACROMOLECULES, V25, P3385, DOI 10.1021/ma00039a012
   POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792
   Rassoulzadegan M, 1998, EMBO J, V17, P4647, DOI 10.1093/emboj/17.16.4647
   Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327
   SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2
   SANDBRINK R, 1994, J BIOL CHEM, V269, P14227
   Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X
   Semisotnov GV, 1996, J MOL BIOL, V262, P559, DOI 10.1006/jmbi.1996.0535
   Sester M, 2000, J BIOL CHEM, V275, P3645, DOI 10.1074/jbc.275.5.3645
   Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568
   TENDIAN SW, 1995, BIOCHEMISTRY-US, V34, P6464, DOI 10.1021/bi00019a028
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303
   Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898
   YORK SS, 1978, BIOCHEMISTRY-US, V9, P1038
NR 49
TC 18
Z9 18
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 5
PY 2003
VL 278
IS 36
BP 34259
EP 34267
DI 10.1074/jbc.M303189200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 716UK
UT WOS:000185047500081
PM 12796495
OA Bronze
DA 2020-09-29
ER

PT J
AU Lima, ACP
   Louzada, PR
   De Mello, FG
   Ferreira, ST
AF Lima, ACP
   Louzada, PR
   De Mello, FG
   Ferreira, ST
TI Neuroprotection against A beta and glutamate toxicity by melatonin: Are
   GABA receptors involved?
SO NEUROTOXICITY RESEARCH
LA English
DT Article; Proceedings Paper
CT 1st Meeting of the Neurotoxicity-Society
CY 2003
CL LA SERENA, CHILE
SP Neurotoxic Soc
DE melatonin; GABA; amyloid; glutamate; neuroprotection
ID AMYLOID PEPTIDES; EXCITOTOXICITY; NEUROTOXICITY; CLONAZEPAM; MECHANISM
AB The beta-amyloid peptide (Abeta) is centrally related to the pathogenesis of Alzheimer's disease (AD). Previous studies have suggested that the neurotoxicity of Abeta may be related to the overactivation of glutamatergic transmission and excitotoxicity, and that blockade of glutamate receptors prevents Abeta-induced cell death. Here, we show that melatonin, a pineal hormone, protects chick retinal neurons in culture against the neurotoxicity of Abeta and glutamate. Right-angle light scattering and thioflavin T fluorescence measurements, as well as light microscopy analysis, indicated that, under our experimental conditions, melatonin had no effect on the aggregation of Abeta. Interestingly, the neuroprotective action of melatonin against the toxicity of Abeta was significantly decreased in the presence of picrotoxin, an antagonist of GABA(A)-like receptors. By itself, picrotoxin had no effect. These results suggest that the neuroprotective effects of melatonin against Abeta neurotoxicity could be at least in part related to a decrease in the excitatory tonus, mediated by activation of GABA receptors and the resulting hyperpolarization of the neurons. Thus, selective pharmacological manipulation of neuronal excitatory/inhibitory tonus could be a potentially interesting new approach in the treatment of AD.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020; Paula-Lima, Andrea C./I-2537-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Paula-Lima, Andrea
   C./0000-0002-0466-7561
CR Blanchard BJ, 1997, BRAIN RES, V776, P40, DOI 10.1016/S0006-8993(97)01003-2
   Espinar A, 2000, J PINEAL RES, V28, P81, DOI 10.1034/j.1600-079X.2001.280203.x
   LIPTON SA, 1994, NEW ENGL J MED, V330, P613
   Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3
   MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992
   NILES L, 1991, ADV EXP MED BIOL, V294, P267
   Pappolla M, 1998, J BIOL CHEM, V273, P7185, DOI 10.1074/jbc.273.13.7185
   Pappolla MA, 2002, J PINEAL RES, V32, P135, DOI 10.1034/j.1600-079x.2002.1o838.x
   Pappolla MA, 1997, J NEUROSCI, V17, P1683
   Tan DX, 1998, J NEUROSCI RES, V54, P382, DOI 10.1002/(SICI)1097-4547(19981101)54:3<382::AID-JNR9>3.0.CO;2-Y
   TENN CC, 1995, J PHARMACOL EXP THER, V274, P84
   Tenn CC, 1997, NEUROPHARMACOLOGY, V36, P1659, DOI 10.1016/S0028-3908(97)00165-2
   WESTLINDDANIELS.AW, 2001, BIOCHEMISTRY-US, V40, P14376
NR 13
TC 44
Z9 45
U1 0
U2 4
PU F P GRAHAM PUBLISHING CO
PI MOUNTAIN HOME
PA PO BOX 370, MOUNTAIN HOME, TN 37684 USA
SN 1029-8428
J9 NEUROTOX RES
JI Neurotox. Res.
PY 2003
VL 5
IS 5
BP 323
EP 327
DI 10.1007/BF03033152
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 741RA
UT WOS:000186470000003
PM 14715451
DA 2020-09-29
ER

PT J
AU Gralle, M
   Botelho, MM
   de Oliveira, CLP
   Torriani, I
   Ferreira, ST
AF Gralle, M
   Botelho, MM
   de Oliveira, CLP
   Torriani, I
   Ferreira, ST
TI Solution studies and structural model of the extracellular domain of the
   human amyloid precursor protein
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID SMALL-ANGLE SCATTERING; DIRECT SHAPE DETERMINATION; X-RAY-SCATTERING;
   ALZHEIMERS-DISEASE; BETA-SECRETASE; BIOLOGICAL MACROMOLECULES; SECONDARY
   STRUCTURE; CRYSTAL-STRUCTURE; INHIBITOR DOMAIN; PICHIA-PASTORIS
AB The amyloid precursor protein (APP) is the precursor of the beta-amyloid peptide (Abeta), which is centrally related to the genesis of Alzheimer's disease (AD). In addition, APP has been suggested to mediate and/or participate in events that lead to neuronal degeneration in AD. Despite the fact that various aspects of the cell biology of APP have been investigated, little information on the structure of this protein is available. In this work, the solution structure of the soluble extracellular domain of APP (sAPP, composing 89% of the amino acid residues of the whole protein) has been investigated through a combination of size-exclusion chromatography, circular dichroism, and synchrotron radiation small-angle x-ray scattering (SAXS) studies. sAPP is monomeric in solution (65 kDa obtained from SAXS measurements) and exhibits an anisometric molecular shape, with a Stokes radius of 39 or 51 Angstrom calculated from SAXS or chromatographic data, respectively. The radius of gyration and the maximum molecular length obtained by SAXS were 38 Angstrom and 130 Angstrom, respectively. Analysis of SAXS data further allowed building a structural model for sAPP in solution. Circular dichroism data and secondary structure predictions based on the amino acid sequence of APP suggested that a significant fraction of APP (30% of the amino acid residues) is not involved in standard secondary structure elements, which may explain the elongated shape of the molecule recovered in our structural model. Possible implications of the structure of APP in ligand binding and molecular recognition events involved in the biological functions of this protein are discussed.
C1 Univ Fed Rio de Janeiro, Dept Med Biochem, BR-21944590 Rio De Janeiro, Brazil.
   Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13084971 Campinas, SP, Brazil.
   LNLS, BR-13084970 Campinas, SP, Brazil.
RP Ferreira, ST (corresponding author), Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Gralle, Matthias/B-9005-2014; Torriani, Iris L/E-5686-2010; Ferreira,
   Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t
   Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257
   Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x
   Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613
   BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109
   BUSH AI, 1994, J BIOL CHEM, V269, P26618
   CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055
   Cappai R, 1999, FEBS LETT, V442, P95, DOI 10.1016/S0014-5793(98)01635-4
   Chacon P, 1998, BIOPHYS J, V74, P2760, DOI 10.1016/S0006-3495(98)77984-6
   Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6
   De la Fourniere-Bessueille L, 1997, EUR J BIOCHEM, V250, P705
   De Strooper B, 2000, J CELL SCI, V113, P1857
   DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0
   Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452
   Durkin JT, 1999, J BIOL CHEM, V274, P20499, DOI 10.1074/jbc.274.29.20499
   Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298
   GAST K, 1995, BIOCHEMISTRY-US, V34, P13211, DOI 10.1021/bi00040a037
   Glatter O., 1982, SMALL ANGLE XRAY SCA
   GUINIER A, 1955, SMALL ANGLE XRAY SCA
   HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564
   Heber S, 2000, J NEUROSCI, V20, P7951
   Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748
   HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X
   Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811
   HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0
   Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829
   Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200
   KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0
   KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E
   Koo EH, 1996, J CELL SCI, V109, P991
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922
   Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456
   LUZZATI V, 1961, J MOL BIOL, V3, P379, DOI 10.1016/S0022-2836(61)80051-X
   Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I
   Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683
   Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0
   Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406
   Multhaup G, 1998, BIOCHEMISTRY-US, V37, P7224, DOI 10.1021/bi980022m
   NARINDRASORASAK S, 1992, LAB INVEST, V67, P643
   Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x
   OLIVEIRA CLP, 1997, DATA TREATMENT PROGR
   Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0
   Proudfoot JM, 1997, FREE RADICAL BIO MED, V23, P720, DOI 10.1016/S0891-5849(97)00015-4
   QIU WQ, 1995, J NEUROSCI, V15, P2157
   Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m
   Rassoulzadegan M, 1998, EMBO J, V17, P4647, DOI 10.1093/emboj/17.16.4647
   ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450
   Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327
   SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2
   Sester M, 2000, J BIOL CHEM, V275, P3645, DOI 10.1074/jbc.275.5.3645
   SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0
   SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5
   Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114
   Sisodia SS, 1998, P NATL ACAD SCI USA, V95, P12074, DOI 10.1073/pnas.95.21.12074
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   STUHRMAN.HB, 1970, ACTA CRYSTALL A-CRYS, VA 26, P297, DOI 10.1107/S0567739470000748
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1991, ACTA CRYSTALLOGR A, V47, P736, DOI 10.1107/S0108767391006414
   Svergun DI, 1996, ACTA CRYSTALLOGR A, V52, P419, DOI 10.1107/S0108767396000177
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0
   Trewhella J, 1997, CURR OPIN STRUC BIOL, V7, P702, DOI 10.1016/S0959-440X(97)80081-4
   VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95
   WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758
   WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107
NR 77
TC 24
Z9 24
U1 0
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD DEC
PY 2002
VL 83
IS 6
BP 3513
EP 3524
DI 10.1016/S0006-3495(02)75351-4
PG 12
WC Biophysics
SC Biophysics
GA 633AD
UT WOS:000180256300054
PM 12496118
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Ferreira, ST
AF De Felice, FG
   Ferreira, ST
TI beta-amyloid production, aggregation, and clearance as targets for
   therapy in Alzheimer's disease
SO CELLULAR AND MOLECULAR NEUROBIOLOGY
LA English
DT Review
DE Alzheimer's disease; beta-amyloid peptide; aggregation; AD therapy;
   small-molecule inhibitors; drug development
ID GAMMA-SECRETASE INHIBITORS; RADICAL OXIDATIVE STRESS; INSULIN-DEGRADING
   ENZYME; SHEET BREAKER PEPTIDES; A-BETA; PRECURSOR PROTEIN; FIBRIL
   FORMATION; IN-VIVO; SENILE PLAQUES; BILAYER-MEMBRANES
AB 1. Despite major efforts aimed at elucidating the molecular basis and physiopathology of Alzheimer's disease (AD), there is still no effective treatment available for this devastating disorder. The biological mechanisms underlying the development of AD are complex, as multiple factors appear to modulate (either positively or negatively) the progression of neurodegeneration in the brains of AD patients. Not surprisingly, a number of different therapeutic approaches aimed at distinct aspects of the disease are currently being pursued. Given its central role in the neuropathology of AD, the beta-amyloid peptide (Abeta) is the focus of many such approaches.
   2. In this review, we discuss recent developments along three major lines of investigation: (i) identification and characterization of inhibitors of the enzymes involved in proteolytic processing of the amyloid precursor protein and production of Abeta; (ii) identification of the pathways involved in cerebral degradation and clearance of Abeta; and (iii) characterization of small-molecule inhibitors of amyloid aggregation that prevent cerebral amyloid deposition and neurotoxicity.
   3. Significant progress has been achieved in these directions, opening up new perspectives toward the development of effective approaches for the treatment or prevention of AD.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim, BR-21944590 Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim, BR-21944590 Rio De Janeiro, Brazil.
EM felice@bioqmed.ufrj.br; ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Abraham CR, 2000, ANN NY ACAD SCI, V920, P245
   ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573
   ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567
   Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710
   ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022
   Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525
   Bai DL, 2000, CURR MED CHEM, V7, P355, DOI 10.2174/0929867003375281
   Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682
   Bhatia R, 2000, FASEB J, V14, P1233
   Birmingham K, 2002, NAT MED, V8, P199, DOI 10.1038/nm0302-199b
   Bodovitz S, 1996, J BIOL CHEM, V271, P4436
   Butterfield DA, 1997, CHEM RES TOXICOL, V10, P495, DOI 10.1021/tx960130e
   CAMILLERI P, 1994, FEBS LETT, V341, P256, DOI 10.1016/0014-5793(94)80467-2
   Chesneau V, 2000, BIOCHEM J, V351, P509, DOI 10.1042/0264-6021:3510509
   Citron M, 2000, MOL MED TODAY, V6, P392, DOI 10.1016/S1357-4310(00)01759-7
   Citron M, 1996, NEURON, V17, P171, DOI 10.1016/S0896-6273(00)80290-1
   Cordell GA, 2000, PHYTOCHEMISTRY, V55, P463, DOI 10.1016/S0031-9422(00)00230-2
   Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893
   Czech C, 2000, PROG NEUROBIOL, V60, P363, DOI 10.1016/S0301-0082(99)00033-7
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   Defelice FG, 2002, AN ACAD BRAS CIENC, V74, P265, DOI 10.1590/S0001-37652002000200006
   Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x
   Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899
   Edgar PF, 2000, MOL PSYCHIATR, V5, P85, DOI 10.1038/sj.mp.4000580
   EIKELENBOOM P, 1994, TRENDS PHARMACOL SCI, V15, P447, DOI 10.1016/0165-6147(94)90057-4
   Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638
   Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   GANDY S, 1994, INT REV NEUROBIOL, V36, P29, DOI 10.1016/S0074-7742(08)60302-5
   Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001
   Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827
   Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525
   Giacobini E, 1997, JPN J PHARMACOL, V74, P225, DOI 10.1254/jjp.74.225
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Golde TE, 2001, DRUG DISCOV TODAY, V6, P1049, DOI 10.1016/S1359-6446(01)01965-1
   Grant SGN, 2001, J NEUROSCI, V21, P8315
   Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095
   Haugabook SJ, 2001, J NEUROSCI METH, V108, P171, DOI 10.1016/S0165-0270(01)00388-0
   HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4
   Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150
   Howlett DR, 1999, BIOCHEM J, V340, P283, DOI 10.1042/0264-6021:3400283
   Howlett DR, 1999, BIOCHEM J, V343, P419, DOI 10.1042/0264-6021:3430419
   Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200
   Hughes E, 2000, J BIOL CHEM, V275, P25109, DOI 10.1074/jbc.M003554200
   Iwata N, 2000, NAT MED, V6, P143
   Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946
   IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8
   Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110
   JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x
   Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X
   Kakimura J, 2001, BIOCHEM BIOPH RES CO, V281, P6, DOI 10.1006/bbrc.2001.4299
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0
   Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200
   Klunk WE, 1998, LIFE SCI, V63, P1807, DOI 10.1016/S0024-3205(98)00454-8
   KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419
   Lauer D, 2001, EXP NEUROL, V167, P385, DOI 10.1006/exnr.2000.7569
   Li MD, 2000, J NEUROSCI, V20, P1318
   Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456
   Lin YM, 2001, AMYLOID, V8, P182, DOI 10.3109/13506120109007361
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3
   Lowe TL, 2001, BIOCHEMISTRY-US, V40, P7882, DOI 10.1021/bi002734u
   Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992
   MATTSON MP, 1992, EXP GERONTOL, V27, P29, DOI 10.1016/0531-5565(92)90027-W
   Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4
   Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2
   Mohajeri MH, 2002, J BIOL CHEM, V277, P35460, DOI 10.1074/jbc.M202899200
   Moore CL, 2000, ANN NY ACAD SCI, V920, P197
   Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116
   Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0
   Mukherjee A, 2000, J NEUROSCI, V20, P8745
   National Institute on Aging, 1998, PROGR REP ALZH DIS
   Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7
   Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409
   Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e
   Pappolla M, 1998, J BIOL CHEM, V273, P7185, DOI 10.1074/jbc.273.13.7185
   Pappolla MA, 1997, J NEUROSCI, V17, P1683
   Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7
   Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a
   PIKE CJ, 1993, J NEUROSCI, V13, P1676
   Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.0.CO;2-E
   Poeggeler B, 2001, BIOCHEMISTRY-US, V40, P14995, DOI 10.1021/bi0114269
   POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I
   Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x
   Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779
   Reixach N, 2000, J STRUCT BIOL, V130, P247, DOI 10.1006/jsbi.2000.4245
   Rogers J, 2000, ANN NY ACAD SCI, V924, P132
   Salomon AR, 1996, BIOCHEMISTRY-US, V35, P13568, DOI 10.1021/bi9617264
   Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124
   Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864
   Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200
   Selkoe Dennis J., 1994, Current Opinion in Neurobiology, V4, P708, DOI 10.1016/0959-4388(94)90014-0
   Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295
   SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2
   Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023
   Sennvik K, 2001, J NEUROSCI RES, V63, P429, DOI 10.1002/1097-4547(20010301)63:5<429::AID-JNR1038>3.0.CO;2-U
   SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J
   Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200
   Sigurdsson EM, 2000, J NEUROPATH EXP NEUR, V59, P11, DOI 10.1093/jnen/59.1.11
   SILVA EFDE, 1995, MOL MED, V1, P535, DOI 10.1007/BF03401590
   Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114
   Small DH, 1999, J NEUROCHEM, V73, P443, DOI 10.1046/j.1471-4159.1999.0730443.x
   Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822
   Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3
   Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413
   St George-Hyslop PH, 1999, NATURE, V400, P116
   Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200
   Tomiyama T, 1996, J BIOL CHEM, V271, P6839, DOI 10.1074/jbc.271.12.6839
   Tsuzuki K, 2000, NEUROSCI LETT, V281, P171, DOI 10.1016/S0304-3940(00)00834-X
   Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   Vekrellis K, 2000, J NEUROSCI, V20, P1657
   Verbeek MM, 1997, BIOL CHEM, V378, P937
   Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198
   Wood SJ, 1996, J BIOL CHEM, V271, P4086
   Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107
   Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009
   Zamani MR, 1997, NEUROREPORT, V8, P513, DOI 10.1097/00001756-199701200-00027
NR 120
TC 61
Z9 64
U1 1
U2 16
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4340
EI 1573-6830
J9 CELL MOL NEUROBIOL
JI Cell. Mol. Neurobiol.
PD DEC
PY 2002
VL 22
IS 5-6
BP 545
EP 563
DI 10.1023/A:1021832302524
PG 19
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 632XP
UT WOS:000180250400009
PM 12585679
DA 2020-09-29
ER

PT J
AU Martins, SM
   Chapeaurouge, A
   Ferreira, ST
AF Martins, SM
   Chapeaurouge, A
   Ferreira, ST
TI Equilibrium unfolding and conformational plasticity of troponin I and T
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE troponin I; troponin T; urea; guanidine hydrochloride; circular
   dichroism
ID SKELETAL-MUSCLE; GUANIDINE-HYDROCHLORIDE; ESCHERICHIA-COLI; MOLTEN
   GLOBULE; PROTEIN; BINDING; UREA; DENATURATION; EXPRESSION; STABILITY
AB The structures and stabilities of recombinant chicken muscle troponin I (TnI) and T (TnT) were investigated by a combination of bis-ANS binding and equilibrium unfolding studies. Unlike most folded proteins, isolated TnI and TnT bind the hydrophobic fluorescent probe bis-ANS, indicating the existence of solvent-exposed hydrophobic domains in their structures. Bis-ANS binding to binary or ternary mixtures of TnI, TnT and troponin C (TnC) in solution is significantly lower than binding to the isolated subunits, which can be explained by burial of previously exposed hydrophobic domains upon association of the subunits to form the native troponin complex. Equilibrium unfolding studies of TnT and TnI by guanidine hydrochloride and urea monitored by changes in far-UV CD and bis-ANS fluorescence revealed noncooperative folding transitions for both proteins and the existence of partially folded intermediate states. Taken together, these results indicate that isolated TnI and TnT are partially unstructured proteins, and suggest that conformational plasticity of the isolated subunits may play an important role in macromolecular recognition for the assembly of the troponin complex.
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250
   Bothra A, 1998, J BIOMOL STRUCT DYN, V15, P959, DOI 10.1080/07391102.1998.10508216
   DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5
   FARAH CS, 1994, J BIOL CHEM, V269, P5230
   Frostfeldt G, 2001, CORONARY ARTERY DIS, V12, P227, DOI 10.1097/00019501-200105000-00009
   Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   Haugland RP, 1996, HDB FLUORESCENT PROB
   HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0
   HUANG TS, 1974, FEBS LETT, V42, P249, DOI 10.1016/0014-5793(74)80738-6
   Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504
   KUMON A, 1979, BIOCHIM BIOPHYS ACTA, V566, P305, DOI 10.1016/0005-2744(79)90034-2
   Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594
   MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110
   MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461
   Morjana N, 1998, BIOTECHNOL APPL BIOC, V28, P7
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   OLAH GA, 1994, BIOCHEMISTRY-US, V33, P12800, DOI 10.1021/bi00209a011
   PEARLMAN JA, 1994, FEBS LETT, V354, P183, DOI 10.1016/0014-5793(94)01119-2
   PERRY SV, 1974, BIOCHEM J, V141, P733, DOI 10.1042/bj1410733
   QUAGGIO RB, 1993, PROTEIN SCI, V2, P1053, DOI 10.1002/pro.5560020618
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   SHI L, 1994, BIOCHEMISTRY-US, V33, P7536, DOI 10.1021/bi00190a006
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   SMILLIE LB, 1988, J BIOL CHEM, V263, P18816
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Stefancsik R, 1998, P NATL ACAD SCI USA, V95, P957, DOI 10.1073/pnas.95.3.957
   Stone DB, 1998, J MOL BIOL, V281, P689, DOI 10.1006/jmbi.1998.1965
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   TANOKURA M, 1983, J BIOCHEM, V93, P331, DOI 10.1093/oxfordjournals.jbchem.a134185
   TENDIAN SW, 1995, BIOCHEMISTRY-US, V34, P6464, DOI 10.1021/bi00019a028
   Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.ph.58.030196.002311
   Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x
   Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847
   WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0
   WILKINSON JM, 1978, EUR J BIOCHEM, V82, P493, DOI 10.1111/j.1432-1033.1978.tb12043.x
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   WU CSC, 1976, BIOCHEMISTRY-US, V15, P3007, DOI 10.1021/bi00659a011
   Zhang J, 1998, BIOCHEMISTRY-US, V37, P14881, DOI 10.1021/bi9811157
NR 40
TC 12
Z9 12
U1 0
U2 1
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD NOV
PY 2002
VL 269
IS 22
BP 5484
EP 5491
DI 10.1046/j.1432-1033.2002.03248.x
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 613CX
UT WOS:000179115100016
PM 12423346
DA 2020-09-29
ER

PT J
AU Defelice, FG
   Ferreira, ST
AF Defelice, FG
   Ferreira, ST
TI Physiopathological modulators of amyloid aggregation and novel
   pharmacological approaches in Alzheimer's disease
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Review
DE Alzheimer's disease; A beta peptide; aggregation; neurotoxicity;
   physiopathological modulators
ID A-BETA PEPTIDE; ESTROGEN REPLACEMENT THERAPY; GAMMA-SECRETASE
   INHIBITORS; INSULIN-DEGRADING ENZYME; PROTEIN FIBRIL FORMATION;
   LOW-DENSITY-LIPOPROTEIN; SHEET BREAKER PEPTIDES; CENTRAL-NERVOUS-SYSTEM;
   PRECURSOR PROTEIN; IN-VITRO
AB The biological mechanisms underlying the neuropathology of Alzheimer's disease (AD) are complex. as several factors likely contribute to the development of the disease, Therefore. it is not surprising that a number of different possible therapeutic approaches addressing distinct aspects of this disease are currently being investigated. Among these are ways to prevent amyloid aggregation and/or deposition. to prevent neuronal degeneration, and to increase brain neurotransmitter levels. Here, we discuss possible roles of endogenous modulators of Abeta aggregation in the physiopathology of AD and some of the strategies currently under consideration to interfere with brain levels of beta-amyloid, its aggregation and neurotoxicity.
C1 Univ Fed Rio de Janeiro, Inst Biomed Sci, Dept Biochem Med, BR-21944590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Dept Biochem Med, BR-21944590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X
   Abraham CR, 2000, ANN NY ACAD SCI, V920, P245
   Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X
   AlonsoSolis R, 1996, CELL MOL NEUROBIOL, V16, P357, DOI 10.1007/BF02088101
   Alvarez A, 1997, J MOL BIOL, V272, P348, DOI 10.1006/jmbi.1997.1245
   ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022
   Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817
   Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525
   Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682
   BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647
   Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990
   BRIELAND JK, 1991, ARCH BIOCHEM BIOPHYS, V284, P78, DOI 10.1016/0003-9861(91)90266-L
   Brown AM, 1997, J NEUROCHEM, V69, P1204
   BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x
   BUEE L, 1993, BRAIN RES, V627, P199, DOI 10.1016/0006-8993(93)90321-D
   BUEE L, 1993, BRAIN RES, V601, P154, DOI 10.1016/0006-8993(93)91706-X
   BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293
   Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x
   Castillo GM, 1997, J NEUROCHEM, V69, P2452
   Cherny RA, 2000, J STRUCT BIOL, V130, P209, DOI 10.1006/jsbi.2000.4285
   Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223
   Chesneau V, 2000, BIOCHEM J, V351, P509, DOI 10.1042/0264-6021:3510509
   Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937
   Citron M, 1996, NEURON, V17, P171, DOI 10.1016/S0896-6273(00)80290-1
   Clapp-Lilly KL, 2001, CHEM-BIOL INTERACT, V134, P101, DOI 10.1016/S0009-2797(00)00319-7
   Clements A, 1996, J NEUROCHEM, V66, P740
   Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816
   Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292
   Daniels WMU, 1998, J PINEAL RES, V24, P78, DOI 10.1111/j.1600-079X.1998.tb00370.x
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   De Ferrari GV, 2001, BIOCHEMISTRY-US, V40, P10447, DOI 10.1021/bi0101392
   DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398
   DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081
   Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x
   Drouet B, 2001, J NEUROCHEM, V76, P117, DOI 10.1046/j.1471-4159.2001.00047.x
   Du YS, 1998, J NEUROCHEM, V70, P1182
   ERIKSSON S, 1995, P NATL ACAD SCI USA, V92, P2313, DOI 10.1073/pnas.92.6.2313
   EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763
   Ferreira ST, 2001, FEBS LETT, V498, P129, DOI 10.1016/S0014-5793(01)02491-7
   FRASER PE, 1993, J NEUROCHEM, V61, P298, DOI 10.1111/j.1471-4159.1993.tb03568.x
   FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3
   FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x
   Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200
   Frenkel D, 1998, J NEUROIMMUNOL, V88, P85, DOI 10.1016/S0165-5728(98)00098-8
   Frenkel D, 2000, J NEUROIMMUNOL, V106, P23, DOI 10.1016/S0165-5728(99)00232-5
   Frenkel D, 1999, J NEUROIMMUNOL, V95, P136, DOI 10.1016/S0165-5728(99)00003-X
   Games D, 2000, ANN NY ACAD SCI, V920, P274
   GANDY S, 1994, INT REV NEUROBIOL, V36, P29, DOI 10.1016/S0074-7742(08)60302-5
   Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827
   Giacobini E, 1997, JPN J PHARMACOL, V74, P225, DOI 10.1254/jjp.74.225
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Gouras GK, 2000, P NATL ACAD SCI USA, V97, P1202, DOI 10.1073/pnas.97.3.1202
   Gridley KE, 1997, BRAIN RES, V778, P158, DOI 10.1016/S0006-8993(97)01056-1
   Gupta-Bansal R, 1998, J NEUROCHEM, V70, P292
   Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916
   Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2
   Head E, 2001, NEUROBIOL DIS, V8, P252, DOI 10.1006/nbdi.2000.0380
   HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4
   Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150
   Hosoda T, 2001, NEUROREPORT, V12, P1965, DOI 10.1097/00001756-200107030-00038
   Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464
   Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275
   INOUYE H, 1993, BIOPHYS J, V64, P502, DOI 10.1016/S0006-3495(93)81393-6
   Iwata N, 2000, NAT MED, V6, P143
   JAFFE AB, 1994, J BIOL CHEM, V269, P13065
   Janciauskiene S, 1996, NAT STRUCT BIOL, V3, P668, DOI 10.1038/nsb0896-668
   Janciauskiene S, 1998, J BIOL CHEM, V273, P28360, DOI 10.1074/jbc.273.43.28360
   Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110
   Kakimura J, 2001, BIOCHEM BIOPH RES CO, V281, P6, DOI 10.1006/bbrc.2001.4299
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0
   Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517
   Kiuchi Y, 2001, NEUROSCI LETT, V305, P119, DOI 10.1016/S0304-3940(01)01831-6
   KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419
   Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k
   LAMB DJ, 1994, FEBS LETT, V352, P15, DOI 10.1016/0014-5793(94)00903-1
   Lauer D, 2001, EXP NEUROL, V167, P385, DOI 10.1006/exnr.2000.7569
   LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584
   Li R, 2000, J NEUROCHEM, V75, P1447, DOI 10.1046/j.1471-4159.2000.0751447.x
   Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456
   Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6
   Lukacs CM, 1996, PROTEINS, V25, P420, DOI 10.1002/(SICI)1097-0134(199608)25:4<420::AID-PROT2>3.3.CO;2-I
   Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059
   MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0
   Manthey D, 2001, EUR J BIOCHEM, V268, P4285, DOI 10.1046/j.1432-1327.2001.02346.x
   MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x
   Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671
   McLaurin J, 1997, EUR J BIOCHEM, V245, P355, DOI 10.1111/j.1432-1033.1997.t01-2-00355.x
   McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482
   McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x
   McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677
   McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199
   MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959
   Moir RD, 1999, BIOCHEMISTRY-US, V38, P4595, DOI 10.1021/bi982437d
   Monji A, 1998, BRAIN RES, V796, P171, DOI 10.1016/S0006-8993(98)00342-4
   MookJung I, 1997, NEUROSCI LETT, V235, P101, DOI 10.1016/S0304-3940(97)00632-0
   Moore CL, 2000, ANN NY ACAD SCI, V920, P197
   Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116
   Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0
   Mukherjee A, 2000, J NEUROSCI, V20, P8745
   Nilsson LNG, 2001, J NEUROSCI, V21, P1444
   Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7
   ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080
   Pappolla M, 1998, J BIOL CHEM, V273, P7185, DOI 10.1074/jbc.273.13.7185
   Pappolla MA, 1999, J PINEAL RES, V27, P226, DOI 10.1111/j.1600-079X.1999.tb00619.x
   Pappolla MA, 1997, J NEUROSCI, V17, P1683
   Pappolla MA, 2000, J NEURAL TRANSM, V107, P203, DOI 10.1007/s007020050018
   Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7
   PIKE CJ, 1993, J NEUROSCI, V13, P1676
   Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.0.CO;2-E
   Price DL, 1998, NAT GENET, V19, P314, DOI 10.1038/1196
   Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x
   Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124
   Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864
   Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200
   Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4
   SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105
   Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023
   Sennvik K, 2001, J NEUROSCI RES, V63, P429, DOI 10.1002/1097-4547(20010301)63:5<429::AID-JNR1038>3.0.CO;2-U
   Seshadri S, 2001, ARCH NEUROL-CHICAGO, V58, P435, DOI 10.1001/archneur.58.3.435
   SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J
   Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200
   Sigurdsson EM, 2000, J NEUROPATH EXP NEUR, V59, P11, DOI 10.1093/jnen/59.1.11
   Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4
   SILVA EFDE, 1995, MOL MED, V1, P535, DOI 10.1007/BF03401590
   Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114
   SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503
   SKENE DJ, 1990, BRAIN RES, V528, P170, DOI 10.1016/0006-8993(90)90214-V
   Small DH, 1999, J NEUROCHEM, V73, P443, DOI 10.1046/j.1471-4159.1999.0730443.x
   SNOW AD, 1995, ARCH BIOCHEM BIOPHYS, V320, P84, DOI 10.1006/abbi.1995.1345
   Snow AD, 1996, EXP NEUROL, V138, P305, DOI 10.1006/exnr.1996.0069
   SNOW AD, 1992, J HISTOCHEM CYTOCHEM, V40, P105, DOI 10.1177/40.1.1370306
   SNOW AD, 1988, AM J PATHOL, V133, P456
   Solomon B, 1996, P NATL ACAD SCI USA, V93, P452, DOI 10.1073/pnas.93.1.452
   Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109
   Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822
   Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3
   Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413
   St George-Hyslop PH, 1999, NATURE, V400, P116
   Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200
   Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374
   Talesa VN, 2001, MECH AGEING DEV, V122, P1961, DOI 10.1016/S0047-6374(01)00309-8
   TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525
   TERZI E, 1994, BIOCHEMISTRY-US, V33, P7434, DOI 10.1021/bi00189a051
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   Vekrellis K, 2000, J NEUROSCI, V20, P1657
   Verbeek MM, 1997, BIOL CHEM, V378, P937
   Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617
   Webster S, 1995, BIOCHEM BIOPH RES CO, V217, P869, DOI 10.1006/bbrc.1995.2852
   WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I
   Wood SJ, 1996, CHEM BIOL, V3, P949, DOI 10.1016/S1074-5521(96)90183-0
   Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447
   Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107
   Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970
   Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4
   Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009
   Zhang Y, 2001, J NEUROSCI, V21, part. no.
NR 158
TC 14
Z9 14
U1 0
U2 3
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD JUN
PY 2002
VL 74
IS 2
BP 265
EP 284
DI 10.1590/S0001-37652002000200006
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 556FL
UT WOS:000175838700006
PM 12098753
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Chapeaurouge, A
   Johansson, JS
   Ferreira, ST
AF Chapeaurouge, A
   Johansson, JS
   Ferreira, ST
TI Folding of a de novo designed native-like four-helix bundle protein
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID COLD DENATURATION; ARC REPRESSOR; PRESSURE; DISSOCIATION; INTERMEDIATE;
   STABILITY; ASSOCIATION; RECEPTOR; BINDING; MODEL
AB The folding of a model native-like dimeric four-helix bundle protein, (alpha(2))(2), was investigated using guanidine hydrochloride, hydrostatic pressure, and low temperature. Unfolding by guanidine hydrochloride followed by circular dichroism and intrinsic fluorescence spectroscopy revealed a highly cooperative transition between the native-like and unfolded states, with free energy of unfolding determined from CD data, DeltaG(unf) = 14.3 +/- 0.8 kcal/mol. However, CD and intrinsic fluorescence data were not superimposable, indicating the presence of an intermediate state during the folding transition. To stabilize the folding intermediate, we used hydrostatic pressure and low temperature. In both cases, dissociation of the dimeric native-like (alpha(2))(2) into folded monomers (alpha(2)) was observed, van't Hoff analysis of the low temperature experiments, assuming a two-state dimer 171-monomer transition, yielded a free energy of dissociation of (alpha(2))(2) of DeltaG(diss) = 11.4 +/- 0.4 kcal/mol, in good agreement with the free energy determined from pressure dissociation experiments (DeltaG(diss) = 10.5 +/- 0.1 kcal/mol). Binding of the hydrophobic fluorescent probe 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid (bis-ANS) to the pressure- and cold-dissociated states of (alpha(2))(2) indicated the existence of molten-globule monomers. In conclusion, we demonstrate that the folding pathway of (alpha(2))(2) can be described by a three-state transition including a monomeric molten globule-like state.
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA.
RP Chapeaurouge, A (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM55876] Funding Source: Medline
CR Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200
   DeGrado WF, 1991, CURR OPIN STRUC BIOL, V1, P984, DOI 10.1016/0959-440X(91)90095-B
   DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776
   Gibney BR, 1997, J AM CHEM SOC, V119, P2323, DOI 10.1021/ja963561s
   Gibney BR, 1997, BIOCHEMISTRY-US, V36, P2798, DOI 10.1021/bi9618225
   Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329
   Johansson JS, 1998, BIOCHEMISTRY-US, V37, P1421, DOI 10.1021/bi9721290
   KAMTEKAR S, 1995, FASEB J, V9, P1013
   LEDERER F, 1981, J MOL BIOL, V148, P427, DOI 10.1016/0022-2836(81)90185-6
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PENG XD, 1993, P NATL ACAD SCI USA, V90, P1776, DOI 10.1073/pnas.90.5.1776
   Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280
   PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612
   Ptitsyn Oleg B., 1992, P243
   RALEIGH DP, 1992, J AM CHEM SOC, V114, P10079, DOI 10.1021/ja00051a061
   Richardson JM, 2000, BIOCHEMISTRY-US, V39, P11154, DOI 10.1021/bi000610b
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6
   RUAN K, 1993, BIOCHEMISTRY-US, V32, P6293
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   Sauder JM, 1998, FOLD DES, V3, P293, DOI 10.1016/S1359-0278(98)00040-6
   Sikorski A, 1998, BIOPHYS J, V75, P92, DOI 10.1016/S0006-3495(98)77497-1
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   Vis H, 1998, J AM CHEM SOC, V120, P6427, DOI 10.1021/ja9811187
   WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X
   WILSON C, 1994, STRUCTURE, V2, P713, DOI 10.1016/S0969-2126(00)00072-1
   YORK SS, 1978, BIOCHEMISTRY-US, V21, P4480
NR 29
TC 32
Z9 32
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 10
PY 2002
VL 277
IS 19
BP 16478
EP 16483
DI 10.1074/jbc.M105232200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 551MB
UT WOS:000175564500020
PM 11832477
OA Bronze
DA 2020-09-29
ER

PT J
AU Lopes, DHJ
   Maria-Engler, SS
   Sogayar, MC
   Ferreira, ST
AF Lopes, DHJ
   Maria-Engler, SS
   Sogayar, MC
   Ferreira, ST
TI Human amylin: Mechanisms of amyloidogenesis in the pancreatic islets and
   potential role in diabetes mellitus
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 Univ Fed Rio de Janeiro, BR-21941590 Rio De Janeiro, Brazil.
   Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
RI Engler, Silvya Stuchi Maria/K-5936-2016; Ferreira, Sergio/AAZ-1576-2020;
   Sogayar, Mari C/B-3980-2017
OI Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Ferreira,
   Sergio/0000-0001-7160-9866; Sogayar, Mari C/0000-0003-4805-4609
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2002
VL 82
IS 1
MA 1481A
BP 306A
EP 306A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 511EY
UT WOS:000173252701498
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Nascimento, MN
   Morozova-Roche, L
   Dobson, CM
   Ferreira, ST
AF De Felice, FG
   Nascimento, MN
   Morozova-Roche, L
   Dobson, CM
   Ferreira, ST
TI Entrapping amyloidogenic partially folded intermediates of human
   lysozyme using hydrostatic pressure
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, Brazil.
   Umea Univ, S-90187 Umea, Sweden.
   Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 2
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2002
VL 82
IS 1
MA 1560
BP 321A
EP 322A
PN 2
PG 2
WC Biophysics
SC Biophysics
GA 511EY
UT WOS:000173252701577
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   De Felice, FG
AF Ferreira, ST
   De Felice, FG
TI Protein dynamics, folding and misfolding: from basic physical chemistry
   to human conformational diseases
SO FEBS LETTERS
LA English
DT Article
DE deterministic behavior; molecular individuality; conformational disease;
   amyloidosis; prion; spongiform encephalopathy; Alzheimer's disease
ID HUMAN PRION PROTEIN; TRIOSE PHOSPHATE ISOMERASE; ALZHEIMERS-DISEASE;
   PRESSURE DISSOCIATION; SUPEROXIDE-DISMUTASE; NMR STRUCTURE;
   FLUORESCENCE; NEUROTOXICITY; SPECTROSCOPY; STABILITY
AB Proteins exhibit a variety of motions ranging from amino acid side-chain rotations to the motions of large domains, Recognition of their conformational flexibility has led to the view that protein molecules undergo fast dynamic interconversion between different conformational substates, This proposal has received support from a wide variety of experimental techniques and from computer simulations of protein dynamics. More recently, studies of the subunit dissociation of oligomeric proteins induced by hydrostatic pressure have shown that the characteristic times for subunit exchange between oligomers and for interconversion between different conformations may be rather slow (hours or days). In such cases, proteins cannot be treated as an ensemble of rapidly interconverting conformational substates, but rather as a persistently heterogeneous population of different long-lived conformers. This is reminiscent of the deterministic behavior exhibited by macroscopic bodies, and may have important implications for our understanding of protein folding and biological functions. Here, we propose that the deterministic behavior of proteins may be closely related to the genesis of conformational diseases, a class of pathological conditions that includes transmissible spongiform encephalopathies, Alzheimer's disease and other amyloidosis, (C) 2001 Published by Elsevier Science B,V, on behalf of the Federation of European Biochemical Societies.
C1 Fed Univ Rio De Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Fed Univ Rio De Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0
   ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223
   ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000
   BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002
   BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801
   BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036
   CARERI G, 1984, FLUCTUATING ENZYME, pCH10
   Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632
   Clarke AR, 2001, PHILOS T ROY SOC B, V356, P185, DOI 10.1098/rstb.2000.0764
   DAPOIAN AT, 1993, J MOL BIOL, V231, P999, DOI 10.1006/jmbi.1993.1347
   DEFEICE FG, 2001, FASEB J
   ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022
   FERREIRA ST, 1994, BIOPHYS J, V66, P1185, DOI 10.1016/S0006-3495(94)80901-4
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933
   FRAUENFELDER H, 1986, METHOD ENZYMOL, V127, P207
   Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334
   Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827
   GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0
   Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916
   Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935
   James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086
   KARPLUS M, 1983, ANNU REV BIOCHEM, V52, P263, DOI 10.1146/annurev.bi.52.070183.001403
   LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044
   Linderstrom-Lang K. U., 1958, S PROTEIN STRUCTURE
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   MEI G, 1992, BIOCHEMISTRY-US, V31, P7224, DOI 10.1021/bi00147a003
   ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201
   PIKE CJ, 1993, J NEUROSCI, V13, P1676
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SUBRAMANIAM V, 1995, BIOCHEMISTRY-US, V34, P1133, DOI 10.1021/bi00004a005
   Subramaniam V, 1996, PROTEIN SCI, V5, P2089, DOI 10.1002/pro.5560051015
   SUN AQ, 1992, J BIOL CHEM, V267, P20168
   Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m
   Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079
   Verbeek MM, 1997, BIOL CHEM, V378, P937
   WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165
   Weber G, 1996, BIOPHYS J, V70, P167, DOI 10.1016/S0006-3495(96)79557-7
   WEBER G, 1992, PROTEIN INTERACTIONS
   WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447
   WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719
   Wuthrich K, 1981, Biochem Soc Symp, P17
   Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145
NR 50
TC 56
Z9 60
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUN 8
PY 2001
VL 498
IS 2-3
BP 129
EP 134
DI 10.1016/S0014-5793(01)02491-7
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 444VG
UT WOS:000169420300003
PM 11412843
DA 2020-09-29
ER

PT J
AU Souza-Santos, P
   Ramos, RS
   Ferreira, ST
   Carvalho-Alves, PC
AF Souza-Santos, P
   Ramos, RS
   Ferreira, ST
   Carvalho-Alves, PC
TI Iron-induced oxidative damage of corn root plasma membrane H+-ATPase
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE H+-ATPase; plasma membrane; iron; oxidative stress; plant
ID SARCOPLASMIC-RETICULUM CA2+-ATPASE; METAL-CATALYZED OXIDATION;
   LIPID-PEROXIDATION; OXYGEN RADICALS; PROTEIN DAMAGE; BINDING-SITE;
   FRAGMENTATION; CONSEQUENCES; DEGRADATION; MECHANISM
AB The effect of iron on the activity of the plasma membrane H+-ATPase (PMA) from corn root microsomal fraction (CRMF) was investigated. In the presence of either Fe2+ or Fe3+ (100-200 muM of FeSO4 or FeCl3, respectively), 80-90% inhibition of ATP hydrolysis by PMA was observed. Half-maximal inhibition was attained at 25 muM and 50 muM for Fe2+ and Fe3+, respectively. Inhibition of the ATPase activity was prevented in the presence of metal ion chelators such as EDTA, deferoxamine or o-phenanthroline in the incubation medium. However, preincubation of CRMF in the presence of 100 muM Fe2+, but not with 100 muM Fe3+, rendered the ATPase activity (measured in the presence of excess EDTA) irreversibly inhibited. Inhibition was also observed using a preparation further enriched in plasma membranes by gradient centrifugation. Addition of 0.5 mM ATP to the preincubation medium, either in the presence or in the absence of 5 mM MgCl2, reduced the extent of irreversible inhibition of the H+-ATPase. Addition of 40 muM butylated hydroxytoluene and/or 5 mM dithiothreitol, or deoxygenation of the incubation medium by bubbling a stream of argon in the solution, also caused significant protection of the ATPase activity against irreversible inhibition by iron. Western blots of CRMF probed with a polyclonal antiserum against the yeast plasma membrane H+-ATPase showed a 100 kDa cross-reactive band, which disappeared in samples previously exposed to 500 muM Fe2+. Interestingly, preservation of the 100 kDa band was observed when CRMF were exposed to Fe2+ in the presence of either 5 mM dithiothreitol or 40 muM butylated hydroxytoluene. These results indicate that iron causes irreversible inhibition of the corn root plasma membrane H+-ATPase by oxidation of sulfhydryl groups of the enzyme following lipid peroxidation. (C) 2001 Published by Elsevier Science B.V.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Carvalho-Alves, PC (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM pccalves@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X
   Belogrudov GI, 1996, ARCH BIOCHEM BIOPHYS, V335, P131, DOI 10.1006/abbi.1996.0490
   BIENFAIT HF, 1988, J PLANT NUTR, V11, P605, DOI 10.1080/01904168809363828
   BOUCHEPILLON S, 1994, PLANT PHYSIOL, V105, P691, DOI 10.1104/pp.105.2.691
   BRISKIN DP, 1988, PLANT PHYSIOL, V88, P84, DOI 10.1104/pp.88.1.84
   Buege J A, 1978, Methods Enzymol, V52, P302
   Castilho RF, 1996, MOL CELL BIOCHEM, V159, P105, DOI 10.1007/BF00420912
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9908
   FAGIAN MM, 1990, J BIOL CHEM, V265, P19955
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Frias I, 1996, PLANT CELL, V8, P1533
   Gallego SM, 1996, PLANT SCI, V121, P151, DOI 10.1016/S0168-9452(96)04528-1
   GRUBMEYER C, 1981, J BIOL CHEM, V264, P5929
   GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815
   Halliwell B, 1989, FREE RADICALS BIOL M
   KAMPFENKEL K, 1995, PLANT PHYSIOL, V107, P725, DOI 10.1104/pp.107.3.725
   KISS T, 1994, PHARMACOL REV, V46, P245
   KORGE P, 1993, ARCH BIOCHEM BIOPHYS, V304, P420, DOI 10.1006/abbi.1993.1370
   Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MINOTTI G, 1987, J BIOL CHEM, V262, P1098
   Moreau VH, 1998, FREE RADICAL BIO MED, V25, P554, DOI 10.1016/S0891-5849(98)00084-7
   Morsomme P, 2000, BBA-BIOMEMBRANES, V1465, P1, DOI 10.1016/S0005-2736(00)00128-0
   ORRENIUS S, 1989, CELL CALCIUM METABOL, P451
   Palmgren MG, 1998, ADV BOT RES, V28, P1
   PLATIS IE, 1993, BIOCHEMISTRY-US, V32, P12761, DOI 10.1021/bi00210a027
   ROHN TT, 1993, BIOCHEM PHARMACOL, V46, P525, DOI 10.1016/0006-2952(93)90530-A
   ROMHELD V, 1991, PLANT SOIL, V130, P127, DOI 10.1007/BF00011867
   SAMUELS AL, 1992, PLANT PHYSIOL, V99, P1509, DOI 10.1104/pp.99.4.1509
   SERRANO R, 1989, ANNU REV PLANT PHYS, V40, P61
   SERRANO R, 1988, METHOD ENZYMOL, V157, P533
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   SUSSMAN MR, 1994, ANNU REV PLANT PHYS, V45, P211, DOI 10.1146/annurev.pp.45.060194.001235
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TRUMP BF, 1989, CELL CALCIUM METABOL, P441
   UCHIDA K, 1990, BIOCHEM BIOPH RES CO, V169, P265, DOI 10.1016/0006-291X(90)91463-3
   Viner RI, 1997, BIOCHEMISTRY-US, V36, P7706, DOI 10.1021/bi970058z
   Viner RI, 1996, FREE RADICAL RES, V24, P243, DOI 10.3109/10715769609088022
   Xu KY, 1997, ANN NY ACAD SCI, V834, P680, DOI 10.1111/j.1749-6632.1997.tb52349.x
   Xu KY, 1997, CIRC RES, V80, P76, DOI 10.1161/01.RES.80.1.76
   YAMADA S, 1978, J BIOL CHEM, V253, P6801
NR 44
TC 11
Z9 12
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD JUN 6
PY 2001
VL 1512
IS 2
BP 357
EP 366
DI 10.1016/S0005-2736(01)00341-8
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 444TG
UT WOS:000169415700022
PM 11406113
DA 2020-09-29
ER

PT J
AU Ramirez-Silva, L
   Ferreira, ST
   Nowak, T
   de Gomez-Puyou, MT
   Gomez-Puyou, A
AF Ramirez-Silva, L
   Ferreira, ST
   Nowak, T
   de Gomez-Puyou, MT
   Gomez-Puyou, A
TI Dimethylsulfoxide promotes K+-independent activity of pyruvate kinase
   and the acquisition of the active catalytic conformation
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE catalytic conformation; cosolvents; dimethylsulfoxide; pyruvate kinase
ID RABBIT MUSCLE; POLYETHYLENE-GLYCOL; ANGSTROM RESOLUTION;
   SELF-ASSOCIATION; ACTIVATION; WATER; MECHANISM; PHOSPHOFRUCTOKINASE;
   ENZYMOLOGY; PROTEINS
AB Pyruvate kinase requires K+ for maximal activity; the enzyme exhibits 0.02% of maximal activity in its absence [Kayne, EJ. (1971) Arch. Biochem. Biophys. 143, 232-239]. However, pyruvate kinase entrapped in reverse micelles exhibits an important K+-independent activity [Ramirez-Silva,L., Tuena de Gomez-Puyou,M., & Gomez-Puyou, A. (1993) Biochemistry 32, 5332-5338]. It is possible that the amount of water, as well as interactions of the protein with the micelles, can account for this behavior. We therefore explored the solvent effects on the catalytic properties of muscle pyruvate kinase. The enzyme exhibited an activity of 19.4 mu mol min(-1). mg(-1) in 40% dimethylsulfoxide, compared with 280 and 0.023 mu mol. min(-1).mg(-1) observed with and without K+ in water, respectively. pH activity profiles and kinetic constants for the substrates of pyruvate kinase in dimethylsulfoxide without K+ were similar to those in 100% water with K+, and differed from those in water without K+. The spectral center of mass of the emission spectrum of pyruvate kinase in 100% water exhibited a blue shift of 3.5 nm in the presence of Mg2+, phosphenolpyruvate, and K+, ligands that induce the active conformation of the enzyme. The spectral center of mass of the apoenzyme in 30-40% dimethylsulfoxide coincided with that of the enzyme -Mg2+ -phosphenolpyruvate-K+ complex in 100% water. The water relaxation rate enhancement factor and binding of phosphenolpyruvate to the pyruvate kinase-Mn2+-(CH3)(4)N+ complex in 30-40% dimethylsulfoxide were similar to those of the pyruvate kinase-Mn2+-K+ complex in water. The aforementioned results indicate that when muscle pyruvate kinase is without K+, 30-40% dimethylsulfoxide induces its active conformation.
C1 Natl Autonomous Univ Mexico, Dept Bioquim, Fac Med, Mexico City 04510, DF, Mexico.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941 Rio De Janeiro, Brazil.
   Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.
   Natl Autonomous Univ Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.
RP Ramirez-Silva, L (corresponding author), Natl Autonomous Univ Mexico, Dept Bioquim, Fac Med, Apartado Postal 70-159, Mexico City 04510, DF, Mexico.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Almarsson O, 1996, BIOTECHNOL BIOENG, V49, P87, DOI 10.1002/(SICI)1097-0290(19960105)49:1<87::AID-BIT11>3.0.CO;2-8
   ARAKAWA T, 1985, BIOCHEMISTRY-US, V24, P6756, DOI 10.1021/bi00345a005
   ARNETT EM, 1966, J AM CHEM SOC, V88, P5031, DOI 10.1021/ja00973a052
   Bhattacharjya S, 1997, PROTEINS, V29, P492, DOI 10.1002/(SICI)1097-0134(199712)29:4<492::AID-PROT9>3.0.CO;2-A
   BOSCA L, 1985, J BIOL CHEM, V260, P2100
   BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9
   CHAN TC, 1976, J SOLUTION CHEM, V5, P107, DOI 10.1007/BF00648893
   CHANGWEI L, 1998, BIOCHIM BIOPHYS ACTA, V1385, P53
   COHN M, 1963, BIOCHEMISTRY-US, V2, P623, DOI 10.1021/bi00904a001
   COTTAM GL, 1969, J BIOL CHEM, V244, P1481
   DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2
   GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023
   Hlavaty JJ, 2000, BIOCHEMISTRY-US, V39, P1373, DOI 10.1021/bi991692a
   JACKSON M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P231, DOI 10.1016/0167-4838(91)90563-F
   JEANICKE R, 1968, EUR J BIOCHEM, V4, P157
   Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5
   KACHMAR JF, 1953, J BIOL CHEM, V200, P669
   KASAHARA M, 1978, J BIOL CHEM, V253, P4180
   KAYNE FJ, 1971, ARCH BIOCHEM BIOPHYS, V143, P232, DOI 10.1016/0003-9861(71)90204-9
   KAYNE FJ, 1965, J AM CHEM SOC, V87, P897, DOI 10.1021/ja01082a035
   KAYNE FJ, 1970, J AM CHEM SOC, V92, P220, DOI 10.1021/ja00704a048
   KITA Y, 1994, BIOCHEMISTRY-US, V33, P15178, DOI 10.1021/bi00254a029
   KNOLL D, 1983, J BIOL CHEM, V258, P5710
   LARRETAGARDE V, 1988, BIOCHEM BIOPH RES CO, V155, P816, DOI 10.1016/S0006-291X(88)80568-0
   Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s
   Larsen TM, 1997, ARCH BIOCHEM BIOPHYS, V345, P199, DOI 10.1006/abbi.1997.0257
   LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033
   Laughlin LT, 1997, ARCH BIOCHEM BIOPHYS, V348, P262, DOI 10.1006/abbi.1997.0448
   MALCOLM GN, 1957, T FARADAY SOC, V53, P921, DOI 10.1039/tf9575300921
   MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6
   MAUREL P, 1978, J BIOL CHEM, V253, P1677
   MEDINA R, 1985, FEBS LETT, V180, P77, DOI 10.1016/0014-5793(85)80235-0
   MILDVAN AS, 1963, BIOCHEMISTRY-US, V2, P910, DOI 10.1021/bi00905a003
   MILDVAN AS, 1966, J BIOL CHEM, V241, P1178
   MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x
   NICHOL LW, 1981, FEBS LETT, V126, P18, DOI 10.1016/0014-5793(81)81022-8
   NOWAK T, 1972, BIOCHEMISTRY-US, V11, P2819, DOI 10.1021/bi00765a014
   NOWAK T, 1976, J BIOL CHEM, V251, P73
   NOWAK T, 1981, SPECTROSCOPY BIOCH, V2, P109
   PODESTA FE, 1993, PLANT PHYSIOL, V103, P285, DOI 10.1104/pp.103.1.285
   RAMIREZSILVA L, 1993, BIOCHEMISTRY-US, V32, P5332, DOI 10.1021/bi00071a008
   RamirezSilva L, 1997, EUR J BIOCHEM, V250, P583, DOI 10.1111/j.1432-1033.1997.0583a.x
   RAUSHEL FM, 1980, BIOCHEMISTRY-US, V19, P5481, DOI 10.1021/bi00565a003
   REINHART GD, 1980, J BIOL CHEM, V255, P576
   Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918
   SALVUCCI ME, 1992, ARCH BIOCHEM BIOPHYS, V298, P688, DOI 10.1016/0003-9861(92)90467-B
   SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870
   SORGER GJ, 1965, P NATL ACAD SCI USA, V54, P1614, DOI 10.1073/pnas.54.6.1614
   SUELTER CH, 1963, J BIOL CHEM, V238, P4108
   SUELTER CH, 1966, BIOCHEMISTRY-US, V5, P131, DOI 10.1021/bi00865a017
   SUELTER CH, 1967, BIOCHEMISTRY-US, V6, P418, DOI 10.1021/bi00854a008
   TAN KH, 1972, J BIOL CHEM, V247, P3278
   UBERREITER K, 1982, COLLOID POLYM SCI, V260, P37
   WESTHEAD EW, 1964, J BIOL CHEM, V239, P2464
NR 54
TC 15
Z9 15
U1 0
U2 5
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD JUN
PY 2001
VL 268
IS 11
BP 3267
EP 3274
DI 10.1046/j.1432-1327.2001.02222.x
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 443RC
UT WOS:000169353300016
PM 11389729
DA 2020-09-29
ER

PT J
AU Chapeaurouge, A
   Johansson, JS
   Ferreira, ST
AF Chapeaurouge, A
   Johansson, JS
   Ferreira, ST
TI Folding intermediates of a model three-helix bundle protein - Pressure
   and cold denaturation studies
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID 3-HELIX BUNDLE; CHYMOTRYPSIN INHIBITOR-2; HYDROGEN-EXCHANGE;
   CRYSTAL-STRUCTURE; ENERGY SURFACE; BINDING DOMAIN; STABILITY; STATE;
   THERMODYNAMICS; DISSOCIATION
AB The stability and equilibrium unfolding of a model three-helix bundle protein, alpha (3)-1, by guanidine hydrochloride (GdnHCl), hydrostatic pressure, and temperature have been investigated. The combined use of these denaturing agents allowed detection of two partially folded states of alpha (3)-1, as monitored by circular dichroism, intrinsic fluorescence emission, and fluorescence of the hydrophobic probe bis-ANS (4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid). The overall free-energy change for complete unfolding of (alpha (3)-1, determined from GdnHCl unfolding data, is +4.6 kcal/mol, The native state is stabilized by -1.4 kcal/mol relative to a partially folded pressure-denatured intermediate (I-1). Cold denaturation at high pressure gives rise to a second partially (un)folded conformation (I-2), suggesting a significant contribution of hydrophobic interactions to the stability of alpha (3)-1. The free energy of stabilization of the native-like state relative to I-2 is evaluated to be -2.5 kcal/mol, Bis-ANS binding to the pressure- and cold denatured states indicates the existence of significant residual hydrophobic structure in the partially (un)folded states of alpha (3)-1, The demonstration of folding intermediates of alpha (3)-1 lends experimental support to a number of recent protein folding simulation studies of other three-helix bundle proteins that predicted the existence of such intermediates. The results are discussed in terms of the significance of de novo designed proteins for protein folding studies.
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM55876] Funding Source: Medline
CR ARCUS VL, 1994, P NATL ACAD SCI USA, V91, P9412, DOI 10.1073/pnas.91.20.9412
   BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103
   BRANDTS JF, 1970, BIOCHEMISTRY-US, V9, P1038, DOI 10.1021/bi00806a045
   BRIDGMAN PV, 1931, PHYSICS HIGH PRESSUR
   Clarke J, 1996, FOLD DES, V1, P243, DOI 10.1016/S1359-0278(96)00038-7
   EFTINK MR, 1991, BIOCHEMISTRY-US, V30, P1193, DOI 10.1021/bi00219a005
   FERSHT AR, 1993, FEBS LETT, V325, P5, DOI 10.1016/0014-5793(93)81405-O
   FOGUEL D, 1994, P NATL ACAD SCI USA, V91, P8244, DOI 10.1073/pnas.91.17.8244
   GOROVITS BM, 1995, BIOCHEMISTRY-US, V34, P13928, DOI 10.1021/bi00042a026
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   Guo ZY, 1997, P NATL ACAD SCI USA, V94, P10161, DOI 10.1073/pnas.94.19.10161
   HANDEL TM, 1993, SCIENCE, V261, P879, DOI 10.1126/science.8346440
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   HILL CP, 1990, SCIENCE, V249, P543, DOI 10.1126/science.2382133
   HUANG GS, 1995, P NATL ACAD SCI USA, V92, P6878, DOI 10.1073/pnas.92.15.6878
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10436, DOI 10.1021/bi00107a011
   Johansson JS, 1998, J AM CHEM SOC, V120, P3881, DOI 10.1021/ja973538m
   KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034
   KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012
   KIPPEN AD, 1994, BIOCHEMISTRY-US, V33, P3778, DOI 10.1021/bi00178a039
   KRAGELUND BB, 1995, BIOCHEMISTRY-US, V34, P7217, DOI 10.1021/bi00021a037
   LIEBERMAN M, 1994, J AM CHEM SOC, V116, P5035, DOI 10.1021/ja00091a002
   Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3
   MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   NEUMAN RC, 1973, J PHYS CHEM-US, V77, P2687, DOI 10.1021/j100640a025
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7
   PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5
   PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417
   REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666
   ROYER CA, 1993, BIOCHEMISTRY-US, V32, P5222, DOI 10.1021/bi00070a034
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   Scalley ML, 1997, BIOCHEMISTRY-US, V36, P3373, DOI 10.1021/bi9625758
   SCHINDLER T, 1995, NAT STRUCT BIOL, V2, P663, DOI 10.1038/nsb0895-663
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   SOSNICK TR, 1994, NAT STRUCT BIOL, V1, P149, DOI 10.1038/nsb0394-149
   Sosnick TR, 1996, PROTEINS, V24, P413
   Spector S, 1998, J MOL BIOL, V276, P479, DOI 10.1006/jmbi.1997.1522
   UVERSKY VN, 1994, BIOCHEMISTRY-US, V33, P2782, DOI 10.1021/bi00176a006
   WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   WEBER G, 1987, NATO ASI SER C, V197, P401
   YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097
   YORK SS, 1978, BIOCHEMISTRY-US, V17, P4480, DOI 10.1021/bi00614a019
   Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940
   Zhou YQ, 1997, P NATL ACAD SCI USA, V94, P14429, DOI 10.1073/pnas.94.26.14429
   ZIPP A, 1973, BIOCHEMISTRY-US, V12, P4217, DOI 10.1021/bi00745a028
NR 49
TC 36
Z9 37
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 4
PY 2001
VL 276
IS 18
BP 14861
EP 14866
DI 10.1074/jbc.M009622200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 429QQ
UT WOS:000168528800046
PM 11278529
OA Bronze
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Houzel, JC
   Garcia-Abreu, J
   Louzada, PRF
   Afonso, RC
   Meirelles, MNL
   Lent, R
   Neto, VM
   Ferreira, ST
AF De Felice, FG
   Houzel, JC
   Garcia-Abreu, J
   Louzada, PRF
   Afonso, RC
   Meirelles, MNL
   Lent, R
   Neto, VM
   Ferreira, ST
TI Inhibition of Alzheimer's disease beta-amyloid aggregation,
   neurotoxicity, and in vivo deposition by nitrophenols: implications for
   Alzheimer's therapy
SO FASEB JOURNAL
LA English
DT Article
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Anat, BR-21944590 Rio De Janeiro, Brazil.
   FIOCRUZ, Inst Oswaldo Cruz, Dept Ultraestrutura & Biol Celular, BR-21045900 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
RI Houzel, Jean Christophe/M-7936-2019; Ferreira, Sergio/AAZ-1576-2020;
   Houzel, Jean Christophe/G-3723-2010; Moura-Neto, VIVALDO/V-9913-2019;
   Abreu, Jose GR/G-6159-2010
OI Houzel, Jean Christophe/0000-0001-5128-438X; Ferreira,
   Sergio/0000-0001-7160-9866; Houzel, Jean Christophe/0000-0001-5128-438X;
   Moura-Neto, VIVALDO/0000-0002-6266-043X; Abreu, Jose
   GR/0000-0002-9875-7786
NR 0
TC 89
Z9 91
U1 0
U2 9
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAY
PY 2001
VL 15
IS 7
BP 1297
EP 1299
PG 3
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 431WR
UT WOS:000168655200041
PM 29470943
DA 2020-09-29
ER

PT J
AU Louzada, PR
   Lima, ACP
   de Mello, FG
   Ferreira, ST
AF Louzada, PR
   Lima, ACP
   de Mello, FG
   Ferreira, ST
TI Dual role of glutamatergic neurotransmission on amyloid beta(1-42)
   aggregation and neurotoxicity in embryonic avian retina
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE beta-amyloid; Alzheimer's disease; glutamate; glutamate receptors;
   glutamate antagonists; retina; neurotoxicity
ID CORTICAL-NEURONS; CALCIUM HOMEOSTASIS; ALZHEIMERS-DISEASE; NUCLEUS
   BASALIS; BETA PEPTIDE; PROTEIN; EXCITOTOXICITY; FRAGMENT; CELLS
AB The effects of glutamate receptor antagonists on the toxicity of the beta -amyloid peptide (A beta (1-42)) in embryonic chick retina were investigated. When used alo ne or in combination, the N-methyl-D-asparate antagonist, MK-801, the (+/-)-alpha amino-3-hydroxyl-5-methylisoxazole-4-propinic acid/kainate antagonist, DNQX, and the metabotropic receptor antagonist, (RS)1-aminoindan-1,5-dicarboxylic acid, blocked the neurotoxicity of A beta (1-42) Aggregation of A beta (1-42) was significantly increased in the presence of acidic glutamate solutions, but not in the presence of other neurotransmitters. These results point to a dual role of glutamatergic transmission in Alzheimer's disease (AD): (i) A beta neurotoxicity requires activation of glutamate receptors and its blockade prevents cell death; Iii] high concentrations of glutamate in the synaptic cleft indirectly enhance A beta aggregation through acidification of the medium, resulting in increased amounts of neurotoxic amyloid fibrils. These results suggest that glutamatergic neurotransmission may represent a novel target for therapeutic approaches in AD. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020; Paula-Lima, Andrea C./I-2537-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Paula-Lima, Andrea
   C./0000-0002-0466-7561
CR Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1
   Alvarez A, 1998, J NEUROSCI, V18, P3213
   Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817
   Bruno V, 2000, NEUROPHARMACOLOGY, V39, P2223, DOI 10.1016/S0028-3908(00)00079-4
   BUSCIGLIO J, 1993, J NEUROCHEM, V61, P1565, DOI 10.1111/j.1471-4159.1993.tb13658.x
   Cadavid D, 2000, J NEUROPATH EXP NEUR, V59, P768, DOI 10.1093/jnen/59.9.768
   GARRET RH, 1995, MOL ASPECTS CELL BIO, P1236
   GRAY CW, 1995, BRAIN RES, V691, P169, DOI 10.1016/0006-8993(95)00669-H
   Harkany T, 1999, NEUROBIOL DIS, V6, P109, DOI 10.1006/nbdi.1998.0230
   Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x
   Hasegawa Y, 1995, BIOL PHARM BULL, V18, P1750
   HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270
   Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2
   Kim HS, 2000, FASEB J, V14, P1508, DOI 10.1096/fj.14.11.1508
   KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K
   KOWALL NW, 1992, NEUROBIOL AGING, V13, P537, DOI 10.1016/0197-4580(92)90053-Z
   LAUNDERBACK CM, 1999, LIFE SCI, V650, P1977
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992
   MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X
   Noda M, 1999, NEUROSCIENCE, V92, P1465, DOI 10.1016/S0306-4522(99)00036-6
   PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D
   PIKE CJ, 1993, J NEUROSCI, V13, P1676
   Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023
   Tremblay R, 2000, J NEUROSCI, V20, P7183
   VANDYKE RW, 1988, J BIOL CHEM, V263, P2603
   Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133
NR 27
TC 28
Z9 29
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD MAR 23
PY 2001
VL 301
IS 1
BP 59
EP 63
DI 10.1016/S0304-3940(01)01585-3
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 411NB
UT WOS:000167505200015
PM 11239716
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   Chapeaurouge, A
   Johansson, JS
AF Ferreira, ST
   Chapeaurouge, A
   Johansson, JS
TI Folding intermediates of a model three-helix bundle protein: Pressure
   and cold denaturation studies
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 Univ Fed Rio de Janeiro, ICB, CCS, BR-21941 Rio De Janeiro, Brazil.
   Univ Penn, Philadelphia, PA 19104 USA.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 1
Z9 1
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2001
VL 80
IS 1
MA 2488
BP 552A
EP 552A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 397JH
UT WOS:000166692202512
DA 2020-09-29
ER

PT J
AU Oliveira, KMG
   Valente-Mesquita, VL
   Botelho, MM
   Sawyer, L
   Ferreira, ST
   Polikarpov, I
AF Oliveira, KMG
   Valente-Mesquita, VL
   Botelho, MM
   Sawyer, L
   Ferreira, ST
   Polikarpov, I
TI Crystal structures of bovine beta-lactoglobulin in the orthorhombic
   space group C222(1) - Structural differences between genetic variants A
   and B and features of the Tanford transition
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE bovine beta-lactoglobulin; genetic variants; Tanford transition; X-ray
   structure
ID PROTEIN CRYSTALLOGRAPHY BEAMLINE; HEAT-TREATMENT; X-RAY; RETINOL;
   CONFORMATION; COMPLEX; BINDING; PH
AB The crystal structures of beta -lactoglobulin genetic variants A and B have been determined in the orthorhombic space group C222(1) (lattice Y) by X-ray diffraction at 2.0 Angstrom and 1.95 Angstrom resolution, respectively. The structural comparison shows that both variants exhibit the open conformation of the EF loop at the pH of crystallization (pH 7.9), in contrast to what has been reported for the same genetic variants at pH 7.1 in the trigonal space group P3(2)21 (lattice Z) [Qin, B.Y., Bewley, M.C., Creamer, L.K., Baker, E.N. & Jameson, G.B. (1999) Protein Sci. 8, 75-83]. Furthermore, it was found that the stereochemical environment of Tyr42 changes significantly with pH variation between pH 7 and pH 8. This may provide a structural explanation for an as yet unexplained feature of the Tanford transition, namely the increase in exposure of a tyrosine residue.
C1 LNLS, BR-13083970 Campinas, SP, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941 Rio De Janeiro, Brazil.
   Univ Edinburgh, ICMB, Struct Biochem Grp, Edinburgh EH8 9YL, Midlothian, Scotland.
RP Polikarpov, I (corresponding author), LNLS, CP 6192, BR-13083970 Campinas, SP, Brazil.
EM igor@lnls.br
RI Polikarpov, Igor/D-2575-2012; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Polikarpov,
   Igor/0000-0001-9496-4174
CR ASCHAFFENBURG R, 1955, NATURE, V176, P218, DOI 10.1038/176218b0
   ASCHAFFENBURG R, 1965, J MOL BIOL, V13, P194, DOI 10.1016/S0022-2836(65)80089-4
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bewley MC, 1997, MILK PROTEIN POLYMORPHISM, P100
   BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0
   Botelho MM, 2000, EUR J BIOCHEM, V267, P2235, DOI 10.1046/j.1432-1327.2000.01226.x
   Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0
   BRUNGER A, 1992, X PLOR VERS 3 1 SYST
   Chaudhuri BN, 1999, ACTA CRYSTALLOGR D, V55, P753, DOI 10.1107/S0907444998017211
   Crowfoot D, 1938, NATURE, V141, P521, DOI 10.1038/141521b0
   Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645
   Dong A, 1996, BIOCHEMISTRY-US, V35, P1450, DOI 10.1021/bi9518104
   DUNNILL P, 1966, J MOL BIOL, V15, P147, DOI 10.1016/S0022-2836(66)80216-4
   FALLSTROM SP, 1978, INT ARCH ALLER A IMM, V56, P97, DOI 10.1159/000232011
   GREEN DW, 1979, J MOL BIOL, V131, P375, DOI 10.1016/0022-2836(79)90082-2
   GROVES ML, 1951, J AM CHEM SOC, V73, P2790, DOI 10.1021/ja01150a106
   Hambling S. G., 1992, ADV DAIRY CHEM, V1, P141
   Hill JP, 1996, ACS SYM SER, V650, P281
   HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   MALIK Z, 1988, BIOCHEM SOC T, V16, P338, DOI 10.1042/bst0160338
   Manderson GA, 1999, J AGR FOOD CHEM, V47, P4557, DOI 10.1021/jf981291m
   Manderson GA, 1998, J AGR FOOD CHEM, V46, P5052, DOI 10.1021/jf980515y
   Manderson GA, 1999, J AGR FOOD CHEM, V47, P3617, DOI 10.1021/jf990591g
   Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9
   MONACO HL, 1987, J MOL BIOL, V197, P695, DOI 10.1016/0022-2836(87)90476-1
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Palmer AH, 1934, J BIOL CHEM, V104, P359
   PANTALONI D, 1963, CR HEBD ACAD SCI, V256, P4994
   PAPIZ MZ, 1986, NATURE, V324, P383, DOI 10.1038/324383a0
   Pedersen KO, 1936, BIOCHEM J, V30, P961, DOI 10.1042/bj0300961
   PEREZ MD, 1995, J DAIRY SCI, V78, P978, DOI 10.3168/jds.S0022-0302(95)76713-3
   Polikarpov I, 1998, NUCL INSTRUM METH A, V405, P159, DOI 10.1016/S0168-9002(97)01202-3
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   Qin BY, 1998, FEBS LETT, V438, P272, DOI 10.1016/S0014-5793(98)01199-5
   Qin BY, 1999, PROTEIN SCI, V8, P75, DOI 10.1110/ps.8.1.75
   Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t
   TANFORD C, 1959, J AM CHEM SOC, V81, P4032, DOI 10.1021/ja01524a054
   TANFORD C, 1961, J AM CHEM SOC, V83, P1634, DOI 10.1021/ja01468a022
   TANFORD C, 1959, J BIOL CHEM, V234, P2874
   TIMASHEF.SN, 1966, J BIOL CHEM, V241, P2496
   TIMASHEFF S, 1961, J AM CHEM SOC, V83, P470, DOI 10.1021/ja01463a050
   TOWNEND R, 1969, ARCH BIOCHEM BIOPHYS, V129, P567, DOI 10.1016/0003-9861(69)90216-1
   TREECE JM, 1964, ARCH BIOCHEM BIOPHYS, V108, P99, DOI 10.1016/0003-9861(64)90360-1
   Wu SY, 1999, J BIOL CHEM, V274, P170, DOI 10.1074/jbc.274.1.170
NR 51
TC 92
Z9 94
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD JAN
PY 2001
VL 268
IS 2
BP 477
EP 483
DI 10.1046/j.1432-1033.2001.01918.x
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 394WL
UT WOS:000166547100034
PM 11168385
DA 2020-09-29
ER

PT J
AU Aparicio, R
   Ferreira, ST
   Leite, NR
   Polikarpov, I
AF Aparicio, R
   Ferreira, ST
   Leite, NR
   Polikarpov, I
TI Preliminary X-ray diffraction studies of rabbit muscle triose phosphate
   isomerase (TIM)
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE; PROTEIN CRYSTALLOGRAPHY
   BEAMLINE; AMINO-ACID SEQUENCE; REVERSE MICELLES; DIMER; ENZYME;
   DIMERIZATION; REACTIVATION; RESOLUTION; DEFICIENCY
AB Triose phosphate isomerase (TIM) is responsible for the interconversion between GAP and DHAP in the glycolytic pathway. Two crystal forms belonging to space group P2(1)2(1)2(1) were obtained by the hanging-drop method and were designated A and B. Synchrotron X-ray diffraction data were collected for both forms. Form A had unit-cell parameters a = 65.14, b = 72.45, c = 93.24 Angstrom and diffracted to 2.25 Angstrom at 85 K, whereas form B had unit-cell parameters a = 73.02, b = 79.80, c = 172.85 Angstrom and diffracted to 2.85 Angstrom at room temperature. Molecular replacement was employed to solve the structures, using human TIM as a search model. Further refinement of both structures is under way and is expected to shed light on the recently reported conformational studies for rabbit TIM.
C1 Lab Nacl Luz Sincrotron, BR-13083970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, Brazil.
   Univ Fed Rio de Janeiro, Dept Bioquim Med, Rio de Janeiro, Brazil.
   Univ Estadual Ponta Grossa, Ponta Grossa, PR, Brazil.
RP Polikarpov, I (corresponding author), Lab Nacl Luz Sincrotron, Caixa Postal 6192, BR-13083970 Campinas, SP, Brazil.
EM igor@lnls.br
RI Polikarpov, Igor/D-2575-2012; Aparicio, Ricardo/G-5802-2012; Ferreira,
   Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Polikarpov,
   Igor/0000-0001-9496-4174
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0
   BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703, DOI 10.1111/j.1432-1033.1993.tb17599.x
   Branden C., 1991, INTRO PROTEIN STRUCT
   CASTRESANA J, 1988, BIOCHEM BIOPH RES CO, V152, P69, DOI 10.1016/S0006-291X(88)80681-8
   CORRAN PH, 1975, BIOCHEM J, V145, P335, DOI 10.1042/bj1450335
   DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903
   Doenhoff MJ, 1998, PARASITOL TODAY, V14, P105, DOI 10.1016/S0169-4758(97)01204-0
   FARBER GK, 1993, CURR OPIN STRUC BIOL, V3, P409, DOI 10.1016/S0959-440X(05)80114-9
   FERNANDEZVELASCO DA, 1995, BIOCHEMISTRY-US, V34, P361, DOI 10.1021/bi00001a044
   GARZARAMOS G, 1992, EUR J BIOCHEM, V208, P389, DOI 10.1111/j.1432-1033.1992.tb17199.x
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0
   KRIETSCH WK, 1970, EUR J BIOCHEM, V14, P289, DOI 10.1111/j.1432-1033.1970.tb00289.x
   LAMBEIR AM, 1987, EUR J BIOCHEM, V168, P69, DOI 10.1111/j.1432-1033.1987.tb13388.x
   Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174
   MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510
   MAQUAT LE, 1985, J BIOL CHEM, V260, P3748
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Polikarpov I, 1998, NUCL INSTRUM METH A, V405, P159, DOI 10.1016/S0168-9002(97)01202-3
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   Schliebs W, 1996, PROTEIN SCI, V5, P229
   Schliebs W, 1997, BIOCHEMISTRY-US, V36, P9655, DOI 10.1021/bi963086a
   SCOPES RK, 1977, BIOCHEM J, V161, P253, DOI 10.1042/bj1610253
   TANAKA T, 1994, PROTEIN SCI, V3, P419
   Watanabe M, 1996, AM J HUM GENET, V58, P308
   WIERENGA RK, 1992, J MOL BIOL, V224, P1115, DOI 10.1016/0022-2836(92)90473-W
   WIERENGA RK, 1991, J MOL BIOL, V220, P995, DOI 10.1016/0022-2836(91)90368-G
   YUKSEL KU, 1991, STUDY ENZYMES, V2
NR 33
TC 3
Z9 3
U1 0
U2 2
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD NOV
PY 2000
VL 56
BP 1492
EP 1494
DI 10.1107/S0907444900011380
PN 11
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 374FX
UT WOS:000165336100032
PM 11053862
OA Green Published
DA 2020-09-29
ER

PT J
AU Oliveira, MF
   d'Avila, JC
   Torres, CR
   Oliveira, PL
   Tempone, AJ
   Rumjanek, FD
   Braga, CMS
   Silva, JR
   Dansa-Petretski, M
   Oliveira, MA
   de Souza, W
   Ferreira, ST
AF Oliveira, MF
   d'Avila, JC
   Torres, CR
   Oliveira, PL
   Tempone, AJ
   Rumjanek, FD
   Braga, CMS
   Silva, JR
   Dansa-Petretski, M
   Oliveira, MA
   de Souza, W
   Ferreira, ST
TI Haemozoin in Schistosoma mansoni
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
DE Schistosoma mansoni; haemozoin; haem
ID RED-BLOOD-CELLS; MALARIA PIGMENT; HEME; DEGRADATION; RESISTANCE;
   PROTEINS
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   CENPES, Setor Quim Organ, Div Quim, BR-21949900 Rio De Janeiro, Brazil.
   Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, BR-28015620 Sao Jose Dos Campos, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Oliveira, MF (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
RI d'Avila, Joana/L-8970-2013; Oliveira, Marcus/G-3158-2011; de Oliveira,
   Marco/B-7543-2013; Ferreira, Sergio/AAZ-1576-2020; Tempone, Antonio
   J/E-5118-2011; Oliveira, Pedro/A-9438-2010
OI d'Avila, Joana/0000-0002-2045-0813; Oliveira,
   Marcus/0000-0002-9890-8425; de Oliveira, Marco/0000-0001-5971-2553;
   Ferreira, Sergio/0000-0001-7160-9866; Oliveira,
   Pedro/0000-0003-0307-354X; Rumjanek, Franklin/0000-0002-6618-7096
CR ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876
   Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4
   CIOLI D, 1993, PARASITOL TODAY, V9, P162, DOI 10.1016/0169-4758(93)90138-6
   CLEGG JA, 1965, EXP PARASITOL, V16, P133, DOI 10.1016/0014-4894(65)90037-8
   DINGEMANS KP, 1978, ANN TROP MED PARASIT, V72, P231, DOI 10.1080/00034983.1978.11719311
   FITCH CD, 1987, J BIOL CHEM, V262, P15552
   Grevelding CG, 1997, PARASITOLOGY, V115, P635, DOI 10.1017/S0031182097001728
   GUPTA BC, 1987, J PARASITOL, V73, P481, DOI 10.2307/3282125
   Halton DW, 1997, INT J PARASITOL, V27, P693, DOI 10.1016/S0020-7519(97)00011-8
   HOMEWOOD CA, 1972, COMP BIOCHEM PHYSIOL, V43, P517, DOI 10.1016/0305-0491(72)90135-6
   KLOETZEL K, 1966, AM J TROP MED HYG, V15, P28, DOI 10.4269/ajtmh.1966.15.28
   Kusel J, 1999, PARASITOL TODAY, V15, P352, DOI 10.1016/S0169-4758(99)01510-0
   LAWRENCE C, 1986, AM J CLIN PATHOL, V86, P360, DOI 10.1093/ajcp/86.3.360
   LAWRENCE JD, 1973, J PARASITOL, V59, P60, DOI 10.2307/3278572
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MOORE GA, 1975, ANN TROP MED PARASIT, V69, P373, DOI 10.1080/00034983.1975.11687021
   Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5
   Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910
   Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132
   Pandey AV, 1996, FEBS LETT, V393, P189, DOI 10.1016/0014-5793(96)00881-2
   POPIEL I, 1986, Parasitology Today, V2, P10, DOI 10.1016/0169-4758(86)90068-2
   RIDLEY RG, 1995, NATURE, V378, P138, DOI 10.1038/378138b0
   Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3
   SANO M, 1979, EXPERIENTIA, V35, P472, DOI 10.1007/BF01922713
   SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325
   SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0
   SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248
   STENGER RJ, 1967, AM J TROP MED HYG, V16, P473, DOI 10.4269/ajtmh.1967.16.473
   Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219
   VINCENT SH, 1989, SEMIN HEMATOL, V26, P105
NR 30
TC 96
Z9 99
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD NOV
PY 2000
VL 111
IS 1
BP 217
EP 221
DI 10.1016/S0166-6851(00)00299-1
PG 5
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA 380KY
UT WOS:000165702100021
PM 11087932
DA 2020-09-29
ER

PT J
AU Pedrosa, C
   De Felice, FG
   Trisciuzzi, C
   Ferreira, ST
AF Pedrosa, C
   De Felice, FG
   Trisciuzzi, C
   Ferreira, ST
TI Selective neoglycosylation increases the structural stability of
   vicilin, the 7S storage globulin from pea seeds
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE glycosylation; stability; subunit dissociation; hydrostatic pressure;
   guanidine hydrochloride; vicilin
ID PISUM-SATIVUM-L; GLYCOSYLATED DERIVATIVES; CONFORMATIONAL DYNAMICS;
   FUNCTIONAL-PROPERTIES; SUPEROXIDE-DISMUTASE; COVALENT ATTACHMENT;
   PROTEINS; FLUORESCENCE; CARBOHYDRATE; NEOGLYCOPROTEINS
AB The effects of glycosylation on the stability and subunit interactions of vicilin, the major storage protein in pea seeds, were investigated. Glycosylated vicilin derivatives were prepared by alkylation of lysine epsilon -amino groups with various carbohydrates. Average modification levels of 13.4 +/- 3.0, 11.1 +/- 3.6, 7.5 +/- 4.2, and 4.7 +/- 0.3 moles of carbohydrate/mol of vicilin were obtained with glucose, galactose, galacturonic acid, and lactose, respectively. Nondenaturing polyacrylamide gel electrophoresis and size-exclusion chromatography indicated that the quaternary structure and hydrodynamic radius of vicilin were not affected by glycosylation at the levels used. We have previously shown that application of hydrostatic pressure causes dissociation of vicilin subunits [C. Pedrosa and S. T. Ferreira (1994) Biochemistry 33, 4046-4055]. Analysis of pressure dissociation data allowed determination of the Gibbs free energy change (DeltaG(diss)) and molar volume change (DeltaV(diss)) of dissociation of vicilin subunits. For unmodified vicilin, DeltaG(diss) = 18.2 kcal/mol and DeltaV(diss) = -102 ml/mol. Glycosylated vicilin derivatives were significantly stabilized against subunit dissociation, with DeltaG(diss) of 19.4, 19.2, 20.6, and 22.1 kcal/mol for glucose, galactose, lactose, and galacturonic acid derivatives, respectively. No changes in DeltaV(diss) were found for the glucose and galactose derivatives, whereas DeltaV(diss) of -128 and -135 ml/mol, respectively, were found for the lactose and galacturonic acid derivatives. The glycosylated derivatives also appeared more resistant to unfolding by guanidine hydrochloride than unmodified vicilin. Intrinsic fluorescence lifetime measurements showed that glycosylation caused a significant increase in heterogeneity of the fluorescence decay, possibly reflecting increased conformational heterogeneity of glycosylated derivatives relative to unmodified vicilin. These results indicate that the stability and subunit interactions of vicilin may be modulated by mild, selective glycosylation at low modification levels, an effect that may be of interest in the study of other oligomeric proteins. (C) 2000 Academic Press.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   BANIEL A, 1992, J AGR FOOD CHEM, V40, P200, DOI 10.1021/jf00014a007
   BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   BISMUTO E, 1988, BIOCHEMISTRY-US, V27, P2132, DOI 10.1021/bi00406a047
   CAER D, 1990, J AGR FOOD CHEM, V38, P1700, DOI 10.1021/jf00098a016
   COLAS B, 1993, J AGR FOOD CHEM, V41, P1811, DOI 10.1021/jf00035a001
   COURTHAUDON JL, 1989, J AGR FOOD CHEM, V37, P32, DOI 10.1021/jf00085a008
   CUMMING DA, 1992, DEV BIOLOGICALS, V76, P83
   DWEK RA, 1995, SCIENCE, V269, P1234, DOI 10.1126/science.7652569
   DWEK RA, 1995, PERSPECTIVES PROTEIN, P296
   FERREIRA ST, 1994, BIOPHYS J, V66, P1185, DOI 10.1016/S0006-3495(94)80901-4
   FERREIRA ST, 1991, J LUMIN, V48-9, P430, DOI 10.1016/0022-2313(91)90153-M
   FERREIRA ST, 1989, J BIOL CHEM, V264, P15392
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   GATEHOUSE JA, 1982, BIOCHEM J, V207, P629, DOI 10.1042/bj2070629
   Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X
   JOAO HC, 1992, FEBS LETT, V307, P343, DOI 10.1016/0014-5793(92)80709-P
   KALISZ HM, 1991, BIOCHIM BIOPHYS ACTA, V1080, P138, DOI 10.1016/0167-4838(91)90140-U
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYCETT GW, 1983, NUCLEIC ACIDS RES, V11, P2367, DOI 10.1093/nar/11.8.2367
   MARSHALL JJ, 1978, TRENDS BIOCHEM SCI, V3, P79, DOI 10.1016/S0968-0004(78)80003-6
   MARSHALL JJ, 1975, ARCH BIOCHEM BIOPHYS, V167, P777, DOI 10.1016/0003-9861(75)90525-1
   Mathieu ME, 1996, BIOCHEMISTRY-US, V35, P4084, DOI 10.1021/bi952924i
   MEI G, 1992, BIOCHEMISTRY-US, V31, P7224, DOI 10.1021/bi00147a003
   Mer G, 1996, NAT STRUCT BIOL, V3, P45, DOI 10.1038/nsb0196-45
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Pedrosa C, 1997, J AGR FOOD CHEM, V45, P2025, DOI 10.1021/jf960815k
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   ROMANOWSKA A, 1994, METHOD ENZYMOL, V242, P90
   RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E
   SCHNELLER M, 1992, BIOL CHEM H-S, V373, P1095, DOI 10.1515/bchm3.1992.373.2.1095
   SCHWARTZ BA, 1978, PROG CLIN BIOL RES, V23, P583
   Stowell C P, 1980, Adv Carbohydr Chem Biochem, V37, P225
   TAKEGAWA K, 1995, J BIOL CHEM, V270, P3094, DOI 10.1074/jbc.270.7.3094
   TAO MH, 1989, J IMMUNOL, V143, P2595
   WANISKA RD, 1984, INT J PEPT PROT RES, V23, P573
   WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031
   WEERS PMM, 1994, BIOCHEMISTRY-US, V33, P3617, DOI 10.1021/bi00178a019
   WOLD F, 1981, ANNU REV BIOCHEM, V50, P783, DOI 10.1146/annurev.bi.50.070181.004031
   WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493
NR 44
TC 37
Z9 41
U1 0
U2 15
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2000
VL 382
IS 2
BP 203
EP 210
DI 10.1006/abbi.2000.2024
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 367PN
UT WOS:000090070800006
PM 11068870
DA 2020-09-29
ER

PT J
AU Martins, SM
   Torres, CR
   Ferreira, ST
AF Martins, SM
   Torres, CR
   Ferreira, ST
TI Inhibition of the Ecto-ATPdiphosphohydrolase of Schistosoma mansoni by
   thapsigargin
SO BIOSCIENCE REPORTS
LA English
DT Article
DE ATPdiphosphohydrolase; thapsigargin; Schistosoma mansoni
ID NUCLEOSIDE TRIPHOSPHATE HYDROLASE; SARCOPLASMIC-RETICULUM CA2+-ATPASE;
   ATP-DIPHOSPHOHYDROLASE APYRASE; PROTOZOAN TOXOPLASMA-GONDII; TEGUMENTAL
   OUTER-MEMBRANE; CA2+ TRANSPORT ATPASE; ENDOPLASMIC-RETICULUM;
   LYMPHOCYTES-T; SMOOTH-MUSCLE; BOVINE AORTA
AB ATPdiphosphohydrolases (ATPDases) are ubiquitous enzymes capable of hydrolyzing nucleoside di- and triphosphates. Although a number of possible physiological roles have been proposed for ATPDases, detailed studies on structure-function relationships have generally been hampered by the lack of specific inhibitors of these enzymes. We have previously characterized a Ca2+-activated ATPDase on the external surface of the tegument of Schistosoma mansoni, the etiologic agent of human schistosomiasis. In the present work, we have examined the effects of thapsigargin. a sesquiterpene lactone known as a high affinity inhibitor of sarco-endoplasmic reticulum calcium transport (SERCA) ATPase, on ATPDase activity. Whereas other lactones tested had little or no inhibitory action, thapsigargin inhibited ATP hydrolysis by the ATPDase (K(1)similar to 20 muM). Interestingly, hydrolysis of ADP was not inhibited by thapsigargin. The lack of inhibition of ATPase activity by orthovanadate, a specific inhibitor of P-type ATPases. and the inhibition of the Mg2+-stimulated ATP hydrolysis by thapsigargin ruled out the possibility that the observed inhibition of the ATPDase by thapsigargin could be due to the presence of contaminating SERCA ATPases in our preparation. Kinetic analysis indicated that a single active site in the ATPDase is responsible for hydrolysis of both ATP and ADP. Thapsigargin caused changes in both V-max and K-m for ATP, indicating a mixed type of inhibition. Inhibition by thapsigargin was little or not affected by changes in free Ca2+ or Mg2+ concentrations. These results suggest that interaction of thapsigargin with the S. mansoni ATPDase prevents binding of ATP or its hydrolysis at the active site, while ADP can still undergo catalysis.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21944590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307
   AGREN G, 1976, ACTA PHYSIOL SCAND, V98, P67, DOI 10.1111/j.1748-1716.1976.tb10303.x
   ASAI T, 1983, J BIOL CHEM, V258, P6816
   ASAI T, 1995, J BIOL CHEM, V270, P11391, DOI 10.1074/jbc.270.19.11391
   BARANKIEWICZ J, 1988, J BIOL CHEM, V263, P7094
   BENECH JC, 1995, BIOCHEM J, V306, P35, DOI 10.1042/bj3060035
   BERMUDES D, 1994, J BIOL CHEM, V269, P29252
   CHEVILLARD C, 1993, BIOCHEM J, V289, P599, DOI 10.1042/bj2890599
   CHRISTENSEN SB, 1988, ACTA CHEM SCAND B, V42, P623, DOI 10.3891/acta.chem.scand.42b-0623
   CHRISTENSEN SB, 1982, J ORG CHEM, V47, P649
   CHRISTOFORIDIS S, 1995, EUR J BIOCHEM, V234, P66, DOI 10.1111/j.1432-1033.1995.066_c.x
   COOPER DR, 1979, THROMB RES, V14, P901, DOI 10.1016/0049-3848(79)90008-2
   COTE YP, 1991, BIOCHIM BIOPHYS ACTA, V1078, P187, DOI 10.1016/0167-4838(91)99008-G
   COTE YP, 1992, BIOCHIM BIOPHYS ACTA, V1139, P133, DOI 10.1016/0925-4439(92)90092-2
   Cunha VMN, 1996, COMP BIOCHEM PHYS B, V114, P199, DOI 10.1016/0305-0491(95)02136-1
   DEJESUS F, 1993, FEBS LETT, V332, P229, DOI 10.1016/0014-5793(93)80638-B
   DORNAND J, 1986, CELLULAR BIOL ECTOEN, P72
   El-Garem AA, 1998, DIGESTION, V59, P589, DOI 10.1159/000007534
   FERREIRA ST, 1995, J BRAZIL ASS ADV SCI, V47, P151
   FILIPPINI A, 1990, J BIOL CHEM, V265, P334
   FOX RM, 1981, J CLIN INVEST, V68, P544, DOI 10.1172/JCI110286
   GLASGOW JG, 1978, THROMB RES, V13, P255, DOI 10.1016/0049-3848(78)90013-0
   Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162
   Hua SM, 1997, BIOCHEMISTRY-US, V36, P11865, DOI 10.1021/bi970105n
   JOHNSON AM, 1989, GENE, V85, P215, DOI 10.1016/0378-1119(89)90484-8
   KIJIMA Y, 1991, J BIOL CHEM, V266, P22912
   Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYTTON J, 1991, J BIOL CHEM, V266, P17067
   Moreau VH, 1998, FREE RADICAL BIO MED, V25, P554, DOI 10.1016/S0891-5849(98)00084-7
   Nagy AK, 1998, J BIOL CHEM, V273, P16043, DOI 10.1074/jbc.273.26.16043
   Nagy AK, 1997, ECTO-ATPASES, P1
   PAYARES G, 1985, PARASITE IMMUNOL, V7, P45, DOI 10.1111/j.1365-3024.1985.tb00478.x
   PLESNER L, 1995, INT REV CYTOL, V158, P141
   PLESNER L, 1997, ECTOATPASES
   SAGARA Y, 1991, J BIOL CHEM, V266, P13503
   SAGARA Y, 1992, J BIOL CHEM, V267, P1286
   SAGARA Y, 1992, J BIOL CHEM, V267, P12606
   Schwarzenbach G, 1969, COMPLEXOMETRIC TITRA
   SEVIGNY J, 1995, BIOCHEM J, V312, P351, DOI 10.1042/bj3120351
   Sevigny J, 1997, BBA-GEN SUBJECTS, V1334, P73, DOI 10.1016/S0304-4165(96)00079-7
   SIMPSON AJG, 1981, PARASITOLOGY, V83, P163, DOI 10.1017/S0031182000050137
   Smith TM, 1997, ARCH BIOCHEM BIOPHYS, V337, P351, DOI 10.1006/abbi.1996.9779
   Smith TM, 1998, BBA-PROTEIN STRUCT M, V1386, P65, DOI 10.1016/S0167-4838(98)00063-6
   Smith TM, 1999, BIOCHEMISTRY-US, V38, P321, DOI 10.1021/bi9820457
   SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128
   STOUT JG, 1994, J BIOCHEM BIOPH METH, V29, P61, DOI 10.1016/0165-022X(94)90057-4
   TAUSSKY HH, 1953, J BIOL CHEM, V202, P675
   Taylor CW, 1998, TRENDS PHARMACOL SCI, V19, P370, DOI 10.1016/S0165-6147(98)01243-7
   THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466
   Torres CR, 1998, EUR J BIOCHEM, V251, P516, DOI 10.1046/j.1432-1327.1998.2510516.x
   Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5
   Valenzuela JG, 1998, J BIOL CHEM, V273, P30583, DOI 10.1074/jbc.273.46.30583
   Vasconcelos EG, 1996, J BIOL CHEM, V271, P22139, DOI 10.1074/jbc.271.36.22139
   Vasconcelos EG, 1997, ECTO-ATPASES, P221
   VASCONCELOS EG, 1993, MOL BIOCHEM PARASIT, V58, P205, DOI 10.1016/0166-6851(93)90042-V
   Wells KM, 1998, J BIOL CHEM, V273, P5020, DOI 10.1074/jbc.273.9.5020
   Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542
   Zhong L, 1998, J BIOL CHEM, V273, P12994, DOI 10.1074/jbc.273.21.12994
NR 59
TC 8
Z9 8
U1 0
U2 1
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0144-8463
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD OCT
PY 2000
VL 20
IS 5
BP 369
EP 381
DI 10.1023/A:1010330017583
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 409QY
UT WOS:000167396600004
PM 11332599
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Botelho, MM
   Valente-Mesquita, VL
   Oliveira, KMG
   Polikarpov, I
   Ferreira, ST
AF Botelho, MM
   Valente-Mesquita, VL
   Oliveira, KMG
   Polikarpov, I
   Ferreira, ST
TI Pressure denaturation of beta-lactoglobulin - Different stabilities of
   isoforms A and B, and an investigation of the Tanford transition
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE cavity; hydrostatic pressure; beta-lactoglobulin; Tanford transition;
   thermodynamics
ID FATTY-ACIDS; SPECTROSCOPIC CHARACTERIZATION; STRUCTURAL DIFFERENCES;
   PROTEIN-STRUCTURE; AGGREGATION; RETINOL; BINDING; MILK; FLUORESCENCE;
   DISSOCIATION
AB beta-Lactoglobulin, the main whey protein in bovine milk, exists in several isoforms of which the most abundant are isoforms A and B. We have previously reported the denaturation of beta-lactoglobulin A by hydrostatic pressure [Valente-Mesquita, V.L., Botelho, M.M. & Ferreira, S.T. (1998) Biophys. J. 75, 471-476]. Here, we compare the pressure stabilities of isoforms A and B. These isoforms differ by two amino-acid substitutions: Asp64 and Val118 in isoform A are replaced by glycine and alanine, respectively, in isoform B. Replacement of the buried Val118 residue by the smaller alanine side-chain is not accompanied by significant structural rearrangements of the neighbouring polypeptide chain and creates a cavity in the core of beta-lactoglobulin. Pressure denaturation experiments revealed different stabilities of the two isoforms. Standard volume changes (Delta V-unf) of - 49 +/- 8 mL.mol(-1) and -75 +/- 3 mL.mol(-1), and unfolding free energy changes (Delta G(unf)) of 8.5 +/- 1.3 kJ.mol(-1) and 11.3 +/- 0.4 kJ.mol(-1) were obtained for isoforms A and B, respectively. The volume occupied by the two methyl groups of Val118 removed in the V118A substitution is approximate to 40 Angstrom(3) per monomer of beta-lactoglobulin, in excellent agreement with the experimentally measured difference in Delta V-unf for the two isoforms (Delta Delta V-unf = 26 mL.mol(-1), corresponding to approximate to 43 Angstrom(3) per monomer). Thus, the existence of a core cavity in beta-lactoglobulin B may explain its enhanced pressure sensitivity relative to beta-lactoglobulin A. beta-Lactoglobulin undergoes a reversible pH-induced conformational change around pH 7, known as the Tanford transition. We have compared the pressure denaturation of beta-lactoglobulin A at pH 7 and 8. Unfolding free energy changes of 8.5 +/- 1.3 and 8.3 +/- 0.3 kJ.mol(-1) were obtained at pH 7 and 8, respectively, showing that the thermodynamic stability of beta-lactoglobulin is identical at these pH values. Interestingly, Delta V-unf was dependent on pH, and varied from -49 +/- 8 mL.mol(-1) to -68 +/- 2 mL.mol(-1) at pH 7 and 8, respectively. The large increase in Delta V-unf at pH 8 relative to pH 7 appears to be associated with an overall expansion of the protein structure and could explain the increased pressure sensitivity of beta-lactoglobulin at alkaline pH.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Lab Nacl Luz Sincrotron, Campinas, SP, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020; Polikarpov, Igor/D-2575-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Polikarpov,
   Igor/0000-0001-9496-4174
CR Consonni R, 1999, BIOCHEMISTRY-US, V38, P12709, DOI 10.1021/bi9911280
   Dong A, 1996, BIOCHEMISTRY-US, V35, P1450, DOI 10.1021/bi9518104
   DUFOUR E, 1994, BBA-PROTEIN STRUCT M, V1206, P166, DOI 10.1016/0167-4838(94)90204-6
   EIGEL WN, 1984, J DAIRY SCI, V67, P1599, DOI 10.3168/jds.S0022-0302(84)81485-X
   ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543
   FUGATE RD, 1980, BIOCHIM BIOPHYS ACTA, V625, P28, DOI 10.1016/0005-2795(80)90105-1
   FUNTENBERGER S, 1995, FOOD SCI TECHNOL-LEB, V28, P410
   Funtenberger S, 1997, J AGR FOOD CHEM, V45, P912, DOI 10.1021/jf960383d
   GODOVAC-ZIMMERMANN J, 1990, BIOL CHEM H-S, V371, P871, DOI 10.1515/bchm3.1990.371.2.871
   Godovac-Zimmermann J, 1996, J PROTEIN CHEM, V15, P743, DOI 10.1007/BF01887148
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   Hambling S. G., 1992, ADV DAIRY CHEM, V1, P141
   Lange DC, 1998, BIOPHYS CHEM, V74, P45, DOI 10.1016/S0301-4622(98)00164-1
   MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035
   MONACO HL, 1987, J MOL BIOL, V197, P695, DOI 10.1016/0022-2836(87)90476-1
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   MOZHAEV VV, 1994, TRENDS BIOTECHNOL, V124, P494
   Narayan M, 1998, PROTEIN SCI, V7, P150, DOI 10.1002/pro.5560070116
   Narayan M, 1997, BIOCHEMISTRY-US, V36, P1906, DOI 10.1021/bi9621526
   OLIVEIRA KMG, 1999, THESIS STATE U CAMPI
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Panick G, 1999, BIOCHEMISTRY-US, V38, P6512, DOI 10.1021/bi982825f
   Pedersen KO, 1936, BIOCHEM J, V30, P961, DOI 10.1042/bj0300961
   PEREZ MD, 1989, J BIOCHEM-TOKYO, V106, P1094, DOI 10.1093/oxfordjournals.jbchem.a122971
   Qin BY, 1999, PROTEIN SCI, V8, P75, DOI 10.1110/ps.8.1.75
   Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t
   SEIBLES TS, 1969, BIOCHEMISTRY-US, V8, P2949, DOI 10.1021/bi00835a039
   SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007
   SPECTOR AA, 1970, LIPIDS, V5, P403, DOI 10.1007/BF02532106
   Tanaka N, 1996, INT J BIOL MACROMOL, V19, P63, DOI 10.1016/0141-8130(96)01102-6
   TANFORD C, 1959, J AM CHEM SOC, V81, P4032, DOI 10.1021/ja01524a054
   Valente-Mesquita VL, 1998, BIOPHYS J, V75, P471, DOI 10.1016/S0006-3495(98)77535-6
   WEBER G, 1990, ANNU REV BIOPHYS BIO, V19, P1
   WEBER G, 1987, NATO ASI SER C, V197, P401
NR 34
TC 33
Z9 33
U1 0
U2 7
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD APR
PY 2000
VL 267
IS 8
BP 2235
EP 2241
DI 10.1046/j.1432-1327.2000.01226.x
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 308DM
UT WOS:000086695300011
PM 10759846
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Louzada, PRF
   Garcia-Abreu, J
   Meirelles, MNL
   Neto, VM
   Ferreira, ST
AF De Felice, FG
   Louzada, PRF
   Garcia-Abreu, J
   Meirelles, MNL
   Neto, VM
   Ferreira, ST
TI Characterization of compounds that prevent aggregation and neurotoxicity
   of Alzheimer's disease A beta peptide.
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 2
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2000
VL 78
IS 1
MA 1713Pos
BP 289A
EP 289A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 274RR
UT WOS:000084779301691
DA 2020-09-29
ER

PT J
AU De Felice, FG
   Soares, VC
   Ferreira, ST
AF De Felice, FG
   Soares, VC
   Ferreira, ST
TI Subunit dissociation and inactivation of pyruvate kinase by hydrostatic
   pressure - Oxidation of sulfhydryl groups and ligand effects on enzyme
   stability
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE pyruvate kinase; hydrostatic pressure; ligand binding; subunit
   dissociation; inactivation
ID LINKED FUNCTION-ANALYSIS; THERMODYNAMIC LINKAGES; LACTATE-DEHYDROGENASE;
   CONFORMATIONAL DRIFT; BETA-LACTOGLOBULIN; DOMAIN INTERACTION; MUSCLE;
   ACTIVATION; HETEROGENEITY; DENATURATION
AB The effect of hydrostatic pressure on the stability of tetrameric rabbit muscle pyruvate kinase was investigated by enzyme activity measurements, size-exclusion chromatography, circular dichroism and fluorescence spectroscopies. Under nonreducing conditions, enzyme activity was irreversibly inhibited by increasing pressure and was completely abolished at 350 MPa. Inhibition was dependent on the concentration of pyruvate kinase, indicating that it was related to pressure-induced subunit dissociation. Size-exclusion chromatography of pressurized samples confirmed a decrease in the proportion of tetramers and an increase in monomers relative to native samples. Addition of dithiothreitol immediately following pressure release led to full recovery of both enzyme activity and of native tetramers. Furthermore, no irreversible inhibition of pyruvate kinase was observed if pressure treatment was carried out in the presence of dithiothreitol. These data suggest that pressure-dissociated monomers undergo conformational changes leading to oxidation of sulfhydryl groups, which prevents correct refolding of native tetramers on decompression. These conformational changes are relatively subtle, as indicated by the lack of significant changes in far-UV circular dichroism and intrinsic fluorescence emission spectra of previously pressurized samples. The effects of various physiological ligands on the pressure stability of pyruvate kinase were also investigated. A slight protection against inhibition was observed in the simultaneous presence of K+, Mg2+ and ADP. Both phosphoenolpyruvate and the allosteric inhibitor, phenylalanine, caused marked stabilization against pressure, suggesting significant energy coupling between binding of these ligands and stabilization of the tetramer.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR BAEK YH, 1982, ARCH BIOCHEM BIOPHYS, V217, P491, DOI 10.1016/0003-9861(82)90529-X
   Boyer P. D., 1962, ENZYMES, P95
   BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9
   CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002
   CONSLER TG, 1989, BIOCHEMISTRY-US, V28, P8756, DOI 10.1021/bi00448a012
   CONSLER TG, 1988, J BIOL CHEM, V263, P2794
   CONSLER TG, 1992, BIOCHEMISTRY-US, V31, P7870, DOI 10.1021/bi00149a018
   CONSLER TG, 1988, J BIOL CHEM, V263, P2787
   COTTAM GL, 1969, J BIOL CHEM, V244, P1481
   DEVILLEBONNE D, 1991, EUR J BIOCHEM, V200, P747, DOI 10.1111/j.1432-1033.1991.tb16240.x
   DOSTER W, 1981, BIOCHEMISTRY-US, V20, P772, DOI 10.1021/bi00507a019
   GLAZER AN, 1965, J BIOL CHEM, V240, P201
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   Heremans K, 1998, BBA-PROTEIN STRUCT M, V1386, P353, DOI 10.1016/S0167-4838(98)00102-2
   JOHNSON GD, METABOLIC CONTROL ST, V8, P2455
   KACHMAR JF, 1953, J BIOL CHEM, V200, P669
   KAYNE FJ, 1971, ARCH BIOCHEM BIOPHYS, V143, P232, DOI 10.1016/0003-9861(71)90204-9
   KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4
   KAYNE FJ, 1968, BIOCHEMISTRY-US, V7, P1678, DOI 10.1021/bi00845a009
   KING L, 1986, BIOCHEMISTRY-US, V25, P3637, DOI 10.1021/bi00360a024
   KUCZENSKI RT, 1971, BIOCHEMISTRY-US, V10, P2867, DOI 10.1021/bi00791a011
   LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033
   LOW PS, 1975, P NATL ACAD SCI USA, V72, P3305, DOI 10.1073/pnas.72.9.3305
   LOW PS, 1975, P NATL ACAD SCI USA, V72, P3014, DOI 10.1073/pnas.72.8.3014
   LOW PS, 1976, J EXP ZOOL, V198, P1, DOI 10.1002/jez.1401980102
   LOW PS, 1975, COMP BIOCHEM PHYS B, V52, P67, DOI 10.1016/0305-0491(75)90117-0
   Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6803, DOI 10.1021/bi962870s
   Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6792, DOI 10.1021/bi962869t
   MILDVAN AS, 1965, J BIOL CHEM, V240, P238
   MILDVAN AS, 1966, J BIOL CHEM, V241, P1178
   MOZHAEV VV, 1994, TRENDS BIOTECHNOL, V124, P494
   MULLER K, 1981, BIOPHYS CHEM, V14, P101, DOI 10.1016/0301-4622(81)85011-9
   MULLER K, 1982, BIOPHYS CHEM, V16, P1, DOI 10.1016/0301-4622(82)85001-1
   MUSTAFA T, 1971, AM ZOOL, V11, P451
   NOWAK T, 1973, J BIOL CHEM, V248, P7191
   OBERFELDER RW, 1984, BIOCHEMISTRY-US, V23, P3813, DOI 10.1021/bi00312a004
   OBERFELDER RW, 1984, BIOCHEMISTRY-US, V23, P3822, DOI 10.1021/bi00312a005
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   PRICE NC, 1983, BIOCHEM J, V209, P763, DOI 10.1042/bj2090763
   RAMIREZSILVA L, 1992, BIOCHEMISTRY-US, V32, P5322
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   ROYER CA, 1986, BIOCHEMISTRY-US, V25, P8308, DOI 10.1021/bi00373a027
   RUAN K, 1989, BIOCHEMISTRY-US, V28, P2144, DOI 10.1021/bi00431a028
   RUAN KC, 1993, BIOCHEMISTRY-US, V32, P6295, DOI 10.1021/bi00075a025
   SCARLATA SF, 1989, BIOCHEMISTRY-US, V28, P6637, DOI 10.1021/bi00442a016
   SCHMID G, 1978, EUR J BIOCHEM, V86, P219, DOI 10.1111/j.1432-1033.1978.tb12302.x
   SHADE BC, 1980, BIOPHYS CHEM, V11, P257
   STEINMET.MA, 1966, BIOCHEMISTRY-US, V5, P1399, DOI 10.1021/bi00868a038
   Tanaka N, 1996, INT J BIOL MACROMOL, V19, P63, DOI 10.1016/0141-8130(96)01102-6
   Valente-Mesquita VL, 1998, BIOPHYS J, V75, P471, DOI 10.1016/S0006-3495(98)77535-6
NR 51
TC 14
Z9 14
U1 0
U2 5
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD NOV
PY 1999
VL 266
IS 1
BP 163
EP 169
DI 10.1046/j.1432-1327.1999.00840.x
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 258JA
UT WOS:000083835000017
PM 10542061
DA 2020-09-29
ER

PT J
AU Wettreich, A
   Sebollela, A
   Carvalho, MA
   Azevedo, SP
   Borojevic, R
   Ferreira, ST
   Coelho-Sampaio, T
AF Wettreich, A
   Sebollela, A
   Carvalho, MA
   Azevedo, SP
   Borojevic, R
   Ferreira, ST
   Coelho-Sampaio, T
TI Acidic pH modulates the interaction between human granulocyte-macrophage
   colony-stimulating factor and glycosaminoglycans
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FIBROBLAST GROWTH-FACTOR; HEPARIN-LIKE MOLECULES; HIGH-AFFINITY
   RECEPTOR; BASIC FIBROBLAST; EXTRACELLULAR-MATRIX; INTERFERON-GAMMA;
   BINDING DOMAIN; GM-CSF; SULFATE; CELLS
AB Granulocyte-macrophage colony-stimulating factor (GM-CSF) controls growth and differentiation of hematopoietic cells. Previous reports have indicated that the mitogenic activity of GM-CSF may be modulated by the glycosidic moiety of proteoglycans associated with the membrane of stromal cells. In this work, we have performed in vitro studies of the interaction between GM-CSF and glycosaminoglycans. The addition of heparin promoted a marked blue shift in the fluorescence emission spectrum of GM-CSF as well as a 30-fold increase in the intensity of light scattering, which indicates formation of large molecular weight complexes between the two molecules. Interestingly, heparin-induced changes in the spectral properties of GM-CSF were only observed at acidic pH. The dependence on acidic pH, together with a strict dependence on glycosaminoglycan sulfation and the fact that high ionic strength destabilized the interaction, indicates that the association between GM-CSF and glycosaminoglycans is mediated by electrostatic interactions. These interactions probably involve sulfate groups in the glycosaminoglycans and positively charged histidine residues in GM-CSF. We propose that negatively charged glycolipids present on the plasma membrane of the hematopoietic and/or the stromal cell could promote an acidic microenvironment capable of triggering interaction between GM-CSF and membrane-bound proteoglycans in vivo.
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Histol & Embriol, Hosp Univ Clementino Fraga Filho, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, PABCAM, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
RI Borojevic, Radovan/V-8500-2019; Sebollela, Adriano/O-4385-2014;
   Carvalho, Marcelo A/J-7144-2012; Ferreira, Sergio/AAZ-1576-2020
OI Borojevic, Radovan/0000-0002-2393-7280; Sebollela,
   Adriano/0000-0002-7444-9156; Carvalho, Marcelo A/0000-0002-7053-0053;
   Ferreira, Sergio/0000-0001-7160-9866
CR ALLEN TD, 1990, COLONY STIMULATING F
   AlvarezSilva M, 1996, J LEUKOCYTE BIOL, V59, P435
   ALVAREZSILVA M, 1993, J CELL SCI, V104, P477
   BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047
   BOHLEN P, 1985, FEBS LETT, V185, P177, DOI 10.1016/0014-5793(85)80765-1
   BREMER EG, 1982, BIOCHEM BIOPH RES CO, V106, P711, DOI 10.1016/0006-291X(82)91769-7
   BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x
   Cantor C.R., 1980, BIOPHYSICAL CHEM 2, P838
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   DECRISTAN G, 1990, J CELL PHYSIOL, V144, P505
   DiGabriele AD, 1998, NATURE, V393, P812
   GALLAGHER JT, 1988, EXPT HAEMATOLOGY TOD, P36
   GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0
   GOSPODAROWICZ D, 1984, P NATL ACAD SCI-BIOL, V81, P6963, DOI 10.1073/pnas.81.22.6963
   Gupta P, 1996, BLOOD, V87, P3229, DOI 10.1182/blood.V87.8.3229.bloodjournal8783229
   GUPTABANSAL R, 1995, J BIOL CHEM, V270, P18666, DOI 10.1074/jbc.270.31.18666
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   ISHIHARA M, 1993, J BIOL CHEM, V268, P4675
   KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318
   KOIKE M, 1994, INT ARCH ALLERGY IMM, V104, P1, DOI 10.1159/000236702
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LEHNINGER AL, 1968, P NATL ACAD SCI USA, V60, P1069, DOI 10.1073/pnas.60.4.1069
   LI LY, 1994, GROWTH FACTORS, V11, P1, DOI 10.3109/08977199409015046
   Lipscombe RJ, 1998, J LEUKOCYTE BIOL, V63, P342
   LOBB RR, 1984, BIOCHEMISTRY-US, V23, P6295, DOI 10.1021/bi00321a001
   Lortat-Jacob H, 1996, J BIOL CHEM, V271, P16139, DOI 10.1074/jbc.271.27.16139
   LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497
   MARGALIT H, 1993, J BIOL CHEM, V268, P19228
   MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226
   METCALF D, 1986, BLOOD, V67, P257
   Meuillet E, 1996, GLIA, V17, P206, DOI 10.1002/(SICI)1098-1136(199607)17:3<206::AID-GLIA3>3.0.CO;2-Z
   Modrowski D, 1998, J CELL PHYSIOL, V177, P187, DOI 10.1002/(SICI)1097-4652(199810)177:1<187::AID-JCP19>3.3.CO;2-O
   MUTHER H, 1994, GROWTH FACTORS, V10, P17, DOI 10.3109/08977199409019600
   NAGASAWA K, 1980, METHODS CARBOHYDR CH, V8, P287
   Naito M, 1997, BLOOD, V89, P2060, DOI 10.1182/blood.V89.6.2060
   NARHI LO, 1991, J PROTEIN CHEM, V10, P359, DOI 10.1007/BF01025250
   ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240
   PINEDALUCENA A, 1994, EUR J BIOCHEM, V222, P425, DOI 10.1111/j.1432-1033.1994.tb18881.x
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0
   Rourke AM, 1996, BIOCHEMISTRY-US, V35, P11913, DOI 10.1021/bi960491t
   SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743
   Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508
   STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526
   TILLACK TW, 1983, BIOCHIM BIOPHYS ACTA, V733, P15, DOI 10.1016/0005-2736(83)90086-X
   Valente-Mesquita VL, 1998, BIOPHYS J, V75, P471, DOI 10.1016/S0006-3495(98)77535-6
   VANBROCKLYN J, 1993, J NEUROCHEM, V61, P371
   VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0
   WANG HM, 1991, BIOCHEM J, V278, P689, DOI 10.1042/bj2780689
   WINGFIELD P, 1988, EUR J BIOCHEM, V173, P65, DOI 10.1111/j.1432-1033.1988.tb13967.x
   YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W
NR 51
TC 26
Z9 26
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 29
PY 1999
VL 274
IS 44
BP 31468
EP 31475
DI 10.1074/jbc.274.44.31468
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 250FY
UT WOS:000083379400053
PM 10531349
OA Bronze
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   Rietveld, AWM
AF Ferreira, ST
   Rietveld, AWM
TI Characterization, possible origins and biological significance of
   deterministic behavior in protein folding/subunit interactions.
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, Inst Ciencias Biomed, BR-21944590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR 23
PY 1999
VL 13
IS 7
SU S
BP A1426
EP A1426
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 226QX
UT WOS:000082033400603
DA 2020-09-29
ER

PT J
AU Moreau, VH
   Castilho, RF
   Ferreira, ST
   Carvalho-Alves, PC
AF Moreau, VH
   Castilho, RF
   Ferreira, ST
   Carvalho-Alves, PC
TI Oxidative damage to sarcoplasmic reticulum Ca2+-ATPase at submicromolar
   iron concentrations: Evidence for metal-catalyzed oxidation
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE sarcoplasmic reticulum; ATPase; oxidative damage; oxidative stress; iron
   overload; fenton reaction; free radical
ID HYDROXYL RADICALS; TRANSPORT ATPASE; PROTEINS; MECHANISMS; CALCIUM;
   OXYGEN; CA-2+-ATPASE; RADIOLYSIS; INHIBITION; CLEAVAGE
AB The sarcoplasmic reticulum (SR) calcium ATPase carries out active Ca2+ pumping at the expense of ATP hydrolysis. We have previously described the inhibition of SR ATPase by oxidative stress induced by the Fenton reaction (Fe2+ + H2O2 --> HO . + HO- + Fe3+). Inhibition was not related to peroxidation of the SR membrane nor to oxidation of ATPase thiols, and involved fragmentation of the ATPase polypeptide chain. The present study aims at further characterizing the mechanism of inhibition of the Ca2+-ATPase by oxygen reactive species at Fe2+ concentrations possibly found in pathological conditions of iron overload. ATP hydrolysis by SR vesicles was inhibited in a dose-dependent manner by micromolar concentrations of Fe2+, H2O2, and ascorbate. Measuring the rate constants of inactivation (k(inact)) at different Fe2+ concentrations in the presence of saturating concentrations of H2O2 and ascorbate (100 mu M each) revealed a saturation profile with half-maximal inactivation rate at ca. 2 mu M Fe2+. Inhibition was not affected by addition of 200 mu M Ca2+ to the medium, indicating that it was not related to iron binding to the high affinity Ca2+ binding sites in the ATPase. Furthermore, inhibition was not prevented by the water-soluble hydroxyl radical scavengers mannitol or dimethylsulfoxide, nor by butylated hydroxytoluene (a lipid peroxidation blocker) or dithiothreitol (DTT). However, when Cu2+ was used instead of Fe2+ in the Fenton reaction, ATPase inhibition could be prevented by DTT. We propose that functional impairment of the Ca2+-pump may be related to oxidative protein fragmentation mediated by site-specific Fe2+ binding at submicromolar or low micromolar concentrations, which may occur in pathological conditions of iron overload.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Campinas, Brazil.
RP Carvalho-Alves, PC (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM pccalves@bioqmed.ufrj.br
RI Moreau, Vitor Hugo/B-8865-2009; Ferreira, Sergio/AAZ-1576-2020; Moreau,
   Vitor Hugo/J-4829-2015; Castilho, Roger F/G-3906-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Moreau, Vitor
   Hugo/0000-0002-5393-0645; Castilho, Roger/0000-0003-2338-8717
CR BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122
   BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U
   Buege J A, 1978, Methods Enzymol, V52, P302
   Castilho RF, 1996, MOL CELL BIOCHEM, V159, P105, DOI 10.1007/BF00420912
   COAN CR, 1977, J BIOL CHEM, V252, P3044
   CRICHTON RR, 1992, BIOCHEMISTRY-US, V31, P11255, DOI 10.1021/bi00161a001
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9908
   DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2
   DEMEIS L, 1991, J BIOL CHEM, V266, P5736
   DEMEIS L, 1981, SARCOPLASMIC RETICUL
   FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463
   GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006
   GRUBMEYER C, 1981, J BIOL CHEM, V264, P5929
   GUNTER TE, 1990, AM J PHYSIOL, V258, pC755
   HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3
   Halliwell B, 1989, FREE RADICALS BIOL M
   HEBBEL RP, 1986, BIOCHIM BIOPHYS ACTA, V862, P8, DOI 10.1016/0005-2736(86)90463-3
   INESI G, 1992, ADV ENZYMOL RAMB, V65, P185
   KANEKO M, 1989, AM J PHYSIOL, V257, pH804
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LESNEFSKY EJ, 1994, ADV EXP MED BIOL, V366, P129
   MAIA JCC, 1983, GENES ANTIGENES PARA, P139
   MEIS LD, 1971, J BIOL CHEM, V246, P4759
   MOORE RB, 1990, ARCH BIOCHEM BIOPHYS, V278, P416, DOI 10.1016/0003-9861(90)90279-8
   Morris TE, 1997, FREE RADICAL BIO MED, V22, P37, DOI 10.1016/S0891-5849(96)00238-9
   NICOTERA P, 1992, ANNU REV PHARMACOL, V32, P449, DOI 10.1146/annurev.pa.32.040192.002313
   NICOTERA P, 1985, FEBS LETT, V181, P149, DOI 10.1016/0014-5793(85)81131-5
   PLATIS IE, 1993, BIOCHEMISTRY-US, V32, P12761, DOI 10.1021/bi00210a027
   REED DJ, 1990, CHEM RES TOXICOL, V3, P495, DOI 10.1021/tx00018a002
   SCHERER NM, 1986, ARCH BIOCHEM BIOPHYS, V246, P589, DOI 10.1016/0003-9861(86)90314-0
   SCHUESSLER H, 1984, INT J RADIAT BIOL, V45, P267, DOI 10.1080/09553008414550381
   SCHWARTZENBACH G, 1957, COMPLEXIMETRIC TITRA
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   UCHIDA K, 1990, BIOCHEM BIOPH RES CO, V169, P265, DOI 10.1016/0006-291X(90)91463-3
   YAMADA S, 1978, J BIOL CHEM, V253, P6801
NR 37
TC 67
Z9 69
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD SEP
PY 1998
VL 25
IS 4-5
BP 554
EP 560
DI 10.1016/S0891-5849(98)00084-7
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 113ET
UT WOS:000075538000018
PM 9741592
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   Silva, JL
   Foguel, D
   Coelho-Sampaio, T
AF Ferreira, ST
   Silva, JL
   Foguel, D
   Coelho-Sampaio, T
TI International Symposium on Protein Condensation, in honor of Gregorio
   Weber, May 21-25, 1997, Rio de Janeiro, Brazil
SO BIOPHYSICAL JOURNAL
LA English
DT Editorial Material
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020; Silva, Jerson/J-8984-2014
OI Ferreira, Sergio/0000-0001-7160-9866; Silva, Jerson/0000-0001-9523-9441
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JUL
PY 1998
VL 75
IS 1
BP 418
EP 418
DI 10.1016/S0006-3495(98)77527-7
PG 1
WC Biophysics
SC Biophysics
GA 108BM
UT WOS:000075246200038
OA Green Published
DA 2020-09-29
ER

PT J
AU Valente-Mesquita, VL
   Botelho, MM
   Ferreira, ST
AF Valente-Mesquita, VL
   Botelho, MM
   Ferreira, ST
TI Pressure-induced subunit dissociation and unfolding of dimeric
   beta-lactoglobulin
SO BIOPHYSICAL JOURNAL
LA English
DT Article; Proceedings Paper
CT International Symposium on Protein Condensation - In Honor of Gregorio
   Weber
CY MAY 21-25, 1997
CL RIO JANEIRO, BRAZIL
ID REVERSIBLE DISSOCIATION; COLD DENATURATION; STABILITY; PROTEINS;
   EXCHANGE; HEAT
AB Effects of hydrostatic pressure on dimeric beta-lactoglobulin A (beta-Lg) were investigated. Application of pressures of up to 3.5 kbar induced a significant red shift (similar to 11 nm) and a 60% increase in intrinsic fluorescence emission of beta-Lg. These changes were very similar to those induced by guanidine hydrochloride, which caused subunit dissociation and unfolding of beta-Lg. A large hysteresis in the recovery of fluorescence parameters was observed upon decompression of beta-Lg. Pressure-induced dissociation and unfolding were not fully reversible, because of the formation of a nonnative intersubunit disulfide bond that hampered correct refolding of the dimer. Comparison between pressure dissociation/unfolding at 3 degrees C and 23 degrees C revealed a marked destabilization of beta-Lg at low temperature. The stability of beta-Lg toward pressure was significantly enhanced by 1 M NaCl, but not by glycerol (up to 20% v/v). These observations suggest that salt stabilization was not related to a general cosolvent effect, but may reflect charge screening. Interestingly, pressure-induced dissociation/unfolding was completely independent of beta-Lg concentration, in apparent violation of the law of mass action. Possible causes for this anomalous behavior are discussed.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Aymard P, 1996, INT J BIOL MACROMOL, V19, P213, DOI 10.1016/0141-8130(96)01130-0
   Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0
   DUFOUR E, 1994, BBA-PROTEIN STRUCT M, V1205, P105, DOI 10.1016/0167-4838(94)90098-1
   ERIJMAN L, 1993, BIOCHEMISTRY-US, V32, P5187, DOI 10.1021/bi00070a030
   ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022
   GRIKO YV, 1994, BIOPHYS J, V67, P356, DOI 10.1016/S0006-3495(94)80488-6
   GRIKO YV, 1992, BIOCHEMISTRY-US, V31, P8810, DOI 10.1021/bi00152a017
   GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   KELLA NKD, 1988, INT J PEPT PROT RES, V32, P396
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   MOZHAEV VV, 1994, TRENDS BIOTECHNOL, V124, P494
   Narayan M, 1997, BIOCHEMISTRY-US, V36, P1906, DOI 10.1021/bi9621526
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   Privalov Peter L., 1992, P83
   PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   Rietveld AWM, 1998, BIOCHEMISTRY-US, V37, P933, DOI 10.1021/bi9721593
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   Subramaniam V, 1996, PROTEIN SCI, V5, P2089, DOI 10.1002/pro.5560051015
   Tanaka N, 1996, INT J BIOL MACROMOL, V18, P33, DOI 10.1016/0141-8130(95)01053-X
   Tanaka N, 1996, INT J BIOL MACROMOL, V19, P63, DOI 10.1016/0141-8130(96)01102-6
   Timasheff S. N., 1989, PROTEIN STRUCTURE PR, P331
   TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435
   WEBER G, 1992, PROTEIN INTERACTIONS
NR 29
TC 52
Z9 54
U1 0
U2 4
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JUL
PY 1998
VL 75
IS 1
BP 471
EP 476
DI 10.1016/S0006-3495(98)77535-6
PG 6
WC Biophysics
SC Biophysics
GA 108BM
UT WOS:000075246200046
PM 9649408
OA Green Published
DA 2020-09-29
ER

PT J
AU Rietveld, AWM
   Ferreira, ST
AF Rietveld, AWM
   Ferreira, ST
TI Kinetics and energetics of subunit dissociation/unfolding of TIM: The
   importance of oligomerization for conformational persistence and
   chemical stability of proteins
SO BIOCHEMISTRY
LA English
DT Article
ID TRIOSE-PHOSPHATE ISOMERASE; TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE;
   CRYSTAL-STRUCTURE; TRANSITION-STATE; RESOLUTION; YEAST; CHICKEN;
   MUTANTS; DIMER
AB Kinetics of unfolding and refolding of rabbit muscle triosephosphate isomerase (TIM) were measured as a function of guanidine hydrochloride (GdnHCl) concentration. From the rate constants of these processes, the activation free-energy barriers (Delta G double dagger) were calculated using the Arrhenius equation. Assuming a linear dependence of Delta G double dagger on the concentration of GdnHCl, activation energies in the absence of GdnHCl were estimated. The Gibbs free-energy change of dissociation/unfolding (Delta G) was determined from GdnHCl unfolding curves in equilibrium. Using these data and the literature value for the bimolecular association rate constant of folded TIM monomers [Zabori, S., Rudolph, R., and Jaenicke, R. (1980) Z. Naturforsch. 35C, 999-1004], a model was developed that fully describes both kinetics and energetics of subunit dissociatian/unfolding of TIM. Unfolded TIM monomers are susceptible to proteolytic digestion and thiol oxidation, while native TIM is resistant to both. The present model explains how the dimeric nature of TIM decreases the frequency of subunit unfolding by several orders of magnitude, thus increasing the chemical stability of the protein. Furthermore, the model also explains the recently demonstrated persistence (on a time scale of hours to days) of conformational heterogeneity of native TIM dimers [Rietveld, A. W. M., and Ferreira, S. T. (1996) Biochemistry, 35, 7743-7751]. Again, it appears that the dimeric nature of TIM is essential for this behavior.
C1 Fed Univ Rio De Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Rietveld, AWM (corresponding author), Fed Univ Rio De Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0
   BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104
   BORCHERT TV, 1995, FEBS LETT, V367, P315, DOI 10.1016/0014-5793(95)00586-X
   DELBONI LF, 1995, PROTEIN SCI, V4, P2594, DOI 10.1002/pro.5560041217
   ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022
   LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6609, DOI 10.1021/bi00480a009
   Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174
   Malecki J, 1997, EUR J BIOCHEM, V243, P660, DOI 10.1111/j.1432-1033.1997.00660.x
   MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510
   MATOUSCHEK A, 1995, BIOCHEMISTRY-US, V34, P13656, DOI 10.1021/bi00041a047
   MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814
   NOBLE MEM, 1993, ACTA CRYSTALLOGR D, V49, P403, DOI 10.1107/S0907444993002628
   Pace C N, 1986, Methods Enzymol, V131, P266
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   ROBINSON DR, 1965, J AM CHEM SOC, V87, P2462, DOI 10.1021/ja01089a028
   SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SUN AW, 1992, ARCH BIOCHEM BIOPHYS, V293, P382, DOI 10.1016/0003-9861(92)90410-X
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165
   WIERENGA RK, 1992, J MOL BIOL, V224, P1115, DOI 10.1016/0022-2836(92)90473-W
   WIERENGA RK, 1991, J MOL BIOL, V220, P995, DOI 10.1016/0022-2836(91)90368-G
   YUKSEL KU, 1994, J BIOL CHEM, V269, P5005
   ZABORI S, 1980, Z NATURFORSCH C, V35, P999
NR 25
TC 72
Z9 73
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JAN 20
PY 1998
VL 37
IS 3
BP 933
EP 937
DI 10.1021/bi9721593
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA YU546
UT WOS:000071728700018
PM 9454583
DA 2020-09-29
ER

PT J
AU Torres, CR
   Vasconcelos, EG
   Ferreira, ST
   Verjovski-Almeida, S
AF Torres, CR
   Vasconcelos, EG
   Ferreira, ST
   Verjovski-Almeida, S
TI Divalent cation dependence and inhibition of Schistosoma mansoni ATP
   diphosphohydrolase by fluorosulfonylbenzoyl adenosine
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE ecto-ATPase; ATP diphosphohydrolase; Schistosoma mansoni;
   fluorosulfonylbenzoyl adenosine; calcium and magnesium dependence
ID PLATELET-AGGREGATION; IDENTIFICATION; PURIFICATION; MEMBRANE; APYRASE;
   TRIPHOSPHATASE; LOCALIZATION; MECHANISMS; BINDING; SURFACE
AB Hydrolysis of ATP or ADP catalyzed by the ATP diphosphohydrolase of Schistosoma mansoni tegument was measured in the presence of different cations. ATP diphosphohydrolase was stimulated by micromolar concentrations of either Ca2+ or Mg2+, Ca2+ producing threefold higher maximal activities than Mg2+. Kinetic studies indicated that Ca2+ and Mg2+ compete for the same binding site on the enzyme. The effect of covalent labeling of ATP diphosphohydrolase with the ATP analog fluorosulfonylbenzoyl adenosine (FSO(2)BzAdo) was studied. Schistosome tegument was passed through with Sephadex G-50 filtration centrifugation columns to remove endogenous nucleotides, and this was followed by labeling with FSO(2)BzAdo. Incubation of ATP diphosphohydrolase with 1 mM FSO(2)BzAdo for 1 h inhibited ATPase or ADPase activities by 60% and 50%, respectively. Addition of ATP together with FSO(2)BzAdo provided greater than 90% protection against FSO(2)BzAdo inactivation, indicating that FSO(2)BzAdo binds to an ATP-binding site on the ATP diphosphohydrolase. Furthermore, addition of FSO(2)BzAdo to a medium containing intact worms caused 30% and 50% inhibition of ATPase and ADPase activities, respectively, indicating that the ATP-binding site of diphosphohydrolase is accessible to FSO(2)BzAdo from the external surface of S. mansoni worms.
C1 Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05599970 Sao Paulo, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, Rio De Janeiro, Brazil.
   Univ Fed Juiz de Fora, Inst Ciencias Biol, Dept Bioquim, Juiz De Fora, Brazil.
RP Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Caixa Postal 26077, BR-05599970 Sao Paulo, Brazil.
RI Verjovski-Almeida, Sergio/E-4082-2012; Verjovski-Almeida,
   Sergio/AAI-2728-2020; Ferreira, Sergio/AAZ-1576-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Ferreira, Sergio/0000-0001-7160-9866
CR ALLISON WS, 1986, METHOD ENZYMOL, V126, P741
   BENNETT JS, 1978, J BIOL CHEM, V253, P7346
   BOUT D, 1986, SCIENCE, V231, P153, DOI 10.1126/science.3079916
   Candinas D, 1996, THROMB HAEMOSTASIS, V76, P807
   CAPRON A, 1982, IMMUNOL REV, V61, P41, DOI 10.1111/j.1600-065X.1982.tb00373.x
   CARAFOLI E, 1991, PHYSIOL REV, V71, P129
   COLES GC, 1984, PARASITOLOGY, V89, P603, DOI 10.1017/S0031182000056808
   COTE YP, 1992, BIOCHIM BIOPHYS ACTA, V1160, P246, DOI 10.1016/0167-4838(92)90084-Q
   DAY H J, 1971, Series Haematologica, V4, P3
   Ferreira Sergio T., 1995, Ciencia e Cultura (Sao Paulo), V47, P151
   FILIPPINI A, 1990, J BIOL CHEM, V265, P334
   Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162
   Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116
   KASAHARA M, 1978, J BIOL CHEM, V253, P4180
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marti E, 1996, BBA-BIOMEMBRANES, V1282, P17, DOI 10.1016/0005-2736(96)00030-2
   MELNICK RL, 1979, ANAL BIOCHEM, V96, P7, DOI 10.1016/0003-2697(79)90546-3
   PERIYASAMY SM, 1983, COMP BIOCHEM PHYS B, V76, P449, DOI 10.1016/0305-0491(83)90274-2
   PLESNER L, 1995, INT REV CYTOL, V158, P141
   Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153
   RUPPEL A, 1986, EXP PARASITOL, V62, P223, DOI 10.1016/0014-4894(86)90027-5
   SAITO H, 1991, J LAB CLIN MED, V117, P341
   Sarkis Joao J. F., 1995, Ciencia e Cultura (Sao Paulo), V47, P131
   SEVIGNY J, 1995, BIOCHEM J, V312, P351, DOI 10.1042/bj3120351
   SIMPSON AJG, 1981, PARASITOLOGY, V83, P163, DOI 10.1017/S0031182000050137
   SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128
   TAUSSKY HH, 1953, J BIOL CHEM, V202, P675
   TRAN A, 1992, AGENTS ACTIONS, V36, P39, DOI 10.1007/BF01991226
   VARGAFTIG BB, 1981, BIOCHEM PHARMACOL, V30, P263, DOI 10.1016/0006-2952(81)90052-6
   Vasconcelos EG, 1996, J BIOL CHEM, V271, P22139, DOI 10.1074/jbc.271.36.22139
   Vasconcelos EG, 1997, ECTO-ATPASES, P221
   VASCONCELOS EG, 1993, MOL BIOCHEM PARASIT, V58, P205, DOI 10.1016/0166-6851(93)90042-V
   VerjovskiAlmeida S, 1997, ECTO-ATPASES, P153
   VERMUND SH, 1983, AM J TROP MED HYG, V32, P1040, DOI 10.4269/ajtmh.1983.32.1040
NR 34
TC 15
Z9 15
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD JAN 15
PY 1998
VL 251
IS 1-2
BP 516
EP 521
DI 10.1046/j.1432-1327.1998.2510516.x
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA YU333
UT WOS:000071706800064
PM 9492326
OA Bronze
DA 2020-09-29
ER

PT J
AU MayaMonteiro, C
   Oliveira, PL
   Gondim, KC
   Masuda, H
   Ferreira, ST
AF MayaMonteiro, C
   Oliveira, PL
   Gondim, KC
   Masuda, H
   Ferreira, ST
TI Role of phospholipids in the protein stability of an insect lipoprotein,
   lipophorin from Rhodnius prolixus
SO BIOCHEMISTRY
LA English
DT Article
ID APOLIPOPROTEIN-A-I; DIACYLGLYCEROL-CARRYING LIPOPROTEIN; HIGH-DENSITY
   LIPOPROTEIN-3; HIGH HYDROSTATIC-PRESSURE; APOLIPOPHORIN-III; LIPID
   TRANSPORT; PLASMA-LIPOPROTEINS; LOCUSTA-MIGRATORIA; MANDUCA-SEXTA;
   HEMOLYMPH
AB Lipophorin (Lp) is the major lipoprotein in insect hemolymph. The structural organization proposed for Lp is basically the same as that suggested for vertebrate lipoproteins, consisting of a hydrophobic core containing neutral lipids, stabilized in the aqueous environment by surrounding polar moieties of protein and phospholipids at the particle surface. After complete removal of phospholipids from Lp by phospholipase A(2), the particle remains soluble [Gondim, K. C., Atella, G. C., Kawooya, J, K., Bi Masuda, H. (1992) Arch. Insect Biochem. Physiol. 20, 303-314]. However, studies on the roles of phospholipid on the structural stability of Lp are still lacking. In the present work, we have studied the structure and stability of dephospholipidated lipophorin (d-Lp). Trypsinolysis of d-Lp indicated no exposure of new cleavage sites on the protein when compared to Lp. However, an enhanced rate of proteolysis of the apoproteins (especially apolipophorin II) was observed in d-Lp. Circular dichroism analysis indicated that the secondary structure of Lp was not significantly affected by phospholipid removal. Furthermore, the exposure of tryptophan residues to the aqueous solvent in d-Lp was the same as in Lp, as indicated by intrinsic fluorescence emission spectra and fluorescence quenching experiments. Interestingly, d-Lp was more resistant to denaturation by guanidine hydrochloride than Lp. d-Lp was also found to be less sensitive than Lp to structural changes induced by hydrostatic pressure. Taken together, these results indicate that, although changes in its structural organization were subtle, dephospholipidated lipophorin may have additional protein-protein and/or protein-neutral lipid interactions that are responsible for the observed increase in stability. Therefore, phospholipids are not only not essential for Lp stability, but their presence in the particle seems to result in a less stable structure in the aqueous environment.
RP MayaMonteiro, C (corresponding author), UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,BR-21944 RIO JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020; Gondim, Katia C./AAN-4059-2020;
   maya-monteiro, clarissa/A-9091-2010; Oliveira, Pedro/A-9438-2010
OI Ferreira, Sergio/0000-0001-7160-9866; Oliveira,
   Pedro/0000-0003-0307-354X
CR ATELLA GC, 1992, ARCH INSECT BIOCHEM, V19, P133, DOI 10.1002/arch.940190206
   ATELLA GC, 1995, ARCH INSECT BIOCHEM, V30, P337, DOI 10.1002/arch.940300404
   ATKINSON D, 1986, ANNU REV BIOPHYS BIO, V15, P403
   AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4586, DOI 10.1021/bi00839a053
   BEENAKKERS AMT, 1981, COMP BIOCHEM PHYS B, V69, P315, DOI 10.1016/0305-0491(81)90320-5
   BLACKLOCK BJ, 1994, INSECT BIOCHEM MOLEC, V24, P855, DOI 10.1016/0965-1748(94)90015-9
   BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8
   CHINO H, 1969, BIOCHIM BIOPHYS ACTA, V176, P1
   CHINO H, 1986, J LIPID RES, V27, P377
   CHINO H, 1971, INSECT BIOCHEM, V1, P337, DOI 10.1016/0020-1790(71)90051-5
   CHINO H, 1981, J LIPID RES, V22, P7
   CHINO H, 1977, BIOCHIM BIOPHYS ACTA, V487, P508
   CHINO H, 1981, J LIPID RES, V22, P1402
   COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   DOWNER RGH, 1985, INSECT BIOCHEM, V15, P627, DOI 10.1016/0020-1790(85)90124-6
   EDELSTEIN C, 1979, J LIPID RES, V20, P143
   GONDIM KC, 1989, J INSECT PHYSIOL, V35, P19, DOI 10.1016/0022-1910(89)90032-2
   GONDIM KC, 1992, ARCH INSECT BIOCHEM, V20, P303, DOI 10.1002/arch.940200406
   GONDIM KC, 1989, INSECT BIOCHEM, V19, P153, DOI 10.1016/0020-1790(89)90086-3
   GOTTO AM, 1986, METHOD ENZYMOL, V128, P3
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   HIRZ R, 1970, BIOCHIM BIOPHYS ACTA, V207, P364, DOI 10.1016/0005-2795(70)90029-2
   JONAS A, 1993, J BIOL CHEM, V268, P1596
   JONAS A, 1986, METHOD ENZYMOL, V128, P553
   KASHIWAZAKI Y, 1985, ARCH BIOCHEM BIOPHYS, V237, P160, DOI 10.1016/0003-9861(85)90265-6
   KATAGIRI C, 1985, BIOCHIM BIOPHYS ACTA, V834, P139
   KATAGIRI C, 1987, J BIOL CHEM, V262, P15857
   KATASE H, 1982, BIOCHIM BIOPHYS ACTA, V710, P341
   KAWOOYA JK, 1991, J LIPID RES, V32, P1781
   KAWOOYA JK, 1988, J BIOL CHEM, V263, P8748
   KAWOOYA JK, 1989, BIOCHEMISTRY-US, V28, P6658, DOI 10.1021/bi00442a019
   KAWOOYA JK, 1984, J BIOL CHEM, V259, P733
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lakowicz JR, 1983, PRINCIPLES FLUORESCE, P257
   LEE J C, 1974, Biochemistry, V13, P257, DOI 10.1021/bi00699a005
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUX SE, 1972, J BIOL CHEM, V247, P2598
   Machado EA, 1996, ARCH INSECT BIOCHEM, V31, P185, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;185::AID-ARCH6&gt;3.0.CO;2-Z
   MANTULIN WW, 1985, BIOCHIM BIOPHYS ACTA, V836, P215, DOI 10.1016/0005-2760(85)90069-4
   MORRISETT JD, 1977, BIOCHIM BIOPHYS ACTA, V472, P93, DOI 10.1016/0304-4157(77)90015-6
   MORRISETT JD, 1975, ANNU REV BIOCHEM, V44, P183, DOI 10.1146/annurev.bi.44.070175.001151
   MOZHAEV VV, 1994, TRENDS BIOTECHNOL, V12, P493, DOI 10.1016/0167-7799(94)90057-4
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PATTNAIK NM, 1976, J BIOL CHEM, V251, P1984
   PRASAD SV, 1986, J BIOL CHEM, V261, P558
   REIJNGOUD DJ, 1982, BIOCHEMISTRY-US, V21, P2969, DOI 10.1021/bi00541a026
   RIMOLDI OJ, 1990, ACTA PHYSIOL PHARM L, V40, P239
   ROBINSON DR, 1965, J AM CHEM SOC, V87, P2462, DOI 10.1021/ja01089a028
   RYAN RO, 1992, J LIPID RES, V33, P55
   RYAN RO, 1986, J BIOL CHEM, V261, P563
   RYAN RO, 1984, BIOESSAYS, V1, P250, DOI 10.1002/bies.950010604
   SHAPIRO JP, 1984, J BIOL CHEM, V259, P3680
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SOULAGES JL, 1994, BIOCHEMISTRY-US, V33, P2356, DOI 10.1021/bi00175a002
   SOULAGES JL, 1994, ADV PROTEIN CHEM, V45, P371
   SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079
   Sundermeyer K, 1996, INSECT BIOCHEM MOLEC, V26, P735, DOI 10.1016/S0965-1748(96)00060-4
   TALL AR, 1975, P NATL ACAD SCI USA, V72, P4940, DOI 10.1073/pnas.72.12.4940
   THOMAS KK, 1967, J INSECT PHYSIOL, V13, P963, DOI 10.1016/0022-1910(67)90059-5
   VANDERHORST DJ, 1981, INSECT BIOCHEM, V11, P717, DOI 10.1016/0020-1790(81)90064-0
   VANHEUSDEN MC, 1991, J LIPID RES, V32, P1789
   WEERS PMM, 1994, BIOCHEMISTRY-US, V33, P3617, DOI 10.1021/bi00178a019
   WELLS MA, 1985, INSECT BIOCHEM, V15, P565, DOI 10.1016/0020-1790(85)90116-7
   WHEELER CH, 1984, INSECT BIOCHEM, V14, P261, DOI 10.1016/0020-1790(84)90058-1
NR 66
TC 5
Z9 5
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD SEP 16
PY 1997
VL 36
IS 37
BP 11216
EP 11222
DI 10.1021/bi9706069
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA XW733
UT WOS:A1997XW73300019
PM 9287164
DA 2020-09-29
ER

PT J
AU Pedrosa, C
   Trisciuzzi, C
   Ferreira, ST
AF Pedrosa, C
   Trisciuzzi, C
   Ferreira, ST
TI Effects of glycosylation on functional properties of vicilin, the 7S
   storage globulin from pea (Pisum sativum)
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE vicilin; storage globulins; glycosylation; Pisum sativum
ID BRASSICA-NAPUS L; EMULSIFYING PROPERTIES; OLIGOMERIC STRUCTURE;
   BETA-LACTOGLOBULIN; FOAMING PROPERTIES; COVALENT BINDING;
   PLANT-PROTEINS; FABA BEANS; LEGUMIN; SUCCINYLATION
AB Functional properties (solubility, foaming, and emulsifying capacities) of neoglycosylated derivatives of pea vicilin were investigated and compared with unmodified vicilin. Glysosylation was achieved by reductive alkylation of epsilon-amino groups of lysine residues using different carbohydrates (lactose, galactose, glucose, or galacturonic acid). Levels of carbohydrate incorporation ranged from 5 to 13 mol of carbohydrate/mol of vicilin. Solubilities of glycosylated derivatives (notably derivatives modified with glucose or galacturonic acid) were significantly improved in the pH range 5-6 compared to unmodified vicilin. Emulsifying capacity and emulsion stability were also significantly increased in glycosylated vicilin derivatives. Modification with galacturonic acid was the most effective in increasing both emulsifying capacity and stability. Derivatives containing lactose or galactose displayed enhanced foaming capacity relative to unmodified vicilin. However, foam stability was found to decrease by glycosylation of the protein. These results indicate that glycosylation can be used as an efficient method to improve emulsifying capacity and emulsion stability of vicilin.
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,BR-21941590 RIO JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR BANIEL A, 1992, J AGR FOOD CHEM, V40, P200, DOI 10.1021/jf00014a007
   BEWLEY JD, 1985, SEEDS PHYSL DEV GERM, P284
   BRINEGAR AC, 1980, J AGR FOOD CHEM, V28, P818, DOI 10.1021/jf60230a016
   CAER D, 1990, J AGR FOOD CHEM, V38, P1700, DOI 10.1021/jf00098a016
   CHAMBERS SJ, 1990, BIOCHIM BIOPHYS ACTA, V1037, P66, DOI 10.1016/0167-4838(90)90102-L
   COFFMANN CW, 1977, J FOOD TECHNOL, V12, P473, DOI 10.2174/0929866054395257
   COLAS B, 1993, J AGR FOOD CHEM, V41, P1811, DOI 10.1021/jf00035a001
   COURTHAUDON JL, 1989, J AGR FOOD CHEM, V37, P32, DOI 10.1021/jf00085a008
   DAGORNSCAVINER C, 1987, J FOOD SCI, V52, P335, DOI 10.1111/j.1365-2621.1987.tb06607.x
   DAVEY R A, 1979, Australian Journal of Plant Physiology, V6, P435
   DEFELICE FG, 1995, PERSPECTIVES PROTEIN, P306
   GALLOP PM, 1981, ANAL BIOCHEM, V117, P427, DOI 10.1016/0003-2697(81)90802-2
   GATEHOUSE JA, 1982, BIOCHEM J, V207, P629, DOI 10.1042/bj2070629
   GATEHOUSE JA, 1983, BIOCHEM J, V212, P427, DOI 10.1042/bj2120427
   GATEHOUSE JA, 1984, CRC CR REV PLANT SCI, V1, P287, DOI 10.1080/07352688409382182
   GUEGUEN J, 1990, J AGR FOOD CHEM, V38, P61, DOI 10.1021/jf00091a013
   KATO A, 1983, J FOOD SCI, V48, P62, DOI 10.1111/j.1365-2621.1983.tb14788.x
   KIM KS, 1990, J AGR FOOD CHEM, V38, P669, DOI 10.1021/jf00093a018
   KINSELLA JE, 1979, J AM OIL CHEM SOC, V56, P242, DOI 10.1007/BF02671468
   KINSELLA JE, 1979, FUNCTIONALITY PROTEI, P37
   KITABATAKE N, 1985, J AGR FOOD CHEM, V33, P125, DOI 10.1021/jf00061a036
   LARRE C, 1992, J AGR FOOD CHEM, V40, P1121, DOI 10.1021/jf00019a006
   LEE RT, 1980, BIOCHEMISTRY-US, V19, P156, DOI 10.1021/bi00542a024
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYCETT GW, 1983, NUCLEIC ACIDS RES, V11, P2367, DOI 10.1093/nar/11.8.2367
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   PEARCE KN, 1978, J AGR FOOD CHEM, V26, P716, DOI 10.1021/jf60217a041
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   PRAHL L, 1986, NAHRUNG, V30, P311
   SCHWENKE KD, 1990, EUR J BIOCHEM, V194, P621, DOI 10.1111/j.1432-1033.1990.tb15661.x
   SCHWENKE KD, 1986, NAHRUNG, V30, P263, DOI 10.1002/food.19860300314
   SCHWENKE KD, 1983, NAHRUNG, V27, P335, DOI 10.1002/food.19830270407
   SNEDECOR GW, 1962, STAT METHODS, P85
   SUBIRADE M, 1994, BBA-PROTEIN STRUCT M, V1205, P239, DOI 10.1016/0167-4838(94)90239-9
   WANISKA RD, 1984, INT J PEPT PROT RES, V23, P573
   WATSON MD, 1988, BIOCHEM J, V251, P857, DOI 10.1042/bj2510857
   WRIGHT DJ, 1984, PHILOS T ROY SOC B, V304, P381, DOI 10.1098/rstb.1984.0033
   WRIGHT JR, 1985, J HEAT RECOV SYST, V5, P81, DOI 10.1016/0198-7593(85)90040-2
NR 38
TC 28
Z9 28
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUN
PY 1997
VL 45
IS 6
BP 2025
EP 2030
DI 10.1021/jf960815k
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA XF143
UT WOS:A1997XF14300008
DA 2020-09-29
ER

PT J
AU Mesquita, VLV
   Botelho, MM
   Ferreira, ST
AF Mesquita, VLV
   Botelho, MM
   Ferreira, ST
TI Dissociation/unfolding of beta-lactoglobulin induced by hydrostatic
   pressure.
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO, DEPT BIOQUIM MED, BR-21941950 RIO DE JANEIRO, BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 1997
VL 72
IS 2
BP TU453
EP TU453
PN 2
PG 1
WC Biophysics
SC Biophysics
GA WE747
UT WOS:A1997WE74701236
DA 2020-09-29
ER

PT B
AU VerjovskiAlmeida, S
   Vasconcelos, EG
   Ferreira, ST
   Kettlun, AM
   Mancilla, M
   Valenzuela, MA
AF VerjovskiAlmeida, S
   Vasconcelos, EG
   Ferreira, ST
   Kettlun, AM
   Mancilla, M
   Valenzuela, MA
BE Plesner, L
   Kirley, TL
   Knowles, AF
TI ATP diphosphohydrolase from Schistosoma mansoni belongs to a new family
   of apyrases
SO ECTO-ATPASES: RECENT PROGRESS ON STRUCTURE AND FUNCTION
LA English
DT Proceedings Paper
CT 1st International Workshop on Ecto-ATPases
CY AUG 26-30, 1996
CL MAR DEL PLATA, ARGENTINA
SP Univ Aarhus, Dept Biophys, Denmark
AB ATP diphosphohydrolase from S. mansoni tegument was characterized as a 63-kDa protein with two isoforms possessing different isoelectric points. Antibodies against potato apyrase and Toxoplasma gondii nucleoside triphosphatase react with the 63-kDa protein, thus revealing the presence of common epitopes and suggesting that S. mansoni ATP diphosphohydrolase belongs to the family of apyrases. This is a new family of nucleotide-splitting enzymes so far unnoticed which became evident after sequencing 59 amino acids from potato apyrase. The novel potato apyrase sequences obtained have considerable homologies to eight sequences recently deposited in the data bank, including that of T. gondii nucleoside triphosphatase. The new family of apyrases contain a conserved motif (I/V)(V/M/I)(I/L/F/C)DAGS(S/T) near the amino terminal and three other regions showing four to six conserved amino acids.
RP VerjovskiAlmeida, S (corresponding author), UNIV SAO PAULO,DEPT BIOQUIM,INST QUIM,BR-05508900 SAO PAULO,SP,BRAZIL.
RI Verjovski-Almeida, Sergio/AAI-2728-2020; Verjovski-Almeida,
   Sergio/E-4082-2012; Ferreira, Sergio/AAZ-1576-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 2
Z9 2
U1 0
U2 1
PU PLENUM PRESS DIV PLENUM PUBLISHING CORP
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013
BN 0-306-45584-6
PY 1997
BP 153
EP 159
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BH52N
UT WOS:A1997BH52N00019
DA 2020-09-29
ER

PT B
AU Vasconcelos, EG
   Torres, CR
   Martins, SM
   VerjovskiAlmeida, S
   Ferreira, ST
AF Vasconcelos, EG
   Torres, CR
   Martins, SM
   VerjovskiAlmeida, S
   Ferreira, ST
BE Plesner, L
   Kirley, TL
   Knowles, AF
TI The ATP-diphosphohydrolase of Schistosoma mansoni - Ecto-localization
   and possible roles in host-parasite interactions
SO ECTO-ATPASES: RECENT PROGRESS ON STRUCTURE AND FUNCTION
LA English
DT Proceedings Paper
CT 1st International Workshop on Ecto-ATPases
CY AUG 26-30, 1996
CL MAR DEL PLATA, ARGENTINA
SP Univ Aarhus, Dept Biophys, Denmark
AB We have recently described an ecto-ATP diphosphohydrolase in the tegument of the endoparasite Schistosoma mansoni. In this work, evidence indicating the ecto-localization of this enzyme is discussed. Biochemical characterization of this enzyme is presented, along with a discussion on its possible biological roles in the physiology of S. mansoni and in particular regarding interactions of this parasite with the human host.
RP Vasconcelos, EG (corresponding author), UNIV SAO PAULO,DEPT BIOQUIM,INST QUIM,BR-05599970 SAO PAULO,SP,BRAZIL.
RI Verjovski-Almeida, Sergio/E-4082-2012; Ferreira, Sergio/AAZ-1576-2020;
   Verjovski-Almeida, Sergio/AAI-2728-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Ferreira,
   Sergio/0000-0001-7160-9866; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401
NR 0
TC 3
Z9 4
U1 0
U2 0
PU PLENUM PRESS DIV PLENUM PUBLISHING CORP
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013
BN 0-306-45584-6
PY 1997
BP 221
EP 226
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BH52N
UT WOS:A1997BH52N00027
DA 2020-09-29
ER

PT J
AU SepulvedaBecerra, MA
   Ferreira, ST
   Strasser, RJ
   GarzonRodriguez, W
   Beltran, C
   GomezPuyou, A
   Darszon, A
AF SepulvedaBecerra, MA
   Ferreira, ST
   Strasser, RJ
   GarzonRodriguez, W
   Beltran, C
   GomezPuyou, A
   Darszon, A
TI Refolding of triosephosphate isomerase in low-water media investigated
   by fluorescence resonance energy transfer
SO BIOCHEMISTRY
LA English
DT Article
ID TRIOSE PHOSPHATE ISOMERASE; AMINO-ACID SEQUENCE; REVERSE MICELLES;
   ENZYME CATALYSIS; RESOLUTION; PROTEINS; DEHYDROGENASE; DIMERIZATION;
   REACTIVATION; EFFICIENCY
AB The refolding and reassociation of rabbit muscle triosephosphate isomerase (TPI) monomers unfolded with guanidine hydrochloride (GdnHCl) was studied in aqueous media and in reverse micelles (RM) formed with hexadecyltrimethylammonium bromide and n-octane/hexanol. Fluorescence resonance energy transfer (FRET) studies were carried out using TPI labeled at Cys-217 with 5-((2-((iodoacetyl)-amino)ethyl)amino)naphthalene-1-sulfonic acid (1,5-IAEDANS) and TPI labeled at one of the free amino groups with fluorescein 5'-isothiocyanate (FITC). Efficient FRET between monomers of AEDANS-TPI and FITC-TPI in aqueous media was detected 2-3 min after denaturant dilution and remained constant for hours. The distance between AEDANS and FITC in a labeled, renatured hetero-TPI dimer calculated from FRET results was 48 Angstrom, in reasonable agreement with estimates based on the crystal structure of TPI. In RM, recovery of enzyme activity during renaturation correlates with the appearance of a high-intrinsic fluorescence intermediate believed to be a partially folded monomer (Fernandez-Velasco et al., 1995). Nevertheless, when AEDANS- and FITC-labeled monomers were mixed in RM, FRET occurred as soon as GdnHCl was diluted (FRET efficiency = 0.36), preceding the changes in TPI intrinsic fluorescence and reactivation. Thereafter, the efficiency of FRET increased during the next hour up to similar to 0.50, where it remained after 24 h, when 80% of the enzyme activity was recovered. The high initial FRET seen in RM could indicate the formation of an inactive dimer within the first minutes after denaturant dilution. The further increase in FRET observed over the next hour could reflect conformational rearrangements of the protein and transition from the inactive to the active dimer.
C1 UNIV NACL AUTONOMA MEXICO, INST BIOTECNOL, DEPT GENET & FISIOL MOL, CUERNAVACA 62271, MORELOS, MEXICO.
   FED UNIV RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOQUIM MED, BR-21941590 RIO DE JANEIRO, BRAZIL.
   NATL AUTONOMOUS UNIV MEXICO, INST FISIOL CELULAR, DEPT BIOENERGET, MEXICO CITY 04510, DF, MEXICO.
   UNIV GENEVA, BIOENERGET LAB, CH-1254 LULLIER, GENEVA, SWITZERLAND.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ALBER T, 1981, PHILOS T ROY SOC B, V293, P159, DOI 10.1098/rstb.1981.0069
   ALBERY WJ, 1977, ANGEW CHEM INT EDIT, V16, P285, DOI 10.1002/anie.197702851
   ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032
   BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0
   Cheung H. C., 1991, TOPICS FLUORESCENCE, P127
   CORRAN PH, 1973, FEBS LETT, V30, P97, DOI 10.1016/0014-5793(73)80627-1
   Creighton T. E., 1993, PROTEINS STRUCTURES
   DOSREMEDIOS CG, 1995, BBA-BIOENERGETICS, V1228, P99, DOI 10.1016/0005-2728(94)00169-6
   FERNANDEZVELASCO DA, 1995, BIOCHEMISTRY-US, V34, P361, DOI 10.1021/bi00001a044
   FLETCHER PDI, 1988, J CHEM SOC FARAD T 1, V84, P1131, DOI 10.1039/f19888401131
   GARZARAMOS G, 1992, EUR J BIOCHEM, V208, P389, DOI 10.1111/j.1432-1033.1992.tb17199.x
   GAZIT E, 1995, J BIOL CHEM, V270, P2571, DOI 10.1074/jbc.270.6.2571
   HILHORST R, 1984, EUR J BIOCHEM, V144, P459, DOI 10.1111/j.1432-1033.1984.tb08488.x
   JOSHI NB, 1988, EUR J BIOCHEM, V178, P483, DOI 10.1111/j.1432-1033.1988.tb14474.x
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAKEY JH, 1991, J MOL BIOL, V218, P639, DOI 10.1016/0022-2836(91)90707-D
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LU HS, 1984, J BIOL CHEM, V259, P1958
   LUISI PL, 1988, BIOCHIM BIOPHYS ACTA, V947, P209, DOI 10.1016/0304-4157(88)90025-1
   MALLENDER WD, 1994, BIOCHEMISTRY-US, V33, P10100, DOI 10.1021/bi00199a038
   MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510
   MARTENSSON LG, 1995, BIOCHEMISTRY-US, V34, P1011, DOI 10.1021/bi00003a036
   MATTHEWS CR, 1993, ACTA CRYSTALLOGR D, V49, P403
   NOBLE MEM, 1993, ACTA CRYSTALLOGR D, V49, P403, DOI 10.1107/S0907444993002628
   Penefsky H S, 1979, Methods Enzymol, V56, P527
   PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   ROZACKY EE, 1971, ARCH BIOCHEM BIOPHYS, V146, P312, DOI 10.1016/S0003-9861(71)80069-3
   RUPLEY JA, 1991, ADV PROTEIN CHEM, V41, P37
   SAWYER TH, 1975, ARCH BIOCHEM BIOPHYS, V169, P51, DOI 10.1016/0003-9861(75)90315-X
   STRAMBINI GB, 1988, J PHYS CHEM-US, V92, P2850, DOI 10.1021/j100321a030
   STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131
   SWINKELS BW, 1986, EMBO J, V5, P1291, DOI 10.1002/j.1460-2075.1986.tb04358.x
   WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165
   WIERENGA RK, 1992, J MOL BIOL, V224, P1115, DOI 10.1016/0022-2836(92)90473-W
   WIERENGA RK, 1991, J MOL BIOL, V220, P995, DOI 10.1016/0022-2836(91)90368-G
   WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134
   ZABORI S, 1980, Z NATURFORSCH C, V35, P999
NR 40
TC 24
Z9 24
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD DEC 10
PY 1996
VL 35
IS 49
BP 15915
EP 15922
DI 10.1021/bi961548e
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA VX510
UT WOS:A1996VX51000037
PM 8961958
DA 2020-09-29
ER

PT J
AU Vasconcelos, EG
   Ferreira, ST
   deCarvalho, TMU
   deSouza, W
   Kettlun, AM
   Mancilla, M
   Valenzuela, MA
   VerjovskiAlmeida, S
AF Vasconcelos, EG
   Ferreira, ST
   deCarvalho, TMU
   deSouza, W
   Kettlun, AM
   Mancilla, M
   Valenzuela, MA
   VerjovskiAlmeida, S
TI Partial purification and immunohistochemical localization of ATP
   diphosphohydrolase from Schistosoma mansoni - Immunological
   cross-reactivities with potato apyrase and Toxoplasma gondii nucleoside
   triphosphate hydrolase
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SOLANUM-TUBEROSUM; PROTEIN
AB ATP diphosphohydrolase from tegumental membranes of Schistosoma mansoni was solubilized with Triton X-100 plus deoxycholate and separated by preparative nondenaturing polyacrylamide gel electrophoresis. Two isoforms with ATP-hydrolytic activity were identified and excised from nondenaturing gels. For each of the active bands, two protein bands (63 and 55 kDa) were detected with Coomassie Blue staining, following sodium dodecyl sulfate polyacrylamide gel electrophoresis. Western blots developed with polyclonal antipotato apyrase antibody revealed a single protein of 63 kDa, either with samples excised from active bands or with total S. mansoni tegument. Anti-potato apyrase antibody immobilized on Sepharose-Protein A depleted over 95% of ATPase and ADPase activities from detergent-solubilized tegument. Confocal laser scanning microscopy showed anti-potato apyrase antibody on the outer surface of S. mansoni tegument. A different antibody against a fusion protein derived from recently cloned Toxoplasma gondii nucleoside triphosphate hydrolase (Bermudes, D., Peck, K. R., Afifi, M. A. Peckers, C. J. M., and Joiner, K. A. (1994) J. Biol. Chem. 269, 29252-29260) revealed the same 63-kDa band in Western blots of S. mansoni tegument. Since anti-potato apyrase antibodies exhibited cross-reactivity with S. mansoni ATP diphosphohydrolase, we decided to gain further information on the primary structure of potato apyrase by sequencing the protein. Three novel peptides were obtained: amino-terminal sequence and two internal sequences from tryptic fragments. Eight sequences recently deposited in the data bank, including that of T. gondii nucleoside triphosphate hydrolase, have considerable homologies to potato apyrase suggesting a new family of nucleoside triphosphatases which contains a conserved motif (I/V)(V/M/I)(I/L/F/C)DAGS(S/T) near the amino-terminal. Antibody cross-reactivities in the present work suggest that conserved epitopes from S. mansoni ATP diphosphohydrolase are present in this family of nucleotide-splitting enzymes.
C1 UNIV SAO PAULO,INST QUIM,DEPT BIOQUIM,BR-05599970 SAO PAULO,BRAZIL.
   UNIV FED RIO DE JANEIRO,DEPT BIOQUIM MED,BR-21941590 RIO JANEIRO,BRAZIL.
   UNIV ESTADUAL NORTE FLUMINENSE,LAB BIOL CELULAR & TECIDUAL,BR-28015620 RIO JANEIRO,BRAZIL.
   UNIV CHILE,DEPT BIOQUIM & BIOL MOL,SANTIAGO,CHILE.
RI Verjovski-Almeida, Sergio/E-4082-2012; Ferreira, Sergio/AAZ-1576-2020;
   Verjovski-Almeida, Sergio/AAI-2728-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Ferreira,
   Sergio/0000-0001-7160-9866; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401
CR ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   ASAI T, 1995, J BIOL CHEM, V270, P11391, DOI 10.1074/jbc.270.19.11391
   BERMUDES D, 1994, J BIOL CHEM, V269, P29252
   BOUT D, 1986, SCIENCE, V231, P153, DOI 10.1126/science.3079916
   CAPRON A, 1982, IMMUNOL REV, V61, P41, DOI 10.1111/j.1600-065X.1982.tb00373.x
   CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694
   Ferreira Sergio T., 1995, Ciencia e Cultura (Sao Paulo), V47, P151
   FILIPPINI A, 1990, J BIOL CHEM, V265, P334
   FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041
   Harlow E., 1988, ANTIBODIES LAB MANUA
   KETTLUN AM, 1992, PHYTOCHEMISTRY, V31, P1889, DOI 10.1016/0031-9422(92)80328-C
   KETTLUN AM, 1982, PHYTOCHEMISTRY, V21, P551, DOI 10.1016/0031-9422(82)83139-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIN TI, 1977, ANAL BIOCHEM, V77, P10, DOI 10.1016/0003-2697(77)90284-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574
   PLESNER L, 1995, INT REV CYTOL, V158, P141
   SIBLEY LD, 1993, MOL PAR C SEPT 26 29
   SIMPSON AJG, 1981, PARASITOLOGY, V83, P163, DOI 10.1017/S0031182000050137
   Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4
   TAUSSKY HH, 1953, J BIOL CHEM, V202, P675
   TRAN A, 1992, AGENTS ACTIONS, V36, P39, DOI 10.1007/BF01991226
   TRAVERSOCORI A, 1995, ARCH BIOCHEM BIOPHYS, V109, P173
   VASCONCELOS EG, 1993, MOL BIOCHEM PARASIT, V58, P205, DOI 10.1016/0166-6851(93)90042-V
   VERJOVSKIALMEIDA S, 1981, J BIOL CHEM, V256, P2940
   VERMUND SH, 1983, AM J TROP MED HYG, V32, P1040, DOI 10.4269/ajtmh.1983.32.1040
NR 27
TC 112
Z9 116
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 6
PY 1996
VL 271
IS 36
BP 22139
EP 22145
DI 10.1074/jbc.271.36.22139
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA VF612
UT WOS:A1996VF61200067
PM 8703025
OA Bronze
DA 2020-09-29
ER

PT J
AU Castilho, RF
   CarvalhoAlves, PC
   Vercesi, AE
   Ferreira, ST
AF Castilho, RF
   CarvalhoAlves, PC
   Vercesi, AE
   Ferreira, ST
TI Oxidative damage to sarcoplasmic reticulum Ca2+-pump induced by
   Fe2+/H2O2/ascorbate is not mediated by lipid peroxidation or thiol
   oxidation and leads to protein fragmentation
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE sarcoplasmic reticulum; Ca2+-ATPase; free radicals; protein oxidation;
   lipid peroxidation
ID INNER MITOCHONDRIAL-MEMBRANE; TERT-BUTYL HYDROPEROXIDE; FAST
   SKELETAL-MUSCLE; HEART-MITOCHONDRIA; SULFHYDRYL-GROUPS; OXYGEN RADICALS;
   CALCIUM; INHIBITION; MECHANISM; CA-2+
AB The major protein in the sarcoplasmic reticulum (SR) membrane is the Ca2+ transporting ATPase which carries out active Ca2+ pumping at the expense of ATP hydrolysis. The aim of this work was to elucidate the mechanisms by which oxidative stress induced by Fenton's reaction (Fe2++H2O2-->HO .+OH-+Fe3+) alters the function of SR. ATP hydrolysis by both SR vesicles (SRV) and purified ATPase was inhibited in a dose-dependent manner in the presence of 0-1.5 mM H2O2 plus 50 mu M Fe2+ and 6 mM ascorbate. Ca2+ uptake carried out by the Ca2+-ATPase in SRV was also inhibited in parallel. The inhibition of hydrolysis and Ca2+ uptake was not prevented by butylhydroxytoluene (BHT) at concentrations which significantly blocked formation of thiobarbituric acid-reactive substances (TBARS), suggesting that inhibition of the ATPase was not due to lipid peroxidation of the SR membrane. In addition, dithiothreitol (DTT) did not prevent inhibition of either ATPase activity or Ca2+ uptake, suggesting that inhibition was not related to oxidation of ATPase thiols. The passive efflux of Ca-45(2+) from pre-loaded SR vesicles was greatly increased by oxidative stress and this effect could be only partially prevented (ca 20%) by addition of BHT or DTT. Trifluoperazine (which specifically binds to the Ca2+-ATPase, causing conformational changes in the enzyme) fully protected the ATPase activity against oxidative damage. These results suggest that the alterations in function observed upon oxidation of SRV are mainly due to direct effects on the Ca2+-ATPase. Electrophoretic analysis of oxidized Ca2+-ATPase revealed a decrease in intensity of the silver-stained 110 kDa Ca2+-ATPase band and the appearance of low molecular weight peptides (MW < 100 kDa) and high molecular weight protein aggregates, Presence of DTT during oxidation prevented the appearance of protein aggregates and caused a simultaneous increase in the amount of low molecular weight peptides, We propose that impairment of function of the Ca2+-pump may be related to aminoacid oxidation and fragmentation of the protein.
C1 FED UNIV RIO DE JANEIRO, ICB CCS, DEPT BIOQUIM MED, BR-21941590 RIO DE JANEIRO, BRAZIL.
   UNIV ESTADUAL CAMPINAS, INST BIOL, DEPT BIOQUIM, BR-13084100 CAMPINAS, SP, BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020; Vercesi, Anibal E/C-8767-2012; Castilho,
   Roger F/G-3906-2012
OI Ferreira, Sergio/0000-0001-7160-9866; Castilho,
   Roger/0000-0003-2338-8717
CR ANDERSEN JP, 1977, BIOCHIM BIOPHYS ACTA, V485, P188, DOI 10.1016/0005-2744(77)90206-6
   ARIKI M, 1983, BIOCHIM BIOPHYS ACTA, V734, P83, DOI 10.1016/0005-2736(83)90078-0
   BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U
   BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203
   Buege J A, 1978, Methods Enzymol, V52, P302
   CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143
   CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H
   CHIESI M, 1979, J BIOL CHEM, V254, P370
   CHU A, 1987, ARCH BIOCHEM BIOPHYS, V258, P13, DOI 10.1016/0003-9861(87)90317-1
   CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002
   COAN CR, 1977, J BIOL CHEM, V252, P3044
   CROMPTON M, 1988, BIOCHEM J, V255, P357
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9908
   DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2
   DEMEIS L, 1991, J BIOL CHEM, V266, P5736
   DEMEIS L, 1981, TRANSPORT ENERGY TRA
   DINIS TCP, 1993, ARCH BIOCHEM BIOPHYS, V301, P256, DOI 10.1006/abbi.1993.1142
   FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463
   FAGIAN MM, 1990, J BIOL CHEM, V265, P19955
   FISKUM G, 1985, CELL CALCIUM, V6, P25, DOI 10.1016/0143-4160(85)90032-6
   GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006
   GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718
   GUNTER TE, 1990, AM J PHYSIOL, V258, pC755
   Halliwell B, 1989, FREE RADICALS BIOL M
   HANSFORD RG, 1982, J BIOENERG BIOMEMBR, V14, P361, DOI 10.1007/BF00743064
   HEBBEL RP, 1986, BIOCHIM BIOPHYS ACTA, V862, P8, DOI 10.1016/0005-2736(86)90463-3
   HERMESLIMA M, 1995, MOL CELL BIOCHEM, V145, P53, DOI 10.1007/BF00925713
   INESI G, 1989, J BIOL CHEM, V264, P5929
   INUI M, 1987, J BIOL CHEM, V262, P1740
   KANEKO M, 1989, AM J PHYSIOL, V257, pH804
   KORGE P, 1993, ARCH BIOCHEM BIOPHYS, V304, P420, DOI 10.1006/abbi.1993.1370
   KUKREJA RC, 1988, ARCH BIOCHEM BIOPHYS, V261, P447, DOI 10.1016/0003-9861(88)90361-X
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEMASTERS JJ, 1987, NATURE, V325, P78, DOI 10.1038/325078a0
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   MAIA JCC, 1983, GENES ANTIGENES PARA
   MALIS CD, 1986, J BIOL CHEM, V261, P14201
   MASAKI N, 1989, ARCH BIOCHEM BIOPHYS, V270, P672, DOI 10.1016/0003-9861(89)90550-X
   MEIS LD, 1971, J BIOL CHEM, V246, P4759
   MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6
   MOORE RB, 1990, ARCH BIOCHEM BIOPHYS, V278, P416, DOI 10.1016/0003-9861(90)90279-8
   NICOTERA P, 1992, ANNU REV PHARMACOL, V32, P449, DOI 10.1146/annurev.pa.32.040192.002313
   NICOTERA P, 1985, FEBS LETT, V181, P149, DOI 10.1016/0014-5793(85)81131-5
   OHTA A, 1989, BIOCHIM BIOPHYS ACTA, V984, P151, DOI 10.1016/0005-2736(89)90210-1
   ORRENIUS S, 1989, CELL CALCIUM METABOL, P451
   PALLER MS, 1994, ANN NY ACAD SCI, V723, P59, DOI 10.1111/j.1749-6632.1994.tb36717.x
   PARINANDI NL, 1990, ARCH BIOCHEM BIOPHYS, V280, P45, DOI 10.1016/0003-9861(90)90516-2
   PEREIRA RS, 1992, BIOCHEM PHARMACOL, V44, P1795, DOI 10.1016/0006-2952(92)90074-S
   PFEIFFER DR, 1979, J BIOL CHEM, V254, P1485
   PLATIS IE, 1993, BIOCHEMISTRY-US, V32, P12761, DOI 10.1021/bi00210a027
   REED DJ, 1990, CHEM RES TOXICOL, V3, P495, DOI 10.1021/tx00018a002
   SCHERER NM, 1986, ARCH BIOCHEM BIOPHYS, V246, P589, DOI 10.1016/0003-9861(86)90314-0
   SCHERER NM, 1986, BIOCHIM BIOPHYS ACTA, V862, P309, DOI 10.1016/0005-2736(86)90233-6
   SCHUESSLER H, 1984, INT J RADIAT BIOL, V45, P267, DOI 10.1080/09553008414550381
   SCHWARZENBACH G, 1957, COMPLEXOMETRIC TITRA
   SOMLYO AP, 1985, NATURE, V314, P622, DOI 10.1038/314622a0
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   SUTTON HC, 1984, ARCH BIOCHEM BIOPHYS, V235, P106, DOI 10.1016/0003-9861(84)90259-5
   THOMAS CE, 1990, ARCH BIOCHEM BIOPHYS, V281, P96, DOI 10.1016/0003-9861(90)90418-X
   TRUMP BF, 1989, CELL CALCIUM METABOL, P441
   UCHIDA K, 1990, BIOCHEM BIOPH RES CO, V169, P265, DOI 10.1016/0006-291X(90)91463-3
   YAMADA S, 1978, J BIOL CHEM, V253, P6801
   YAMAZAKI I, 1990, J BIOL CHEM, V265, P13589
   YAMAZAKI I, 1991, J AM CHEM SOC, V113, P7588, DOI 10.1021/ja00020a021
NR 66
TC 51
Z9 53
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD JUN 21
PY 1996
VL 159
IS 2
BP 105
EP 114
DI 10.1007/BF00420912
PG 10
WC Cell Biology
SC Cell Biology
GA VB210
UT WOS:A1996VB21000003
PM 8858560
DA 2020-09-29
ER

PT J
AU Rietveld, AWM
   Ferreira, ST
AF Rietveld, AWM
   Ferreira, ST
TI Deterministic pressure dissociation and unfolding of triose phosphate
   isomerase: Persistent heterogeneity of a protein dimer
SO BIOCHEMISTRY
LA English
DT Article
ID TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE; ACTIVE-SITE MODIFICATION;
   CONFORMATIONAL DRIFT; EXTRACELLULAR HEMOGLOBIN; HYDROSTATIC-PRESSURE;
   ASSOCIATION; DENATURATION; FLUORESCENCE; THERMODYNAMICS; DEHYDROGENASE
AB Subunit dissociation and unfolding of dimeric rabbit muscle triose phosphate isomerase (TIM) induced by hydrostatic pressure were investigated. Changes in fluorescence emission of TIM (both intrinsic and of covalently attached probes) indicated that pressure ranging from 1 bar to 3.5 kbar promoted subunit dissociation and unfolding. Intrinsic fluorescence changes upon unfolding by pressure included a 27 nm red-shift of the emission, a decrease in fluorescence anisotropy from 0.14 to about 0.01, and a 1.5-fold increase in fluorescence quantum yield, similar to that observed in the presence of guanidine hydrochloride. Kinetics of pressure-induced fluorescence changes were slow (t(1/2) approximate to 15 min) and little dependent on pressure. In order to selectively monitor subunit dissociation, fluorescence resonance energy transfer (FRET) measurements were carried out with TIM that was separately labeled with 5-((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid (1,5-IAEDANS) or fluorescein-5-isothiocyanate (FITC). FRET measurements indicated that subunit dissociation and unfolding took place concomitantly, both under equilibrium conditions and in kinetic experiments in which dissociation/unfolding was triggered by a sudden increase in pressure. Release of pressure caused monomer refolding and dimerization. Contrary to what would be expected for a process involving subunit dissociation, pressure effects on TIM were not dependent on protein concentration. Experiments involving a series of pressure jumps demonstrated persistent heterogeneity in sensitivity toward pressure,in the ensemble of TIM dimers. This kind of deterministic behavior is similar to that exhibited by higher order protein aggregates and indicates that not all individual dimers are energetically identical in solution. The heterogeneity of native TIM revealed by sensitivity to pressure could not be detected by traditional means of protein separation, such as polyacrylamide gel electrophoresis (under both native and denaturing conditions) and size exclusion gel chromatography. This suggests that energetic heterogeneity originates from conformational heterogeneity of the protein. The possible biological relevance of the deterministic character of stability of TIM is discussed.
C1 FED UNIV RIO DE JANEIRO, CCS, ICB, DEPT BIOQUIM MED, BR-12941590 RIO DE JANEIRO, BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031
   ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032
   BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0
   BONAFE CFS, 1991, J BIOL CHEM, V266, P13210
   BORCHERT TV, 1994, P NATL ACAD SCI USA, V91, P1515, DOI 10.1073/pnas.91.4.1515
   BORCHERT TV, 1995, FEBS LETT, V367, P315, DOI 10.1016/0014-5793(95)00586-X
   BRANDTS JF, 1970, BIOCHEMISTRY-US, V9, P1038, DOI 10.1021/bi00806a045
   CHEUNG HC, 1991, TOPICS FLUORESCENCE, V2, P128
   CREIGHTON TE, 1994, MECHANISMS PROTEIN F, P1
   EFTINK MR, 1991, BIOCHEMISTRY-US, V30, P1193, DOI 10.1021/bi00219a005
   ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022
   FERNANDEZVELASCO DA, 1995, BIOCHEMISTRY-US, V34, P361, DOI 10.1021/bi00001a044
   GARZARAMOS G, 1992, EUR J BIOCHEM, V208, P389, DOI 10.1111/j.1432-1033.1992.tb17199.x
   HAWLEY SA, 1971, BIOCHEMISTRY-US, V10, P2436, DOI 10.1021/bi00789a002
   HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245
   KING L, 1986, BIOCHEMISTRY-US, V25, P3637, DOI 10.1021/bi00360a024
   KISHAN KVR, 1994, PROTEIN SCI, V3, P779
   KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0
   LACKOWICZ, 1983, FLUORESCENCE SPECTRO
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LODI PJ, 1994, BIOCHEMISTRY-US, V33, P2809, DOI 10.1021/bi00176a009
   LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6609, DOI 10.1021/bi00480a009
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PEDROSA C, 1994, BIOCHEMISTRY-US, V33, P4046, DOI 10.1021/bi00179a033
   PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5
   RHOLAM M, 1981, BIOCHEMISTRY-US, V20, P5837, DOI 10.1021/bi00523a029
   Richards F. M., 1992, P1
   ROYER CA, 1993, BIOCHEMISTRY-US, V32, P5222, DOI 10.1021/bi00070a034
   RUAN K, 1989, BIOCHEMISTRY-US, V28, P2144, DOI 10.1021/bi00431a028
   RUAN KC, 1993, BIOCHEMISTRY-US, V32, P6295, DOI 10.1021/bi00075a025
   SAWYER TH, 1975, ARCH BIOCHEM BIOPHYS, V169, P51, DOI 10.1016/0003-9861(75)90315-X
   SCARLATA SF, 1986, BIOCHEMISTRY-US, V25, P4925, DOI 10.1021/bi00365a030
   SCHNACKERZ KD, 1991, EUR J BIOCHEM, V199, P231, DOI 10.1111/j.1432-1033.1991.tb16114.x
   SILVA JL, 1989, J BIOL CHEM, V264, P15863
   SILVA JL, 1988, J MOL BIOL, V199, P149, DOI 10.1016/0022-2836(88)90385-3
   SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   SUN AQ, 1992, J BIOL CHEM, V267, P20168
   SUN AW, 1992, ARCH BIOCHEM BIOPHYS, V293, P382, DOI 10.1016/0003-9861(92)90410-X
   VANDERKOOI JM, 1977, BIOCHEMISTRY-US, V16, P1262, DOI 10.1021/bi00626a003
   WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165
   WEBER G, 1986, BIOCHEMISTRY-US, V25, P3626, DOI 10.1021/bi00360a022
   WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   WEBER G, 1992, PROTEIN INTERACTIONS
   WEBER G, 1987, NATO ASI SER C, V197, P401
   WIERENGA RK, 1992, J MOL BIOL, V224, P1115, DOI 10.1016/0022-2836(92)90473-W
   WIERENGA RK, 1991, J MOL BIOL, V220, P995, DOI 10.1016/0022-2836(91)90368-G
   XU GJ, 1982, P NATL ACAD SCI-BIOL, V79, P5268, DOI 10.1073/pnas.79.17.5268
   YUAN PM, 1981, MECH AGEING DEV, V17, P151, DOI 10.1016/0047-6374(81)90081-6
   YUKSEL KU, 1986, ARCH BIOCHEM BIOPHYS, V248, P452, DOI 10.1016/0003-9861(86)90498-4
   ZABORI S, 1980, Z NATURFORSCH C, V35, P999
   ZIPP A, 1973, BIOCHEMISTRY-US, V12, P4217, DOI 10.1021/bi00745a028
NR 54
TC 49
Z9 50
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUN 18
PY 1996
VL 35
IS 24
BP 7743
EP 7751
DI 10.1021/bi952118b
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA UR904
UT WOS:A1996UR90400014
PM 8672474
DA 2020-09-29
ER

PT J
AU Ferreira, ST
   CoelhoSampaio, T
AF Ferreira, ST
   CoelhoSampaio, T
TI Intrinsic fluorescence as a probe of structure-function relationships in
   Ca2+-transport ATPases
SO BIOSCIENCE REPORTS
LA English
DT Review
DE ATPase; Ca2+; fluorescence
ID SARCOPLASMIC-RETICULUM ATPASE; ERYTHROCYTE PLASMA-MEMBRANE; CALCIUM
   ADENOSINE-TRIPHOSPHATASE; TIME-RESOLVED FLUORESCENCE;
   INORGANIC-PHOSPHATE; BINDING-SITES; CA-2+ PUMP; TRYPTOPHAN FLUORESCENCE;
   ENERGY INTERCONVERSION; CONFORMATIONAL-CHANGES
AB Applications of intrinsic fluorescence measurements in the study of Ca2+-transport ATPases are reviewed. Since the initial reports showing that the fluorescence emission was sensitive to Ca2+ binding, a substantial amount of work has focused on the use of both steady-state and time-resolved fluorescence spectroscopy to investigate structure-function relationships in sarcoplasmic reticulum and plasma membrane Ca2+-ATPases. These studies have revealed ligand-induced conformational changes, as well as provided information on protein-protein, protein-solvent and/or protein-lipid interactions in different functional states of these proteins. The main results of these studies, as well as possible future prospects are discussed.
RP Ferreira, ST (corresponding author), FED UNIV RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,BR-21944590 RIO JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ADAMO HP, 1990, J BIOL CHEM, V265, P3789
   ALVES EW, 1992, ARCH BIOCHEM BIOPHYS, V292, P613, DOI 10.1016/0003-9861(92)90039-Y
   ANDERSEN JP, 1983, EUR J BIOCHEM, V134, P205, DOI 10.1111/j.1432-1033.1983.tb07552.x
   ARRONDO JLR, 1985, BIOCHEM BIOPH RES CO, V128, P1159, DOI 10.1016/0006-291X(85)91062-9
   BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43
   BEECHEM JM, 1989, FLUORESCENCE SPECTRO, V1
   Berridge M.J., 1985, Scientific American, V253, P124
   BUCHET R, 1991, BIOCHIM BIOPHYS ACTA, V1069, P209, DOI 10.1016/0005-2736(91)90126-S
   CAFFREY M, 1981, BIOCHEMISTRY-US, V20, P1949, DOI 10.1021/bi00510a034
   CARAFOLI E, 1992, J BIOL CHEM, V267, P2115
   CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143
   CENTENO F, 1994, FEBS LETT, V3544, P117
   CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012
   CHAMPEIL P, 1983, J BIOL CHEM, V258, P4453
   CHINI EN, 1992, ARCH BIOCHEM BIOPHYS, V299, P73, DOI 10.1016/0003-9861(92)90245-R
   CLARKE DM, 1990, J BIOL CHEM, V265, P6262
   CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0
   COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266
   COELHOSAMPAIO T, 1994, EUR J BIOCHEM, V221, P1103, DOI 10.1111/j.1432-1033.1994.tb18830.x
   COELHOSAMPAIO T, 1992, BIOPHYS CHEM, V42, P243, DOI 10.1016/0301-4622(92)80016-X
   DASILVA ACR, 1991, TRENDS BIOCHEM SCI, V16, P53, DOI 10.1016/0968-0004(91)90024-P
   DEFORESTA B, 1989, BIOCHEMISTRY-US, V28, P2558, DOI 10.1021/bi00432a032
   DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2
   DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275
   DEMEIS L, 1988, J BIOL CHEM, V263, P157
   DEMEIS L, 1981, WILEY SERIES TRANSPO
   DUPONT Y, 1982, BIOCHIM BIOPHYS ACTA, V688, P75, DOI 10.1016/0005-2736(82)90580-6
   DUPONT Y, 1985, J BIOL CHEM, V260, P7241
   DUPONT Y, 1976, BIOCHEM BIOPH RES CO, V71, P544, DOI 10.1016/0006-291X(76)90821-4
   DUPONT Y, 1978, NATURE, V273, P396, DOI 10.1038/273396a0
   FERNANDEZBELDA F, 1988, ARCH BIOCHEM BIOPHYS, V260, P118, DOI 10.1016/0003-9861(88)90431-6
   FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687
   FERNANDEZBELDA F, 1986, BIOCHIM BIOPHYS ACTA, V854, P57
   FERREIRA ST, 1994, BIOPHYS J, V66, P1185, DOI 10.1016/S0006-3495(94)80901-4
   FERREIRA ST, 1991, J LUMIN, V48-9, P430, DOI 10.1016/0022-2313(91)90153-M
   FERREIRA ST, 1989, J BIOL CHEM, V264, P15392
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   FERREIRA ST, 1993, PHOTOCHEM PHOTOBIOL, V58, P195, DOI 10.1111/j.1751-1097.1993.tb09548.x
   FORGE V, 1993, J BIOL CHEM, V268, P10961
   GEORG H, 1994, BBA-BIOENERGETICS, V1188, P139, DOI 10.1016/0005-2728(94)90032-9
   GIRARDET JL, 1993, EUR J BIOCHEM, V217, P225, DOI 10.1111/j.1432-1033.1993.tb18237.x
   GIRARDET JL, 1992, FEBS LETT, V296, P103, DOI 10.1016/0014-5793(92)80413-B
   GOMEZFERNANDEZ JC, 1985, J BIOL CHEM, V260, P7168
   GOPINATH RM, 1977, BIOCHEM BIOPH RES CO, V77, P1203, DOI 10.1016/S0006-291X(77)80107-1
   GRATTON E, 1984, ANNU REV BIOPHYS BIO, V13, P105
   GRYCZYNSKI I, 1989, BIOCHEMISTRY-US, V28, P3490, DOI 10.1021/bi00434a051
   GUILLAIN F, 1984, BIOCHEMISTRY-US, V23, P4754, DOI 10.1021/bi00315a034
   GUILLAIN F, 1982, J BIOL CHEM, V257, P7366
   GUILLAIN F, 1981, J BIOL CHEM, V256, P6140
   GUIMARAESMOTTA H, 1984, J BIOL CHEM, V259, P8699
   HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7
   HENAO F, 1992, J BIOL CHEM, V267, P10302
   HIGHSMITH SR, 1982, BIOCHEMISTRY-US, V21, P3786, DOI 10.1021/bi00259a010
   HOLGUIN JA, 1986, ARCH BIOCHEM BIOPHYS, V251, P9, DOI 10.1016/0003-9861(86)90045-7
   IMAMURA Y, 1991, J BIOCHEM-TOKYO, V110, P214, DOI 10.1093/oxfordjournals.jbchem.a123559
   INESI G, 1980, J BIOL CHEM, V255, P3025
   KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421
   KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184
   KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P3772, DOI 10.1021/bi00467a025
   KOSKKOSICKA D, 1985, FEBS LETT, V189, P67, DOI 10.1016/0014-5793(85)80843-7
   KREBS J, 1987, BIOCHEMISTRY-US, V26, P3921, DOI 10.1021/bi00387a027
   KURTENBACH E, 1985, J BIOL CHEM, V260, P636
   LACAPERE JJ, 1990, J BIOL CHEM, V265, P348
   LACAPERE JJ, 1981, J BIOL CHEM, V256, P2302
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LEMAIRE M, 1987, BIOCHEMISTRY-US, V26, P4803, DOI 10.1021/bi00389a030
   LEMAIRE M, 1976, BIOCHEMISTRY-US, V15, P2336, DOI 10.1021/bi00656a014
   LONDON E, 1981, BIOCHEMISTRY-US, V20, P1939, DOI 10.1021/bi00510a033
   LUDI H, 1985, BIOCHIM BIOPHYS ACTA, V814, P120, DOI 10.1016/0005-2736(85)90426-2
   LUSHCHAK VI, 1984, BIOL NAUK, V5, P26
   MACLENNAN DH, 1992, ACTA PHYSIOL SCAND, V146, P141
   MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6
   MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0
   MARUYAMA K, 1989, J BIOL CHEM, V264, P13038
   MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006
   MOLLER JV, 1986, PROGR PROTEIN LIPID, V2, P147
   MOUTIN MJ, 1991, J BIOL CHEM, V266, P5580
   MOUTIN MJ, 1994, J BIOL CHEM, V269, P11147
   NAKAMURA S, 1994, J BIOL CHEM, V269, P16015
   NIGGLI V, 1982, J BIOL CHEM, V257, P2350
   NIGGLI V, 1979, J BIOL CHEM, V254, P9955
   NIGGLI V, 1981, J BIOL CHEM, V256, P8588
   ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007
   PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5
   SCOTT TL, 1988, MOL CELL BIOCHEM, V82, P51
   SHULL GE, 1988, J BIOL CHEM, V263, P8646
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   STREHLER EE, 1990, J BIOL CHEM, V265, P2835
   SUMBILLA C, 1991, J BIOL CHEM, V266, P12682
   TEALE FWJ, 1957, BIOCHEM J, V65, P476, DOI 10.1042/bj0650476
   VERJOVSKIALMEID.S, 1988, PHYSICAL PROPERTIES, P177
   VERJOVSKIALMEIDA S, 1981, J BIOL CHEM, V256, P2940
   VERJOVSKIALMEIDA S, 1986, J BIOL CHEM, V261, P9872
   VERJOVSKIALMEIDA S, 1981, J BIOL CHEM, V256, P2662
   VERMA AK, 1988, J BIOL CHEM, V263, P14152
   VIEYRA A, 1991, J BIOL CHEM, V266, P10324
   Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G
   WEBER G, 1987, NATO ASI SER C, V197, P401
   WEBER G, 1965, PROTEINS, V3, P477
   WRZOSEK A, 1989, BIOCHIM BIOPHYS ACTA, V986, P263, DOI 10.1016/0005-2736(89)90476-8
   ZVARITCH E, 1990, BIOCHEMISTRY-US, V29, P8070, DOI 10.1021/bi00487a012
NR 101
TC 4
Z9 4
U1 0
U2 2
PU PLENUM PUBL CORP
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013
SN 0144-8463
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD APR
PY 1996
VL 16
IS 2
BP 87
EP 106
DI 10.1007/BF01206199
PG 20
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA UR329
UT WOS:A1996UR32900002
PM 8790915
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Rietveld, AWM
   Ferreira, ST
AF Rietveld, AWM
   Ferreira, ST
TI Deterministic pressure dissociation and unfolding of triose phosphate
   isomerase: Persistent heterogeneity of a protein dimer
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 FED UNIV RIO DE JANEIRO, ICB, CCS, DEPT BIOCHEM, BR-21944590 RIO DE JANEIRO, BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 1996
VL 70
IS 2
BP TU235
EP TU235
PN 2
PG 1
WC Biophysics
SC Biophysics
GA TZ682
UT WOS:A1996TZ68201753
DA 2020-09-29
ER

PT J
AU SEPULVEDABECERRA, MA
   FERREIRA, ST
   STRASSER, R
   GARZONRODRIGUEZ, W
   BELTRAN, C
   GOMEZPUYOU, A
   DARSZON, A
AF SEPULVEDABECERRA, MA
   FERREIRA, ST
   STRASSER, R
   GARZONRODRIGUEZ, W
   BELTRAN, C
   GOMEZPUYOU, A
   DARSZON, A
TI REASSOCIATION OF TRIOSEPHOSPHATE ISOMERASE IN REVERSE MICELLES MEASURED
   BY ENERGY-TRANSFER
SO PROTEIN ENGINEERING
LA English
DT Article; Proceedings Paper
CT 1995 Miami Bio/Technology Winter Symposium - Advances in Gene
   Technology: Protein Engineering and Structural Biology
CY FEB 04-09, 1995
CL MIAMI, FL
SP Univ Miami, Nature Publishing Co
C1 FED UNIV RIO DE JANEIRO,INST CIENCIAS BIOMED,BR-21945 RIO JANEIRO,BRAZIL.
   UNIV GENEVA,BIOENERGET LAB,GENEVA,SWITZERLAND.
   UNIV NACL AUTONOMA MEXICO,INST FISIOL CELULAR,MEXICO CITY,DF,MEXICO.
RP SEPULVEDABECERRA, MA (corresponding author), UNIV NACL AUTONOMA MEXICO,INST BIOTECHNOL,CUERNAVACA 62191,MORELOS,MEXICO.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR FERNANDEZVELASC.A, 1994, UNPUB BIOCHEMISTRY
   GARZARAMOS G, 1992, EUR J BIOCHEM, V208, P389, DOI 10.1111/j.1432-1033.1992.tb17199.x
   MASAO M, 1990, EUR J BIOCHEM, V187, P155
   SAWYER TH, 1975, ARCH BIOCHEM BIOPHYS, V169, P51, DOI 10.1016/0003-9861(75)90315-X
   WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165
   WIERENGA RK, 1991, PROTEINS, V10, P33, DOI 10.1002/prot.340100105
   ZABORI S, 1980, Z NATURFORSCH C, V35, P999
   ZHIDONG Z, 1994, BIOCHEMISTRY-US, V33, P2830
NR 8
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0269-2139
J9 PROTEIN ENG
JI Protein Eng.
PY 1995
VL 8
SU S
BP 22
EP 22
PG 1
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA RL742
UT WOS:A1995RL74200038
DA 2020-09-29
ER

PT J
AU MALLENDER, WD
   FERREIRA, ST
   VOSS, EW
   COELHOSAMPAIO, T
AF MALLENDER, WD
   FERREIRA, ST
   VOSS, EW
   COELHOSAMPAIO, T
TI INTER-ACTIVE-SITE DISTANCE AND SOLUTION DYNAMICS OF A
   BIVALENT-BISPECIFIC SINGLE-CHAIN ANTIBODY MOLECULE
SO BIOCHEMISTRY
LA English
DT Article
ID FLUORESCENCE ENERGY-TRANSFER; TIME-RESOLVED FLUORESCENCE; TRYPTOPHAN
   RESIDUES; STRANDED-DNA; FAB COMPLEX; PROTEINS; AUTOANTIBODY; MOTIONS;
   PHASE; FV
AB The solution dynamics of a bivalent bispecific single-chain antibody (BiSCA) specific against fluorescein (Fl) and single-stranded DNA (ssDNA) were investigated. Fluorescence resonance energy transfer (FRET) studies were performed in order to estimate the average distances, R, between the anti-Fl and the anti-ssDNA active sites. In separate experiments, either 2-(dimethylamino)naphthalene-5-sulfonyl chloride coupled to the 5' end of an oligothymidylate polymer of 6 residues length (2,5-DNS-dT(6)) served as energy donor to Fl or eosin isothiocyanate coupled to the 5' end of an oligothymidylate polymer of 6 residues length (eosin-dT(6)) served as energy acceptor from Fl. Labeling of dT(6) with 2,5-DNS or eosin did not significantly interfere with recognition by the anti-ssDNA binding site. With the 2,5-DNS/Fl energy transfer pair, the calculated values of R(k(2) = 2/3), R(min), and R(max) were 44, 37, and 54 Angstrom, respectively. With Fl/eosin (opposite direction of FRET), values of 40, 33, and 51 Angstrom, respectively, were obtained. Considering the sizes of the two SCA domains and the length of the interdomain polypeptide linker, an R value of approximately 140 Angstrom would be expected for the extended molecule. The fact that measured R distances were on average 3-fold shorter than 140 Angstrom indicated that BiSCA was not an extended and rigid molecule. The efficiency of energy transfer increased with increasing temperature in the range of 10-30 degrees C, suggesting that conformational fluctuations of the protein resulted in decreased average distance between BiSCA active sites. The decay of the intrinsic fluorescence anisotropy in BiSCA was dominated by local mobility of tryptophan residues, as indicated by the predominance of a subnanosecond rotational correlation time component. A second rotational correlation time of approximately 7 ns was also found. The expected value for the overall rotation of the 57-kDa BiSCA molecule is approximately 21 ns. Comparison between measured and expected rotational correlation times indicated that the fluorescence anisotropy decay in BiSCA did not report overall tumbling of the whole molecule but independent rotational motions of the two SCA domains. These results, along with FRET data, suggest that BiSCA displays considerable conformational dynamics in solution, which likely results from flexibility of the linker.
C1 UNIV ILLINOIS, DEPT MICROBIOL, URBANA, IL 61801 USA.
   UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOQUIM MED, BR-21944 RIO DE JANEIRO, BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU NCRR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [RR03155-01] Funding Source: Medline
CR BALLARD DW, 1984, J BIOL CHEM, V259, P3492
   BATES RM, 1985, MOL IMMUNOL, V22, P871, DOI 10.1016/0161-5890(85)90072-0
   BEDZYK WD, 1990, J BIOL CHEM, V265, P18615
   Beechem J.M., 1988, P SPIE INT SOC OPT E, P70
   BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379
   BRUNET JE, 1994, BIOPHYS J, V66, P446, DOI 10.1016/S0006-3495(94)80796-9
   CHEUNG HC, 1991, TOPICS FLUORESCENCE, V2, P128
   COELHOSAMPAIO T, 1993, BIOCHEMISTRY-US, V32, P10929, DOI 10.1021/bi00092a001
   COOPER JP, 1990, BIOCHEMISTRY-US, V29, P9261, DOI 10.1021/bi00491a022
   CORBALANGARCIA S, 1993, EUR J BIOCHEM, V217, P737, DOI 10.1111/j.1432-1033.1993.tb18300.x
   DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1
   DENZIN LK, 1991, J BIOL CHEM, V266, P14095
   EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4
   FERREIRA ST, 1994, BIOPHYS J, V66, P1185, DOI 10.1016/S0006-3495(94)80901-4
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105
   FREUND C, 1994, BIOCHEMISTRY-US, V33, P3296, DOI 10.1021/bi00177a021
   FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025
   GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7
   GRATTON E, 1984, ANNU REV BIOPHYS BIO, V13, P105
   GRATTON E, 1986, BIOCHEM SOC T, V14, P835, DOI 10.1042/bst0140835
   HAAS E, 1978, BIOCHEMISTRY-US, V17, P5064, DOI 10.1021/bi00616a032
   HARAN G, 1992, P NATL ACAD SCI USA, V89, P11764, DOI 10.1073/pnas.89.24.11764
   HAZLETT TL, 1989, BIOCHEMISTRY-US, V28, P4109, DOI 10.1021/bi00435a073
   HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302
   HERRON JN, 1989, PROTEINS, V5, P271, DOI 10.1002/prot.340050404
   HERRON JN, 1981, J BIOCHEM BIOPH METH, V5, P1, DOI 10.1016/0165-022X(81)90029-4
   HUSTON JS, 1991, METHOD ENZYMOL, V203, P46
   KRANZ DM, 1981, MOL IMMUNOL, V18, P889, DOI 10.1016/0161-5890(81)90012-2
   KURUCZ I, 1993, P NATL ACAD SCI USA, V90, P3830, DOI 10.1073/pnas.90.9.3830
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAKEY JH, 1993, J MOL BIOL, V230, P1055, DOI 10.1006/jmbi.1993.1218
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LAKOWICZ JR, 1994, TOPICS FLUORESCENCE, P293
   MALLENDER WD, 1994, J BIOL CHEM, V269, P199
   MUNRO I, 1979, P NATL ACAD SCI USA, V76, P56, DOI 10.1073/pnas.76.1.56
   MURASE S, 1993, BIOCHEM BIOPH RES CO, V195, P1159, DOI 10.1006/bbrc.1993.2166
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   RUMBLEY CA, 1993, J BIOL CHEM, V268, P13667
   STRYER L, 1982, ANNU REV BIOPHYS BIO, V11, P203, DOI 10.1146/annurev.bb.11.060182.001223
   STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131
   TETIN SY, 1993, BIOCHEMISTRY-US, V32, P9011, DOI 10.1021/bi00086a005
   WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2
   WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0
   WATT RM, 1978, IMMUNOCHEMISTRY, V15, P875, DOI 10.1016/0161-5890(78)90121-9
   WATT RM, 1977, IMMUNOCHEMISTRY, V14, P741
   WEBER G, 1977, J CHEM PHYS, V66, P4081, DOI 10.1063/1.434481
   WERNER TC, 1972, P NATL ACAD SCI USA, V69, P795, DOI 10.1073/pnas.69.4.795
   YGUERABIDE J, 1970, J MOL BIOL, V51, P573, DOI 10.1016/0022-2836(70)90009-4
   YOKOTA T, 1992, CANCER RES, V52, P3402
NR 51
TC 22
Z9 22
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD AUG 23
PY 1994
VL 33
IS 33
BP 10100
EP 10108
DI 10.1021/bi00199a038
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA PD219
UT WOS:A1994PD21900038
PM 8060979
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
   GRATTON, E
AF FERREIRA, ST
   GRATTON, E
TI ANISOTROPIC ROTATIONAL DIFFUSION OF THE ADENINE MOIETY IN
   1,N-6-ETHENOADENOSINE TRIPHOSPHATE IN VISCOUS SOLVENTS INVESTIGATED BY
   TIME-RESOLVED FLUORESCENCE SPECTROSCOPY
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID FRICTIONAL RESISTANCE; PHASE FLUOROMETRY; LOCAL ROTATIONS; FLUOROPHORES;
   COENZYMES
AB A recent C-13 NMR study of the rotational dynamics of ATP in viscous solvents suggested that rotation of the adenine moiety about the glycosidic bond that attaches it to the ribose persists at high rates even at high viscosities [Rao, B. D. N.; Ray, B. D. J. Am, Chem. Sec. 1992, 114, 1566-1573]. This is a surprising finding, since it is generally accepted that the rotational diffusion of solutes is attenuated by viscous drag from solvent molecules (according to the classical Stokes-Einstein relationship). In the present study, we have carried out a detailed fluorescence spectroscopic investigation of the rotational diffusion of the adenine in ATP in aqueous solutions containing increasing concentrations of glycerol. For this purpose, we have utilized the well-characterized fluorescent ATP derivative, 1,N-6-ethenoadenosine triphosphate (epsilon-ATP), in which the adenine moiety has been rendered fluorescent. Fluorescence lifetimes and anisotropy decay measurements of epsilon-ATP were performed in solutions presenting viscosities spanning 3 orders of magnitude (ranging from ca. 1.7 to 1310 cp). We have further explored the effect of viscosity on the rotations of the adenine moiety by performing fluorescence anisotropy measurements across the entire excitation band of epsilon-ATP. Selective excitation of epsilon-ATP at different relative orientations between the absorption and emission dipole moments enabled detection of anisotropic rotations of the molecule. Regardless of the direction of the axis selected for excitation of fluorescence, rotations of the adenine moiety in epsilon-ATP were found to be linearly attenuated by increasing solvent viscosity,
C1 UNIV ILLINOIS,DEPT PHYS,FLUORESCENCE DYNAM LAB,URBANA,IL 61801.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR Beechem J.M., 1988, P SPIE INT SOC OPT E, P70
   BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P552
   LEONARD NJ, 1984, CRC CR REV BIOCH MOL, V15, P125, DOI 10.3109/10409238409102299
   MANTULIN WW, 1977, J CHEM PHYS, V66, P4092, DOI 10.1063/1.434482
   MINOR CS, 1953, GLYCEROL, P278
   OCONNOR DV, 1984, TIME RESOLVED SINGLE, P257
   RAO BDN, 1992, J AM CHEM SOC, V114, P1566, DOI 10.1021/ja00031a005
   RHOLAM M, 1984, BIOCHEMISTRY-US, V23, P6793, DOI 10.1021/bi00321a079
   SCARLATA S, 1984, BIOCHEMISTRY-US, V23, P6789, DOI 10.1021/bi00321a078
   SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001
   SECRIST JA, 1972, SCIENCE, V175, P646, DOI 10.1126/science.175.4022.646
   SHINITZKY M, 1971, BIOCHEMISTRY-US, V10, P2106
   SPENCER RD, 1974, EUR J BIOCHEM, V45, P425, DOI 10.1111/j.1432-1033.1974.tb03566.x
   WEBER G, 1977, J CHEM PHYS, V66, P4081, DOI 10.1063/1.434481
   WEBER G, 1984, BIOCHEMISTRY-US, V23, P6785, DOI 10.1021/bi00321a077
NR 16
TC 2
Z9 2
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUN 29
PY 1994
VL 116
IS 13
BP 5791
EP 5795
DI 10.1021/ja00092a033
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA NV421
UT WOS:A1994NV42100033
DA 2020-09-29
ER

PT J
AU COELHOSAMPAIO, T
   FERREIRA, ST
   CASTRO, EJ
   VIEYRA, A
AF COELHOSAMPAIO, T
   FERREIRA, ST
   CASTRO, EJ
   VIEYRA, A
TI BETAINE COUNTERACTS UREA-INDUCED CONFORMATIONAL-CHANGES AND UNCOUPLING
   OF THE HUMAN ERYTHROCYTE CA2+ PUMP
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
ID PLASMA-MEMBRANE CA2+-ATPASE; SARCOPLASMIC-RETICULUM;
   ADENOSINE-TRIPHOSPHATASE; ELASMOBRANCH FISHES; CALCIUM-PUMP; CALMODULIN;
   FLUORESCENCE; INHIBITION; PROTEINS; CA-2+-ATPASE
AB We have investigated the effects of the protein structure-perturbing and function-perturbing osmolyte urea, and one of its physiological counteracting solutes, the methylamine compound (carboxymethyl)trimethylammonium hydroxide (betaine), on the structure and function of the human erythrocyte plasma-membrane Ca2+-ATPase. Betaine per se promoted a conformational change in the purified ATPase as revealed by steady-state and time-resolved intrinsic fluorescence spectroscopy. The conformational change promoted by betaine was shown to be related to changes in the degree of compaction of the protein structure, as detected by fluorescence-quenching measurements using acrylamide and iodide, non-charged and charged quenchers, respectively. In contrast, urea promoted a biphasic increase in exposure of tryptophan residues of the purified ATPase to the aqueous medium. With the use of membrane-bound ATPase, increasing concentrations of urea up to 1.5 M promoted a twofold increase in the Ca2+-ATPase activity, and the simultaneous inhibition of Ca2+ accumulation indicated that ATP hydrolysis became uncoupled from Ca2+ transport. Higher urea concentrations promoted a pronounced inhibition of ATP hydrolysis. In the absence of urea, betaine decreased ATP hydrolysis without affecting Ca2+ transport, whereas it counteracted the strong inhibition of Ca2+-ATPase activity by urea concentrations as high as 7 M. Betaine also protected Ca2+ accumulation against inhibition with concentrations of urea up to 1.5 M, indicating that the methylamine is able to counteract the uncoupling of the ATPase observed at lower urea concentrations. These results suggest that betaine modifies the effects of urea on the erythrocyte Ca2+-ATPase, through specific solute-induced conformational changes that protect the energy-transduction capacity of the enzyme.
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,BR-21941590 RIO JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR BALABAN RS, 1987, KIDNEY INT, V31, P562, DOI 10.1038/ki.1987.36
   BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4
   BERMAN MC, 1982, BIOCHIM BIOPHYS ACTA, V694, P95, DOI 10.1016/0304-4157(82)90015-6
   CARAFOLI E, 1992, J BIOL CHEM, V267, P2115
   CARAFOLI E, 1991, PHYSIOL REV, V71, P129
   CHINI EN, 1992, ARCH BIOCHEM BIOPHYS, V299, P73, DOI 10.1016/0003-9861(92)90245-R
   COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266
   COELHOSAMPAIO T, 1992, BIOPHYS CHEM, V42, P243, DOI 10.1016/0301-4622(92)80016-X
   DEMEIS L, 1988, J BIOL CHEM, V263, P157
   Eftink M.R., 2001, TOPICS FLUORESCENCE, V2, P53
   EFTINK MR, 1984, BIOCHEMISTRY-US, V23, P3894
   FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209
   FALCHETTO R, 1991, J BIOL CHEM, V266, P2930
   FORSTER RP, 1976, AM J PHYSIOL, V230, P925
   GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081
   GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718
   INESI G, 1989, J BIOL CHEM, V264, P5929
   JOHNSON DA, 1985, BIOPHYS J, V48, P949, DOI 10.1016/S0006-3495(85)83858-3
   JORGEGARCIA I, 1988, ARCH BIOCHEM BIOPHYS, V265, P82, DOI 10.1016/0003-9861(88)90373-6
   KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LEE JC, 1981, J BIOL CHEM, V256, P7193
   LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAIA JCC, 1983, GENES ANTIGENES PARA, P146
   MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V258, P356, DOI 10.1016/0003-9861(87)90355-9
   NIGGLI V, 1981, J BIOL CHEM, V256, P395
   NIGGLI V, 1979, J BIOL CHEM, V254, P9955
   PIERCE SK, 1990, ANNU REV PHYSIOL, V52, P27, DOI 10.1146/annurev.ph.52.030190.000331
   SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P5278, DOI 10.1021/bi00138a006
   SHULL GE, 1988, J BIOL CHEM, V263, P8646
   Somero GN, 1986, NEWS PHYSIOL SCI, V1, P9
   SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128
   TIMASHEFF SN, 1989, PROTEIN STRUCTURE PR, V14, P331
   VIEYRA A, 1991, J BIOL CHEM, V266, P10324
   VIEYRA A, 1989, METH SURV I, V19, P31
   WEBER G, 1965, PROTEINS, V3, P477
   YANCEY PH, 1980, J EXP ZOOL, V212, P205, DOI 10.1002/jez.1402120207
   YANCEY PH, 1979, BIOCHEM J, V183, P317, DOI 10.1042/bj1830317
   YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124
NR 41
TC 30
Z9 30
U1 0
U2 3
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD MAY 1
PY 1994
VL 221
IS 3
BP 1103
EP 1110
DI 10.1111/j.1432-1033.1994.tb18830.x
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA NK281
UT WOS:A1994NK28100027
PM 8181468
DA 2020-09-29
ER

PT J
AU PEDROSA, C
   FERREIRA, ST
AF PEDROSA, C
   FERREIRA, ST
TI DETERMINISTIC PRESSURE-INDUCED DISSOCIATION OF VICILIN, THE 7S STORAGE
   GLOBULIN FROM PEA-SEEDS - EFFECTS OF PH AND COSOLVENTS ON OLIGOMER
   STABILITY
SO BIOCHEMISTRY
LA English
DT Article
ID PISUM-SATIVUM-L; SARCOPLASMIC-RETICULUM ATPASE; CONFORMATIONAL DRIFT;
   HYDROSTATIC-PRESSURE; GLYCOSYLATED DERIVATIVES; EXTRACELLULAR
   HEMOGLOBIN; ASSOCIATION-DISSOCIATION; FUNCTIONAL-PROPERTIES; PROTEIN;
   LEGUMIN
AB A thermodynamic characterization of subunit association of vicilin, a storage protein from pea seeds, was performed using a combination of hydrostatic pressure and fluorescence spectroscopy. Application of pressure up to 2.4 kbar caused dissociation of vicilin subunits, as revealed by (1) size-exclusion FPLC of pressurized samples, (2) fluorescence anisotropy measurements of a dansyl-vicilin conjugate under pressure, and (3) quenching of the intrinsic fluorescence of vicilin. Pressure dissociation data were well described by a model for dissociation of a trimer. This enabled calculation of the standard molar volume change of association (DELTAV(o)) and the equilibrium dissociation constant at atmospheric pressure (K(o)); at pH 10 these were found to be DELTAV(o) = 146 mL/mol and K(o) = 2.2 x 10(-15) M2, respectively, corresponding to C1/2 (the concentration of protein at 50% dissociation at atmospheric pressure) = 18 nM and a stabilization free energy of -19.6 kcal/mol for the oligomer. Vicilin exhibited an anomalously low dependence on protein concentration for pressure dissociation. This appeared related to conformational changes in the dissociated subunits, which caused a loss of ca. 5 kcal/mol in the free energy of association and to structural/energetic heterogeneity in the population of oligomers. Pressure dissociation was markedly pH-dependent, with a stabilization free energy loss of 3.4 kcal/mol upon raising pH from 9 to 10. Circular dichroism and intrinsic fluorescence lifetime measurements at atmospheric pressure showed that the structure of vicilin was largely unaffected by pH in the range investigated. These results suggest that the effect of pH may involve deprotonation of lysine residues participating in salt bridges between vicilin subunits. Pressure dissociation of vicilin was significantly inhibited by addition of salts (NaCl, KCl, LiCl) or glycerol. Dissociation curves obtained in the presence of salts enabled calculation of the free energies of stabilization (ranging from ca. -1.2 to -2.4 kcal/mol) of the vicilin oligomers by these cosolvents. The similar effects of salts or glycerol suggest a common mechanism of stabilization of the oligomer involving exclusion of the cosolvents from the protein interface and preferential hydration of the protein.
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,BR-21944 RIO JANEIRO,RJ,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR BANIEL A, 1992, J AGR FOOD CHEM, V40, P200, DOI 10.1021/jf00014a007
   BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   Bewley JD, 1985, SEEDS PHYSL DEV GERM
   BONAFE CFS, 1991, J BIOL CHEM, V266, P13210
   BRAND BP, 1956, T FARADAY SOC, V52, P438, DOI 10.1039/tf9565200438
   CAER D, 1990, J AGR FOOD CHEM, V38, P1700, DOI 10.1021/jf00098a016
   CHAMBERS SJ, 1990, BIOCHIM BIOPHYS ACTA, V1037, P66, DOI 10.1016/0167-4838(90)90102-L
   CHANDRA BRS, 1985, J BIOSCIENCE, V9, P177, DOI 10.1007/BF02702692
   COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266
   CROY RRD, 1982, NATURE, V295, P76, DOI 10.1038/295076a0
   DOMONEY C, 1985, NUCLEIC ACIDS RES, V13, P687, DOI 10.1093/nar/13.3.687
   DREYFUS G, 1988, BIOCHEMISTRY-US, V27, P6704, DOI 10.1021/bi00418a010
   ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0
   ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022
   FERREIRA ST, 1991, J LUMIN, V48-9, P430, DOI 10.1016/0022-2313(91)90153-M
   FERREIRA ST, 1989, J BIOL CHEM, V264, P15392
   GARCIA CRS, 1992, EUR J BIOCHEM, V209, P1005, DOI 10.1111/j.1432-1033.1992.tb17375.x
   GATEHOUSE JA, 1982, BIOCHEM J, V207, P629, DOI 10.1042/bj2070629
   GATEHOUSE JA, 1983, BIOCHEM J, V212, P427, DOI 10.1042/bj2120427
   GATEHOUSE JA, 1984, CRC CR REV PLANT SCI, V1, P287, DOI 10.1080/07352688409382182
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   GRANT DR, 1964, ARCH BIOCHEM BIOPHYS, V108, P552, DOI 10.1016/0003-9861(64)90441-2
   GUEGUEN J, 1988, J SCI FOOD AGR, V44, P167, DOI 10.1002/jsfa.2740440208
   GUERRIERI N, 1990, J PROTEIN CHEM, V9, P397, DOI 10.1007/BF01024615
   HAMANN SD, 1988, ORGANIC HIGH PRESSUR, P50
   Heremans K., 1980, High Pressure Science and Technology. Proceedings of the VIIth International AIRAPT Conference, P845
   HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245
   HEREMANS L, 1989, BIOCHIM BIOPHYS ACTA, V999, P192, DOI 10.1016/0167-4838(89)90217-3
   KAUZMANN W, 1962, J AM CHEM SOC, V84, P1777, DOI 10.1021/ja00869a002
   KING L, 1986, BIOCHEMISTRY-US, V25, P3637, DOI 10.1021/bi00360a024
   KING L, 1986, BIOCHEMISTRY-US, V25, P3632, DOI 10.1021/bi00360a023
   KINSELLA JE, 1979, J AM OIL CHEM SOC, V56, P242, DOI 10.1007/BF02671468
   KOSHIYAMA I, 1971, AGR BIOL CHEM TOKYO, V35, P385, DOI 10.1080/00021369.1971.10859931
   LAMBERT N, 1986, BIOCHEM SOC T, V14, P1186
   LEE JC, 1975, BIOCHEMISTRY-US, V14, P5183, DOI 10.1021/bi00694a025
   LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037
   LOW PS, 1975, P NATL ACAD SCI USA, V72, P3305, DOI 10.1073/pnas.72.9.3305
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYCETT GW, 1983, NUCLEIC ACIDS RES, V11, P2367, DOI 10.1093/nar/11.8.2367
   Miner C.S., 1953, GLYCEROL
   MUGA A, 1990, BIOCHEMISTRY-US, V29, P2925, DOI 10.1021/bi00464a006
   NEWMANN RC, 1973, J PHYS CHEM-US, V77, P2687
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PICHL I, 1982, BIOCHEM PHYSIOL PFL, V177, P547, DOI 10.1016/S0015-3796(82)80048-6
   PRAKASH V, 1977, INT J PEPT PROT RES, V9, P319
   RODGERS KK, 1991, J MOL BIOL, V221, P1453, DOI 10.1016/0022-2836(91)90945-3
   RUAN K, 1989, BIOCHEMISTRY-US, V28, P2144, DOI 10.1021/bi00431a028
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   SCHWENKE K D, 1975, Nahrung, V19, P425, DOI 10.1002/food.19750190506
   SILVA JL, 1989, J BIOL CHEM, V264, P15863
   SILVA JL, 1988, J MOL BIOL, V199, P149, DOI 10.1016/0022-2836(88)90385-3
   SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065
   SILVA JL, 1994, IN PRESS ANN REV PHY, V44
   THOMPSON RB, 1984, BIOCHEMISTRY-US, V23, P3411, DOI 10.1021/bi00310a005
   Timasheff S. N., 1989, PROTEIN STRUCTURE PR, P331
   TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435
   VERJOVSKIALMEIDA S, 1986, J BIOL CHEM, V261, P9872
   WATSON MD, 1988, BIOCHEM J, V251, P857, DOI 10.1042/bj2510857
   WEBER G, 1986, BIOCHEMISTRY-US, V25, P3626, DOI 10.1021/bi00360a022
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   WEBER G, 1992, PROTEIN INTERACTIONS
   WEBER G, 1987, NATO ASI SER C, V197, P401
   WRIGHT DJ, 1984, PHILOS T ROY SOC B, V304, P381, DOI 10.1098/rstb.1984.0033
   WRIGHT JR, 1985, J HEAT RECOV SYST, V5, P81, DOI 10.1016/0198-7593(85)90040-2
   XU GJ, 1982, P NATL ACAD SCI-BIOL, V79, P5268, DOI 10.1073/pnas.79.17.5268
NR 65
TC 30
Z9 30
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD APR 5
PY 1994
VL 33
IS 13
BP 4046
EP 4055
DI 10.1021/bi00179a033
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA NE341
UT WOS:A1994NE34100033
PM 8142407
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
   STELLA, L
   GRATTON, E
AF FERREIRA, ST
   STELLA, L
   GRATTON, E
TI CONFORMATIONAL DYNAMICS OF BOVINE CU, ZN SUPEROXIDE-DISMUTASE REVEALED
   BY TIME-RESOLVED FLUORESCENCE SPECTROSCOPY OF THE SINGLE TYROSINE
   RESIDUE
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID DIFFERENTIAL SCANNING CALORIMETRY; FREQUENCY-DOMAIN FLUOROMETRY;
   LIFETIME DISTRIBUTIONS; PROTEIN DYNAMICS; PICOSECOND RESOLUTION;
   POLARIZATION DECAY; PHASE FLUOROMETRY; ANISOTROPY DECAYS; STEADY-STATE;
   MOTIONS
AB The structural dynamics of bovine erythrocyte Cu, Zn superoxide dismutase (BSOD) was studied by time-resolved fluorescence spectroscopy. BSOD is a homodimer containing a single tyrosine residue (and no tryptophan) per subunit. Frequency-domain fluorometry revealed a heterogeneous fluorescence decay that could be described with a Lorentzian distribution of lifetimes. The lifetime distribution parameters (center and width) were markedly dependent on temperature. The distribution center (average lifetime) displayed Arrhenius behavior with an E(a) of 4.2 kcal/mol, in contrast with an E(a) of 7.4 kcal/mol for the single-exponential decay of L-tyrosine. This indicated that thermal quenching of tyrosine emission was not solely responsible for the effect of temperature on the lifetimes of BSOD. The distribution width was broad (1 ns at 8 degrees C) and decreased significantly at higher temperatures. Furthermore, the width of the lifetime distribution increased in parallel to increasing viscosity of the medium. The combined effects of temperature and viscosity on the fluorescence decay suggest the existence of multiple conformational substates in BSOD that interconvert during the excited-state lifetime. Denaturation of BSOD by guanidine hydrochloride produced an increase in the lifetime distribution width, indicating a larger number of conformations probed by the tyrosine residue in the denatured state. The rotational mobility of the tyrosine in BSOD was also investigated. Analysis of fluorescence anisotropy decay data enabled resolution of two rotational correlation times. One correlation time corresponded to a fast (picosecond) rotation that contributed 62% of the anisotropy decay and likely reported local mobility of the tyrosine ring. The longer correlation time was 50% of the expected value for rotation of the whole (dimeric) BSOD molecule and appeared to reflect segmental motions in the protein in addition to overall tumbling. Comparison between rotational correlation times and fluorescence lifetimes of BSOD indicates that the heterogeneity in lifetimes does not arise from mobility of the tyrosine per se, but rather from dynamics of the protein matrix surrounding this residue which affect its fluorescence decay.
RP FERREIRA, ST (corresponding author), UNIV ILLINOIS, DEPT PHYS, FLUORESCENCE DYNAM LAB, URBANA, IL 61801 USA.
RI Ferreira, Sergio/AAZ-1576-2020; Stella, Lorenzo/A-7996-2010
OI Ferreira, Sergio/0000-0001-7160-9866; Stella,
   Lorenzo/0000-0002-5489-7381
FU NCRR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [RR03155] Funding Source: Medline
CR ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   ALCALA JR, 1987, BIOPHYS J, V51, P597, DOI 10.1016/S0006-3495(87)83384-2
   ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0
   BACKLUND BM, 1992, BIOPHYS CHEM, V45, P17, DOI 10.1016/0301-4622(92)87019-F
   BANNISTER J, 1971, EUR J BIOCHEM, V18, P178, DOI 10.1111/j.1432-1033.1971.tb01228.x
   BANNISTER JV, 1984, METHOD ENZYMOL, V105, P88
   BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001
   Beechem J. M., 1988, SPIE, V909, P70
   BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43
   BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   BISMUTO E, 1988, BIOCHEMISTRY-US, V27, P2132, DOI 10.1021/bi00406a047
   CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P550
   CARERI G, 1979, ANNU REV BIOPHYS BIO, V8, P69, DOI 10.1146/annurev.bb.08.060179.000441
   DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519
   DILORIO EE, 1991, BIOPHYS J, V59, P742, DOI 10.1016/S0006-3495(91)82287-1
   FERREIRA S, 1990, J MOL LIQ, V45, P253, DOI 10.1016/0167-7322(90)80034-H
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   FORMAN HJ, 1973, J BIOL CHEM, V248, P2645
   FRAUENFELDER H, 1986, METHOD ENZYMOL, V127, P207
   FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451
   GAUDUCHON P, 1978, BIOPHYS CHEM, V8, P87, DOI 10.1016/0301-4622(78)85026-1
   GRATTON E, 1989, FLUORESCENT BIOMOLEC, P17
   GRATTON E, 1988, BIOL ARTIFICIAL INTE, P49
   GRYCZYNSKI I, 1991, BIOPHYS CHEM, V39, P69, DOI 10.1016/0301-4622(91)85007-D
   Gurd F R, 1979, Adv Protein Chem, V33, P73, DOI 10.1016/S0065-3233(08)60459-3
   KARPLUS M, 1981, CRC CR REV BIOCH MOL, V9, P293, DOI 10.3109/10409238109105437
   KINOSITA K, 1977, BIOPHYS J, V20, P289, DOI 10.1016/S0006-3495(77)85550-1
   Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2
   KUNGL AJ, 1992, BIOPHYS CHEM, V45, P41, DOI 10.1016/0301-4622(92)87022-B
   LAKOWICZ JR, 1986, BIOPHYS CHEM, V24, P97, DOI 10.1016/0301-4622(86)80002-3
   LAKOWICZ JR, 1987, BIOCHEMISTRY-US, V26, P82, DOI 10.1021/bi00375a012
   LAWS WR, 1986, BIOCHEMISTRY-US, V25, P599, DOI 10.1021/bi00351a013
   LEPOCK JR, 1990, J BIOL CHEM, V265, P21612
   LEPOCK JR, 1985, ARCH BIOCHEM BIOPHYS, V241, P243, DOI 10.1016/0003-9861(85)90380-7
   LIBERTINI LJ, 1989, BIOPHYS CHEM, V34, P269, DOI 10.1016/0301-4622(89)80064-X
   LIBERTINI LJ, 1985, BIOPHYS J, V47, P765, DOI 10.1016/S0006-3495(85)83979-5
   MALINOWSKI DP, 1979, BIOCHEMISTRY-US, V18, P5055, DOI 10.1021/bi00590a005
   MCNAMARA JO, 1993, NATURE, V362, P20, DOI 10.1038/362020a0
   MCREE DE, 1990, J BIOL CHEM, V265, P14234
   MEI G, 1992, BIOCHEMISTRY-US, V31, P7224, DOI 10.1021/bi00147a003
   MINER CS, 1953, GLYCEROL, P278
   MOTULSKY HJ, 1987, FASEB J, V1, P365
   MUNRO I, 1979, P NATL ACAD SCI USA, V76, P56, DOI 10.1073/pnas.76.1.56
   NORDLUND TM, 1986, P NATL ACAD SCI USA, V83, P8977, DOI 10.1073/pnas.83.23.8977
   PAOLETTI F, 1990, METHOD ENZYMOL, V186, P209
   PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109
   PERMYAKOV EA, 1985, ARCH BIOCHEM BIOPHYS, V240, P781, DOI 10.1016/0003-9861(85)90087-6
   RIGLER R, 1990, EUR J BIOCHEM, V188, P541, DOI 10.1111/j.1432-1033.1990.tb15434.x
   RIGO A, 1978, BIOCHEMISTRY-US, V17, P534, DOI 10.1021/bi00596a025
   ROE JA, 1988, BIOCHEMISTRY-US, V27, P950, DOI 10.1021/bi00403a017
   ROSATO N, 1990, BIOPHYS CHEM, V36, P41, DOI 10.1016/0301-4622(90)85005-Q
   ROSATO N, 1990, BIOPHYS J, V58, P817, DOI 10.1016/S0006-3495(90)82427-9
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Ross J. B. A., 1992, TOPICS FLUORESCENCE, V3, P1
   ROSS JBA, 1986, BIOCHEMISTRY-US, V25, P607, DOI 10.1021/bi00351a014
   RUSTING RL, 1992, SCI AM           DEC, P131
   TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7
   Timasheff S. N., 1989, PROTEIN STRUCTURE PR, P331
   Valentine J.S., 1981, COPPER PROTEINS, P291
   WEBER G, 1977, J CHEM PHYS, V66, P4081, DOI 10.1063/1.434481
   WUTHRICH K, 1976, NUCLEAR MAGNETIC RES
   ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404
NR 62
TC 49
Z9 50
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD APR
PY 1994
VL 66
IS 4
BP 1185
EP 1196
DI 10.1016/S0006-3495(94)80901-4
PG 12
WC Biophysics
SC Biophysics
GA ND194
UT WOS:A1994ND19400027
PM 8038390
OA Green Published
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
   STELLA, L
   GRATTON, E
AF FERREIRA, ST
   STELLA, L
   GRATTON, E
TI DYNAMICS OF BOVINE CU,ZN SUPEROXIDE-DISMUTASE REVEALED BY TIME-RESOLVED
   FLUORESCENCE SPECTROSCOPY
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 UNIV ILLINOIS,DEPT PHYS,FLUORESCENCE DYNAM LAB,URBANA,IL 61801.
RI Stella, Lorenzo/A-7996-2010; Ferreira, Sergio/AAZ-1576-2020
OI Stella, Lorenzo/0000-0002-5489-7381; Ferreira,
   Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 1994
VL 66
IS 2
BP A166
EP A166
PN 2
PG 1
WC Biophysics
SC Biophysics
GA MU462
UT WOS:A1994MU46200963
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
AF FERREIRA, ST
TI FLUORESCENCE LIFETIME AND QUENCHING STUDIES OF SARCOPLASMIC-RETICULUM
   CA2+-ADENOSINE-5'-TRIPHOSPHATASE
SO PHOTOCHEMISTRY AND PHOTOBIOLOGY
LA English
DT Article
ID ADENOSINE-TRIPHOSPHATASE; ATPASE; MEMBRANES; PROTEINS; DOMAINS; OXYGEN;
   WATER
AB Different classes of tryptophan residues in sarcoplasmic reticulum calcium-ATPase were investigated with respect to their exposure to quenchers and sensitivity to high-affinity calcium binding to the ATPase. The charged quenchers, iodide and cesium, produced only slight quenching of ATPase fluorescence, whereas noncharged acrylamide and notably oxygen produced significant quenching. This finding gives support to the proposed location of most of the tryptophan residues of the ATPase in transmembrane domains of this protein (MacLennan et al, 1985, Nature 316r, 696-700). Among the different quenchers tested, oxygen quenching alone was sensitive to calcium binding to the ATPase, indicating that oxygen quenched tryptophan residues located in regions of the ATPase molecule which undergo conformational changes upon calcium binding. Time-resolved oxygen quenching data were analyzed with a recently described model that takes into account the existence of two different classes of emitters in the ATPase (Ferreira and Verjovski-Almeida, 1991, J. Lumin. 48, 430-434): a short-lived blue-shifted exponential component plus a long-lived red-shifted continuous lifetime distribution. Oxygen quenching of the single-exponential lifetime component was found to be insensitive to calcium, whereas quenching of the distributed lifetime component was significantly (ca 25%) enhanced by calcium binding. The different sensitivities of the two tryptophan classes to calcium binding to the ATPase are interpreted in terms of the proposed location of tryptophan residues in relation to the calcium transport sites in the ATPase molecule.
RP FERREIRA, ST (corresponding author), UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,BR-21944 RIO JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   BEECHEM JM, 1989, FLUORESCENCE SPECTRO, V1, P241
   BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2
   CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0
   DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017
   DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2
   DEMEIS L, 1981, SARCOPLASMIC RETICUL, V2
   DUPONT Y, 1976, BIOCHEM BIOPH RES CO, V71, P544, DOI 10.1016/0006-291X(76)90821-4
   EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7
   FERREIRA ST, 1991, J LUMIN, V48-9, P430, DOI 10.1016/0022-2313(91)90153-M
   FERREIRA ST, 1989, J BIOL CHEM, V264, P15392
   GRYCZYNSKI I, 1989, BIOCHEMISTRY-US, V28, P3490, DOI 10.1021/bi00434a051
   HAVERSTICK DM, 1987, P NATL ACAD SCI USA, V84, P4475, DOI 10.1073/pnas.84.13.4475
   INESI G, 1990, PHYSIOL REV, V70, P749
   INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041
   LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020
   LUDI H, 1983, BIOCHIM BIOPHYS ACTA, V732, P479, DOI 10.1016/0005-2736(83)90066-4
   MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0
   MANTULIN WW, 1986, BIOCHEMISTRY-US, V25, P8034, DOI 10.1021/bi00372a036
   MOTULSKY HJ, 1987, FASEB J, V1, P365
   RODGERS W, 1991, P NATL ACAD SCI USA, V88, P1364, DOI 10.1073/pnas.88.4.1364
   SMOTKIN ES, 1991, BIOCHIM BIOPHYS ACTA, V1061, P33, DOI 10.1016/0005-2736(91)90265-A
   SUBCZYNSKI WK, 1983, BIOPHYS J, V41, P283, DOI 10.1016/S0006-3495(83)84439-7
   TEALE FWJ, 1957, BIOCHEM J, V75, P335
   VERJOVSKIALMEIDA S, 1981, J BIOL CHEM, V256, P2662
   VILSEN B, 1991, J BIOL CHEM, V266, P18839
   WASHBURN EW, 1928, INT CRIT TABLES, P257
NR 27
TC 5
Z9 5
U1 0
U2 0
PU AMER SOC PHOTOBIOLOGY
PI AUGUSTA
PA BIOTECH PARK, 1021 15TH ST, SUITE 9, AUGUSTA, GA 30901-3158
SN 0031-8655
J9 PHOTOCHEM PHOTOBIOL
JI Photochem. Photobiol.
PD AUG
PY 1993
VL 58
IS 2
BP 195
EP 199
DI 10.1111/j.1751-1097.1993.tb09548.x
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA LT882
UT WOS:A1993LT88200008
PM 8415909
DA 2020-09-29
ER

PT J
AU VIEYRA, A
   FERREIRA, ST
AF VIEYRA, A
   FERREIRA, ST
TI PROCEEDINGS OF THE WORKSHOP THERMODYNAMICS AND KINETICS IN
   BIOLOGICAL-SYSTEMS - IN HONOR OF WEBER,GREGORIO
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Editorial Material
RP VIEYRA, A (corresponding author), UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,RIO JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD APR
PY 1993
VL 26
IS 4
BP 335
EP 335
PG 1
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA LC789
UT WOS:A1993LC78900001
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
AF FERREIRA, ST
TI STRUCTURAL FLUCTUATIONS IN PROTEINS REVEALED BY TIME-RESOLVED
   FLUORESCENCE SPECTROSCOPY
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE FLUORESCENCE LIFETIMES; FLUORESCENCE ANISOTROPY; HYDRATION; REVERSE
   MICELLES; CALCIUM; PARVALBUMIN; LYSOZYME
ID NUCLEAR MAGNETIC-RESONANCE; LIFETIME DISTRIBUTIONS; DYNAMICS; EXCHANGE;
   MOTIONS
AB Time-resolved fluorescence spectroscopy permits the direct assessment of protein motions in the picosecond-nanosecond time-scale, i.e., in a time-window compatible with the observation of relevant motions of the protein matrix. The intrinsic fluorescence emission from tryptophan and tyrosine residues provides a convenient tool to follow these dynamic events in proteins. In the present investigation, the use of time-resolved fluorescence spectroscopy to monitor protein dynamics is illustrated by a study of the effects of temperature and calcium binding on the internal dynamics of the calcium-binding protein, parvalbumin, and by an investigation of the effects of hydration on the mobility of tryptophan side chains of lysozyme and azurin in low-water media. Our results showed that measurements of both fluorescence intensity and anisotropy decays provided complementary information regarding the flexibility of aromatic side chains in the proteins investigated, which could be correlated with environmental effects on protein structure.
RP FERREIRA, ST (corresponding author), UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOQUIM MED, BR-21941-590 RIO DE JANEIRO, BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   ALCALA JR, 1987, BIOPHYS J, V51, P597, DOI 10.1016/S0006-3495(87)83384-2
   ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0
   BANNISTER JV, 1984, METHOD ENZYMOL, V105, P88
   BEECHEM JM, 1989, FLUORESCENCE SPECTRO, V1
   CARERI G, 1975, Critical Reviews in Biochemistry, V3, P141, DOI 10.3109/10409237509102555
   CARERI G, 1979, ANNU REV BIOPHYS BIO, V8, P69, DOI 10.1146/annurev.bb.08.060179.000441
   CARERI G, 1980, NATURE, V284, P572, DOI 10.1038/284572a0
   CLOSSET JI, 1971, ARCH INT PHYS BIOCH, V79, P624
   FERREIRA S, 1990, J MOL LIQ, V45, P253, DOI 10.1016/0167-7322(90)80034-H
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   GRATTON E, 1988, BIOL ARTIFICIAL INTE, P49
   IKEGAMI A, 1984, FLUCTUATING ENNZYME, pCH9
   KARPLUS M, 1983, ANNU REV BIOCHEM, V52, P263, DOI 10.1146/annurev.bi.52.070183.001403
   KARPLUS M, 1987, COLD SPRING HARB SYM, V52, P381, DOI 10.1101/SQB.1987.052.01.044
   LINDERSTROMLANG KU, 1959, ENZYMES, V1, P443
   MUNRO I, 1979, P NATL ACAD SCI USA, V76, P56, DOI 10.1073/pnas.76.1.56
   NAKANISHI M, 1972, J MOL BIOL, V64, P363, DOI 10.1016/0022-2836(72)90504-9
   SILVA N, 1992, THESIS U ILLINOIS
   WAGNER G, 1982, J MOL BIOL, V160, P343, DOI 10.1016/0022-2836(82)90180-2
   WLODAWER A, 1982, P NATL ACAD SCI-BIOL, V79, P1418, DOI 10.1073/pnas.79.5.1418
   WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719
   WUTHRICH K, 1989, ACCOUNTS CHEM RES, V22, P36, DOI 10.1021/ar00157a006
NR 23
TC 0
Z9 0
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD APR
PY 1993
VL 26
IS 4
BP 395
EP 403
PG 9
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA LC789
UT WOS:A1993LC78900010
PM 16121443
DA 2020-09-29
ER

PT J
AU VASCONCELOS, EG
   NASCIMENTO, PS
   MEIRELLES, MNL
   VERJOVSKIALMEIDA, S
   FERREIRA, ST
AF VASCONCELOS, EG
   NASCIMENTO, PS
   MEIRELLES, MNL
   VERJOVSKIALMEIDA, S
   FERREIRA, ST
TI CHARACTERIZATION AND LOCALIZATION OF AN ATP-DIPHOSPHOHYDROLASE ON THE
   EXTERNAL SURFACE OF THE TEGUMENT OF SCHISTOSOMA-MANSONI
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
DE ATP-DIPHOSPHOHYDROLASE; ECTO-ATPASE; SCHISTOSOMA-MANSONI; PLATELET
   AGGREGATION
ID PLATELET-AGGREGATION; PLASMA-MEMBRANE; OUTER-MEMBRANE; INHIBITION;
   COAGULATION; MG-2+; HOST
AB An ATP-diphosphohydrolase (EC 3.6.1.5) was identified in the tegumental fraction isolated from Schistosoma mansoni worms. Both ATP and ADP were hydrolyzed to AMP at similar rates by the enzyme. Other nucleotides were also degraded by the tegument enzyme, revealing a broad substrate specificity. Electrophoretic separation of tegumental proteins under non-denaturing conditions followed by addition of ATP or ADP as substrate revealed a single band of activity with similar mobility. In addition, similar heat-inactivation profiles were obtained for ATPase or ADPase activities, indicating that a single enzyme is responsible for degrading both nucleotides. The enzyme was not inhibited by vanadate, levamisole, tetramisole, ouabain or sodium azide. The ADPase activity was not affected by adenosine (5')-pentaphospho-(5')-adenosine (Ap5A) or by an excess of glucose and hexokinase used as an ATP-trapping system, thus excluding the presence of any significant adenylate kinase activity. The ATP-diphosphohydrolase displayed micromolar affinities for both Mg2+ and Ca2+ and the calcium-activated enzyme was inhibited by millimolar Mg2+. In intact live worms a calcium phosphate precipitate was formed on the outer tegumental surface upon incubation of the worms with either ATP or ADP, indicating the ecto-localization of this enzyme. In addition, ultrastructural hystochemical localization of the enzyme was obtained. A distinct deposition of lead phosphate granules on the outer surface of the tegument was observed by electron microscopy, in the presence of either ATP or ADP as substrate. It is suggested that the ATP-diphosphohydrolase could regulate the concentration of purine nucleotides around the parasites and hence enable them to escape the host hemostasis by preventing ADP-induced platelet activation.
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,CAIXA POSTAL 68041,BR-21944-970 RIO JANEIRO,BRAZIL.
   FIOCRUZ MS,INST OSWALDO CRUZ,DEPT ULTRAESTRUTURA & BIOL CELULAR,RIO JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020; Verjovski-Almeida, Sergio/E-4082-2012;
   Verjovski-Almeida, Sergio/AAI-2728-2020
OI Ferreira, Sergio/0000-0001-7160-9866; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401
CR BATTASTINI AMO, 1991, NEUROCHEM RES, V16, P1303, DOI 10.1007/BF00966661
   BOUT D, 1986, SCIENCE, V231, P153, DOI 10.1126/science.3079916
   BUEDING E, 1962, BIOCHEM PHARMACOL, V11, P17, DOI 10.1016/0006-2952(62)90087-4
   CARAFOLI E, 1991, PHYSIOL REV, V71, P129
   CESARI IM, 1981, BIOCHEM J, V198, P467, DOI 10.1042/bj1980467
   COTE YP, 1991, BIOCHIM BIOPHYS ACTA, V1078, P187, DOI 10.1016/0167-4838(91)99008-G
   CUNHA VMN, 1992, MOL BIOCHEM PARASIT, V52, P167, DOI 10.1016/0166-6851(92)90049-P
   JOSEPH M, 1983, NATURE, V303, P810, DOI 10.1038/303810a0
   KHODAPARASTSHARIFI SH, 1989, INT J BIOCHEM, V21, P401, DOI 10.1016/0020-711X(89)90364-9
   KNOWLES AF, 1983, BIOCHIM BIOPHYS ACTA, V731, P88, DOI 10.1016/0005-2736(83)90401-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIN SH, 1989, J BIOL CHEM, V264, P14408
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUTHJE J, 1988, EUR J BIOCHEM, V175, P285, DOI 10.1111/j.1432-1033.1988.tb14195.x
   MELNICK RL, 1979, ANAL BIOCHEM, V96, P7, DOI 10.1016/0003-2697(79)90546-3
   NAON R, 1989, AM J PHYSIOL, V256, pR313
   NECHAY BR, 1980, J PARASITOL, V66, P596, DOI 10.2307/3280515
   PAYARES G, 1985, PARASITE IMMUNOL, V7, P45, DOI 10.1111/j.1365-3024.1985.tb00478.x
   RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335
   ROBERTSON NP, 1985, COMP BIOCHEM PHYS B, V82, P299, DOI 10.1016/0305-0491(85)90245-7
   SAITO H, 1991, J LAB CLIN MED, V117, P341
   SHER A, 1989, PARASITOLOGY, V98, pS61, DOI 10.1017/S0031182000072255
   SIMPSON AJG, 1981, PARASITOLOGY, V83, P163, DOI 10.1017/S0031182000050137
   SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128
   SUN HT, 1990, J BIOCHEM-TOKYO, V108, P730, DOI 10.1093/oxfordjournals.jbchem.a123273
   TAUSSKY HH, 1953, J BIOL CHEM, V202, P675
   TAYLOR DW, 1991, EXPERIENTIA, V47, P152, DOI 10.1007/BF01945416
   TSANG VCW, 1977, AM J TROP MED HYG, V26, P243, DOI 10.4269/ajtmh.1977.26.243
   VARGAFTIG BB, 1981, BIOCHEM PHARMACOL, V30, P263, DOI 10.1016/0006-2952(81)90052-6
   VERMUND SH, 1983, AM J TROP MED HYG, V32, P1040, DOI 10.4269/ajtmh.1983.32.1040
   ZINGALI RB, 1990, THROMB RES, V58, P303, DOI 10.1016/0049-3848(90)90100-Q
NR 31
TC 70
Z9 71
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD APR
PY 1993
VL 58
IS 2
BP 205
EP 214
DI 10.1016/0166-6851(93)90042-V
PG 10
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA KU715
UT WOS:A1993KU71500002
PM 8479445
DA 2020-09-29
ER

PT J
AU COELHOSAMPAIO, T
   FERREIRA, ST
AF COELHOSAMPAIO, T
   FERREIRA, ST
TI TIME-RESOLVED FLUORESCENCE OF ERYTHROCYTE PLASMA-MEMBRANE CA2+-ATPASE IN
   DIFFERENT FUNCTIONAL-STATES
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
DE ERYTHROCYTE PLASMA MEMBRANE; CA2+-ATPASE; CONFORMATIONAL STATES;
   CALMODULIN; FLUORESCENCE LIFETIMES
ID SARCOPLASMIC-RETICULUM; PHASE FLUOROMETER; CALMODULIN; BINDING;
   LIFETIME; DOMAIN; ATPASE
AB The fluorescence decay of the plasma membrane calmodulin-activated Ca2+-ATPase from the erythrocyte was measured for the first time.  The availability of a novel procedure for on-line blank subtraction in frequency-domain lifetime data acquisition (G.G. Reinhart, B. Feddersen, D. Jameson and E. Gratton, Biophys. J. 57 (1990) 189a) permitted the elimination of background interference from detergent-solubilized purified plasma membrane ATPase samples.  The fluorescence decay of the erythrocyte Ca2+-ATPase was measured in the absence of Ca2+, or in the presence of Ca2+ or Ca2+ plus calmodulin.  In the three different experimental conditions the fluorescence decay was very heterogeneous and could be best described by Lorentzian distributions of lifetime values.  In the absence of Ca2+ the decay was described by a broad lifetime distribution centered at 4.4 ns with a width of 3.2 ns, indicating heterogeneity of tryptophan microenvironments in the ATPase.  Calcium ion binding promoted an 11% increase in the center and a 27% decrease in the width of the distribution.  By contrast, addition of calmodulin in the presence of Ca2+ caused a 15% decrease in the center of the distribution, revealing structural difference between calmodulin-activated and Ca2+-activated states of the ATPase.  These results indicate the usefulness of on-line blank subtraction in frequency-domain lifetime measurements to investigate conformational changes in detergent-solubilized membrane protein samples.
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,BR-21944 RIO DE JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
CR ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0
   ALCALA JR, 1985, ANAL INSTRUM, V14, P225
   BEECHEM JM, 1989, FLUORESCENCE SPECTRO, V1
   CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143
   FERREIRA ST, 1989, J BIOL CHEM, V264, P15392
   FERREIRA ST, 1989, BIOCHEMISTRY-US, V28, P10066, DOI 10.1021/bi00452a028
   GOPINATH RM, 1977, BIOCHEM BIOPH RES CO, V77, P1203, DOI 10.1016/S0006-291X(77)80107-1
   GRAF E, 1982, BIOCHEMISTRY-US, V21, P4511, DOI 10.1021/bi00261a049
   GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7
   GRATTON E, 1988, BIOL ARTIFICIAL INTE, P49
   JAMES P, 1988, J BIOL CHEM, V263, P2905
   KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P3772, DOI 10.1021/bi00467a025
   KOSKKOSICKA D, 1985, FEBS LETT, V189, P67, DOI 10.1016/0014-5793(85)80843-7
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   MOTULSKY HJ, 1987, FASEB J, V1, P365
   NIGGLI V, 1979, J BIOL CHEM, V254, P9955
   REINHART GD, 1990, BIOPHYS J, V57, pA189
   Schatzmann H. J., 1982, MEMBRANE TRANSPORT C, P41
   SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128
   WRZOSEK A, 1989, BIOCHIM BIOPHYS ACTA, V986, P263, DOI 10.1016/0005-2736(89)90476-8
NR 20
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-4622
J9 BIOPHYS CHEM
JI Biophys. Chem.
PD APR
PY 1992
VL 42
IS 3
BP 243
EP 248
DI 10.1016/0301-4622(92)80016-X
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA HN044
UT WOS:A1992HN04400004
PM 1533798
DA 2020-09-29
ER

PT J
AU COELHOSAMPAIO, T
   FERREIRA, ST
   BENAIM, G
   VIEYRA, A
AF COELHOSAMPAIO, T
   FERREIRA, ST
   BENAIM, G
   VIEYRA, A
TI DISSOCIATION OF PURIFIED ERYTHROCYTE CA2+-ATPASE BY HYDROSTATIC-PRESSURE
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SARCOPLASMIC-RETICULUM ATPASE; RED-CELL MEMBRANES; PLASMA-MEMBRANE;
   CA-2+ PUMP; ADENOSINE-TRIPHOSPHATASE; CONFORMATIONAL DRIFT;
   CIRCULAR-DICHROISM; SELF-ASSOCIATION; PROTEIN-KINASE; CALMODULIN
AB Subunit interactions in the Ca2+-ATPase from erythrocyte plasma membranes were investigated through a combination of fluorescence spectroscopy and high-pressure techniques. Application of hydrostatic pressure in the range of 1 bar to 2.4 kbar promoted full dissociation of the ATPase, as revealed by spectral shifts of the intrinsic fluorescence emission and by changes in the fluorescence polarization of dansyl-conjugated ATPase. Pressure dissociation of the ATPase displayed a dependence on protein concentration compatible with dissociation of a dimer. Calculated from pressure-dissociation curves, the standard volume change dV0 for the association of subunits was 43-50 ml/mol and K0, the dissociation constant at atmospheric pressure, was 6-9 x 10(-8) M. Addition of Ca2+ stabilized the dimeric ATPase structure against pressure dissociation, whereas addition of vanadate facilitated dissociation by pressure. These results suggest that inter-subunit interactions depend on the equilibrium between the two major conformational states E1 and E2 of the ATPase. Addition of calmodulin in the presence of Ca2+ had no additional effect when compared to that observed in the presence of Ca2+ alone. This finding is interpreted in terms of the mechanism of calmodulin activation of ATPase catalysis.
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,BR-21944 RIO DE JANEIRO,BRAZIL.
   CENT UNIV VENEZUELA,FAC CIENCIAS,CTR BIOL CELULAR,CARACAS,VENEZUELA.
RI Ferreira, Sergio/AAZ-1576-2020; Benaim, Gustavo/H-5552-2019
OI Ferreira, Sergio/0000-0001-7160-9866; Benaim,
   Gustavo/0000-0002-9359-5546
FU NCRR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [RR03155-01] Funding Source: Medline
CR ADAMO HP, 1990, J BIOL CHEM, V265, P3789
   ADAMO HP, 1988, J BIOL CHEM, V263, P17548
   BARRABIN H, 1980, BIOCHIM BIOPHYS ACTA, V600, P796, DOI 10.1016/0005-2736(80)90482-4
   BENAIM G, 1984, J BIOL CHEM, V259, P8471
   BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4
   CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143
   FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463
   GOPINATH RM, 1977, BIOCHEM BIOPH RES CO, V77, P1203, DOI 10.1016/S0006-291X(77)80107-1
   HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245
   KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184
   KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495
   KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P3772, DOI 10.1021/bi00467a025
   KOSKKOSICKA D, 1985, FEBS LETT, V189, P67, DOI 10.1016/0014-5793(85)80843-7
   KREBS J, 1987, BIOCHEMISTRY-US, V26, P3921, DOI 10.1021/bi00387a027
   Lakowicz JR, 1983, PRINCIPLES FLUORESCE, P257
   LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015
   LEW VL, 1982, NATURE, V298, P478, DOI 10.1038/298478a0
   MUALLEM S, 1980, BIOCHIM BIOPHYS ACTA, V597, P631, DOI 10.1016/0005-2736(80)90235-7
   MUALLEM S, 1981, BIOCHIM BIOPHYS ACTA, V647, P73, DOI 10.1016/0005-2736(81)90296-0
   NEUMAN RC, 1973, J PHYS CHEM-US, V77, P2687, DOI 10.1021/j100640a025
   NEYSES L, 1985, J BIOL CHEM, V260, P283
   NIGGLI V, 1982, J BIOL CHEM, V257, P2350
   NIGGLI V, 1981, J BIOL CHEM, V256, P395
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P186, DOI 10.1016/0968-0004(87)90090-9
   PIN S, 1990, BIOCHEMISTRY-US, V29, P9194, DOI 10.1021/bi00491a013
   ROSS J B A, 1989, Biophysical Journal, V55, p517A
   ROSSI JPFC, 1986, BIOCHIM BIOPHYS ACTA, V858, P21, DOI 10.1016/0005-2736(86)90287-7
   RUAN K, 1989, BIOCHEMISTRY-US, V28, P2144, DOI 10.1021/bi00431a028
   RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026
   SCHATZMANN HJ, 1989, ANNU REV PHYSIOL, V51, P473, DOI 10.1146/annurev.physiol.51.1.473
   SCOFANO HM, 1979, J BIOL CHEM, V254, P227
   SENEAR DF, 1988, BIOPHYS J, V53, pA104
   SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065
   SMALLWOOD JI, 1988, J BIOL CHEM, V263, P2195
   SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128
   THOMPSON RB, 1984, BIOCHEMISTRY-US, V23, P3411, DOI 10.1021/bi00310a005
   VERJOVSKIALMEIDA S, 1986, J BIOL CHEM, V261, P9872
   VIEYRA A, 1979, BIOCHIM BIOPHYS ACTA, V568, P437, DOI 10.1016/0005-2744(79)90312-7
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   WEBER G, 1987, NATO ASI SER C, V197, P401
   WRZOSEK A, 1989, BIOCHIM BIOPHYS ACTA, V986, P263, DOI 10.1016/0005-2736(89)90476-8
   XU GJ, 1982, P NATL ACAD SCI-BIOL, V79, P5268, DOI 10.1073/pnas.79.17.5268
   YAMAMOTO T, 1984, J BIOCHEM, V95, P1783, DOI 10.1093/oxfordjournals.jbchem.a134791
NR 44
TC 34
Z9 34
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 25
PY 1991
VL 266
IS 33
BP 22266
EP 22272
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GR564
UT WOS:A1991GR56400034
PM 1834668
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
   VERJOVSKIALMEIDA, S
AF FERREIRA, ST
   VERJOVSKIALMEIDA, S
TI GLOBAL ANALYSIS OF WAVELENGTH-RESOLVED FLUORESCENCE DECAY IN
   SARCOPLASMIC-RETICULUM CALCIUM-ATPASE
SO JOURNAL OF LUMINESCENCE
LA English
DT Article
ID CURVES
AB The intrinsic fluorescence decay of sarcoplasmic reticulum Ca2+-ATPase was measured in the frequency-domain at 10 nm intervals across the emission spectrum. Data were globally analysed in terms of a unique set of lifetime values, allowing for changes in fractional intensities of each lifetime across the emission. The wavelength-resolved decay was optimally described by a Lorentzian distribution of lifetimes plus two exponential terms. Analysis of chi-2 surfaces associated with uncertainties in fitting parameters revealed that the recovered parameters were well-defined despite the complexity of the decay. Thus, global analysis enables resolution of ATPase fluorescence into decay-associated spectral components, which should permit investigation of ligand-induced changes in each individual component.
RP FERREIRA, ST (corresponding author), UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOQUIM, BR-21944 RIO DE JANEIRO, BRAZIL.
RI Verjovski-Almeida, Sergio/E-4082-2012; Verjovski-Almeida,
   Sergio/AAI-2728-2020; Ferreira, Sergio/AAZ-1576-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Ferreira, Sergio/0000-0001-7160-9866
CR BEECHEM JM, 1989, FLUORESCENCE SPECTRO, V1
   FERREIRA ST, 1989, J BIOL CHEM, V264, P15392
   FERREIRA ST, 1988, J BIOL CHEM, V263, P9973
   GRYCZYNSKI I, 1989, BIOCHEMISTRY-US, V28, P3490, DOI 10.1021/bi00434a051
   KNUTSON JR, 1983, CHEM PHYS LETT, V102, P501, DOI 10.1016/0009-2614(83)87454-5
   MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0
   MEIS LD, 1971, J BIOL CHEM, V246, P4759
   MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6
   MOTULSKY HJ, 1987, FASEB J, V1, P365
   VERJOVSKIALMEID.S, 1988, PHYSICAL PROPERTIES, pCH6
   WEBER G, 1965, PROTEINS, V3, P477
NR 11
TC 5
Z9 5
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2313
EI 1872-7883
J9 J LUMIN
JI J. Lumines.
PD JAN-FEB
PY 1991
VL 48-9
BP 430
EP 434
DI 10.1016/0022-2313(91)90153-M
PN 1
PG 5
WC Optics
SC Optics
GA FC344
UT WOS:A1991FC34400088
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
AF FERREIRA, ST
TI FLUORESCENCE STUDIES OF THE CONFORMATIONAL DYNAMICS OF PARVALBUMIN IN
   SOLUTION LIFETIME AND ROTATIONAL MOTIONS OF THE SINGLE TRYPTOPHAN
   RESIDUE
SO BIOCHEMISTRY
LA English
DT Article
RP FERREIRA, ST (corresponding author), UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,BR-21910 RIO DE JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU NCRR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [RR 03155-01] Funding Source: Medline
CR ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   ALCALA JR, 1987, BIOPHYS J, V51, P597, DOI 10.1016/S0006-3495(87)83384-2
   ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0
   BURSTEIN EA, 1975, BIOCHIM BIOPHYS ACTA, V400, P1, DOI 10.1016/0005-2795(75)90121-X
   CASTELLI F, 1988, BIOCHEMISTRY-US, V27, P3366, DOI 10.1021/bi00409a037
   CLOSSET JI, 1971, ARCH INT PHYS BIOCH, V79, P624
   EFTINK MR, 1989, BIOCHEMISTRY-US, V28, P382, DOI 10.1021/bi00427a053
   GRATTON E, 1986, BIOCHEM SOC T, V14, P835, DOI 10.1042/bst0140835
   GRATTON E, 1988, BIOL ARTIFICIAL INTE, P49
   HAMOIR G, 1965, BIOCHEM J, V96, P85, DOI 10.1042/bj0960085
   HENDRICKSON WA, 1973, J BIOL CHEM, V248, P3327
   JAMES DR, 1988, P SPIE INT SOC OPT E, V909, P90
   KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467
   KRETSINGER RH, 1971, J MOL BIOL, V59, P213, DOI 10.1016/0022-2836(71)90423-2
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   MOEWS PC, 1975, J MOL BIOL, V91, P201, DOI 10.1016/0022-2836(75)90160-6
   MOTULSKY HJ, 1987, FASEB J, V1, P365
   PECHERE JF, 1971, BIOCHIM BIOPHYS ACTA, V236, P391, DOI 10.1016/0005-2795(71)90220-0
   PECHERE JF, 1973, SYST ZOOL, V22, P533, DOI 10.2307/2412958
   PERMYAKOV EA, 1985, ARCH BIOCHEM BIOPHYS, V240, P781, DOI 10.1016/0003-9861(85)90087-6
   PERMYAKOV EA, 1980, EUR J BIOCHEM, V109, P307, DOI 10.1111/j.1432-1033.1980.tb04796.x
   ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0
   SCHWARZENBACH G, 1957, COMPLEXOMETRIC TITRA
   SZABO AG, 1980, J AM CHEM SOC, V102, P554, DOI 10.1021/ja00522a020
   WEBER G, 1977, J CHEM PHYS, V66, P4081, DOI 10.1063/1.434481
   WHITE HD, 1988, BIOCHEMISTRY-US, V27, P3357, DOI 10.1021/bi00409a036
NR 26
TC 31
Z9 31
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD DEC 26
PY 1989
VL 28
IS 26
BP 10066
EP 10072
DI 10.1021/bi00452a028
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CG236
UT WOS:A1989CG23600028
PM 2620061
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
   VERJOVSKIALMEIDA, S
AF FERREIRA, ST
   VERJOVSKIALMEIDA, S
TI FLUORESCENCE DECAY OF SARCOPLASMIC-RETICULUM ATPASE - LIGAND-BINDING AND
   HYDRATION EFFECTS
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
RP FERREIRA, ST (corresponding author), UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOQUIM, BR-21910 RIO DE JANEIRO, BRAZIL.
RI Verjovski-Almeida, Sergio/AAI-2728-2020; Ferreira, Sergio/AAZ-1576-2020;
   Verjovski-Almeida, Sergio/E-4082-2012
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Ferreira,
   Sergio/0000-0001-7160-9866; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401
CR ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0
   BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43
   BEECHEM JM, 1989, IN PRESS FLUORESCENC, V1
   BUCCI E, 1988, J BIOL CHEM, V263, P6972
   CACECI MS, 1984, BYTE, V9, P340
   DEMEIS L, 1987, CHEM SCRIPTA, V27B, P107
   DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2
   DUPONT Y, 1976, BIOCHEM BIOPH RES CO, V71, P544, DOI 10.1016/0006-291X(76)90821-4
   GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7
   GRATTON E, 1988, BIOL ARTIFICIAL INTE, P49
   HIGHSMITH S, 1986, BIOCHEMISTRY-US, V25, P1049, DOI 10.1021/bi00353a015
   INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041
   KURTENBACH E, 1985, J BIOL CHEM, V260, P9636
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LONDON E, 1978, FEBS LETT, V96, P51, DOI 10.1016/0014-5793(78)81060-6
   LUISI PL, 1986, CRIT REV BIOCHEM MOL, V20, P409, DOI 10.3109/10409238609081999
   LUISI PL, 1988, BIOCHIM BIOPHYS ACTA, V947, P209, DOI 10.1016/0304-4157(88)90025-1
   MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0
   MEIS LD, 1971, J BIOL CHEM, V246, P4759
   MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6
   MOTULSKY HJ, 1987, FASEB J, V1, P365
   PICK U, 1981, FEBS LETT, V123, P127, DOI 10.1016/0014-5793(81)80035-X
   SCOTT TL, 1985, J BIOL CHEM, V260, P4421
   SQUIER TC, 1987, J BIOL CHEM, V262, P4748
   VERJOVSKIALMEID.S, 1988, PHYSICAL PROPERTIES, pCH6
   VERJOVSKIALMEIDA S, 1981, J BIOL CHEM, V256, P2662
   WEBER G, 1981, J PHYS CHEM-US, V85, P949, DOI 10.1021/j150608a006
   WEBER G, 1965, PROTEINS, V3, P477
NR 28
TC 20
Z9 20
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 15
PY 1989
VL 264
IS 26
BP 15392
EP 15397
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AP725
UT WOS:A1989AP72500040
PM 2527852
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
   VERJOVSKIALMEIDA, S
AF FERREIRA, ST
   VERJOVSKIALMEIDA, S
TI STOICHIOMETRY AND MAPPING OF THE NUCLEOTIDE SITES IN
   SARCOPLASMIC-RETICULUM ATPASE WITH THE USE OF UTP
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
RP FERREIRA, ST (corresponding author), UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOQUIM, BR-21910 RIO DE JANEIRO, RJ, BRAZIL.
RI Verjovski-Almeida, Sergio/E-4082-2012; Verjovski-Almeida,
   Sergio/AAI-2728-2020; Ferreira, Sergio/AAZ-1576-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Ferreira, Sergio/0000-0001-7160-9866
CR BALL WJ, 1987, BIOCHEM BIOPH RES CO, V148, P246, DOI 10.1016/0006-291X(87)91102-8
   BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031
   BARRABIN H, 1983, Z NATURFORSCH C, V38, P845
   BASTIDE F, 1973, J BIOL CHEM, V248, P8485
   BODLEY AL, 1987, J BIOL CHEM, V262, P13997
   CABLE MB, 1984, J BIOL CHEM, V259, P3612
   CAMPBELL KP, 1983, J BIOL CHEM, V258, P1391
   CARVALHOALVES PC, 1985, J BIOL CHEM, V260, P4282
   de Meis L, 1973, J Biol Chem, V248, P3691
   DEGANI C, 1973, J BIOL CHEM, V248, P8222
   DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275
   DEMEIS L, 1972, BIOCHEMISTRY-US, V11, P2460, DOI 10.1021/bi00763a012
   DEMEIS L, 1982, J BIOL CHEM, V257, P4993
   DUPONT Y, 1985, J BIOL CHEM, V260, P7241
   DUPONT Y, 1980, EUR J BIOCHEM, V109, P231, DOI 10.1111/j.1432-1033.1980.tb04788.x
   FROEHLICH JP, 1975, J BIOL CHEM, V250, P2013
   GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147
   IKEMOTO N, 1982, ANNU REV PHYSIOL, V44, P297, DOI 10.1146/annurev.ph.44.030182.001501
   INESI G, 1973, J MOL BIOL, V81, P483, DOI 10.1016/0022-2836(73)90518-4
   INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041
   INESI G, 1974, BIOCHEMISTRY-US, V13, P3298, DOI 10.1021/bi00713a019
   JENCKS WP, 1983, CURR TOP MEMBR TRANS, V19, P1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LICHTNER R, 1979, BIOCHEM J, V181, P759, DOI 10.1042/bj1810759
   LUDI H, 1984, FEBS LETT, V167, P33, DOI 10.1016/0014-5793(84)80827-3
   MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0
   MARTONOSI A, 1969, J BIOL CHEM, V244, P613
   MEIS LD, 1971, J BIOL CHEM, V246, P4759
   MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6
   MITCHINSON C, 1982, FEBS LETT, V146, P87, DOI 10.1016/0014-5793(82)80710-2
   PETITHORY JR, 1986, BIOCHEMISTRY-US, V25, P4493, DOI 10.1021/bi00364a006
   PICK U, 1981, FEBS LETT, V123, P127, DOI 10.1016/0014-5793(81)80035-X
   PUCELL A, 1971, J BIOL CHEM, V246, P3389
   SCOFANO HM, 1979, J BIOL CHEM, V254, P227
   SHAMOO AE, 1976, J BIOL CHEM, V251, P4147
   SOUZA DOG, 1976, J BIOL CHEM, V251, P6355
   SQUIER TC, 1987, J BIOL CHEM, V262, P4748
   STEWART PS, 1976, J BIOL CHEM, V251, P712
   TAKISAWA H, 1981, NATURE, V290, P271, DOI 10.1038/290271a0
   THORLEYL.DA, 1973, EUR J BIOCHEM, V40, P403, DOI 10.1111/j.1432-1033.1973.tb03209.x
   VERJOVSKIALMEIDA S, 1977, BIOCHEMISTRY-US, V16, P329, DOI 10.1021/bi00621a026
   VERJOVSKIALMEIDA S, 1979, J BIOL CHEM, V254, P18
   VERJOVSKIALMEIDA S, 1978, BIOCHEMISTRY-US, V17, P5006, DOI 10.1021/bi00616a023
   WANG CT, 1979, J BIOL CHEM, V254, P9209
   YAMAMOTO T, 1967, J BIOCHEM-TOKYO, V62, P558, DOI 10.1093/oxfordjournals.jbchem.a128706
NR 45
TC 22
Z9 21
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 15
PY 1988
VL 263
IS 20
BP 9973
EP 9980
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA P1538
UT WOS:A1988P153800065
PM 2968343
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
   GRATTON, E
   PRENDERGAST, FG
AF FERREIRA, ST
   GRATTON, E
   PRENDERGAST, FG
TI HYDRATION AND PROTEIN DYNAMICS - A FLUORESCENCE LIFETIME APPROACH
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 UNIV ILLINOIS,URBANA,IL 61801.
   MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905.
   UNIV FED RIO DE JANEIRO,BR-21910 RIO DE JANEIRO,RJ,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 1988
VL 53
IS 2
BP A298
EP A298
PN 2
PG 1
WC Biophysics
SC Biophysics
GA L8643
UT WOS:A1988L864300834
DA 2020-09-29
ER

PT J
AU FERREIRA, ST
   VERJOVSKIALMEIDA, S
AF FERREIRA, ST
   VERJOVSKIALMEIDA, S
TI MAPPING THE NUCLEOTIDE DOMAIN OF SARCOPLASMIC-RETICULUM ATPASE BY
   PHOTOLABELING
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 FED UNIV RIO DE JANEIRO,DEPT BIOCHEM,BR-21910 RIO DE JANEIRO,RJ,BRAZIL.
RI Verjovski-Almeida, Sergio/E-4082-2012; Ferreira, Sergio/AAZ-1576-2020;
   Verjovski-Almeida, Sergio/AAI-2728-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Ferreira,
   Sergio/0000-0001-7160-9866; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 1987
VL 51
IS 2
BP A348
EP A348
PN 2
PG 1
WC Biophysics
SC Biophysics
GA F7993
UT WOS:A1987F799300974
DA 2020-09-29
ER

PT J
AU VERJOVSKIALMEIDA, S
   CARVALHOALVES, PC
   OLIVEIRA, CG
   FERREIRA, ST
AF VERJOVSKIALMEIDA, S
   CARVALHOALVES, PC
   OLIVEIRA, CG
   FERREIRA, ST
TI PROBING THE NUCLEOTIDE BINDING-SITES OF SARCOPLASMIC-RETICULUM ATPASE BY
   PHOTOAFFINITY-LABELING
SO BIOPHYSICAL JOURNAL
LA English
DT Article
RP VERJOVSKIALMEIDA, S (corresponding author), UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,BR-21910 RIO DE JANEIRO,BRAZIL.
RI Ferreira, Sergio/AAZ-1576-2020; Verjovski-Almeida, Sergio/AAI-2728-2020;
   Verjovski-Almeida, Sergio/E-4082-2012; Garcia, Celia R. S./A-4093-2011
OI Ferreira, Sergio/0000-0001-7160-9866; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Garcia, Celia R. S./0000-0003-2825-1701
CR BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031
   CABLE MB, 1984, J BIOL CHEM, V259, P3612
   CARVALHOALVES PC, 1985, J BIOL CHEM, V260, P4282
   de Meis L, 1973, J Biol Chem, V248, P3691
   DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275
   DUPONT Y, 1985, J BIOL CHEM
   DUPONT Y, 1977, EUR J BIOCH, V72, P181
   ECKERT K, 1977, ACTA BIOL MED GERM B, V36, P1
   FROEHLICH JP, 1975, J BIOL CHEM, V250, P2013
   GAFNI A, 1984, BIOCHEMISTRY-US, V23, P4362, DOI 10.1021/bi00314a018
   IKEMOTO N, 1982, ANNU REV PHYSIOL, V44, P297, DOI 10.1146/annurev.ph.44.030182.001501
   INESI G, 1967, J BIOL CHEM, V242, P4637
   JAKOBY WB, 1977, METHODS ENZYMOL, V46
   MOLLER JV, 1980, J BIOL CHEM, V255, P1912
   SILVA JL, 1983, BIOCHEMISTRY-US, V22, P707, DOI 10.1021/bi00272a028
   VERJOVSKIALMEIDA S, 1979, J BIOL CHEM, V254, P18
   YAMAMOTO T, 1967, J BIOCHEM-TOKYO, V62, P558, DOI 10.1093/oxfordjournals.jbchem.a128706
NR 17
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 1986
VL 49
IS 1
BP 108
EP 109
DI 10.1016/S0006-3495(86)83612-8
PG 2
WC Biophysics
SC Biophysics
GA AYX53
UT WOS:A1986AYX5300046
PM 19431605
OA Green Published
DA 2020-09-29
ER

EF